
<html lang="en"     class="pb-page"  data-request-id="a0fcb7a6-8e2d-41de-be99-82fccda8b77c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01799"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Zhiqing  Liu" /></meta><meta name="dc.Creator" content="Pingyuan  Wang" /></meta><meta name="dc.Creator" content="Eric A.  Wold" /></meta><meta name="dc.Creator" content="Qiaoling  Song" /></meta><meta name="dc.Creator" content="Chenyang  Zhao" /></meta><meta name="dc.Creator" content="Changyun  Wang" /></meta><meta name="dc.Creator" content="Jia  Zhou" /></meta><meta name="dc.Description" content="Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding t..." /></meta><meta name="Description" content="Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 6, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01799" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01799" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01799" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01799" /></link>
        
    
    

<title>Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01799" /></meta><meta property="og:title" content="Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0031.jpeg" /></meta><meta property="og:description" content="Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding to membrane receptors, and the β-catenin destruction complex to the expansive β-catenin transcriptional complex, multiple components have been investigated as drug targets to modulate WNT signaling. Significant progress in developing WNT inhibitors such as porcupine inhibitors, tankyrase inhibitors, β-catenin/coactivators, protein–protein interaction inhibitors, casein kinase modulators, DVL inhibitors, and dCTPP1 inhibitors has been made, with several candidates (e.g., LGK-974, PRI-724, and ETC-159) in human clinical trials. Herein we summarize recent progress in the drug discovery and development of small-molecule inhibitors targeting the canonical WNT pathway, focusing on their specific target proteins, in vitro and in vivo activities, physicochemical properties, and therapeutic potential. The relevant opportunities and challenges toward maintaining the balance between efficacy and toxicity in effectively targeting this pathway are also highlighted." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding to membrane receptors, and the β-catenin destruction complex to the expansive β-catenin transcriptional complex, multiple components have been investigated as drug targets to modulate WNT signaling. Significant progress in developing WNT inhibitors such as porcupine inhibitors, tankyrase inhibitors, β-catenin/coactivators, protein–protein interaction inhibitors, casein kinase modulators, DVL inhibitors, and dCTPP1 inhibitors has been made, with several candidates (e.g., LGK-974, PRI-724, and ETC-159) in human clinical trials. Herein we summarize recent progress in the drug discovery and development of small-molecule inhibitors targeting the canonical WNT pathway, focusing on their specific target proteins, in vitro and in vivo activities, physicochemical properties, and therapeutic potential. The relevant opportunities and challenges toward maintaining the balance between efficacy and toxicity in effectively targeting this pathway are also highlighted." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0031.jpeg" /></meta><meta name="twitter:title" content="Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01799"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01799">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01799&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01799&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01799&amp;href=/doi/10.1021/acs.jmedchem.0c01799" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4257-4288</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01974" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhiqing Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiqing Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Evolution and Marine Biodiversity, College of Food Science and Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86 (0532) 8203-1503. Email: <a href="/cdn-cgi/l/email-protection#e08c89959a888991898e87a08f9583ce858495ce838e"><span class="__cf_email__" data-cfemail="90fcf9e5eaf8f9e1f9fef7d0ffe5f3bef5f4e5bef3fe">[email protected]</span></a> (Z.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqing++Liu">Zhiqing Liu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0266-6677" title="Orcid link">http://orcid.org/0000-0003-0266-6677</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pingyuan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pingyuan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pingyuan++Wang">Pingyuan Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric A. Wold</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric A. Wold</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Wold">Eric A. Wold</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiaoling Song</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiaoling Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Evolution and Marine Biodiversity, College of Food Science and Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiaoling++Song">Qiaoling Song</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chenyang Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chenyang Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Evolution and Marine Biodiversity, College of Food Science and Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chenyang++Zhao">Chenyang Zhao</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Changyun Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Changyun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Evolution and Marine Biodiversity, College of Food Science and Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86 (0532) 8203-1536. Email: <a href="/cdn-cgi/l/email-protection#ff9c979e9198868a91bf908a9cd19a9b8ad19c91"><span class="__cf_email__" data-cfemail="a7c4cfc6c9c0ded2c9e7c8d2c489c2c3d289c4c9">[email protected]</span></a> (C.W.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Changyun++Wang">Changyun Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0236-1606" title="Orcid link">http://orcid.org/0000-0002-0236-1606</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jia Zhou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +1 (409) 772-9748. Email: <a href="/cdn-cgi/l/email-protection#b4deddcedcdbc1f4c1c0d9d69ad1d0c1"><span class="__cf_email__" data-cfemail="f59f9c8f9d9a80b580819897db909180">[email protected]</span></a> (J.Z.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Zhou">Jia Zhou</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01799&amp;href=/doi/10.1021%2Facs.jmedchem.0c01799" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4257–4288</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 6, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 October 2020</li><li><span class="item_label"><b>Published</b> online</span>6 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01799</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4257%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhiqing%2BLiu%252C%2BPingyuan%2BWang%252C%2BEric%2BA.%2BWold%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D8%26contentID%3Dacs.jmedchem.0c01799%26title%3DSmall-Molecule%2BInhibitors%2BTargeting%2Bthe%2BCanonical%2BWNT%2BSignaling%2BPathway%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4288%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01799"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2088</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01799" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhiqing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Pingyuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Wold&quot;},{&quot;first_name&quot;:&quot;Qiaoling&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Chenyang&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Changyun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;4257-4288&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01799&quot;},&quot;abstract&quot;:&quot;Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding to membrane receptors, and the β-catenin destruction complex to the expansive β-catenin transcriptional complex, multiple components have been investigated as drug targets to modulate WNT signaling. Significant progress in developing WNT inhibitors such as porcupine inhibitors, tankyrase inhibitors, β-catenin/coactivators, protein–protein interaction inhibitors, casein kinase modulators, DVL inhibitors, and dCTPP1 inhibitors has been made, with several candidates (e.g., LGK-974, PRI-724, and ETC-159) in human clinical trials. Herein we summarize recent progress in the drug discovery and development of small-molecule inhibitors targeting the canonical WNT pathway, focusing on their specific target proteins, in vitro and in vivo activities, physicochemical properties, and therapeutic potential. The relevant opportuniti&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01799" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01799&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01799" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01799&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01799" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01799&amp;href=/doi/10.1021/acs.jmedchem.0c01799" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01799" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01799" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01799%26sid%3Dliteratum%253Aachs%26pmid%3D33822624%26genre%3Darticle%26aulast%3DLiu%26date%3D2021%26atitle%3DSmall-Molecule%2BInhibitors%2BTargeting%2Bthe%2BCanonical%2BWNT%2BSignaling%2BPathway%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D8%26spage%3D4257%26epage%3D4288%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/8" title="Go to Volume 64, Issue 8"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/jmcmar.2021.64.issue-8/20210422/jmcmar.2021.64.issue-8.largecover.jpg" alt="Go to Volume 64, Issue 8"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Canonical WNT signaling is an important developmental pathway that has attracted increased attention for anticancer drug discovery. From the production and secretion of WNT ligands, their binding to membrane receptors, and the β-catenin destruction complex to the expansive β-catenin transcriptional complex, multiple components have been investigated as drug targets to modulate WNT signaling. Significant progress in developing WNT inhibitors such as porcupine inhibitors, tankyrase inhibitors, β-catenin/coactivators, protein–protein interaction inhibitors, casein kinase modulators, DVL inhibitors, and dCTPP1 inhibitors has been made, with several candidates (<i>e.g.</i>, LGK-974, PRI-724, and ETC-159) in human clinical trials. Herein we summarize recent progress in the drug discovery and development of small-molecule inhibitors targeting the canonical WNT pathway, focusing on their specific target proteins, <i>in vitro</i> and <i>in vivo</i> activities, physicochemical properties, and therapeutic potential. The relevant opportunities and challenges toward maintaining the balance between efficacy and toxicity in effectively targeting this pathway are also highlighted.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Wingless/integrase-1 (WNT) is a family of secreted cysteine-rich glycoprotein growth factors encoded by <i>WNT</i> genes, which are highly conserved among vertebrate species.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The first <i>WNT</i> gene, <i>WNT1</i> (initially named <i>Int-1</i>), was discovered in 1982 as a proto-oncogene activated by integration of the mouse mammary tumor virus in virally induced breast tumors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Subsequent characterization showed that the gene encoded a hydrophobic cysteine-rich protein that acts as a signaling molecule. To date, 19 different WNT family members have been identified in humans. Generally, WNT proteins are composed of 350–400 amino acids with a molecular weight of about 40 kDa. WNT proteins usually contain 11 or 12 intramolecular disulfide bonds formed by conserved cysteine residues, which have been shown to be critical for the protein functional activity and secretion.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Before secretion, all known WNT proteins require glycosylation and a post-translational palmitoylation catalyzed by the membrane-bound <i>O</i>-acyltransferase (MBOAT) porcupine.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Currently, three WNT protein crystal structures have been disclosed, and one of them is human-derived. The crystal structure of <i>Xenopus</i> WNT8 (xWNT8 palmitated at Ser187 and glycosylated at Asn104 and Asn263) in complex with mouse Frizzled-8 (mFZD8) cysteine-rich domain (CRD) was resolved in 2012 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0A">4F0A</a>; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> xWNT8 maintains an unusual two-domain structure that includes an N-terminal domain (NTD) and a C-terminal domain (CTD) connected by a linker, resembling a palm with thumb and index fingers. FZD8 is grabbed by these two fingers, and two binding sites are formed. One year later, the crystal structure of CTD-truncated <i>Drosophila</i> WNTD fragment was reported, and mutation studies revealed a critical role of the linker for low-density lipoprotein receptor 6 (LRP6) binding (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KRR">4KRR</a>; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The structure of human WNT3 is similar to that of xWNT8 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY">6AHY</a>; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C,D) where the WNT3-bound FZD8 CRD forms a symmetrical dimer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The hypervariable linker opposite from the FZD8 binding interface has been confirmed to interact with LRP6 directly through surface plasmon resonance (SPR) experiments. By interactions with FZD, LRP5/6, and coreceptors, WNT activates various downstream signaling pathways and plays important roles in regulating cell proliferation, movement, polarity, and death during organ development. Mice with WNT1 deficiency resulted in severe abnormalities in the development of the midbrain and cerebellum by late gestation.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of WNT proteins. (A) Ribbon representation of <i>Xenopus</i> WNT8 (xWNT8), (highlighted in magenta, in complex with mouse Frizzled-8 cysteine-rich domain (mFZD8 CRD), highlighted in cyan (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0A">4F0A</a>). Post-translational modification sites (residues Ser187, Asn104, and Asn263) are labeled. (B) Crystal structure of the <i>Drosophila</i> WNTD N-terminal domain and linker (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KRR">4KRR</a>). (C) Cylinder representation of the human WNT3–mouse FZD8 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY">6AHY</a>). (D) Schematic diagram of the primary structure of hWNT3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While WNT proteins participate in multiple important signaling pathways, their roles are not well understood. Currently, the reported WNT signaling pathways are mainly grouped into the canonical pathway (a.k.a. WNT/β-catenin signaling)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and noncanonical pathways (<i>e.g.</i>, WNT/planar-cell-polarity-like pathway and the WNT/Ca<sup>2+</sup> pathway).<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> The canonical WNT signaling pathway is β-catenin-dependent and regulates the transcription of T-cell factor (TCF)/lymphoid enhancer factor (LEF) target genes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> WNT signaling is initiated by binding of the extracellular secreted WNT ligands (mainly WNT1, WNT3A, and WNT8) to the seven transmembrane receptor FZD and its coreceptors LRP5 and LRP6. The subsequent activation of dishevelled (DVL) protein and phosphorylation of LRP5/6 lead to inactivation of the destruction complex composed of adenomatous polyposis coli (APC), axis inhibition protein (AXIN), glycogen synthase kinase-3β (GSK-3β), and casein kinase 1 (CK1).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> In the absence of WNTs, the destruction complex executes phosphorylation, ubiquitylation, and proteasomal degradation of cytosolic β-catenin, which is the key effector of canonical WNT signaling. Inhibition of the destruction complex results in the accumulation of free β-catenin in the cytoplasm and its translocation into the nucleus. In the nucleus, β-catenin binds to TCF/LEF family transcription factors, histone acetylase cyclic AMP response element binding protein (CBP)/p300, BCL9, and other coactivators to evoke the canonical gene transcription to mediate cell proliferation, survival, and differentiation. Over 120 target genes have been identified, including <i>AXIN-2</i>, <i>LEF-1</i>, and <i>WNT3A</i>, which further modulate WNT signaling by themselves, indicating that there likely exists a feedback loop.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In contrast, some WNTs (<i>e.g.</i>, WNT4, WNT5A, and WNT11) activate noncanonical WNT signaling, which does not depend on β-catenin as a downstream effector and plays an important role in cell–cell adhesion and cell migration.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> Since β-catenin does not participate in the noncanonical WNT pathway, other canonical WNT signaling components may be engaged. Like the canonical WNT pathway, the noncanonical WNT pathway is diverse but less well characterized. In addition, noncanonical WNT signaling always occurs along with other signaling pathways such as WNT/Ca<sup>2+</sup> and WNT/planar cell polarity (PCP), which may explain the diverse set of target genes regulated across different cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Canonical WNT/β-catenin signaling pathway. (A) After palmitoylation by porcupine, WNT ligands are secreted and bind to receptors FZD and LRP5/6 at the membrane to initiate WNT signaling. (B) In the cytoplasm, inactivation of the destruction complex leads to the translocation of β-catenin rather than its degradation. (C) In the nucleus, β-catenin interacts with transcription factors and coactivators to evoke the transcription of downstream target genes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The canonical WNT signaling pathway is critical for normal embryonic development and the maintenance of adult tissue homeostasis by regulating cell proliferation, differentiation, migration, genetic stability, and apoptosis in nearly every tissue and organ system. WNT signaling has also been implicated in the control of various types of stem cells and maintains these stem cells in a self-renewing state. Aberrant activation of WNT signaling plays a critical role in cancer cell proliferation, survival, and metastasis as well as the maintenance of cancer stem cells.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Activation of WNT signaling is usually induced by either mutational alterations (<i>e.g.</i>, gain-of-function mutations for β-catenin and TCF or loss-of-function mutations for negative regulators like APC and AXIN) or nonmutational alterations (<i>e.g.</i>, epigenetic silencing of extracellular WNT antagonist) as well as paracrine or autocrine of WNT ligands and receptors.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> Gene mutations in <i>APC</i> and <i>CTNNB1</i> (which encodes β-catenin) were identified as early events in almost all colorectal cancer patients.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> WNT10B is highly expressed in triple-negative breast cancer, and WNT7B is overexpressed in about 10% of breast cancer patients.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> WNT signaling pathways are activated in more than 50% of breast cancer patients and associated with a reduction in overall survival.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Canonical WNT ligands and receptors like FZD7 and LRP6 are often overexpressed, while secreted antagonists are silenced in breast cancers.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> Aberrant WNT signaling was found in upward of 20% of tumors from patients with metastatic castration-resistant prostate cancer (mCRPC).<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Activating mutations of β-catenin have also been reported in hepatocellular carcinomas, skin tumors, melanoma, and endometrial carcinoma.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46">(39−46)</a> Additionally, WNT signaling mediates cancer resistance to conventional chemotherapy, radiotherapy, targeted therapy, and immunotherapy.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Thus, targeting the WNT signaling cascade holds great promise for the treatment of myriad human cancers.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Meanwhile, anti-WNT-based combination cancer therapy is a unique approach to overcoming acquired resistance.</div><div class="NLM_p">The discovery and development of WNT signaling inhibitors have attracted tremendous effort in both academic and industrial settings.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Multiple strategies, including small-molecule modulators (<i>e.g.</i>, <b>1</b>–<b>4</b> in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>)<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51−54)</a> as well as peptide agonists/antagonists and antibodies (not discussed here), have been developed and are in different stages of clinical trials (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Herein we focus on the recent progress in developing small-molecule inhibitors targeting the canonical WNT signaling pathway as potential cancer therapeutics.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of representative WNT signaling inhibitors in human clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Details of Small-Molecule WNT Signaling Inhibitors in Human Clinical Trials<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug</th><th class="colsep0 rowsep0" align="center">mode of action</th><th class="colsep0 rowsep0" align="center">phase</th><th class="colsep0 rowsep0" align="center">indication</th><th class="colsep0 rowsep0" align="center">NCT identifier</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>1</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">porcupine inhibitor</td><td class="colsep0 rowsep0" align="left">I/II</td><td class="colsep0 rowsep0" align="left">MCC</td><td class="colsep0 rowsep0" align="left">NCT02278133</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">PC, BRAF MT CRC, melanoma, TNBC, HNSCC, CSCC, ESCC, LSCC</td><td class="colsep0 rowsep0" align="left">NCT01351103</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">porcupine inhibitor</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">solid tumors</td><td class="colsep0 rowsep0" align="left">NCT02521844</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RXC004 (structure not disclosed)</td><td class="colsep0 rowsep0" align="left">porcupine inhibitor</td><td class="colsep0 rowsep0" align="left">I/II</td><td class="colsep0 rowsep0" align="left">advanced malignancies</td><td class="colsep0 rowsep0" align="left">NCT03447470</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left"><b>3</b></td><td class="colsep0 rowsep0" rowspan="5" align="left">CBP/β-catenin antagonist</td><td class="colsep0 rowsep0" align="left">I/II</td><td class="colsep0 rowsep0" align="left">HCV LC; HBV LC</td><td class="colsep0 rowsep0" align="left">NCT03620474</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">APC, MPC, PA</td><td class="colsep0 rowsep0" align="left">NCT01764477</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">HCV LC</td><td class="colsep0 rowsep0" align="left">NCT02195440</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I/II</td><td class="colsep0 rowsep0" align="left">AML, CML</td><td class="colsep0 rowsep0" align="left">NCT01606579</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">PBC</td><td class="colsep0 rowsep0" align="left">NCT04047160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">CWP232291 (structure not disclosed)</td><td class="colsep0 rowsep0" rowspan="3" align="left">CBP/β-catenin antagonist</td><td class="colsep0 rowsep0" align="left">I/II</td><td class="colsep0 rowsep0" rowspan="3" align="left">AML, CML, MM</td><td class="colsep0 rowsep0" align="left">NCT03055286</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">NCT02426723</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">NCT01398462</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left"><b>4</b></td><td class="colsep0 rowsep0" rowspan="8" align="left">WNT inhibitor</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT04385303</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT03928184</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT03727022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT03706521</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT03122860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">knee osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT02536833</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">moderate to severe osteoarthritis</td><td class="colsep0 rowsep0" align="left">NCT02095548</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">AML, CML, MDS, myelofibrosis</td><td class="colsep0 rowsep0" align="left">NCT01398462</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SM08502 (structure not disclosed)</td><td class="colsep0 rowsep0" align="left">CDC-like kinase inhibitor</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">adult solid tumor</td><td class="colsep0 rowsep0" align="left">NCT03355066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">SM04755 (structure not disclosed)</td><td class="colsep0 rowsep0" rowspan="3" align="left">WNT inhibitor</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">tendinopathy</td><td class="colsep0 rowsep0" align="left">NCT03229291</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">CRC, gastric/hepatic/pancreatic cancer</td><td class="colsep0 rowsep0" align="left">NCT02191760</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">tendinopathy</td><td class="colsep0 rowsep0" align="left">NCT03502434</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data were collected from a search of <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> on October 13, 2020. “Terminated” and “withdrawn” trials are not included. Abbreviations: MCC, metastatic colorectal cancer; PC, pancreatic cancer; BRAF MT CRC, BRAF mutant colorectal cancer; TNBC, triple-negative breast cancer; HNSCC, head and neck squamous cell cancer; CSCC, cervical squamous cell cancer; ESCC, esophageal squamous cell cancer; LSCC, lung squamous cell cancer; HCV LC, hepatitis C-related liver cirrhosis; HBV LC, hepatitis B-related liver cirrhosis; APC, advanced pancreatic cancer; MPC, metastatic pancreatic cancer; PA, pancreatic adenocarcinoma; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; PBC, primary biliary cholangitis; MDS, myelodysplastic syndrome.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Emerging Targets and Small-Molecule Inhibitors in the Canonical WNT Signaling Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Porcupine Inhibitors</h3><div class="NLM_p">Porcupine is an MBOAT that acylates (adds a monounsaturated fatty acid to) WNT ligands in the endoplasmic reticulum (ER). The deacylation of WNT ligands in the extracellular matrix is regulated by Notum,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> which will be discussed comprehensively in another review paper. This post-translational palmitoylation is critical for the secretion and binding of WNT ligands to the FZD receptor.<a onclick="showRef(event, 'ref4 ref5 ref55'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref55">(4,5,55)</a> Compromised porcupine activity was found to result in development disorders, while its hyperactivity may induce cancerous cell growth.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a> Porcupine is overexpressed in various human cancer cells and tissues (<i>e.g.</i>, lung cancer tissues) but not in normal cells.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Knockdown of porcupine mRNA resulted in decreased activity of the WNT pathway and subsequent apoptosis of lung cancer cells. Thus, porcupine represents an attractive target for developing effective small-molecule WNT inhibitors.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a></div><div class="NLM_p">Chen et al. discovered the first class of porcupine inhibitors via a cell-based screening from a ∼200k synthetic chemical compound library.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> Among them, compounds <b>5</b> (IWP-1) and <b>6</b> (IWP-2) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) inhibit WNT pathway activity with IC<sub>50</sub> values of 58 and 27 nM, respectively. Both compounds act as inhibitors of WNT production and can block WNT-dependent biochemical changes such as phosphorylation of the LRP6 receptor and DVL and accumulation of β-catenin. Further studies suggest that these two compounds target acyltransferase porcupine specifically without disrupting other MBOAT family members. The levels of lipidated WNT3A were found to be reduced in cells treated with compound <b>6</b> but recovered in porcupine-overexpressed cells. Direct binding of these two compounds with porcupine was also observed. Structure–activity relationship (SAR) studies of these lead inhibitors were extensively explored on the basis of the hypothesis that phthalazinone/pyrimidinone and benzothiazole moieties fit into the binding site of porcupine.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Compound <b>7</b> (IWP-L6) with the benzothiazole moiety replaced by a biphenyl group was then identified and exhibited subnanomolar porcupine-inhibiting activity, with an EC<sub>50</sub> value of 0.5 nM. Compound <b>7</b> was found to be stable in human plasma (over 24 h) without elevated activity of carboxylesterase. At low micromolar concentrations, compound <b>7</b> can effectively block the regeneration of the tailfin in zebrafish and posterior axis formation. In addition, compound <b>7</b> is 100-fold more potent than compound <b>6</b> in blocking WNT signaling and WNT-mediated branching morphogenesis in cultured mouse embryonic kidneys.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of compounds <b>5</b>–<b>7</b> as porcupine inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers from the Genomics Institute of the Novartis Research Foundation identified GNF-1331 (<b>8</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) as a specific porcupine inhibitor through a cellular WNT-pathway-based assay screen against ∼2.4 million compounds, and a Hedgehog coculture assay was used as a counterscreen.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Although compound <b>8</b> displays potent WNT secretion inhibitory activity (IC<sub>50</sub> = 12 nM) and binds to porcupine with an IC<sub>50</sub> value of 8 nM, its pharmacokinetic (PK) properties are poor, with rapid clearance and low systemic exposure after oral administration in mice. Further medicinal chemistry optimization led to the discovery of compound <b>1</b>, a highly specific and potent porcupine inhibitor with an IC<sub>50</sub> value of 1 nM in the porcupine radioligand binding assay. It can block WNTs (<i>e.g.</i>, WNT1, -2, -3, -3A, -6, -7A, and -9A) in WNT-dependent reporter assays and suppress WNT signaling <i>in vitro</i>. It was found to be very efficacious in a well-established WNT-dependent mouse mammary tumor virus (MMTV)-driven WNT1 model, with tumor volume inhibition rates (treated/control (T/C) ratios) of 47% and 63% at a doses of 1 and 3 mg/kg, respectively. The observed <i>in vivo</i> antitumor activity of compound <b>1</b> is highly correlated with WNT signaling inhibition, as evidenced by decreased LRP6 phosphorylation and expression of WNT target genes (<i>e.g.</i>, <i>AXIN2</i>). At a dose of 3 mg/kg, no abnormal histopathology in WNT-dependent tissue was found, whereas at a dose of 20 mg/kg for 14 days, loss of intestinal epithelium was observed. Thus, a good therapeutic window for compound <b>1</b> was preliminarily defined. Compound <b>1</b> substantially inhibited tumor growth in a mouse xenograft model of the HNSCC HN30 cell line, with T/C ratios of 31% and 50% at doses of 1 and 3 mg/kg, respectively. More importantly, exome sequencing results indicated that LoF Notch1 mutations are highly enriched in compound <b>1</b>-responsive HNSCC cells, which may be helpful for clinical application. Compound <b>1</b> was listed in phase I/II clinical trials in patients with malignancies dependent on WNT ligands (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, recent updates are not promising: NCT02649530 was withdrawn, and NCT02278133 was completed with no results posted. Though updates for NCT01351103 have been posted inconsistently (the latest update was posted on January 6, 2021), the changes focused on contacts/locations and time for study start/completion. Early in 2012, the indication for compound <b>1</b> was revised from melanoma and lobular breast cancer to malignancies dependent on WNT ligands.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Discovery and development of porcupine inhibitors <b>1</b> and <b>8</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a continuation of previous work, Cheng et al. from Novartis further attempted to improve the PK profile based on the lead compound <b>8</b> to obtain a tool compound suitable for <i>in vivo</i> efficacy validation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Systematic SAR analysis was focused on the metabolically labile thioether moiety, adjacent substitution of pyridine, and the highly lipophilic benzo[<i>d</i>]thiazole. GNF6231 (<b>9</b>) was discovered with an IC<sub>50</sub> value of 0.8 nM in a WNT3A coculture reporter assay, an aqueous solubility of 357 μM (in neutral-pH buffer), and no obvious inhibition of the cytochrome P450 (CYP450) enzymes tested (2C9, 2D6, and 3A4) at 10 μM. It also exhibits excellent oral bioavailability ranging from 72% to 96% in mouse, rat, and dog. <i>In vivo</i> tumor growth inhibition of compound <b>9</b> in MMTV-WNT1 tumor-bearing mice was reported with impressive T/C ratios of 15%, 74%, and 84% at doses of 0.3, 1, and 3 mg/kg, respectively, by daily oral administration for 2 weeks.</div><div class="NLM_p">To identify a potent, orally available, and stable porcupine inhibitor, Proffitt et al. also evaluated the commercially available small-molecule compound <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> which had previously been disclosed in Novartis’ patent WO2010101849. Compound <b>10</b> inhibits porcupine PORCN activity in a WNT3A-mediated Super8xTopFlash (STF) assay with an IC<sub>50</sub> value of 0.074 nM. However, it did not suppress the proliferation of 46 tested cancer cell lines, indicating that WNT secretion is not essential for most of those cells to proliferate. The plasma concentration of compound <b>10</b> is above 1 nM after 24 h of oral administration (5 mg/kg). It can block progression of mammary tumors in MMTV-WNT1 transgenic mice, which was associated with downregulation of WNT/β-catenin target genes (<i>e.g.</i>, <i>AXIN2</i>, <i>TCF7</i>, and <i>c-MYC</i>) without apparent toxicity.</div><div class="NLM_p">Dong et al. hybridized the biphenyl fragments of compound <b>1</b> and linkage of compound <b>7</b> and explored the SAR carefully, leading to the identification of the subnanomolar WNT signaling inhibitor <b>11</b> with an IC<sub>50</sub> value of 0.11 nM in a paracrine cellular reporter assay.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Compound <b>11</b> also exhibits good chemical stability (71% remaining in simulated gastric fluid at 40 °C for 8 h) at 200 μM and plasma stability (100% remaining in rat plasma for 8 h) at 1 μM.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, Xu et al. discovered compound <b>12</b> as a porcupine inhibitor through the introduction of a tricyclic scaffold into lead compound <b>1</b>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Compound <b>12</b> showed inhibitory activity of 2.3 nM in the cellular STF reporter assay, and it was able to block the secretion of WNT3A in human embryonic kidney (HEK) 293T cells. Moreover, it was found to be stable in simulated gastric fluid and rat plasma. Rat PK studies indicated that it has a half-life of 3.1 h, <i>C</i><sub>max</sub> of 2880 ng/mL, and AUC of 11 293 ng·L/mL with an oral bioavailability of 30%. The value of <i>C</i><sub>max</sub> is over 4000 times higher than the <i>in vitro</i> IC<sub>50</sub> value (2.3 nM, 0.67 ng/mL), which suggests sufficient <i>in vivo</i> drug concentration in the target organ. Combination of this carbazole and the reversed amide generated compound <b>13</b>, which exhibited good <i>in vitro</i> potency (0.5 nM) similar to that of the clinical compound <b>1</b>.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> However, the high clearance of compound <b>13</b> in mouse microsomes (109 mL/min/kg) limited its suitability for further <i>in vivo</i> study.</div><div class="NLM_p">Duraiswamy et al. identified WNT secretion inhibitor hit <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) through a HEK293-STF cellular high-throughput screening (HTS) assay.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Further studies confirmed compound <b>14</b> as a porcupine inhibitor. Chemical optimization based on compound <b>14</b> was performed through imidazole substituents in an attempt to improve the potency and the introduction of nitrogen atoms to improve the aqueous solubility. The resulting compound <b>15</b> significantly inhibited WNT3A secretion with an IC<sub>50</sub> value of 1 nM, and its overall pharmacokinetic properties, including solubility, permeability, and oral bioavailability, were also substantially improved.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery of porcupine inhibitors <b>14</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HTS via a multistep cell-based assay by Madan et al. led to the discovery of ETC-159 (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Compound <b>2</b> shows inhibitory effects on the WNT/β-catenin gene reporter activity and WNT3A secretion and palmitoylation as well as the promotion of β-catenin degradation. It is orally available (<i>F</i> = 100% in mice) and efficacious in the MMTV-WNT1 mouse model (tumor growth inhibition of 94% at 10 mg/kg/day). Differences in β-catenin staining on tumors from the control group and treatment group indicate that compound <b>2</b> takes effect through WNT/β-catenin signaling <i>in vivo</i>. More importantly, CRCs with R-spondin (RSPO) translocations are highly sensitive to compound <b>2</b>. In two patient-derived colon cancer xenograft mouse models, it inhibited tumor growth and promoted the cellular differentiation of tumors. RNA sequencing analysis on tumors treated with compound <b>2</b> provided a global gene expression profile in colon cancers with RSPO translocation. Among the downregulated 2744 genes in the treatment group, five CRC clinical markers (RRM2, MKI67, MCM4, CCNB1, and CLDN2) were most significantly reduced. Additionally, markers of differentiated intestinal cells were largely enriched and intestinal stem cell markers were decreased upon treatment with compound <b>2</b>. Currently, <b>2</b> is undergoing phase I human clinical trials for the treatment of solid tumors.</div><div class="NLM_p last">Ho et al. reported hit <b>16</b> derived from compound <b>2</b>.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> As depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, optimization began with bioisosteric replacement of the xanthine scaffold, which produced compound <b>17</b> with good <i>in vitro</i> potency but poor aqueous solubility. The combination of introducing aromatic nitrogen and small substituents led to the discovery of compound <b>18</b>, which maintained good <i>in vitro</i> activity and achieved an approximately 60-fold increase in aqueous solubility. With an oral bioavailability of 81% in rats, compound <b>18</b> displayed excellent tumor growth inhibition of 97% at 10 mg/kg in the MMTV-WNT1 mouse model without significant body weight loss.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Tankyrase Inhibitors</h3><div class="NLM_p">Tankyrase 1 (TNKS1, a.k.a. PARP5a and ARTD5) and tankyrase 2 (TNKS2, a.k.a. PARP5b and ARTD6) belong to the poly(ADP-ribose) polymerases (PARP) family, which was also called the diphtheria toxin-like ADP-ribosyltransferase (ARTD) family.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> PARP proteins perform mono- or poly-ADP-ribosylation (PARsylation) of their target proteins to regulate ubiquitylation, stability, and function. The PARP family comprises at least 17 family members sharing a catalytic PARP domain that is able to introduce ADP ribose to the surface of target proteins using the cofactor nicotinamide adenine dinucleotide (NAD<sup>+</sup>) as a substrate (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> PARP1 and PARP2 are the most studied family members, and their inhibitors are known to be highly efficient in killing tumors bearing BRAC1/2 mutations via synthetic lethality. Four PARP1/2 inhibitors have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of ovarian cancer and breast cancer in the past decade.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The architecture of TNKS comprises an HSP region (histidine, proline, and serine residues), ankyrin (ANK) repeat clusters (ARCs), sterile alpha motifs (SAM) that mediate TNKS oligomerization, and a C-terminal catalytic PARP domain (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). TNKSs regulate telomere elongation via binding to telomeric repeat-binding factor 1.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> In the WNT signaling pathway, TNKSs mark AXIN for β-catenin degradation, and their inhibition antagonizes WNT signaling through stabilization of AXIN.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> TNKS inhibition has gained attention as a potential anticancer target covering diverse mechanisms. Most TNKS inhibitors bind to the catalytic PARP domain, as depicted in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> while several small molecules target the ARCs, which participate in the specific protein’s recognition for PARylation.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) PARP catalyzes PARsylation of the target proteins. (B) Domain architectures of TNKS1 and TNKS2. (C) Ribbon presentation of the TNKS2 catalytic PARP domain in complex with nicotinamide (colored in green) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U9H">3U9H</a>). Key residues participating interactions are highlighted in yellow, and hydrogen bonds are colored in red. (D) Ribbon presentation of the TNKS2 ARC domain (colored in wheat) in complex with myeloid cell leukemia-1 (MCL-1) peptide LPHLQRPPPIGQSFR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TWT">3TWT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2009, scientists from Novartis identified XAV939 (<b>19</b>), the first small-molecule TNKS inhibitor (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), via a WNT-responsive STF luciferase reporter assay.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Compound <b>19</b> blocks WNT signaling by increasing AXIN levels, which then promote the phosphorylation-dependent degradation of β-catenin. A three-channel iTRAQ quantitative chemical proteomics approach was applied to identify the cellular efficacy target of compound <b>19</b>. Its binding affinities to TNKS1/TNKS2 are about 100 nM, and it binds to recombinant PARP1 with a <i>K</i><sub>d</sub> value of 1.2 μM. Double-knockdown experiments confirmed that TNKS1 and TNKS2 rather than PARP1 are the cellular targets of compound <b>19</b>. Although compound <b>19</b> displays strong TNKS inhibition (IC<sub>50</sub> values of 11 and 4 nM for TNKS1 and TNKS2, respectively) in biochemical assays with more than 10-fold selectivity over PARP1/2, re-evaluation using full-length PARP1 indicated that compound <b>19</b> is not specific for TNKS.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The cocrystal structure of compound <b>19</b> with the TNKS2 PARP domain (residues 946–1162) indicates that compound <b>19</b> occupies the nicotinamide cavity of the NAD<sup>+</sup> binding site, which is similar to its cocomplex with PARP1 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). The amide of compound <b>19</b> forms multiple hydrogen bonds with Ser1068 and Gly1032, and the pyrimidine ring is π–π-stacked with Tyr1071.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Interestingly, IWR1 (<b>20</b>) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B), an AXIN stabilizer that can inhibit WNT response,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> was discovered to mediate its effects through TNKS, with IC<sub>50</sub> values of 131 and 56 nM for TNKS1 and TNKS2, respectively. The cocomplex structure of compound <b>20</b> with TNKS2 indicates that it binds to an induced adenosine crevice rather than to the nicotinamide site.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The carbonyl oxygen forms two hydrogen bonds with His1031 and Tyr1060, while the NH interacts with the backbone of Asp1045 directly. This may explain why compound <b>20</b> has better selectivity for TNKSs over PARP1 in comparison with <b>19</b>. Administration of compound <b>20</b> at a dose of 5 mg/kg induced obvious tumor growth inhibition (71%) in a human osteosarcoma xenograft mouse model.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Chemical structure of <b>19</b> (left panel) and ribbon representations of its cocrystal structures with TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KR8">3KR8</a>) (middle panel) and PARP1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R5W">4R5W</a>) (right panel). (B) Chemical structure of compound <b>20</b> (left panel), ribbon representations of its cocomplex with TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TKF">4TKF</a>) (middle panel), and superimposition of compounds <b>19</b> and <b>20</b> in complex with TNKS2 illustrating two binding sites, the nicotinamide subsite shown in green and the adenosine subsite shown in magenta (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scientists from Amgen hypothesized that a small molecule may extend into the induced adenosine site from the nicotinamide site, and thus, they performed a substructure search using the TNKS1/2 cocrystal structure.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compound <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) was found to be the most potent hit, with IC<sub>50</sub> values of 8 and 2 nM against TNKS1 and TNKS2, respectively. Compound <b>21</b> also exhibited a cellular activity of 160 nM in a total β-catenin degradation assay in SW480 cells. The cocrystal structure with TNKS1 indicates that compound <b>21</b> occupies both pockets and forms multiple hydrogen bonds with Ser1221, Gly1185, Tyr1213, and Asp1198 as well as a π–π-stacking interaction with Tyr1224. Nevertheless, compound <b>21</b> suffers from poor PK properties, including a short half-life (40 min), low solubility (6.6 μg/mL), and high clearance (10.9 L/h/kg). By modification of the two hydrolytic labile amides and saturation of the central phenyl ring, compound <b>22</b> (TNKS1 IC<sub>50</sub> = 0.1 nM) with 10 000-fold selectivity over PARP1/2 was identified.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Compound <b>22</b> displays potent cellular activities in several functional assays, including an enzymatic TNKS auto-PARsylation assay, AXIN2 accumulation in SW480 cells, and STF reporter transcription in DLD-1 cells. More importantly, the PK profile of compound <b>22</b> is significantly improved (<i>t</i><sub>1/2</sub> = 2.8 h and CL = 0.12 L/h/kg) compared with compound <b>21</b>. The <i>in vivo</i> efficacy of compound <b>22</b> was also demonstrated by AXIN accumulation and STF inhibition in a mouse model bearing human DLD-1 tumors.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TNKS inhibitors derived from compound <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve the potency, selectivity, solubility, and metabolic stability of compound <b>19</b>, scientists from Novartis combined structure-based drug design and LipE-based structure efficiency relationships, leading to the potent TNKS2 inhibitor NVP-TNKS656 (<b>23</b>) with an IC<sub>50</sub> value of 6 nM.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Similar to <b>20</b>, compound <b>23</b> is also able to reach the adenosine pocket and thus exhibits over 5000-fold selectivity versus PARP1/2 and potent cellular activity (3.5 nM) in the STF reporter assay in HEK293 cells. The pharmacokinetic/pharmacodynamic (PK/PD) relationship of compound <b>23</b> in an athymic nude mouse model bearing MMTV-WNT1 tumors revealed that <b>23</b> was able to decrease WNT/β-catenin target gene AXIN2 mRNA expression by 70–80%, which persisted from 4 h after treatment to the end point of 24 h.</div><div class="NLM_p">Utilizing the cocrystal structure of compound <b>19</b> with TNKS2, Nathubhai et al. designed a series of 2-arylquinazolin-4-ones as TNKS inhibitors.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> SAR exploration suggested that a methyl at the 8-position and a modest bulky group at the 4-position of the 2-phenyl ring are preferred. Compound <b>24</b> shows potent TNKS inhibition with IC<sub>50</sub> values of 32 and 5.5 nM against TNKS1 and TNKS2, respectively, while its inhibitory activity against PARP1 is >5 μM. Further study resulted in isoquinolin-1-one inhibitor <b>25</b> with IC<sub>50</sub> values of 5.1 and 30 nM against TNKS2 and TNKS1, respectively, and >300-fold selectivity versus PARP1/2.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> By extension of the SAR into azo analogues, a series of arylnaphthyridinones and arylpyridinopyrimidinones as well as their tetrahydro derivatives were designed, and 7-aryl-1-methyltetrahydronaphthyridinones exhibited high potency for TNKS inhibition.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Compound <b>26</b> displays an IC<sub>50</sub> of 6.1 nM for TNKS2 inhibition with 70-fold selectivity over TNKS1 and >300-fold selectivity over PARP1. The cocrystal structure of compound <b>26</b> with TNKS2 indicates that compound <b>26</b> occupies the nicotinamide pocket in a conformation similar to that of compound <b>19</b>. Structure alignment of 2-arylquinazolin-4-ones (analogues of compound <b>24</b>) and compound <b>20</b> in complex with TNKS2 inspired the idea of introducing the quinolone of <b>20</b> at the 2-position of the 8-methylquinazolin-4-one core with a linker to bind the nicotinamide and adenosine sites.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The resulting compounds <b>27</b> and <b>28</b> display single-digit nanomolar inhibition effects against TNKS1 and subnanomolar inhibitory activity against TNKS2 with more than 700-fold selectivity versus other PARP family proteins. Both compounds <b>27</b> and <b>28</b> were demonstrated to be effective in inhibiting WNT signaling activity (29 and 37 nM, respectively) in TCF/LEF reporter-HEK293 cells and displayed antiproliferative activity in human colon cancer cells under normal serum conditions. Another 2-arylquinazolinone TNKS inhibitor, <b>29</b>, was discovered through a high-throughput biochemical screen and SAR exploration.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>29</b> showed potent TNKS inhibition (IC<sub>50</sub> = 10 nM for TNKS1 and 7 nM for TNKS2), selectivity over PARP1 (>70-fold), and good PK/PD correlation and efficacy in the DLD1 xenograft model at a dose of 10 mg/kg by oral gavage.</div><div class="NLM_p">Scientists from AstraZeneca also discovered 2-phenylquinazolinone <b>30</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A) as a potent TNKS1 inhibitor (7 nM potency) with a cellular activity of 2 μM in a WNT reporter assay in DLD-1 cells.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Systematic exploration of substituents around the quinazolinone core were studied, and it was found that introduction of substituents at the 8-position of the quinazolinone and an isopropyl group on the 2-phenyl ring could significantly improve the cellular WNT inhibitory potency. Compound AZ1366 (<b>31</b>) maintained the TNKS1 inhibitory activity with a single-digit nanomolar WNT signaling inhibitory activity in DLD-1 cells. The combination of compound <b>31</b> and EGFR inhibition in multiple nonsmall cell lung cancer (NSCLC) lines synergistically suppressed proliferation and displayed control of tumor growth in an orthotopic mouse model.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Further optimization on the nicotinamide mimetic core of <b>31</b> led to compound AZ6102 (<b>32</b>), which displayed an IC<sub>50</sub> of 3 nM against TNKS1 with greatly improved selectivity over PARP1 (>660-fold).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Compound <b>32</b> has an oral bioavailability of 18% in rat and a low efflux ratio of 2.7, which may possibly enable it to avoid tumor resistance mechanisms.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Chemical structures of TNKS inhibitors <b>30</b>–<b>32</b>. (B) Structures of compounds <b>33</b>–<b>35</b> (in green) and their cocomplexes with TNKS2 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQO">5ZQO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQR">5ZQR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6KRO">6KRO</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Shirai et al. identified the HTS hit RK-140160 (<b>33</b>) with an IC<sub>50</sub> value of 20.5 nM against TNKS1.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Despite an acceptable WNT signaling inhibitory potency (IC<sub>50</sub> = 233 nM) and cellular proliferative inhibitory activity (50% growth inhibition concentration (GI<sub>50</sub>) = 3.2 μM) as a hit, its aqueous solubility (10 μg/mL at pH 7.4) and mouse liver microsomal stability (0% remaining after incubation for 30 min) were not favorable for oral administration and remain to be improved. In addition to the routine hydrogen bonds with Ser1068 and Gly1032, the methoxyphenyl group forms π–π-stacking interactions with Phe1035 and Ile1075, as depicted by the cocomplex of compound <b>33</b> with TNKS2 (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). Both cocrystal structures and preliminary SAR analysis suggest that the placement of a terminal phenyl ring was essential for <i>in vitro</i> activity, and thus, a bicyclic spiro structure was used to obtain a conformation perpendicular to the connected ring. After introduction of the hydroxyethyl substituent, the potent TNKS inhibitor RK-287107 (<b>34</b>) was obtained with high selectivity versus PARP1 (TNKS1 IC<sub>50</sub> = 14.3 nM, PARP1 IC<sub>50</sub> > 100 μM). The cocrystal structure indicates that <b>34</b> occupies the nicotinamide binding site and that the hydroxyethyl group forms an indirect hydrogen bond with Ser1033 via a water molecule. Compound <b>34</b> was able to stabilize AXIN and decrease β-catenin accumulation as well as WNT target gene expression (<i>e.g.</i>, <i>MYC</i>) in COLO-320DM cells harboring truncated APC mutations.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Importantly, compared with compound <b>33</b>, compound <b>34</b> displays a >7-fold higher aqueous solubility of 72 μg/mL at pH 7.4. Moreover, compound <b>34</b> is orally available (<i>F</i> = 60% in rat), showing a tumor growth inhibition (TGI) of 52% at a dose of 300 mg/kg in the COLO-320 xenograft mouse model. The <i>in vivo</i> efficacy was correlated with changes in pharmacodynamic biomarkers like AXIN2 accumulation and MYC downregulation. The moderate TGI at the high dose was likely due to insufficient cellular activity and low microsomal stability. Most recently, to improve the <i>in vivo</i> efficacy of <b>34</b>, extensive SAR studies were undertaken, leading to compound <b>35</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B),<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> which maintained good TNKS inhibitory activities (TNKS1 IC<sub>50</sub> = 36.1 nM and TNKS2 IC<sub>50</sub> = 39.2 nM) as well as excellent PARP1 selectivity (PARP1 IC<sub>50</sub> = 18,187 nM). In addition, compound <b>35</b> has excellent oral bioavailability (<i>F</i> = 100% in rat). More importantly, compound <b>35</b> is efficacious with a TGI of 52%, comparable to that of compound <b>34</b>, at a dose of 10 mg/kg via oral administration.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> It inhibited the proliferation of human CRC COLO-320DM cells with a GI<sub>50</sub> of 230 nM and blocked WNT/β-catenin signaling by stabilizing AXIN2 and decreasing active β-catenin levels. The cocomplex of compound <b>35</b> with TNKS2 indicates that the tetrahydropyridopyrimidinone core forms a CH−π interaction with Tyr1060 while the oxygen of the indolinone amide moiety forms a hydrogen bond with Tyr1060 through a water molecule.</div><div class="NLM_p">To improve the PK properties and cellular potency of compound <b>20</b>, scientists from Amgen explored the SAR carefully.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The replacement of the phenyl lactam with a <i>gem</i>-dimethyl phenyl oxazolidinone generated compound <b>36</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), for which the TNKS1 inhibition activity was maintained (TNKS1 IC<sub>50</sub> = 200 nM) and the intrinsic stability was significantly improved (mouse plasma <i>t</i><sub>1/2</sub> = 312 min) but the cellular potency was decreased (SW480 β-catenin IC<sub>50</sub> = 2.1 μM and SW480 AXIN EC<sub>50</sub> = 10.5 μM). Cocomplex structural analysis indicated that compound <b>36</b> interacts with TNKS1 residues ASP1198 and Tyr1213 through two hydrogen bonds. Hybridization of <b>36</b> and compound <b>37</b>, another hit from TNKS1 auto-PARsylation HTS that was predicted to form a hydrogen bond with Asp1198 via the oxygen of the benzimidazolone carbonyl group, improved the enzyme and β-catenin potency. The introduction of a cyano group and fluorine resulted in compound <b>38</b>, which exhibited single-digit nanomolar TNKS1 inhibition (TNKS1 IC<sub>50</sub> = 1 nM), nanomolar cellular WNT signaling inhibitory activity (SW480 β-catenin IC<sub>50</sub> = 0.15 μM and SW480 AXIN EC<sub>50</sub> = 61 nM), and good plasma exposure (<i>C</i><sub>max</sub> = 27.4 μM at an oral dose of 30 mg/kg). Meanwhile, the metabolically labile amide of compound <b>36</b> was optimized to the aminopyridine with a repositioned aromatic pyrimidinyl group from compound <b>39</b>, another TNKS1 hit, leading to compound <b>40</b>,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> which exhibits good TNKS inhibitory activities with IC<sub>50</sub> values of 49 nM for TNKS1 and 26 nM for TNKS2. It also displays excellent selectivity over other PARP family members such as PARP1 (IC<sub>50</sub> > 85 μM) and PARP2 (IC<sub>50</sub> > 170 μM). More importantly, compound <b>40</b> was found to be more stable in human and mouse liver microsomes, with clearances of 33 and 48 μL/mg/min, respectively. Replacement of the central phenyl ring with a saturated cyclohexyl group led to compound <b>41</b>. Compared with <b>40</b>, compound <b>41</b> (TNKS1 IC<sub>50</sub> = 2 nM and TNKS2 IC<sub>50</sub> = 2 nM) showed >13-fold increased enzyme inhibition activities, and the cellular potency (TBC IC<sub>50</sub> of 91 nM vs 233 nM) was improved. Nevertheless, neither compound was considered favorable for <i>in vivo</i> studies because of their moderate cellular antiproliferative activity (IC<sub>50</sub> = 3 μM in a DLD-1 cell proliferation assay).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Drug discovery of TNKS inhibitors <b>36</b>–<b>41</b>. Hydrogen bonds of compounds <b>36</b> and <b>39</b> (in green) with TNKS1 residues (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4F">4K4F</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3N3R">3N3R</a>) are shown with red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Waaler et al. screened the canonical WNT signaling inhibitor JW74 (<b>42</b>) (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) in the HEK293 STF assay, and it showed an IC<sub>50</sub> value of 790 nM.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> It displays TNKS inhibition with IC<sub>50</sub> values of 2.55 μM for TNKS1 and 0.65 μM for TNKS2. Like other TNKS inhibitors, compound <b>42</b> was able to induce AXIN2 stabilization, reduce the active form of β-catenin in SW480 cells, affect the expression of WNT target genes, and decrease the double-axis formation (87% at 0.4 pmol by injection) in a <i>Xenopus laevis</i> axis duplication assay. Meanwhile, compound <b>42</b> reduced tumor growth by 33% and 35% at doses of 150 and 300 mg/kg, respectively, in a CB17/SCID xenograft model. It also reduced small intestinal adenomas by 48% at a dose of 150 mg/kg in the APC multiple intestinal neoplasia (Min) mouse model, which harbors mutations in one allele of the <i>APC</i> tumor suppressor gene. However, it is not stable in human liver microsomes (<i>t</i><sub>1/2</sub> = 2.5 min) and inhibits CYP2C9, CYP2D6, and CYP3A4 with IC<sub>50</sub> values ranging from 1 to 2 μM. SAR modification by Shultz et al. resulted in compound <b>43</b>, which exhibited a TNKS2 IC<sub>50</sub> of 33 nM without CYP2D6 inhibition liability (>50 μM) while showing moderate CYP2C9 and CYP3A4 inhibitory activities.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The cocrystal structure of compound <b>43</b> within the catalytic domain of TNKS1 indicates that it interacts with Try1213 and Asp1198 via two hydrogen bonds. Unlike traditional TNKS inhibitors, compound <b>43</b> displayed neither π–π-stacking interactions with Tyr1213/Tyr1224 nor hydrogen-bonding interactions with Gly1185 and Ser1221. Interestingly, the methoxyphenyl on the triazole ring occupies a hydrophobic nook, forming van der Waals interactions with Ser1186, Pro1187, Phe1188, and Ile1128 (colored in magenta in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). This hydrophobic nook, which is not conserved in the PARP family, overlays very well with Tyr1203 in the TNKS1 apo structure and is excluded from the active site through binding of compound <b>43</b>. G007-LK (<b>44</b>), which has IC<sub>50</sub> values of 46 and 25 nM against TNKS1 and TNKS2, respectively,<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> was obtained from another optimization based on compound <b>42</b> by Lau et al.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Compared with lead compound <b>42</b>, <b>44</b> displays 20-fold increased cellular activity (IC<sub>50</sub> [ST-Luc] = 50 nM vs 1,010 nM) and a 34-fold increase in HLM stability (<i>t</i><sub>1/2</sub> = 101 min). Its cocomplex with TNKS2 indicates two hydrogen bonds with Tyr1060 and ASP1045 as well as two π–π-stacking interactions with His1048 and Phe1035, providing a structural basis for the selectivity over PARP1. Moreover, compound <b>44</b> exhibits an excellent oral bioavailability of 94% in ICR mice and good tumor growth inhibition in the COLO-320DM mouse model (TGI of 61% at a dose of 20 mg/kg twice daily) and SW403 xenograft model (TGI of 71% at a dose of 40 mg/kg once daily). To further improve its PK properties in rats, a hybridization approach with privileged fragments from compounds <b>44</b> and <b>37</b> was used to generate the cyclohexyl derivative compound <b>45</b>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> As depicted in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, compound <b>45</b> shows moderate TNKS2 inhibitory activity with an IC<sub>50</sub> value of 330 nM. Further modification of the cyclohexyl linker of <b>45</b> led to compound <b>46</b>, which exhibits single-digit nanomolar TNKS2 inhibitory activity (TNKS2 IC<sub>50</sub> = 6.3 nM), excellent PARP1 selectivity (>100 μM), and WNT signaling inhibition with an IC<sub>50</sub> value of 19 nM in HEK293 cells. The cocrystal structure of compound <b>46</b> with TNKS2 demonstrates the formation of direct hydrogen bonds with Asp1045 through the O atom of benzimidazolone and Tyr1060 through the N atom of the triazole. Its pyrimidine ring is π–π-stacked with Tyr1060 and interacts with Tyr1071, Tyr1050, and Gly1058 via two N atoms. Moreover, compound <b>46</b> is orally available (<i>F</i> = 35–91% in mouse, rat, and dog) and efficacious in a BALB/c nude male mouse COLO-320DM xenograft model with a TGI of 63% and in a syngeneic leukemic p388 mouse model with a TGI of 57% at a dose of 30 mg/kg.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery of TNKS inhibitors <b>42</b>–<b>46</b> and structures of the cocomplexes of <b>43</b>, <b>44</b>, and <b>46</b> (in green) with TNKS (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD">3UDD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HYF">4HYF</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB">5NOB</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>47</b>–<b>53</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) can also be classified as triazole-chemotype TNKS inhibitors, except for <b>50</b>, which belongs to the tetrazole class. Compound <b>47</b> (WIKI4) was identified via an HTS campaign in A375 melanoma cells stably transduced with β-catenin-activated reporter.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Compound <b>47</b> inhibits WNT signaling with a cellular IC<sub>50</sub> value of 75 nM and blocks auto-ADP-ribosylation of TNKS2 with an IC<sub>50</sub> value of 15 nM. Compound <b>48</b> (NML) was identified in a cocrystal complex with TNKS2, and SAR exploration yielded compound <b>49</b>, which displayed an IC<sub>50</sub> value of 12 nM against TNKS1 with more than 800-fold selectivity over PARP1/2.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Compound <b>50</b> was developed from tetrazolo[1,5-<i>a</i>]quinoxaline hits and showed potent TNKS inhibition (2.5 nM) and cellular WNT signaling inhibitory activity.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Compound <b>50</b> displayed submicromolar inhibition of cell growth in 30 tested cell lines, but there was no apparent correlation between the magnitude of compound <b>50</b> efficacy and the cell line tissue origin. [1,2,4]Triazol-3-ylamines <b>51</b>–<b>53</b> were also identified as novel nicotinamide isosteres exhibiting potent TNKS inhibition, with IC<sub>50</sub> values ranging from 9 to 395 nM.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Lipophilic-efficacy-driven optimization promoted the drug development process from HTS hit <b>51</b> to compound <b>53</b>, which significantly inhibited TNKS2 with an IC<sub>50</sub> value of 9 nM.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of TNKS inhibitors <b>47</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">JW55 (<b>54</b>) (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) was obtained from an HTS campaign along with compound <b>42</b>.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Compound <b>54</b> exhibited auto-PARsylation inhibitory activity with IC<sub>50</sub> values of 1.9 μM and 830 nM against TNKS1 and TNKS2 and >10-fold selectivity over PARP1. Furthermore, compound <b>54</b> was able to decrease the growth of SW480 colon cancer cells and reduce intestinal tumor development in conditional <i>APC</i> knockout mice. In a similar HTS method, K-756 (<b>55</b>) with an IC<sub>50</sub> value of 110 nM was discovered using a WNT/β-catenin reporter assay in APC mutant DLD-1 colon cancer cells.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Compound <b>55</b> has IC<sub>50</sub> values of 31 and 36 nM against TNKS1 and TNKS2 via binding to the induced pocket, resulting in AXIN stabilization and changes to the expression of WNT/β-catenin target genes. Moreover, compound <b>55</b> can also inhibit cell growth of WNT/β-catenin-dependent APC mutant colorectal cancer cells, such as COLO-320DM (GI<sub>50</sub> = 780 nM) and SW403 (GI<sub>50</sub> = 270 nM). In addition, compound <b>55</b> decreased the expression of <i>FGF20</i> and <i>LGR5</i> in the DLD-1/TCF-Luc cell xenograft SCID mouse model at doses of 100, 200, and 400 mg/kg by oral administration. Flavone <b>56</b> was reported by two independent groups as a submicromolar TNKS inhibitor with moderate selectivity versus PARP1.<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a> Compound <b>56</b> binds to the conserved nicotinamide site of the substrate NAD<sup>+</sup>, as most PARP1 inhibitors do.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> On the basis of compound <b>56</b>, Narwal et al. designed and synthesized compound <b>57</b> (MN-64) as an efficacious TNKS inhibitor with an IC<sub>50</sub> value of 6 nM against TNKS1 and good selectivity over PARP1.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Fragment hit <b>58</b> was identified from a thermal shift assay (TSA)-based strategy and was further developed into compounds <b>59</b> and <b>60</b> via expansion and optimization.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Compound <b>59</b> has an IC<sub>50</sub> value of 52 nM against TNKS2 with 16-fold selectivity over TNKS1 and >100-fold selectivity over other PARPs. Compound <b>60</b> was shown to be 5-fold more potent in TNKS2 inhibition (9 nM) compared with <b>59</b>, and their central interactions in the nicotinamide binding pocket are similar to those observed for compound <b>19</b>. Biochemical screening of an in-house fragment library validated pyranopyridone <b>61</b> with micromolar-range TNKS inhibition potency (IC<sub>50</sub> = 1.0 μM for TNKS1 and 1.7 μM for TNKS2).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Classical fragment- and structure-based drug optimization strategies on fragment <b>61</b> resulted in compound <b>62</b>, which exhibited potent TNKS2 inhibitory activity (IC<sub>50</sub> < 60 nM) and on-target action in diverse WNT signaling functional assays. Compound <b>62</b> also showed good cellular potency in a TCF-luciferase cell assay, with an EC<sub>50</sub> value of 7 nM. Additionally, compound <b>62</b> has desirable PK parameters in male C57BL/6J mice, with an oral bioavailability of 92% at a dose of 50 mg/kg, supporting it as a promising candidate for <i>in vivo</i> studies.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures and <i>in vitro</i> activities of TNKS inhibitors <b>54</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the crystal structure of the substrate-derived peptide REAGDGEE in complex with the TNKS2 ARC4 domain, Xu et al. developed macrocyclic peptides such as <b>63</b> and <b>64</b> (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) via a double-click reaction.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Peptide <b>63</b> shows a <i>K</i><sub>d</sub> value of 2.8 μM and forms multiple interactions with TNKS2 ARC4, including a salt bridge with Glu598 and Asp589 as well as hydrogen bonds with Ser527, Arg525, Tyr569, and His 571. TRAMA-labeled peptide <b>64</b> with a more rigid linker displays improved potency in TNKS2 ARC4 binding, with a <i>K</i><sub>d</sub> value of 440 nM. Their abilities to disrupt TNKS–substrate peptide interactions were also confirmed by an orthogonal isothermal titration calorimetry (ITC) method. Incorporation of cell-penetrating peptide enabled them to inhibit the WNT signaling in HEK293 cells in a dose-dependent manner. The other small molecule disrupting the TNKS2–ubiquitin-specific protease 25 (USP25) protein–protein interaction, C44 (<b>65</b>), was identified through virtual screening.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> The <i>K</i><sub>i</sub> value of <b>65</b> was determined to be20.5 μM in a fluorescence polarization (FP)-based binding competition assay and 27.9 μM in an ITC assay. Compound <b>65</b> can interrupt the TNKS–AXIN1 interaction, promote TNKS degradation, and inhibit the WNT/β-catenin pathway. Furthermore, compound <b>65</b> attenuated the proliferation of prostate cancer cells and significantly blocked tumor growth in a PC-3 cell xenograft mouse model at a dose of 50 mg/kg.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Discovery of TNKS2 ARC4 inhibitors <b>63</b>–<b>65</b> and ribbon representation of compound <b>63</b> (in green) in complex with TNKS2 ARC4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BXU">5BXU</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3.  Inhibitors That Interfere with Interactions between β-Catenin and Its Partners</h3><div class="NLM_p">β-Catenin is the key downstream effector of the WNT signaling pathway. WNT activation can lead to increased levels of nuclear β-catenin, which binds to TCF/LEF and several cofactors such as CBP,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> p300, BCL9, Pygopus, and Brg1 to induce the overexpression of WNT target genes (<i>e.g.</i>, <i>cyclin D1</i>, <i>c-MYC</i>, and <i>survivin</i>) to modulate cell proliferation, migration, and survival.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Thus, disrupting the β-catenin/TCF protein–protein interaction (PPI) and the β-catenin/cofactor (<i>e.g.</i>, CBP, BCL9, and P300) interactions represents a promising therapeutic approach with great potential for the treatment of cancer given the key role of β-catenin in WNT signaling.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The structure of β-catenin comprises an N-terminal domain, a C-terminal domain, and a central armadillo repeat domain (ARD) containing 12 armadillo repeats.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div><div class="NLM_p">With the goal of searching for CRT-inhibitory drugs that do not affect β-catenin/E-cadherin (E-cad) or β-catenin/other cofactor interactions, Gonsalves et al. developed an RNAi-based modifier screening strategy and identified small molecule <b>66</b> of the oxazole class (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) with significant inhibitory activity (>70%) in a dTF12 luciferase reporter assay.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Compound <b>66</b> specifically suppresses CRT and inhibits β-catenin/TCF4 interactions directly in HEK293 cells. In addition, it is toxic to WNT/CRT-addicted colon cancer cells, indicating that these compounds have the potential to specifically target WNT-dependent cancers without affecting healthy cells.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of β-catenin/TCF inhibitors <b>66</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of a well-defined hot spot around Lys435 and Arg469 on the β-catenin–TCF3 interface, Trosset et al. performed virtual screening and identified PNU74654 (<b>67</b>) as an active hit with a <i>K</i><sub>d</sub> value of 450 nM in an ITC experiment.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Another hot-spot-based rational design led to the discovery of compound <b>68</b> (UU-T01) using bioisostere replacement of two carboxylic acids on Asp16 and Glu17 of TCF4 that formed critical interactions with β-catenin Lys435, Lys508, and Asn430.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a> ITC studies indicated that compound <b>68</b> binds to β-catenin with an IC<sub>50</sub> value of 0.5 μM, and site-directed mutagenesis identified key residues such as Arg469, Lys435, and Lys508 that are required for binding affinity.</div><div class="NLM_p">Comparing the crystal structures of β-catenin with TCF3, TCF4, Lef1, E-cad, and APC enabled the identification of a binding site that is selective for β-catenin/TCF.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Peptide GANDE (<b>69</b>, Gly13-Ala14-Asn15-Asp16-Gln17 of TCF4) (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>) binds to this site and was employed as the template to design peptidomimetics that disturb β-catenin/TCF interactions. The introduction of an electron-rich indole ring and the replacement of Asn with commercially available hydrophobic amino acids resulted in compound <b>70</b>, which had an <i>K</i><sub>i</sub> value of 5.7 μM for interruption of β-catenin/TCF interactions in an FP competitive inhibition assay. Optimization of <b>70</b> yielded compound <b>71</b> exhibiting low micromolar inhibition with an <i>K</i><sub>i</sub> of 1.36 μM against β-catenin/TCF and good selectivity over β-catenin/E-cad, β-catenin/APC, TCF/cadherin, and TCF/APC. Ethyl ester prodrug <b>72</b> demonstrated IC<sub>50</sub> values of 28.7 μM in luciferase reporter assays and 10.8 μM in cell growth inhibition for SW480 cells by reducing expression of WNT target genes, including <i>cyclin D1</i> and <i>c-MYC</i>. To improve the cellular activity of compound <b>71</b>, SAR studies were performed and led to the discovery of compounds <b>73</b> and <b>74</b> with submicromolar inhibition against β-catenin/TCF and selectivity over interactions between β-catenin and other cofactors.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> In the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) cell viability assay, compound <b>73</b> showed an IC<sub>50</sub> value of 20.6 μM in MDA-MB-468 cells.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Discovery of β-catenin/TCF inhibitors <b>69</b>–<b>74</b> and ribbon representation of peptide <b>69</b> (in magenta) from xTCF3 CBD in complex with β-catenin (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J">1G3J</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Grossmann et al. derived the stapled peptide <b>75</b> (fStAx-3) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) from the α-helix of AXIN β-catenin binding domain (CBD), which interrupts the β-catenin/TCF4 interaction because of its similarity to the α-helix of the TCF4 CBD.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Peptide <b>75</b> binds to β-catenin with a <i>K</i><sub>d</sub> value of 60 nM, corresponding to 83-fold greater potency than fluorescein-labeled wild-type AXIN (fAxWT). Affinity optimization of the StAx peptides via phage display technology generated peptides <b>76</b> (<i>K</i><sub>d</sub> = 53 nM) and <b>77</b> (<i>K</i><sub>d</sub> = 13 nM), which displayed potent β-catenin binding affinities and can penetrate cell membranes, as illustrated by confocal fluorescence microscopy. The cocrystal structure of <b>77</b> with β-catenin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJS">4DJS</a>) was found to superimpose with that of β-catenin/AXIN (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ7">1QZ7</a>) very well. These compounds can also block β-catenin-mediated transcriptional activities and specifically reduce the viability of WNT-dependent cancer cells such as DLD1, SW480, and HCT116. However, peptide <b>76</b> suffers from low bioactivity, likely due to suboptimal cellular uptake. Optimization was focused on tuning the hydrophobicity of the core sequence and introducing an N-terminal hydrophobic or polar group, leading to peptide <b>78</b> with a nuclear localization sequence.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> It is cell-permeable as demonstrated by flow cytometry, binds to β-catenin in pull-down experiments, blocks WNT-dependent gene expression, and inhibits proliferation and migration of colorectal cancer cells.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Development of peptides <b>75</b>–<b>78</b> that interrupt β-catenin/TCF interactions and overlay of compound <b>77</b> (in yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJS">4DJS</a>) and AXIN (in cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ7">1QZ7</a>) with β-catenin (in light gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Small-molecule β-catenin/TCF inhibitor <b>79</b> (ZINC02092166) (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) was discovered through HTS by homogeneous FP (5.8 μM) and AlphaScreen (1.2 μM) assays.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Compound <b>79</b> inhibited the FOPFlash luciferase activity in pcDNA3.1−β-catenin-transfected HEK293 and SW480 cells with IC<sub>50</sub> values of 0.86 and 0.71 μM, respectively. Compound <b>79</b> suppressed the expression of WNT target genes such as AXIN2, cyclin D1, and c-MYC. Co-immunoprecipitation illustrated that it blocked β-catenin/TCF interactions in a dose-dependent manner. Unfortunately, its pan-assay interference (PAINS) substructure (the acyl hydrazine moiety) gave rise to drug development liabilities. Dynamic combinatorial chemistry was applied to explore the SAR of compound <b>79</b>, resulting in <b>80</b>–<b>82</b>, which showed biochemical and cellular activities. There was a preference for inhibition of β-catenin/TCF interactions in the FP selectivity assay, and compound <b>82</b> exhibited similar cellular and biochemical potencies. LF3 (<b>83</b>), identified by HTS via AlphaScreen and ELISA techniques, disrupted the β-catenin/TCF interaction with an IC<sub>50</sub> value of 2 μM.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Despite inhibiting WNT signaling in cells and suppressing features of cancer cells related to the WNT/β-catenin pathway, <b>83</b> failed to induce cancer cell death (HCT116). A small library of peptoid–peptide macrocycles were designed <i>in silico</i> to target the cleft on the surface of β-catenin created by armadillo repeats 8–10.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Cyclic peptide <b>84</b> inhibited both WNT (105 nM) and AR (1.02 μM) luciferase reporters effectively, better than its linear version. It interrupted β-catenin/TCF association at 10 μM as demonstrated by co-immunoprecipitation. Moreover, compound <b>84</b> was able to block the expression of WNT target genes (<i>e.g.</i>, cyclin D1 and c-MYC) and inhibit proliferation of the prostate cell line LNCaP-abl with an IC<sub>50</sub> value of 195 nM. Importantly, the <i>in vivo</i> efficacy of compound <b>84</b> was confirmed in a zebrafish model, and treatment of compound <b>84</b> rescued eye and forebrain development.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of β-catenin/TCF inhibitors <b>79</b>–<b>84</b> and the rationale for the design of macrocycle <b>84</b> as depicted by the ribbon representation of β-catenin/xTCF3 interactions (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J">1G3J</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The small molecule ICG-001 (<b>85</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) was found to inhibit β-catenin/TCF transcription in the TopFlash reporter system with an IC<sub>50</sub> value of 3 μM.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The direct molecular target was revealed as the transcription coactivator CBP through its biotinylated derivative. Compound <b>85</b> disrupted β-catenin/CBP interactions by binding to CBP competitively with β-catenin without affecting β-catenin/p300 interactions or CBP-dependent reporter activities. Moreover, compound <b>85</b> suppressed the expression of the β-catenin/TCF-mediated genes <i>survivin</i> and <i>cyclin D1</i> and inhibited SW480 cell growth with an IC<sub>50</sub> value of 4.4 μM. Compound <b>85</b> also displayed <i>in vivo</i> efficacies in the Min mouse and SW620 nude mouse xenograft models. Further modification of <b>85</b> led to the second generation β-catenin/CBP interaction inhibitor <b>86</b>, which showed an ability to disrupt the β-catenin/CBP interaction similar to that of <b>85</b>.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Compound <b>3</b> was obtained by phosphorylation of <b>86</b> to improve the PK profile and exhibited an acceptable toxicity profile in preclinical studies.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Currently, compound <b>3</b> is undergoing clinical trials for various cancers including APC, MPC, AML, and CML. The results of a single-center, open-labeled phase I trial illustrated that iv administration of compound <b>3</b> at a dose of 10 or 40 mg/m<sup>2</sup>/day was well-tolerated by patients with HCV cirrhosis.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> However, in the 160 mg/m<sup>2</sup>/day cohort, serious adverse events like liver injury were observed. Thus, the toxicity and safety characteristics of small-molecule β-catenin/CBP PPI inhibitors can be further improved. The other analogue, CWP232228 (<b>87</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>), inhibited breast cancer stem cell (CSC) growth and clonogenicity<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and reduced tumor growth in 4T1 and MDA-MB-435 xenograft murine models at a dose of 100 mg/kg via ip administration. These effects were proposed to be mediated by WNT/β-catenin target gene insulin-like growth factor-I, which is associated with radioresistance and tumor recurrence in breast cancer. One year later, the same research group discovered that compound <b>87</b> can inhibit liver cancer stem cell clonogenicity and CSC marker expression <i>in vitro</i> as well as suppress hepatocarcinogenesis <i>in vivo</i>.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The following mechanism study of this series of compounds by Benoit et al. revealed that <b>87</b> selectively targets CSCs compared with healthy hematopoietic stem cells through Sam68, which is a regulator of human CSC vulnerability and a modulator of WNT/β-catenin signaling within CSCs.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> As a prodrug, compound <b>87</b> is bioconverted into CWP231904 (<b>88</b>) via plasma alkaline phosphatase. Compound <b>88</b> was found to reduce the transcription levels of WNT target genes <i>survivin</i> and <i>c-myc</i> and result in the degradation of β-catenin in MV4-11 and HL-60 cells.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> It was also able to decrease tumor growth in MV4-11, HL-60, and MOLM-13 xenograft mouse models, suggesting that <b>88</b> has great potential as a drug development candidate for the treatment of AML. CWP232291 (chemical structure not disclosed),<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> another analogue of <b>85</b>, is also undergoing human clinical trials and to date has displayed evidence for safe and single-agent efficacy in AML patients.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of β-catenin/CBP PPI inhibitors <b>85</b>–<b>90</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By a morphological similarity search, Delgado et al. recognized <b>89</b> as a β-catenin/CBP inhibitor and carried out its pharmacological characterization through immunoprecipitation studies, cellular luciferase activity, downstream WNT signaling in HepG2 cells, viability and proliferation in multiple HCC cell lines, and WNT/β-catenin signaling in zebrafish embryos.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Phenotypic screening using fertilized zebrafish embryos identified windorphen (<b>90</b>) as a WNT inhibitor with an IC<sub>50</sub> value of 1.5 μM in the TopFlash luciferase reporter assay.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Co-immunoprecipitation experiments revealed that compound <b>90</b> interrupted the association between the C-terminal transactivation domain of β-catenin-1 and p300 and specifically targeted the histone acetyltransferase activity of p300 with an IC<sub>50</sub> of 4.2 μM. Furthermore, compound <b>90</b> induced apoptosis of WNT-dependent tumor cells, such as the human colon cancer cell line SW480 and prostate cancer cell line DU145, rather than the common human lung cancer cell line H460.</div><div class="NLM_p">The β-catenin/BCL-9 interaction, which is mediated by homology domain 2 (HD2) from BCL9 and a large binding groove in β-catenin, represents a promising cancer therapeutic target.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Kawamoto et al. generated double triazole-staple BCL-9 α-helix peptide <b>91</b> (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) via the Huisgen 1,3-dipolar cycloaddition reaction.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Peptide <b>91</b> had a helicity of 99% and a <i>K</i><sub>i</sub> value of 100 nM in a BCL-9-competitive FP binding assay. Peptide <b>91</b> also displayed improved resistance to proteolytic degradation compared with the linear peptide.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. β-Catenin/BCL-9/TCF4 cocomplex of (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GL7">2GL7</a>) and stapled peptide <b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A similar hydrocarbon stapling method was applied to generate peptide <b>92</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), which could mimic BCL9 HD2.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Peptide <b>92</b> disrupted the β-catenin/BCL-9 complex in a dose-dependent manner with an IC<sub>50</sub> value of 135 nM. Also, peptide <b>92</b> could reduce the expression of WNT-target genes (<i>e.g.</i>, VEGF, <i>c-MYC</i>, <i>LEF1</i>, and <i>AXIN2</i>), while WNT-irrelevant genes like Actin were not altered. Meanwhile, it was able to inhibit the proliferation of CRC and MM cell lines expressing BCL9 and not that of noncancer cells. More importantly, peptide <b>92</b> displayed good <i>in vivo</i> efficacies in both CRC and MM xenograft models. To advance BCL-9-target peptides into potential clinical use, extensive optimization was performed to improve their potency and pharmacological properties. Among them, compound <b>93</b> displayed the most potent β-catenin binding affinity, with a <i>K</i><sub>d</sub> value of 4.2 nM.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Mechanism studies indicated that peptide <b>93</b> targeted WNT/β-catenin signaling specifically, with an IC<sub>50</sub> value of 191 nM in a β-catenin reporter assay, without affecting other pathways like Janus kinase/signal transducer and activator of transcription (JAK/STAT), phosphatidylinositol 3-kinase (PI3K)/AKT, or tumor necrosis factor-α/c-Jun N-terminal kinase (TNF-α/JNK). In addition to its favorable PK profile (bioavailability of 80% for IP and 56% for SC), peptide <b>93</b> showed efficacy in several mouse models with TGIs of 58.8% at a dose of 15 mg/kg in a COLO-320 M xenograft model, 75% at a dose of 15 mg/kg in a PDX model of human CRC, and 92% in a CT26 mouse CRC model. More interestingly, peptide <b>93</b> reduced intratumoral infiltration of T<sub>reg</sub> cells, which is a key reason for resistance to immune checkpoint therapy (<i>e.g.</i>, anti-PD-1 inhibitors), and thus, the combination of peptide <b>93</b> with anti-PD-1 antibody provided a TGI of 95%, presenting a promising synergistic antitumor strategy with the potential to overcome PD-1 antibody resistance.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Chemical structures of peptides <b>92</b>–<b>95</b> that disrupt β-catenin/BCL-9 interactions. * indicates (<i>S</i>)-2-(4′-pentenyl)alanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">β-Catenin/BCL-9 inhibitory peptide <b>94</b> was developed from E-cadherin region V and includes two mutations, cyclization with a 1,3-bis(bromomethyl)benzene linker and the introduction of a gold nanoparticle (pAuNP) system to improve the nuclease stability and low membrane permeability.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> The cyclized peptide without the nanocarrier binds to β-catenin with a <i>K</i><sub>d</sub> value of 1.5 μM, while the linear peptide has no binding affinity. Peptide <b>94</b> with pAuNP has improved colloidal stability and significantly suppresses WNT signaling by disturbing β-catenin/BCL-9 interactions. Proteolytically stable peptidomimetic γ-AApeptides were also designed, aiming to interrupt the β-catenin/BCL-9 interaction, and peptide <b>95</b> displays the most potent binding affinity with β-catenin, with a <i>K</i><sub>d</sub> value of 160 nM in the FP assay.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> FITC-labeled <b>95</b> is cell-permeable, as illustrated by confocal fluorescence microscopy. Compared with normal A549 cancer cells, peptidomimetic γ-AApeptides are more efficacious toward WNT/β-catenin-hyperactive cells like SW480. Moreover, they inhibited the β-catenin/BCL-9 PPI in a dose-dependent manner in a co-immunoprecipitation experiment and showed stability against enzymatic degradation.</div><div class="NLM_p">Hoggard et al. designed generic fragment <b>96</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) that can mimic the binding mode of side chains of hydrophobic projecting hot spots at positions <i>i</i>, <i>i</i> + 3, and <i>i</i> + 7 of an α-helix.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> A bioisostere-based fragment hopping protocol and hit optimization led to compound <b>97</b> with a <i>K</i><sub>i</sub> value of 2.1 μM for the β-catenin/BCL-9 PPI and 125-fold selectivity over β-catenin/E-cad interactions. The <i>K</i><sub>d</sub> value of <b>97</b> with the β-catenin D145A/E155A double mutant decreased significantly in both ITC and Alpha assays, suggesting that the side chain of ASP145 and Glu155 are critical for inhibition potency. HPLC/MS analysis revealed that compound <b>97</b> is membrane-permeable in HCT116 cancer cells and inhibits transactivation of canonical WNT signaling.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> This research group then designed compound <b>98</b> containing a 1,4-dibenzoylpiperazine scaffold with a <i>K</i><sub>i</sub> value of 5.2 μM for disruption of the β-catenin/BCL-9 interaction and 98-fold selectivity over β-catenin/E-cad.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Compound <b>98</b> inhibited growth of WNT-dependent SW480 and HCT116 cells with IC<sub>50</sub> values of 22 and 26 μM, respectively. To further improve the potency and selectivity of this series of compounds, they performed a structure-based optimization that led to compound <b>99</b> containing a tetrazole.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Compound <b>99</b> interrupted the β-catenin/BCL-9 PPI with a <i>K</i><sub>i</sub> value of 0.47 μM and demonstrated >1,900-fold selectivity over β-catenin/E-cad. Although compound <b>99</b> inhibited the mRNA expression of <i>Axin2</i>, <i>cyclin D1</i>, and <i>LEF1</i> in SW480 cells in a dose-dependent manner, it moderately suppressed the growth of SW480, HCT116, and MDA-MB-231 cancer cells with IC<sub>50</sub> values ranging from 41 to 73 μM in MTS assays and displayed no obvious cytotoxicity in the lactate dehydrogenase assay.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of small molecules <b>96</b>–<b>99</b> that disrupt β-catenin/BCL-9 interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.4.  Casein Kinase Modulators</h3><div class="NLM_p">The casein kinase I (CKI or CK1) family of serine/threonine protein kinases, comprising CK1α, CK1β, CK1γ1, CK1γ2, CK1γ3, CK1δ, and CK1ε,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> participate in diverse cellular processes, including cell division, DNA repair, and nuclear localization.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> CK1 isoforms regulate WNT signaling in both negative and positive ways.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> On one hand, CK1α is part of the destruction complex that promotes β-catenin degradation.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> On the other hand, CK1δ and CK1ε can phosphorylate AXIN and DVL, inducing conformational changes in the destruction complex and contributing to the stabilization of β-catenin.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></div><div class="NLM_p">Thorne et al. repurposed pyrvinium (<b>100</b>) (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>), an FDA-approved noncancer drug that was shown to be an effective WNT inhibitor via reconstituted WNT signaling in <i>Xenopus laevis</i> egg extract using a soluble form of LRP6.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Compound <b>100</b> inhibited WNT signaling with an EC<sub>50</sub> of 10 nM in a HEK293 luciferase reporter assay, while biochemical/transcriptional responses of four additional major pathways (<i>i.e.</i>, TGFα, BMP4, IL-4, and Notch) were not affected. Besides <i>in vitro</i> activity, compound <b>100</b> also blocked the xWNT8-mediated secondary axis formation in <i>Xenopus laevis</i>. Further target characterization showed that <b>100</b> bound to all CK1 isoforms but activated only CK1α. Knockdown of CK1α by short hairpin RNA abrogates its effects on WNT signaling, and overexpression of CK1α is sufficient to inhibit lithium-induced activation of the WNT pathway. Compound <b>100</b> stabilized AXIN, prevented the nuclear accumulation of β-catenin, and promoted <i>Pygopus</i> degradation. Moreover, compound <b>100</b> selectively reduced the cell viability of colon cancer cells like SW480 and DLD-1 containing activating mutations in the WNT pathway.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of casein kinase modulators <b>100</b>–<b>104</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, poor bioavailability limited <i>in vivo</i> applications of compound <b>100</b>. In subsequent studies, this team combined an <i>in silico</i> scaffold screening approach and a WNT-driven gene reporter assay, leading to the discovery of SSTC3 (<b>101</b>) (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Compound <b>101</b> had an EC<sub>50</sub> value of 30 nM in a gene reporter assay and bound to purified recombinant CK1α with a <i>K</i><sub>d</sub> value of 32 nM. Additionally, compound <b>101</b> decreased the viability of WNT-dependent cell lines with EC<sub>50</sub> values of 132 nM for HT29, 63 nM for SW403, and 123 nM for HCT116, while WNT-independent cells were less sensitive. Moreover, compound <b>101</b> displayed inhibitory efficacy (<i>i.e.</i>, growth of CRC, cell density of residual cancer, and expression of WNT biomarkers) in patient-derived CRC xenograft mouse models. On the contrary, no inhibitory effects on the proliferation of intestinal epithelium cells were observed in the SW403 xenograft mouse model.</div><div class="NLM_p">Optimization of the purine scaffold inhibitor SR-653234 (<b>102</b>) (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) resulted in SR-3029 (<b>103</b>), which showed an IC<sub>50</sub> value of 44 nM against CK1δ.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Interestingly, breast cancer cells overexpressing CK1δ, such as MDA-MB-231 cells, were more sensitive to <b>103</b>.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> In several breast cancer xenograft mouse models, compound <b>103</b> induced significant suppression of tumor growth at a dose of 20 mg/kg via ip administration, which was mediated by on-target inhibition of CK1δ.</div><div class="NLM_p last">Similar to CK1, casein kinase 2 (CK2 or CKII) employs several key components of the WNT/β-catenin pathway as substrates, however it functions only as a positive regulator of WNT signaling. CK2 is activated in response to WNT3a stimulation and is essential for WNT signaling.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> In a HTS search for CK2 inhibitors, Dowling et al. identified a series of pyrazolo[1,5-<i>a</i>]pyrimidines that exhibited submicromolar potency.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> SAR analysis was carried out on these pyrazolo[1,5-<i>a</i>]pyrimidine hits to figure out the link between CK2 inhibition and WNT signaling. After comprehensive SAR exploration, compound <b>104</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) was identified as a specific CK2 inhibitor with an IC<sub>50</sub> value of < 3 nM, and compound <b>104</b> also exhibited inhibition against WNT signaling in DLD-1 cells with an IC<sub>50</sub> value of 50 nM.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> The cocrystal structure of compound <b>104</b> with CK2α indicates that it occupies the ATP-binding site and forms multiple hydrogen bonds with residues Asn161, Asp175, and Val116. It is worth mentioning that compound <b>104</b> has a very high binding affinity for CK2α, with a <i>K</i><sub>d</sub> value of 6.33 pM in the SPR assay. Further studies revealed that the DLD-1 TopFlash reporter assay result correlated with CK2 pAKT<sup>S129</sup> inhibition in cells. In addition, compound <b>104</b> had IC<sub>50</sub> values of 10, 50, and 5 nM for HCT-116, DLD-1, and SW620 cell growth inhibition, respectively. <i>In vivo</i>, compound <b>104</b> displayed inhibitory efficacies at a dose of 30 mg/kg with TGIs of 94% and 74% in the HCT-116 and SW620 xenograft mouse models, respectively.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.5.  DVL PDZ Domain Inhibitors</h3><div class="NLM_p">The cytoplasmic protein DVL, consisting of an N-terminal DIX domain, a central PDZ domain, and a C-terminal DEP domain,<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> and the associated membrane-bound FZD are essential for functionality of the canonical WNT signaling pathway. Wong et al. revealed that the DVL PDZ domain binds to FZD directly, which is critical for transduction of the signal from FZD to the downstream molecules.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Using structure-based virtual ligand screening, Shan et al. identified the peptide NSC668036 (<b>105</b>) (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) that can bind directly to the PDZ domain of DVL.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Binding of compound <b>105</b> to the DVL PDZ domain was then confirmed by NMR spectroscopy and fluorescence spectroscopy experiments. Moreover, compound <b>105</b> can inhibit <i>Siamois</i> expression in <i>Xenopus</i> embryos and substantially reduce secondary axis formation induced by WNT3A. An additional peptide, VWV (<b>106</b>) (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>), was developed from Val-Val-Val (VVV) and bound to the PDZ domain with a <i>K</i><sub>d</sub> value of 2 μM as determined using fluorescence spectroscopy.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> More studies are needed to validate its effects on WNT signaling and other PDZ domains. By means of a similar structure-based virtual screen and NMR spectroscopy, compound <b>107</b> (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) was identified as a DVL PDZ domain inhibitor with IC<sub>50</sub> values of 10.6 μM by fluorescence anisotropy and 4.9 μM in a competition binding assay.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Compound <b>107</b> showed WNT signaling inhibitory activity in an STF assay and <i>Xenopus</i> system. Compound <b>107</b> also blocked the growth of PC-3 cells with an IC<sub>50</sub> value of 12.5 μM, which was mediated by cellular WNT inhibition. The binding of compound <b>108</b>, discovered by virtual screening, to the PDZ domain was confirmed by NMR titration, and it displayed moderate inhibition (60% at 100 μM) of the proliferation of BT-20 triple-negative breast cancer cells.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structures of DVL PDZ domain inhibitors <b>105</b>–<b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.6.  CDK8 Inhibitors</h3><div class="NLM_p">Cyclin-dependent kinase-8 (CDK8) is reported to be required in different stages of the cell cycle and is related to WNT signaling pathways via phosphorylation of transcription factors or association with the mediator complex.<a onclick="showRef(event, 'ref167 ref168 ref169'); return false;" href="javascript:void(0);" class="ref ref167 ref168 ref169">(167−169)</a> It functions as an important hub for transcription regulation. Therefore, CDK8 has been a promising target for the treatment of cancers.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> CCT251545 (<b>109</b>) (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) is an orally available WNT signaling inhibitor that was characterized <i>in vitro</i> with an IC<sub>50</sub> value of 5 nM in the 7dF3 luciferase reporter assay and <i>in vivo</i> by growth inhibitory efficacy in the COLO205 human colon cancer xenograft model.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Further exploration revealed that compound <b>109</b> binds to CDK8 (2 nM in SPR) and CDK19 directly, and the CDK8 binding affinity is well-correlated with the previously reported 7dF3 WNT-reporter potencies.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> The cocrystal structure of <b>109</b> with the CDK8 C-terminus demonstrated that the pyridine nitrogen forms a hydrogen bond with the backbone of Ala100 (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>). The amide of the spirolactam interacts with Lys52 and the guanidine side chain of Arg356, forming a cation−π interaction with the phenyl ring of compound <b>109</b>. In addition, compound <b>109</b> regulated WNT-target gene expression and displayed <i>in vivo</i> efficacy in a mouse model of intestinal hyperplasia in which a dox-inducible mutant β-catenin transgene was expressed.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Scaffold hopping from <b>109</b> led to the structurally differentiated backup series compound <b>110</b>, which had an IC<sub>50</sub> values of 1.1 nM against CDK8 and 7.2 nM in the 7dF3 cellular WNT-reporter assay.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> PK/PD studies of compound <b>110</b> in a SW620 colorectal carcinoma xenograft model at a dose of 5 mg/kg demonstrated time-dependent inhibition of phopho-STAT1<sup>SER727</sup>, a biomarker of CDK8 inhibition, indicating that twice a day administration was needed at this dose to maintain maximal target engagement. Another medicinal chemistry optimization to decrease the lipophilicity of <b>109</b> resulted in <b>111</b> with IC<sub>50</sub> values of 2.3 nM against CDK8 and 11.8 nM in the 7dF3 cellular WNT-reporter assay.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Compound <b>111</b> exhibited good PK profiles in multiple species and reduced tumor weight by 54% in the <i>APC</i> mutant SW620 human colorectal carcinoma xenograft model at a dose of 30 mg/kg by oral administration. Czodrowski et al. identified a series of imidazothiadiazoles as CDK8 inhibitors from a biochemical HTS campaign with submicromolar CDK8 inhibitory activities, but they lacked microsomal stability. Systematic structure-based drug optimization together with a scaffold hopping strategy gave compound <b>112</b> with IC<sub>50</sub> values of 2.6 nM against CDK8 and 6.5 nM in the 7dF3 WNT-reporter assay.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> More importantly, compound <b>112</b> demonstrated good microsomal stability (clearance of <10 μL/min/mg), an impressive PK profile (predicted <i>F</i> > 75% in human), and <i>in vivo</i> efficacy in the SW620 colorectal cancer xenograft model (T/C ratio of 49% at a dose of 50 mg/kg). 3-Benzylindazoles were identified as CDK8 inhibitors with strong HSP90 affinity through HTS initially, and after further modifications compound <b>113</b> was obtained, with IC<sub>50</sub> values of 10 nM against CDK8 and 65 nM in a cellular assay without effects on HSP90 (0% inhibition at a dose of 4 μM).<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Furthermore, compound <b>113</b> displayed good <i>in vivo</i> efficacy in an <i>APC</i> mutant SW620 human colorectal carcinoma xenograft model with a 75% decrease in tumor phopho-STAT1<sup>SER727</sup> at both 2 and 6 h postdose.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Discovery of CDK8 inhibitors <b>109</b>–<b>113</b> and X-ray crystal structure of <b>109</b> (drawn as yellow sticks) in CDK8/cyclin C (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BNJ">5BNJ</a>). Critical residues are drawn as magenta sticks. Hydrogen bonds are shown as red dashed lines, and the cation−π interaction is shown as a black dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.7.  TNIK</h3><div class="NLM_p">Traf2- and Nck-interacting kinase (TNIK) was reported as an activating kinase for TCF4 and is an essential regulatory component of the TCF4 and β-catenin transcriptional complex. siRNA targeting of TNIK displayed suppression of colorectal cancer growth <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref177 ref178">(177,178)</a> TNIK-deficient mice demonstrated resistance to azoxymethane-induced tumorigenesis, while APC<sup>min/+</sup>/TNIK<sup>–/–</sup> mice developed fewer tumors in the small intestine than APC<sup>min/+</sup>/TNIK<sup>+/+</sup> mice. Thus, TNIK is a promising therapeutic target for controlling aberrant WNT signaling in colorectal cancer.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> Masuda et al. identified a series of quinazoline analogues as TNIK inhibitors from an in-house kinase-focused library, and further optimization of the screening hit led to NCB-0846 (<b>114</b>) (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Compound <b>114</b> had an IC<sub>50</sub> value of 21 nM against TNIK and inhibited other kinases like FLT3 and JAK3 with IC<sub>50</sub> values of <100 nM. The cocrystal structure with TNIK indicates that compound <b>114</b> forms two critical hydrogen bonds with the backbone carbonyl and amide groups of Cys108. Compound <b>114</b> blocked the phosphorylation of TNIK as well as TCF4, inhibited the TCF/LEF transcriptional activity of WNT3a-treated HEK293 cells, and decreased the expression of WNT-signaling target genes. Further studies illustrated that compound <b>114</b> reduced the multiplicity and dimensions of tumors developed in the small intestine in the WNT-driven APC <sup>min/+</sup> mouse model. The efficacy of <b>114</b> was then confirmed by a reduction of colorectal cancer stemness and tumor growth inhibition in a patient-derived spheroid xenograft mouse model.</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Chemical structure of NCB-0846 (<b>114</b>) (in magenta) and its ribbon representation in complex with TNIK (colored in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D7A">5D7A</a>). Key residues are drawn as green sticks, and hydrogen bonds are shown as yellow dashes lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.8.  PAD2 Inhibitors</h3><div class="NLM_p">Peptidyl arginine deiminases (PADs), comprising PAD1–4 and PAD6, catalyze the conversion of protein arginine residues into citrulline during post-translational modification and belong to the superfamily of amidinotransferases, which participate in a number of cellular processes. PAD2 can directly interact with and citrullinate β-catenin, indicating a critical role in the WNT signaling pathway. Using the TopFlash assay, Qu et al. identified the potent WNT signaling inhibitor NTZ (<b>115</b>) (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>), which was a clinically approved antiparasitic drug.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Compound <b>115</b> had good <i>in vitro</i> activity on WNT-activated human colon cancer cells (<i>e.g.</i>, SW480 and HCT116) and <i>in vivo</i> efficacy using an APC<sup>min/+</sup> murine model. PAD2 was then validated as the direct target of compound <b>115</b> via drug-affinity-responsive target stability (DARTS), and shRNA knockdown of PAD2 blocked compound <b>115</b>-mediated β-catenin reduction and TopFlash assay activity. Their direct interaction was then confirmed by a microscale thermophoresis (MST) assay with a <i>K</i><sub>d</sub> value in the micromolar range. Compound <b>115</b> increased β-catenin citrullination in wild-type SW480 cells, whereas no effects were observed in PAD2 knockdown cells.</div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Chemical structures of WNT signaling inhibitors <b>115</b> and <b>116</b> and overlay of compound <b>116</b> (surface representation in yellow):FZD8 CRD (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TFB">6TFB</a>) and WNT3a (in green):FZD8 CRD (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY">6AHY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.9.  FZD8</h3><div class="NLM_p last">FZD proteins are composed of an extracellular WNT-binding cysteine-rich domain (CRD), a seven-helix transmembrane domain (TMD), and a cytoplasmic tail. They are overexpressed in cancers and considered to be promising targets for cancer therapeutics. Several clinical trials have been initiated with anti-FZD antibodies, whereas the development of small molecules that target specific FZD proteins is a continuing challenge. FZD proteins play essential roles in the WNT pathway since WNT ligands bind to the CRD of FZD receptors to initiate WNT signaling. Zhao et al. screened small molecules for binding to the FZD8 CRD using SPR and found that carbamazepine (<b>116</b>) interacts with FZD8 with a <i>K</i><sub>d</sub> value of 16.8 μM without interfering with FZD5 or FZD7.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> The cocrystal structure (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>, right) indicates that it binds to FZD8 CRD in a novel pocket that is different from the traditional FZD8 ligand binding sites. However, in the FZD1, -2, and -7 knockout HEK293T cell line, compound <b>116</b> only partially reduced WNT3A-induced luciferase activity.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.10.  dCTPP1</h3><div class="NLM_p">As a housekeeping nucleotide hydrolase, dCT pyrophosphatase 1 (dCTPP1) decreases the intracellular level of deoxycutidine triphosphate (dCTP) and its subsequent insertion into nascent DNA during replication by catalyzing the hydrolysis of dNTPs to their corresponding monophosphates. It was not considered to be an important regulator of WNT signaling until Friese et al. identified the WNT signaling inhibitor pyrcoumin (<b>117</b>) (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>), which displayed an IC<sub>50</sub> value of 8.4 μM in the STF reporter assay.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> Target validation by affinity-based chemical proteomics using probe <b>118</b> revealed that dCTPP1 is the target of <b>117</b>. A pull-down experiment using immunoblotting and a cellular thermal shift assay further confirmed this interaction. Knockout of dCTPP1 resulted in a 50% decrease in WNT reporter activity. Further co-immunoprecipitation and mass spectrometry studies using HCT116 suggested that dCTPP1 regulates WNT signaling through direct interaction with ubiquitin carboxyl-terminal hydrolase 7 (USP7), which mediates the deubiquitination of tumor suppressors and oncogenes. The binding affinity of <b>118</b> is about 1.2 μM in the FP assay and decreased to 10.5 μM in the presence of 20 μM <b>117</b>.</div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of compounds <b>117</b> and <b>118</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.11.  Phenotypic WNT Inhibitors</h3><div class="NLM_p">Other than the aforementioned molecular-target-based WNT inhibitors, there are a number of small molecules that show interference with WNT signaling without known targets.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Compounds <b>119</b>–<b>122</b> (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) all display potent <i>in vitro</i> WNT inhibitory activities and significant <i>in vivo</i> efficacies,<a onclick="showRef(event, 'ref184 ref185 ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref184 ref185 ref186 ref187">(184−187)</a> but their specific targets remain unclear.</div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structures of WNT inhibitors <b>119</b>–<b>122</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">3.  Concluding Remarks: Challenges and Opportunities</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the discovery of the first WNT family member in 1982, WNT signaling has attracted increased attention in the drug discovery field. As discussed in this review, WNT signaling pathway activation was found in more than 50% of breast cancer patients, 20% of mCRPC patients, and other cancer patients. Aberrant WNT signaling leads to resistance of cancer to conventional cancer therapy. From the production and secretion of WNT ligands to the transcription of WNT target genes, nearly all of the known components that participate in the WNT signaling pathway have the potential to be molecular targets for cancer therapy. Thus, targeting the WNT signaling cascade holds great promise for cancer therapeutics, and anti-WNT-based combination cancer therapy is a unique approach to overcome acquired resistance.</div><div class="NLM_p">There are promising pharmacological modulation opportunities in this systemic WNT signaling network. Both small-molecule chemical space and the potential hubs of WNT transduction networks are enormous. To date, eight canonical WNT signaling inhibitors targeting porcupine, CBP/β-catenin, and CDC-like kinase have been advanced into human clinical trials ranging from phase I to phase III. Direct β-catenin inhibitors derived from its protein–protein interaction partners are challenging because the PPI interface is large and shallow. The approval of the BCL-2 PPI inhibitor ABT-199<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> offers great confidence in non-peptide β-catenin/CBP inhibitors (<i>e.g.</i>, <b>3</b>) in clinical trials. Additionally, a number of canonical WNT signaling inhibitors targeting casein kinase, the DVL PDI domain, CDK8, TNIK, PAD2, FZD8, and dCTPP1 are at an early drug discovery stage. Most of the WNT signaling pathway components have not been explored as anticancer targets, and the discovery of new WNT signaling targets will also benefit current WNT inhibitor drug discovery programs. Furthermore, understanding the systemic WNT signaling network in a dynamic way will be helpful for effective development of targeted modulators. The availability of high-resolution crystal structures of WNT component proteins, WNT reporter assays, and WNT-driven <i>in vivo</i> mouse models are anticipated to facilitate the discovery and development of more WNT signaling inhibitors as novel pharmacological tools or potential drug candidates. Moreover, WNT signaling has been reported to mediate resistance to traditional chemo/radiotherapy,<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> targeted therapies,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> and immunotherapy through multiple mechanisms<a onclick="showRef(event, 'ref47 ref192'); return false;" href="javascript:void(0);" class="ref ref47 ref192">(47,192)</a> such as protecting the cancer stem cell from cell cycle arrest or apoptosis,<a onclick="showRef(event, 'ref193 ref194'); return false;" href="javascript:void(0);" class="ref ref193 ref194">(193,194)</a> enhancing DNA damage (<i>e.g.</i>, PARP inhibitors),<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> facilitating transcriptional plasticity (<i>e.g.</i>, bromodomain and extraterminal domain protein inhibitors),<a onclick="showRef(event, 'ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref196 ref197">(196,197)</a> and promoting immune evasion.<a onclick="showRef(event, 'ref198 ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref198 ref199 ref200">(198−200)</a> The combination of WNT signaling inhibitors with other cancer treatment approaches may provide superior cancer therapeutic cocktails with the potential to overcome resistance. The recent porcupine inhibitor RXC004 developed by Redx Pharma provides a framework for immunotherapy combinations that were demonstrated to display effects in both WNT suppression and the enhancement of immune responses within the tumor microenvironment.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div><div class="NLM_p">Challenges also exist in multiple aspects regarding the development of small-molecule WNT inhibitors from bench to bedside. Nearly all of the participating components together with positive or negative regulatory proteins constitute a comprehensive and complicated WNT signaling network that is dependent on space and time.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Canonical WNT signaling also has crosstalk with other developmental pathways (<i>e.g.</i>, notch signaling, the sonic hedgehog pathway, and the HGF-Met pathway) as well as noncanonical WNT signaling.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This systematic transduction network is context-dependent and very heterogeneous even in the same tumor, thus requiring precise regulation to maintain cellular homeostasis. For example, the WNTs play an important role in osteoblast and osteoclast differentiation, but acute suppression of WNT signaling or systemic abolition of WNT secretion results in gut homeostasis, bone loss, and other side effects.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Considering that TNKS inhibition can increase AXIN protein and thus mediate β-catenin degradation,<a onclick="showRef(event, 'ref75 ref204'); return false;" href="javascript:void(0);" class="ref ref75 ref204">(75,204)</a> TNKS is likely to be the next target focus for clinical trials. However, TNKS inhibitors structurally similar to NAD<sup>+</sup> may cause off-target concerns, and complete TNKS inhibition may cause on-target gastrointestinal toxicity. Achieving a suitable selectivity profile and therapeutic window may be the biggest obstacle for TNKS inhibitors toward human clinical trials. Other off-target effects have been observed in the administration of the dual WNT inhibitor and AMPK activator FH535 (<i>N</i>-arylbenzenesulfonamide, 2,5-dichloro-<i>N</i>-(2-methyl-4-nitrophenyl)benzenesulfonamide).<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> Therefore, the selectivities of various targeted WNT inhibitors should be evaluated against a panel of relevant proteins, signaling pathways, and kinases. Another hurdle to address for TNKS inhibitors is the inconsistent correlation of target inhibitory activity with <i>in vivo</i> efficacy. This observation could have resulted from insufficient cellular activity, low microsomal stability, unmatched <i>in vivo</i> model, or resistance to the WNT signaling blockade. Elevated ATP-binding cassette transporters, secondary mutations of WNT signaling components, and activation of other compensatory pathways may also compromise the effects of WNT inhibitors.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Improving the physiochemical properties of WNT inhibitors and employing other targeted therapeutic strategies may provide enhanced clinical efficacy.</div><div class="NLM_p">To address these challenges, several strategies may be applied. Knowledge with a clear view of the biomarkers will help with the development of effective WNT inhibition therapies and define the benefit populations. To minimize adverse effects, tissue-targeted drug delivery methods like antibody–drug conjugates may be considered. Additionally, local administration strategies and small molecules with focused distribution may also provide benefits for mitigating toxicity and improving efficacy. Combining WNT inhibitors with other anticancer drugs could achieve the same efficacy at lower doses of the WNT inhibitors to overcome the side effects. To maintain the balance between efficacy and side effects, network pharmacology, which encompasses systems biology, bioinformatics, and network analysis, may be beneficial for the effective discovery and development of WNT inhibitors.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Network pharmacology may provide us a perspective on systemic medicine rather than maximizing the activity and selectivity in one dimension. In addition, new biotechnologies such as proteolysis-targeting chimeras (PROTACs)<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> may be appropriately applied to promote the degradation of β-catenin directly, which may offer new opportunities and open new avenues to the clinic for targeting this classic developmental signaling pathway. As PROTACs work as catalysts leading to the target protein degradation, they may provide benefits for mitigating toxicity and improving efficacy. Meanwhile, drug repurposing has proven to be an effective approach to accelerating drug development and may provide an additional strategy to address those challenges.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> The design of allosteric modulators may also provide an effective solution to find target-specific WNT signaling pathway inhibitors.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a></div><div class="NLM_p">Given that downstream mutations are independent of upstream WNT ligand stimulation, porcupine inhibitors appear to be less effective for cancers driven by mutations of downstream WNT components, even though they have achieved impressive <i>in vitro</i> activities (subnanomolar level), <i>in vivo</i> efficacies, and physiochemical properties. Thus, choosing an appropriate subset of cancer patients for personalized medicine is deemed to be increasingly necessary. Meanwhile, during HTS assays special attention should be paid to pan-assay interference compounds (PAINS), which may show good <i>in vitro</i> WNT inhibition as hits but are likely false positives or problematic during further drug development.</div><div class="NLM_p last">In summary, significant progress has been made in recent years in developing small-molecule inhibitors targeting the canonical WNT signaling pathway for the treatment of cancer. The balance between efficacy and potential toxicity is critical for WNT inhibitors, and this balance will be instrumental to achieve viable drug candidates and elucidate the complete and precise signal transduction network associated with WNT signaling. Despite the relevant challenges, developing novel small molecules that selectively and precisely target the canonical WNT signaling pathway has promising therapeutic potential to afford unique chemotherapy regimens to benefit cancer patients.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01799" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqing Liu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Evolution and Marine Biodiversity, College of Food Science and
Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0266-6677" title="Orcid link">http://orcid.org/0000-0003-0266-6677</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbb7b2aea1b3b2aab2b5bc9bb4aeb8f5bebfaef5b8b5"><span class="__cf_email__" data-cfemail="462a2f333c2e2f372f28210629332568232233682528">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Changyun Wang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Evolution and Marine Biodiversity, College of Food Science and
Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0236-1606" title="Orcid link">http://orcid.org/0000-0002-0236-1606</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#701318111e1709051e301f05135e1514055e131e"><span class="__cf_email__" data-cfemail="b1d2d9d0dfd6c8c4dff1dec4d29fd4d5c49fd2df">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Zhou</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bed4d7c4d6d1cbfecbcad3dc90dbdacb"><span class="__cf_email__" data-cfemail="88e2e1f2e0e7fdc8fdfce5eaa6edecfd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pingyuan Wang</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Wold</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiaoling Song</span> - <span class="hlFld-Affiliation affiliation">Institute
of Evolution and Marine Biodiversity, College of Food Science and
Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenyang Zhao</span> - <span class="hlFld-Affiliation affiliation">Institute
of Evolution and Marine Biodiversity, College of Food Science and
Technology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Zhiqing Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3960-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhiqing Liu</b> received her Ph.D. from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2014 under the supervision of Professor Ao Zhang. After 5 years of postdoctoral training in Professor Jia Zhou’s chemical biology program at the University of Texas Medical Branch (UTMB), she joined Ocean University of China as a professor in 2019. Her research interests include the rational design and chemical synthesis of small molecules as novel pharmacological probes and therapeutics for the treatment of cancer, inflammation, infectious diseases, and central nervous system (CNS) disorders.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Pingyuan Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3965-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pingyuan Wang</b> received his Ph.D. in Pesticide Science and Medicinal Chemistry from Central China Normal University (CCNU) in 2016 under the joint supervision of Professor Guang-Fu Yang from CCNU and Professor Ao Zhang from Shanghai Institute of Materia Medica, Chinese Academy of Sciences. He is currently pursuing his postdoctoral training under the supervision of Professor Jia Zhou in the Chemical Biology Program at the Department of Pharmacology and Toxicology at UTMB. His research interests focus on the design and synthesis of novel small molecules as chemical probes and drug candidates for neurological disorders, cancer, and other human diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Eric A. Wold</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3970-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eric A. Wold</b> received his B.S. in Biotechnology from the University of Houston, completing undergraduate capstone research on microbial expression systems and enzymatic organophosphate hydrolysis under the guidance of Dr. Rupa Iyer. He is pursuing a Ph.D. with a focus in neuropharmacology and medicinal chemistry at UTMB under the training of Professor Jia Zhou. Currently he is using computational methods to identify prospective GPCR binding sites for small-molecule allosteric modulators, enabling the rational design of new CNS-targeted ligands. Additionally, his work on targeting membrane proteins has contributed to the discovery of pharmacological probes to study CNS disorders, human cancers, and infectious diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Qiaoling Song</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3975-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qiaoling Song</b> received her Ph.D. from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2017 under the supervision of Professor Qiang Yu. After graduation, she joined Ocean University of China as a postdoctoral fellow. Her research interests include multi-omics data integration for precision medicine and drug development and the pivotal role of JAK/STAT signaling for shaping macrophage polarization in the tumor microenvironment and inflammatory disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Chenyang Zhao</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3980-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chenyang Zhao</b> received her Ph.D. from University of Paris Diderot in 2004 under the supervision of Professor Botao Fan and Professor Guy Dodin. She then obtained her postdoctoral training in Professor Tom Hamilton’s lab at Cleveland Clinic and was further promoted to Research Associate staff. In 2016 she joined Ocean University of China as a professor. Her research focuses on macrophage functions in inflammation and the tumor microenvironment and high-throughput screening for antitumor and anti-inflammation drug discovery.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Changyun Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3985-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Changyun Wang</b> received his Ph.D. from Ocean University of China in 1999 under the supervision of Professor Huashi Guan. In 2000 he joined the research group of Prof. Peter Proksch at the Institute for Pharmaceutical Biology and Biotechnology at the University of Duesseldorf in Germany as a German Academic Exchange Service (DAAD) Fellow. In 2002 he returned to work at the School of Medicine and Pharmacy at Ocean University of China as a professor. His research interests are focused on the discovery of new bioactive ingredients from marine resources and the development of marine natural products into drug-like compounds for the treatment of cancer, inflammation, infectious diseases, and other human conditions.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Jia Zhou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=BIO-d7e3990-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jia Zhou</b> received his Ph.D. in organic chemistry from Nankai University in China in 1997. He proceeded to join the chemistry faculty at the same university and was promoted to associate professor there. He started his postdoctoral research in organic chemistry with Dr. Sidney M. Hecht at the University of Virginia in 1999. After further postdoctoral training in medicinal chemistry with Dr. Alan P. Kozikowski at Georgetown University Medical Center, he worked in the U.S. pharmaceutical industry as a Senior Principal Scientist for 7 years. He is currently a tenured professor at UTMB and leads a drug discovery team with research programs for CNS disorders, cancer, inflammation, and infectious diseases. He is an author of more than 190 peer-reviewed papers and seven book chapters and an inventor of 26 patents. He is the Editor-in-Chief of <i>Current Topics in Medicinal Chemistry</i> and a National Academy of Inventors (NAI) Fellow.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (41830535 to C.W.). J.Z. was partially supported by the John D. Stobo, M.D. Distinguished Chair Endowment Fund at UTMB. E.A.W. was supported by National Institutes of Health (NIH) National Research Service Award (NRSA) F31 DA04551.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">WNT</td><td class="NLM_def"><p class="first last">wingless/integrase-1</p></td></tr><tr><td class="NLM_term">xWNT8</td><td class="NLM_def"><p class="first last"><i>Xenopus</i> WNT8</p></td></tr><tr><td class="NLM_term">mFZD8</td><td class="NLM_def"><p class="first last">mouse Frizzled-8</p></td></tr><tr><td class="NLM_term">CRD</td><td class="NLM_def"><p class="first last">cysteine-rich domain</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">C-terminal domain</p></td></tr><tr><td class="NLM_term">LRP6</td><td class="NLM_def"><p class="first last">low-density lipoprotein receptor 6</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TCF</td><td class="NLM_def"><p class="first last">T-cell factor</p></td></tr><tr><td class="NLM_term">LEF</td><td class="NLM_def"><p class="first last">lymphoid enhancer factor</p></td></tr><tr><td class="NLM_term">DVL</td><td class="NLM_def"><p class="first last">disheveled proteins</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">AXIN</td><td class="NLM_def"><p class="first last">axis inhibition protein</p></td></tr><tr><td class="NLM_term">GSK-3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase-3β</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">casein kinase</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">cyclic AMP response element binding protein</p></td></tr><tr><td class="NLM_term">mCRPC</td><td class="NLM_def"><p class="first last">metastatic castration-resistant prostate cancer</p></td></tr><tr><td class="NLM_term">MCC</td><td class="NLM_def"><p class="first last">metastatic colorectal cancer</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">pancreatic cancer</p></td></tr><tr><td class="NLM_term">BRAF MT CRC</td><td class="NLM_def"><p class="first last">BRAF mutant colorectal cancer</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">HNSCC</td><td class="NLM_def"><p class="first last">head and neck squamous cell cancer</p></td></tr><tr><td class="NLM_term">CSCC</td><td class="NLM_def"><p class="first last">cervical squamous cell cancer</p></td></tr><tr><td class="NLM_term">ESCC</td><td class="NLM_def"><p class="first last">esophageal squamous cell cancer</p></td></tr><tr><td class="NLM_term">LSCC</td><td class="NLM_def"><p class="first last">lung squamous cell cancer</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">HCV LC</td><td class="NLM_def"><p class="first last">hepatitis C-related liver cirrhosis</p></td></tr><tr><td class="NLM_term">HBV LC</td><td class="NLM_def"><p class="first last">hepatitis B-related liver cirrhosis</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">advanced pancreatic cancer</p></td></tr><tr><td class="NLM_term">MPC</td><td class="NLM_def"><p class="first last">metastatic pancreatic cancer</p></td></tr><tr><td class="NLM_term">PA</td><td class="NLM_def"><p class="first last">pancreatic adenocarcinoma</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">PBC</td><td class="NLM_def"><p class="first last">primary biliary cholangitis</p></td></tr><tr><td class="NLM_term">MDS</td><td class="NLM_def"><p class="first last">myelodysplastic syndrome</p></td></tr><tr><td class="NLM_term">MBOAT</td><td class="NLM_def"><p class="first last">membrane-bound <i>O</i>-acyltransferase</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">MMTV</td><td class="NLM_def"><p class="first last">mouse mammary tumor virus</p></td></tr><tr><td class="NLM_term">T/C</td><td class="NLM_def"><p class="first last">treated/control</p></td></tr><tr><td class="NLM_term">CYP450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">STF</td><td class="NLM_def"><p class="first last">Super8xTopFlash</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">RSPO</td><td class="NLM_def"><p class="first last">R-spondin</p></td></tr><tr><td class="NLM_term">TNKS</td><td class="NLM_def"><p class="first last">tankyrase</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">ARTD</td><td class="NLM_def"><p class="first last">diphtheria toxin-like ADP-ribosyltransferase</p></td></tr><tr><td class="NLM_term">NAD<sup>+</sup></td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">ARC</td><td class="NLM_def"><p class="first last">ankyrin repeat cluster</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last">sterile alpha motifs</p></td></tr><tr><td class="NLM_term">MCL-1</td><td class="NLM_def"><p class="first last">myeloid cell leukemia-1</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">50% growth inhibition</p></td></tr><tr><td class="NLM_term">MIN</td><td class="NLM_def"><p class="first last">multiple intestinal neoplasia</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">thermal shift assay</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">USP25</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease 25</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">ARD</td><td class="NLM_def"><p class="first last">armadillo repeat domain</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">CRT</td><td class="NLM_def"><p class="first last">β-catenin-regulated transcription</p></td></tr><tr><td class="NLM_term">E-cad</td><td class="NLM_def"><p class="first last">E-cadherin</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">CBD</td><td class="NLM_def"><p class="first last">β-catenin binding domain</p></td></tr><tr><td class="NLM_term">fAxWT</td><td class="NLM_def"><p class="first last">fluorescein-labeled wild-type axin</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">CDK8</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase-8</p></td></tr><tr><td class="NLM_term">RGS</td><td class="NLM_def"><p class="first last">regulator of G-protein signaling domain</p></td></tr><tr><td class="NLM_term">TNIK</td><td class="NLM_def"><p class="first last">Traf2- and Nck-interacting kinase</p></td></tr><tr><td class="NLM_term">PAD</td><td class="NLM_def"><p class="first last">protein arginine deiminase</p></td></tr><tr><td class="NLM_term">DART</td><td class="NLM_def"><p class="first last">drug affinity responsive target stability</p></td></tr><tr><td class="NLM_term">MST</td><td class="NLM_def"><p class="first last">microscale thermophoresis</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">dCTP</td><td class="NLM_def"><p class="first last">deoxycytidine triphosphate</p></td></tr><tr><td class="NLM_term">dCTPP1</td><td class="NLM_def"><p class="first last">dCT pyrophosphatase 1</p></td></tr><tr><td class="NLM_term">USP7</td><td class="NLM_def"><p class="first last">ubiquitin carboxyl-terminal hydrolase 7</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan-assay inference compounds</p></td></tr><tr><td class="NLM_term">HD2</td><td class="NLM_def"><p class="first last">homology domain 2</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis targeting chimera.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 208 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span> <span> </span><span class="NLM_article-title">The Wnts</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">reviews3001.1</span> <span class="refDoi"> DOI: 10.1186/gb-2001-3-1-reviews3001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1186%2Fgb-2001-3-1-reviews3001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&author=J.+R.+Miller&title=The+Wnts&doi=10.1186%2Fgb-2001-3-1-reviews3001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fgb-2001-3-1-reviews3001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2001-3-1-reviews3001%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Wnts%26jtitle%3DGenome%2520Biol.%26date%3D2001%26volume%3D3%26doi%3D10.1186%2Fgb-2001-3-1-reviews3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varmus, H. E.</span></span> <span> </span><span class="NLM_article-title">Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(82)90409-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2882%2990409-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=6297757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaL3sXht1aluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1982&pages=99-109&author=R.+Nusseauthor=H.+E.+Varmus&title=Many+tumors+induced+by+the+mouse+mammary+tumor+virus+contain+a+provirus+integrated+in+the+same+region+of+the+host+genome&doi=10.1016%2F0092-8674%2882%2990409-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome</span></div><div class="casAuthors">Nusse, Roel; Varmus, Harold E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">It was asked whether oncogenesis by the mouse mammary tumor virus (MMTV), a slowly oncogenic retrovirus, involves integration of viral DNA within a certain region of the host genome.  First, a C3H mouse mammary tumor bearing a single new MMTV provirus was identified, and a 19-kilobase (kb) DNA restriction fragment contg. a junction of viral and host sequences was cloned.  Host sequences from this clone were used to retrieve 25 kb of the uninterrupted locus (termed MMTV int1) from a library of normal mouse DNA.  Hybridization with subcloned DNA fragments of MMTV int1 detected abnormal restriction fragments in digests of DNA from 18 of 26 C3H mammary tumors.  The rearrangements all appeared to be due to the insertion of an MMTV provirus, and the integration sites were located in ≥5 clusters over a total distance of 19 kb.  A polyadenylated 2.6-kb RNA species transcribed from int1 was found in the few tumors tested but not in lactating mammary glands from C3H mice.  Of 12 tested viral oncogenes, none exhibited homol. with cloned DNA from this locus.  Apparently, tumorigenesis by MMTV is strongly favored by proviral insertion within the int1 locus, perhaps as a consequence of enhanced expression of a novel cellular oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYzg6JZuOObVg90H21EOLACvtfcHk0lhGEimV4WySGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXht1aluw%253D%253D&md5=fc21bbcfc4c23ae3bd0f588664e8da42</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2882%2990409-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252882%252990409-3%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26atitle%3DMany%2520tumors%2520induced%2520by%2520the%2520mouse%2520mammary%2520tumor%2520virus%2520contain%2520a%2520provirus%2520integrated%2520in%2520the%2520same%2520region%2520of%2520the%2520host%2520genome%26jtitle%3DCell%26date%3D1982%26volume%3D31%26spage%3D99%26epage%3D109%26doi%3D10.1016%2F0092-8674%2882%2990409-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iranloye, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Disulfide bond requirements for active Wnt ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">18122</span>– <span class="NLM_lpage">18136</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.575027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M114.575027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24841207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=18122-18136&author=B.+T.+MacDonaldauthor=A.+Hienauthor=X.+Zhangauthor=O.+Iranloyeauthor=D.+M.+Virshupauthor=M.+L.+Watermanauthor=X.+He&title=Disulfide+bond+requirements+for+active+Wnt+ligands&doi=10.1074%2Fjbc.M114.575027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide Bond Requirements for Active Wnt Ligands</span></div><div class="casAuthors">MacDonald, Bryan T.; Hien, Annie; Zhang, Xinjun; Iranloye, Oladoyin; Virshup, David M.; Waterman, Marian L.; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">18122-18136</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Secreted Wnt lipoproteins are cysteine-rich and lipid-modified morphogens that bind to the Frizzled (FZD) receptor and LDL receptor-related protein 6 (LRP6).  Wnt engages FZD through protruding thumb and index finger domains, which are each assembled from paired β strands secured by disulfide bonds and grasp two sides of the FZD ectodomain.  The importance of Wnt disulfide bonds has been assumed but uncharacterized.  We systematically analyzed cysteines and assocd. disulfide bonds in the prototypic Wnt3a.  Our data show that mutation of any individual cysteine of Wnt3a results in covalent Wnt oligomers through ectopic intermol. disulfide bond formation and diminishes/abolishes Wnt signaling.  Although individual cysteine mutations in the amino part of the saposin-like domain and in the base of the index finger are better tolerated and permit residual Wnt3a secretion/activity, those in the amino terminus, the thumb, and at the tip of the index finger are incompatible with secretion and/or activity.  A few select double cysteine mutants based on the disulfide bond pattern restore Wnt secretion/activity.  Further, a double cysteine mutation at the index finger tip results in a Wnt3a with normal secretion but minimal FZD binding and dominant neg. properties.  Our results exptl. validate predictions from the Wnt crystal structure and highlight crit. but different roles of the saposin-like and cytokine-like domains, including the thumb and the index finger in Wnt folding/secretion and FZD binding.  Finally, we modified existing expression vectors for 19 epitope-tagged human WNT proteins by removal of a tag-supplied ectopic cysteine, thereby generating tagged WNT ligands active in canonical and non-canonical signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp_TrmWCaVKLVg90H21EOLACvtfcHk0lhGEimV4WySGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsLzE&md5=8bb4036d9e6abca734caab37025d0041</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.575027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.575027%26sid%3Dliteratum%253Aachs%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DHien%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DIranloye%26aufirst%3DO.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DWaterman%26aufirst%3DM.%2BL.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DDisulfide%2520bond%2520requirements%2520for%2520active%2520Wnt%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D18122%26epage%3D18136%26doi%3D10.1074%2Fjbc.M114.575027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norioka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, S.</span></span> <span> </span><span class="NLM_article-title">Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2006.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.devcel.2006.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17141155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=791-801&author=R.+Takadaauthor=Y.+Satomiauthor=T.+Kurataauthor=N.+Uenoauthor=S.+Noriokaauthor=H.+Kondohauthor=T.+Takaoauthor=S.+Takada&title=Monounsaturated+fatty+acid+modification+of+Wnt+protein%3A+its+role+in+Wnt+secretion&doi=10.1016%2Fj.devcel.2006.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion</span></div><div class="casAuthors">Takada, Ritsuko; Satomi, Yoshinori; Kurata, Tomoko; Ueno, Naoto; Norioka, Shigemi; Kondoh, Hisato; Takao, Toshifumi; Takada, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-801</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The secretion and extracellular transport of Wnt protein are thought to be well-regulated processes.  Wnt is known to be acylated with palmitic acid at a conserved cysteine residue (Cys77 in murine Wnt-3a), and this residue appears to be required for the control of extracellular transport.  Here, we show that murine Wnt-3a is also acylated at a conserved serine residue (Ser209).  Of note, we demonstrated that this residue is modified with a monounsatd. fatty acid, palmitoleic acid.  Wnt-3a defective in acylation at Ser209 is not secreted from cells in culture or in Xenopus embryos, but it is retained in the endoplasmic reticulum (ER).  Furthermore, Porcupine, a protein with structural similarities to membrane-bound O-acyltransferases, is required for Ser209-dependent acylation, as well as for Wnt-3a transport from the ER for secretion.  These results strongly suggest that Wnt protein requires a particular lipid modification for proper intracellular transport during the secretory process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP25CDqQrcu7Vg90H21EOLACvtfcHk0lhb9ByqRwXHKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqs7vM&md5=278d498e2c0b6ace529555e3e9b67387</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2006.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2006.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DR.%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DKurata%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DN.%26aulast%3DNorioka%26aufirst%3DS.%26aulast%3DKondoh%26aufirst%3DH.%26aulast%3DTakao%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DS.%26atitle%3DMonounsaturated%2520fatty%2520acid%2520modification%2520of%2520Wnt%2520protein%253A%2520its%2520role%2520in%2520Wnt%2520secretion%26jtitle%3DDev.%2520Cell%26date%3D2006%26volume%3D11%26spage%3D791%26epage%3D801%26doi%3D10.1016%2Fj.devcel.2006.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Wnt recognition by Frizzled</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1126/science.1222879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscience.1222879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22653731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=59-64&author=C.+Y.+Jandaauthor=D.+Waghrayauthor=A.+M.+Levinauthor=C.+Thomasauthor=K.+C.+Garcia&title=Structural+basis+of+Wnt+recognition+by+Frizzled&doi=10.1126%2Fscience.1222879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Wnt Recognition by Frizzled</span></div><div class="casAuthors">Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6090</span>),
    <span class="NLM_cas:pages">59-64</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Wnts are lipid-modified morphogens that play crit. roles in development, principally through engagement of Frizzled receptors.  The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites.  One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD.  In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD.  The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMgZd5hKMfLVg90H21EOLACvtfcHk0lhb9ByqRwXHKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D&md5=8a32c44b73fe281cccedc285311759ce</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222879%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DWaghray%26aufirst%3DD.%26aulast%3DLevin%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructural%2520basis%2520of%2520Wnt%2520recognition%2520by%2520Frizzled%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D59%26epage%3D64%26doi%3D10.1126%2Fscience.1222879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">structural Studies of Wnts and identification of an LRP6 binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.str.2013.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23791946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1235-1242&author=M.+L.+Chuauthor=V.+E.+Ahnauthor=H.+J.+Choiauthor=D.+L.+Danielsauthor=R.+Nusseauthor=W.+I.+Weis&title=structural+Studies+of+Wnts+and+identification+of+an+LRP6+binding+site&doi=10.1016%2Fj.str.2013.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Studies of Wnts and Identification of an LRP6 Binding Site</span></div><div class="casAuthors">Chu, Matthew Ling-Hon; Ahn, Victoria E.; Choi, Hee-Jung; Daniels, Danette L.; Nusse, Roel; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1235-1242</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Wnts are secreted growth factors that have crit. roles in cell fate detn. and stem cell renewal.  The Wnt/β-catenin pathway is initiated by binding of a Wnt protein to a Frizzled (Fzd) receptor and a coreceptor, LDL receptor-related protein 5 or 6 (LRP5/6).  We report the 2.1 Å resoln. crystal structure of a Drosophila WntD fragment encompassing the N-terminal domain and the linker that connects it to the C-terminal domain.  Differences in the structures of WntD and Xenopus Wnt8, including the positions of a receptor-binding β hairpin and a large solvent-filled cavity in the helical core, indicate conformational plasticity in the N-terminal domain that may be important for Wnt-Frizzled specificity.  Structure-based mutational anal. of mouse Wnt3a shows that the linker between the N- and C-terminal domains is required for LRP6 binding.  These findings provide important insights into Wnt function and evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocf8bzxBb8nLVg90H21EOLACvtfcHk0ljinHOCqaiyoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymurg%253D&md5=cf27dcf85bb2711693dd0e4792b0baf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%26aulast%3DAhn%26aufirst%3DV.%2BE.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3Dstructural%2520Studies%2520of%2520Wnts%2520and%2520identification%2520of%2520an%2520LRP6%2520binding%2520site%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1235%26epage%3D1242%26doi%3D10.1016%2Fj.str.2013.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matoba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a mammalian Wnt-frizzled complex</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/s41594-019-0216-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41594-019-0216-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31036956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosFKqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=372-379&author=H.+Hiraiauthor=K.+Matobaauthor=E.+Miharaauthor=T.+Arimoriauthor=J.+Takagi&title=Crystal+structure+of+a+mammalian+Wnt-frizzled+complex&doi=10.1038%2Fs41594-019-0216-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a mammalian Wnt-frizzled complex</span></div><div class="casAuthors">Hirai, Hidenori; Matoba, Kyoko; Mihara, Emiko; Arimori, Takao; Takagi, Junichi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Wnt signaling plays fundamental roles in organogenesis, tissue regeneration and cancer, but high-resoln. structural information of mammalian Wnt proteins is lacking.  We solved a 2.8-Å resoln. crystal structure of human Wnt3 in complex with mouse Frizzled 8 Cys-rich domain (CRD).  Wnt3 grabs the receptor in a manner very similar to that found in Xenopus Wnt8 complexed with the same receptor.  Unlike Xenopus Wnt8-bound CRD, however, Wnt3-bound CRD formed a sym. dimer in the crystal by exchanging the tip of the unsatd. acyl chain attached to each Wnt3, confirming the ability of Wnt and Frizzled CRD to form a 2:2 complex.  The hypervariable 'linker' region of Wnt3 formed a β-hairpin protrusion opposite from the Frizzled binding interface, consistent with its proposed role in the coreceptor recognition.  Direct binding between this segment and the Wnt coreceptor LRP6 was confirmed, enabling us to build a structural model of the Wnt-Frizzled-LRP6 ternary complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRy21GogTH7Vg90H21EOLACvtfcHk0ljinHOCqaiyoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosFKqtrY%253D&md5=abd63699c8b0253ae511f3f4bf794121</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41594-019-0216-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-019-0216-z%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DMatoba%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DArimori%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520a%2520mammalian%2520Wnt-frizzled%2520complex%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D372%26epage%3D379%26doi%3D10.1038%2Fs41594-019-0216-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1038/346847a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F346847a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2202907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Klt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=847-850&author=K.+R.+Thomasauthor=M.+R.+Capecchi&title=Targeted+disruption+of+the+murine+int-1+proto-oncogene+resulting+in+severe+abnormalities+in+midbrain+and+cerebellar+development&doi=10.1038%2F346847a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development</span></div><div class="casAuthors">Thomas, Kirk R.; Capecchi, Mario R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6287</span>),
    <span class="NLM_cas:pages">847-50</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The function of gene int-1 in the mouse was explored by disrupting one of the two int-1 alleles in mouse embryo-derived stem cells using pos.-neg. selection.  This cell line was used to generate a chimeric mouse that transmitted the mutant allele to its progeny.  Mice heterozygous for the int-1 null mutation are normal and fertile, whereas mice homozygous for the mutation may exhibit a range of phenotypes from death before birth to survival with severe ataxia.  The latter pathol. in mice and humans is often assocd. with defects in the cerebellum.  Examn. of int-1-/int-1- mice at several stages of embryogenesis revealed severe abnormalities in the development of the mesencephalon and metencephalon indicating a prominent role for the int-1 protein is in the induction of the mesencephalon and cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1t2VtcDJgsrVg90H21EOLACvtfcHk0liUouccAopjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Klt7g%253D&md5=f81098f10d5d25c36a40e723867bce49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F346847a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346847a0%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DK.%2BR.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520murine%2520int-1%2520proto-oncogene%2520resulting%2520in%2520severe%2520abnormalities%2520in%2520midbrain%2520and%2520cerebellar%2520development%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D847%26epage%3D850%26doi%3D10.1038%2F346847a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, A.</span></span> <span> </span><span class="NLM_article-title">The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(90)90385-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2890%2990385-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2205396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1Gms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1990&pages=1073-1085&author=A.+P.+McMahonauthor=A.+Bradley&title=The+Wnt-1+%28int-1%29+proto-oncogene+is+required+for+development+of+a+large+region+of+the+mouse+brain&doi=10.1016%2F0092-8674%2890%2990385-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain</span></div><div class="casAuthors">McMahon, Andrew P.; Bradley, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1073-85</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The Wnt-1 (int-1) proto-oncogene, which encodes a putative signaling mol., is expressed exclusively in the developing central nervous system and adult testes.  To examine the role of Wnt-1, 6 independent embryonic stem cell lines were generated in which insertion of a neoR gene by homologous recombination inactivated a Wnt-1 allele.  Germline chimeras were generated from 2 lines, and progeny from matings between heterozygous parents were examd.  In all 9.5 day fetuses homozygous for mutated Wnt-1 alleles, most of the midbrain and some rostral metencephalon were absent.  The remainder of the neutral tube and all other tissues were normal.  In late-gestation homozygotes, there was virtually no midbrain and no cerebellum, while the rest of the fetus was normal.  Homozygotes are born, but die within 24 h.  Thus the normal role of Wnt-1 is in detn. or subsequent development of a specific region of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIdpxhG3usCrVg90H21EOLACvtfcHk0liUouccAopjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1Gms7Y%253D&md5=2e375adbdb825e31bd6b821f92cb49de</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990385-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990385-R%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DBradley%26aufirst%3DA.%26atitle%3DThe%2520Wnt-1%2520%2528int-1%2529%2520proto-oncogene%2520is%2520required%2520for%2520development%2520of%2520a%2520large%2520region%2520of%2520the%2520mouse%2520brain%26jtitle%3DCell%26date%3D1990%26volume%3D62%26spage%3D1073%26epage%3D1085%26doi%3D10.1016%2F0092-8674%2890%2990385-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2Fbeta-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0liUouccAopjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heisenberg, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saude, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemple, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. W.</span></span> <span> </span><span class="NLM_article-title">Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/35011068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F35011068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10811221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD3c3mvFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=76-81&author=C.+P.+Heisenbergauthor=M.+Tadaauthor=G.+J.+Rauchauthor=L.+Saudeauthor=M.+L.+Conchaauthor=R.+Geislerauthor=D.+L.+Stempleauthor=J.+C.+Smithauthor=S.+W.+Wilson&title=Silberblick%2FWnt11+mediates+convergent+extension+movements+during+zebrafish+gastrulation&doi=10.1038%2F35011068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation</span></div><div class="casAuthors">Heisenberg C P; Tada M; Rauch G J; Saude L; Concha M L; Geisler R; Stemple D L; Smith J C; Wilson S W</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6782</span>),
    <span class="NLM_cas:pages">76-81</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Vertebrate gastrulation involves the specification and coordinated movement of large populations of cells that give rise to the ectodermal, mesodermal and endodermal germ layers.  Although many of the genes involved in the specification of cell identity during this process have been identified, little is known of the genes that coordinate cell movement.  Here we show that the zebrafish silberblick (slb) locus encodes Wnt11 and that Slb/Wnt11 activity is required for cells to undergo correct convergent extension movements during gastrulation.  In the absence of Slb/Wnt11 function, abnormal extension of axial tissue results in cyclopia and other midline defects in the head.  The requirement for Slb/Wnt11 is cell non-autonomous, and our results indicate that the correct extension of axial tissue is at least partly dependent on medio-lateral cell intercalation in paraxial tissue.  We also show that the slb phenotype is rescued by a truncated form of Dishevelled that does not signal through the canonical Wnt pathway, suggesting that, as in flies, Wnt signalling might mediate morphogenetic events through a divergent signal transduction cascade.  Our results provide genetic and experimental evidence that Wnt activity in lateral tissues has a crucial role in driving the convergent extension movements underlying vertebrate gastrulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaaoXCzFFPPu_Q9URG6Dx8fW6udTcc2eZ7DDK2fSP6_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3mvFemug%253D%253D&md5=43378fa9443ee8e719dd1d9ec2b1390a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F35011068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35011068%26sid%3Dliteratum%253Aachs%26aulast%3DHeisenberg%26aufirst%3DC.%2BP.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DRauch%26aufirst%3DG.%2BJ.%26aulast%3DSaude%26aufirst%3DL.%26aulast%3DConcha%26aufirst%3DM.%2BL.%26aulast%3DGeisler%26aufirst%3DR.%26aulast%3DStemple%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DWilson%26aufirst%3DS.%2BW.%26atitle%3DSilberblick%252FWnt11%2520mediates%2520convergent%2520extension%2520movements%2520during%2520zebrafish%2520gastrulation%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D76%26epage%3D81%26doi%3D10.1038%2F35011068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldahl, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape</span>. <i>Trends Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0168-9525(00)02028-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS0168-9525%2800%2902028-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10858654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=279-283&author=M.+Kuhlauthor=L.+C.+Sheldahlauthor=M.+Parkauthor=J.+R.+Millerauthor=R.+T.+Moon&title=The+Wnt%2FCa2%2B+pathway%3A+a+new+vertebrate+Wnt+signaling+pathway+takes+shape&doi=10.1016%2FS0168-9525%2800%2902028-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt/Ca2+ pathway, a new vertebrate Wnt signaling pathway takes shape</span></div><div class="casAuthors">Kuhl, M.; Sheldahl, L. C.; Park, M.; Miller, J. R.; Moon, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">279-283</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 27 refs.  Members of the vertebrate Wnt family have been subdivided into two functional classes according to their biol. activities.  Some Wnts signal through the canonical Wnt-1/wingless pathway by stabilizing cytoplasmic β-catenin.  By contrast other Wnts stimulate intracellular Ca2+ release and activate two kinases, CamKII and PKC, in a G-protein-dependent manner.  Moreover, putative Wnt receptors belonging to the Frizzled gene family have been identified that preferentially couple to the two prospective pathways in the absence of ectopic Wnt ligand and that might account for the signaling specificity of the Wnt pathways.  As Ca2+ release was the first described feature of the noncanonical pathway, and as Ca2+ probably plays a key role in the activation of CamKII and PKC, we have named this Wnt pathway the Wnt/Ca2+ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEmZZlWD-4bVg90H21EOLACvtfcHk0licEoFfwhMfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlCnur8%253D&md5=7072c500b1057e6629557c94a9889d29</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2800%2902028-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252800%252902028-X%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DM.%26aulast%3DSheldahl%26aufirst%3DL.%2BC.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DThe%2520Wnt%252FCa2%252B%2520pathway%253A%2520a%2520new%2520vertebrate%2520Wnt%2520signaling%2520pathway%2520takes%2520shape%26jtitle%3DTrends%2520Genet.%26date%3D2000%26volume%3D16%26spage%3D279%26epage%3D283%26doi%3D10.1016%2FS0168-9525%2800%2902028-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">SnapShot: noncanonical Wnt signaling pathways</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1378</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2007.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18160045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD2sjms1ymuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=1378&author=M.+V.+Semenovauthor=R.+Habasauthor=B.+T.+Macdonaldauthor=X.+He&title=SnapShot%3A+noncanonical+Wnt+signaling+pathways&doi=10.1016%2Fj.cell.2007.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SnapShot: Noncanonical Wnt Signaling Pathways</span></div><div class="casAuthors">Semenov Mikhail V; Habas Raymond; Macdonald Bryan T; He Xi</div><div class="citationInfo"><span class="NLM_cas:title">Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1378</span>
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSocIG91z82hXwOGIfWJ7-GfW6udTcc2ebdep4ltCTvB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjms1ymuw%253D%253D&md5=f61de278fbca85e9aa8f99770763c4ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSemenov%26aufirst%3DM.%2BV.%26aulast%3DHabas%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DB.%2BT.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DSnapShot%253A%2520noncanonical%2520Wnt%2520signaling%2520pathways%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D1378%26doi%3D10.1016%2Fj.cell.2007.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuijers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1002/embj.201385358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fembj.201385358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24413017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOhu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=146-156&author=J.+Schuijersauthor=M.+Mokryauthor=P.+Hatzisauthor=E.+Cuppenauthor=H.+Clevers&title=Wnt-induced+transcriptional+activation+is+exclusively+mediated+by+TCF%2FLEF&doi=10.1002%2Fembj.201385358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF</span></div><div class="casAuthors">Schuijers, Jurian; Mokry, Michal; Hatzis, Pantelis; Cuppen, Edwin; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-156</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Active canonical Wnt signaling results in recruitment of β-catenin to DNA by TCF/LEF family members, leading to transcriptional activation of TCF target genes.  However, addnl. transcription factors have been suggested to recruit β-catenin and tether it to DNA.  Here, we describe the genome-wide pattern of β-catenin DNA binding in murine intestinal epithelium, Wnt-responsive colorectal cancer (CRC) cells and HEK293 embryonic kidney cells.  We identify two classes of β-catenin binding sites.  The first class represents the majority of the DNA-bound β-catenin and co-localizes with TCF4, the prominent TCF/LEF family member in these cells.  The second class consists of β-catenin binding sites that colocalize with a minimal amt. of TCF4.  The latter consists of lower affinity β-catenin binding events, does not drive transcription and often does not contain a consensus TCF binding motif.  Surprisingly, a dominant-neg. form of TCF4 abrogates the β-catenin/DNA interaction of both classes of binding sites, implying that the second class comprises low affinity TCF-DNA complexes.  Our results indicate that β-catenin is tethered to chromatin overwhelmingly through the TCF/LEF transcription factors in these three systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6_rFdgL2v8rVg90H21EOLACvtfcHk0lgXWOx5h137CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOhu7vJ&md5=9bd0de551dc5e7b4ec08872db89e3948</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fembj.201385358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fembj.201385358%26sid%3Dliteratum%253Aachs%26aulast%3DSchuijers%26aufirst%3DJ.%26aulast%3DMokry%26aufirst%3DM.%26aulast%3DHatzis%26aufirst%3DP.%26aulast%3DCuppen%26aufirst%3DE.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt-induced%2520transcriptional%2520activation%2520is%2520exclusively%2520mediated%2520by%2520TCF%252FLEF%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D146%26epage%3D156%26doi%3D10.1002%2Fembj.201385358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling in development and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2006.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17081971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=469-480&author=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling+in+development+and+disease&doi=10.1016%2Fj.cell.2006.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling in development and disease</span></div><div class="casAuthors">Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-480</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  A remarkable interdisciplinary effort has unraveled the WNT (Wingless and INT-1) signal transduction cascade over the last 2 decades.  Wnt genes encode small secreted proteins that are found in all animal genomes.  Wnt signaling is involved in virtually every aspect of embryonic development and also controls homeostatic self-renewal in a no. of adult tissues.  Germline mutations in the Wnt pathway cause several hereditary diseases, and somatic mutations are assocd. with cancer of the intestine and a variety of other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocxHAkoIZJG7Vg90H21EOLACvtfcHk0lgXWOx5h137CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbbN&md5=930a55e85abd29329c845dec6683fac8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520in%2520development%2520and%2520disease%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D469%26epage%3D480%26doi%3D10.1016%2Fj.cell.2006.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling: components, mechanisms, and diseases</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.devcel.2009.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19619488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2msb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=9-26&author=B.+T.+MacDonaldauthor=K.+Tamaiauthor=X.+He&title=Wnt%2Fbeta-catenin+signaling%3A+components%2C+mechanisms%2C+and+diseases&doi=10.1016%2Fj.devcel.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling: components, mechanisms, and diseases</span></div><div class="casAuthors">MacDonald, Bryan T.; Tamai, Keiko; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-26</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Signaling by the Wnt family of secreted glycolipoproteins via the transcriptional coactivator β-catenin controls embryonic development and adult homeostasis.  Here we review recent progress in this so-called canonical Wnt signaling pathway.  We discuss Wnt ligands, agonists, and antagonists, and their interactions with Wnt receptors.  We also dissect crit. events that regulate β-catenin stability, from Wnt receptors to the cytoplasmic β-catenin destruction complex, and nuclear machinery that mediates β-catenin-dependent transcription.  Finally, we highlight some key aspects of Wnt/β-catenin signaling in human diseases including congenital malformations, cancer, and osteoporosis, and discuss potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNap4TpxXFWbVg90H21EOLACvtfcHk0lgXWOx5h137CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2msb8%253D&md5=25e1a7dd5c3aca54a1cfc7993fd5bb43</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%253A%2520components%252C%2520mechanisms%252C%2520and%2520diseases%26jtitle%3DDev.%2520Cell%26date%3D2009%26volume%3D17%26spage%3D9%26epage%3D26%26doi%3D10.1016%2Fj.devcel.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Proximal events in Wnt signal transduction</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/nrm2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrm2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19536106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVagtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=468-477&author=S.+Angersauthor=R.+T.+Moon&title=Proximal+events+in+Wnt+signal+transduction&doi=10.1038%2Fnrm2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proximal events in Wnt signal transduction</span></div><div class="casAuthors">Angers, Stephane; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">468-477</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The Wnt family of secreted ligands act through many receptors to stimulate distinct intracellular signaling pathways in embryonic development, in adults and in disease processes.  The binding of Wnt to the Frizzled family of receptors and to LDL receptor-related protein 5 (LRP5) or LRP6 co-receptors stimulates the intracellular Wnt-β-catenin signaling pathway, which regulates β-catenin stability and context-dependent transcription.  This signaling pathway controls many processes, such as cell fate detn., cell proliferation, and self-renewal of stem and progenitor cells.  Intriguingly, transmembrane receptor Tyr kinases Ror2 and Ryk, as well as Frizzled receptors that act independently of LRP5 or LRP6, function as receptors for Wnt and activate β-catenin-independent pathways.  This leads to changes in cell movement and polarity and to the antagonism of the β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSa8RXI0O7ibVg90H21EOLACvtfcHk0ljq0Lrkr3yAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVagtLs%253D&md5=35448720b91c4b994da87f0dfd50da64</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrm2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2717%26sid%3Dliteratum%253Aachs%26aulast%3DAngers%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DProximal%2520events%2520in%2520Wnt%2520signal%2520transduction%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D468%26epage%3D477%26doi%3D10.1038%2Fnrm2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span> <i>Wnt Target genes</i>. <a href="https://web.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes" class="extLink">https://web.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes</a> (accessed 2020-05-20).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wnt+Target+genes.+https%3A%2F%2Fweb.stanford.edu%2Fgroup%2Fnusselab%2Fcgi-bin%2Fwnt%2Ftarget_genes+%28accessed+2020-05-20%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DWnt%2520Target%2520genes" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, M.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1084-9521(02)00050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS1084-9521%2802%2900050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12137733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Wksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=243-249&author=M.+Kuhl&title=Non-canonical+Wnt+signaling+in+Xenopus%3A+regulation+of+axis+formation+and+gastrulation&doi=10.1016%2FS1084-9521%2802%2900050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation</span></div><div class="casAuthors">Kuhl, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Wnt proteins form a family of secreted glycoproteins that are involved in different developmental processes such as differentiation, proliferation, cell migration, and cell polarity.  To exert its function, Wnt proteins activate different intracellular signaling cascades.  Whereas the canonical, Wnt/β-catenin pathway is well characterized, less is known about the function of non-canonical Wnt pathways in vertebrates.  I here summarize recent findings implicating important roles for Wnt/Ca2+ and Wnt/JNK signaling during different aspects of early X. laevis development, namely axis formation and gastrulation movements.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTK6H_cgzrbVg90H21EOLACvtfcHk0ljq0Lrkr3yAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Wksbc%253D&md5=d502d77e666e139a1059c8d94528573a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1084-9521%2802%2900050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1084-9521%252802%252900050-2%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DM.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520in%2520Xenopus%253A%2520regulation%2520of%2520axis%2520formation%2520and%2520gastrulation%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2002%26volume%3D13%26spage%3D243%26epage%3D249%26doi%3D10.1016%2FS1084-9521%2802%2900050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortunato, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzarossa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Cejudo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. A.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e45853</span>, <span class="refDoi"> DOI: 10.7554/eLife.45853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.7554%2FeLife.45853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31246175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlGisLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=e45853&author=J.+R.+Carvalhoauthor=I.+C.+Fortunatoauthor=C.+G.+Fonsecaauthor=A.+Pezzarossaauthor=P.+Barbacenaauthor=M.+A.+Dominguez-Cejudoauthor=F.+F.+Vasconcelosauthor=N.+C.+Santosauthor=F.+A.+Carvalhoauthor=C.+A.+Franco&title=Non-canonical+Wnt+signaling+regulates+junctional+mechanocoupling+during+angiogenic+collective+cell+migration&doi=10.7554%2FeLife.45853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration</span></div><div class="casAuthors">Carvalho, Joana R.; Fortunato, Isabela C.; Fonseca, Catarina G.; Pezzarossa, Anna; Barbacena, Pedro; Dominguez-Cejudo, Maria A.; Vasconcelos, Francisca F.; Santos, Nuno C.; Carvalho, Filomena A.; Franco, Claudio A.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e45853/1-e45853/35</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Morphogenesis of hierarchical vascular networks depends on the integration of multiple biomech. signals by endothelial cells, the cells lining the interior of blood vessels.  Expansion of vascular networks arises through sprouting angiogenesis, a process involving extensive cell rearrangements and collective cell migration.  Yet, the mechanisms controlling angiogenic collective behavior remain poorly understood.  Here, we show this collective cell behavior is regulated by non-canonical Wnt signaling.  We identify that Wnt5a specifically activates Cdc42 at cell junctions downstream of ROR2 to reinforce coupling between adherens junctions and the actin cytoskeleton.  We show that Wnt5a signaling stabilizes vinculin binding to alpha-catenin, and abrogation of vinculin in vivo and in vitro leads to uncoordinated polarity and deficient sprouting angiogenesis in Mus musculus.  Our findings highlight how non-canonical Wnt signaling coordinates collective cell behavior during vascular morphogenesis by fine-tuning junctional mechanocoupling between endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_01o_cQcDV7Vg90H21EOLACvtfcHk0lgl05ph4ez0kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlGisLbK&md5=f6305c8fc3ca41731ea4d3b926ca3f08</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.7554%2FeLife.45853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45853%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DJ.%2BR.%26aulast%3DFortunato%26aufirst%3DI.%2BC.%26aulast%3DFonseca%26aufirst%3DC.%2BG.%26aulast%3DPezzarossa%26aufirst%3DA.%26aulast%3DBarbacena%26aufirst%3DP.%26aulast%3DDominguez-Cejudo%26aufirst%3DM.%2BA.%26aulast%3DVasconcelos%26aufirst%3DF.%2BF.%26aulast%3DSantos%26aufirst%3DN.%2BC.%26aulast%3DCarvalho%26aufirst%3DF.%2BA.%26aulast%3DFranco%26aufirst%3DC.%2BA.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520regulates%2520junctional%2520mechanocoupling%2520during%2520angiogenic%2520collective%2520cell%2520migration%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26spage%3De45853%26doi%3D10.7554%2FeLife.45853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkosis, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garkun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02440-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41467-017-02440-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29296000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC1MzmvFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=36&author=M.+Chavaliauthor=M.+Klingenerauthor=A.+G.+Kokkosisauthor=Y.+Garkunauthor=S.+Felongauthor=A.+Maffeiauthor=A.+Aguirre&title=Non-canonical+Wnt+signaling+regulates+neural+stem+cell+quiescence+during+homeostasis+and+after+demyelination&doi=10.1038%2Fs41467-017-02440-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination</span></div><div class="casAuthors">Chavali Manideep; Klingener Michael; Kokkosis Alexandros G; Felong Sylwia; Aguirre Adan; Chavali Manideep; Chavali Manideep; Garkun Yury; Maffei Arianna</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adult neural stem cells (NSCs) reside in a specialized microenvironment, the subventricular zone (SVZ), which provides them with unique signaling cues to control their basic properties and prevent their exhaustion.  While the signaling mechanisms that regulate NSC lineage progression are well characterized, the molecular mechanisms that trigger the activation of quiescent NSCs during homeostasis and tissue repair are still unclear.  Here, we uncovered that the NSC quiescent state is maintained by Rho-GTPase Cdc42, a downstream target of non-canonical Wnt signaling.  Mechanistically, activation of Cdc42 induces expression of molecules involved in stem cell identity and anchorage to the niche.  Strikingly, during a demyelination injury, downregulation of non-canonical Wnt-dependent Cdc42 activity is necessary to promote activation and lineage progression of quiescent NSCs, thereby initiating the process of tissue repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFg9X85G-ufdts4TFFB11gfW6udTcc2eaZjE3Vnqtlxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzmvFKjsA%253D%253D&md5=3f6f36c454df705a8dca8c68d2e02a8c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02440-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02440-0%26sid%3Dliteratum%253Aachs%26aulast%3DChavali%26aufirst%3DM.%26aulast%3DKlingener%26aufirst%3DM.%26aulast%3DKokkosis%26aufirst%3DA.%2BG.%26aulast%3DGarkun%26aufirst%3DY.%26aulast%3DFelong%26aufirst%3DS.%26aulast%3DMaffei%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DA.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520regulates%2520neural%2520stem%2520cell%2520quiescence%2520during%2520homeostasis%2520and%2520after%2520demyelination%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D36%26doi%3D10.1038%2Fs41467-017-02440-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ctrv.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29169144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=50-60&author=N.+Krishnamurthyauthor=R.+Kurzrock&title=Targeting+the+Wnt%2Fbeta-catenin+pathway+in+cancer%3A+Update+on+effectors+and+inhibitors&doi=10.1016%2Fj.ctrv.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span></div><div class="casAuthors">Krishnamurthy, Nithya; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Wnt/beta-catenin pathway is a family of proteins that is implicated in many vital cellular functions like stem cell regeneration and organogenesis.  Several intra-cellular signal transduction pathways are induced by Wnt, notably the Wnt/beta-catenin dependent pathway or canonical pathway and the non-canonical or beta-catenin-independent pathway, the latter includes the Wnt/Ca2+ and Planar Cell Polarity pathway (PCP).  Wnt activation occurs at the intestinal crypt floor, and is crit. to optimal maintenance of stem cells.  Colorectal cancers show evidence of Wnt signaling pathway activation and this is assocd. with loss of function of the tumor regulator APC.  Wnt activation has been obsd. in breast, lung, and hematopoietic malignancies and contributes to tumor recurrence.  The Wnt pathway cross talks with the Notch and Sonic Hedgehog pathways, which has implications for therapeutic interventions in cancers.  There are significant challenges in targeting the Wnt pathway, including finding agents that are efficacious without damaging the system of normal somatic stem cell function in cellular repair and tissue homeostasis.  Here, we comprehensively review the Wnt pathway and its interactions with the Notch and Sonic Hedgehog pathways.  We present the state of the field in effectors and inhibitors of Wnt signaling, including updates on clin. trials in various cancers with inhibitors of Wnt, Notch, and Sonic Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHbcA6nGH3rVg90H21EOLACvtfcHk0lgl05ph4ez0kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF&md5=1a46da27b4932cbd31695e004a48b3c2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DN.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520cancer%253A%2520Update%2520on%2520effectors%2520and%2520inhibitors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.ctrv.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchartre, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">The Wnt signaling pathway in cancer</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.critrevonc.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.critrevonc.2015.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26775730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28nhtVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=141-149&author=Y.+Duchartreauthor=Y.+M.+Kimauthor=M.+Kahn&title=The+Wnt+signaling+pathway+in+cancer&doi=10.1016%2Fj.critrevonc.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt signaling pathway in cancer</span></div><div class="casAuthors">Duchartre Yann; Kim Yong-Mi; Kahn Michael</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Wnt signaling pathway is critically involved in both the development and homeostasis of tissues via regulation of their endogenous stem cells.  Aberrant Wnt signaling has been described as a key player in the initiation of and/or maintenance and development of many cancers, via affecting the behavior of Cancer Stem Cells (CSCs).  CSCs are considered by most to be responsible for establishment of the tumor and also for disease relapse, as they possess inherent drug-resistance properties.  The development of new therapeutic compounds targeting the Wnt signaling pathway promises new hope to eliminate CSCs and achieve cancer eradication.  However, a major challenge resides in developing a strategy efficient enough to target the dysregulated Wnt pathway in CSCs, while being safe enough to not damage the normal somatic stem cell population required for tissue homeostasis and repair.  Here we review recent therapeutic approaches to target the Wnt pathway and their clinical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFhVYHuBPqTEBuFdjgVNKSfW6udTcc2eaxeugryECwObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nhtVyktA%253D%253D&md5=12c352d164ae33f2b2cfc2a2f9b0a580</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DDuchartre%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DThe%2520Wnt%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2016%26volume%3D99%26spage%3D141%26epage%3D149%26doi%3D10.1016%2Fj.critrevonc.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span> <span> </span><span class="NLM_article-title">Development of small molecules targeting the Wnt signaling pathway in cancer stem cells for the treatment of colorectal cancer</span>. <i>Clin. Colorectal Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.clcc.2015.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.clcc.2015.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25799881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmvFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=133-145&author=L.+Songauthor=Y.+Liauthor=B.+Heauthor=Y.+Gong&title=Development+of+small+molecules+targeting+the+Wnt+signaling+pathway+in+cancer+stem+cells+for+the+treatment+of+colorectal+cancer&doi=10.1016%2Fj.clcc.2015.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer</span></div><div class="casAuthors">Song Lele; Li Yuemin; He Baoming; Gong Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical colorectal cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer (CRC) was ranked third in morbidity and mortality in the United States in 2013.  Although substantial progress has been made in surgical techniques and postoperative chemotherapy in recent years, the prognosis for colon cancer is still not satisfactory, mainly because of cancer recurrence and metastasis.  The latest studies have shown that cancer stem cells (CSCs) play important roles in cancer recurrence and metastasis.  Drugs that target CSCs might therefore have great therapeutic potential in prevention of cancer recurrence and metastasis.  The wingless-int (Wnt) signaling pathway in CSCs has been suggested to play crucial roles in colorectal carcinogenesis, and has become a popular target for anti-CRC therapy.  Dysregulation of the Wnt signaling pathway, mostly by inactivating mutations of the adenomatous polyposis coli tumor suppressor or oncogenic mutations of β-catenin, has been implicated as a key factor in colorectal tumorigenesis.  Abnormal increases of β-catenin levels represents a common pathway in Wnt signaling activation and is also observed in other human malignancies.  These findings highlight the importance of developing small-molecule drugs that target the Wnt pathway.  Herein we provide an overview on the current development of small molecules that target the Wnt pathway in colorectal CSCs and discuss future research directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLC7t3nDzoRjToTC3aBaesfW6udTcc2eaxeugryECwObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmvFKisA%253D%253D&md5=aaf27eaa823e8ce494d15e3345411388</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.clcc.2015.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clcc.2015.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DGong%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520small%2520molecules%2520targeting%2520the%2520Wnt%2520signaling%2520pathway%2520in%2520cancer%2520stem%2520cells%2520for%2520the%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Colorectal%2520Cancer%26date%3D2015%26volume%3D14%26spage%3D133%26epage%3D145%26doi%3D10.1016%2Fj.clcc.2015.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcaroli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderbilt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, C. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the WNT signaling pathway in cancer therapeutics</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2015-0057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1634%2Ftheoncologist.2015-0057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26306903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1189-1198&author=D.+Taiauthor=K.+Wellsauthor=J.+Arcaroliauthor=C.+Vanderbiltauthor=D.+L.+Aisnerauthor=W.+A.+Messersmithauthor=C.+H.+Lieu&title=Targeting+the+WNT+signaling+pathway+in+cancer+therapeutics&doi=10.1634%2Ftheoncologist.2015-0057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the WNT signaling pathway in cancer therapeutics</span></div><div class="casAuthors">Tai, David; Wells, Keith; Arcaroli, John; Vaderilt, Chad; Aisner, Dara L.; Messersmith, Wells A.; Lieh, Christopher H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1189-1198</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The WNT signaling cascade is integral in numerous biol. processes including embryonic development, cell cycle regulation, inflammation, and cancer.  Hyperactivation of WNT signaling secondary to alterations to varying nodes of the pathway have been identified in multiple tumor types.  These alterations converge into increased tumorigenicity, sustained proliferation, and enhanced metastatic potential.  This review seeks to evaluate the evidence supporting the WNT pathway in cancer, the therapeutic strategies in modulating this pathway, and potential challenges in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovtyZMAmAumrVg90H21EOLACvtfcHk0li_IJo28y8y-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1GmsL4%253D&md5=bc6a05a448bde55a59013c405063a4ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2015-0057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2015-0057%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DArcaroli%26aufirst%3DJ.%26aulast%3DVanderbilt%26aufirst%3DC.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DLieu%26aufirst%3DC.%2BH.%26atitle%3DTargeting%2520the%2520WNT%2520signaling%2520pathway%2520in%2520cancer%2520therapeutics%26jtitle%3DOncologist%26date%3D2015%26volume%3D20%26spage%3D1189%26epage%3D1198%26doi%3D10.1634%2Ftheoncologist.2015-0057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bafico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span> <span> </span><span class="NLM_article-title">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ccr.2004.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15542433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=497-506&author=A.+Baficoauthor=G.+Liuauthor=L.+Goldinauthor=V.+Harrisauthor=S.+A.+Aaronson&title=An+autocrine+mechanism+for+constitutive+Wnt+pathway+activation+in+human+cancer+cells&doi=10.1016%2Fj.ccr.2004.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span></div><div class="casAuthors">Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer.  In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of β-catenin without mutations afflicting downstream components.  Extracellular Wnt antagonists FRP1 and DKK1 caused a dramatic downregulation of β-catenin levels in these tumor cells assocd. with alteration of biol. properties and increased expression of epithelial differentiation markers.  Colorectal carcinoma cells with knockout of the mutant β-catenin allele retained upregulated β-catenin levels, which also could be inhibited by these Wnt antagonists.  Together, these findings establish the involvement of autocrine Wnt signaling in human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPoqwc2vXarVg90H21EOLACvtfcHk0lh-C1H9Oo9IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO&md5=d120566809d1ee0f6474a22eff99630d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DBafico%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldin%26aufirst%3DL.%26aulast%3DHarris%26aufirst%3DV.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DAn%2520autocrine%2520mechanism%2520for%2520constitutive%2520Wnt%2520pathway%2520activation%2520in%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D497%26epage%3D506%26doi%3D10.1016%2Fj.ccr.2004.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span> <span> </span><span class="NLM_article-title">Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1038/nature07329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature07329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18806781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yju73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=1119-1123&author=G.+Linauthor=N.+Xuauthor=R.+Xi&title=Paracrine+Wingless+signalling+controls+self-renewal+of+Drosophila+intestinal+stem+cells&doi=10.1038%2Fnature07329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells</span></div><div class="casAuthors">Lin, Guonan; Xu, Na; Xi, Rongwen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7216</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the Drosophila midgut, multipotent intestinal stem cells (ISCs) that are scattered along the epithelial basement membrane maintain tissue homeostasis by their ability to steadily produce daughters that differentiate into either enterocytes or enteroendocrine cells, depending on the levels of Notch activity.  However, the mechanisms controlling ISC self-renewal remain elusive.  A canonical Wnt signaling pathway controls ISC self-renewal.  The ligand Wingless (Wg) is specifically expressed in the circular muscles next to ISCs, sepd. by a thin layer of basement membrane.  Reduced function of wg causes ISC quiescence and differentiation, whereas wg overexpression produces excessive ISC-like cells that express high levels of the Notch ligand, Delta.  Clonal anal. shows that the main downstream components of the Wg pathway, including Frizzled, Dishevelled and Armadillo, are autonomously required for ISC self-renewal.  Furthermore, epistatic anal. suggests that Notch acts downstream of the Wg pathway and a hierarchy of Wg/Notch signaling pathways controls the balance between self-renewal and differentiation of ISCs.  These data suggest that the underlying circular muscle constitutes the ISC niche, which produce Wg signals that act directly on ISCs to promote ISC self-renewal.  This study demonstrates markedly conserved mechanisms regulating ISCs from Drosophila to mammals.  The identification of the Drosophila ISC niche and the principal self-renewal signal will facilitate further understanding of intestinal homeostasis control and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SDgf1C7-arVg90H21EOLACvtfcHk0lh-C1H9Oo9IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yju73K&md5=2a701115a03841d361cfb025e04bef19</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature07329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07329%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DR.%26atitle%3DParacrine%2520Wingless%2520signalling%2520controls%2520self-renewal%2520of%2520Drosophila%2520intestinal%2520stem%2520cells%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature07329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">A genetic model for colorectal tumorigenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(90)90186-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2890%2990186-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2188735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1990&pages=759-767&author=E.+R.+Fearonauthor=B.+Vogelstein&title=A+genetic+model+for+colorectal+tumorigenesis&doi=10.1016%2F0092-8674%2890%2990186-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic model for colorectal tumorigenesis</span></div><div class="casAuthors">Fearon, Eric R.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 76 refs. on various genetic aspects of colonic neoplasia, including genetic alterations of oncogenes, clonal selection, allelic losses and tumor suppressor genes, multiple allelic losses, and accumulation and multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4CC_sLtNt7Vg90H21EOLACvtfcHk0lh-C1H9Oo9IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D&md5=d88588a58ce05a327c3e7ff8afccd3a7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990186-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990186-I%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DA%2520genetic%2520model%2520for%2520colorectal%2520tumorigenesis%26jtitle%3DCell%26date%3D1990%26volume%3D61%26spage%3D759%26epage%3D767%26doi%3D10.1016%2F0092-8674%2890%2990186-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span> <span> </span><span class="NLM_article-title">Molecular genetics of colorectal cancer</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1146%2Fannurev-pathol-011110-130235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21090969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVWrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=479-507&author=E.+R.+Fearon&title=Molecular+genetics+of+colorectal+cancer&doi=10.1146%2Fannurev-pathol-011110-130235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular genetics of colorectal cancer</span></div><div class="casAuthors">Fearon, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-507</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past three decades, mol. genetic studies have revealed some crit. mutations underlying the pathogenesis of the sporadic and inherited forms of colorectal cancer (CRC).  A relatively limited no. of oncogenes and tumor-suppressor genes-most prominently the APC, KRAS, and p53 genes-are mutated in a sizeable fraction of CRCs, and a larger collection of genes that are mutated in subsets of CRC have begun to be defined.  Together with DNA-methylation and chromatin-structure changes, the mutations act to dysregulate conserved signaling networks that exert context-dependent effects on crit. cell phenotypes, including the regulation of cellular metab., proliferation, differentiation, and survival.  Much work remains to be done to fully understand the nature and significance of the individual and collective genetic and epigenetic defects in CRC.  Some key concepts for the field have emerged, two of which are emphasized in this review.  Specifically, the gene defects in CRC often target proteins and pathways that exert pleiotropic effects on the cancer cell phenotype, and particular genetic and epigenetic alterations are linked to biol. and clin. distinct subsets of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNapMY1VRd2bVg90H21EOLACvtfcHk0lgwbjrgtrKjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVWrs7k%253D&md5=68a29f10d67e1dd153ca5cc6e2df8572</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130235%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26atitle%3DMolecular%2520genetics%2520of%2520colorectal%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2011%26volume%3D6%26spage%3D479%26epage%3D507%26doi%3D10.1146%2Fannurev-pathol-011110-130235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindtorff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutros, M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1461</span>– <span class="NLM_lpage">1473</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2016.304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27617575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2gsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1461-1473&author=T.+Zhanauthor=N.+Rindtorffauthor=M.+Boutros&title=Wnt+signaling+in+cancer&doi=10.1038%2Fonc.2016.304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in cancer</span></div><div class="casAuthors">Zhan, T.; Rindtorff, N.; Boutros, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1461-1473</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Wnt signaling is one of the key cascades regulating development and stemness, and has also been tightly assocd. with cancer.  The role of Wnt signaling in carcinogenesis has most prominently been described for colorectal cancer, but aberrant Wnt signaling is obsd. in many more cancer entities.  Here, we review current insights into novel components of Wnt pathways and describe their impact on cancer development.  Furthermore, we highlight expanding functions of Wnt signaling for both solid and liq. tumors.  We also describe current findings how Wnt signaling affects maintenance of cancer stem cells, metastasis and immune control.  Finally, we provide an overview of current strategies to antagonize Wnt signaling in cancer and challenges that are assocd. with such approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5DnHKAd0M3rVg90H21EOLACvtfcHk0lgwbjrgtrKjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2gsL3O&md5=abef967a4e295e8d997ea2f241b035bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.304%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DT.%26aulast%3DRindtorff%26aufirst%3DN.%26aulast%3DBoutros%26aufirst%3DM.%26atitle%3DWnt%2520signaling%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1461%26epage%3D1473%26doi%3D10.1038%2Fonc.2016.304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Differential expression of human <i>Wnt</i> genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=8168088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1ynsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=2615-2621&author=E.+L.+Huguetauthor=J.+A.+McMahonauthor=A.+P.+McMahonauthor=R.+Bicknellauthor=A.+L.+Harris&title=Differential+expression+of+human+Wnt+genes+2%2C+3%2C+4%2C+and+7B+in+human+breast+cell+lines+and+normal+and+disease+states+of+human+breast+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue</span></div><div class="casAuthors">Huguet, Emmanuel L.; McMahon, Jill A.; McMahon, Andrew P.; Bicknell, Roy; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2615-21</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Wnt gene expression was investigated by RNase protection anal. in human breast cancer, nontumorous breast tissue, and a variety of human breast cell lines.  The authors report the expression of Wnt3, Wnt4, and Wnt7b in human breast cell lines and Wnt2, Wnt3, Wnt4, and Wnt7b in human breast tissues.  Wnt3 and Wnt7a were absent in the cell lines and tissues tested.  The level of expression of Wnt2 and Wnt4 was 10- to 20-fold higher in fibroadenomas than it was in normal or malignant breast tissue, and in 10% of tumors Wnt7b expression was 30-fold higher than n normal or benign breast tissues.  In contrast to the mouse, in which Wnt1 and Wnt3 are involved in tumorigenesis, the authors' results suggest that Wnt2, Wnt4, and Wnt7b may be assocd. with abnormal proliferation in human breast tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN19X-Y5nL9bVg90H21EOLACvtfcHk0lgwbjrgtrKjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1ynsbc%253D&md5=fc2a49c10fe1bf78e17d64b394ef0924</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuguet%26aufirst%3DE.%2BL.%26aulast%3DMcMahon%26aufirst%3DJ.%2BA.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DBicknell%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520expression%2520of%2520human%2520Wnt%2520genes%25202%252C%25203%252C%25204%252C%2520and%25207B%2520in%2520human%2520breast%2520cell%2520lines%2520and%2520normal%2520and%2520disease%2520states%2520of%2520human%2520breast%2520tissue%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D2615%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wend, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wend, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchondo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yesayan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loddenkemper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentolila, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda-Carboni, G. A.</span></span> <span> </span><span class="NLM_article-title">WNT10B/beta-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Femmm.201201320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23307470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=264-279&author=P.+Wendauthor=S.+Runkeauthor=K.+Wendauthor=B.+Anchondoauthor=M.+Yesayanauthor=M.+Jardonauthor=N.+Hardieauthor=C.+Loddenkemperauthor=I.+Ulasovauthor=M.+S.+Lesniakauthor=R.+Wolskyauthor=L.+A.+Bentolilaauthor=S.+G.+Grantauthor=D.+Elashoffauthor=S.+Lehrauthor=J.+J.+Latimerauthor=S.+Boseauthor=H.+Sattarauthor=S.+A.+Krumauthor=G.+A.+Miranda-Carboni&title=WNT10B%2Fbeta-catenin+signalling+induces+HMGA2+and+proliferation+in+metastatic+triple-negative+breast+cancer&doi=10.1002%2Femmm.201201320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer</span></div><div class="casAuthors">Wend, Peter; Runke, Stephanie; Wend, Korinna; Anchondo, Brenda; Yesayan, Maria; Jardon, Meghan; Hardie, Natalie; Loddenkemper, Christoph; Ulasov, Ilya; Lesniak, Maciej S.; Wolsky, Rebecca; Bentolila, Laurent A.; Grant, Stephen G.; Elashoff, David; Lehr, Stephan; Latimer, Jean J.; Bose, Shikha; Sattar, Husain; Krum, Susan A.; Miranda-Carboni, Gustavo A.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-279</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt/β-catenin signalling has been suggested to be active in basal-like breast cancer.  However, in highly aggressive metastatic triple-neg. breast cancers (TNBC) the role of β-catenin and the underlying mechanism(s) for the aggressiveness of TNBC remain unknown.  We illustrate that WNT10B induces transcriptionally active β-catenin in human TNBC and predicts survival-outcome of patients with both TNBC and basal-like tumors.  We provide evidence that transgenic murine Wnt10b-driven tumors are devoid of ERα, PR and HER2 expression and can model human TNBC.  Importantly, HMGA2 is specifically expressed during early stages of embryonic mammogenesis and absent when WNT10B expression is lost, suggesting a developmentally conserved mode of action.  Mechanistically, ChIP anal. uncovered that WNT10B activates canonical β-catenin signalling leading to up-regulation of HMGA2.  Treatment of mouse and human triple-neg. tumor cells with two Wnt/β-catenin pathway modulators or siRNA to HMGA2 decreases HMGA2 levels and proliferation.  We demonstrate that WNT10B has epistatic activity on HMGA2, which is necessary and sufficient for proliferation of TNBC cells.  Furthermore, HMGA2 expression predicts relapse-free-survival and metastasis in TNBC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIglwkRBu1a7Vg90H21EOLACvtfcHk0lgpQLV8sGMe9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyktbo%253D&md5=daab997602f31e4eff201deb3051df49</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201320%26sid%3Dliteratum%253Aachs%26aulast%3DWend%26aufirst%3DP.%26aulast%3DRunke%26aufirst%3DS.%26aulast%3DWend%26aufirst%3DK.%26aulast%3DAnchondo%26aufirst%3DB.%26aulast%3DYesayan%26aufirst%3DM.%26aulast%3DJardon%26aufirst%3DM.%26aulast%3DHardie%26aufirst%3DN.%26aulast%3DLoddenkemper%26aufirst%3DC.%26aulast%3DUlasov%26aufirst%3DI.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26aulast%3DWolsky%26aufirst%3DR.%26aulast%3DBentolila%26aufirst%3DL.%2BA.%26aulast%3DGrant%26aufirst%3DS.%2BG.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DLehr%26aufirst%3DS.%26aulast%3DLatimer%26aufirst%3DJ.%2BJ.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DSattar%26aufirst%3DH.%26aulast%3DKrum%26aufirst%3DS.%2BA.%26aulast%3DMiranda-Carboni%26aufirst%3DG.%2BA.%26atitle%3DWNT10B%252Fbeta-catenin%2520signalling%2520induces%2520HMGA2%2520and%2520proliferation%2520in%2520metastatic%2520triple-negative%2520breast%2520cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D264%26epage%3D279%26doi%3D10.1002%2Femmm.201201320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spohn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span> <span> </span><span class="NLM_article-title">Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4266</span>, <span class="refDoi"> DOI: 10.1073/pnas.060025397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.060025397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10759547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4262-4266&author=S.+Y.+Linauthor=W.+Xiaauthor=J.+C.+Wangauthor=K.+Y.+Kwongauthor=B.+Spohnauthor=Y.+Wenauthor=R.+G.+Pestellauthor=M.+C.+Hung&title=Beta-catenin%2C+a+novel+prognostic+marker+for+breast+cancer%3A+its+roles+in+cyclin+D1+expression+and+cancer+progression&doi=10.1073%2Fpnas.060025397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression</span></div><div class="casAuthors">Lin, Shiaw-Yih; Xia, Weiya; Wang, Jo C.; Kwong, Ka Yin; Spohn, Bill; Wen, Yong; Pestell, Richard G.; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4262-4266</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">β-Catenin can function as an oncogene when it is translocated to the nucleus, binds to T cell factor or lymphoid enhancer factor family members, and transactivates its target genes.  In this study, the authors demonstrate that cyclin D1 is one of the targets of β-catenin in breast cancer cells.  Transactivation of β-catenin correlated significantly with cyclin D1 expression both in eight breast cell lines in vitro and in 123 patient samples.  More importantly, the authors found that high β-catenin activity significantly correlated with poor prognosis of the patients and was a strong and independent prognostic factor in breast cancer.  The authors' studies, therefore, indicated that β-catenin can be involved in breast cancer formation and/or progression and may serve as a target for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonlL8mUVXDjbVg90H21EOLACvtfcHk0lgpQLV8sGMe9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSnsr4%253D&md5=62c595a192c6fb5fbeb582db0140e341</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.060025397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.060025397%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DKwong%26aufirst%3DK.%2BY.%26aulast%3DSpohn%26aufirst%3DB.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26aulast%3DHung%26aufirst%3DM.%2BC.%26atitle%3DBeta-catenin%252C%2520a%2520novel%2520prognostic%2520marker%2520for%2520breast%2520cancer%253A%2520its%2520roles%2520in%2520cyclin%2520D1%2520expression%2520and%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4262%26epage%3D4266%26doi%3D10.1073%2Fpnas.060025397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, G.</span></span> <span> </span><span class="NLM_article-title">LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">5136</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1073/pnas.0911220107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0911220107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20194742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=5136-5141&author=C.+C.+Liuauthor=J.+Priorauthor=D.+Piwnica-Wormsauthor=G.+Bu&title=LRP6+overexpression+defines+a+class+of+breast+cancer+subtype+and+is+a+target+for+therapy&doi=10.1073%2Fpnas.0911220107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy</span></div><div class="casAuthors">Liu, Chia-Chen; Prior, Julie; Piwnica-Worms, David; Bu, Guojun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5136-5141, S5136/1-S5136/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway is activated in breast cancer, a leading cause of cancer mortality in women.  Because mutations in the key intracellular components of this pathway are rare, identifying the mol. mechanisms of aberrant Wnt activation in breast cancer is crit. for development of pathway-targeted therapy.  Here, we show that expression of the Wnt signaling coreceptor LRP6 is upregulated in a subpopulation of human breast cancers.  LRP6 silencing in breast cancer cells reduces Wnt signaling, cell proliferation, and in vivo tumor growth.  In vivo administration of an LRP6 antagonist, Mesd, markedly suppressed growth of MMTV-Wnt1 tumors without causing undesirable side effects.  These results demonstrate that Wnt activation at the cell surface contributes to breast cancer tumorigenesis.  Together, our studies highlight LRP6 as a potential therapeutic target in breast cancer, and introduce Mesd as a promising antitumor agent for treating breast cancer subtypes with Wnt activation at the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqewdoR2h7bVg90H21EOLACvtfcHk0lggmLl_2CebWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFGntbo%253D&md5=e97aee8ef764393f9266ac97b2c040f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0911220107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0911220107%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DPrior%26aufirst%3DJ.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DBu%26aufirst%3DG.%26atitle%3DLRP6%2520overexpression%2520defines%2520a%2520class%2520of%2520breast%2520cancer%2520subtype%2520and%2520is%2520a%2520target%2520for%2520therapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D5136%26epage%3D5141%26doi%3D10.1073%2Fpnas.0911220107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somlo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, Y.</span></span> <span> </span><span class="NLM_article-title">FZD7 has a critical role in cell proliferation in triple negative breast cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">4437</span>– <span class="NLM_lpage">4446</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2011.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21532620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4437-4446&author=L.+Yangauthor=X.+Wuauthor=Y.+Wangauthor=K.+Zhangauthor=J.+Wuauthor=Y.+C.+Yuanauthor=X.+Dengauthor=L.+Chenauthor=C.+C.+Kimauthor=S.+Lauauthor=G.+Somloauthor=Y.+Yen&title=FZD7+has+a+critical+role+in+cell+proliferation+in+triple+negative+breast+cancer&doi=10.1038%2Fonc.2011.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">FZD7 has a critical role in cell proliferation in triple negative breast cancer</span></div><div class="casAuthors">Yang, L.; Wu, X.; Wang, Y.; Zhang, K.; Wu, J.; Yuan, Y-C.; Deng, X.; Chen, L.; Kim, C. C. H.; Lau, S.; Somlo, G.; Yen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4437-4446</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Breast cancer is genetically and clin. heterogeneous.  Triple neg. breast cancer (TNBC) is a subtype of breast cancer that is usually assocd. with poor outcome and lack of benefit from targeted therapy.  We used microarray anal. to perform a pathway anal. of TNBC compared with non-triple neg. breast cancer (non-TNBC).  Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low d. lipoprotein receptor-related protein 6 and transcription factor 7 (TCF7) was obsd. in TNBC, and we directed our focus to the Wnt pathway receptor, FZD7.  To validate the function of FZD7, FZD7shRNA was used to knock down FZD7 expression.  Notably, reduced cell proliferation and suppressed invasiveness and colony formation were obsd. in TNBC MDA-MB-231 and BT-20 cells.  Study of the possible mechanism indicated that these effects occurred through silencing of the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of β-catenin and decreased transcriptional activity of TCF7.  In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts without FZD7 expression.  Our findings suggest that FZD7-involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC, and thus, FZD7 shows promise as a biomarker and a potential therapeutic target for TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwcoa3WO2erVg90H21EOLACvtfcHk0lggmLl_2CebWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGlsLY%253D&md5=f8931e5d9d38dfd4abfd1db9cf8c8037</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DY.%2BC.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DC.%2BC.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DYen%26aufirst%3DY.%26atitle%3DFZD7%2520has%2520a%2520critical%2520role%2520in%2520cell%2520proliferation%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D4437%26epage%3D4446%26doi%3D10.1038%2Fonc.2011.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, W. L.</span></span> <span> </span><span class="NLM_article-title">Epigenetic gene silencing in the Wnt pathway in breast cancer</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.4161/epi.3.2.5899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.4161%2Fepi.3.2.5899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18398311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD1czmvVKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=59-63&author=G.+J.+Klarmannauthor=A.+Deckerauthor=W.+L.+Farrar&title=Epigenetic+gene+silencing+in+the+Wnt+pathway+in+breast+cancer&doi=10.4161%2Fepi.3.2.5899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic gene silencing in the Wnt pathway in breast cancer</span></div><div class="casAuthors">Klarmann George J; Decker Amy; Farrar William L</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the most common malignancies in women.  Despite advances in treatment of endocrine-dependent tumors, the complete molecular basis of transformation is still unknown.  What is clear is that a variety of genetic lesions and epigenetic modifications are present in the neoplasm.  Disregulation of several signaling pathways is known to be associated with breast cancer development, among them is the wingless and integration site growth factor (Wnt) pathway.  While genetic mutations of certain components of this pathway, such as APC, are significant contributing factors for colorectal cancers, they are typically not the predominate mechanism associated with breast cancer.  Instead, it appears that DNA hypermethylation leads to aberrant regulation of the Wnt pathway in breast cancer, and as such, this review focuses on the epigenetic regulation of Wnt pathway components in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBeaLtFoQ8kI2y4bB4mnvYfW6udTcc2eZW6QGbfA9ejbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czmvVKgtA%253D%253D&md5=81310f7369d65c9b525773c02a9756bb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4161%2Fepi.3.2.5899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.3.2.5899%26sid%3Dliteratum%253Aachs%26aulast%3DKlarmann%26aufirst%3DG.%2BJ.%26aulast%3DDecker%26aufirst%3DA.%26aulast%3DFarrar%26aufirst%3DW.%2BL.%26atitle%3DEpigenetic%2520gene%2520silencing%2520in%2520the%2520Wnt%2520pathway%2520in%2520breast%2520cancer%26jtitle%3DEpigenetics%26date%3D2008%26volume%3D3%26spage%3D59%26epage%3D63%26doi%3D10.4161%2Fepi.3.2.5899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonigro, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosquera, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taplin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abida, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vats, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunju, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathkopf, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balk, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaviola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sougnez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostaghel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">True, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plymate, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvinge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraldeschi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafeiriou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunariu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demichelis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanus, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagawa, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigaras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elemento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sboner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantoff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span> <span> </span><span class="NLM_article-title">Integrative clinical genomics of advanced prostate cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2015.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26000489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Sgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1215-1228&author=D.+Robinsonauthor=E.+M.+Van+Allenauthor=Y.+M.+Wuauthor=N.+Schultzauthor=R.+J.+Lonigroauthor=J.+M.+Mosqueraauthor=B.+Montgomeryauthor=M.+E.+Taplinauthor=C.+C.+Pritchardauthor=G.+Attardauthor=H.+Beltranauthor=W.+Abidaauthor=R.+K.+Bradleyauthor=J.+Vinsonauthor=X.+Caoauthor=P.+Vatsauthor=L.+P.+Kunjuauthor=M.+Hussainauthor=F.+Y.+Fengauthor=S.+A.+Tomlinsauthor=K.+A.+Cooneyauthor=D.+C.+Smithauthor=C.+Brennanauthor=J.+Siddiquiauthor=R.+Mehraauthor=Y.+Chenauthor=D.+E.+Rathkopfauthor=M.+J.+Morrisauthor=S.+B.+Solomonauthor=J.+C.+Durackauthor=V.+E.+Reuterauthor=A.+Gopalanauthor=J.+Gaoauthor=M.+Lodaauthor=R.+T.+Lisauthor=M.+Bowdenauthor=S.+P.+Balkauthor=G.+Gaviolaauthor=C.+Sougnezauthor=M.+Guptaauthor=E.+Y.+Yuauthor=E.+A.+Mostaghelauthor=H.+H.+Chengauthor=H.+Mulcahyauthor=L.+D.+Trueauthor=S.+R.+Plymateauthor=H.+Dvingeauthor=R.+Ferraldeschiauthor=P.+Flohrauthor=S.+Mirandaauthor=Z.+Zafeiriouauthor=N.+Tunariuauthor=J.+Mateoauthor=R.+Perez-Lopezauthor=F.+Demichelisauthor=B.+D.+Robinsonauthor=M.+Schiffmanauthor=D.+M.+Nanusauthor=S.+T.+Tagawaauthor=A.+Sigarasauthor=K.+W.+Engauthor=O.+Elementoauthor=A.+Sbonerauthor=E.+I.+Heathauthor=H.+I.+Scherauthor=K.+J.+Pientaauthor=P.+Kantoffauthor=J.+S.+de+Bonoauthor=M.+A.+Rubinauthor=P.+S.+Nelsonauthor=L.+A.+Garrawayauthor=C.+L.+Sawyersauthor=A.+M.+Chinnaiyan&title=Integrative+clinical+genomics+of+advanced+prostate+cancer&doi=10.1016%2Fj.cell.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Integrative clinical genomics of advanced prostate cancer</span></div><div class="casAuthors">Robinson, Dan; Van Allen, Eliezer M.; Wu, Yi-Mi; Schultz, Nikolaus; Lonigro, Robert J.; Mosquera, Juan-Miguel; Montgomery, Bruce; Taplin, Mary-Ellen; Pritchard, Colin C.; Attard, Gerhardt; Beltran, Himisha; Abida, Wassim; Bradley, Robert K.; Vinson, Jake; Cao, Xuhong; Vats, Pankaj; Kunju, Lakshmi P.; Hussain, Maha; Feng, Felix Y.; Tomlins, Scott A.; Cooney, Kathleen A.; Smith, David C.; Brennan, Christine; Siddiqui, Javed; Mehra, Rohit; Chen, Yu; Rathkopf, Dana E.; Morris, Michael J.; Solomon, Stephen B.; Durack, Jeremy C.; Reuter, Victor E.; Gopalan, Anuradha; Gao, Jianjiong; Loda, Massimo; Lis, Rosina T.; Bowden, Michaela; Balk, Stephen P.; Gaviola, Glenn; Sougnez, Carrie; Gupta, Manaswi; Yu, Evan Y.; Mostaghel, Elahe A.; Cheng, Heather H.; Mulcahy, Hyojeong; True, Lawrence D.; Plymate, Stephen R.; Dvinge, Heidi; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; Demichelis, Francesca; Robinson, Brian D.; Schiffman, Marc; Nanus, David M.; Tagawa, Scott T.; Sigaras, Alexandros; Eng, Kenneth W.; Elemento, Olivier; Sboner, Andrea; Heath, Elisabeth I.; Scher, Howard I.; Pienta, Kenneth J.; Kantoff, Philip; de Bono, Johann S.; Rubin, Mark A.; Nelson, Peter S.; Garraway, Levi A.; Sawyers, Charles L.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1215-1228</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established a multi-institutional clin. sequencing infrastructure to conduct prospective whole-exome and transcriptome sequencing of bone or soft tissue tumor biopsies from a cohort of 150 mCRPC affected individuals.  Aberrations of AR, ETS genes, TP53, and PTEN were frequent (40%-60% of cases), with TP53 and AR alterations enriched in mCRPC compared to primary prostate cancer.  We identified new genomic alterations in PIK3CA/B, R-spondin, BRAF/RAF1, APC, β-catenin, and ZBTB16/PLZF.  Moreover, aberrations of BRCA2, BRCA1, and ATM were obsd. at substantially higher frequencies (19.3% overall) compared to those in primary prostate cancers. 89% of affected individuals harbored a clin. actionable aberration, including 62.7% with aberrations in AR, 65% in other cancer-related genes, and 8% with actionable pathogenic germline alterations.  This cohort study provides clin. actionable information that could impact treatment decisions for these affected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewpXHDFXwNrVg90H21EOLACvtfcHk0lhA2J_v3Ow-Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Sgt7w%253D&md5=11155c903c7699036c56482d39097fb6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DMosquera%26aufirst%3DJ.%2BM.%26aulast%3DMontgomery%26aufirst%3DB.%26aulast%3DTaplin%26aufirst%3DM.%2BE.%26aulast%3DPritchard%26aufirst%3DC.%2BC.%26aulast%3DAttard%26aufirst%3DG.%26aulast%3DBeltran%26aufirst%3DH.%26aulast%3DAbida%26aufirst%3DW.%26aulast%3DBradley%26aufirst%3DR.%2BK.%26aulast%3DVinson%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DVats%26aufirst%3DP.%26aulast%3DKunju%26aufirst%3DL.%2BP.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DCooney%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRathkopf%26aufirst%3DD.%2BE.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSolomon%26aufirst%3DS.%2BB.%26aulast%3DDurack%26aufirst%3DJ.%2BC.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DLis%26aufirst%3DR.%2BT.%26aulast%3DBowden%26aufirst%3DM.%26aulast%3DBalk%26aufirst%3DS.%2BP.%26aulast%3DGaviola%26aufirst%3DG.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DE.%2BY.%26aulast%3DMostaghel%26aufirst%3DE.%2BA.%26aulast%3DCheng%26aufirst%3DH.%2BH.%26aulast%3DMulcahy%26aufirst%3DH.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26aulast%3DDvinge%26aufirst%3DH.%26aulast%3DFerraldeschi%26aufirst%3DR.%26aulast%3DFlohr%26aufirst%3DP.%26aulast%3DMiranda%26aufirst%3DS.%26aulast%3DZafeiriou%26aufirst%3DZ.%26aulast%3DTunariu%26aufirst%3DN.%26aulast%3DMateo%26aufirst%3DJ.%26aulast%3DPerez-Lopez%26aufirst%3DR.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DB.%2BD.%26aulast%3DSchiffman%26aufirst%3DM.%26aulast%3DNanus%26aufirst%3DD.%2BM.%26aulast%3DTagawa%26aufirst%3DS.%2BT.%26aulast%3DSigaras%26aufirst%3DA.%26aulast%3DEng%26aufirst%3DK.%2BW.%26aulast%3DElemento%26aufirst%3DO.%26aulast%3DSboner%26aufirst%3DA.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DKantoff%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DP.%2BS.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DIntegrative%2520clinical%2520genomics%2520of%2520advanced%2520prostate%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1215%26epage%3D1228%26doi%3D10.1016%2Fj.cell.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quist, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonigro, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asangani, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ateeq, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prensner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palanisamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryslik, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunju, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span> <span> </span><span class="NLM_article-title">The mutational landscape of lethal castration-resistant prostate cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1038/nature11125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature11125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22722839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWisLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=239-243&author=C.+S.+Grassoauthor=Y.+M.+Wuauthor=D.+R.+Robinsonauthor=X.+Caoauthor=S.+M.+Dhanasekaranauthor=A.+P.+Khanauthor=M.+J.+Quistauthor=X.+Jingauthor=R.+J.+Lonigroauthor=J.+C.+Brennerauthor=I.+A.+Asanganiauthor=B.+Ateeqauthor=S.+Y.+Chunauthor=J.+Siddiquiauthor=L.+Samauthor=M.+Anstettauthor=R.+Mehraauthor=J.+R.+Prensnerauthor=N.+Palanisamyauthor=G.+A.+Ryslikauthor=F.+Vandinauthor=B.+J.+Raphaelauthor=L.+P.+Kunjuauthor=D.+R.+Rhodesauthor=K.+J.+Pientaauthor=A.+M.+Chinnaiyanauthor=S.+A.+Tomlins&title=The+mutational+landscape+of+lethal+castration-resistant+prostate+cancer&doi=10.1038%2Fnature11125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The mutational landscape of lethal castration-resistant prostate cancer</span></div><div class="casAuthors">Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Anstett, Matt; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Ryslik, Gregory A.; Vandin, Fabio; Raphael, Benjamin J.; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7406</span>),
    <span class="NLM_cas:pages">239-243</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Characterization of the prostate cancer transcriptome and genome has identified chromosomal rearrangements and copy no. gains and losses, including ETS gene family fusions, PTEN loss and androgen receptor (AR) amplification, which drive prostate cancer development and progression to lethal, metastatic castration-resistant prostate cancer (CRPC).  However, less is known about the role of mutations.  Here we sequenced the exomes of 50 lethal, heavily pre-treated metastatic CRPCs obtained at rapid autopsy (including three different foci from the same patient) and 11 treatment-naive, high-grade localized prostate cancers.  We identified low overall mutation rates even in heavily treated CRPCs (2.00 per megabase) and confirmed the monoclonal origin of lethal CRPC.  Integrating exome copy no. anal. identified disruptions of CHD1 that define a subtype of ETS gene family fusion-neg. prostate cancer.  Similarly, we demonstrate that ETS2, which is deleted in approx. one-third of CRPCs (commonly through TMPRSS2:ERG fusions), is also deregulated through mutation.  Furthermore, we identified recurrent mutations in multiple chromatin- and histone-modifying genes, including MLL2 (mutated in 8.6% of prostate cancers), and demonstrate interaction of the MLL complex with the AR, which is required for AR-mediated signaling.  We also identified novel recurrent mutations in the AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers (both untreated localized prostate cancer and CRPC), and showed that mutated FOXA1 represses androgen signaling and increases tumor growth.  Proteins that phys. interact with the AR, such as the ERG gene fusion product, FOXA1, MLL2, UTX (also known as KDM6A) and ASXL1 were found to be mutated in CRPC.  In summary, we describe the mutational landscape of a heavily treated metastatic cancer, identify novel mechanisms of AR signaling deregulated in prostate cancer, and prioritize candidates for future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzVYOnnaqVLVg90H21EOLACvtfcHk0li6rCSTcja7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWisLfP&md5=15b1780d9cd2189325baf4e4fec84687</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature11125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11125%26sid%3Dliteratum%253Aachs%26aulast%3DGrasso%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DKhan%26aufirst%3DA.%2BP.%26aulast%3DQuist%26aufirst%3DM.%2BJ.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DAteeq%26aufirst%3DB.%26aulast%3DChun%26aufirst%3DS.%2BY.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DSam%26aufirst%3DL.%26aulast%3DAnstett%26aufirst%3DM.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DPalanisamy%26aufirst%3DN.%26aulast%3DRyslik%26aufirst%3DG.%2BA.%26aulast%3DVandin%26aufirst%3DF.%26aulast%3DRaphael%26aufirst%3DB.%2BJ.%26aulast%3DKunju%26aufirst%3DL.%2BP.%26aulast%3DRhodes%26aufirst%3DD.%2BR.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26atitle%3DThe%2520mutational%2520landscape%2520of%2520lethal%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D239%26epage%3D243%26doi%3D10.1038%2Fnature11125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
La Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billuart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrane, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldjord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, C.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8847</span>– <span class="NLM_lpage">8851</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.15.8847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.95.15.8847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9671767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8847-8851&author=A.+de%0ALa+Costeauthor=B.+Romagnoloauthor=P.+Billuartauthor=C.+A.+Renardauthor=M.+A.+Buendiaauthor=O.+Soubraneauthor=M.+Fabreauthor=J.+Chellyauthor=C.+Beldjordauthor=A.+Kahnauthor=C.+Perret&title=Somatic+mutations+of+the+beta-catenin+gene+are+frequent+in+mouse+and+human+hepatocellular+carcinomas&doi=10.1073%2Fpnas.95.15.8847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas</span></div><div class="casAuthors">De La Coste, Alix; Romagnolo, Beatrice; Billuart, Pierre; Renard, Claire-Angelique; Buendia, Marie-Annick; Soubrane, Olivier; Fabre, Monique; Chelly, Jamel; Beldjord, Cherif; Kahn, Axel; Perret, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8847-8851</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the major primary malignant tumor in the human liver, but the mol. changes leading to liver cell transformation remain largely unknown.  The Wnt-β-catenin pathway is activated in colon cancers and some melanoma cell lines, but has not yet been investigated in HCC.  The authors have examd. the status of the β-catenin gene in different transgenic mouse lines of HCC obtained with the oncogenes c-myc or H-ras.  Fifty percent of the hepatic tumors in these transgenic mice had activating somatic mutations within the β-catenin gene similar to those found in colon cancers and melanomas.  These alterations in the β-catenin gene (point mutations or deletions) lead to a dysregulation of the signaling function of β-catenin and thus to carcinogenesis.  The authors then analyzed human HCCs and found similar mutations in eight of 31 (26%) human liver tumors tested and in HepG2 and HuH6 hepatoma cells.  The mutations led to the accumulation of β-catenin in the nucleus.  Thus alterations in the β-catenin gene frequently are selected for during liver tumorigenesis and suggest that dysregulation of the Wnt-β-catenin pathway is a major event in the development of HCC in humans and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vBi5Xd806LVg90H21EOLACvtfcHk0li6rCSTcja7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFaltrk%253D&md5=f4621e5c36e490cf39ca8a24341908b3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8847%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLa%2BCoste%26aufirst%3DA.%26aulast%3DRomagnolo%26aufirst%3DB.%26aulast%3DBilluart%26aufirst%3DP.%26aulast%3DRenard%26aufirst%3DC.%2BA.%26aulast%3DBuendia%26aufirst%3DM.%2BA.%26aulast%3DSoubrane%26aufirst%3DO.%26aulast%3DFabre%26aufirst%3DM.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBeldjord%26aufirst%3DC.%26aulast%3DKahn%26aufirst%3DA.%26aulast%3DPerret%26aufirst%3DC.%26atitle%3DSomatic%2520mutations%2520of%2520the%2520beta-catenin%2520gene%2520are%2520frequent%2520in%2520mouse%2520and%2520human%2520hepatocellular%2520carcinomas%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8847%26epage%3D8851%26doi%3D10.1073%2Fpnas.95.15.8847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kameyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9500465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=1021-1026&author=K.+Iwaoauthor=S.+Nakamoriauthor=M.+Kameyamaauthor=S.+Imaokaauthor=M.+Kinoshitaauthor=T.+Fukuiauthor=S.+Ishiguroauthor=Y.+Nakamuraauthor=Y.+Miyoshi&title=Activation+of+the+beta-catenin+gene+by+interstitial+deletions+involving+exon+3+in+primary+colorectal+carcinomas+without+adenomatous+polyposis+coli+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations</span></div><div class="casAuthors">Iwao, Kyoko; Nakamori, Syoji; Kameyama, Masao; Imaoka, Shingi; Kinoshita, Moritoshi; Fukui, Takafumi; Ishiguro, Shingo; Nakamura, Yusuke; Miyoshi, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1026</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Among 222 primary colorectal cancers we examd., 58 showed no detectable APC mutations by the protein truncation test.  Those 58 tumors were screened for somatic mutations in the β-catenin gene.  Although amino acid substitutions in serine or threonine residues in exon 3 had been reported, no such mutations were found; however, in 7 tumors, somatic interstitial deletions of 234-760 bp were found, each of which included all or part of exon 3.  Short nucleotide sequences at both ends of each deletion were either identical or complementary, indicating that repeated or inversely repeated sequences were involved in the somatic rearrangements.  Reverse transcription-PCR expts. using RNAs isolated from 3 of these 7 tumors detected transcripts that lacked exon 3, in addn. to the normal transcript.  In one of these cases, accumulation of aberrant β-catenin protein in cytoplasm and nuclei of cancer cells was confirmed by Western and immunohistochem. analyses.  This result suggested that, in the absence of a peptide encoded by exon 3, β-catenin is stabilized and has a dominant oncogenic effect on colorectal tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLIb1VXiKnKbVg90H21EOLACvtfcHk0ljI__o5iR2HfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFersL4%253D&md5=2ed6252edb14321accef5585479083f6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwao%26aufirst%3DK.%26aulast%3DNakamori%26aufirst%3DS.%26aulast%3DKameyama%26aufirst%3DM.%26aulast%3DImaoka%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMiyoshi%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520beta-catenin%2520gene%2520by%2520interstitial%2520deletions%2520involving%2520exon%25203%2520in%2520primary%2520colorectal%2520carcinomas%2520without%2520adenomatous%2520polyposis%2520coli%2520mutations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D1021%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zurawel, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiappa, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffel, C.</span></span> <span> </span><span class="NLM_article-title">Sporadic medulloblastomas contain oncogenic β-catenin mutations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9500446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=896-899&author=R.+H.+Zurawelauthor=S.+A.+Chiappaauthor=C.+Allenauthor=C.+Raffel&title=Sporadic+medulloblastomas+contain+oncogenic+%CE%B2-catenin+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sporadic medulloblastomas contain oncogenic β-catenin mutations</span></div><div class="casAuthors">Zurawel, Russell H.; Chiappa, Sharon A.; Allen, Cory; Raffel, Corey</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">896-899</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The β-catenin, glycogen synthase kinase 3β (GSK-3β), and adenomatous polyposis coli (APC) gene products interact to form a network that influences the rate of cell proliferation.  Medulloblastoma occurs as part of Turcot's syndrome, and patients with Turcot's who develop medulloblastomas have been shown to harbor germ-line APC mutations.  Although APC mutations have been investigated and not identified in sporadic medulloblastomas, the status of the β-catenin and GSK-3β genes has not been evaluated in this tumor.  Here we show that 3 of 67 medulloblastomas harbor β-catenin mutations, each of which converts a GSK-3β phosphorylation site from serine to cysteine.  The β-catenin mutation seen in the tumors was not present in matched constitutional DNA in the two cases where matched DNA was available.  A loss of heterozygosity anal. of 32 medulloblastomas with paired normal DNA samples was performed with four microsatellite markers flanking the GSK-3β locus; loss of heterozygosity with at least one marker was identified in 7 tumors.  Sequencing of the remaining GSK-3β allele in these cases failed to identify any mutations.  Taken together, these data suggest that activating mutations in the β-catenin gene may be involved in the development of a subset of medulloblastomas.  The GSK-3β gene does not appear to be a target for inactivation in this tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxedg6t4SfjLVg90H21EOLACvtfcHk0ljI__o5iR2HfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFersr8%253D&md5=bf043549310f5af6cd55c6225488305e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZurawel%26aufirst%3DR.%2BH.%26aulast%3DChiappa%26aufirst%3DS.%2BA.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DRaffel%26aufirst%3DC.%26atitle%3DSporadic%2520medulloblastomas%2520contain%2520oncogenic%2520%25CE%25B2-catenin%2520mutations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D896%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voeller, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truica, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmann, E. P.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mutations in human prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2520</span>– <span class="NLM_lpage">2523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9635571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXktVajt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2520-2523&author=H.+J.+Voellerauthor=C.+I.+Truicaauthor=E.+P.+Gelmann&title=%CE%B2-Catenin+mutations+in+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin mutations in human prostate cancer</span></div><div class="casAuthors">Voeller, H. James; Truica, Cristina I.; Gelmann, Edward P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2520-2523</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Catenin plays essential roles in both intercellular adhesion and signal transduction.  As a signaling mol., β-catenin supplies an activating domain to the T-cell factor/lymphoid enhancer-binding factor family of DNA-binding proteins and activates gene transcription.  Posttranslational stabilization of β-catenin, leading to elevated protein levels and constitutive gene activation, has been proposed as an important step in oncogenesis.  Stabilization of β-catenin can occur through mutation to highly conserved amino acids encoded in exon 3 of the β-catenin gene (CTNNB1).  To det. whether this pathway of malignant transformation is important in prostate cancer, we analyzed 104 prostate cancer tissue specimens, 4 prostate cancer cell lines, and 3 prostate tumor xenografts for activating mutations in exon 3 of CTNNB1.  Mutations were detected in 5 of the 104 prostate cancer tissue samples.  Four of the five mutations involved serine or threonine residues implicated in the degrdn. of β-catenin.  A fifth tumor had a mutation at codon 32, changing a highly conserved aspartic acid to a tyrosine.  Mutational anal. of multiple regions from several tumor samples showed that the β-catenin mutations were present focally and therefore may occur during tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vqM9ELrfR7Vg90H21EOLACvtfcHk0ljI__o5iR2HfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVajt70%253D&md5=66a78b4c65381851cde0e998e1da2be8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoeller%26aufirst%3DH.%2BJ.%26aulast%3DTruica%26aufirst%3DC.%2BI.%26aulast%3DGelmann%26aufirst%3DE.%2BP.%26atitle%3D%25CE%25B2-Catenin%2520mutations%2520in%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2520%26epage%3D2523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9635572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXktVajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2524-2527&author=Y.+Miyoshiauthor=K.+Iwaoauthor=Y.+Nagasawaauthor=T.+Aiharaauthor=Y.+Sasakiauthor=S.+Imaokaauthor=M.+Murataauthor=T.+Shimanoauthor=Y.+Nakamura&title=Activation+of+the+%CE%B2-catenin+gene+in+primary+hepatocellular+carcinomas+by+somatic+alterations+involving+exon+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3</span></div><div class="casAuthors">Miyoshi, Yasuo; Iwao, Kyoko; Nagasawa, Yutaka; Aihara, Tomohiko; Sasaki, Yo; Imaoka, Shingi; Murata, Masaru; Shimano, Takashi; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2524-2527</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We screened 75 primary hepatocellular carcinomas for somatic mutations in the entire coding region of the β-catenin gene.  We detected somatic mutations in 14 tumors; 12 were considered to cause amino acid substitutions and 2 were interstitial deletions of 51 or 195 nucleotides of genomic DNA, corresponding to exon 3.  Among the 12 point mutations, 6 occurred at potential serine/threonine phosphorylation residues of codons 33, 41, or 45.  The remaining six tumors contained a mutation at codon 32 (aspartic acid) or 34 (glycine), flanking to the serine residue at codon 33.  By Western blot anal., we confirmed accumulation of β-catenin in five tumors for which frozen tissues were available; the five included tumors in which amino acid alterations had occurred at codons 32, 34, or 45, and one with a 17-amino acid deletion.  Our results suggested that accumulation of β-catenin due to amino acid substitutions at potential serine/threonine phosphorylation residues or at their neighboring codons or interstitial deletions involving exon 3 could contribute to hepatocellular carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7m-OG8zR0-7Vg90H21EOLACvtfcHk0lgZXUXzEQapWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVajt7o%253D&md5=90e01c724bcc55b8c9f286ad554a52b6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DIwao%26aufirst%3DK.%26aulast%3DNagasawa%26aufirst%3DY.%26aulast%3DAihara%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DImaoka%26aufirst%3DS.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DShimano%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520%25CE%25B2-catenin%2520gene%2520in%2520primary%2520hepatocellular%2520carcinomas%2520by%2520somatic%2520alterations%2520involving%2520exon%25203%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2524%26epage%3D2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gat, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNiff, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, E.</span></span> <span> </span><span class="NLM_article-title">A common human skin tumour is caused by activating mutations in beta-catenin</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1038/7747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F7747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10192393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1MXitFKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=410-413&author=E.+F.+Chanauthor=U.+Gatauthor=J.+M.+McNiffauthor=E.+Fuchs&title=A+common+human+skin+tumour+is+caused+by+activating+mutations+in+beta-catenin&doi=10.1038%2F7747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A common human skin tumor is caused by activating mutations in β-catenin</span></div><div class="casAuthors">Chan, Edward F.; Gat, Uri; McNiff, Jennifer M.; Fuchs, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-413</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">WNT signaling orchestrates a no. of developmental programs.  In response to this stimulus, cytoplasmic β-catenin (encoded by CTNNB1) is stabilized, enabling downstream transcriptional activation by members of the LEF/TCF family.  One of the target genes for β-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon.  Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degrdn. of β-catenin, but a small percentage of colon and some other cancers harbor β-catenin-stabilizing mutations.  Recently, the authors discovered that transgenic mice expressing an activated β-catenin are predisposed to developing skin tumors resembling pilomatricomas.  Given that the skin of these adult mice also exhibits signs of de novo hair-follicle morphogenesis, human pilomatricomas might originate from hair matrix cells, and they might possess β-catenin-stabilizing mutations.  Here, the cell origin and etiol. of this common human skin tumor were explored.  Nuclear LEF-1 was found in the dividing tumor cells, providing biochem. evidence that pilomatricomas are derived from hair matrix cells.  At least 75% of these tumors possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degrdn. of the protein.  This percentage of CTNNB1 mutations is greater than in all other human tumors examd. thus far, and directly implicates β-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXAsTMyiZd6bVg90H21EOLACvtfcHk0lgZXUXzEQapWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFKrsL8%253D&md5=d87581007383aa50dabb60d3047a655c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2F7747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F7747%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DE.%2BF.%26aulast%3DGat%26aufirst%3DU.%26aulast%3DMcNiff%26aufirst%3DJ.%2BM.%26aulast%3DFuchs%26aufirst%3DE.%26atitle%3DA%2520common%2520human%2520skin%2520tumour%2520is%2520caused%2520by%2520activating%2520mutations%2520in%2520beta-catenin%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D410%26epage%3D413%26doi%3D10.1038%2F7747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mutation in carcinoma of the uterine endometrium</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9721853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=3526-3528&author=T.+Fukuchiauthor=M.+Sakamotoauthor=H.+Tsudaauthor=K.+Maruyamaauthor=S.+Nozawaauthor=S.+Hirohashi&title=%CE%B2-Catenin+mutation+in+carcinoma+of+the+uterine+endometrium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin mutation in carcinoma of the uterine endometrium</span></div><div class="casAuthors">Fukuchi, Takeshi; Sakamoto, Michiie; Tsuda, Hitoshi; Maruyama, Keiji; Nozawa, Shiro; Hirohashi, Setsuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3526-3528</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Catenin forms complexes with Tcf and Lef-1 and functions as a transcriptional activator downstream of the Wnt signaling pathway.  Activation of the pathway by stabilization of β-catenin has been shown to be important in the development of colorectal carcinoma, which is mainly caused by inactivating mutations of the adenomatous polyposis coli tumor suppressor gene or by activating mutations in exon 3 of the β-catenin gene.  Here, we analyzed mutations in exon 3 of the β-catenin gene in endometrial carcinoma cases in which loss of heterozygosity at the adenomatous polyposis coli tumor suppressor gene locus has been rarely reported.  We found that 10 of 76 cases had β-catenin gene mutations.  All mutations identified were single-base missense mutations on serine/threonine residues (codons 33, 37, 41, and 45), altering the glycogen synthase kinase-3β phosphorylation consensus motif, which participates in the degrdn. of β-catenin.  To det. whether these β-catenin mutations actually led to stabilization of this protein, expression of β-catenin was analyzed immunohistochem., and 9 of 10 cases with the β-catenin mutation and 20 of 66 cases without it showed accumulation of β-catenin in the cytoplasm and/or nucleus.  In total, 38% of cases showed accumulation of β-catenin.  These data indicate that stabilization of β-catenin due to mutations in exon 3 of the β-catenin gene and other mechanisms may have an important role in development of endometrial carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0N42QpYBp7Vg90H21EOLACvtfcHk0lgZXUXzEQapWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFajsbk%253D&md5=7ab581d912cbf01b0fabdd83e5c58d01</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DNozawa%26aufirst%3DS.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3D%25CE%25B2-Catenin%2520mutation%2520in%2520carcinoma%2520of%2520the%2520uterine%2520endometrium%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D3526%26epage%3D3528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonsdorf, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulikauskas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothberg, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimm, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1073/pnas.0811902106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0811902106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19144919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1193-1198&author=A.+J.+Chienauthor=E.+C.+Mooreauthor=A.+S.+Lonsdorfauthor=R.+M.+Kulikauskasauthor=B.+G.+Rothbergauthor=A.+J.+Bergerauthor=M.+B.+Majorauthor=S.+T.+Hwangauthor=D.+L.+Rimmauthor=R.+T.+Moon&title=Activated+Wnt%2Fbeta-catenin+signaling+in+melanoma+is+associated+with+decreased+proliferation+in+patient+tumors+and+a+murine+melanoma+model&doi=10.1073%2Fpnas.0811902106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model</span></div><div class="casAuthors">Chien, Andy J.; Moore, Erin C.; Lonsdorf, Anke S.; Kulikauskas, Rima M.; Rothberg, Bonnie Gould; Berger, Aaron J.; Major, Michael B.; Hwang, Sam T.; Rimm, David L.; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1193-1198</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This study demonstrates that in malignant melanoma, elevated levels of nuclear Β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer.  The redn. in proliferation obsd. in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-mol. activators of Β-catenin signaling.  Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice.  Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression.  These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/Β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive.  Our results may explain the obsd. loss of nuclear Β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/Β-catenin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAtr4lEONxrVg90H21EOLACvtfcHk0lh7sY08LQNhtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyisr0%253D&md5=f2728ac61f3a81349aef7f58c501160c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0811902106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0811902106%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DA.%2BJ.%26aulast%3DMoore%26aufirst%3DE.%2BC.%26aulast%3DLonsdorf%26aufirst%3DA.%2BS.%26aulast%3DKulikauskas%26aufirst%3DR.%2BM.%26aulast%3DRothberg%26aufirst%3DB.%2BG.%26aulast%3DBerger%26aufirst%3DA.%2BJ.%26aulast%3DMajor%26aufirst%3DM.%2BB.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DActivated%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520melanoma%2520is%2520associated%2520with%2520decreased%2520proliferation%2520in%2520patient%2520tumors%2520and%2520a%2520murine%2520melanoma%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D1193%26epage%3D1198%26doi%3D10.1073%2Fpnas.0811902106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling and drug resistance in cancer</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1124/mol.119.117978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1124%2Fmol.119.117978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31787618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=72-89&author=Z.+Zhongauthor=D.+M.+Virshup&title=Wnt+signaling+and+drug+resistance+in+cancer&doi=10.1124%2Fmol.119.117978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling and drug resistance in cancer</span></div><div class="casAuthors">Zhong, Zheng; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-89</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Wnts are secreted proteins that bind to cell surface receptors to activate downstream signaling cascades.  Normal Wnt signaling plays key roles in embryonic development and adult tissue homeostasis.  The secretion of Wnt ligands, the turnover of Wnt receptors, and the signaling transduction are tightly regulated and fine-tuned to keep the signaling output "just right." Hyperactivated Wnt signaling due to recurrent genetic alterations drives several human cancers.  Elevated Wnt signaling also confers resistance to multiple conventional and targeted cancer therapies through diverse mechanisms including maintaining the cancer stem cell population, enhancing DNA damage repair, facilitating transcriptional plasticity, and promoting immune evasion.  Different classes of Wnt signaling inhibitors targeting key nodes of the pathway have been developed and show efficacy in treating Wnt-driven cancers and subverting Wnt-mediated therapy resistance in preclin. studies.  Several of these inhibitors have advanced to clin. trials, both singly and in combination with other existing US Food and Drug Administration-approved anti-cancer modalities.  In the near future, pharmacol. inhibition of Wnt signaling may be a real choice for patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFB7w3hUGUTbVg90H21EOLACvtfcHk0lh7sY08LQNhtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktVSru78%253D&md5=769a381e1d76642f8bd15c62729cc9f3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.119.117978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.119.117978%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520signaling%2520and%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DMol.%2520Pharmacol.%26date%3D2020%26volume%3D97%26spage%3D72%26epage%3D89%26doi%3D10.1124%2Fmol.119.117978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3368</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1111/cas.13771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.13771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30137666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCms7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=3368-3375&author=P.+Yinauthor=W.+Wangauthor=Z.+Zhangauthor=Y.+Baiauthor=J.+Gaoauthor=C.+Zhao&title=Wnt+signaling+in+human+and+mouse+breast+cancer%3A+Focusing+on+Wnt+ligands%2C+receptors+and+antagonists&doi=10.1111%2Fcas.13771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists</span></div><div class="casAuthors">Yin, Ping; Wang, Wei; Zhang, Zhongbo; Bai, Yu; Gao, Jian; Zhao, Chenghai</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3368-3375</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt proteins, a group of secreted glycoproteins, mainly combine with receptors Frizzled (FZD) and/or low-d.-lipoprotein receptor-related proteins 5/6 (LRP5/6), initiating β-catenin-dependent and -independent signaling pathways.  These pathways, which can be regulated by some secreted antagonists such as secreted Frizzled-related proteins (SFRP) and dickkopf-related protein (DKK), play a crit. role in embryo development and adult homeostasis.  Overactivation of Wnt signaling has been implicated in some human diseases including cancer.  Wnt transgenic mice provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clin. breast cancer patients and studies on in vitro cultured human breast cancer cells.  This review focuses on the roles of Wnt ligands, receptors and antagonists in breast cancer development instead of mols. or signaling transactivating β-catenin independent on Wnt upstream components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcYwJ7R_KlybVg90H21EOLACvtfcHk0lh7sY08LQNhtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCms7nO&md5=5adcd73c8a91817e90561670ca98de61</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fcas.13771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13771%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DWnt%2520signaling%2520in%2520human%2520and%2520mouse%2520breast%2520cancer%253A%2520Focusing%2520on%2520Wnt%2520ligands%252C%2520receptors%2520and%2520antagonists%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D3368%26epage%3D3375%26doi%3D10.1111%2Fcas.13771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0ljUTdVwzINo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2505</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.4155%2Ffmc.15.159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26670195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2485-2505&author=S.+Zhengauthor=J.+Liuauthor=Y.+Wuauthor=T.+L.+Huangauthor=G.+Wang&title=Small-molecule+inhibitors+of+Wnt+signaling+pathway%3A+towards+novel+anticancer+therapeutics&doi=10.4155%2Ffmc.15.159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics</span></div><div class="casAuthors">Zheng, Shilong; Liu, Jiawang; Wu, Yanyuan; Huang, Tien L.; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2485-2505</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Wnt signaling pathway involves secreted glycoproteins that bind to the Frizzled family receptors to activate intracellular signal transduction events that regulate cell proliferation, apoptosis, cell migration and many crit. aspects of developmental biol.  Discussion: Aberrant Wnt signaling underlies a wide range of pathologies in humans including tumor initiation, tumor growth, cell senescence, cell death, differentiation and metastasis.  The inhibition of Wnt signaling offers a novel approach for anticancer therapeutics.  Conclusion: Focusing on recent developments, we reviewed the small-mol. inhibitors targeting various components of Wnt signaling pathways and the progress from the discovery of lead compds. to highly potent inhibitors with significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZuYMdLj6RR7Vg90H21EOLACvtfcHk0ljUTdVwzINo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeqt7fE&md5=007f442c99f3ada5037f3e6187b5eafb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.159%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520Wnt%2520signaling%2520pathway%253A%2520towards%2520novel%2520anticancer%2520therapeutics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D2485%26epage%3D2505%26doi%3D10.4155%2Ffmc.15.159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boral, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">20224</span>– <span class="NLM_lpage">20229</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314239110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1314239110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24277854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=20224-20229&author=J.+Liuauthor=S.+Panauthor=M.+H.+Hsiehauthor=N.+Ngauthor=F.+Sunauthor=T.+Wangauthor=S.+Kasibhatlaauthor=A.+G.+Schullerauthor=A.+G.+Liauthor=D.+Chengauthor=J.+Liauthor=C.+Tompkinsauthor=A.+Pferdekamperauthor=A.+Steffyauthor=J.+Chengauthor=C.+Kowalauthor=V.+Phungauthor=G.+Guoauthor=Y.+Wangauthor=M.+P.+Grahamauthor=S.+Flynnauthor=J.+C.+Brennerauthor=C.+Liauthor=M.+C.+Villarroelauthor=P.+G.+Schultzauthor=X.+Wuauthor=P.+McNamaraauthor=W.+R.+Sellersauthor=L.+Petruzzelliauthor=A.+L.+Boralauthor=H.+M.+Seidelauthor=M.+E.+McLaughlinauthor=J.+Cheauthor=T.+E.+Careyauthor=G.+Vanasseauthor=J.+L.+Harris&title=Targeting+Wnt-driven+cancer+through+the+inhibition+of+Porcupine+by+LGK974&doi=10.1073%2Fpnas.1314239110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span></div><div class="casAuthors">Liu, Jun; Pan, Shifeng; Hsieh, Mindy H.; Ng, Nicholas; Sun, Fangxian; Wang, Tao; Kasibhatla, Shailaja; Schuller, Alwin G.; Li, Allen G.; Cheng, Dai; Li, Jie; Tompkins, Celin; Pferdekamper, Anne Marie; Steffy, Auzon; Cheng, Jane; Kowal, Colleen; Phung, Van; Guo, Guirong; Wang, Yan; Graham, Martin P.; Flynn, Shannon; Brenner, J. Chad; Li, Chun; Villarroel, M. Cristina; Schultz, Peter G.; Wu, Xu; McNamara, Peter; Sellers, William R.; Petruzzelli, Lilli; Boral, Anthony L.; Seidel, H. Martin; McLaughlin, Margaret E.; Che, Jianwei; Carey, Thomas E.; Vanasse, Gary; Harris, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20224-20229,S20224/1-S20224/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Wnt signaling is one of the key oncogenic pathways in multiple cancers, and targeting this pathway is an attractive therapeutic approach.  However, therapeutic success was limited because of the lack of therapeutic agents for targets in the Wnt pathway and the lack of a defined patient population that would be sensitive to a Wnt inhibitor.  We developed a screen for small mols. that block Wnt secretion.  This effort led to the discovery of LGK974, a potent and specific small-mol. Porcupine (PORCN) inhibitor.  PORCN is a membrane-bound O-acyltransferase that is required for and dedicated to palmitoylation of Wnt ligands, a necessary step in the processing of Wnt ligand secretion.  We show that LGK974 potently inhibits Wnt signaling in vitro and in vivo, including redn. of the Wnt-dependent LRP6 phosphorylation and the expression of Wnt target genes, such as AXIN2.  LGK974 is potent and efficacious in multiple tumor models at well-tolerated doses in vivo, including murine and rat mechanistic breast cancer models driven by MMTV-Wnt1 and a human head and neck squamous cell carcinoma model (HN30).  We also show that head and neck cancer cell lines with loss-of-function mutations in the Notch signaling pathway have a high response rate to LGK974.  Together, these findings provide both a strategy and tools for targeting Wnt-driven cancers through the inhibition of PORCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJMitDc62tbVg90H21EOLACvtfcHk0ljRQ5eWaVLfUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL&md5=5fac5db1bd762356350f11706f1a70ae</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314239110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314239110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPferdekamper%26aufirst%3DA.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKowal%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGraham%26aufirst%3DM.%2BP.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DVillarroel%26aufirst%3DM.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DPetruzzelli%26aufirst%3DL.%26aulast%3DBoral%26aufirst%3DA.%2BL.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DT.%2BE.%26aulast%3DVanasse%26aufirst%3DG.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26atitle%3DTargeting%2520Wnt-driven%2520cancer%2520through%2520the%2520inhibition%2520of%2520Porcupine%2520by%2520LGK974%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D20224%26epage%3D20229%26doi%3D10.1073%2Fpnas.1314239110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frois, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petretto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt addiction of genetically defined cancers reversed by PORCN inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2197</span>– <span class="NLM_lpage">2207</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2015.280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26257057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2197-2207&author=B.+Madanauthor=Z.+Keauthor=N.+Harmstonauthor=S.+Y.+Hoauthor=A.+O.+Froisauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=V.+Pendharkarauthor=K.+Ghoshauthor=I.+H.+Virshupauthor=V.+Manoharanauthor=E.+H.+Ongauthor=K.+Sangthongpitagauthor=J.+Hillauthor=E.+Petrettoauthor=T.+H.+Kellerauthor=M.+A.+Leeauthor=A.+Matterauthor=D.+M.+Virshup&title=Wnt+addiction+of+genetically+defined+cancers+reversed+by+PORCN+inhibition&doi=10.1038%2Fonc.2015.280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt addiction of genetically defined cancers reversed by PORCN inhibition</span></div><div class="casAuthors">Madan, B.; Ke, Z.; Harmston, N.; Ho, S. Y.; Frois, A. O.; Alam, J.; Jeyaraj, D. A.; Pendharkar, V.; Ghosh, K.; Virshup, I. H.; Manoharan, V.; Ong, E. H. Q.; Sangthongpitag, K.; Hill, J.; Petretto, E.; Keller, T. H.; Lee, M. A.; Matter, A.; Virshup, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2197-2207</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors.  Whether these mutations identify a clin. opportunity is an important question.  Inhibition of Wnt secretion by blocking an essential post-translational modification, palmitoleation, provides a useful therapeutic intervention.  We developed a novel potent, orally available PORCN inhibitor, ETC-1922159 (henceforth called ETC-159) that blocks the secretion and activity of all Wnts.  ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts.  This is the first example of effective targeted therapy for this subset of CRC.  Consistent with a central role of Wnt signaling in regulation of gene expression, inhibition of PORCN in RSPO3-translocated cancers causes a marked remodeling of the transcriptome, with loss of cell cycle, stem cell and proliferation genes, and an increase in differentiation markers.  Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLVP6tUQlqerVg90H21EOLACvtfcHk0ljRQ5eWaVLfUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSntrfF&md5=a6d155fcad286c92b6cf70105a085c9f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.280%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DHarmston%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DFrois%26aufirst%3DA.%2BO.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DVirshup%26aufirst%3DI.%2BH.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DPetretto%26aufirst%3DE.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMatter%26aufirst%3DA.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520addiction%2520of%2520genetically%2520defined%2520cancers%2520reversed%2520by%2520PORCN%2520inhibition%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D2197%26epage%3D2207%26doi%3D10.1038%2Fonc.2015.280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1111/cas.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24975284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=1087-1092&author=H.+J.+Lenzauthor=M.+Kahn&title=Safely+targeting+cancer+stem+cells+via+selective+catenin+coactivator+antagonism&doi=10.1111%2Fcas.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span></div><div class="casAuthors">Lenz, Heinz-Josef; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1087-1092</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Throughout our life, long-lived somatic stem cells (SSC) regenerate adult tissues both during homeostatic processes and repair after injury.  The role of aberrant regulation of SSC has also recently gained prominence in the field of cancer research.  Following malignant transformation, so termed cancer stem cells (CSC), endowed with the same properties as SSC (i.e. the ability to both self-renew and generate differentiated progenitors), play a major part in tumor initiation, therapy resistance and ultimately relapse.  The same signaling pathways involved in regulating SSC maintenance are involved in the regulation of CSC.  CSC exist in a wide array of tumor types, including leukemias, and brain, breast, prostate and colon tumors.  Consequently, one of the key goals in cancer research over the past decade has been to develop therapeutic strategies to safely eliminate the CSC population without damaging the endogenous SSC population.  A major hurdle to this goal lies in the identification of the key mechanisms that distinguish CSC from the normal endogenous tissue stem cells.  This review will discuss the discovery of the specific CBP/catenin antagonist ICG-001 and the ongoing clin. development of the second generation CBP/catenin antagonist PRI-724.  Importantly, specific CBP/catenin antagonists appear to have the ability to safely eliminate CSC by taking advantage of an intrinsic differential preference in the way SSC and CSC divide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-k-p-7uTHrVg90H21EOLACvtfcHk0ljELI9QBla5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN&md5=dc580aeb47d1aeb8d95b1c02f428fca8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fcas.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12471%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DSafely%2520targeting%2520cancer%2520stem%2520cells%2520via%2520selective%2520catenin%2520coactivator%2520antagonism%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D1087%26epage%3D1092%26doi%3D10.1111%2Fcas.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlindon, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibofsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clauw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFrancesco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simsek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambiah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochberg, M. C.</span></span> <span> </span><span class="NLM_article-title">Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment of knee osteoarthritis: a phase II randomized trial</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1694</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.1002/art.41315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fart.41315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32432388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOitb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2020&pages=1694-1706&author=Y.+Yaziciauthor=T.+E.+McAlindonauthor=A.+Gibofskyauthor=N.+E.+Laneauthor=D.+Clauwauthor=M.+Jonesauthor=J.+Bergfeldauthor=C.+J.+Swearingenauthor=A.+DiFrancescoauthor=I.+Simsekauthor=J.+Tambiahauthor=M.+C.+Hochberg&title=Lorecivivint%2C+a+novel+intraarticular+CDC-like+kinase+2+and+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+inhibitor+and+Wnt+pathway+modulator+for+the+treatment+of+knee+osteoarthritis%3A+a+phase+II+randomized+trial&doi=10.1002%2Fart.41315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial</span></div><div class="casAuthors">Yazici, Yusuf; McAlindon, Timothy E.; Gibofsky, Allan; Lane, Nancy E.; Clauw, Daniel; Jones, Morgan; Bergfeld, John; Swearingen, Christopher J.; DiFrancesco, Anita; Simsek, Ismail; Tambiah, Jeyanesh; Hochberg, Marc C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1694-1706</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To assess the safety and efficacy of a novel Wnt pathway modulator, lorecivivint (SM04690), for treating pain and inhibiting structural progression in moderately to severely symptomatic knee osteoarthritis (OA).  Methods : Subjects in this 52-wk, phase IIa, multicenter, randomized, double-blind, placebo-controlled, dose-ranging trial received a single 2-mL intraarticular injection of lorecivivint (dose of 0.03 mg, 0.07 mg, or 0.23 mg) or placebo.  Efficacy was assessed based on change from baseline on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score subscales for pain and function (scale 0-100 for each) and change from baseline in the radiog. medial joint space width (JSW).  Baseline-adjusted anal. of covariance with multiple imputation was performed sep. to evaluate efficacy.  This proof-of-concept study evaluated the intent-to-treat population as well as a prespecified group of subjects with unilateral symptoms of knee OA (designated UNI) and an addnl. post hoc subgroup of subjects with unilateral symptoms but without widespread pain (designated UNI WP-).  Results : In this trial, 455 subjects were randomized to a treatment group.  The primary end point, significant improvement in the WOMAC pain score compared with placebo at week 13, was not met by any lorecivivint dose group (mean ± SD change from baseline, -23.3 ± 2.2 in the 0.03 mg group, -23.5 ± 2.1 in the 0.07 mg group, -21.3 ± 2.2 in the 0.23 mg group, and -22.1 ± 2.1 in the placebo group; each P > 0.05 vs. placebo).  All groups (including placebo) demonstrated clin. meaningful (≥20-point) improvements from baseline in the WOMAC pain score.  The durability of response was evaluated through week 52.  In the prespecified UNI group and post hoc UNI WP- group at week 52, treatment with 0.07 mg lorecivivint significantly improved the WOMAC pain score (between-group difference vs. placebo, -8.73, 95% confidence interval [95% CI] -17.44, -0.03 [P = 0.049] and -11.21, 95% CI -20.99, -1.43 [P = 0.025], resp.) and WOMAC function score (between-group difference vs. placebo, -10.26, 95% CI -19.82, -0.69 [P = 0.036] and -13.38, 95% CI -24.33, -2.43 [P = 0.017], resp.).  Relative to baseline, the mean change in the medial JSW at week 52 was -0.04 mm in the 0.03 mg cohort, -0.09 mm in the 0.07 mg cohort, -0.16 mm in the 0.23 mg cohort, and -0.14 mm in the placebo cohort; no treatment group achieved a significant change in medial JSW compared with placebo at week 52.  In both unilateral symptom subgroups, the 0.07 mg lorecivivint dose significantly increased medial JSW compared with placebo at week 52 (medial JSW 0.39 mm, 95% CI 0.06, 0.72 in the UNI group [P = 0.021] and 0.42 mm, 95% CI 0.04, 0.80 in the UNI WP- group [P = 0.032]).  Changes obsd. in the 0.03 mg and 0.23 mg dose groups were not significantly different from those in the placebo group for any of these measures.  Lorecivivint appeared safe and well tolerated.  Conclusion : This phase IIa, proof-of-concept trial in patients with symptomatic knee OA did not meet its primary end point.  Nevertheless, the study identified a target population in whom to evaluate the potential efficacy of lorecivivint for the treatment of knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5ujK29FWXrVg90H21EOLACvtfcHk0ljELI9QBla5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOitb%252FO&md5=c86a3f9bac8837387ad725fda5513f7b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fart.41315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.41315%26sid%3Dliteratum%253Aachs%26aulast%3DYazici%26aufirst%3DY.%26aulast%3DMcAlindon%26aufirst%3DT.%2BE.%26aulast%3DGibofsky%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DN.%2BE.%26aulast%3DClauw%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBergfeld%26aufirst%3DJ.%26aulast%3DSwearingen%26aufirst%3DC.%2BJ.%26aulast%3DDiFrancesco%26aufirst%3DA.%26aulast%3DSimsek%26aufirst%3DI.%26aulast%3DTambiah%26aufirst%3DJ.%26aulast%3DHochberg%26aufirst%3DM.%2BC.%26atitle%3DLorecivivint%252C%2520a%2520novel%2520intraarticular%2520CDC-like%2520kinase%25202%2520and%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520inhibitor%2520and%2520Wnt%2520pathway%2520modulator%2520for%2520the%2520treatment%2520of%2520knee%2520osteoarthritis%253A%2520a%2520phase%2520II%2520randomized%2520trial%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2020%26volume%3D72%26spage%3D1694%26epage%3D1706%26doi%3D10.1002%2Fart.41315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Modulating Wnt signaling at the root: Porcupine and Wnt acylation</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.pharmthera.2019.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30790642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslOlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2019&pages=34-45&author=V.+I.+Torresauthor=J.+A.+Godoyauthor=N.+C.+Inestrosa&title=Modulating+Wnt+signaling+at+the+root%3A+Porcupine+and+Wnt+acylation&doi=10.1016%2Fj.pharmthera.2019.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Wnt signaling at the root: Porcupine and Wnt acylation</span></div><div class="casAuthors">Torres, Viviana I.; Godoy, Juan A.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-45</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Communication between cells occurs through secreted mols., among which Wnt ligands play a crit. role in balancing cell proliferation, differentiation and cellular homeostasis.  The action of Wnt signaling can be modulated at several levels, including posttranslational modification of the Wnt ligands, whose acylation is crit. for biol. activity.  At least three enzymes are necessary for Wnt acylation/deacylation: stearoyl CoA desaturase (SCD), porcupine (PORCN) and Notum.  At the endoplasmic reticulum (ER), SCD provides the monounsatd. fatty acid to PORCN, which adds it to the Wnt ligand; at the extracellular matrix, the fatty acid is removed by Notum.  Obviously, the interplay between these enzymes will define Wnt signaling ligand secretion and activity.  Excessive activation of Wnt signaling has been obsd. in a variety of solid tumors, which has led the pharmaceutical industry to develop specific inhibitors for this pathway that mainly target PORCN, some of which are in early clin. trials.  In the central nervous system (CNS), Wnt signaling activation has been shown to have a neuroprotective effect, and conversely, its inhibition induces neurodegeneration, which implies that the inhibition of PORCN in cancer therapies should be used with caution, and the cognitive performance of the patient should be monitored during treatment.  This review collects information about the PORCN enzyme in relation to its role in the Wnt pathway through the acylation of Wnt ligands, its inhibition by drugs in the treatment of some cancers, and its putative modulation in the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRYOk4Y_x7urVg90H21EOLACvtfcHk0ljELI9QBla5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslOlsbo%253D&md5=681889dc0efbd794c6409473ae05ce2c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DV.%2BI.%26aulast%3DGodoy%26aufirst%3DJ.%2BA.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DModulating%2520Wnt%2520signaling%2520at%2520the%2520root%253A%2520Porcupine%2520and%2520Wnt%2520acylation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D198%26spage%3D34%26epage%3D45%26doi%3D10.1016%2Fj.pharmthera.2019.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Precise regulation of porcupine activity is required for physiological Wnt signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">34167</span>– <span class="NLM_lpage">34178</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.381970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M112.381970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22888000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=34167-34178&author=K.+D.+Proffittauthor=D.+M.+Virshup&title=Precise+regulation+of+porcupine+activity+is+required+for+physiological+Wnt+signaling&doi=10.1074%2Fjbc.M112.381970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling</span></div><div class="casAuthors">Proffitt, Kyle D.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34167-34178</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Gradients of diverse Wnt proteins regulate development, renewal, and differentiation.  Porcupine (PORCN) is a membrane-bound O-acyltransferase that is required for post-translational modification of all Wnts to enable their transport, secretion, and activity.  Mutations in PORCN are assocd. with focal dermal hypoplasia (FDH), whereas gene deletion causes embryonic lethality in mice.  To study the protein in more detail, zinc finger nucleases were used to edit the PORCN genomic locus, establishing two HT1080 fibrosarcoma clones null for PORCN activity that facilitate the study of PORCN structure and function.  We establish that PORCN is a key non-redundant node for the regulation of global Wnt signaling because PORCN null cells are completely incapable of autocrine Wnt signaling.  The strength of Wnt signaling is exquisitely sensitive to PORCN expression, with a dynamic range of at least 3 orders of magnitude, suggesting that PORCN activity is a key modulator of all Wnt ligand activity.  Consistent with this, we find that multiple FDH-assocd. mutants have only subtle alterations in enzyme activity yet are assocd. with a severe FDH phenotype.  These studies support an essential regulatory role of PORCN in shaping Wnt signaling gradients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk2OwLjD27rVg90H21EOLACvtfcHk0ljfQNuF0p4FZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLnN&md5=91c827f5f6076c8e9ef25b0660c78290</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.381970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.381970%26sid%3Dliteratum%253Aachs%26aulast%3DProffitt%26aufirst%3DK.%2BD.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPrecise%2520regulation%2520of%2520porcupine%2520activity%2520is%2520required%2520for%2520physiological%2520Wnt%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D34167%26epage%3D34178%26doi%3D10.1074%2Fjbc.M112.381970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannoush, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-12-2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23188502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlalug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=502-507&author=K.+D.+Proffittauthor=B.+Madanauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+Dingauthor=M.+A.+Leeauthor=R.+N.+Hannoushauthor=D.+M.+Virshup&title=Pharmacological+inhibition+of+the+Wnt+acyltransferase+PORCN+prevents+growth+of+WNT-driven+mammary+cancer&doi=10.1158%2F0008-5472.CAN-12-2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer</span></div><div class="casAuthors">Proffitt, Kyle David; Madan, Babita; Ke, Zhiyuan; Pendharkar, Vishal; Ding, Lijun; Lee, May Ann; Hannoush, Rami N.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study offers preclin. proof of concept for a safe and effective strategy to target the many types of tumors driven by a deregulated Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU7Y0ZVAxwrbVg90H21EOLACvtfcHk0ljfQNuF0p4FZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlalug%253D%253D&md5=156f5bbfc77a717b297eb8b1f21933f1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-2258%26sid%3Dliteratum%253Aachs%26aulast%3DProffitt%26aufirst%3DK.%2BD.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DHannoush%26aufirst%3DR.%2BN.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPharmacological%2520inhibition%2520of%2520the%2520Wnt%2520acyltransferase%2520PORCN%2520prevents%2520growth%2520of%2520WNT-driven%2520mammary%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D502%26epage%3D507%26doi%3D10.1158%2F0008-5472.CAN-12-2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, K.</span></span> <span> </span><span class="NLM_article-title">WNT secretion and signalling in human disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.molmed.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22796206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKns7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=483-493&author=P.+Herrauthor=G.+Hausmannauthor=K.+Basler&title=WNT+secretion+and+signalling+in+human+disease&doi=10.1016%2Fj.molmed.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">WNT secretion and signalling in human disease</span></div><div class="casAuthors">Herr, Patrick; Hausmann, George; Basler, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">483-493</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Wnt signalling, a key pathway involved in various aspects of embryonic development, also underlies many human diseases, in particular, cancer.  Research focused on signal transduction within signal-receiving cells led to the discovery of many Wnt pathway components, but study of the secretion of Wnt ligands themselves was neglected until recently.  Attention was drawn to this highly regulated process by the assocn. of aberrant Wnt levels with an increasing no. of diseases.  Studying the biogenesis and processing of active Wnt ligands will open new avenues for generating therapeutics to specifically target aberrant Wnt signalling.  Here we review the proteins required for Wnt secretion and signalling at the plasma membrane, ending with a discussion on potential therapeutic approaches to treat Wnt-induced diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq_X3hsEStgLVg90H21EOLACvtfcHk0ljfQNuF0p4FZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKns7zE&md5=fcff68d21b33b931aa854a581d27e230</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DHerr%26aufirst%3DP.%26aulast%3DHausmann%26aufirst%3DG.%26aulast%3DBasler%26aufirst%3DK.%26atitle%3DWNT%2520secretion%2520and%2520signalling%2520in%2520human%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D483%26epage%3D493%26doi%3D10.1016%2Fj.molmed.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. M.</span></span> <span> </span><span class="NLM_article-title">Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3483</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1211006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fsj.onc.1211006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18193088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVagu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3483-3488&author=Z.+Chenauthor=J.+Liauthor=Q.+S.+Liauthor=J.+Q.+Fanauthor=X.+M.+Dongauthor=J.+P.+Xuauthor=X.+M.+Wangauthor=G.+W.+Yangauthor=P.+Yanauthor=G.+Z.+Wenauthor=Y.+T.+Zhangauthor=R.+G.+Niuauthor=P.+H.+Nanauthor=J.+Heauthor=H.+M.+Zhou&title=Suppression+of+PPN%2FMG61+attenuates+Wnt%2Fbeta-catenin+signaling+pathway+and+induces+apoptosis+in+human+lung+cancer&doi=10.1038%2Fsj.onc.1211006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of PPN/MG61 attenuates Wnt/β-catenin signaling pathway and induces apoptosis in human lung cancer</span></div><div class="casAuthors">Chen, Z.; Li, J.; Li, Q. S.; Fan, J. Q.; Dong, X. M.; Xu, J. P.; Wang, X. M.; Yang, G. W.; Yan, P.; Wen, G. Z.; Zhang, Y. T.; Niu, R. G.; Nan, P. H.; He, J.; Zhou, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3483-3488</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wingless and int homolog (Wnt) family proteins have been shown to have important roles in the decision of cell fate and behavior at multiple stages during the development and tumorigenesis.  One of the Drosophila segment polarity genes, porcupine (porc) gene, encodes an evolutionarily conserved endoplasmic reticulum membrane protein involving in the post-translational processing of the Wnt family proteins.  Here, we report that human homolog of Drosophila porc gene, PPN/MG61, was abundantly expressed in human cancer cell lines, but not in normal cells.  We also found that PPN/MG61 was overexpressed in primary lung cancer tissue samples, compared to their matched normal tissue samples.  Furthermore, when we used small interfering RNA to knock down PPN/MG61 mRNA in lung cancer cells expressing the gene, we obsd. apoptosis induction, along with decreased activity of Wnt pathway in those lung cancer cells.  These data suggest that PPN/MG61 may be a novel marker for human lung cancer and that post-translational modification of the Wnt signal mols. by PPN/MG61 may be important for the function of Wnt pathway in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppLv49RKwC7rVg90H21EOLACvtfcHk0lg9R8FpSc3OAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVagu7s%253D&md5=3604f3d97eaba53827320f560d65593e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211006%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%2BS.%26aulast%3DFan%26aufirst%3DJ.%2BQ.%26aulast%3DDong%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYang%26aufirst%3DG.%2BW.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DWen%26aufirst%3DG.%2BZ.%26aulast%3DZhang%26aufirst%3DY.%2BT.%26aulast%3DNiu%26aufirst%3DR.%2BG.%26aulast%3DNan%26aufirst%3DP.%2BH.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%2BM.%26atitle%3DSuppression%2520of%2520PPN%252FMG61%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520pathway%2520and%2520induces%2520apoptosis%2520in%2520human%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3483%26epage%3D3488%26doi%3D10.1038%2Fsj.onc.1211006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in development, disease and translational medicine</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.2174/138945008784911796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.2174%2F138945008784911796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18673238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=513-531&author=G.+S.+Coombsauthor=T.+M.+Coveyauthor=D.+M.+Virshup&title=Wnt+signaling+in+development%2C+disease+and+translational+medicine&doi=10.2174%2F138945008784911796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in development, disease and translational medicine</span></div><div class="casAuthors">Coombs, Gary S.; Covey, Tracy M.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-531</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Wnt signaling regulates a multitude of crit. processes in development and tissue homeostasis.  The wingless (wg) gene product was first identified in Drosophila in 1973.  Subsequently, the proto-oncogene INT-1 was identified in mice in 1984 when its activation by mouse mammary tumor virus' proviral insertion was found to induce tumor formation.  The discovery in 1987 that wg and INT-1 are orthologs contributed to an appreciation of the intimate connection between oncogenic and developmental processes.  Diverse diseases including cancer, diabetes, osteoporosis and psychiatric disorders may be amenable to treatment via modulation of Wnt-mediated signaling pathways.  There are a no. of attractive targets that are the object of ongoing drug development studies aiming to capitalize on these opportunities.  In this review, we present a historical overview of key events in this field that have elucidated the known signaling cascades assocd. with Wnt ligands and shaped our understanding of the roles of these cascades in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpVdAnUrHZprVg90H21EOLACvtfcHk0lg9R8FpSc3OAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOqtLo%253D&md5=34ce96a870ae6894be8e1462bd2c591f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F138945008784911796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945008784911796%26sid%3Dliteratum%253Aachs%26aulast%3DCoombs%26aufirst%3DG.%2BS.%26aulast%3DCovey%26aufirst%3DT.%2BM.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520signaling%2520in%2520development%252C%2520disease%2520and%2520translational%2520medicine%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2008%26volume%3D9%26spage%3D513%26epage%3D531%26doi%3D10.2174%2F138945008784911796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.+W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0lg7SzowcxW46A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argenton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23246</span>– <span class="NLM_lpage">23254</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.372029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M112.372029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22593577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23246-23254&author=M.+E.+Dodgeauthor=J.+Moonauthor=R.+Tuladharauthor=J.+Luauthor=L.+S.+Jacobauthor=L.+S.+Zhangauthor=H.+Shiauthor=X.+Wangauthor=E.+Moroauthor=A.+Mongeraauthor=F.+Argentonauthor=C.+M.+Karnerauthor=T.+J.+Carrollauthor=C.+Chenauthor=J.+F.+Amatrudaauthor=L.+Lum&title=Diverse+chemical+scaffolds+support+direct+inhibition+of+the+membrane-bound+O-acyltransferase+porcupine&doi=10.1074%2Fjbc.M112.372029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Chemical Scaffolds Support Direct Inhibition of the Membrane-bound O-Acyltransferase Porcupine</span></div><div class="casAuthors">Dodge, Michael E.; Moon, Jesung; Tuladhar, Rubina; Lu, Jianming; Jacob, Leni S.; Zhang, Li-shu; Shi, Heping; Wang, Xiaolei; Moro, Enrico; Mongera, Alessandro; Argenton, Francesco; Karner, Courtney M.; Carroll, Thomas J.; Chen, Chuo; Amatruda, James F.; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23246-23254</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Secreted Wnt proteins constitute one of the largest families of intercellular signaling mols. in vertebrates with essential roles in embryonic development and adult tissue homeostasis.  The functional redundancy of Wnt genes and the many forms of cellular responses they elicit, including some utilizing the transcriptional co-activator β-catenin, has limited the ability of classical genetic strategies to uncover their roles in vivo.  The authors had previously identified a chem. compd. class termed Inhibitor of Wnt Prodn. (or IWP) that targets Porcupine (Porcn), an acyltransferase catalyzing the addn. of fatty acid adducts onto Wnt proteins.  Diverse chem. structures are able to inhibit Porcn by targeting its putative active site.  When deployed in concert with small mols. that modulate the activity of Tankyrase enzymes and glycogen synthase kinase 3 β (GSK3β), addnl. transducers of Wnt/β-catenin signaling, the IWP compds. reveal an essential role for Wnt protein fatty acylation in eliciting β-catenin-dependent and -independent forms of Wnt signaling during zebrafish development.  This collection of small mols. facilitates rapid dissection of Wnt gene function in vivo by limiting the influence of redundant Wnt gene functions on phenotypic outcomes and enables temporal manipulation of Wnt-mediated signaling in vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Vku7lZhTOrVg90H21EOLACvtfcHk0lhCs1cL6-ZbUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmtb0%253D&md5=88ddad96c49cb032ec0347a6d3029ba1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.372029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.372029%26sid%3Dliteratum%253Aachs%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DTuladhar%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DL.%2BS.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMoro%26aufirst%3DE.%26aulast%3DMongera%26aufirst%3DA.%26aulast%3DArgenton%26aufirst%3DF.%26aulast%3DKarner%26aufirst%3DC.%2BM.%26aulast%3DCarroll%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DDiverse%2520chemical%2520scaffolds%2520support%2520direct%2520inhibition%2520of%2520the%2520membrane-bound%2520O-acyltransferase%2520porcupine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23246%26epage%3D23254%26doi%3D10.1074%2Fjbc.M112.372029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">The development of highly potent inhibitors for porcupine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2700</span>– <span class="NLM_lpage">2704</span>, <span class="refDoi"> DOI: 10.1021/jm400159c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2700-2704&author=X.+Wangauthor=J.+Moonauthor=M.+E.+Dodgeauthor=X.+Panauthor=L.+Zhangauthor=J.+M.+Hansonauthor=R.+Tuladharauthor=Z.+Maauthor=H.+Shiauthor=N.+S.+Williamsauthor=J.+F.+Amatrudaauthor=T.+J.+Carrollauthor=L.+Lumauthor=C.+Chen&title=The+development+of+highly+potent+inhibitors+for+porcupine&doi=10.1021%2Fjm400159c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of Highly Potent Inhibitors for Porcupine</span></div><div class="casAuthors">Wang, Xiaolei; Moon, Jesung; Dodge, Michael E.; Pan, Xinchao; Zhang, Lishu; Hanson, Jordan M.; Tuladhar, Rubina; Ma, Zhiqiang; Shi, Heping; Williams, Noelle S.; Amatruda, James F.; Carroll, Thomas J.; Lum, Lawrence; Chen, Chuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2700-2704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Porcupine is a member of the membrane-bound O-acyltransferase family of proteins.  It catalyzes the palmitoylation of Wnt proteins, a process required for their secretion and activity.  We recently disclosed a class of small mols. (IWPs) as the first reported Porcn inhibitors.  We now describe the structure-activity relationship studies and the identification of subnanomolar inhibitors.  We also report herein the effects of IWPs on Wnt-dependent developmental processes, including zebrafish posterior axis formation and kidney tubule formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KrCYiGjajLVg90H21EOLACvtfcHk0lhCs1cL6-ZbUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGns7w%253D&md5=61a2891ab476e52b62ffad123711067a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm400159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400159c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DJ.%2BM.%26aulast%3DTuladhar%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DCarroll%26aufirst%3DT.%2BJ.%26aulast%3DLum%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DThe%2520development%2520of%2520highly%2520potent%2520inhibitors%2520for%2520porcupine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2700%26epage%3D2704%26doi%3D10.1021%2Fjm400159c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyridinyl acetamide derivatives as potent, selective, and orally bioavailable porcupine inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=676-680&author=D.+Chengauthor=J.+Liuauthor=D.+Hanauthor=G.+Zhangauthor=W.+Gaoauthor=M.+H.+Hsiehauthor=N.+Ngauthor=S.+Kasibhatlaauthor=C.+Tompkinsauthor=J.+Liauthor=A.+Steffyauthor=F.+Sunauthor=C.+Liauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=S.+Pan&title=Discovery+of+pyridinyl+acetamide+derivatives+as+potent%2C+selective%2C+and+orally+bioavailable+porcupine+inhibitors&doi=10.1021%2Facsmedchemlett.6b00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors</span></div><div class="casAuthors">Cheng, Dai; Liu, Jun; Han, Dong; Zhang, Guobao; Gao, Wenqi; Hsieh, Mindy H.; Ng, Nicholas; Kasibhatla, Shailaja; Tompkins, Celin; Li, Jie; Steffy, Auzon; Sun, Fangxian; Li, Chun; Seidel, H. Martin; Harris, Jennifer L.; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">676-680</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of aberrant Wnt signaling is an attractive therapeutic approach in multiple cancers.  We developed and performed a cellular high-throughput screen for inhibitors of Wnt secretion and pathway activation.  A lead structure (GNF-1331) was identified from the screen.  Further studies identified the mol. target of GNF-1331 as Porcupine, a membrane bound O-acyl transferase.  Structure-activity relationship studies led to the discovery of a novel series of potent and selective Porcupine inhibitors.  Compd. 19, GNF-6231, demonstrated excellent pathway inhibition and induced robust antitumor efficacy in a mouse MMTV-WNT1 xenograft tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGZaZIx4MI7Vg90H21EOLACvtfcHk0lgmX7dEvje-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D&md5=b4634dbc71bdfade7e5a71de96b37e2b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00038%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DPan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520pyridinyl%2520acetamide%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520porcupine%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D676%26epage%3D680%26doi%3D10.1021%2Facsmedchemlett.6b00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6855</span>– <span class="NLM_lpage">6868</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26455655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6855-6868&author=Y.+Dongauthor=K.+Liauthor=Z.+Xuauthor=H.+Maauthor=J.+Zhengauthor=Z.+Huauthor=S.+Heauthor=Y.+Wuauthor=Z.+Sunauthor=L.+Luoauthor=J.+Liauthor=H.+Zhangauthor=X.+Zhang&title=Exploration+of+the+linkage+elements+of+porcupine+antagonists+led+to+potent+Wnt+signaling+pathway+inhibitors&doi=10.1016%2Fj.bmc.2015.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors</span></div><div class="casAuthors">Dong, Yan; Li, Kehuang; Xu, Zhixiang; Ma, Haikuo; Zheng, Jiyue; Hu, Zhilin; He, Sudan; Wu, Yiyuan; Sun, Zhijian; Luo, Lusong; Li, Jiajun; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6855-6868</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is a pivotal developmental pathway.  It operates through control of cellular functions such as proliferation, differentiation, migration and polarity.  Aberrant Wnt signaling has been implicated in the formation and metastasis of tumors.  Porcupine is a component of the Wnt signaling pathway.  It is a member of the membrane-bound O-acyltransferase family of proteins.  Porcupine catalyzes the palmitoylation of Wnt proteins, a process which is essential to their secretion and activity.  Here we report a novel series of compds. obtained by a scaffold hybridization strategy from two known porcupine inhibitor classes.  The leading compd. 62 demonstrated subnanomolar (IC50 0.11 nM) inhibition of Wnt signaling in a paracrine cellular reporter gene assay.  Compd. 62 also potently inhibited Wnt secretion into culture medium, an indication of direct inhibition of the porcupine protein.  Furthermore, compd. 62 showed excellent chem., plasma and liver microsomal stabilities.  Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5CxdsEaQJzLVg90H21EOLACvtfcHk0lgmX7dEvje-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLnE&md5=be49dceee0597ec439af4ef1b720a789</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DExploration%2520of%2520the%2520linkage%2520elements%2520of%2520porcupine%2520antagonists%2520led%2520to%2520potent%2520Wnt%2520signaling%2520pathway%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6855%26epage%3D6868%26doi%3D10.1016%2Fj.bmc.2015.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ejmech.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26647303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFantbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=154-165&author=Z.+Xuauthor=J.+Liauthor=Y.+Wuauthor=Z.+Sunauthor=L.+Luoauthor=Z.+Huauthor=S.+Heauthor=J.+Zhengauthor=H.+Zhangauthor=X.+Zhang&title=Design%2C+synthesis%2C+and+evaluation+of+potent+Wnt+signaling+inhibitors+featuring+a+fused+3-ring+system&doi=10.1016%2Fj.ejmech.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system</span></div><div class="casAuthors">Xu, Zhixiang; Li, Jiajun; Wu, Yiyuan; Sun, Zhijian; Luo, Lusong; Hu, Zhilin; He, Sudan; Zheng, Jiyue; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">154-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is a crit. developmental pathway which operates through control of cellular functions such as proliferation and differentiation.  Aberrant Wnt signaling has been linked to the formation and metastasis of tumors.  Porcupine, a member of the membrane-bound O-acyltransferase family of proteins, is an important component of the Wnt pathway.  Porcupine catalyzes the palmitoylation of Wnt proteins, a process needed for their secretion and activity.  Here we report a novel series of compds. obtained by a scaffold hybridization strategy from a known porcupine inhibitor class.  The leading compd. 59 demonstrated subnanomolar inhibition of Wnt signaling in a paracrine cellular assay.  Compd. 59 also showed excellent chem., plasma and liver microsomal stabilities.  Furthermore, compd. 59 exhibited good pharmacokinetic profiles with 30% oral bioavailability in rat.  Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj_OMopMr2d7Vg90H21EOLACvtfcHk0liTkwVMZOnntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFantbnP&md5=b7741015a9cec46673a375ead5be57a2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520Wnt%2520signaling%2520inhibitors%2520featuring%2520a%2520fused%25203-ring%2520system%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D154%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Laoi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the “reversed” amide scaffold</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5861</span>– <span class="NLM_lpage">5872</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2016.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27692509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOrtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5861-5872&author=Z.+Xuauthor=X.+Xuauthor=R.+O%E2%80%99Laoiauthor=H.+Maauthor=J.+Zhengauthor=S.+Chenauthor=L.+Luoauthor=Z.+Huauthor=S.+Heauthor=J.+Liauthor=H.+Zhangauthor=X.+Zhang&title=Design%2C+synthesis%2C+and+evaluation+of+novel+porcupine+inhibitors+featuring+a+fused+3-ring+system+based+on+the+%E2%80%9Creversed%E2%80%9D+amide+scaffold&doi=10.1016%2Fj.bmc.2016.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold</span></div><div class="casAuthors">Xu, Zhixiang; Xu, Xiangxiang; O'Laoi, Ruadhan; Ma, Haikuo; Zheng, Jiyue; Chen, Shuaishuai; Luo, Lusong; Hu, Zhilin; He, Sudan; Li, Jiajun; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5861-5872</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is an essential signal transduction pathway which leads to the regulation of cellular processes such as proliferation, differentiation and migration.  Aberrant Wnt signaling is known to have an assocn. with multiple cancers.  Porcupine is an enzyme that catalyzes the addn. of palmitoleate to a serine residue in Wnt proteins, a process which is required for the secretion of Wnt proteins.  Here the authors report the synthesis and structure-activity-relationship of the novel porcupine inhibitors based on a 'reversed' amide scaffold.  The leading compd. I was as potent as the clin. compd. LGK974 in a cell based STF reporter gene assay.  Compd. I potently inhibited the secretion of Wnt3A, therefore was confirmed to be a porcupine inhibitor.  Furthermore, compd. I showed excellent chem. and plasma stabilities.  However, the clearance of compd. I in liver microsomal tests was moderate to high, and the soly. of compd. I was suboptimal.  Collective efforts toward further optimization of this novel tricyclic template to develop better porcupine inhibitors will be subsequently undertaken and reported in due course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjAFRMGIf9TLVg90H21EOLACvtfcHk0liTkwVMZOnntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOrtrrO&md5=f58d5e064fb64cba7f9ec153806ed6ed</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Laoi%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520porcupine%2520inhibitors%2520featuring%2520a%2520fused%25203-ring%2520system%2520based%2520on%2520the%2520%25E2%2580%259Creversed%25E2%2580%259D%2520amide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5861%26epage%3D5872%26doi%3D10.1016%2Fj.bmc.2016.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswamy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of a porcupine inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5899</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5889-5899&author=A.+J.+Duraiswamyauthor=M.+A.+Leeauthor=B.+Madanauthor=S.+H.+Angauthor=E.+S.+Tanauthor=W.+W.+Cheongauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=Y.+S.+Chewauthor=V.+Manoharanauthor=K.+Sangthongpitagauthor=J.+Alamauthor=A.+Poulsenauthor=S.+Y.+Hoauthor=D.+M.+Virshupauthor=T.+H.+Keller&title=Discovery+and+optimization+of+a+porcupine+inhibitor&doi=10.1021%2Facs.jmedchem.5b00507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of a Porcupine Inhibitor</span></div><div class="casAuthors">Duraiswamy, Athisayamani Jeyaraj; Lee, May Ann; Madan, Babita; Ang, Shi Hua; Tan, Eldwin Sum Wai; Cheong, Wei Wen Vivien; Ke, Zhiyuan; Pendharkar, Vishal; Ding, Li Jun; Chew, Yun Shan; Manoharan, Vithya; Sangthongpitag, Kanda; Alam, Jenefer; Poulsen, Anders; Ho, Soo Yei; Virshup, David M.; Keller, Thomas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5889-5899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wnt proteins regulate various cellular functions and serve distinct roles in normal development throughout life.  Wnt signaling is dysregulated in various diseases including cancers.  Porcupine (PORCN) is a membrane-bound O-acyltransferase that palmitoleates the Wnts and hence is essential for their secretion and function.  The inhibition of PORCN could serve as a therapeutic approach for the treatment of a no. of Wnt-dependent cancers.  Herein, the authors describe the identification of a Wnt secretion inhibitor from cellular high throughput screening.  Classical SAR based cellular optimization provided us with a PORCN inhibitor I with nanomolar activity and excellent bioavailability that demonstrated efficacy in a Wnt-driven murine tumor model.  Finally, the authors also discovered that enantiomeric PORCN inhibitors show very different activity in the reporter assay, suggesting that such compds. may be useful for mode of action studies on the PORCN O-acyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93eq8v4hPU7Vg90H21EOLACvtfcHk0lgsygjWL936XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitb7P&md5=11decbf7f776098c61a4cec7796ac07f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDuraiswamy%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%26aulast%3DCheong%26aufirst%3DW.%2BW.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520porcupine%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5889%26epage%3D5899%26doi%3D10.1021%2Facs.jmedchem.5b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span> <span> </span><span class="NLM_article-title">Scaffold hopping and optimization of maleimide based porcupine inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6678-6692&author=S.+Y.+Hoauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=W.+Wangauthor=G.+R.+Linauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=M.+A.+Leeauthor=Z.+Keauthor=B.+Madanauthor=D.+M.+Virshupauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=C.+B.+Lowauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+Poulsen&title=Scaffold+hopping+and+optimization+of+maleimide+based+porcupine+inhibitors&doi=10.1021%2Facs.jmedchem.7b00662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors</span></div><div class="casAuthors">Ho, Soo Yei; Alam, Jenefer; Jeyaraj, Duraiswamy Athisayamani; Wang, Weiling; Lin, Grace Ruiting; Ang, Shi Hua; Tan, Eldwin Sum Wai; Lee, May Ann; Ke, Zhiyuan; Madan, Babita; Virshup, David M.; Ding, Li Jun; Manoharan, Vithya; Chew, Yun Shan; Low, Choon Bing; Pendharkar, Vishal; Sangthongpitag, Kanda; Hill, Jeffrey; Keller, Thomas H.; Poulsen, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6678-6692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Porcupine is an O-acyltransferase that regulates Wnt secretion.  Inhibiting porcupine may block the Wnt pathway which is often dysregulated in various cancers.  Consequently porcupine inhibitors are thought to be promising oncol. therapeutics.  A high throughput screen against porcupine revealed several potent hits that were confirmed to be Wnt pathway inhibitors in secondary assays.  We developed a pharmacophore model and used the putative bioactive conformation of a xanthine inhibitor for scaffold hopping.  The resulting maleimide scaffold was optimized to subnanomolar potency while retaining good phys. druglike properties.  A preclin. development candidate was selected for which extensive in vitro and in vivo profiling is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ENAXwy5NLbVg90H21EOLACvtfcHk0lj9WoqPq5yzYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr%252FP&md5=e3d6e7267c9270905b5166a3688f00c5</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00662%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DPoulsen%26aufirst%3DA.%26atitle%3DScaffold%2520hopping%2520and%2520optimization%2520of%2520maleimide%2520based%2520porcupine%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6678%26epage%3D6692%26doi%3D10.1021%2Facs.jmedchem.7b00662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hottiger, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassa, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch-Nolte, F.</span></span> <span> </span><span class="NLM_article-title">Toward a unified nomenclature for mammalian ADP-ribosyltransferases</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.tibs.2009.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20106667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVegs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=208-219&author=M.+O.+Hottigerauthor=P.+O.+Hassaauthor=B.+Luscherauthor=H.+Schulerauthor=F.+Koch-Nolte&title=Toward+a+unified+nomenclature+for+mammalian+ADP-ribosyltransferases&doi=10.1016%2Fj.tibs.2009.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a unified nomenclature for mammalian ADP-ribosyltransferases</span></div><div class="casAuthors">Hottiger, Michael O.; Hassa, Paul O.; Luescher, Bernhard; Schueler, Herwig; Koch-Nolte, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">208-219</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  ADP-ribosylation is a post-translational modification of proteins catalyzed by ADP-ribosyltransferases.  It comprises the transfer of the ADP-ribose moiety from NAD+ to specific amino acid residues on substrate proteins or to ADP-ribose itself.  Currently, 22 human genes encoding proteins that possess an ADP-ribosyltransferase catalytic domain are known.  Recent structural and enzymol. evidence of poly(ADP-ribose)polymerase (PARP) family members demonstrate that earlier proposed names and classifications of these proteins are no longer accurate.  Here we summarize these new findings and propose a new consensus nomenclature for all ADP-ribosyltransferases (ARTs) based on the catalyzed reaction and on structural features.  A unified nomenclature would facilitate communication between researchers both inside and outside the ADP-ribosylation field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg6kR-35XzU7Vg90H21EOLACvtfcHk0liu5tW2MoiHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVegs70%253D&md5=0e63a298da9140bea11180b58bec7357</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DKoch-Nolte%26aufirst%3DF.%26atitle%3DToward%2520a%2520unified%2520nomenclature%2520for%2520mammalian%2520ADP-ribosyltransferases%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D208%26epage%3D219%26doi%3D10.1016%2Fj.tibs.2009.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, G. G.</span></span> <span> </span><span class="NLM_article-title">PARP inhibition: PARP1 and beyond</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1038/nrc2812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrc2812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20200537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=293-301&author=M.+Rouleauauthor=A.+Patelauthor=M.+J.+Hendzelauthor=S.+H.+Kaufmannauthor=G.+G.+Poirier&title=PARP+inhibition%3A+PARP1+and+beyond&doi=10.1038%2Fnrc2812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">PARP inhibition: PARP1 and beyond</span></div><div class="casAuthors">Rouleau, Michele; Patel, Anand; Hendzel, Michael J.; Kaufmann, Scott H.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-301</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent findings have thrust poly(ADP-ribose) polymerases (PARPs) into the limelight as potential chemotherapeutic targets.  To provide a framework for understanding these recent observations, the authors have reviewed what is known about the structures and functions of the family of PARP enzymes, and then outlined a series of questions that should be addressed to guide the rational development of PARP inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOiY_n1IClmbVg90H21EOLACvtfcHk0liu5tW2MoiHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D&md5=fa3e3964e84229317dadbd505f11ad86</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrc2812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2812%26sid%3Dliteratum%253Aachs%26aulast%3DRouleau%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DPARP%2520inhibition%253A%2520PARP1%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D293%26epage%3D301%26doi%3D10.1038%2Fnrc2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castroviejo-Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaknin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span> <span> </span><span class="NLM_article-title">A decade of clinical development of PARP inhibitors in perspective</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdz192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1093%2Fannonc%2Fmdz192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31218365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3M3os1Kjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=1437-1447&author=J.+Mateoauthor=C.+J.+Lordauthor=V.+Serraauthor=A.+Tuttauthor=J.+Balmanaauthor=M.+Castroviejo-Bermejoauthor=C.+Cruzauthor=A.+Oakninauthor=S.+B.+Kayeauthor=J.+S.+de+Bono&title=A+decade+of+clinical+development+of+PARP+inhibitors+in+perspective&doi=10.1093%2Fannonc%2Fmdz192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of clinical development of PARP inhibitors in perspective</span></div><div class="casAuthors">Mateo J; Balmana J; Cruz C; Oaknin A; Lord C J; Serra V; Castroviejo-Bermejo M; Tutt A; Kaye S B; de Bono J S</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1437-1447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells.  DNA damage repair defects are common in different cancer types; these alterations can also induce tumour-specific vulnerabilities that can be exploited therapeutically.  In 2009, a first-in-man clinical trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib clinically validated the synthetic lethal interaction between inhibition of PARP1, a key sensor of DNA damage, and BRCA1/BRCA2 deficiency.  In this review, we summarize a decade of PARP inhibitor clinical development, a work that has resulted in the registration of several PARP inhibitors in breast (olaparib and talazoparib) and ovarian cancer (olaparib, niraparib and rucaparib, either alone or following platinum chemotherapy as maintenance therapy).  Over the past 10 years, our knowledge on the mechanism of action of PARP inhibitor as well as how tumours become resistant has been extended, and we summarise this work here.  We also discuss opportunities for expanding the precision medicine approach with PARP inhibitors, identifying a wider population who could benefit from this drug class.  This includes developing and validating better predictive biomarkers for patient stratification, mainly based on homologous recombination defects beyond BRCA1/BRCA2 mutations, identifying DNA repair deficient tumours in other cancer types such as prostate or pancreatic cancer, or by designing combination therapies with PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA9h2s1R9Zwcjl5L8hwNX0fW6udTcc2eazY31bbx-4o7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3os1Kjtg%253D%253D&md5=f7755588b156a5fe67ba16dfbccdf889</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdz192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdz192%26sid%3Dliteratum%253Aachs%26aulast%3DMateo%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DBalmana%26aufirst%3DJ.%26aulast%3DCastroviejo-Bermejo%26aufirst%3DM.%26aulast%3DCruz%26aufirst%3DC.%26aulast%3DOaknin%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26atitle%3DA%2520decade%2520of%2520clinical%2520development%2520of%2520PARP%2520inhibitors%2520in%2520perspective%26jtitle%3DAnn.%2520Oncol.%26date%3D2019%26volume%3D30%26spage%3D1437%26epage%3D1447%26doi%3D10.1093%2Fannonc%2Fmdz192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giriat, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lange, T.</span></span> <span> </span><span class="NLM_article-title">Tankyrase, a poly(ADP-ribose) polymerase at human telomeres</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1126/science.282.5393.1484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscience.282.5393.1484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9822378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXns1yms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1484-1487&author=S.+Smithauthor=I.+Giriatauthor=A.+Schmittauthor=T.+de+Lange&title=Tankyrase%2C+a+poly%28ADP-ribose%29+polymerase+at+human+telomeres&doi=10.1126%2Fscience.282.5393.1484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase, a poly(ADP-ribose) polymerase at human telomeres</span></div><div class="casAuthors">Smith, Susan; Giriat, Izabela; Schmitt, Anja; De Langet, Titia</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5393</span>),
    <span class="NLM_cas:pages">1484-1488</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tankyrase, a protein with homol. to ankyrins and to the catalytic domain of poly(ADP-ribose) polymerase (PARP), was identified and localized to human telomeres.  Tankyrase binds to the telomeric protein TRF1 (telomeric repeat binding factor-1), a neg. regulator of telomere length maintenance.  Like ankyrins, tankyrase contains 24 ankyrin repeats in a domain responsible for its interaction with TRF1.  Recombinant tankyrase was found to have PARP activity in vitro, with both TRF1 and tankyrase functioning as acceptors for ADP-ribosylation.  ADP-ribosylation of TRF1 diminished its ability to bind to telomeric DNA in vitro, suggesting that telomere function in human cells is regulated by poly(ADP-ribosyl)ation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxdALI6ymFrVg90H21EOLACvtfcHk0lhN4ibbCzQTfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1yms78%253D&md5=8c991efb258d26af8fcc8c0126f76eee</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5393.1484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5393.1484%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DGiriat%26aufirst%3DI.%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3Dde%2BLange%26aufirst%3DT.%26atitle%3DTankyrase%252C%2520a%2520poly%2528ADP-ribose%2529%2520polymerase%2520at%2520human%2520telomeres%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1484%26epage%3D1487%26doi%3D10.1126%2Fscience.282.5393.1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruo, T.</span></span> <span> </span><span class="NLM_article-title">Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ccr.2004.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15652747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVaitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=25-37&author=H.+Seimiyaauthor=Y.+Muramatsuauthor=T.+Ohishiauthor=T.+Tsuruo&title=Tankyrase+1+as+a+target+for+telomere-directed+molecular+cancer+therapeutics&doi=10.1016%2Fj.ccr.2004.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics</span></div><div class="casAuthors">Seimiya, Hiroyuki; Muramatsu, Yukiko; Ohishi, Tomokazu; Tsuruo, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-37</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Telomere elongation by telomerase is repressed in cis by the telomeric protein TRF1.  Tankyrase 1 poly(ADP-ribosyl)ates TRF1 and releases it from telomeres, allowing access of telomerase to telomeres.  Here we demonstrate that tankyrase 1 inhibition in human cancer cells enhances telomere shortening by a telomerase inhibitor and hastens cell death.  Conversely, either tankyrase 1 upregulation or telomere shortening, each of which decreased TRF1 loading on a chromosome end, attenuated the impact of telomerase inhibition.  These results are consistent with the idea that telomeres having fewer TRF1s increase the efficiency of their elongation by telomerase.  This study implies that both enzyme activity and accessibility to telomeres can be targets for telomerase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl5BeU2RExnrVg90H21EOLACvtfcHk0lhyOD3AK7mcyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVaitrg%253D&md5=b1f4ea3ea97d3415371b0354451485e3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DTankyrase%25201%2520as%2520a%2520target%2520for%2520telomere-directed%2520molecular%2520cancer%2520therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D25%26epage%3D37%26doi%3D10.1016%2Fj.ccr.2004.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0lhyOD3AK7mcyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of selective inhibition of human tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1367</span>, <span class="refDoi"> DOI: 10.1021/jm201510p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201510p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1360-1367&author=M.+Narwalauthor=H.+Venkannagariauthor=L.+Lehtio&title=Structural+basis+of+selective+inhibition+of+human+tankyrases&doi=10.1021%2Fjm201510p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Selective Inhibition of Human Tankyrases</span></div><div class="casAuthors">Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1360-1367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases are poly(ADP-ribose) polymerases that have many cellular functions.  They play pharmaceutically important roles, at least in telomere homeostasis and Wnt signaling, by covalently ADP-ribosylating target proteins and consequently regulating their functions.  These features make tankyrases potential targets for treatment of cancer.  We report here crystal structures of human tankyrase 2 catalytic fragment in complex with a byproduct, nicotinamide, and with selective inhibitors of tankyrases (IWR-1) and PARPs 1 and 2 (olaparib).  Binding of these inhibitors to tankyrase 2 induces specific conformational changes.  The crystal structures explain the selectivity of the inhibitors, reveal the flexibility of a substrate binding loop, and explain existing structure-activity relationship data.  The first crystal structure of a PARP enzyme in complex with a potent inhibitor, IWR-1, that does not bind to the widely utilized nicotinamide-binding site makes the structure valuable for development of PARP inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84kvenfSo3rVg90H21EOLACvtfcHk0lhyOD3AK7mcyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ajsg%253D%253D&md5=7865a047f39d4b65fee0008a800f25ce</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm201510p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201510p%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DStructural%2520basis%2520of%2520selective%2520inhibition%2520of%2520human%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1360%26epage%3D1367%26doi%3D10.1021%2Fjm201510p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsalaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottapel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1354</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.10.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2011.10.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22153077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1340-1354&author=S.+Guettlerauthor=J.+LaRoseauthor=E.+Petsalakiauthor=G.+Gishauthor=A.+Scotterauthor=T.+Pawsonauthor=R.+Rottapelauthor=F.+Sicheri&title=Structural+basis+and+sequence+rules+for+substrate+recognition+by+Tankyrase+explain+the+basis+for+cherubism+disease&doi=10.1016%2Fj.cell.2011.10.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease</span></div><div class="casAuthors">Guettler, Sebastian; LaRose, Jose; Petsalaki, Evangelia; Gish, Gerald; Scotter, Andy; Pawson, Tony; Rottapel, Robert; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1340-1354</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The poly(ADP-ribose)polymerases Tankyrase 1/2 (TNKS/TNKS2) catalyze the covalent linkage of ADP-ribose polymer chains onto target proteins, regulating their ubiquitylation, stability, and function.  Dysregulation of substrate recognition by Tankyrases underlies the human disease cherubism.  Tankyrases recruit specific motifs (often called RxxPDG "hexapeptides") in their substrates via an N-terminal region of ankyrin repeats.  These ankyrin repeats form five domains termed ankyrin repeat clusters (ARCs), each predicted to bind substrate.  Here we report crystal structures of a representative ARC of TNKS2 bound to targeting peptides from six substrates.  Using a soln.-based peptide library screen, we derive a rule-based consensus for Tankyrase substrates common to four functionally conserved ARCs.  This 8-residue consensus allows us to rationalize all known Tankyrase substrates and explains the basis for cherubism-causing mutations in the Tankyrase substrate 3BP2.  Structural and sequence information allows us to also predict and validate other Tankyrase targets, including Disc1, Striatin, Fat4, RAD54, BCR, and MERIT40.  Structural studies combined with a peptide library screen reveal the rules of substrate recognition by the poly(ADP-ribose)polymerase Tankyrase, explaining how mutations that cause cherubism disrupt the interaction between Tankyrase and one of its substrates, 3BP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXBvt-q3D-MLVg90H21EOLACvtfcHk0lgLmKBiujV_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgtr3N&md5=cd3925d7dbbdf0e9893906e37befde9f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.046%26sid%3Dliteratum%253Aachs%26aulast%3DGuettler%26aufirst%3DS.%26aulast%3DLaRose%26aufirst%3DJ.%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520and%2520sequence%2520rules%2520for%2520substrate%2520recognition%2520by%2520Tankyrase%2520explain%2520the%2520basis%2520for%2520cherubism%2520disease%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1340%26epage%3D1354%26doi%3D10.1016%2Fj.cell.2011.10.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorsell, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and Tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2hu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1262-1271&author=A.+G.+Thorsellauthor=T.+Ekbladauthor=T.+Karlbergauthor=M.+Lowauthor=A.+F.+Pintoauthor=L.+Tresauguesauthor=M.+Mocheauthor=M.+S.+Cohenauthor=H.+Schuler&title=Structural+basis+for+potency+and+promiscuity+in+poly%28ADP-ribose%29+polymerase+%28PARP%29+and+Tankyrase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors</span></div><div class="casAuthors">Thorsell, Ann-Gerd; Ekblad, Torun; Karlberg, Tobias; Loew, Mirjam; Pinto, Ana Filipa; Tresaugues, Lionel; Moche, Martin; Cohen, Michael S.; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors could help unveil the mechanisms by which inhibition of poly(ADP-ribose) polymerases (PARPs) elicits clin. benefits in cancer therapy.  The authors profiled ten clin. PARP inhibitors and commonly used research tools for their inhibition of multiple PARP enzymes.  The authors also detd. crystal structures of these compds. bound to PARP1 or PARP2.  Veliparib and Niraparib are selective inhibitors of PARP1 and PARP2; Olaparib, Rucaparib and Talazoparib are more potent inhibitors of PARP1, but are less selective.  PJ34 and UPF1069 are broad PARP inhibitors; PJ34 inserts a flexible moiety into hydrophobic subpockets in various ADP-ribosyltransferases.  XAV939 is a promiscuous tankyrase inhibitor, and a potent inhibitor of PARP1 in vitro and in cells, whereas IWR1 and AZ6102 are tankyrase selective.  The authors' biochem. and structural anal. of PARP inhibitor potencies establishes a mol. basis for either selectivity or promiscuity and provides a benchmark for exptl. design in assessment of PARP inhibitor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQSmV0dV9abrVg90H21EOLACvtfcHk0lgLmKBiujV_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2hu77E&md5=fce2c08efcf47cbc24929b62df782a39</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00990%26sid%3Dliteratum%253Aachs%26aulast%3DThorsell%26aufirst%3DA.%2BG.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DLow%26aufirst%3DM.%26aulast%3DPinto%26aufirst%3DA.%2BF.%26aulast%3DTresaugues%26aufirst%3DL.%26aulast%3DMoche%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520potency%2520and%2520promiscuity%2520in%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520and%2520Tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1262%26epage%3D1271%26doi%3D10.1021%2Facs.jmedchem.6b00990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5352</span>– <span class="NLM_lpage">5355</span>, <span class="refDoi"> DOI: 10.1021/jm100249w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100249w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5352-5355&author=T.+Karlbergauthor=N.+Markovaauthor=I.+Johanssonauthor=M.+Hammarstromauthor=P.+Schutzauthor=J.+Weigeltauthor=H.+Schuler&title=Structural+basis+for+the+interaction+between+tankyrase-2+and+a+potent+Wnt-signaling+inhibitor&doi=10.1021%2Fjm100249w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor</span></div><div class="casAuthors">Karlberg, Tobias; Markova, Natalia; Johansson, Ida; Hammarstrom, Martin; Schutz, Patrick; Weigelt, Johan; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5352-5355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report two crystal structures of the PARP domain of human tankyrase-2 (TNKS2).  Tankyrases are involved in fundamental cellular processes such as telomere homeostasis and Wnt signaling.  The complex of TNKS2 with the potent inhibitor XAV939 provides insights into the mol. basis of the strong interaction and suggests routes for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8HUahD927bVg90H21EOLACvtfcHk0lj-djncHWBUiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D&md5=3b037afbe6f4dc86a492855fa800fb44</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm100249w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100249w%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DHammarstrom%26aufirst%3DM.%26aulast%3DSchutz%26aufirst%3DP.%26aulast%3DWeigelt%26aufirst%3DJ.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520tankyrase-2%2520and%2520a%2520potent%2520Wnt-signaling%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5352%26epage%3D5355%26doi%3D10.1021%2Fjm100249w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Neves, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Oliveira, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes-Ribeiro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. M. F.</span></span> <span> </span><span class="NLM_article-title">IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>414</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29126913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2018&pages=1-15&author=S.+R.+Martins-Nevesauthor=D.+I.+Paiva-Oliveiraauthor=C.+Fontes-Ribeiroauthor=J.+Boveeauthor=A.+M.+Cleton-Jansenauthor=C.+M.+F.+Gomes&title=IWR-1%2C+a+tankyrase+inhibitor%2C+attenuates+Wnt%2Fbeta-catenin+signaling+in+cancer+stem-like+cells+and+inhibits+in+vivo+the+growth+of+a+subcutaneous+human+osteosarcoma+xenograft&doi=10.1016%2Fj.canlet.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span></div><div class="casAuthors">Martins-Neves, Sara R.; Paiva-Oliveira, Daniela I.; Fontes-Ribeiro, Carlos; Bovee, Judith V. M. G.; Cleton-Jansen, Anne-Marie; Gomes, Celia M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Wnt/β-catenin or canonical Wnt signaling pathway regulates the self-renewal of cancer stem-like cells (CSCs) and is involved in tumor progression and chemotherapy resistance.  Previously, we reported that this pathway is activated in a subset of osteosarcoma CSCs and that doxorubicin induced stemness properties in differentiated cells through Wnt/β-catenin activation.  Here, we investigated whether pharmacol. Wnt/β-catenin inhibition, using a tankyrase inhibitor (IWR-1), might constitute a strategy to target CSCs and improve chemotherapy efficacy in osteosarcoma.  IWR-1 was specifically cytotoxic for osteosarcoma CSCs.  IWR-1 impaired spheres' self-renewal capacity by compromising landmark steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets.  IWR-1 also hampered the activity and expression of key stemness-related markers.  In vitro, IWR-1 induced apoptosis of osteosarcoma spheres and combined with doxorubicin elicited synergistic cytotoxicity, reversing spheres' resistance to this drug.  In vivo, IWR-1 co-administration with doxorubicin substantially decreased tumor progression, assocd. with specific down-regulation of TCF/LEF transcriptional activity, nuclear β-catenin and expression of the putative CSC marker Sox2.  We suggest that targeting the Wnt/β-catenin pathway can eliminate CSCs populations in osteosarcoma.  Combining conventional chemotherapy with Wnt/β-catenin inhibition may ameliorate therapeutic outcomes, by eradicating the aggressive osteosarcoma CSCs and reducing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocG-gCNsSkwbVg90H21EOLACvtfcHk0lj-djncHWBUiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK&md5=c3aa5ed1a5fa31daa1d180ed72394202</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Neves%26aufirst%3DS.%2BR.%26aulast%3DPaiva-Oliveira%26aufirst%3DD.%2BI.%26aulast%3DFontes-Ribeiro%26aufirst%3DC.%26aulast%3DBovee%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.%2BM.%26aulast%3DGomes%26aufirst%3DC.%2BM.%2BF.%26atitle%3DIWR-1%252C%2520a%2520tankyrase%2520inhibitor%252C%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520cancer%2520stem-like%2520cells%2520and%2520inhibits%2520in%2520vivo%2520the%2520growth%2520of%2520a%2520subcutaneous%2520human%2520osteosarcoma%2520xenograft%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D414%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.canlet.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1341</span>– <span class="NLM_lpage">1345</span>, <span class="refDoi"> DOI: 10.1021/jm301607v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301607v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1341-1345&author=H.+Bregmanauthor=H.+Gunaydinauthor=Y.+Guauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauroauthor=X.+Huang&title=Discovery+of+a+class+of+novel+tankyrase+inhibitors+that+bind+to+both+the+nicotinamide+pocket+and+the+induced+pocket&doi=10.1021%2Fjm301607v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Class of Novel Tankyrase Inhibitors that Bind to Both the Nicotinamide Pocket and the Induced Pocket</span></div><div class="casAuthors">Bregman, Howard; Gunaydin, Hakan; Gu, Yan; Schneider, Steve; Wilson, Cindy; DiMauro, Erin F.; Huang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1341-1345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent and selective inhibitors of tankyrases have recently been characterized to bind to an induced pocket.  Here we report the identification of a novel potent and selective tankyrase inhibitor that binds to both the nicotinamide pocket and the induced pocket.  The crystal structure of human TNKS1 in complex with this "dual-binder" provides a mol. basis for their strong and specific interactions and suggests clues for the further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHc_P8ufAdAbVg90H21EOLACvtfcHk0lj-djncHWBUiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeitQ%253D%253D&md5=09681629c9a117caa6faeb64474091a5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm301607v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301607v%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520a%2520class%2520of%2520novel%2520tankyrase%2520inhibitors%2520that%2520bind%2520to%2520both%2520the%2520nicotinamide%2520pocket%2520and%2520the%2520induced%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1341%26epage%3D1345%26doi%3D10.1021%2Fjm301607v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emkey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10003</span>– <span class="NLM_lpage">10015</span>, <span class="refDoi"> DOI: 10.1021/jm401317z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401317z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10003-10015&author=Z.+Huaauthor=H.+Bregmanauthor=J.+L.+Buchananauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=X.+Huangauthor=Y.+Guauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=R.+Emkeyauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=L.+Acquavivaauthor=J.+Doveyauthor=A.+Mishraauthor=J.+Newcombauthor=D.+Saffranauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=M.+Stantonauthor=C.+Wilsonauthor=E.+F.+Dimauro&title=Development+of+novel+dual+binders+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm401317z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Hua, Zihao; Bregman, Howard; Buchanan, John L.; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Huang, Xin; Gu, Yan; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Emkey, Renee; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Acquaviva, Lisa; Dovey, Jennifer; Mishra, Ankita; Newcomb, John; Saffran, Douglas; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Stanton, Mary; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10003-10015</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS1 and TNKS2) are proteins in the poly ADP-ribose polymerase (PARP) family.  They have been shown to directly bind to axin proteins, which neg. regulate the Wnt pathway by promoting β-catenin degrdn.  Inhibition of tankyrases may offer a novel approach to the treatment of APC-mutant colorectal cancer.  Hit compd. N-(2-methoxyphenyl)-4-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamido)benzamide was identified as an inhibitor of tankyrases through a combination of substructure searching of the Amgen compd. collection based on a minimal binding pharmacophore hypothesis and high-throughput screening.  Herein the authors report the structure- and property-based optimization of N-(2-methoxyphenyl)-4-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamido)benzamide leading to the identification of more potent and selective tankyrase inhibitors with improved pharmacokinetic properties in rodents, which are well suited as tool compds. for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-WJLflGn1C7Vg90H21EOLACvtfcHk0ljkPRgGik2UtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbN&md5=4620a3232873c1767b8289df2fac0c49</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm401317z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401317z%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DAcquaviva%26aufirst%3DL.%26aulast%3DDovey%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSaffran%26aufirst%3DD.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DStanton%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26atitle%3DDevelopment%2520of%2520novel%2520dual%2520binders%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10003%26epage%3D10015%26doi%3D10.1021%2Fjm401317z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Toureauthor=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+the+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0ljkPRgGik2UtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520the%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 2-arylquinazolin-4-ones as potent and selective inhibitors of Tankyrases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/ml400260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1173-1177&author=A.+Nathubhaiauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=M.+D.+Threadgill&title=Design+and+discovery+of+2-arylquinazolin-4-ones+as+potent+and+selective+inhibitors+of+Tankyrases&doi=10.1021%2Fml400260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of 2 Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases</span></div><div class="casAuthors">Nathubhai, Amit; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKSs) are poly-(ADP-ribose)-polymerases (PARPs) that are overexpressed in several clin. cancers.  They regulate elongation of telomeres, regulate the Wnt system, and are essential for the function of the mitotic spindle.  A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs.  TNKS-2.  Me was preferred at the 8-position and modest bulk at the 4-position of the 2-Ph group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided.  Mol. modeling facilitated initial design of the compds. and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes.  These compds. have potential for further development into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfmX1o7LIsrVg90H21EOLACvtfcHk0ljozEvrqQ97Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM&md5=23eb9a910b7952c76392bb1ae3b1185b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fml400260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400260b%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520discovery%2520of%25202-arylquinazolin-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Tankyrases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1173%26epage%3D1177%26doi%3D10.1021%2Fml400260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paine, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunderland, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5891</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26189030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5891-5908&author=H.+A.+Paineauthor=A.+Nathubhaiauthor=E.+C.+Woonauthor=P.+T.+Sunderlandauthor=P.+J.+Woodauthor=M.+F.+Mahonauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=M.+Narwalauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Exploration+of+the+nicotinamide-binding+site+of+the+tankyrases%2C+identifying+3-arylisoquinolin-1-ones+as+potent+and+selective+inhibitors+in+vitro&doi=10.1016%2Fj.bmc.2015.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span></div><div class="casAuthors">Paine, Helen A.; Nathubhai, Amit; Woon, Esther C. Y.; Sunderland, Peter T.; Wood, Pauline J.; Mahon, Mary F.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Narwal, Mohit; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5891-5908</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases-1 and -2 (TNKS-1 and TNKS-2) have three cellular roles which make them important targets in cancer.  Using NAD+ as a substrate, they poly(ADP-ribosyl)ate TRF1 (regulating lengths of telomeres), NuMA (facilitating mitosis) and axin (in wnt/β-catenin signaling).  Using mol. modeling and the structure of the weak inhibitor 5-aminoiso quinolin-1-one, 3-aryl-5-substituted-isoquinolin-1-ones were designed as inhibitors to explore the structure-activity relationships (SARs) for binding and to define the shape of a hydrophobic cavity in the active site.  5-Amino-3-arylisoquinolinones were synthesized by Suzuki-Miyaura coupling of arylboronic acids to 3-bromo-1-methoxy-5-nitro-isoquinoline, redn. and O-demethylation.  3-Aryl-5-methylisoquinolin-1-ones, 3-aryl-5-fluoroisoquinolin-1-ones and 3-aryl-5-methoxyisoquinolin-1-ones were accessed by deprotonation of 3-substituted-N,N,2-trimethylbenzamides and quench with an appropriate benzonitrile.  SAR around the isoquinolinone core showed that aryl was required at the 3-position, optimally with a para-substituent.  Small meta-substituents were tolerated but groups in the ortho-positions reduced or abolished activity.  This was not due to lack of coplanarity of the rings, as shown by the potency of 4,5-dimethyl-3-phenylisoquinolin-1-one.  Me and methoxy were optimal at the 5-position.  SAR was rationalized by modeling and by crystal structures of examples with TNKS-2.  The 3-aryl unit was located in a large hydrophobic cavity and the para-substituents projected into a tunnel leading to the exterior.  Potency against TNKS-1 paralleled potency against TNKS-2.  Most inhibitors were highly selective for TNKSs over PARP-1 and PARP-2.  A range of highly potent and selective inhibitors is now available for cellular studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorPYvLKQ94bVg90H21EOLACvtfcHk0ljozEvrqQ97Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK&md5=a0c5d0ca6be15f5a565e66ba201d0c57</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DH.%2BA.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSunderland%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DExploration%2520of%2520the%2520nicotinamide-binding%2520site%2520of%2520the%2520tankyrases%252C%2520identifying%25203-arylisoquinolin-1-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520in%2520vitro%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5891%26epage%3D5908%26doi%3D10.1016%2Fj.bmc.2015.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumpan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3013</span>– <span class="NLM_lpage">3032</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26026769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3013-3032&author=K.+Kumpanauthor=A.+Nathubhaiauthor=C.+Zhangauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Structure-based+design%2C+synthesis+and+evaluation+in+vitro+of+arylnaphthyridinones%2C+arylpyridopyrimidinones+and+their+tetrahydro+derivatives+as+inhibitors+of+the+tankyrases&doi=10.1016%2Fj.bmc.2015.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases</span></div><div class="casAuthors">Kumpan, Katerina; Nathubhai, Amit; Zhang, Chenlu; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3013-3032</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The tankyrase enzymes [i.e., poly(ADP-ribose) polymerase enzymes] are members of the PARP superfamily.  They poly(ADP-ribosyl)ate their target proteins using NAD+ as a source of electrophilic ADP-ribosyl units.  The three principal protein substrates of the tankyrase enzymes (TRF1, NuMA and axins) are involved in replication of cancer cells.  Thus, inhibitors of the tankyrase enzymes may have anticancer activity (antitumor activity).  Using a structure-based drug design and by analogy with known 3-aryl-1-isoquinolinone and 2-aryl-4-quinazolinone inhibitors, series of (aryl)naphthyridinone derivs., (aryl)pyridopyrimidinone derivs. and their tetrahydro-derivs. were synthesized and evaluated in vitro.  7-Aryl-1,6-naphthyridin-5-one derivs., 3-aryl-2,6-naphthyridin-1-one derivs. and 3-aryl-2,7-naphthyridin-1-ones were prepd. by an acid-catalyzed cyclization of the corresponding [(aryl)ethynyl]pyridinecarbonitrile derivs. or reaction of (bromo)pyridinecarboxylic acids with β-diketones, followed by treatment with NH3.  The 7-aryl-1,6-naphthyridin-5-ones were methylated at 1-N and reduced to 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones.  A copper-catalyzed reaction of benzamidines with (bromo)pyridinecarboxylic acids furnished 2-(aryl)pyrido[2,3-d]pyrimidin-4-ones.  A condensation of benzamidines with Me 1-benzyl-4-oxopiperidine-3-carboxylate and deprotection gave 2-aryl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-ones, aza analogs of the known inhibitor XAV939.  Introduction of a ring-nitrogen in the arylnaphthyridinones and the arylpyridopyrimidinones caused >1000-fold loss in activity, compared with their carbocyclic isoquinolinone and quinazolinone analogs (structure-activity relationship).  However, the 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones showed excellent inhibition of the tankyrase enzymes, with some examples having IC50 = 2 nM.  One compd. (7-(4-bromophenyl)-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-one) showed 70-fold selectivity for inhibition of tankyrase-2 vs. tankyrase-1.  The mode of binding was explored through crystal structures of inhibitors in complex with tankyrase-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9836Di5rfRLVg90H21EOLACvtfcHk0lhwhT1f7lcnxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGrsbk%253D&md5=367e1965fd9d3f1d458b1d38bc5a1ca7</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DKumpan%26aufirst%3DK.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520evaluation%2520in%2520vitro%2520of%2520arylnaphthyridinones%252C%2520arylpyridopyrimidinones%2520and%2520their%2520tetrahydro%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520tankyrases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3013%26epage%3D3032%26doi%3D10.1016%2Fj.bmc.2015.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumanov, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Highly potent and isoform selective dual site binding Tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=814-820&author=A.+Nathubhaiauthor=T.+Haikarainenauthor=J.+Koivunenauthor=S.+Murthyauthor=F.+Koumanovauthor=M.+D.+Lloydauthor=G.+D.+Holmanauthor=T.+Pihlajaniemiauthor=D.+Toshauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Highly+potent+and+isoform+selective+dual+site+binding+Tankyrase%2FWnt+signaling+inhibitors+that+increase+cellular+glucose+uptake+and+have+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.6b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity</span></div><div class="casAuthors">Nathubhai, Amit; Haikarainen, Teemu; Koivunen, Jarkko; Murthy, Sudarshan; Koumanov, Francoise; Lloyd, Matthew D.; Holman, Geoffrey D.; Pihlajaniemi, Taina; Tosh, David; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the "std." inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 μM vs. PARP1 for 14.  In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeH2cfPlBFBLVg90H21EOLACvtfcHk0lhwhT1f7lcnxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O&md5=2eb1a9ae15a5b9402b730e67f1ba3d79</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01574%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DKoumanov%26aufirst%3DF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DHolman%26aufirst%3DG.%2BD.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DHighly%2520potent%2520and%2520isoform%2520selective%2520dual%2520site%2520binding%2520Tankyrase%252FWnt%2520signaling%2520inhibitors%2520that%2520increase%2520cellular%2520glucose%2520uptake%2520and%2520have%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D814%26epage%3D820%26doi%3D10.1021%2Facs.jmedchem.6b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective Tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.+P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+Tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lgGqlQzu7dbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520Tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boriack-Sjodin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dishington, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingipalli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1021/ml5003663</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=254-259&author=J.+W.+Johannesauthor=L.+Almeidaauthor=B.+Barlaamauthor=P.+A.+Boriack-Sjodinauthor=R.+Casellaauthor=R.+A.+Croftauthor=A.+P.+Dishingtonauthor=L.+Gingipalliauthor=C.+Guauthor=J.+L.+Hawkinsauthor=J.+L.+Holmesauthor=T.+Howardauthor=J.+Huangauthor=S.+Ioannidisauthor=S.+Kazmirskiauthor=M.+L.+Lambauthor=T.+M.+McGuireauthor=J.+E.+Mooreauthor=D.+Oggauthor=A.+Patelauthor=K.+G.+Pikeauthor=T.+Pontzauthor=G.+R.+Robbauthor=N.+Suauthor=H.+Wangauthor=X.+Wuauthor=H.+J.+Zhangauthor=Y.+Zhangauthor=X.+Zhengauthor=T.+Wang&title=Pyrimidinone+nicotinamide+mimetics+as+selective+tankyrase+and+wnt+pathway+inhibitors+suitable+for+in+vivo+pharmacology&doi=10.1021%2Fml5003663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology</span></div><div class="casAuthors">Johannes, Jeffrey W.; Almeida, Lynsie; Barlaam, Bernard; Boriack-Sjodin, P. Ann; Casella, Robert; Croft, Rosemary A.; Dishington, Allan P.; Gingipalli, Lakshmaiah; Gu, Chungang; Hawkins, Janet L.; Holmes, Jane L.; Howard, Tina; Huang, Jian; Ioannidis, Stephanos; Kazmirski, Steven; Lamb, Michelle L.; McGuire, Thomas M.; Moore, Jane E.; Ogg, Derek; Patel, Anil; Pike, Kurt G.; Pontz, Timothy; Robb, Graeme R.; Su, Nancy; Wang, Haiyun; Wu, Xiaoyun; Zhang, Hai-Jun; Zhang, Yue; Zheng, Xiaolan; Wang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254-259</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The canonical Wnt pathway plays an important role in embryonic development, adult tissue homeostasis, and cancer.  Germline mutations of several Wnt pathway components, such as Axin, APC, and ss-catenin, can lead to oncogenesis.  Inhibition of the poly(ADP-ribose) polymerase (PARP) catalytic domain of the tankyrases (TNKS1 and TNKS2) is known to inhibit the Wnt pathway via increased stabilization of Axin.  In order to explore the consequences of tankyrase and Wnt pathway inhibition in preclin. models of cancer and its impact on normal tissue, the authors sought a small mol. inhibitor of TNKS1/2 with suitable physicochem. properties and pharmacokinetics for hypothesis testing in vivo.  Starting from a 2-Ph quinazolinone hit I, the authors discovered the pyrrolopyrimidinone compd. II (AZ6102), which is a potent TNKS1/2 inhibitor that has 100-fold selectivity against other PARP family enzymes and shows 5 nM Wnt pathway inhibition in DLD-1 cells.  Moreover, compd. II can be formulated well in a clin. relevant i.v. soln. at 20 mg/mL, has demonstrated good pharmacokinetics in preclin. species, and shows low Caco2 efflux to avoid possible tumor resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-61oay9RJRrVg90H21EOLACvtfcHk0lgGqlQzu7dbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVyhuw%253D%253D&md5=c9502fbd9bb7823646af8ae60b6a9980</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fml5003663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003663%26sid%3Dliteratum%253Aachs%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DCasella%26aufirst%3DR.%26aulast%3DCroft%26aufirst%3DR.%2BA.%26aulast%3DDishington%26aufirst%3DA.%2BP.%26aulast%3DGingipalli%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DPyrimidinone%2520nicotinamide%2520mimetics%2520as%2520selective%2520tankyrase%2520and%2520wnt%2520pathway%2520inhibitors%2520suitable%2520for%2520in%2520vivo%2520pharmacology%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D254%26epage%3D259%26doi%3D10.1021%2Fml5003663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfrich, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas-Selves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskurth, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaberezhnyy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGregori, J.</span></span> <span> </span><span class="NLM_article-title">AZ1366: an inhibitor of Tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1531</span>– <span class="NLM_lpage">1541</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-16-1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27663586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1531-1541&author=H.+A.+Scarboroughauthor=B.+A.+Helfrichauthor=M.+Casas-Selvesauthor=A.+G.+Schullerauthor=S.+E.+Grosskurthauthor=J.+Kimauthor=A.+C.+Tanauthor=D.+C.+Chanauthor=Z.+Zhangauthor=V.+Zaberezhnyyauthor=P.+A.+Bunnauthor=J.+DeGregori&title=AZ1366%3A+an+inhibitor+of+Tankyrase+and+the+canonical+Wnt+pathway+that+limits+the+persistence+of+non-small+cell+lung+cancer+cells+following+EGFR+inhibition&doi=10.1158%2F1078-0432.CCR-16-1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition</span></div><div class="casAuthors">Scarborough, Hannah A.; Helfrich, Barbara A.; Casas-Selves, Matias; Schuller, Alwin G.; Grosskurth, Shaun E.; Kim, Jihye; Tan, Aik-Choon; Chan, Daniel C.; Zhang, Zhiyong; Zaberezhnyy, Vadym; Bunn, Paul A.; DeGregori, James</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1531-1541</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The emergence of EGFR inhibitors such as gefitinib, erlotinib, and osimertinib has provided novel treatment opportunities in EGFR-driven non-small cell lung cancer (NSCLC).  However, most patients with EGFR-driven cancers treated with these inhibitors eventually relapse.  Recent efforts have identified the canonical Wnt pathway as a mechanism of protection from EGFR inhibition and that inhibiting tankyrase, a key player in this pathway, is a potential therapeutic strategy for the treatment of EGFR-driven tumors.  We performed a preclin. evaluation of tankyrase inhibitor AZ1366 in combination with multiple EGFR-inhibitors across NSCLC lines, characterizing its antitumor activity, impingement on canonical Wnt signaling, and effects on gene expression.  We performed pharmacokinetic and pharmacodynamic profiling of AZ1366 in mice and evaluated its therapeutic activity in an orthotopic NSCLC model.  Results: In combination with EGFR inhibitors, AZ1366 synergistically suppressed proliferation of multiple NSCLC lines and amplified global transcriptional changes brought about by EGFR inhibition.  Its ability to work synergistically with EGFR inhibition coincided with its ability to modulate the canonical Wnt pathway.  Pharmacokinetic and pharmacodynamic profiling of AZ1366-treated orthotopic tumors demonstrated clin. relevant serum drug levels and intratumoral target inhibition.  Finally, coadministration of an EGFR inhibitor and AZ1366 provided better tumor control and improved survival for Wnt-responsive lung cancers in an orthotopic mouse model.  Tankyrase inhibition is a potent route of tumor control in EGFR-dependent NSCLC with confirmed dependence on canonical Wnt signaling.  These data strongly support further evaluation of tankyrase inhibition as a cotreatment strategy with EGFR inhibition in an identifiable subset of EGFR-driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MFhKGoLoCrVg90H21EOLACvtfcHk0liGgBpYhc8CaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOlur4%253D&md5=71faff9bb76dac0a912fabba448428c7</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1179%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DH.%2BA.%26aulast%3DHelfrich%26aufirst%3DB.%2BA.%26aulast%3DCasas-Selves%26aufirst%3DM.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DGrosskurth%26aufirst%3DS.%2BE.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZaberezhnyy%26aufirst%3DV.%26aulast%3DBunn%26aufirst%3DP.%2BA.%26aulast%3DDeGregori%26aufirst%3DJ.%26atitle%3DAZ1366%253A%2520an%2520inhibitor%2520of%2520Tankyrase%2520and%2520the%2520canonical%2520Wnt%2520pathway%2520that%2520limits%2520the%2520persistence%2520of%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520following%2520EGFR%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D1531%26epage%3D1541%26doi%3D10.1158%2F1078-0432.CCR-16-1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel spiroindoline derivatives as selective Tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3407</span>– <span class="NLM_lpage">3427</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3407-3427&author=F.+Shiraiauthor=T.+Tsumuraauthor=Y.+Yashirodaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=T.+Chikadaauthor=Y.+Kodaauthor=K.+Washizukaauthor=N.+Yoshimotoauthor=M.+Abeauthor=T.+Onukiauthor=Y.+Mazakiauthor=C.+Hiramaauthor=T.+Fukamiauthor=H.+Watanabeauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=M.+Okueauthor=Y.+Kanoauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=A.+Mizutaniauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Discovery+of+novel+spiroindoline+derivatives+as+selective+Tankyrase+inhibitors&doi=10.1021%2Facs.jmedchem.8b01888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors</span></div><div class="casAuthors">Shirai, Fumiyuki; Tsumura, Takeshi; Yashiroda, Yoko; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Chikada, Tsubasa; Koda, Yasuko; Washizuka, Kenichi; Yoshimoto, Nobuko; Abe, Masako; Onuki, Tetsuo; Mazaki, Yui; Hirama, Chizuko; Fukami, Takehiro; Watanabe, Hirofumi; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Okue, Masayuki; Kano, Yuko; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Muramatsu, Yukiko; Yoshida, Haruka; Mizutani, Anna; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3407-3427</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The canonical WNT pathway plays an important role in cancer pathogenesis.  Inhibition of poly(ADP-ribose) polymerase catalytic activity of the tankyrases (TNKS/TNKS2) has been reported to reduce the Wnt/β-catenin signal by preventing poly ADP-ribosylation dependent degrdn. of AXIN, a neg. regulator of Wnt/β-catenin signaling.  With the goal of investigating the effects of tankyrase and Wnt pathway inhibition on tumor growth, we set out to find small mol. inhibitors of TNKS/TNKS2 with suitable drug-like properties.  Starting from 1a(I), a high-throughput screening hit, the spiroindoline deriv. 40c(II) (RK-287107) was discovered as a potent TNKS/TNKS2 inhibitor with >7,000-fold selectivity against the PARP1 enzyme, which inhibits WNT-responsive TCF reporter activity and proliferation of human colorectal cancer cell line COLO-320DM.  II also demonstrated dose-dependent tumor growth inhibition in a mouse xenograft model.  These observations suggest that II is a promising lead compd. for the development of novel tankyrase inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb10HXpjf717Vg90H21EOLACvtfcHk0liGgBpYhc8CaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFertbg%253D&md5=7877414ff5e5cfc908b1248017867639</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01888%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DYoshimoto%26aufirst%3DN.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DOnuki%26aufirst%3DT.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DHirama%26aufirst%3DC.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520novel%2520spiroindoline%2520derivatives%2520as%2520selective%2520Tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3407%26epage%3D3427%26doi%3D10.1021%2Facs.jmedchem.8b01888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0lgPPUdeP3neNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of an orally efficacious spiroindolinone-based Tankyrase inhibitor for the treatment of colon cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4204</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4183-4204&author=F.+Shiraiauthor=A.+Mizutaniauthor=Y.+Yashirodaauthor=T.+Tsumuraauthor=Y.+Kanoauthor=Y.+Muramatsuauthor=T.+Chikadaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=K.+Washizukaauthor=Y.+Kodaauthor=Y.+Mazakiauthor=M.+K.+Jangauthor=H.+Yoshidaauthor=A.+Nagamoriauthor=M.+Okueauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=T.+Fukamiauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Design+and+discovery+of+an+orally+efficacious+spiroindolinone-based+Tankyrase+inhibitor+for+the+treatment+of+colon+cancer&doi=10.1021%2Facs.jmedchem.0c00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer</span></div><div class="casAuthors">Shirai, Fumiyuki; Mizutani, Anna; Yashiroda, Yoko; Tsumura, Takeshi; Kano, Yuko; Muramatsu, Yukiko; Chikada, Tsubasa; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Washizuka, Kenichi; Koda, Yasuko; Mazaki, Yui; Jang, Myung-Kyu; Yoshida, Haruka; Nagamori, Akiko; Okue, Masayuki; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Fukami, Takehiro; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4183-4204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS/TNKS2) belong to the poly(ADP-ribose) polymerase family.  Inhibition of their enzymic activities attenuates the Wnt/β-catenin signaling, which plays an important role in cancer pathogenesis.  We previously reported the discovery of RK-287107, a spiroindoline-based, highly selective, potent tankyrase inhibitor.  Herein we describe the optimization process of RK-287107 leading to RK-582, which exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.  In addn. to the dose-dependent elevation and attenuation of the levels of biomarkers AXIN2 and β-catenin, resp., results of the TCF reporter and cell proliferation studies on COLO-320DM are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnxMuxDScpWLVg90H21EOLACvtfcHk0lgPPUdeP3neNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D&md5=8c55fd054daf7ccc91975379c2d8085b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00045%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DNagamori%26aufirst%3DA.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDesign%2520and%2520discovery%2520of%2520an%2520orally%2520efficacious%2520spiroindolinone-based%2520Tankyrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520colon%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4183%26epage%3D4204%26doi%3D10.1021%2Facs.jmedchem.0c00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lgylSXA4foxkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1223</span>, <span class="refDoi"> DOI: 10.1021/ml4003315</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003315" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1218-1223&author=H.+Huangauthor=A.+Guzman-Perezauthor=L.+Acquavivaauthor=V.+Berryauthor=H.+Bregmanauthor=J.+Doveyauthor=H.+Gunaydinauthor=X.+Huangauthor=L.+Huangauthor=D.+Saffranauthor=R.+Serafinoauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Structure-based+design+of+2-aminopyridine+oxazolidinones+as+potent+and+selective+tankyrase+inhibitors&doi=10.1021%2Fml4003315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors</span></div><div class="casAuthors">Huang, Hongbing; Guzman-Perez, Angel; Acquaviva, Lisa; Berry, Virginia; Bregman, Howard; Dovey, Jennifer; Gunaydin, Hakan; Huang, Xin; Huang, Liyue; Saffran, Doug; Serafino, Randy; Schneider, Steve; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1218-1223</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant activation of the Wnt pathway has been implicated in the development and formation of many cancers.  TNKS inhibition has been shown to antagonize Wnt signaling via Axin stabilization in APC mutant colon cancer cell lines.  We employed structure-based design to identify a series of 2-aminopyridine oxazolidinones as potent and selective TNKS inhibitors.  These compds. exhibited good enzyme and cell potency as well as selectivity over other PARP isoforms.  Co-crystal structures of these 2-aminopyridine oxazolidinones complexed to TNKS reveal an induced-pocket binding mode that does not involve interactions with the nicotinamide binding pocket.  Oral dosing of lead compds. 3 and 4 resulted in significant effects on several Wnt-pathway biomarkers in a three day DLD-1 mouse tumor PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQcoLA6UEfbVg90H21EOLACvtfcHk0lgylSXA4foxkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrvP&md5=9aa2a27d3694d8ed6dded65ccf85d186</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml4003315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003315%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DAcquaviva%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDovey%26aufirst%3DJ.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSaffran%26aufirst%3DD.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DStructure-based%2520design%2520of%25202-aminopyridine%2520oxazolidinones%2520as%2520potent%2520and%2520selective%2520tankyrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1218%26epage%3D1223%26doi%3D10.1021%2Fml4003315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundenes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedlich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembinski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-10-1282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21199802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=197-205&author=J.+Waalerauthor=O.+Machonauthor=J.+P.+von+Kriesauthor=S.+R.+Wilsonauthor=E.+Lundenesauthor=D.+Wedlichauthor=D.+Gradlauthor=J.+E.+Paulsenauthor=O.+Machonovaauthor=J.+L.+Dembinskiauthor=H.+Dinhauthor=S.+Krauss&title=Novel+synthetic+antagonists+of+canonical+Wnt+signaling+inhibit+colorectal+cancer+cell+growth&doi=10.1158%2F0008-5472.CAN-10-1282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; von Kries, Jens Peter; Wilson, Steven Ray; Lundenes, Elsa; Wedlich, Doris; Gradl, Dietmar; Paulsen, Jan Erik; Machonova, Olga; Dembinski, Jennifer L.; Dinh, Huyen; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is deregulated in several types of human cancer where it plays a central role in tumor cell growth and progression.  Here we report the identification of 2 new small mols. that specifically inhibit canonical Wnt pathway at the level of the destruction complex.  Specificity was verified in various cellular reporter systems, a Xenopus double-axis formation assay and a gene expression profile anal.  In human colorectal cancer (CRC) cells, the new compds. JW67 and JW74 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.  Notably, AXIN2 protein levels were strongly increased after compd. exposure.  Long-term treatment with JW74 inhibited the growth of tumor cells in both a mouse xenograft model of CRC and in ApcMin mice (multiple intestinal neoplasia, Min).  Our findings rationalize further preclin. and clin. evaluation of these new compds. as novel modalities for cancer treatment.  Cancer Res; 71(1); 197-205.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zbK2VV5PbVg90H21EOLACvtfcHk0lhsMcJ-eNqskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFOh&md5=e641536f7aea88b75d5cacc8b10458ab</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1282%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DLundenes%26aufirst%3DE.%26aulast%3DWedlich%26aufirst%3DD.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DDembinski%26aufirst%3DJ.%2BL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DNovel%2520synthetic%2520antagonists%2520of%2520canonical%2520Wnt%2520signaling%2520inhibit%2520colorectal%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D197%26epage%3D205%26doi%3D10.1158%2F0008-5472.CAN-10-1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">[1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1021/jm2011222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1127-1136&author=M.+D.+Shultzauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=D.+N.+Chinauthor=J.+Blankauthor=O.+Charlatauthor=H.+Chengauthor=A.+Cheungauthor=F.+Congauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Hoodauthor=V.+Tyagiauthor=M.+Xuauthor=B.+Zhangauthor=W.+Shao&title=%5B1%2C2%2C4%5Dtriazol-3-ylsulfanylmethyl%29-3-phenyl-%5B1%2C2%2C4%5Doxadiazoles%3A+antagonists+of+the+Wnt+pathway+that+inhibit+tankyrases+1+and+2+via+novel+adenosine+pocket+binding&doi=10.1021%2Fjm2011222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">[1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt Pathway That Inhibit Tankyrases 1 and 2 via Novel Adenosine Pocket Binding</span></div><div class="casAuthors">Shultz, Michael D.; Kirby, Christina A.; Stams, Travis; Chin, Donovan N.; Blank, Jutta; Charlat, Olga; Cheng, Hong; Cheung, Atwood; Cong, Feng; Feng, Yun; Fortin, Pascal D.; Hood, Tami; Tyagi, Viraj; Xu, Ming; Zhang, Bailin; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1127-1136</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is crit. to the regulation of key cellular processes.  When deregulated, it has been shown to play a crucial role in the growth and progression of multiple human cancers.  The identification of small mol. modulators of Wnt signaling has proven challenging, largely due to the relative paucity of druggable nodes in this pathway.  Several recent publications have identified small mol. inhibitors of the Wnt pathway, and tankyrase (TNKS) inhibition has been demonstrated to antagonize Wnt signaling via axin stabilization.  Herein, we report the early hit assessment of a series of compds. previously reported to antagonize Wnt signaling.  We report the biophys., computational characterization, structure-activity relationship, and physicochem. properties of a novel series of ([1,2,4]-triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazole inhibitors of TNKS1 and 2.  Furthermore, a cocrystal structure of compd. 24 complexed to TNKS1 demonstrates an alternate binding mode for PARP family member proteins that does not involve interactions with the nicotinamide binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt6LM9w0WsSLVg90H21EOLACvtfcHk0lhsMcJ-eNqskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyisg%253D%253D&md5=bfa82a3296a7c620cd5a71eec07f4f75</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm2011222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011222%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShao%26aufirst%3DW.%26atitle%3D%255B1%252C2%252C4%255Dtriazol-3-ylsulfanylmethyl%2529-3-phenyl-%255B1%252C2%252C4%255Doxadiazoles%253A%2520antagonists%2520of%2520the%2520Wnt%2520pathway%2520that%2520inhibit%2520tankyrases%25201%2520and%25202%2520via%2520novel%2520adenosine%2520pocket%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1127%26epage%3D1136%26doi%3D10.1021%2Fjm2011222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lhAvQI8urLS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lhAvQI8urLS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anumala, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazare, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of Tankyrase inhibitors by a hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10025</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10013-10025&author=U.+R.+Anumalaauthor=J.+Waalerauthor=Y.+Nkizinkikoauthor=A.+Ignatevauthor=K.+Lazarowauthor=P.+Lindemannauthor=P.+A.+Olsenauthor=S.+Murthyauthor=E.+Obajiauthor=A.+G.+Majougaauthor=S.+Leonovauthor=J.+P.+von+Kriesauthor=L.+Lehtioauthor=S.+Kraussauthor=M.+Nazare&title=Discovery+of+a+novel+series+of+Tankyrase+inhibitors+by+a+hybridization+approach&doi=10.1021%2Facs.jmedchem.7b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach</span></div><div class="casAuthors">Anumala, Upendra Rao; Waaler, Jo; Nkizinkiko, Yves; Ignatev, Alexander; Lazarow, Katina; Lindemann, Peter; Olsen, Petter Angell; Murthy, Sudarshan; Obaji, Ezeogo; Majouga, Alexander G.; Leonov, Sergey; von Kries, Jens Peter; Lehtioe, Lari; Krauss, Stefan; Nazare, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10013-10025</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-guided hybridization approach using two privileged substructures gave instant access to a new series of tankyrase inhibitors.  The identified inhibitor 16 (1-(trans-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)cyclobutyl)-2,3-dihydro-2-oxo-1H-benzimidazole-5-carbonitrile) displays high target affinity on tankyrase 1 and 2 with biochem. and cellular IC50 values of 29 nM, 6.3 nM and 19 nM, resp., and high selectivity toward other poly (ADP-ribose) polymerase enzymes.  The identified inhibitor shows a favorable in vitro ADME profile as well as good oral bioavailability in mice, rats, and dogs.  Crit. for the approach was the utilization of an appropriate linker between 1,2,4-triazole and benzimidazolone moieties, whereby a cyclobutyl linker displayed superior affinity compared to a cyclohexane and Ph linker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOvTL0NvY8bVg90H21EOLACvtfcHk0lhT_yPOJb6LOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ&md5=d6bf8c8d971a158cdddc7d1c84b5144c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00883%26sid%3Dliteratum%253Aachs%26aulast%3DAnumala%26aufirst%3DU.%2BR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DLazarow%26aufirst%3DK.%26aulast%3DLindemann%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DLeonov%26aufirst%3DS.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DNazare%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520Tankyrase%2520inhibitors%2520by%2520a%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10013%26epage%3D10025%26doi%3D10.1021%2Facs.jmedchem.7b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biechele, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">WIKI4, a novel inhibitor of tankyrase and Wnt/ss-catenin signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e50457</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0050457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1371%2Fjournal.pone.0050457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23227175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVygsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e50457&author=R.+G.+Jamesauthor=K.+C.+Davidsonauthor=K.+A.+Boschauthor=T.+L.+Biecheleauthor=N.+C.+Robinauthor=R.+J.+Taylorauthor=M.+B.+Majorauthor=N.+D.+Campauthor=K.+Fowlerauthor=T.+J.+Martinsauthor=R.+T.+Moon&title=WIKI4%2C+a+novel+inhibitor+of+tankyrase+and+Wnt%2Fss-catenin+signaling&doi=10.1371%2Fjournal.pone.0050457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">WIKI4, a novel inhibitor of Tankyrase and Wnt/β-catenin signaling</span></div><div class="casAuthors">James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Major, Michael B.; Camp, Nathan D.; Fowler, Kerry; Martins, Timothy J.; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e50457</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway controls important cellular events during development and often contributes to disease when dysregulated.  Using high throughput screening we have identified a new small mol. inhibitor of Wnt/β-catenin signaling, WIKI4.  WIKI4 inhibits expression of β-catenin target genes and cellular responses to Wnt/β-catenin signaling in cancer cell lines as well as in human embryonic stem cells.  Furthermore, we demonstrate that WIKI4 mediates its effects on Wnt/β-catenin signaling by inhibiting the enzymic activity of TNKS2, a regulator of AXIN ubiquitylation and degrdn.  While TNKS has previously been shown to be the target of small mol. inhibitors of Wnt/β-catenin signaling, WIKI4 is structurally distinct from previously identified TNKS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-vg3VMIiDnLVg90H21EOLACvtfcHk0lhT_yPOJb6LOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVygsr%252FO&md5=d8bdd1d89e91cadbd83b739b96ca88b2</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050457%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DR.%2BG.%26aulast%3DDavidson%26aufirst%3DK.%2BC.%26aulast%3DBosch%26aufirst%3DK.%2BA.%26aulast%3DBiechele%26aufirst%3DT.%2BL.%26aulast%3DRobin%26aufirst%3DN.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DMajor%26aufirst%3DM.%2BB.%26aulast%3DCamp%26aufirst%3DN.%2BD.%26aulast%3DFowler%26aufirst%3DK.%26aulast%3DMartins%26aufirst%3DT.%2BJ.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DWIKI4%252C%2520a%2520novel%2520inhibitor%2520of%2520tankyrase%2520and%2520Wnt%252Fss-catenin%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De50457%26doi%3D10.1371%2Fjournal.pone.0050457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liscio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asciutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellocchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llacuna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarulo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellicciari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaioni, E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2807</span>– <span class="NLM_lpage">2812</span>, <span class="refDoi"> DOI: 10.1021/jm401356t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401356t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2807-2812&author=P.+Liscioauthor=A.+Carottiauthor=S.+Asciuttiauthor=T.+Karlbergauthor=D.+Bellocchiauthor=L.+Llacunaauthor=A.+Macchiaruloauthor=S.+A.+Aaronsonauthor=H.+Schulerauthor=R.+Pellicciariauthor=E.+Camaioni&title=Design%2C+synthesis%2C+crystallographic+studies%2C+and+preliminary+biological+appraisal+of+new+substituted+triazolo%5B4%2C3-b%5Dpyridazin-8-amine+derivatives+as+tankyrase+inhibitors&doi=10.1021%2Fjm401356t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors</span></div><div class="casAuthors">Liscio, Paride; Carotti, Andrea; Asciutti, Stefania; Karlberg, Tobias; Bellocchi, Daniele; Llacuna, Laura; Macchiarulo, Antonio; Aaronson, Stuart A.; Schuler, Herwig; Pellicciari, Roberto; Camaioni, Emidio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2807-2812</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Searching for selective tankyrases (TNKSs) inhibitors, a new small series of 6,8-disubstituted triazolo[4,3-b]pyridazines has been synthesized and characterized biol.  Structure-based optimization of the starting hit compd. N-(4-chlorophenyl)-6-methyl[1,2,4]triazolo[4,3-b]pyridazin-8-amine (NNL) prompted the authors to the discovery of 4-(2-(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-ylamino)ethyl)phenol (I), a low nanomolar selective TNKSs inhibitor working as NAD isostere as ascertained by crystallog. anal.  Preliminary biol. data candidate this new class of derivs. as a powerful pharmacol. tools in the unraveling of TNKS implications in physiopathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTmQIcE86MErVg90H21EOLACvtfcHk0lj57Ro2kaFLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKhtrs%253D&md5=bd398c0a7ae372ba54863263ff6a6593</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm401356t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401356t%26sid%3Dliteratum%253Aachs%26aulast%3DLiscio%26aufirst%3DP.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAsciutti%26aufirst%3DS.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DBellocchi%26aufirst%3DD.%26aulast%3DLlacuna%26aufirst%3DL.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DCamaioni%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%252C%2520crystallographic%2520studies%252C%2520and%2520preliminary%2520biological%2520appraisal%2520of%2520new%2520substituted%2520triazolo%255B4%252C3-b%255Dpyridazin-8-amine%2520derivatives%2520as%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2807%26epage%3D2812%26doi%3D10.1021%2Fjm401356t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duempelfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeckel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly selective Tankyrase inhibitor displaying growth inhibition effects against a diverse range of tumor derived cell lines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5455</span>– <span class="NLM_lpage">5471</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5455-5471&author=D.+W.+Thomsonauthor=A.+J.+Wagnerauthor=M.+Bantscheffauthor=R.+E.+Bensonauthor=L.+Dittusauthor=B.+Duempelfeldauthor=G.+Drewesauthor=J.+Krauseauthor=J.+T.+Mooreauthor=K.+Muellerauthor=D.+Poeckelauthor=C.+Rauauthor=E.+Salzerauthor=L.+Shewchukauthor=C.+Hopfauthor=J.+G.+Emeryauthor=M.+Muelbaier&title=Discovery+of+a+highly+selective+Tankyrase+inhibitor+displaying+growth+inhibition+effects+against+a+diverse+range+of+tumor+derived+cell+lines&doi=10.1021%2Facs.jmedchem.7b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines</span></div><div class="casAuthors">Thomson, Douglas W.; Wagner, Anne J.; Bantscheff, Marcus; Benson, R. Edward; Dittus, Lars; Duempelfeld, Birgit; Drewes, Gerard; Krause, Jana; Moore, John T.; Mueller, Katrin; Poeckel, Daniel; Rau, Christina; Salzer, Elsa; Shewchuk, Lisa; Hopf, Carsten; Emery, John G.; Muelbaier, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5455-5471</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The availability of high quality probes for specific protein targets is fundamental to the investigation of their function and their validation as therapeutic targets.  The authors report the utilization of a dedicated chemoproteomic assay platform combining affinity enrichment technol. with high-resoln. protein mass spectrometry to the discovery of a novel nicotinamide isoster, the tetrazoloquinoxaline I, a highly potent and selective tankyrase inhibitor.  The authors also describe the use of I to investigate the biol. of tankyrase, revealing the compd. induced growth inhibition of a no. of tumor derived cell lines, demonstrating the potential of tankyrase inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwOPXRn1c-LVg90H21EOLACvtfcHk0lj57Ro2kaFLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSksrc%253D&md5=d39fa9046ab072dbc592482769e0833c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00137%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBenson%26aufirst%3DR.%2BE.%26aulast%3DDittus%26aufirst%3DL.%26aulast%3DDuempelfeld%26aufirst%3DB.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKrause%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DMueller%26aufirst%3DK.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSalzer%26aufirst%3DE.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DMuelbaier%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520selective%2520Tankyrase%2520inhibitor%2520displaying%2520growth%2520inhibition%2520effects%2520against%2520a%2520diverse%2520range%2520of%2520tumor%2520derived%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5455%26epage%3D5471%26doi%3D10.1021%2Facs.jmedchem.7b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7049</span>– <span class="NLM_lpage">7059</span>, <span class="refDoi"> DOI: 10.1021/jm400826j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400826j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7049-7059&author=M.+D.+Shultzauthor=D.+Majumdarauthor=D.+N.+Chinauthor=P.+D.+Fortinauthor=Y.+Fengauthor=T.+Gouldauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=N.+J.+Watersauthor=W.+Shao&title=Structure-efficiency+relationship+of+%5B1%2C2%2C4%5Dtriazol-3-ylamines+as+novel+nicotinamide+isosteres+that+inhibit+tankyrases&doi=10.1021%2Fjm400826j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases</span></div><div class="casAuthors">Shultz, Michael D.; Majumdar, Dyuti; Chin, Donovan N.; Fortin, Pascal D.; Feng, Yun; Gould, Ty; Kirby, Christina A.; Stams, Travis; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7049-7059</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 are members of the poly(ADP-ribose) polymerase (PARP) family of enzymes that modulate Wnt pathway signaling.  While amide- and lactam-based nicotinamide mimetics that inhibit tankyrase activity, such as XAV939, are well-known, the discovery and evaluation of a novel nicotinamide isostere that demonstrates selectivity over other PARP family members is reprted.  The utilization of lipophilic efficiency-based structure-efficiency relationships (SER) to rapidly drive the evaluation of this series is demonstrated.  These efforts led to a series of selective, cell-active compds. with soly., physicochem., and in vitro properties suitable for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWmitTKelbVg90H21EOLACvtfcHk0lj57Ro2kaFLvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7%252FL&md5=b9174e9070c813b598cf15b261de9471</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm400826j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400826j%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DStructure-efficiency%2520relationship%2520of%2520%255B1%252C2%252C4%255Dtriazol-3-ylamines%2520as%2520novel%2520nicotinamide%2520isosteres%2520that%2520inhibit%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7049%26epage%3D7059%26doi%3D10.1021%2Fjm400826j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0ligmO6a-M0QQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada-Iwasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span> <span> </span><span class="NLM_article-title">The discovery and characterization of K-756, a novel Wnt/beta-catenin pathway inhibitor targeting Tankyrase</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1535-7163.MCT-15-0938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27196752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1525-1534&author=R.+Okada-Iwasakiauthor=Y.+Takahashiauthor=Y.+Watanabeauthor=H.+Ishidaauthor=J.+Saitoauthor=R.+Nakaiauthor=A.+Asai&title=The+discovery+and+characterization+of+K-756%2C+a+novel+Wnt%2Fbeta-catenin+pathway+inhibitor+targeting+Tankyrase&doi=10.1158%2F1535-7163.MCT-15-0938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase</span></div><div class="casAuthors">Okada-Iwasaki, Ryoko; Takahashi, Yuichi; Watanabe, Yasuo; Ishida, Hiroshi; Saito, Jun-ichi; Nakai, Ryuichiro; Asai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1525-1534</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Wnt/β-catenin pathway is a well-known oncogenic pathway.  Its suppression has long been considered as an important challenge in treating cancer patients.  Among colon cancer patients in particular, most patients carry an adenomatous polyposis coli (APC) mutation that leads to an aberration of Wnt/β-catenin pathway.  To discover the small mol. inhibitors of the Wnt/β-catenin pathway, we conducted high-throughput screening in APC-mutant colon cancer DLD-1 cells using a transcriptional reporter assay, which identified a selective Wnt/β-catenin pathway inhibitor, K-756.  K-756 stabilizes Axin and reduces active β-catenin, and inhibits the genes downstream of endogenous Wnt/β-catenin.  We subsequently identified that K-756 is a tankyrase (TNKS) inhibitor.  TNKS, which belongs to the PARP family, poly-ADP ribosylates Axin and promotes Axin degrdn. via the proteasome pathway.  K-756 binds to the induced pocket of TNKS and inhibits its enzyme activity.  Moreover, PARP family enzyme assays showed that K-756 is a selective TNKS inhibitor.  K-756 inhibited the cell growth of APC-mutant colorectal cancer COLO 320DM and SW403 cells by inhibiting the Wnt/β-catenin pathway.  An in vivo study showed that the oral administration of K-756 inhibited the Wnt/β-catenin pathway in colon cancer xenografts in mice.  To further explore the therapeutic potential of K-756, we also evaluated the effects of K-756 in non-small cell lung cancer cells.  Although a single treatment of K-756 did not induce antiproliferative activity, when K-756 was combined with an EGFR inhibitor (gefitinib), it showed a strong synergistic effect.  Therefore, K-756, a novel selective TNKS inhibitor, could be a leading compd. in the development of anticancer agents.  Mol Cancer Ther; 15(7); 1525-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpSTLQpJ57hbVg90H21EOLACvtfcHk0ligmO6a-M0QQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtbfM&md5=7fcb0eee155b92e654d83645661769aa</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0938%26sid%3Dliteratum%253Aachs%26aulast%3DOkada-Iwasaki%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DJ.%26aulast%3DNakai%26aufirst%3DR.%26aulast%3DAsai%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520and%2520characterization%2520of%2520K-756%252C%2520a%2520novel%2520Wnt%252Fbeta-catenin%2520pathway%2520inhibitor%2520targeting%2520Tankyrase%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1525%26epage%3D1534%26doi%3D10.1158%2F1535-7163.MCT-15-0938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatsugai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bbrc.2010.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20214890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1KisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2010&pages=569-573&author=Y.+Yashirodaauthor=R.+Okamotoauthor=K.+Hatsugaiauthor=Y.+Takemotoauthor=N.+Goshimaauthor=T.+Saitoauthor=M.+Hamamotoauthor=Y.+Sugimotoauthor=H.+Osadaauthor=H.+Seimiyaauthor=M.+Yoshida&title=A+novel+yeast+cell-based+screen+identifies+flavone+as+a+tankyrase+inhibitor&doi=10.1016%2Fj.bbrc.2010.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor</span></div><div class="casAuthors">Yashiroda, Yoko; Okamoto, Reika; Hatsugai, Kaori; Takemoto, Yasushi; Goshima, Naoki; Saito, Tamio; Hamamoto, Makiko; Sugimoto, Yoshikazu; Osada, Hiroyuki; Seimiya, Hiroyuki; Yoshida, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-573</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The telomere-assocd. protein tankyrase 1 is a poly(ADP-ribose) polymerase and is considered to be a promising target for cancer therapy, esp. for BRCA-assocd. cancers.  However, an efficient assay system for inhibitor screening has not been established, mainly due to the difficulty of efficient prepn. of the enzyme and its substrate.  Here, we report a cell-based assay system for detecting inhibitory activity against tankyrase 1.  We found that overexpression of the human tankyrase 1 gene causes a growth defect in the fission yeast Schizosaccharomyces pombe.  Chems. that restore the growth defect phenotype can be identified as potential tankyrase 1 inhibitors.  We performed a high-throughput screen using this system, and identified flavone as a compd. that restores the growth of yeast cells overexpressing tankyrase 1.  Indeed, flavone inhibited poly(ADP-ribosyl)ation of proteins caused by overexpression of tankyrase 1 in yeast cells.  This system allows rapid identification of inhibitory activity against tankyrase 1 and is amenable to high-throughput screening using robotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10crBBVUDnbVg90H21EOLACvtfcHk0lirRuLW5C1X8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1KisrY%253D&md5=9e3dbf16bb77e5d90d7dc453abde7a47</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DR.%26aulast%3DHatsugai%26aufirst%3DK.%26aulast%3DTakemoto%26aufirst%3DY.%26aulast%3DGoshima%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DHamamoto%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DA%2520novel%2520yeast%2520cell-based%2520screen%2520identifies%2520flavone%2520as%2520a%2520tankyrase%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D394%26spage%3D569%26epage%3D573%26doi%3D10.1016%2Fj.bbrc.2010.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Homogeneous screening assay for human tankyrase</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1177/1087057112436558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1177%2F1087057112436558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22357873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=593-604&author=M.+Narwalauthor=A.+Fallareroauthor=P.+Vuorelaauthor=L.+Lehtio&title=Homogeneous+screening+assay+for+human+tankyrase&doi=10.1177%2F1087057112436558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous screening assay for human tankyrase</span></div><div class="casAuthors">Narwal, Mohit; Fallarero, Adyary; Vuorela, Pia; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-604</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Tankyrase, a member of human PARP protein super-family, catalyzes a covalent post-translational modification of substrate proteins.  This modification, poly(ADP-ribos)ylation, leads to changes in protein interactions and modifies downstream signaling events.  Tankyrase 1 is a potential drug target due to its functions in telomere homeostasis and in Wnt signaling.  We describe here optimization and application of an activity-based homogenous assay for tankyrase inhibitors in a high-throughput screening format.  The method measures the consumption of substrate by the chem. conversion of the remaining NAD+ into a stable fluorescent condensation product.  Conditions were optimized to measure the enzymic auto-modification of a recombinant catalytic fragment of tankyrase 1.  The fluorescence assay is inexpensive, operationally easy and performs well according to the statistical anal. (Z'= 0.7).  A validatory screen with a natural product library confirmed suitability of the assay for finding new tankyrase inhibitors.  Flavone was the most potent (IC50=325 nM) hit from the natural compds.  A flavone deriv., apigenin, and iso-Pr gallate showed potency on the micromolar range, but displayed over 30-fold selectivity for tankyrase over the studied isoenzymes PARP1 and PARP2.  The assay is robust and will be useful for screening new tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAQgc8t_53rVg90H21EOLACvtfcHk0lirRuLW5C1X8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D&md5=e5736a4723ceff0fe1fc072ab9bac977</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1177%2F1087057112436558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112436558%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DHomogeneous%2520screening%2520assay%2520for%2520human%2520tankyrase%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D593%26epage%3D604%26doi%3D10.1177%2F1087057112436558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Screening and structural analysis of flavones inhibiting tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/jm3018783</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3018783" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls12ktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3507-3517&author=M.+Narwalauthor=T.+Haikarainenauthor=A.+Fallareroauthor=P.+M.+Vuorelaauthor=L.+Lehtio&title=Screening+and+structural+analysis+of+flavones+inhibiting+tankyrases&doi=10.1021%2Fjm3018783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and Structural Analysis of Flavones Inhibiting Tankyrases</span></div><div class="casAuthors">Narwal, Mohit; Haikarainen, Teemu; Fallarero, Adyary; Vuorela, Pia M.; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3507-3517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flavonoids are known for their beneficial effects on human health, and therefore the therapeutic potential of these compds. have been extensively studied.  Flavone has been previously identified as a tankyrase inhibitor, and to further elucidate whether tankyrases would be inhibited by other flavonoids, the authors performed a systematic screening of tankyrase 2 inhibitory activity using 500 natural and naturally derived flavonoids covering nine different flavonoid classes.  All identified tankyrase inhibitors were flavones.  The authors report crystal structures of all the hit compds. in complex with the catalytic domain of human tankyrase 2.  Flavone derivs. in all 10 crystal structures bind to the nicotinamide binding site of tankyrase 2.  Potencies of the active flavones toward tankyrases vary between 50 nM and 1.1 μM, and flavones show up to 200-fold selectivity for tankyrases over ARTD1.  The mol. details of the interactions revealed by cocrystal structures efficiently describe the properties of potent flavone derivs. inhibiting tankyrases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok3ooeOpXbt7Vg90H21EOLACvtfcHk0lgUuqIDRGIInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls12ktLc%253D&md5=e27db99eeecde2bd3a4ff9fb03e10024</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm3018783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3018783%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%2BM.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DScreening%2520and%2520structural%2520analysis%2520of%2520flavones%2520inhibiting%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3507%26epage%3D3517%26doi%3D10.1021%2Fjm3018783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legala, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7880</span>– <span class="NLM_lpage">7889</span>, <span class="refDoi"> DOI: 10.1021/jm401463y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401463y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFals7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7880-7889&author=M.+Narwalauthor=J.+Koivunenauthor=T.+Haikarainenauthor=E.+Obajiauthor=O.+E.+Legalaauthor=H.+Venkannagariauthor=P.+Joensuuauthor=T.+Pihlajaniemiauthor=L.+Lehtio&title=Discovery+of+tankyrase+inhibiting+flavones+with+increased+potency+and+isoenzyme+selectivity&doi=10.1021%2Fjm401463y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tankyrase Inhibiting Flavones with Increased Potency and Isoenzyme Selectivity</span></div><div class="casAuthors">Narwal, Mohit; Koivunen, Jarkko; Haikarainen, Teemu; Obaji, Ezeogo; Legala, Ongey E.; Venkannagari, Harikanth; Joensuu, Paivi; Pihlajaniemi, Taina; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7880-7889</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer.  Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivs.  Com. available flavones with single substitutions were used for structure-activity relation studies, and cocrystal structures of the 18 hit compds. were analyzed to explain their potency and selectivity.  The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling.  To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases.  The most effective compd.(I; MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.  This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPfQ4Kazcx4LVg90H21EOLACvtfcHk0lgUuqIDRGIInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFals7%252FM&md5=4f4e2021caf3334462fe597e9e24095b</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm401463y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401463y%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DLegala%26aufirst%3DO.%2BE.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DJoensuu%26aufirst%3DP.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520tankyrase%2520inhibiting%2520flavones%2520with%2520increased%2520potency%2520and%2520isoenzyme%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7880%26epage%3D7889%26doi%3D10.1021%2Fjm401463y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Then, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panicker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Fragment-based ligand design of novel potent inhibitors of tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4497</span>– <span class="NLM_lpage">4508</span>, <span class="refDoi"> DOI: 10.1021/jm400211f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400211f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFartr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4497-4508&author=E.+A.+Larssonauthor=A.+Janssonauthor=F.+M.+Ngauthor=S.+W.+Thenauthor=R.+Panickerauthor=B.+Liuauthor=K.+Sangthongpitagauthor=V.+Pendharkarauthor=S.+J.+Taiauthor=J.+Hillauthor=C.+Danauthor=S.+Y.+Hoauthor=W.+W.+Cheongauthor=A.+Poulsenauthor=S.+Blanchardauthor=G.+R.+Linauthor=J.+Alamauthor=T.+H.+Kellerauthor=P.+Nordlund&title=Fragment-based+ligand+design+of+novel+potent+inhibitors+of+tankyrases&doi=10.1021%2Fjm400211f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based ligand design of novel potent inhibitors of tankyrases</span></div><div class="casAuthors">Larsson, E. Andreas; Jansson, Anna; Ng, Fui Mee; Then, Siew Wen; Panicker, Resmi; Liu, Boping; Sangthongpitag, Kanda; Pendharkar, Vishal; Tai, Shi Jing; Hill, Jeffrey; Dan, Chen; Ho, Soo Yei; Cheong, Wei Wen; Poulsen, Anders; Blanchard, Stephanie; Lin, Grace Ruiting; Alam, Jenefer; Keller, Thomas H.; Nordlund, Par</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4497-4508</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases constitute potential drug targets for cancer and myelin-degrading diseases.  We have applied a structure- and biophysics-driven fragment-based ligand design strategy to discover a novel family of potent inhibitors for human tankyrases.  Biophys. screening based on a thermal shift assay identified highly efficient fragments binding in the nicotinamide-binding site, a local hot spot for fragment binding.  Evolution of the fragment hit 4-methyl-1,2-dihydroquinolin-2-one (2) along its 7-vector yields dramatic affinity improvements in the first cycle of expansion.  A crystal structure of 7-(2-fluorophenyl)-4-methylquinolin-2(1H)-one (11) reveals that the nonplanar compd. extends with its fluorine atom into a pocket, which coincides with a region of the active site where structural differences are seen between tankyrases and other poly(ADP-ribose) polymerase (PARP) family members.  A further cycle of optimization yielded compds. with affinities and IC50 values in the low nanomolar range and with good soly., PARP selectivity, and ligand efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxampX4n-xLVg90H21EOLACvtfcHk0lgUuqIDRGIInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFartr4%253D&md5=4cd39f8715bfc51807129bb04da1e6f0</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm400211f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400211f%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DF.%2BM.%26aulast%3DThen%26aufirst%3DS.%2BW.%26aulast%3DPanicker%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DCheong%26aufirst%3DW.%2BW.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DFragment-based%2520ligand%2520design%2520of%2520novel%2520potent%2520inhibitors%2520of%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4497%26epage%3D4508%26doi%3D10.1021%2Fjm400211f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design of novel pyranopyridones as cell active and orally bioavailable Tankyrase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1024</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00251</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00251" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1019-1024&author=J.+de+Vicenteauthor=P.+Tivitmahaisoonauthor=P.+Berryauthor=D.+R.+Bolinauthor=D.+Carvajalauthor=W.+Heauthor=K.+S.+Huangauthor=C.+Jansonauthor=L.+Liangauthor=C.+Lukacsauthor=A.+Petersenauthor=H.+Qianauthor=L.+Yiauthor=Y.+Zhuangauthor=J.+C.+Hermann&title=Fragment-based+drug+design+of+novel+pyranopyridones+as+cell+active+and+orally+bioavailable+Tankyrase+inhibitors&doi=10.1021%2Facsmedchemlett.5b00251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">de Vicente, Javier; Tivitmahaisoon, Parcharee; Berry, Pamela; Bolin, David R.; Carvajal, Daisy; He, Wei; Huang, Kuo-Sen; Janson, Cheryl; Liang, Lena; Lukacs, Christine; Petersen, Ann; Qian, Hong; Yi, Lin; Zhuang, Yong; Hermann, Johannes C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1019-1024</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase activity has been linked to the regulation of intracellular axin levels, which have been shown to be crucial for the Wnt pathway.  Deregulated Wnt signaling is important for the genesis of many diseases including cancer.  The authors describe herein the discovery and development of a new series of tankyrase inhibitors.  These pyranopyridones are highly active in various cell-based assays.  A fragment/structure based optimization strategy led to a compd. with good pharmacokinetic properties that is suitable for in vivo studies and further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr89-Awr3wTrrVg90H21EOLACvtfcHk0li7Jt3bqjOxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqsL3L&md5=6b1d805d04727286bc324e6f1f99e691</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00251%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DBolin%26aufirst%3DD.%2BR.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DK.%2BS.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DL.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26atitle%3DFragment-based%2520drug%2520design%2520of%2520novel%2520pyranopyridones%2520as%2520cell%2520active%2520and%2520orally%2520bioavailable%2520Tankyrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1019%26epage%3D1024%26doi%3D10.1021%2Facsmedchemlett.5b00251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Roche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span> <span> </span><span class="NLM_article-title">Macrocyclized extended peptides: inhibiting the substrate-recognition domain of Tankyrase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2256</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b10234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b10234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=2245-2256&author=W.+Xuauthor=Y.+H.+Lauauthor=G.+Fischerauthor=Y.+S.+Tanauthor=A.+Chattopadhyayauthor=M.+de+la+Rocheauthor=M.+Hyvonenauthor=C.+Vermaauthor=D.+R.+Springauthor=L.+S.+Itzhaki&title=Macrocyclized+extended+peptides%3A+inhibiting+the+substrate-recognition+domain+of+Tankyrase&doi=10.1021%2Fjacs.6b10234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase</span></div><div class="casAuthors">Xu, Wenshu; Lau, Yu Heng; Fischer, Gerhard; Tan, Yaw Sing; Chattopadhyay, Anasuya; de la Roche, Marc; Hyvonen, Marko; Verma, Chandra; Spring, David R.; Itzhaki, Laura S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2245-2256</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a double-click macrocyclization approach for the design of constrained peptide inhibitors having non-helical or extended conformations.  Our targets are the tankyrase proteins (TNKS), poly(ADP-ribose) polymerases (PARP) that regulate Wnt signaling by targeting Axin for degrdn.  TNKS are deregulated in many different cancer types, and inhibition of TNKS therefore represents an attractive therapeutic strategy.  However, clin. development of TNKS-specific PARP catalytic inhibitors is challenging due to off-target effects and cellular toxicity.  We instead targeted the substrate-recognition domain of TNKS, as it is unique among PARP family members.  We employed a two-component strategy, allowing peptide and linker to be sep. engineered and then assembled in a combinatorial fashion via click chem.  Using the consensus substrate-peptide sequence as a starting point, we optimized the length and rigidity of the linker and its position along the peptide.  Optimization was further guided by high-resoln. crystal structures of two of the macrocyclized peptides in complex with TNKS.  This approach led to macrocyclized peptides with submicromolar affinities for TNKS and high proteolytic stability that are able to disrupt the interaction between TNKS and Axin substrate and to inhibit Wnt signaling in a dose-dependent manner.  The peptides therefore represent a promising starting point for a new class of substrate-competitive inhibitors of TNKS with potential for suppressing Wnt signaling in cancer.  Moreover, by demonstrating the application of the double-click macrocyclization approach to non-helical, extended, or irregularly structured peptides, we greatly extend its potential and scope, esp. given the frequency with which such motifs mediate protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF7lE97s7FALVg90H21EOLACvtfcHk0li7Jt3bqjOxTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKjtbs%253D&md5=7997fc39b425f6862bd208ba35b37c7f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b10234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b10234%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3Dde%2Bla%2BRoche%26aufirst%3DM.%26aulast%3DHyvonen%26aufirst%3DM.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26atitle%3DMacrocyclized%2520extended%2520peptides%253A%2520inhibiting%2520the%2520substrate-recognition%2520domain%2520of%2520Tankyrase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D2245%26epage%3D2256%26doi%3D10.1021%2Fjacs.6b10234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2018.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30472184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2019&pages=80-90&author=H.+Chengauthor=X.+Liauthor=C.+Wangauthor=Y.+Chenauthor=S.+Liauthor=J.+Tanauthor=B.+Tanauthor=Y.+He&title=Inhibition+of+tankyrase+by+a+novel+small+molecule+significantly+attenuates+prostate+cancer+cell+proliferation&doi=10.1016%2Fj.canlet.2018.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation</span></div><div class="casAuthors">Cheng, Honglin; Li, Xin; Wang, Chuanlin; Chen, Yujie; Li, Sijiang; Tan, Jincai; Tan, Bing; He, Yunfeng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-90</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a crucial mediator of Wnt signal transduction and has been recognized as a novel mol. target for Wnt-pathway dependent cancer.  TNKS is stabilized by the ubiquitin-specific protease 25 (USP25).  The effect of disruption of the interaction between TNKS and USP25 by small mols. on prostate cancer proliferation is unknown.  This study conducted a hierarchical virtual screening with more than 200,000 compds. on the characterized structures of the USP25/TNKS-ARC5 protein complex.  In silico anal. and in vitro validation revealed that a small mol., called C44, binds to the protein-protein interaction (PPI) interface of TNKS and USP25.  This show that C44 disrupts the interaction between TNKS and USP25 leading to a higher half-life of AXIN and the breakdown of <beta>-catenin protein.  It also show that the selective inhibition of the TNKS-USP25 interaction by C44 significantly reduces proliferation of prostate cancer cells in vitro and in vivo.  Our study reveals a new PPI inhibitor that lowers the stability of TNKS protein and inhibits Wnt pathway signaling.  C44 is a promising new drug for the treatment of Wnt-pathway dependent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEO5Jl9KTRLVg90H21EOLACvtfcHk0ljNcGHTIEpfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyktr3L&md5=bf474dd36db235d575c9807dc6336c1f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520tankyrase%2520by%2520a%2520novel%2520small%2520molecule%2520significantly%2520attenuates%2520prostate%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D443%26spage%3D80%26epage%3D90%26doi%3D10.1016%2Fj.canlet.2018.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waltzer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienz, M.</span></span> <span> </span><span class="NLM_article-title">Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1038/26785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F26785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9774110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXms1aks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=1998&pages=521-525&author=L.+Waltzerauthor=M.+Bienz&title=Drosophila+CBP+represses+the+transcription+factor+TCF+to+antagonize+Wingless+signalling&doi=10.1038%2F26785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Drosophila CBP represses the transcription factor TCF to antagonize Wingless signaling</span></div><div class="casAuthors">Waltzer, Lucas; Bienz, Mariann</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">6701</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">T-cell factor (TCF), a high-mobility-group domain protein, is the transcription factor activated by Wnt/Wingless signalling.  When signalling occurs, TCF binds to its coactivator, beta-catenin/Armadillo, and stimulates the transcription of the target genes of Wnt/Wingless by binding to TCF-responsive enhancers.  Inappropriate activation of TCF in the colon epithelium and other cells leads to cancer.  It is therefore desirable for unstimulated cells to have a neg. control mechanism to keep TCF inactive.  Here we report that Drosophila CREB-binding protein (dCBP) binds to dTCF.  DCBP mutants show mild Wingless overactivation phenotypes in various tissues.  Consistent with this, dCBP loss-of-function suppresses the effects of armadillo mutation.  Moreover, our data show that dCBP acetylates a conserved lysine in the Armadillo-binding domain of dTCF, and that this acetylation lowers the affinity of Armadillo binding to dTCF.  Although CBP is a coactivator of other transcription factors, our data show that CBP represses TCF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70BOPMN0p-bVg90H21EOLACvtfcHk0ljNcGHTIEpfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1aks7s%253D&md5=4532698946afd3e4ac10b994432b7548</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2F26785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F26785%26sid%3Dliteratum%253Aachs%26aulast%3DWaltzer%26aufirst%3DL.%26aulast%3DBienz%26aufirst%3DM.%26atitle%3DDrosophila%2520CBP%2520represses%2520the%2520transcription%2520factor%2520TCF%2520to%2520antagonize%2520Wingless%2520signalling%26jtitle%3DNature%26date%3D1998%26volume%3D395%26spage%3D521%26epage%3D525%26doi%3D10.1038%2F26785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span> <span> </span><span class="NLM_article-title">Drug discovery approaches to target Wnt signaling in cancer stem cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.18632%2Foncotarget.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21317452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ovFaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=563-577&author=J.+C.+Curtinauthor=M.+V.+Lorenzi&title=Drug+discovery+approaches+to+target+Wnt+signaling+in+cancer+stem+cells&doi=10.18632%2Foncotarget.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery approaches to target Wnt signaling in cancer stem cells</span></div><div class="casAuthors">Curtin Joshua C; Lorenzi Matthew V</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">563-577</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer stem cells (CSCs) represent a unique subset of cells within a tumor that possess self-renewal capacity and pluripotency, and can drive tumor initiation and maintenance.  First identified in hematological malignancies, CSCs are now thought to play an important role in a wide variety of solid tumors such as NSCLC, breast and colorectal cancer.  The role of CSCs in driving tumor formation illustrates the dysregulation of differentiation in tumorigenesis.  The Wnt, Notch and Hedgehog (HH) pathways are developmental pathways that are commonly activated in many types of cancer.  While substantial progress has been made in developing therapeutics targeting Notch and HH, the Wnt pathway has remained an elusive therapeutic target.  This review will focus on the clinical relevance of the Wnt pathway in CSCs and tumor cell biology, as well as points of therapeutic intervention and recent advances in targeting Wnt/β-catenin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFBfpnQKj7OdTiMd2aNQVUfW6udTcc2eYxVqoNyaNB0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ovFaluw%253D%253D&md5=4aa4638b4a1ef0976793623acb8c5fa6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.191%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DJ.%2BC.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26atitle%3DDrug%2520discovery%2520approaches%2520to%2520target%2520Wnt%2520signaling%2520in%2520cancer%2520stem%2520cells%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26spage%3D563%26epage%3D577%26doi%3D10.18632%2Foncotarget.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span> <span> </span><span class="NLM_article-title">Is beta-catenin a druggable target for cancer therapy?</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2018.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.tibs.2018.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30056837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Sjs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=623-634&author=C.+Cuiauthor=X.+Zhouauthor=W.+Zhangauthor=Y.+Quauthor=X.+Ke&title=Is+beta-catenin+a+druggable+target+for+cancer+therapy%3F&doi=10.1016%2Fj.tibs.2018.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Is β-Catenin a Druggable Target for Cancer Therapy?</span></div><div class="casAuthors">Cui, Can; Zhou, Xianglian; Zhang, Weidong; Qu, Yi; Ke, Xisong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">623-634</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mutations of canonical Wnt signaling pathway genes frequently occur in cancer and lead to abnormal accumulation of the key effector β-catenin.  Over the past decades, a no. of Wnt inhibitors have been identified through high-throughput screenings, however, very few of them target β-catenin directly, raising questions regarding its druggability.  Here, we review Wnt inhibitors with a focus on small mols. that directly bind β-catenin, discuss the druggability of β-catenin, and why it has rarely been targeted, esp. in the cellular context.  We also propose strategies to develop small mol. binding and depleting cellular β-catenin, which are generally applicable to other difficult-to-drug or yet-to-be-drugged targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrL5XRxhPzrVg90H21EOLACvtfcHk0ljeFuI1Lrpllg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Sjs7vI&md5=55c9d706caee90039aae17a2c8bdb3e0</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2018.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2018.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DX.%26atitle%3DIs%2520beta-catenin%2520a%2520druggable%2520target%2520for%2520cancer%2520therapy%253F%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2018%26volume%3D43%26spage%3D623%26epage%3D634%26doi%3D10.1016%2Fj.tibs.2018.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemaru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a full-length beta-catenin</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1016/j.str.2007.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.str.2007.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18334222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=478-487&author=Y.+Xingauthor=K.+Takemaruauthor=J.+Liuauthor=J.+D.+Berndtauthor=J.+J.+Zhengauthor=R.+T.+Moonauthor=W.+Xu&title=Crystal+structure+of+a+full-length+beta-catenin&doi=10.1016%2Fj.str.2007.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Full-Length β-Catenin</span></div><div class="casAuthors">Xing, Yi; Takemaru, Ken-Ichi; Liu, Jing; Berndt, Jason D.; Zheng, Jie J.; Moon, Randall T.; Xu, Wenqing</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">478-487</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">β-Catenin plays essential roles in cell adhesion and Wnt signaling, while deregulation of β-catenin is assocd. with multiple diseases including cancers.  Here, we report the crystal structures of full-length zebrafish β-catenin and a human β-catenin fragment that contains both the armadillo repeat and the C-terminal domains.  Our structures reveal that the N-terminal region of the C-terminal domain, a key component of the C-terminal transactivation domain, forms a long α helix that packs on the C-terminal end of the armadillo repeat domain, and thus forms part of the β-catenin superhelical core.  The existence of this helix redefines our view of interactions of β-catenin with some of its crit. partners, including ICAT and Chibby, which may form extensive interactions with this C-terminal domain α helix.  Our crystallog. and NMR studies also suggest that the unstructured N-terminal and C-terminal tails interact with the ordered armadillo repeat domain in a dynamic and variable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrW7RJCw0FLVg90H21EOLACvtfcHk0ljeFuI1Lrpllg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVKjs7k%253D&md5=4fb8e4ebe99b4fe121817b2a8ae7b231</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DTakemaru%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBerndt%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520full-length%2520beta-catenin%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D478%26epage%3D487%26doi%3D10.1016%2Fj.str.2007.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0lhkbI9A7m36Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trosset, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/prot.20955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fprot.20955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16568448" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=60-67&author=J.+Y.+Trossetauthor=C.+Dalvitauthor=S.+Knappauthor=M.+Fasoliniauthor=M.+Veronesiauthor=S.+Manteganiauthor=L.+M.+Gianelliniauthor=C.+Catanaauthor=M.+Sundstromauthor=P.+F.+Stoutenauthor=J.+K.+Moll&title=Inhibition+of+protein-protein+interactions%3A+the+discovery+of+druglike+beta-catenin+inhibitors+by+combining+virtual+and+biophysical+screening&doi=10.1002%2Fprot.20955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fprot.20955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20955%26sid%3Dliteratum%253Aachs%26aulast%3DTrosset%26aufirst%3DJ.%2BY.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DGianellini%26aufirst%3DL.%2BM.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DStouten%26aufirst%3DP.%2BF.%26aulast%3DMoll%26aufirst%3DJ.%2BK.%26atitle%3DInhibition%2520of%2520protein-protein%2520interactions%253A%2520the%2520discovery%2520of%2520druglike%2520beta-catenin%2520inhibitors%2520by%2520combining%2520virtual%2520and%2520biophysical%2520screening%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D64%26spage%3D60%26epage%3D67%26doi%3D10.1002%2Fprot.20955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors for beta-catenin/T-cell factor protein-protein interactions by bioisostere replacement</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/cb300564v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300564v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslKq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=524-529&author=B.+Yuauthor=Z.+Huangauthor=M.+Zhangauthor=D.+R.+Dillardauthor=H.+Ji&title=Rational+design+of+small-molecule+inhibitors+for+beta-catenin%2FT-cell+factor+protein-protein+interactions+by+bioisostere+replacement&doi=10.1021%2Fcb300564v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein-Protein Interactions by Bioisostere Replacement</span></div><div class="casAuthors">Yu, Binxun; Huang, Zheng; Zhang, Min; Dillard, Darren R.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">524-529</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new hot spot-based design strategy using bioisostere replacement is reported to rationally design nonpeptidic small-mol. inhibitors for protein-protein interactions.  This method is applied to design new potent inhibitors for β-catenin/T-cell factor (Tcf) interactions.  Three hot spot regions of Tcf for binding to β-catenin were quant. evaluated; the key binding elements around K435 and K508 of β-catenin were derived; a bioisostere library was used to generate new fragments that can match the proposed crit. binding elements.  The most potent inhibitor, with a mol. wt. of 230, has a Kd of 0.531 μM for binding to β-catenin and a Ki of 3.14 μM to completely disrupt β-catenin/Tcf interactions.  The binding mode of the designed inhibitors was validated by the site-directed mutagenesis and structure-activity relationship (SAR) studies.  This study provides a new approach to design new small-mol. inhibitors that bind to β-catenin and effectively disrupt β-catenin/Tcf interactions specific for canonical Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9WgJGihEBbVg90H21EOLACvtfcHk0lhkbI9A7m36Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslKq&md5=631c9dd6d7f87f92758b73af74e5dbdb</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fcb300564v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300564v%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDillard%26aufirst%3DD.%2BR.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520for%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%2520by%2520bioisostere%2520replacement%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D524%26epage%3D529%26doi%3D10.1021%2Fcb300564v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsakhyan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt beta-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1021/cb400795x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400795x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=193-201&author=Z.+Huangauthor=M.+Zhangauthor=S.+D.+Burtonauthor=L.+N.+Katsakhyanauthor=H.+Ji&title=Targeting+the+Tcf4+G13ANDE17+binding+site+to+selectively+disrupt+beta-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fcb400795x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein-Protein Interactions</span></div><div class="casAuthors">Huang, Zheng; Zhang, Min; Burton, Shawn D.; Katsakhyan, Levon N.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective disruption of protein-protein interactions by small mols. is important for probing the structure and dynamic aspects of cellular network.  It can also provide new therapeutic targets. β-Catenin of the canonical Wnt signaling pathway uses the same pos. charged groove to bind with T-cell factor (Tcf), cadherin, and adenomatous polysis coli (APC).  The extravagant formation of β-catenin/Tcf interactions drives the initiation and progression of many cancers and fibroses, while β-catenin/cadherin and β-catenin/APC interactions are essential for cell-cell adhesion and β-catenin degrdn.  In this study, a selective binding site that can differentiate β-catenin/Tcf, β-catenin/cadherin, and β-catenin/APC interactions was identified by alanine scanning and biochem. assays.  A new peptidomimetic strategy that incorporates SiteMap and multiple-copy simultaneous search was used to design selective small-mol. inhibitors for β-catenin/Tcf interactions.  A potent inhibitor was discovered to bind with β-catenin and completely disrupt β-catenin/Tcf interactions.  It also exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC interactions in both biochem. and cell-based assays.  This study provides a proof of concept for designing selective inhibitors for β-catenin/Tcf interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNcaw5jsvhZbVg90H21EOLACvtfcHk0liuWLuAKmvigg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN&md5=9f59f92f44e5b6cd486d351bd0bf77c6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fcb400795x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400795x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DS.%2BD.%26aulast%3DKatsakhyan%26aufirst%3DL.%2BN.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520Tcf4%2520G13ANDE17%2520binding%2520site%2520to%2520selectively%2520disrupt%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D193%26epage%3D201%26doi%3D10.1021%2Fcb400795x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Optimization of peptidomimetics as selective inhibitors for the beta-catenin/T-cell factor protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3617</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00147</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00147" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFentb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3617-3635&author=Z.+Wangauthor=M.+Zhangauthor=J.+Wangauthor=H.+Ji&title=Optimization+of+peptidomimetics+as+selective+inhibitors+for+the+beta-catenin%2FT-cell+factor+protein-protein+interaction&doi=10.1021%2Facs.jmedchem.9b00147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction</span></div><div class="casAuthors">Wang, Zhen; Zhang, Min; Wang, Jin; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3617-3635</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-catenin/T-cell factor (Tcf) protein-protein interaction (PPI) plays a crit. role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses.  Based on compd. 1, which was designed to target the Tcf4 G13ANDE17 binding site of β-catenin, extensive structure-activity relationship studies have been conducted.  As a result, compds. 53 and 57 were found to disrupt the β-catenin/Tcf PPI with the Ki values of 0.64 and 0.44 μM, resp., and exhibit good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/adenomatous polyposis coli (APC) PPIs.  The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assays revealed that 56, the Et ester of 53, was more potent than 53 in inhibiting viability of most of the Wnt/β-catenin hyperactive cancer cells.  Further cell-based studies indicated that 56 disrupted the β-catenin/Tcf PPI without affecting the β-catenin/E-cadherin and β-catenin/APC PPIs, suppressed transactivation of Wnt/β-catenin signaling in dose-dependent manners, and inhibited migration and invasiveness of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQ02RIKeK5LVg90H21EOLACvtfcHk0liuWLuAKmvigg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFentb8%253D&md5=8b4a19745fe5ae7561093523b07681a6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00147%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DOptimization%2520of%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520for%2520the%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3617%26epage%3D3635%26doi%3D10.1021%2Facs.jmedchem.9b00147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of oncogenic Wnt signaling through direct targeting of beta-catenin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17942</span>– <span class="NLM_lpage">17947</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208396109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1208396109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23071338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17942-17947&author=T.+N.+Grossmannauthor=J.+T.+Yehauthor=B.+R.+Bowmanauthor=Q.+Chuauthor=R.+E.+Moelleringauthor=G.+L.+Verdine&title=Inhibition+of+oncogenic+Wnt+signaling+through+direct+targeting+of+beta-catenin&doi=10.1073%2Fpnas.1208396109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span></div><div class="casAuthors">Grossmann, Tom N.; Yeh, Johannes T.-H.; Bowman, Brian R.; Chu, Qian; Moellering, Raymond E.; Verdine, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17942-17947, S17942/1-S17942/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of signaling by the Wnt pathway is strongly implicated in the onset and progression of numerous types of cancer.  Owing to the persistent dependence of these tumors on Wnt signaling for growth and survival, inhibition of this pathway is considered an attractive mechanism-based therapeutic approach.  Oncogenic activation of Wnt signaling can ensue from a variety of distinct aberrations in the signaling pathway, but most share the common feature of causing increased cellular levels of β-catenin by interfering with its constitutive degrdn.  β-Catenin serves as a central hub in Wnt signaling by engaging in crucial protein-protein interactions with both neg. and pos. effectors of the pathway.  Direct interference with these protein-protein interactions is a biol. compelling approach toward suppression of β-catenin hyperactivity, but such interactions have proven intransigent with respect to small-mol. targeting.  Hence β-catenin remains an elusive target for translational cancer therapy.  Here the authors report the discovery of a hydrocarbon-stapled peptide that directly targets β-catenin and interferes with its ability to serve as a transcriptional coactivator for T-cell factor (TCF) proteins, the downstream transcriptional regulators of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD9Q6Y8-IAI7Vg90H21EOLACvtfcHk0liuWLuAKmvigg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI&md5=3f2fc0f4f616ef057317639fe7c465c6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208396109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208396109%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DYeh%26aufirst%3DJ.%2BT.%26aulast%3DBowman%26aufirst%3DB.%2BR.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DInhibition%2520of%2520oncogenic%2520Wnt%2520signaling%2520through%2520direct%2520targeting%2520of%2520beta-catenin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17942%26epage%3D17947%26doi%3D10.1073%2Fpnas.1208396109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bange, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schade, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Cell permeable stapled peptide inhibitor of Wnt signaling that targets beta-catenin protein-protein interactions</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.chembiol.2017.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28757184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=958-968&author=L.+Dietrichauthor=B.+Rathmerauthor=K.+Ewanauthor=T.+Bangeauthor=S.+Heinrichsauthor=T.+C.+Daleauthor=D.+Schadeauthor=T.+N.+Grossmann&title=Cell+permeable+stapled+peptide+inhibitor+of+Wnt+signaling+that+targets+beta-catenin+protein-protein+interactions&doi=10.1016%2Fj.chembiol.2017.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeable stapled peptide inhibitor of wnt signaling that targets β-catenin protein-protein interactions</span></div><div class="casAuthors">Dietrich, Laura; Rathmer, Bernd; Ewan, Kenneth; Bange, Tanja; Heinrichs, Stefan; Dale, Trevor C.; Schade, Dennis; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">958-968.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a crit. role in cell proliferation and differentiation, thus it is often assocd. with diseases such as cancers.  Unfortunately, although attractive, developing anti-cancer strategy targeting Wnt signaling has been challenging given that the most attractive targets are involved in protein-protein interactions (PPIs).  Here, we develop a stapled peptide inhibitor that targets the interaction between β-catenin and T cell factor/lymphoid enhancer-binding factor transcription factors, which are crucially involved in Wnt signaling.  Our integrative approach combines peptide stapling to optimize proteolytic stability, with lessons learned from cell-penetrating peptide (CPP) design to maximize cellular uptake resulting in NLS-StAx-h, a selective, cell permeable, stapled peptide inhibitor of oncogenic Wnt signaling that efficiently inhibits β-catenin-transcription factor interactions.  We expect that this type of integrative strategy that endows stapled peptides with CPP features will be generally useful for developing inhibitors of intracellular PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4mcl8B_B0B7Vg90H21EOLACvtfcHk0lim_NvQYyw4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK&md5=cbf0b96aab1e21c298b9a6d22b7f05d1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%26aulast%3DRathmer%26aufirst%3DB.%26aulast%3DEwan%26aufirst%3DK.%26aulast%3DBange%26aufirst%3DT.%26aulast%3DHeinrichs%26aufirst%3DS.%26aulast%3DDale%26aufirst%3DT.%2BC.%26aulast%3DSchade%26aufirst%3DD.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DCell%2520permeable%2520stapled%2520peptide%2520inhibitor%2520of%2520Wnt%2520signaling%2520that%2520targets%2520beta-catenin%2520protein-protein%2520interactions%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D958%26epage%3D968%26doi%3D10.1016%2Fj.chembiol.2017.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective small-molecule inhibitors for the beta-catenin/T-cell factor protein-protein interaction through the optimization of the acyl hydrazone moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4678</span>– <span class="NLM_lpage">4692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4678-4692&author=J.+L.+Catrowauthor=Y.+Zhangauthor=M.+Zhangauthor=H.+Ji&title=Discovery+of+selective+small-molecule+inhibitors+for+the+beta-catenin%2FT-cell+factor+protein-protein+interaction+through+the+optimization+of+the+acyl+hydrazone+moiety&doi=10.1021%2Facs.jmedchem.5b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety</span></div><div class="casAuthors">Catrow, J. Leon; Zhang, Yongqiang; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4678-4692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl hydrazone is an important functional group for the discovery of bioactive small mols.  This functional group is also recognized as a pan assay interference structure.  In this study, a new small-mol. inhibitor for the β-catenin/Tcf protein-protein interaction (PPI), ZINC02092166, was identified through AlphaScreen and FP assays.  This compd. contains an acyl hydrazone group and exhibits higher inhibitory activities in cell-based assays than biochem. assays.  Inhibitor optimization resulted in chem. stable derivs. that disrupt the β-catenin/Tcf PPI.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This series of inhibitors with a new scaffold exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC PPIs.  One deriv. of this series suppresses canonical Wnt signaling, downregulates the expression of Wnt target genes, and inhibits the growth of cancer cells.  This compd. represents a solid starting point for the development of potent and selective β-catenin/Tcf inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusdU2c6KIQLVg90H21EOLACvtfcHk0lim_NvQYyw4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D&md5=11aa0209009144341d692c4cf6966790</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00223%26sid%3Dliteratum%253Aachs%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520the%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%2520through%2520the%2520optimization%2520of%2520the%2520acyl%2520hydrazone%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4678%26epage%3D4692%26doi%3D10.1021%2Facs.jmedchem.5b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf-Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the beta-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-15-1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26645562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=891-901&author=L.+Fangauthor=Q.+Zhuauthor=M.+Neuenschwanderauthor=E.+Speckerauthor=A.+Wulf-Goldenbergauthor=W.+I.+Weisauthor=J.+P.+von+Kriesauthor=W.+Birchmeier&title=A+small-molecule+antagonist+of+the+beta-catenin%2FTCF4+interaction+blocks+the+self-renewal+of+cancer+stem+cells+and+suppresses+tumorigenesis&doi=10.1158%2F0008-5472.CAN-15-1519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis</span></div><div class="casAuthors">Fang, Liang; Zhu, Qionghua; Neuenschwander, Martin; Specker, Edgar; Wulf-Goldenberg, Annika; Weis, William I.; von Kries, Jens P.; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">891-901</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is a highly conserved pathway essential for embryogenesis and tissue homeostasis.  However, deregulation of this pathway can initiate and promote human malignancies, esp. of the colon and head and neck.  Therefore, Wnt/β-catenin signaling represents an attractive target for cancer therapy.  We performed high-throughput screening using AlphaScreen and ELISA techniques to identify small mols. that disrupt the crit. interaction between β-catenin and the transcription factor TCF4 required for signal transduction.  We found that compd. LF3, a 4-thioureido-benzenesulfonamide deriv., robustly inhibited this interaction.  Biochem. assays revealed clues that the core structure of LF3 was essential for inhibition.  LF3 inhibited Wnt/β-catenin signals in cells with exogenous reporters and in colon cancer cells with endogenously high Wnt activity.  LF3 also suppressed features of cancer cells related to Wnt signaling, including high cell motility, cell-cycle progression, and the overexpression of Wnt target genes.  However, LF3 did not cause cell death or interfere with cadherin-mediated cell-cell adhesion.  Remarkably, the self-renewal capacity of cancer stem cells was blocked by LF3 in concn.-dependent manners, as examd. by sphere formation of colon and head and neck cancer stem cells under nonadherent conditions.  Finally, LF3 reduced tumor growth and induced differentiation in a mouse xenograft model of colon cancer.  Collectively, our results strongly suggest that LF3 is a specific inhibitor of canonical Wnt signaling with anticancer activity that warrants further development for preclin. and clin. studies as a novel cancer therapy.  Cancer Res; 76(4); 891-901. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3MyJLga-90rVg90H21EOLACvtfcHk0lim_NvQYyw4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGlsrk%253D&md5=bbf6184c7c61b3eda96d22f458f277e5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1519%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520beta-catenin%252FTCF4%2520interaction%2520blocks%2520the%2520self-renewal%2520of%2520cancer%2520stem%2520cells%2520and%2520suppresses%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D891%26epage%3D901%26doi%3D10.1158%2F0008-5472.CAN-15-1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craven, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garabedian, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S. K.</span></span> <span> </span><span class="NLM_article-title">Design of peptoid-peptide macrocycles to inhibit the β-catenin TCF interaction in prostate cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4396</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41467-018-06845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30352998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4396&author=J.+A.+Schneiderauthor=T.+W.+Cravenauthor=A.+C.+Kasperauthor=C.+Yunauthor=M.+Haugbroauthor=E.+M.+Briggsauthor=V.+Svetlovauthor=E.+Nudlerauthor=H.+Knautauthor=R.+Bonneauauthor=M.+J.+Garabedianauthor=K.+Kirshenbaumauthor=S.+K.+Logan&title=Design+of+peptoid-peptide+macrocycles+to+inhibit+the+%CE%B2-catenin+TCF+interaction+in+prostate+cancer&doi=10.1038%2Fs41467-018-06845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer</span></div><div class="casAuthors">Schneider Jeffrey A; Briggs Erica M; Garabedian Michael J; Logan Susan K; Craven Timothy W; Kasper Amanda C; Haugbro Michael; Kirshenbaum Kent; Craven Timothy W; Bonneau Richard; Yun Chi; Knaut Holger; Briggs Erica M; Svetlov Vladimir; Nudler Evgeny; Logan Susan K; Svetlov Vladimir; Nudler Evgeny; Garabedian Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New chemical inhibitors of protein-protein interactions are needed to propel advances in molecular pharmacology.  Peptoids are peptidomimetic oligomers with the capability to inhibit protein-protein interactions by mimicking protein secondary structure motifs.  Here we report the in silico design of a macrocycle primarily composed of peptoid subunits that targets the β-catenin:TCF interaction.  The β-catenin:TCF interaction plays a critical role in the Wnt signaling pathway which is over-activated in multiple cancers, including prostate cancer.  Using the Rosetta suite of protein design algorithms, we evaluate how different macrocycle structures can bind a pocket on β-catenin that associates with TCF.  The in silico designed macrocycles are screened in vitro using luciferase reporters to identify promising compounds.  The most active macrocycle inhibits both Wnt and AR-signaling in prostate cancer cell lines, and markedly diminishes their proliferation.  In vivo potential is demonstrated through a zebrafish model, in which Wnt signaling is potently inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUDToTC3aBaesfW6udTcc2eZ2s7F9u9zB2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D&md5=1c04088452bbaf704ced21bf03541253</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06845-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DCraven%26aufirst%3DT.%2BW.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DYun%26aufirst%3DC.%26aulast%3DHaugbro%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DE.%2BM.%26aulast%3DSvetlov%26aufirst%3DV.%26aulast%3DNudler%26aufirst%3DE.%26aulast%3DKnaut%26aufirst%3DH.%26aulast%3DBonneau%26aufirst%3DR.%26aulast%3DGarabedian%26aufirst%3DM.%2BJ.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DS.%2BK.%26atitle%3DDesign%2520of%2520peptoid-peptide%2520macrocycles%2520to%2520inhibit%2520the%2520%25CE%25B2-catenin%2520TCF%2520interaction%2520in%2520prostate%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4396%26doi%3D10.1038%2Fs41467-018-06845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+beta-catenin%2FCREB-binding+protein+transcription+%5Bcorrected%5D&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0lgPQrPOJQtGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520beta-catenin%252FCREB-binding%2520protein%2520transcription%2520%255Bcorrected%255D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oboki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojika, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saibara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)/beta-catenin reduces liver fibrosis in mice</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2015.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ebiom.2015.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26870800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28jgt1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=1751-1758&author=Y.+Osawaauthor=K.+Obokiauthor=J.+Imamuraauthor=E.+Kojikaauthor=Y.+Hayashiauthor=T.+Hishimaauthor=T.+Saibaraauthor=F.+Shibasakiauthor=M.+Koharaauthor=K.+Kimura&title=Inhibition+of+cyclic+adenosine+monophosphate+%28cAMP%29-response+element-binding+protein+%28CREB%29-binding+protein+%28CBP%29%2Fbeta-catenin+reduces+liver+fibrosis+in+mice&doi=10.1016%2Fj.ebiom.2015.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice</span></div><div class="casAuthors">Osawa Yosuke; Imamura Jun; Kojika Ekumi; Kimura Kiminori; Oboki Keisuke; Shibasaki Futoshi; Hayashi Yukiko; Hishima Tsunekazu; Saibara Toshiji; Kohara Michinori</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1751-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Wnt/β-catenin is involved in every aspect of embryonic development and in the pathogenesis of many human diseases, and is also implicated in organ fibrosis.  However, the role of β-catenin-mediated signaling on liver fibrosis remains unclear.  To explore this issue, the effects of PRI-724, a selective inhibitor of the cAMP-response element-binding protein-binding protein (CBP)/β-catenin interaction, on liver fibrosis were examined using carbon tetrachloride (CCl4)- or bile duct ligation (BDL)-induced mouse liver fibrosis models.  Following repetitive CCl4 administrations, the nuclear translocation of β-catenin was observed only in the non-parenchymal cells in the liver.  PRI-724 treatment reduced the fibrosis induced by CCl4 or BDL.  C-82, an active form of PRI-724, inhibited the activation of isolated primary mouse quiescent hepatic stellate cells (HSCs) and promoted cell death in culture-activated HSCs.  During the fibrosis resolution period, an increase in F4/80(+) CD11b(+) and Ly6C(low) CD11b(+) macrophages was induced by CCl4 and was sustained for two weeks thereafter, even after having stopped CCl4 treatment.  PRI-724 accelerated the resolution of CCl4-induced liver fibrosis, and this was accompanied by increased matrix metalloproteinase (MMP)-9, MMP-2, and MMP-8 expression in intrahepatic leukocytes.  In conclusion, targeting the CBP/β-catenin interaction may become a new therapeutic strategy in treating liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyynf43J2DM7mQt-ICR3qNfW6udTcc2eZsmLeQ-nmAsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jgt1Ortw%253D%253D&md5=cfad915dfce8069236820b2f01c2737e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2015.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2015.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DOboki%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DJ.%26aulast%3DKojika%26aufirst%3DE.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DHishima%26aufirst%3DT.%26aulast%3DSaibara%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DF.%26aulast%3DKohara%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520cyclic%2520adenosine%2520monophosphate%2520%2528cAMP%2529-response%2520element-binding%2520protein%2520%2528CREB%2529-binding%2520protein%2520%2528CBP%2529%252Fbeta-catenin%2520reduces%2520liver%2520fibrosis%2520in%2520mice%26jtitle%3DEBioMedicine%26date%3D2015%26volume%3D2%26spage%3D1751%26epage%3D1758%26doi%3D10.1016%2Fj.ebiom.2015.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikoma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okusaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizokami, M.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and preliminary efficacy of the anti-fibrotic small molecule PRI-724, a CBP/beta-catenin inhibitor, in patients with hepatitis C virus-related cirrhosis: a single-center, open-label, dose escalation phase 1 trial</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2017.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ebiom.2017.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28844410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhvF2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=79-87&author=K.+Kimuraauthor=A.+Ikomaauthor=M.+Shibakawaauthor=S.+Shimodaauthor=K.+Haradaauthor=M.+Saioauthor=J.+Imamuraauthor=Y.+Osawaauthor=M.+Kimuraauthor=K.+Nishikawaauthor=T.+Okusakaauthor=S.+Moritaauthor=K.+Inoueauthor=T.+Kantoauthor=K.+Todakaauthor=Y.+Nakanishiauthor=M.+Koharaauthor=M.+Mizokami&title=Safety%2C+tolerability%2C+and+preliminary+efficacy+of+the+anti-fibrotic+small+molecule+PRI-724%2C+a+CBP%2Fbeta-catenin+inhibitor%2C+in+patients+with+hepatitis+C+virus-related+cirrhosis%3A+a+single-center%2C+open-label%2C+dose+escalation+phase+1+trial&doi=10.1016%2Fj.ebiom.2017.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial</span></div><div class="casAuthors">Kimura Kiminori; Ikoma Akemi; Shibakawa Maki; Imamura Jun; Osawa Yosuke; Kimura Masamichi; Nishikawa Koji; Shimoda Shinji; Harada Kenichi; Saio Masanao; Okusaka Takuji; Morita Satoshi; Inoue Kazuaki; Kanto Tatsuya; Mizokami Masashi; Todaka Koji; Nakanishi Yoichi; Kohara Michinori</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is currently no anti-fibrotic drug therapy available to treat hepatitis C virus (HCV) cirrhosis.  The aim of this study was to assess the safety, tolerability, and anti-fibrotic effect of PRI-724, a small-molecule modulator of Wnt signaling, in patients with HCV cirrhosis.  METHODS:  In this single-center, open-label, phase 1 trial, we sequentially enrolled patients with HCV cirrhosis who were classified as Child-Pugh (CP) class A or B.  PRI-724 was administered as a continuous intravenous infusion of 10, 40, or 160mg/m(2)/day for six cycles of 1week on and 1week off.  The primary endpoints were frequency and severity of adverse events.  The secondary endpoint was efficacy of PRI-724 in treating cirrhosis based on CP score and liver biopsy.  This study is registered with ClinicalTrials.gov (no.  NCT02195440).  FINDINGS:  Between Sept 3, 2014 and May 2, 2016, 14 patients were enrolled: CP class A:B, 6:8; median age, 62 (range: 43 to 74) years; male:female, 10:4.  Twelve of the 14 patients completed six cycles of treatment; one was withdrawn from the study due to possible study drug-related liver injury (grade 3) in the 160mg/m(2)/day dose cohort and one withdrew for personal reasons.  Serious adverse events occurred in three patients [21% (3/14)], one of which was possibly related to PRI-724.  The most common adverse events were nausea [29% (4/14)] and fatigue [21% (3/14)].  After PRI-724 administration, the CP scores worsened by 1 point in two patients in the 10mg/m(2)/day cohort, improved in three patients at 1, 1, and 2 points in the 40mg/m(2)/day cohort, and improved in one patient by 3 points in the 160mg/m(2)/day cohort.  The histology activity index scores of the liver tissue improved in two patients and exacerbated in two patients in the 10mg/m(2)/day cohort, and improved in one patient in the 40mg/m(2)/day cohort.  INTERPRETATION:  This study showed that administration of 10 or 40mg/m(2)/day intravenous PRI-724 over 12weeks was well-tolerated by patients with HCV cirrhosis; however, liver injury as a possible related serious adverse event was observed in the 160mg/m(2)/day cohort.  FUNDING SOURCE:  AMED.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE5aQERxw85wWRJ3OJdH_qfW6udTcc2eZsmLeQ-nmAsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhvF2jtw%253D%253D&md5=be646fe1fe15edef6386c48ad666e0e7</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2017.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2017.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DIkoma%26aufirst%3DA.%26aulast%3DShibakawa%26aufirst%3DM.%26aulast%3DShimoda%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DSaio%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DJ.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKanto%26aufirst%3DT.%26aulast%3DTodaka%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DKohara%26aufirst%3DM.%26aulast%3DMizokami%26aufirst%3DM.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520preliminary%2520efficacy%2520of%2520the%2520anti-fibrotic%2520small%2520molecule%2520PRI-724%252C%2520a%2520CBP%252Fbeta-catenin%2520inhibitor%252C%2520in%2520patients%2520with%2520hepatitis%2520C%2520virus-related%2520cirrhosis%253A%2520a%2520single-center%252C%2520open-label%252C%2520dose%2520escalation%2520phase%25201%2520trial%26jtitle%3DEBioMedicine%26date%3D2017%26volume%3D23%26spage%3D79%26epage%3D87%26doi%3D10.1016%2Fj.ebiom.2017.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. S.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1702</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-14-2041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25660951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1691-1702&author=G.+B.+Jangauthor=I.+S.+Hongauthor=R.+J.+Kimauthor=S.+Y.+Leeauthor=S.+J.+Parkauthor=E.+S.+Leeauthor=J.+H.+Parkauthor=C.+H.+Yunauthor=J.+U.+Chungauthor=K.+J.+Leeauthor=H.+Y.+Leeauthor=J.+S.+Nam&title=Wnt%2Fbeta-catenin+small-molecule+inhibitor+CWP232228+preferentially+inhibits+the+growth+of+breast+cancer+stem-like+cells&doi=10.1158%2F0008-5472.CAN-14-2041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells</span></div><div class="casAuthors">Jang, Gyu-Beom; Hong, In-Sun; Kim, Ran-Ju; Lee, Su-Youn; Park, Se-Jin; Lee, Eun-Sook; Park, Jung Hyuck; Yun, Chi-Ho; Chung, Jae-Uk; Lee, Kyoung-June; Lee, Hwa-Yong; Nam, Jeong-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1691-1702</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">These findings highlight a candidate therapeutic agent that may target stem-like cells as well as bulk tumor cells and lead to more effective treatment of breast cancer.  Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but not all BCSC that can mediate relapses.  In the present study, we showed that the level of Wnt/β-catenin signaling in BCSC is relatively higher than in bulk tumor cells, contributing to a relatively higher level of therapeutic resistance.  We designed a highly potent small-mol. inhibitor, CWP232228, which antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus.  Notably, although CWP232228 inhibited the growth of both BCSC and bulk tumor cells by inhibiting β-catenin-mediated transcription, BCSC exhibited greater growth inhibition than bulk tumor cells.  We also documented evidence of greater insulin-like growth factor-I (IGF-I) expression by BCSC than by bulk tumor cells and that CWP232228 attenuated IGF-I-mediated BCSC functions.  These results suggested that the inhibitory effect of CWP232228 on BCSC growth might be achieved through the disruption of IGF-I activity.  Taken together, our findings indicate that CWP232228 offers a candidate therapeutic agent for breast cancer that preferentially targets BCSC as well as bulk tumor cells.  Cancer Res; 75(8); 1691-702. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqQfzkL0A6K7Vg90H21EOLACvtfcHk0lgVE9uwPIh6vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsb8%253D&md5=7534a35b1407b55131327cc17368f2c2</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2041%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DG.%2BB.%26aulast%3DHong%26aufirst%3DI.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DChung%26aufirst%3DJ.%2BU.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DNam%26aufirst%3DJ.%2BS.%26atitle%3DWnt%252Fbeta-catenin%2520small-molecule%2520inhibitor%2520CWP232228%2520preferentially%2520inhibits%2520the%2520growth%2520of%2520breast%2520cancer%2520stem-like%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D1691%26epage%3D1702%26doi%3D10.1158%2F0008-5472.CAN-14-2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, I. S.</span></span> <span> </span><span class="NLM_article-title">CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">20395</span>– <span class="NLM_lpage">20409</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.18632%2Foncotarget.7954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26967248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28jptFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=20395-20409&author=J.+Y.+Kimauthor=H.+Y.+Leeauthor=K.+K.+Parkauthor=Y.+K.+Choiauthor=J.+S.+Namauthor=I.+S.+Hong&title=CWP232228+targets+liver+cancer+stem+cells+through+Wnt%2Fbeta-catenin+signaling%3A+a+novel+therapeutic+approach+for+liver+cancer+treatment&doi=10.18632%2Foncotarget.7954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment</span></div><div class="casAuthors">Kim Ji-Young; Kim Ji-Young; Choi Yang-Kyu; Lee Hwa-Yong; Park Kwan-Kyu; Nam Jeong-Seok; Hong In-Sun; Hong In-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">20395-409</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not all liver CSCs contribute to tumor initiation, metastasis, and relapse.  In the present study, we showed that liver CSCs with elevated Wnt/β-catenin signaling possess much greater self-renewal and clonogenic potential.  We further documented that the increased clonogenic potential of liver CSCs is highly associated with changes in Wnt/β-catenin signaling and that Wnt/β-catenin signaling activity is positively correlated with CD133 expression and aldehyde dehydrogenase (ALDH) enzymatic activity.  Notably, the small molecule inhibitor CWP232228, which antagonizes the binding of β-catenin to TCF in the nucleus, inhibits Wnt/β-catenin signaling and depletes CD133+/ALDH+ liver CSCs, thus ultimately diminishing the self-renewal capacity of CSCs and decreasing tumorigenicity in vitro and in vivo.  Taken together, our findings suggest that CWP232228 acts as a candidate therapeutic agent for liver cancer by preferentially targeting liver CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYNq4keDr1UQWRJ3OJdH_qfW6udTcc2ebD2hG8FRHvirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jptFOktQ%253D%253D&md5=7dcb30f34a96d6e08a013d2c9bbb0dea</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7954%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DK.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BK.%26aulast%3DNam%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DI.%2BS.%26atitle%3DCWP232228%2520targets%2520liver%2520cancer%2520stem%2520cells%2520through%2520Wnt%252Fbeta-catenin%2520signaling%253A%2520a%2520novel%2520therapeutic%2520approach%2520for%2520liver%2520cancer%2520treatment%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D20395%26epage%3D20409%26doi%3D10.18632%2Foncotarget.7954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risueno, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanasijevic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslostovar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salci, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapovalova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golubeva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xenocostas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trus, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, M.</span></span> <span> </span><span class="NLM_article-title">Sam68 allows selective targeting of human cancer stem cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.chembiol.2017.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28648376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=833-844&author=Y.+D.+Benoitauthor=R.+R.+Mitchellauthor=R.+M.+Risuenoauthor=L.+Orlandoauthor=B.+Tanasijevicauthor=A.+L.+Boydauthor=L.+Aslostovarauthor=K.+R.+Salciauthor=Z.+Shapovalovaauthor=J.+Russellauthor=M.+Eguchiauthor=D.+Golubevaauthor=M.+Grahamauthor=A.+Xenocostasauthor=M.+R.+Trusauthor=R.+Foleyauthor=B.+Leberauthor=T.+J.+Collinsauthor=M.+Bhatia&title=Sam68+allows+selective+targeting+of+human+cancer+stem+cells&doi=10.1016%2Fj.chembiol.2017.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Sam68 Allows Selective Targeting of Human Cancer Stem Cells</span></div><div class="casAuthors">Benoit, Yannick D.; Mitchell, Ryan R.; Risueno, Ruth M.; Orlando, Luca; Tanasijevic, Borko; Boyd, Allison L.; Aslostovar, Lili; Salci, Kyle R.; Shapovalova, Zoya; Russell, Jennifer; Eguchi, Masakatsu; Golubeva, Diana; Graham, Monica; Xenocostas, Anargyros; Trus, Michael R.; Foley, Ronan; Leber, Brian; Collins, Tony J.; Bhatia, Mickie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">833-844.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Targeting of human cancer stem cells (CSCs) requires the identification of vulnerabilities unique to CSCs vs. healthy resident stem cells (SCs).  Unfortunately, dysregulated pathways that support transformed CSCs, such as Wnt/β-catenin signaling, are also crit. regulators of healthy SCs.  Using the ICG-001 and CWP family of small mols., we reveal Sam68 as a previously unappreciated modulator of Wnt/β-catenin signaling within CSCs.  Disruption of CBP-β-catenin interaction via ICG-001/CWP induces the formation of a Sam68-CBP complex in CSCs that alters Wnt signaling toward apoptosis and differentiation induction.  Our study identifies Sam68 as a regulator of human CSC vulnerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzo6C9FRMuj7Vg90H21EOLACvtfcHk0lgVE9uwPIh6vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrvJ&md5=fe6d9637ccb3adecaf29358aa25671cc</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DBenoit%26aufirst%3DY.%2BD.%26aulast%3DMitchell%26aufirst%3DR.%2BR.%26aulast%3DRisueno%26aufirst%3DR.%2BM.%26aulast%3DOrlando%26aufirst%3DL.%26aulast%3DTanasijevic%26aufirst%3DB.%26aulast%3DBoyd%26aufirst%3DA.%2BL.%26aulast%3DAslostovar%26aufirst%3DL.%26aulast%3DSalci%26aufirst%3DK.%2BR.%26aulast%3DShapovalova%26aufirst%3DZ.%26aulast%3DRussell%26aufirst%3DJ.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DGolubeva%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DM.%26aulast%3DXenocostas%26aufirst%3DA.%26aulast%3DTrus%26aufirst%3DM.%2BR.%26aulast%3DFoley%26aufirst%3DR.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DCollins%26aufirst%3DT.%2BJ.%26aulast%3DBhatia%26aufirst%3DM.%26atitle%3DSam68%2520allows%2520selective%2520targeting%2520of%2520human%2520cancer%2520stem%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D833%26epage%3D844%26doi%3D10.1016%2Fj.chembiol.2017.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Briaud, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenzin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of small molecule inhibitor of Wnt signaling in acute myelogenous leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4001</span>– <span class="NLM_lpage">4001</span>, <span class="refDoi"> DOI: 10.1182/blood.V112.11.4001.4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1182%2Fblood.V112.11.4001.4001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=4001-4001&author=I.+Briaudauthor=F.+Tenzinauthor=J.+K.+Chunauthor=S.-W.+Ohauthor=J.+U.+Chungauthor=K.+Y.+Jungauthor=M.+W.+Jeongauthor=J.+Y.+Chaauthor=Y.+Pyonauthor=D.+Leeauthor=J.+E.+Jungauthor=K.+H.+Emami&title=Therapeutic+potential+of+small+molecule+inhibitor+of+Wnt+signaling+in+acute+myelogenous+leukemia&doi=10.1182%2Fblood.V112.11.4001.4001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1182%2Fblood.V112.11.4001.4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V112.11.4001.4001%26sid%3Dliteratum%253Aachs%26aulast%3DBriaud%26aufirst%3DI.%26aulast%3DTenzin%26aufirst%3DF.%26aulast%3DChun%26aufirst%3DJ.%2BK.%26aulast%3DOh%26aufirst%3DS.-W.%26aulast%3DChung%26aufirst%3DJ.%2BU.%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DJeong%26aufirst%3DM.%2BW.%26aulast%3DCha%26aufirst%3DJ.%2BY.%26aulast%3DPyon%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DJ.%2BE.%26aulast%3DEmami%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520potential%2520of%2520small%2520molecule%2520inhibitor%2520of%2520Wnt%2520signaling%2520in%2520acute%2520myelogenous%2520leukemia%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D4001%26epage%3D4001%26doi%3D10.1182%2Fblood.V112.11.4001.4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H.</span></span> <span> </span><span class="NLM_article-title">The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">342</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1342-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1186%2Fs13046-019-1342-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31387608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3MvlsVymsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=342&author=S.+Pakauthor=S.+Parkauthor=Y.+Kimauthor=J.+H.+Parkauthor=C.+H.+Parkauthor=K.+J.+Leeauthor=C.+S.+Kimauthor=H.+Ahn&title=The+small+molecule+WNT%2Fbeta-catenin+inhibitor+CWP232291+blocks+the+growth+of+castration-resistant+prostate+cancer+by+activating+the+endoplasmic+reticulum+stress+pathway&doi=10.1186%2Fs13046-019-1342-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway</span></div><div class="casAuthors">Pak Sahyun; Park Sejun; Kim Yunlim; Kim Choung-Soo; Ahn Hanjong; Kim Yunlim; Park Jung-Hyuck; Park Chan-Hee; Lee Kyoung-June</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients.  Therefore, alternative therapeutic targets are urgently needed.  Since growing evidence demonstrates that WNT/β-catenin signaling plays an important role in CRPC, the antitumor activity and mechanism of action of CWP232291, a small molecule β-catenin inhibitor, were investigated in prostate cancer.  METHODS:  We assessed the antitumor activity of CWP232291 in prostate cancer cell lines and primary cells derived from CRPC patients.  The effect of CWP232291 on apoptotic cell death, endoplasmic reticulum (ER) stress, cell viability, and WNT/β-catenin signaling was evaluated by flow cytometry, western blotting, luciferase reporter assay, and fluorescence microscopy.  Antitumor efficacy was assessed in two CRPC xenograft mouse models.  RESULTS:  CWP232291 induced ER stress, resulting in upregulation of the proapoptotic protein CHOP and activation of caspase-3-dependent apoptosis.  In addition, CWP232291 suppressed the expression of β-catenin by affecting WNT-dependent transcriptional activity, and downregulated AR and its splice variants in prostate cancer cells.  Antitumor activity was observed in prostate cancer cells in vitro and ex vivo, and antitumor efficacy was observed in vivo.  CONCLUSIONS:  Beyond providing preclinical evidence of therapeutic efficacy for the novel small molecule β-catenin inhibitor CWP232291 in CRPC, our results show that inducing ER stress and targeting WNT/β-catenin signaling may be a novel strategy against CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3B7oaVKQRJDUE-swuRqsHfW6udTcc2eaHjjlTzP2tPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvlsVymsA%253D%253D&md5=57de59965a5462c30196dde15deeb568</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1342-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1342-5%26sid%3Dliteratum%253Aachs%26aulast%3DPak%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DAhn%26aufirst%3DH.%26atitle%3DThe%2520small%2520molecule%2520WNT%252Fbeta-catenin%2520inhibitor%2520CWP232291%2520blocks%2520the%2520growth%2520of%2520castration-resistant%2520prostate%2520cancer%2520by%2520activating%2520the%2520endoplasmic%2520reticulum%2520stress%2520pathway%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D342%26doi%3D10.1186%2Fs13046-019-1342-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faderl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardanani, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J. E.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome</span>. <i>Blood Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2043</span>, <span class="refDoi"> DOI: 10.1182/bloodadvances.2019000757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1182%2Fbloodadvances.2019000757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32396615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis12ksLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2020&pages=2032-2043&author=J.+H.+Leeauthor=S.+Faderlauthor=J.+M.+Pagelauthor=C.+W.+Jungauthor=S.+S.+Yoonauthor=A.+D.+Pardananiauthor=P.+S.+Beckerauthor=H.+Leeauthor=J.+Choiauthor=K.+Leeauthor=M.+Kimauthor=J.+E.+Cortes&title=Phase+1+study+of+CWP232291+in+patients+with+relapsed+or+refractory+acute+myeloid+leukemia+and+myelodysplastic+syndrome&doi=10.1182%2Fbloodadvances.2019000757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome</span></div><div class="casAuthors">Lee, Je-Hwan; Faderl, Stefan; Pagel, John M.; Jung, Chul Won; Yoon, Sung-Soo; Pardanani, Animesh D.; Becker, Pamela S.; Lee, Howard; Choi, Jeongeun; Lee, Kyoungjune; Kim, Minkyoung; Cortes, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Advances</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2032-2043</span>CODEN:
                <span class="NLM_cas:coden">BALDBA</span>;
        ISSN:<span class="NLM_cas:issn">2473-9537</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">CWP232291 (CWP291) is a small-mol. inhibitor of Wnt signaling that causes degrdn. of β-catenin via apoptosis induction through endoplasmic reticulum stress activation.  This first-in-human, open-label, dose-escalation study to evaluate the safety, max. tolerated dose (MTD), and preliminary efficacy of CWP291 enrolled 69 patients with hematol. malignancies (acute myeloid leukemia [AML], n = 64; myelodysplastic syndrome, n = 5) in 15 dose-escalation cohorts of 4 to 334 mg/m2 using a modified 313 design and 1 doseexpansion cohort.  CWP291 was administered IV daily for 7 days every 21 days.  The most common treatment-emergent adverse events (TEAEs) were nausea (n = 44, 64%), vomiting (n = 32, 46%), diarrhea (n = 25, 36%), and infusion-related reactions (n = 20, 29%).  Grade ≥3 TEAEs in .3 patients (5%) were pneumonia (n = 8, 12%); hypophosphatemia (n = 6, 8%); leukocytosis, nausea, cellulitis, sepsis, and hypokalemia (n = 5 each, 7% each); and hypertension (n = 4, 6%).  Dose-limiting toxicities included nausea (n = 3) and abdominal pain, anaphylactic reaction, myalgia, and rash (n =1, each); theMTD was defined at 257 mg/m2.  CWP232204, the active metabolite of CWP291, showed pharmacokinetic linearity on both days 1 and 7, and a terminal half-life of ~ 12 h.  Among 54 response-evaluable AML patients, there was one complete response at a dose of 153 mg/m2 and one partial response at 198 mg/m2; bone marrow blast percentage reduced from a median of 58.3% to 3.5% and 15.0% to 4.2%, resp.  Future studies will explore CWP291, with a mechanism of action aimed at eradication of earlier progenitors via Wnt pathway blockade, as combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMEiCukmHSA7Vg90H21EOLACvtfcHk0liKnSIfhrdvKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis12ksLnL&md5=d4c7c55918b5547ec94f75dc2ca3c863</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1182%2Fbloodadvances.2019000757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fbloodadvances.2019000757%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFaderl%26aufirst%3DS.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DJung%26aufirst%3DC.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BS.%26aulast%3DPardanani%26aufirst%3DA.%2BD.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26atitle%3DPhase%25201%2520study%2520of%2520CWP232291%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520acute%2520myeloid%2520leukemia%2520and%2520myelodysplastic%2520syndrome%26jtitle%3DBlood%2520Adv.%26date%3D2020%26volume%3D4%26spage%3D2032%26epage%3D2043%26doi%3D10.1182%2Fbloodadvances.2019000757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimgruber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustata
Wilson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monga, S. P.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">2111</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ajpath.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24819961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVarsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=2111-2122&author=E.+R.+Delgadoauthor=J.+Yangauthor=J.+Soauthor=M.+Fantiauthor=S.+Leimgruberauthor=M.+Kahnauthor=T.+Ishitaniauthor=D.+Shinauthor=G.+Mustata%0AWilsonauthor=S.+P.+Monga&title=Identification+and+characterization+of+a+novel+small-molecule+inhibitor+of+%CE%B2-catenin+signaling&doi=10.1016%2Fj.ajpath.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling</span></div><div class="casAuthors">Delgado, Evan R.; Yang, Jing; So, Juhoon; Leimgruber, Stephanie; Kahn, Michael; Ishitani, Tohru; Shin, Donghun; Mustata Wilson, Gabriela; Monga, Satdarshan P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2111-2122</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC), the third most common cause of cancer-related deaths worldwide, lacks effective medical therapy.  Large subsets of HCC demonstrate Wnt/β-catenin activation, making this an attractive therapeutic target.  We report strategy and characterization of a novel small-mol. inhibitor, ICG-001, known to affect Wnt signaling by disrupting β-catenin-CREB binding protein interactions.  We queried the ZINC online database for structural similarity to ICG-001 and identified PMED-1 as the lead compd., with ≥70% similarity to ICG-001.  PMED-1 significantly reduced β-catenin activity in hepatoblastoma and several HCC cells, as detd. by TOPflash reporter assay, with an IC50 ranging from 4.87 to 32 μmol/L.  Although no toxicity was obsd. in primary human hepatocytes, PMED-1 inhibited Wnt target expression in HCC cells, including those with CTNNB1 mutations, and impaired cell proliferation and viability.  PMED-1 treatment decreased β-catenin-CREB binding protein interactions without affecting total β-catenin levels or activity of other common kinases.  PMED-1 treatment of Tg(OTM:d2EGFP) zebrafish expressing GFP under the β-catenin/Tcf reporter led to a notable decrease in β-catenin activity.  The PMED effect on β-catenin signaling lasted from 12 to 24 h in vitro and 6 to 15 h in vivo.  Thus, using a rapid and cost-effective computational methodol., we have identified a novel and specific small-mol. inhibitor of Wnt signaling that may have implications for HCC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeNmAsFM0YbVg90H21EOLACvtfcHk0liKnSIfhrdvKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVarsrrF&md5=c4a237249fe31982d0ec73ed3c40dc1c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DE.%2BR.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSo%26aufirst%3DJ.%26aulast%3DFanti%26aufirst%3DM.%26aulast%3DLeimgruber%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DIshitani%26aufirst%3DT.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DMustata%2BWilson%26aufirst%3DG.%26aulast%3DMonga%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520%25CE%25B2-catenin%2520signaling%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D2111%26epage%3D2122%26doi%3D10.1016%2Fj.ajpath.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frist, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. C.</span></span> <span> </span><span class="NLM_article-title">Selective small molecule targeting beta-catenin function discovered by in vivo chemical genetic screen</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.celrep.2013.07.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24012757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=898-904&author=J.+Haoauthor=A.+Aoauthor=L.+Zhouauthor=C.+K.+Murphyauthor=A.+Y.+Fristauthor=J.+J.+Keelauthor=C.+A.+Thorneauthor=K.+Kimauthor=E.+Leeauthor=C.+C.+Hong&title=Selective+small+molecule+targeting+beta-catenin+function+discovered+by+in+vivo+chemical+genetic+screen&doi=10.1016%2Fj.celrep.2013.07.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Targeting β-Catenin Function Discovered by In Vivo Chemical Genetic Screen</span></div><div class="casAuthors">Hao, Jijun; Ao, Ada; Zhou, Li; Murphy, Clare K.; Frist, Audrey Y.; Keel, Jessica J.; Thorne, Curtis A.; Kim, Kwangho; Lee, Ethan; Hong, Charles C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">898-904</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The canonical Wnt signaling pathway, mediated by the transcription factor β-catenin, plays crit. roles in embryonic development and represents an important therapeutic target.  In a zebrafish-based in vivo screen for small mols. that specifically perturb embryonic dorsoventral patterning, we discovered a compd. named windorphen that selectively blocks the Wnt signal required for ventral development.  Windorphen exhibits remarkable specificity toward β-catenin-1 function, indicating that the two β-catenin isoforms found in zebrafish are not functionally redundant.  We show that windorphen is a selective inhibitor of p300 histone acetyltransferase, a coactivator that assocs. with β-catenin.  Finally, windorphen robustly and selectively kills cancer cells that harbor Wnt-activating mutations, supporting the therapeutic potential of this Wnt inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou1t5KgGNwA7Vg90H21EOLACvtfcHk0liKnSIfhrdvKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisLzE&md5=08159627e7c7bc18e4cd6d56744c46c9</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DAo%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DC.%2BK.%26aulast%3DFrist%26aufirst%3DA.%2BY.%26aulast%3DKeel%26aufirst%3DJ.%2BJ.%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520small%2520molecule%2520targeting%2520beta-catenin%2520function%2520discovered%2520by%2520in%2520vivo%2520chemical%2520genetic%2520screen%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D4%26spage%3D898%26epage%3D904%26doi%3D10.1016%2Fj.celrep.2013.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramps, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nellen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froesch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zullig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, K.</span></span> <span> </span><span class="NLM_article-title">Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(02)00679-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS0092-8674%2802%2900679-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=11955446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=47-60&author=T.+Krampsauthor=O.+Peterauthor=E.+Brunnerauthor=D.+Nellenauthor=B.+Froeschauthor=S.+Chatterjeeauthor=M.+Muroneauthor=S.+Zulligauthor=K.+Basler&title=Wnt%2Fwingless+signaling+requires+BCL9%2Flegless-mediated+recruitment+of+pygopus+to+the+nuclear+beta-catenin-TCF+complex&doi=10.1016%2FS0092-8674%2802%2900679-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/Wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex</span></div><div class="casAuthors">Kramps, Thomas; Peter, Oliver; Brunner, Erich; Nellen, Denise; Froesch, Barbara; Chatterjee, Sandipan; Murone, Maximilien; Zullig, Stephanie; Basler, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Wnt/Wingless signaling controls many fundamental processes during animal development.  Wnt transduction is mediated by the assocn. of β-catenin with nuclear TCF DNA binding factors.  Here we report the identification of 2 segment polarity genes in Drosophila, legless (lgs), and pygopus (pygo), and we show that their products are required for Wnt signal transduction at the level of nuclear β-catenin.  Lgs encodes the homolog of human BCL9, and we provide genetic and mol. evidence that these proteins exert their function by phys. linking Pygo to β-catenin.  Our results suggest that the recruitment of Pygo permits β-catenin to transcriptionally activate Wnt target genes and raise the possibility that a deregulation of these events may play a causal role in the development of B cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfE9xkxx8BY7Vg90H21EOLACvtfcHk0lhGSNShUWFcXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVOntL4%253D&md5=180d88e509dbf21aadf6761e6542b0e2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900679-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900679-7%26sid%3Dliteratum%253Aachs%26aulast%3DKramps%26aufirst%3DT.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DBrunner%26aufirst%3DE.%26aulast%3DNellen%26aufirst%3DD.%26aulast%3DFroesch%26aufirst%3DB.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DMurone%26aufirst%3DM.%26aulast%3DZullig%26aufirst%3DS.%26aulast%3DBasler%26aufirst%3DK.%26atitle%3DWnt%252Fwingless%2520signaling%2520requires%2520BCL9%252Flegless-mediated%2520recruitment%2520of%2520pygopus%2520to%2520the%2520nuclear%2520beta-catenin-TCF%2520complex%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D47%26epage%3D60%26doi%3D10.1016%2FS0092-8674%2802%2900679-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of triazole-stapled BCL9 alpha-helical peptides to target the beta-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1146</span>, <span class="refDoi"> DOI: 10.1021/jm201125d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201125d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1137-1146&author=S.+A.+Kawamotoauthor=A.+Coleskaauthor=X.+Ranauthor=H.+Yiauthor=C.+Y.+Yangauthor=S.+Wang&title=Design+of+triazole-stapled+BCL9+alpha-helical+peptides+to+target+the+beta-catenin%2FB-cell+CLL%2Flymphoma+9+%28BCL9%29+protein-protein+interaction&doi=10.1021%2Fjm201125d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein-Protein Interaction</span></div><div class="casAuthors">Kawamoto, Steven A.; Coleska, Adriana; Ran, Xu; Yi, Han; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1137-1146</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interaction between β-catenin and B-cell CLL/lymphoma 9 (BCL9), crit. for the transcriptional activity of β-catenin, is mediated by a helical segment from BCL9 and a large binding groove in β-catenin.  Design of potent, metabolically stable BCL9 peptides represents an attractive approach to inhibit the activity of β-catenin.  In this study, we report the use of the Huisgen 1,3-dipolar cycloaddn. reaction to generate triazole-stapled BCL9 α-helical peptides.  The high efficiency and mild conditions of this 'click' reaction combined with the ease of synthesis of the necessary unnatural amino acids allows for facile synthesis of triazole-stapled peptides.  We have performed extensive optimization of this approach and identified the optimal combinations of azido and alkynyl linkers necessary for stapling BCL9 helixes.  The unsym. nature of the triazole staple also allowed the synthesis of double-stapled BCL9 peptides, which show a marked increase in helical character and an improvement in binding affinity and metabolic stability relative to wild-type and linear BCL9 peptides.  This study lays the foundation for further optimization of these triazole-stapled BCL9 peptides as potent, metabolically stable, and cell-permeable inhibitors to target the β-catenin and BCL9 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf88hHn2HxybVg90H21EOLACvtfcHk0lhGSNShUWFcXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfL&md5=d0ab7aaf4074398402ae5f8b004a481b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm201125d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201125d%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DS.%2BA.%26aulast%3DColeska%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520triazole-stapled%2520BCL9%2520alpha-helical%2520peptides%2520to%2520target%2520the%2520beta-catenin%252FB-cell%2520CLL%252Flymphoma%25209%2520%2528BCL9%2529%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1137%26epage%3D1146%26doi%3D10.1021%2Fjm201125d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulciniti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">148ra117</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscitranslmed.3003808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22914623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=148ra117&author=K.+Takadaauthor=D.+Zhuauthor=G.+H.+Birdauthor=K.+Sukhdeoauthor=J.+J.+Zhaoauthor=M.+Maniauthor=M.+Lemieuxauthor=D.+E.+Carrascoauthor=J.+Ryanauthor=D.+Horstauthor=M.+Fulcinitiauthor=N.+C.+Munshiauthor=W.+Xuauthor=A.+L.+Kungauthor=R.+A.+Shivdasaniauthor=L.+D.+Walenskyauthor=D.+R.+Carrasco&title=Targeted+disruption+of+the+BCL9%2F%CE%B2-catenin+complex+inhibits+oncogenic+Wnt+signaling&doi=10.1126%2Fscitranslmed.3003808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003808%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DHorst%26aufirst%3DD.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252F%25CE%25B2-catenin%2520complex%2520inhibits%2520oncogenic%2520Wnt%2520signaling%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D148ra117%26doi%3D10.1126%2Fscitranslmed.3003808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of beta-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">eaau5240</span>, <span class="refDoi"> DOI: 10.1126/sciadv.aau5240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fsciadv.aau5240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31086813" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=eaau5240&author=M.+Fengauthor=J.+Q.+Jinauthor=L.+Xiaauthor=T.+Xiaoauthor=S.+Meiauthor=X.+Wangauthor=X.+Huangauthor=J.+Chenauthor=M.+Liuauthor=C.+Chenauthor=S.+Rafiauthor=A.+X.+Zhuauthor=Y.+X.+Fengauthor=D.+Zhu&title=Pharmacological+inhibition+of+beta-catenin%2FBCL9+interaction+overcomes+resistance+to+immune+checkpoint+blockades+by+modulating+Treg+cells&doi=10.1126%2Fsciadv.aau5240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aau5240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aau5240%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%2BQ.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DRafi%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DFeng%26aufirst%3DY.%2BX.%26aulast%3DZhu%26aufirst%3DD.%26atitle%3DPharmacological%2520inhibition%2520of%2520beta-catenin%252FBCL9%2520interaction%2520overcomes%2520resistance%2520to%2520immune%2520checkpoint%2520blockades%2520by%2520modulating%2520Treg%2520cells%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26spage%3Deaau5240%26doi%3D10.1126%2Fsciadv.aau5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/beta-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide</span>. <i>Nanotechnology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">115102</span>, <span class="refDoi"> DOI: 10.1088/1361-6528/ab5a03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1088%2F1361-6528%2Fab5a03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31751960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWnurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=115102&author=G.+Yangauthor=J.+Zhangauthor=W.+Youauthor=X.+Zhaoauthor=P.+Houauthor=W.+Heauthor=J.+Yanauthor=H.+Guo&title=Targeted+disruption+of+the+BCL9%2Fbeta-catenin+interaction+by+endosomal-escapable+nanoparticles+functionalized+with+an+E-cadherin-derived+peptide&doi=10.1088%2F1361-6528%2Fab5a03"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the BCL9/β-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide</span></div><div class="casAuthors">Yang, Guang; Zhang, Jun; You, Weiming; Zhao, Xinhan; Hou, Peng; He, Wangxiao; Yan, Jin; Guo, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Nanotechnology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">115102</span>CODEN:
                <span class="NLM_cas:coden">NNOTER</span>;
        ISSN:<span class="NLM_cas:issn">1361-6528</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">Abnormal activation of the Wnt/β-catenin signaling pathway, which underlies multiple malignancies, promotes tumor progression; drugs that can block this pathway are therefore highly attractive candidates for anticancer therapy.  Using a therapeutic peptide derived from E-cadherin region V (cECRV), we sought to develop a potent and selective antagonist of β-catenin that can disrupt the carcinogenic interaction between β-catenin and BCL9.  More importantly, to overcome the pharmacol. obstacles of peptide-derived therapeutics (poor nuclease stability and low membrane permeability), a gold nanoparticle (AuNP)-based nanocarrier was designed to deliver cECRV into the cytoplasm to modulate the intracellular interaction of β-catenin and BCL9.  The resultant nanoparticle, pAuNP-cECRV, showed no cytotoxicity towards normal peripheral blood mononuclear cells and induced cycle arrest and subsequent apoptosis of Wnt-hyperactive cancer cells by antagonizing β-catenin to inhibit the Wnt pathway.  Our results indicate that pAuNP-cECRV is very promising for application as an efficient and safe peptide delivery vector for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2l26o_E5ZcLVg90H21EOLACvtfcHk0lhHcR_ssW59iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWnurvP&md5=fc5c979a3be3ac0a9405a927f9c9a1f8</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1088%2F1361-6528%2Fab5a03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1361-6528%252Fab5a03%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHou%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252Fbeta-catenin%2520interaction%2520by%2520endosomal-escapable%2520nanoparticles%2520functionalized%2520with%2520an%2520E-cadherin-derived%2520peptide%26jtitle%3DNanotechnology%26date%3D2020%26volume%3D31%26spage%3D115102%26doi%3D10.1088%2F1361-6528%2Fab5a03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkadir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of β-catenin/B cell lymphoma 9 protein–protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">10757</span>– <span class="NLM_lpage">10762</span>, <span class="refDoi"> DOI: 10.1073/pnas.1819663116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1819663116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31088961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVChsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=10757-10762&author=P.+Sangauthor=M.+Zhangauthor=Y.+Shiauthor=C.+Liauthor=S.+Abdulkadirauthor=Q.+Liauthor=H.+Jiauthor=J.+Cai&title=Inhibition+of+%CE%B2-catenin%2FB+cell+lymphoma+9+protein%E2%80%93protein+interaction+using+%CE%B1-helix-mimicking+sulfono-%CE%B3-AApeptide+inhibitors&doi=10.1073%2Fpnas.1819663116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors</span></div><div class="casAuthors">Sang, Peng; Zhang, Min; Shi, Yan; Li, Chunpu; Abdulkadir, Sami; Li, Qi; Ji, Haitao; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10757-10762</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The rational design of α-helix-mimicking peptidomimetics provides a streamlined approach to discover potent inhibitors for protein-protein interactions (PPIs).  However, designing cell-penetrating long peptidomimetic scaffolds equipped with various functional groups necessary for interacting with large protein-binding interfaces remains challenging.  This is particularly true for targeting β-catenin/BCL9 PPIs.  Here the authors designed a series of unprecedented helical sulfono-γ-AApeptides that mimic the binding mode of the α-helical HD2 domain of B Cell Lymphoma 9 (BCL9).  The studies show that sulfono-γ-AApeptides can structurally and functionally mimic the α-helical domain of BCL9 and selectively disrupt β-catenin/BCL9 PPIs with even higher potency.  More intriguingly, these sulfono-γ-AApeptides can enter cancer cells, bind with β-catenin and disrupt β-catenin/BCL9 PPIs, and exhibit excellent cellular activity, which is much more potent than the BCL9 peptide.  Furthermore, the enzymic stability studies demonstrate the remarkable stability of the helical sulfono-γ-AApeptides, with no degrdn. in the presence of pronase for 24 h, augmenting their biol. potential.  This work represents not only an example of helical sulfono-γ-AApeptides that mimic α-helix and disrupt protein-protein interactions, but also an excellent example of potent, selective, and cell-permeable unnatural foldameric peptidomimetics that disrupt the β-catenin/BCL9 PPI.  The design of helical sulfono-γ-AApeptides may lead to a new strategy to modulate a myriad of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_pKlgpb-_U7Vg90H21EOLACvtfcHk0lgmi3YsPDi56g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVChsr%252FE&md5=145172aa8475bfe4a20b97d6b88d12dd</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1819663116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1819663116%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DAbdulkadir%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520%25CE%25B2-catenin%252FB%2520cell%2520lymphoma%25209%2520protein%25E2%2580%2593protein%2520interaction%2520using%2520%25CE%25B1-helix-mimicking%2520sulfono-%25CE%25B3-AApeptide%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D10757%26epage%3D10762%26doi%3D10.1073%2Fpnas.1819663116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoggard, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of selective small-molecule inhibitors for beta-catenin/B-cell lymphoma 9 protein-protein interactions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">12249</span>– <span class="NLM_lpage">12260</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b04988</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b04988" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=12249-12260&author=L.+R.+Hoggardauthor=Y.+Zhangauthor=M.+Zhangauthor=V.+Panicauthor=J.+A.+Wisniewskiauthor=H.+Ji&title=Rational+design+of+selective+small-molecule+inhibitors+for+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interactions&doi=10.1021%2Fjacs.5b04988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Selective Small-Molecule Inhibitors for β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interactions</span></div><div class="casAuthors">Hoggard, Logan R.; Zhang, Yongqiang; Zhang, Min; Panic, Vanja; Wisniewski, John A.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12249-12260</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of α-helix-mediated protein-protein interactions (PPIs) with small org. mols. provides great potential for the discovery of chem. probes and therapeutic agents.  Protein Data Bank data mining using the HippDB database indicated that (1) the side chains of hydrophobic projecting hot spots at positions i, i + 3, and i + 7 of an α-helix had few orientations when interacting with the second protein and (2) the hot spot pockets of PPI complexes had different sizes, shapes, and chem. groups when interacting with the same hydrophobic projecting hot spots of α-helix.  On the basis of these observations, a small org. mol., 4'-fluoro-N-phenyl-[1,1'-biphenyl]-3-carboxamide, was designed as a generic scaffold that itself directly mimics the binding mode of the side chains of hydrophobic projecting hot spots at positions i, i + 3, and i + 7 of an α-helix.  Convenient decoration of this generic scaffold led to the selective disruption of α-helix-mediated PPIs.  A series of small-mol. inhibitors, e.g. I, selective for β-catenin/B-cell lymphoma 9 (BCL9) over β-catenin/cadherin PPIs was designed and synthesized.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This new class of inhibitors can selectively disrupt β-catenin/BCL9 over β-catenin/cadherin PPIs, suppress the transactivation of canonical Wnt signaling, downregulate the expression of Wnt target genes, and inhibit the growth of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-evFFAIdibVg90H21EOLACvtfcHk0lgmi3YsPDi56g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7jI&md5=37b926ed7c76fbd010394cae8bb54d43</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b04988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b04988%26sid%3Dliteratum%253Aachs%26aulast%3DHoggard%26aufirst%3DL.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DPanic%26aufirst%3DV.%26aulast%3DWisniewski%26aufirst%3DJ.%2BA.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D12249%26epage%3D12260%26doi%3D10.1021%2Fjacs.5b04988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of 1,4-dibenzoylpiperazines as beta-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00284</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00284" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=508-513&author=J.+A.+Wisniewskiauthor=J.+Yinauthor=K.+B.+Teuscherauthor=M.+Zhangauthor=H.+Ji&title=Structure-based+design+of+1%2C4-dibenzoylpiperazines+as+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors</span></div><div class="casAuthors">Wisniewski, John A.; Yin, Jinya; Teuscher, Kevin B.; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small-mol. inhibitor with a 1,4-dibenzoylpiperazine scaffold was designed to match the crit. binding elements in the β-catenin/B-cell lymphoma 9 (BCL9) protein-protein interaction interface.  Inhibitor optimization led to a potent inhibitor that can disrupt the β-catenin/BCL9 interaction and exhibit 98-fold selectivity over the β-catenin/cadherin interaction.  The binding mode of new inhibitors was characterized by structure-activity relationships and site-directed mutagenesis studies.  Cell-based studies demonstrated that this series of inhibitors can selectively suppress canonical Wnt signaling and inhibit growth of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsn0fnki55DrVg90H21EOLACvtfcHk0lgrK25Ag2k2rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrsrc%253D&md5=9e4e1a892bdd6221b9775235fb84231b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00284%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewski%26aufirst%3DJ.%2BA.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DTeuscher%26aufirst%3DK.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%25201%252C4-dibenzoylpiperazines%2520as%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D508%26epage%3D513%26doi%3D10.1021%2Facsmedchemlett.5b00284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of small-molecule inhibitors for the beta-catenin/B-cell lymphoma 9 protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3007</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls12kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2989-3007&author=M.+Zhangauthor=Z.+Wangauthor=Y.+Zhangauthor=W.+Guoauthor=H.+Ji&title=Structure-based+optimization+of+small-molecule+inhibitors+for+the+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interaction&doi=10.1021%2Facs.jmedchem.8b00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction</span></div><div class="casAuthors">Zhang, Min; Wang, Zhen; Zhang, Yongqiang; Guo, Wenxing; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3007</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based optimization was conducted to improve the potency, selectivity, and cell-based activities of β-catenin/B-cell lymphoma 9 (BCL9) inhibitors based on the 4'-fluoro-N-phenyl-[1,1'-biphenyl]-3-carboxamide scaffold, which was designed to mimic the side chains of the hydrophobic α-helical hot spots at positions i, i + 3, and i + 7.  Compd. I was found to disrupt the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.47 μM and >1900-fold selectivity for β-catenin/BCL9 over β-catenin/E-cadherin PPIs.  The proposed binding mode of new inhibitors was consistent with the results of site-directed mutagenesis and structure-activity relationship studies.  Cell-based studies indicated that I disrupted the β-catenin/BCL9 interaction without affecting the β-catenin/E-cadherin interaction, selectively suppressed transactivation of Wnt/β-catenin signaling, downregulated expression of Wnt target genes, and inhibited viability of Wnt/β-catenin-dependent cancer cells in dose-dependent manners.  A comparison of the biochem. and cell-based assay results offered the directions for future inhibitor optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjKijQp_D7qLVg90H21EOLACvtfcHk0lgrK25Ag2k2rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls12kurg%253D&md5=11d6f311eb3ef90c8749c8440335bf71</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00068%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DStructure-based%2520optimization%2520of%2520small-molecule%2520inhibitors%2520for%2520the%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2989%26epage%3D3007%26doi%3D10.1021%2Facs.jmedchem.8b00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burzio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, J. E.</span></span> <span> </span><span class="NLM_article-title">Biochemical and cellular characteristics of the four splice variants of protein kinase CK1alpha from zebrafish (Danio rerio)</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1002/jcb.10263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fjcb.10263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12210746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=805-814&author=V.+Burzioauthor=M.+Antonelliauthor=C.+C.+Allendeauthor=J.+E.+Allende&title=Biochemical+and+cellular+characteristics+of+the+four+splice+variants+of+protein+kinase+CK1alpha+from+zebrafish+%28Danio+rerio%29&doi=10.1002%2Fjcb.10263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and cellular characteristics of the four splice variants of protein kinase CK1α from zebrafish (Danio rerio)</span></div><div class="casAuthors">Burzio, Veronica; Antonelli, Marcelo; Allende, Catherine C.; Allende, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">805-814</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Protein kinase CK1 (previously known as casein kinase 1) conforms to a subgroup of the great protein kinase family found in eukaryotic organisms.  The CK1 subgroup of vertebrates contains seven members known as α, β, γ1, γ2, γ3, δ, and ε.  The CK1α gene can generate four variants (CK1α, CK1αS, CK1αL, and CK1αLS) through alternate splicing, characterized by the presence or absence of two addnl. coding sequences.  Exon "L" encodes a 28-amino acid stretch that is inserted after lysine 152, in the center of the catalytic domain.  The "S" insert encodes 12 amino acid residues and is located close to the C-terminus of the protein.  This work reports some biochem. and cellular properties of the four CK1α variants found to be expressed in zebrafish (Danio rerio).  The results obtained indicate that the presence of the "L" insert affects several biochem. properties of CK1α: (a) it increases the apparent Km for ATP twofold, from ∼30 to ∼60 μM; (b) it decreases the sensitivity to the CK1-7 inhibitor, raising the IC50 values from 113 to ∼230 μM; (c) it greatly decreases the heat stability of the enzyme at 40°.  In addn., the insertion of the "L" fragment exerts very important effects on some cellular properties of the enzyme.  CK1αL concs. in the cell nucleus, excluding nucleoli, while the CK1α variant is predominantly cytoplasmic, although some presence is obsd. in the nucleus.  This finding supports the thesis that the basic-rich region found in the "L" insert acts as a nuclear localization signal.  The "L" insert-contg. variant was also found to be more rapidly degraded (half-life of 100 min) than the CK1α variant (half-life of 400 min) in transfected Cos-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZODmQyffCtLVg90H21EOLACvtfcHk0lheAWa0dGxLqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOhurc%253D&md5=5d0d712d8e53e8c4b7702799e363d685</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fjcb.10263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.10263%26sid%3Dliteratum%253Aachs%26aulast%3DBurzio%26aufirst%3DV.%26aulast%3DAntonelli%26aufirst%3DM.%26aulast%3DAllende%26aufirst%3DC.%2BC.%26aulast%3DAllende%26aufirst%3DJ.%2BE.%26atitle%3DBiochemical%2520and%2520cellular%2520characteristics%2520of%2520the%2520four%2520splice%2520variants%2520of%2520protein%2520kinase%2520CK1alpha%2520from%2520zebrafish%2520%2528Danio%2520rerio%2529%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2002%26volume%3D86%26spage%3D805%26epage%3D814%26doi%3D10.1002%2Fjcb.10263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knippschild, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Reyes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peifer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halekotte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischof, J.</span></span> <span> </span><span class="NLM_article-title">The CK1 family: contribution to cellular stress response and its role in carcinogenesis</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fonc.2014.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffonc.2014.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24904820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=96&author=U.+Knippschildauthor=M.+Kr%C3%BCgerauthor=J.+Richterauthor=P.+Xuauthor=B.+Garc%C3%ADa-Reyesauthor=C.+Peiferauthor=J.+Halekotteauthor=V.+Bakulevauthor=J.+Bischof&title=The+CK1+family%3A+contribution+to+cellular+stress+response+and+its+role+in+carcinogenesis&doi=10.3389%2Ffonc.2014.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis</span></div><div class="casAuthors">Knippschild Uwe; Kruger Marc; Richter Julia; Xu Pengfei; Garcia-Reyes Balbina; Bischof Joachim; Peifer Christian; Halekotte Jakob; Bakulev Vasiliy</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Members of the highly conserved and ubiquitously expressed pleiotropic CK1 family play major regulatory roles in many cellular processes including DNA-processing and repair, proliferation, cytoskeleton dynamics, vesicular trafficking, apoptosis, and cell differentiation.  As a consequence of cellular stress conditions, interaction of CK1 with the mitotic spindle is manifold increased pointing to regulatory functions at the mitotic checkpoint.  Furthermore, CK1 is able to alter the activity of key proteins in signal transduction and signal integration molecules.  In line with this notion, CK1 is tightly connected to the regulation and degradation of β-catenin, p53, and MDM2.  Considering the importance of CK1 for accurate cell division and regulation of tumor suppressor functions, it is not surprising that mutations and alterations in the expression and/or activity of CK1 isoforms are often detected in various tumor entities including cancer of the kidney, choriocarcinomas, breast carcinomas, oral cancer, adenocarcinomas of the pancreas, and ovarian cancer.  Therefore, scientific effort has enormously increased (i) to understand the regulation of CK1 and its involvement in tumorigenesis- and tumor progression-related signal transduction pathways and (ii) to develop CK1-specific inhibitors for the use in personalized therapy concepts.  In this review, we summarize the current knowledge regarding CK1 regulation, function, and interaction with cellular proteins playing central roles in cellular stress-responses and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTjHiOSmRmv6BottYdIAWfW6udTcc2ea2UoBNJIORU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFOmtw%253D%253D&md5=bb32cb676ab1dd0ba2ae290a282e4042</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00096%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DKr%25C3%25BCger%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Reyes%26aufirst%3DB.%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DHalekotte%26aufirst%3DJ.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DBischof%26aufirst%3DJ.%26atitle%3DThe%2520CK1%2520family%253A%2520contribution%2520to%2520cellular%2520stress%2520response%2520and%2520its%2520role%2520in%2520carcinogenesis%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D96%26doi%3D10.3389%2Ffonc.2014.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. A.</span></span> <span> </span><span class="NLM_article-title">CKI, there’s more than one: casein kinase I family members in Wnt and Hedgehog signaling</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1101/gad.1394306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1101%2Fgad.1394306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16481469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=399-410&author=M.+A.+Price&title=CKI%2C+there%E2%80%99s+more+than+one%3A+casein+kinase+I+family+members+in+Wnt+and+Hedgehog+signaling&doi=10.1101%2Fgad.1394306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling</span></div><div class="casAuthors">Price, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">399-410</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Multiple members of the casein kinase I family of serine/threonine protein kinases are involved in pos. and neg. roles in Wnt and Hedgehog signaling.  Here authors review these roles, including recent results on casein kinase I (CKI) phosphorylation and activation of LRP6, and CKI phosphorylation of Ci and mediation of Ci-Slimb/β-TrCP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL3VS0330bDLVg90H21EOLACvtfcHk0lhaS-iN9_PCsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqurg%253D&md5=31844a6a74863b7de9329c47e1ed40c4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1101%2Fgad.1394306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1394306%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3DCKI%252C%2520there%25E2%2580%2599s%2520more%2520than%2520one%253A%2520casein%2520kinase%2520I%2520family%2520members%2520in%2520Wnt%2520and%2520Hedgehog%2520signaling%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D399%26epage%3D410%26doi%3D10.1101%2Fgad.1394306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, N T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhoeve, P M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D M</span></span> <span> </span><span class="NLM_article-title">IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1delta/varepsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2569</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2010.627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21258417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2558-2569&author=J+K+Cheongauthor=N+T+Hungauthor=H+Wangauthor=P+Tanauthor=P+M+Voorhoeveauthor=S+H+Leeauthor=D+M+Virshup&title=IC261+induces+cell+cycle+arrest+and+apoptosis+of+human+cancer+cells+via+CK1delta%2Fvarepsilon+and+Wnt%2Fbeta-catenin+independent+inhibition+of+mitotic+spindle+formation&doi=10.1038%2Fonc.2010.627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/.vepsiln. and Wnt/β-catenin independent inhibition of mitotic spindle formation</span></div><div class="casAuthors">Cheong, J.-K.; Hung, N.-T.; Wang, H.; Tan, P.; Voorhoeve, P. M.; Lee, S.-H.; Virshup, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2558-2569</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Casein kinase 1 delta and epsilon (CK1δ/.vepsiln.) are key regulators of diverse cellular growth and survival processes including Wnt signaling, DNA repair, and circadian rhythms.  Recent studies suggest that they have an important role in oncogenesis.  RNA interference screens identified CK1.vepsiln. as a pro-survival factor in cancer cells in vitro and the CK1δ/.vepsiln.-specific inhibitor IC261 is remarkably effective at selective, synthetic lethal killing of cancer cells.  The recent development of the nanomolar CK1δ/.vepsiln.-selective inhibitor, PF670462 (PF670) and the CK1.vepsiln.-selective inhibitor PF4800567 (PF480) offers an opportunity to further test the role of CK1δ/.vepsiln. in cancer.  Unexpectedly, and unlike IC261, PF670, and PF480 were unable to induce cancer cell death.  PF670 is a potent inhibitor of CK1δ/.vepsiln. in cells; nanomolar concns. are sufficient to inhibit CK1δ/.vepsiln. activity as measured by repression of intramol. autophosphorylation, phosphorylation of disheveled2 proteins and Wnt/β-catenin signaling.  Likewise, small interfering RNA knockdown of CK1δ and CK1.vepsiln. reduced Wnt/β-catenin signaling without affecting cell viability, further suggesting that CK1δ/.vepsiln. inhibition may not be relevant to the IC261-induced cell death.  Thus, while PF670 is a potent inhibitor of Wnt signaling, it only modestly inhibits cell proliferation.  In contrast, while sub-micromolar concns. of IC261 neither inhibited CK1δ/.vepsiln. kinase activity nor blocked Wnt/β-catenin signaling in cancer cells, it caused a rapid induction of prometaphase arrest and subsequent apoptosis in multiple cancer cell lines.  In a stepwise transformation model, IC261-induced killing required both overactive Ras and inactive p53.  IC261 binds to tubulin with an affinity similar to colchicine and is a potent inhibitor of microtubule polymn.  This activity accounts for many of the diverse biol. effects of IC261 and, most importantly, for its selective cancer cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2-oBoBuERhLVg90H21EOLACvtfcHk0lhaS-iN9_PCsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1aiug%253D%253D&md5=c4e1582494dfbfd3fce5084dd5864d41</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.627%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DJ%2BK%26aulast%3DHung%26aufirst%3DN%2BT%26aulast%3DWang%26aufirst%3DH%26aulast%3DTan%26aufirst%3DP%26aulast%3DVoorhoeve%26aufirst%3DP%2BM%26aulast%3DLee%26aufirst%3DS%2BH%26aulast%3DVirshup%26aufirst%3DD%2BM%26atitle%3DIC261%2520induces%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520of%2520human%2520cancer%2520cells%2520via%2520CK1delta%252Fvarepsilon%2520and%2520Wnt%252Fbeta-catenin%2520independent%2520inhibition%2520of%2520mitotic%2520spindle%2520formation%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2558%26epage%3D2569%26doi%3D10.1038%2Fonc.2010.627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. M.</span></span> <span> </span><span class="NLM_article-title">Casein kinase I transduces Wnt signals</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1038/43830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F43830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10517632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFalsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=345-350&author=J.+M.+Petersauthor=R.+M.+McKayauthor=J.+P.+McKayauthor=J.+M.+Graff&title=Casein+kinase+I+transduces+Wnt+signals&doi=10.1038%2F43830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase I transduces Wnt signals</span></div><div class="casAuthors">Peters, John M.; McKay, Renee M.; McKay, James P.; Graff, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6751</span>),
    <span class="NLM_cas:pages">345-350</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We describe a serine kinase, casein kinase I (CKI), which was isolated by expression cloning in Xenopus embryos.  CKI reproduces several properties of Wnt signals, including generation of complete dorsal axes, stabilization of β-catenin, and induction of genes that are direct targets of Wnt signals.  Dominant-neg. forms of CKI and a pharmacol. blocker of CKI inhibited Wnt signals in Xenopus.  Inhibiting CKI in Caenorhabditis elegans generated worms with a mom phenotype, indicative of a loss of Wnt signals.  In addn., CKI bound to and increased the phosphorylation of dishevelled, a known component of the Wnt pathway.  These data indicate that CKI may be a conserved component of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6A1qcH4qY6rVg90H21EOLACvtfcHk0liqc5_e76iHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFalsbg%253D&md5=94c19810e000cc6432bf74f8ab019c96</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2F43830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43830%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DMcKay%26aufirst%3DR.%2BM.%26aulast%3DMcKay%26aufirst%3DJ.%2BP.%26aulast%3DGraff%26aufirst%3DJ.%2BM.%26atitle%3DCasein%2520kinase%2520I%2520transduces%2520Wnt%2520signals%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D345%26epage%3D350%26doi%3D10.1038%2F43830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+Wnt+signaling+through+activation+of+casein+kinase+1alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0liqc5_e76iHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520Wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neitzel, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkbride, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doundoulakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreu, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Differential abundance of CK1alpha provides selectivity for pharmacological CK1alpha activators to target WNT-dependent tumors</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">eaak9916</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aak9916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscisignal.aak9916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28655862" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=eaak9916&author=B.+Liauthor=D.+Ortonauthor=L.+R.+Neitzelauthor=L.+Astudilloauthor=C.+Shenauthor=J.+Longauthor=X.+Chenauthor=K.+C.+Kirkbrideauthor=T.+Doundoulakisauthor=M.+L.+Guerraauthor=J.+Zaiasauthor=D.+L.+Feiauthor=J.+Rodriguez-Blancoauthor=C.+Thorneauthor=Z.+Wangauthor=K.+Jinauthor=D.+M.+Nguyenauthor=L.+R.+Sandsauthor=F.+Marchettiauthor=M.+T.+Abreuauthor=M.+H.+Cobbauthor=A.+J.+Capobiancoauthor=E.+Leeauthor=D.+J.+Robbins&title=Differential+abundance+of+CK1alpha+provides+selectivity+for+pharmacological+CK1alpha+activators+to+target+WNT-dependent+tumors&doi=10.1126%2Fscisignal.aak9916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aak9916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aak9916%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DNeitzel%26aufirst%3DL.%2BR.%26aulast%3DAstudillo%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKirkbride%26aufirst%3DK.%2BC.%26aulast%3DDoundoulakis%26aufirst%3DT.%26aulast%3DGuerra%26aufirst%3DM.%2BL.%26aulast%3DZaias%26aufirst%3DJ.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DThorne%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DSands%26aufirst%3DL.%2BR.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DAbreu%26aufirst%3DM.%2BT.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DDifferential%2520abundance%2520of%2520CK1alpha%2520provides%2520selectivity%2520for%2520pharmacological%2520CK1alpha%2520activators%2520to%2520target%2520WNT-dependent%2520tumors%26jtitle%3DSci.%2520Signaling%26date%3D2017%26volume%3D10%26spage%3Deaak9916%26doi%3D10.1126%2Fscisignal.aak9916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaim, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleveland, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Development of highly selective casein kinase 1delta/1epsilon (CK1delta/epsilon) inhibitors with potent antiproliferative properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4374</span>– <span class="NLM_lpage">4380</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmcl.2013.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23787102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4374-4380&author=M.+Bibianauthor=R.+J.+Rahaimauthor=J.+Y.+Choiauthor=Y.+Noguchiauthor=S.+Schurerauthor=W.+Chenauthor=S.+Nakanishiauthor=K.+Lichtauthor=L.+H.+Rosenbergauthor=L.+Liauthor=Y.+Fengauthor=M.+D.+Cameronauthor=D.+R.+Duckettauthor=J.+L.+Clevelandauthor=W.+R.+Roush&title=Development+of+highly+selective+casein+kinase+1delta%2F1epsilon+%28CK1delta%2Fepsilon%29+inhibitors+with+potent+antiproliferative+properties&doi=10.1016%2Fj.bmcl.2013.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties</span></div><div class="casAuthors">Bibian, Mathieu; Rahaim, Ronald J.; Choi, Jun Yong; Noguchi, Yoshihiko; Schurer, Stephan; Chen, Weimin; Nakanishi, Shima; Licht, Konstantin; Rosenberg, Laura H.; Li, Lin; Feng, Yangbo; Cameron, Michael D.; Duckett, Derek R.; Cleveland, John L.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4374-4380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of a series of potent and highly selective casein kinase 1δ/ε (CK1δ/ε) inhibitors is described.  Starting from a purine scaffold inhibitor (SR-653234) identified by high throughput screening, the authors developed a series of potent and highly kinase selective inhibitors, including SR-2890 and SR-3029, which have IC50 ≤ 50 nM vs. CK1δ.  The two lead compds. have ≤100 nM EC50 values in MTT assays against the human A375 melanoma cell line and have phys., in vitro and in vivo PK properties suitable for use in proof of principle animal xenograft studies against human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4EwGWzCSXbVg90H21EOLACvtfcHk0lh7ZTrFtzHZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGitLo%253D&md5=b9e2f0685bede426f981301cbe87dd7b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DRahaim%26aufirst%3DR.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DSchurer%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DLicht%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DDevelopment%2520of%2520highly%2520selective%2520casein%2520kinase%25201delta%252F1epsilon%2520%2528CK1delta%252Fepsilon%2529%2520inhibitors%2520with%2520potent%2520antiproliferative%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4374%26epage%3D4380%26doi%3D10.1016%2Fj.bmcl.2013.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafitte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quereda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallahi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleveland, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of casein kinase 1delta in breast cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">318ra202</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aac8773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscitranslmed.aac8773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26676609" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=318ra202&author=L.+H.+Rosenbergauthor=M.+Lafitteauthor=V.+Queredaauthor=W.+Grantauthor=W.+Chenauthor=M.+Bibianauthor=Y.+Noguchiauthor=M.+Fallahiauthor=C.+Yangauthor=J.+C.+Changauthor=W.+R.+Roushauthor=J.+L.+Clevelandauthor=D.+R.+Duckett&title=Therapeutic+targeting+of+casein+kinase+1delta+in+breast+cancer&doi=10.1126%2Fscitranslmed.aac8773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aac8773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aac8773%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DL.%2BH.%26aulast%3DLafitte%26aufirst%3DM.%26aulast%3DQuereda%26aufirst%3DV.%26aulast%3DGrant%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DFallahi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520casein%2520kinase%25201delta%2520in%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D318ra202%26doi%3D10.1126%2Fscitranslmed.aac8773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span> <span> </span><span class="NLM_article-title">Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">18394</span>– <span class="NLM_lpage">18400</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601112200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M601112200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16672224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVagsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=18394-18400&author=Y.+Gaoauthor=H.+Y.+Wang&title=Casein+kinase+2+Is+activated+and+essential+for+Wnt%2Fbeta-catenin+signaling&doi=10.1074%2Fjbc.M601112200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Casein Kinase 2 Is Activated and Essential for Wnt/β-Catenin Signaling</span></div><div class="casAuthors">Gao, Yuan; Wang, Hsien-yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18394-18400</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is essential to early development.  Activation of Frizzled-1 by Wnts induces nuclear accumulation of β-catenin and activation of Lef/Tcf-dependent gene expression.  Casein kinase 2 has been shown to affect Wnt/β-catenin signaling.  How casein kinase 2 exerts an influence in Wnt signaling is not clear; casein kinase 2 has been reported to be constitutively active (i.e. not regulated).  Herein we show to the contrary that casein kinase 2 activity is rapidly and transiently increased in response to Wnt3a stimulation and is essential for Wnt/β-catenin signaling.  Chem. inhibition of casein kinase 2 or suppression of its expression blocks Frizzled-1 activation of Lef/Tcf-sensitive gene expression.  Treatment with pertussis toxin or knock down of Gαq or Gαo blocks Wnt stimulation of casein kinase 2 activation, as does suppression of the phosphoprotein Dishevelled, demonstrating that casein kinase 2 is downstream of heterotrimeric G proteins and Dishevelled.  Expression of a constitutively active mutant of either Gαq or Gαo stimulates casein kinase 2 activation and Lef/Tcf-sensitive gene expression.  Thus, casein kinase 2 is shown to be regulated by Wnt3a and essential to stimulation of the Frizzled-1/β-catenin/Lef-Tcf pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVEwpTgwH-7Vg90H21EOLACvtfcHk0lihb0gUzter1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVagsbc%253D&md5=31abb9123eaebaca5510424d40cb77b2</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601112200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601112200%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%2BY.%26atitle%3DCasein%2520kinase%25202%2520Is%2520activated%2520and%2520essential%2520for%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D18394%26epage%3D18400%26doi%3D10.1074%2Fjbc.M601112200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racicot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, E.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibitors of CK2 kinase identified through structure-guided hybridization</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1021/ml200257n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200257n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=278-283&author=J.+E.+Dowlingauthor=C.+Chuaquiauthor=T.+W.+Pontzauthor=P.+D.+Lyneauthor=N.+A.+Larsenauthor=M.+H.+Blockauthor=H.+Chenauthor=N.+Suauthor=A.+Wuauthor=D.+Russellauthor=H.+Pollardauthor=J.+W.+Leeauthor=B.+Pengauthor=K.+Thakurauthor=Q.+Yeauthor=T.+Zhangauthor=P.+Brassilauthor=V.+Racicotauthor=L.+Baoauthor=C.+R.+Denzauthor=E.+Cooke&title=Potent+and+selective+inhibitors+of+CK2+kinase+identified+through+structure-guided+hybridization&doi=10.1021%2Fml200257n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization</span></div><div class="casAuthors">Dowling, James E.; Chuaqui, Claudio; Pontz, Timothy W.; Lyne, Paul D.; Larsen, Nicholas A.; Block, Michael H.; Chen, Huawei; Su, Nancy; Wu, Allan; Russell, Daniel; Pollard, Hannah; Lee, John W.; Peng, Bo; Thakur, Kumar; Ye, Qing; Zhang, Tao; Brassil, Patrick; Racicot, Vicki; Bao, Larry; Denz, Christopher R.; Cooke, Emma</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we describe a series of 3-cyano-5-aryl-7-aminopyrazolo[1,5-a]pyrimidine hits identified by kinase-focused subset screening as starting points for the structure-based design of conformationally constrained 6-acetamido-indole inhibitors of CK2.  The synthesis, SAR, and effects of this novel series on Akt signaling and cell proliferation in vitro are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KiKEaopMGLVg90H21EOLACvtfcHk0lihb0gUzter1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFems7k%253D&md5=4220eac03a382c3e6849da723fd5fc6d</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fml200257n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200257n%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DPontz%26aufirst%3DT.%2BW.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DThakur%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DRacicot%26aufirst%3DV.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DCooke%26aufirst%3DE.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520CK2%2520kinase%2520identified%2520through%2520structure-guided%2520hybridization%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D278%26epage%3D283%26doi%3D10.1021%2Fml200257n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimzhanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span> <span> </span><span class="NLM_article-title">Potent and selective CK2 kinase inhibitors with effects on Wnt pathway signaling in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=300-305&author=J.+E.+Dowlingauthor=M.+Alimzhanovauthor=L.+Baoauthor=C.+Chuaquiauthor=C.+R.+Denzauthor=E.+Jenkinsauthor=N.+A.+Larsenauthor=P.+D.+Lyneauthor=T.+Pontzauthor=Q.+Yeauthor=G.+A.+Holdgateauthor=L.+Snowauthor=N.+O%E2%80%99Connellauthor=A.+D.+Ferguson&title=Potent+and+selective+CK2+kinase+inhibitors+with+effects+on+Wnt+pathway+signaling+in+vivo&doi=10.1021%2Facsmedchemlett.5b00452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span></div><div class="casAuthors">Dowling, James E.; Alimzhanov, Marat; Bao, Larry; Chuaqui, Claudio; Denz, Christopher R.; Jenkins, Emma; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy; Ye, Qing; Holdgate, Geoff A.; Snow, Lindsay; O'Connell, Nichole; Ferguson, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt pathway is an evolutionarily conserved and tightly regulated signaling network with important roles in embryonic development and adult tissue regeneration.  Impaired Wnt pathway regulation, arising from mutations in Wnt signaling components, such as Axin, APC, and β-catenin, results in uncontrolled cell growth and triggers oncogenesis.  To explore the reported link between CK2 kinase activity and Wnt pathway signaling, the authors sought to identify a potent, selective inhibitor of CK2 suitable for proof of concept studies in vivo.  Starting from a pyrazolo[1,5-a]pyrimidine lead, the authors identified N-(2-((2-aminoethyl)(methyl)amino)-5-(3-cyano-7-(cyclopropylamino) pyrazolo[1,5-a]pyrimidin-5-ylamino)phenyl)acetamide (compd. 7h), a potent CK2 inhibitor with picomolar affinity that is highly selectivity against other kinase family enzymes and inhibits Wnt pathway signaling (IC50 = 50 nM) in DLD-1 cells.  In addn., (compd. 7h) has physicochem. properties that are suitable for formulation as an i.v. soln., has demonstrated good pharmacokinetics in preclin. species, and exhibits a high level of activity as a monotherapy in HCT-116 and SW-620 xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9Sjmp1vsrLVg90H21EOLACvtfcHk0lgpzW_LnbwuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D&md5=515b631b98c356f27733856cfdca78b7</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00452%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DJenkins%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DSnow%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26atitle%3DPotent%2520and%2520selective%2520CK2%2520kinase%2520inhibitors%2520with%2520effects%2520on%2520Wnt%2520pathway%2520signaling%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D300%26epage%3D305%26doi%3D10.1021%2Facsmedchemlett.5b00452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/82047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F82047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=11101902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVahsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=1178-1184&author=H.+C.+Wongauthor=J.+Maoauthor=J.+T.+Nguyenauthor=S.+Srinivasauthor=W.+Zhangauthor=B.+Liuauthor=L.+Liauthor=D.+Wuauthor=J.+Zheng&title=Structural+basis+of+the+recognition+of+the+dishevelled+DEP+domain+in+the+Wnt+signaling+pathway&doi=10.1038%2F82047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of the recognition of the Dishevelled DEP domain in the Wnt signaling pathway</span></div><div class="casAuthors">Wong, Hing C.; Mao, Junhao; Nguyen, Jason T.; Srinivas, Shamala; Zhang, Weixing; Liu, Bo; Li, Lin; Wu, Dianqing; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1178-1184</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The DEP domain of Dishevelled (Dvl) proteins transduces signals to effector proteins downstream of Dvl in the Wnt pathway.  Here we report that DEP-contg. mutants inhibit Wnt-induced, but not Dvl-induced, activation of the transcription factor Lef-1.  This inhibitory effect is weakened by a K434M mutation.  NMR spectroscopy revealed that the DEP domain of mouse Dvl1 comprises a 3-helix bundle, a β-hairpin arm, and 2 short β-strands at the C-terminal region.  Lys 434 is located at the tip of the β-hairpin arm.  Based on our findings, we conclude that DEP interacts with regulators upstream of Dvl via a strong elec. dipole on the mol.'s surface created by Lys 434, Asp 445, and Asp 448; the elec. dipole and the putative membrane binding site are at 2 different locations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7wgDtrv3QLVg90H21EOLACvtfcHk0lgpzW_LnbwuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVahsbY%253D&md5=b8519f7eb67edac732dbcd02dc61c2d0</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2F82047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F82047%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BC.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DJ.%2BT.%26aulast%3DSrinivas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520the%2520recognition%2520of%2520the%2520dishevelled%2520DEP%2520domain%2520in%2520the%2520Wnt%2520signaling%2520pathway%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D1178%26epage%3D1184%26doi%3D10.1038%2F82047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlodzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00427-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS1097-2765%2803%2900427-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=14636582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1251-1260&author=H.+C.+Wongauthor=A.+Bourdelasauthor=A.+Kraussauthor=H.+J.+Leeauthor=Y.+Shaoauthor=D.+Wuauthor=M.+Mlodzikauthor=D.+L.+Shiauthor=J.+Zheng&title=Direct+binding+of+the+PDZ+domain+of+Dishevelled+to+a+conserved+internal+sequence+in+the+C-terminal+region+of+Frizzled&doi=10.1016%2FS1097-2765%2803%2900427-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled</span></div><div class="casAuthors">Wong, Hing-C.; Bourdelas, Audrey; Krauss, Anke; Lee, Ho-jin; Shao, Youming; Wu, Dianqing; Mlodzik, Marek; Shi, De-li; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cytoplasmic protein Dishevelled (Dvl) and the assocd. membrane-bound receptor Frizzled (Fz) are essential in canonical and noncanonical Wnt signaling pathways.  However, the mol. mechanisms underlying this signaling are not well understood.  By using NMR spectroscopy, we detd. that an internal sequence of Fz binds to the conventional peptide binding site in the PDZ domain of Dvl; this type of site typically binds to C-terminal binding motifs.  The C-terminal region of the Dvl inhibitor Dapper (Dpr) and Frodo bound to the same site.  In Xenopus, Dvl binding peptides of Fz and Dpr/Frodo inhibited canonical Wnt signaling and blocked Wnt-induced secondary axis formation in a dose-dependent manner, but did not block noncanonical Wnt signaling mediated by the DEP domain.  Together, our results identify a missing mol. connection within the Wnt pathway.  Differences in the binding affinity of the Dvl PDZ domain and its binding partners may be important in regulating signal transduction by Dvl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOkZJXRHLR2rVg90H21EOLACvtfcHk0lgpzW_LnbwuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGhtbc%253D&md5=fcae6a79c94783ee442a260755f0dff1</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900427-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900427-1%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BC.%26aulast%3DBourdelas%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMlodzik%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DDirect%2520binding%2520of%2520the%2520PDZ%2520domain%2520of%2520Dishevelled%2520to%2520a%2520conserved%2520internal%2520sequence%2520in%2520the%2520C-terminal%2520region%2520of%2520Frizzled%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2FS1097-2765%2803%2900427-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a specific inhibitor of the dishevelled PDZ domain</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">15495</span>– <span class="NLM_lpage">15503</span>, <span class="refDoi"> DOI: 10.1021/bi0512602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0512602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFynur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=15495-15503&author=J.+Shanauthor=D.+L.+Shiauthor=J.+Wangauthor=J.+Zheng&title=Identification+of+a+specific+inhibitor+of+the+dishevelled+PDZ+domain&doi=10.1021%2Fbi0512602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Specific Inhibitor of the Dishevelled PDZ Domain</span></div><div class="casAuthors">Shan, Jufang; Shi, De-Li; Wang, Junmei; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15495-15503</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt signaling pathways are involved in embryo development as well as in tumorigenesis.  Dishevelled (Dvl) transduces Wnt signals from the receptor Frizzled (Fz) to downstream components in canonical and noncanonical Wnt signaling pathways.  The Dvl PDZ domain is thought to play an essential role in both pathways, and we recently demonstrated that the Dvl PDZ domain binds directly to Fz receptors.  In this study, using structure-based virtual ligand screening, we identified an org. mol. (NSC668036) from the National Cancer Institute small-mol. library that can bind to the Dvl PDZ domain.  We then used mol. dynamics simulation to analyze the binding between the PDZ domain and NSC668036 in detail.  In addn., we showed that, in Xenopus, as expected, NSC668036 inhibited the signaling induced by Wnt3A.  This compd. provides a basis for rational design of high-affinity inhibitors of the PDZ domain, which can block Wnt signaling by interrupting the Fz-Dvl interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5nd8jL6L9KLVg90H21EOLACvtfcHk0lgQU11reGZoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFynur%252FK&md5=e65f625e85f18f9386fbb181f19e37f9</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fbi0512602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0512602%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520dishevelled%2520PDZ%2520domain%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D15495%26epage%3D15503%26doi%3D10.1021%2Fbi0512602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Identification of tripeptides recognized by the PDZ domain of Dishevelled</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1708</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.12.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2008.12.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19157887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1701-1708&author=H.+J.+Leeauthor=N.+X.+Wangauthor=Y.+Shaoauthor=J.+J.+Zheng&title=Identification+of+tripeptides+recognized+by+the+PDZ+domain+of+Dishevelled&doi=10.1016%2Fj.bmc.2008.12.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of tripeptides recognized by the PDZ domain of Dishevelled</span></div><div class="casAuthors">Lee, Ho-Jin; Wang, Nick X.; Shao, Youming; Zheng, Jie J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1701-1708</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of inhibitors of Dishevelled (Dvl) PDZ protein-protein interactions attracts attention due to a possible application in drug discovery and development.  Using NMR spectroscopy, we found that a tripeptide VVV binds to the PDZ domain of Dvl, which is a key component involved in Wnt signaling.  Using a computational approach calcg. the binding free energy of the complexes of the Dvl PDZ domain and each of the tripeptides VXV (X: any amino acid residue except Pro), we found that a tripeptide VWV had the highest binding affinity.  Consistent with the computational result, exptl. results showed that the binding of the tripeptide VWV to the Dvl PDZ domain was stronger than that of the tripeptide VVV.  The binding affinity of the tripeptide VWV was comparable to that of the org. mol. NSC668036, which was the first identified Dvl PDZ inhibitor.  The three-dimensional structure of the complex Dvl1 PDZ/VWV was detd. to investigate the role of the energetically favorable W(-1) residue in binding.  These interactions were also explored by using mol. dynamic simulation and the mol. mechanics Poisson-Boltzmann surface area method.  Taken together, these two tripeptides may be used as modulators of Wnt signaling or as a scaffold to optimize an antagonist for targeting Dvl1 PDZ protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTheAYjhZ77Vg90H21EOLACvtfcHk0lgQU11reGZoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVyit78%253D&md5=5c97873f33a2066f5fa16bb2215400c7</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.12.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.12.060%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DN.%2BX.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520tripeptides%2520recognized%2520by%2520the%2520PDZ%2520domain%2520of%2520Dishevelled%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1701%26epage%3D1708%26doi%3D10.1016%2Fj.bmc.2008.12.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpatov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">16256</span>– <span class="NLM_lpage">16263</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.009647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M109.009647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19383605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16256-16263&author=D.+Grandyauthor=J.+Shanauthor=X.+Zhangauthor=S.+Raoauthor=S.+Akunuruauthor=H.+Liauthor=Y.+Zhangauthor=I.+Alpatovauthor=X.+A.+Zhangauthor=R.+A.+Langauthor=D.+L.+Shiauthor=J.+J.+Zheng&title=Discovery+and+characterization+of+a+small+molecule+inhibitor+of+the+PDZ+domain+of+dishevelled&doi=10.1074%2Fjbc.M109.009647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled</span></div><div class="casAuthors">Grandy, David; Shan, Jufang; Zhang, Xinxin; Rao, Sujata; Akunuru, Shailaja; Li, Hongyan; Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.; Lang, Richard A.; Shi, De-Li; Zheng, Jie J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16256-16263</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Dishevelled (Dvl) is an essential protein in the Wnt signaling pathways; it uses its PDZ domain to transduce the Wnt signals from the membrane receptor Frizzled to downstream components.  Here, we report identifying a drug-like small mol. compd. through structure-based ligand screening and NMR spectroscopy and show the compd. to interact at low micromolar affinity with the PDZ domain of Dvl.  In a Xenopus testing system, the compd. could permeate the cell membrane and block the Wnt signaling pathways.  In addn., the compd. inhibited Wnt signaling and reduced the levels of apoptosis in the hyaloid vessels of eye.  Moreover, this compd. also suppressed the growth of prostate cancer PC-3 cells.  These biol. effects suggest that by blocking the PDZ domain of Dvl, the compd. identified in our studies effectively inhibits the Wnt signaling and thus provides a useful tool for studies dissecting the Wnt signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTIN1BUc6M1LVg90H21EOLACvtfcHk0lgQU11reGZoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtrk%253D&md5=73ad7afb362cbcbf226f0f0b7cefdead</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.009647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.009647%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%26aulast%3DShan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DAkunuru%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAlpatov%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DX.%2BA.%26aulast%3DLang%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520the%2520PDZ%2520domain%2520of%2520dishevelled%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16256%26epage%3D16263%26doi%3D10.1074%2Fjbc.M109.009647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroaki, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Disheveled/Dvl Inhibitors using virtual screening optimized with NMR-based docking performance index</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">983</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffphar.2018.00983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30233369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=983&author=K.+Horiauthor=K.+Ajiokaauthor=N.+Godaauthor=A.+Shindoauthor=M.+Takagishiauthor=T.+Tennoauthor=H.+Hiroaki&title=Discovery+of+potent+Disheveled%2FDvl+Inhibitors+using+virtual+screening+optimized+with+NMR-based+docking+performance+index&doi=10.3389%2Ffphar.2018.00983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent disheveled/Dvl inhibitors using virtual screening optimized with NMR-based docking performance index</span></div><div class="casAuthors">Hori, Kiminori; Ajioka, Kasumi; Goda, Natsuko; Shindo, Asako; Takagishi, Maki; Tenno, Takeshi; Hiroaki, Hidekazu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">983/1-983/14</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Most solid tumors have their own cancer stem cells (CSCs), which are resistant to std. chemo-therapies.  Recent reports have described that Wnt pathway plays a key role in self-renewal and tumorigenesis of CSCs.  Regarding the Wnt/β-catenin pathway, Dvl (mammalian Disheveled) is an attractive target of drug discovery.  After analyzing the PDZ domain of human Dvl1 (Dvl1-PDZ) using NMR, we subjected it to preliminary NMR titrn. studies with 17 potential PDZ-binding mols. including CalBioChem-322338, a com. available Dvl PDZ domain inhibitor.  Next, we performed virtual screening (VS) using the program GOLD with nine parameter sets.  Results were evaluated using the NMR-derived docking performance index (NMRDPI).  One parameter set of GOLD docking showing the best NMR-DPI was selected and used for the second VS against 5,135 compds.  The second docking trial identified more than 1,700 compds. that exhibited higher scores than CalBioChem- 322338.  Subsequent NMR titrn. expts. with five new candidate mols. (NPL-4001, 4004, 4011, 4012, and 4013), Dvl1-PDZ revealed larger chem. shift changes than those of CalBioChem-322338.  Finally, these compds. showed partial proliferation inhibition activity against BT-20, a triple neg. breast cancer (TNBC) cell.  These compds. are promising Wnt pathway inhibitors that are potentially useful for anti-TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Rjep1UlkkLVg90H21EOLACvtfcHk0liwnbU7etJC5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSltL0%253D&md5=078093aed383e3e5a03a3fa4425e8df5</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00983%26sid%3Dliteratum%253Aachs%26aulast%3DHori%26aufirst%3DK.%26aulast%3DAjioka%26aufirst%3DK.%26aulast%3DGoda%26aufirst%3DN.%26aulast%3DShindo%26aufirst%3DA.%26aulast%3DTakagishi%26aufirst%3DM.%26aulast%3DTenno%26aufirst%3DT.%26aulast%3DHiroaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520Disheveled%252FDvl%2520Inhibitors%2520using%2520virtual%2520screening%2520optimized%2520with%2520NMR-based%2520docking%2520performance%2520index%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D983%26doi%3D10.3389%2Ffphar.2018.00983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, N. J.</span></span> <span> </span><span class="NLM_article-title">E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nature07310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature07310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18794899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKhtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=552-556&author=E.+J.+Morrisauthor=J.+Y.+Jiauthor=F.+Yangauthor=L.+Di+Stefanoauthor=A.+Herrauthor=N.+S.+Moonauthor=E.+J.+Kwonauthor=K.+M.+Haigisauthor=A.+M.+Naarauthor=N.+J.+Dyson&title=E2F1+represses+beta-catenin+transcription+and+is+antagonized+by+both+pRB+and+CDK8&doi=10.1038%2Fnature07310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8</span></div><div class="casAuthors">Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Kwon, Eun-Jeong; Haigis, Kevin M.; Naeaer, Anders M.; Dyson, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7212</span>),
    <span class="NLM_cas:pages">552-556</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumor suppressor protein (pRB).  Here we show that E2F1 is a potent and specific inhibitor of β-catenin/T-cell factor (TCF)-dependent transcription, and that this function contributes to E2F1-induced apoptosis.  E2F1 deregulation suppresses β-catenin activity in an adenomatous polyposis coli (APC)/glycogen synthase kinase-3 (GSK3)-independent manner, reducing the expression of key β-catenin targets including c-MYC.  This interaction explains why colorectal tumors, which depend on β-catenin transcription for their abnormal proliferation, keep RB1 intact.  Remarkably, E2F1 activity is also repressed by cyclin-dependent kinase-8 (CDK8), a colorectal oncoprotein.  Elevated levels of CDK8 protect β-catenin/TCF-dependent transcription from inhibition by E2F1.  Thus, by retaining RB1 and amplifying CDK8, colorectal tumor cells select conditions that collectively suppress E2F1 and enhance the activity of β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DfW83G97UbVg90H21EOLACvtfcHk0liwnbU7etJC5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKhtLbE&md5=b770664f18e774a33f2c7aedbbeb24c6</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnature07310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07310%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DJi%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DDi%2BStefano%26aufirst%3DL.%26aulast%3DHerr%26aufirst%3DA.%26aulast%3DMoon%26aufirst%3DN.%2BS.%26aulast%3DKwon%26aufirst%3DE.%2BJ.%26aulast%3DHaigis%26aufirst%3DK.%2BM.%26aulast%3DNaar%26aufirst%3DA.%2BM.%26aulast%3DDyson%26aufirst%3DN.%2BJ.%26atitle%3DE2F1%2520represses%2520beta-catenin%2520transcription%2520and%2520is%2520antagonized%2520by%2520both%2520pRB%2520and%2520CDK8%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D552%26epage%3D556%26doi%3D10.1038%2Fnature07310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szostek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, J. M.</span></span> <span> </span><span class="NLM_article-title">CDK8 is a stimulus-specific positive coregulator of p53 target genes</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.molcel.2007.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17612495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1elsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=121-133&author=A.+J.+Donnerauthor=S.+Szostekauthor=J.+M.+Hooverauthor=J.+M.+Espinosa&title=CDK8+is+a+stimulus-specific+positive+coregulator+of+p53+target+genes&doi=10.1016%2Fj.molcel.2007.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">CDK8 is a stimulus-specific positive coregulator of p53 target genes</span></div><div class="casAuthors">Donner, Aaron Joseph; Szostek, Stephanie; Hoover, Jennifer Michelle; Espinosa, Joaquin Maximiliano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-133</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The p53 transcriptional network orchestrates alternative stress responses such as cell-cycle arrest and apoptosis.  Here we investigate the mechanism of differential expression of p21, a key mediator of p53-dependent cell-cycle arrest.  We demonstrate that the transcriptional activity of the p21 promoter varies greatly in response to distinct p53-activating stimuli.  Chromatin immunopptn. anal. of the p21 locus indicates that histone acetyltransferases, general transcription factors, and Mediator subunits are assembled into alternative transcriptional complexes of different activity.  Interestingly, core Mediator subunits MED1 and MED17 are recruited to the p21 locus regardless of the p53-activating stimuli utilized.  In contrast, three subunits of the CDK module of Mediator (CDK8, MED12, and cyclin C) are exclusively recruited during conditions of strong p21 transcriptional activation.  Furthermore, increased binding of CDK8 to p53 target genes correlates pos. with transcriptional strength.  RNAi expts. demonstrate that CDK8 functions as a coactivator within the p53 transcriptional program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXx_jyLXAX7Vg90H21EOLACvtfcHk0lhoDMQnOFkWgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1elsL4%253D&md5=27ddf924be6fcd3dca6fda0f7d52de45</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DDonner%26aufirst%3DA.%2BJ.%26aulast%3DSzostek%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DJ.%2BM.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26atitle%3DCDK8%2520is%2520a%2520stimulus-specific%2520positive%2520coregulator%2520of%2520p53%2520target%2520genes%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D121%26epage%3D133%26doi%3D10.1016%2Fj.molcel.2007.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaeian, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. K.</span></span> <span> </span><span class="NLM_article-title">Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6641</span>, <span class="refDoi"> DOI: 10.1038/ncomms7641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fncomms7641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25818643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVCrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6641&author=D.+Xuauthor=C.+F.+Liauthor=X.+Zhangauthor=Z.+Gongauthor=C.+H.+Chanauthor=S.+W.+Leeauthor=G.+Jinauthor=A.+H.+Rezaeianauthor=F.+Hanauthor=J.+Wangauthor=W.+L.+Yangauthor=Z.+Z.+Fengauthor=W.+Chenauthor=C.+Y.+Wuauthor=Y.+J.+Wangauthor=L.+P.+Chowauthor=X.+F.+Zhuauthor=Y.+X.+Zengauthor=H.+K.+Lin&title=Skp2-macroH2A1-CDK8+axis+orchestrates+G2%2FM+transition+and+tumorigenesis&doi=10.1038%2Fncomms7641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis</span></div><div class="casAuthors">Xu, Dazhi; Li, Chien-Feng; Zhang, Xian; Gong, Zhaohui; Chan, Chia-Hsin; Lee, Szu-Wei; Jin, Guoxiang; Rezaeian, Abdol-Hossein; Han, Fei; Wang, Jing; Yang, Wei-Lei; Feng, Zi-Zhen; Chen, Wei; Wu, Ching-Yuan; Wang, Ying-Jan; Chow, Lu-Ping; Zhu, Xiao-Feng; Zeng, Yi-Xin; Lin, Hui-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6641</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Understanding the mechanism by which cell growth, migration, polyploidy, and tumorigenesis are regulated may provide important therapeutic strategies for cancer therapy.  Here we identify the Skp2-macroH2A1 (mH2A1)-cyclin-dependent kinase 8 (CDK8) axis as a crit. pathway for these processes, and deregulation of this pathway is assocd. with human breast cancer progression and patient survival outcome.  We showed that mH2A1 is a new substrate of Skp2 SCF complex whose degrdn. by Skp2 promotes CDK8 gene and protein expression.  Strikingly, breast tumor suppression on Skp2 deficiency can be rescued by mH2A1 knockdown or CDK8 restoration using mouse tumor models.  We further show that CDK8 regulates p27 protein expression by facilitating Skp2-mediated p27 ubiquitination and degrdn.  Our study establishes a crit. role of Skp2-mH2A1-CDK8 axis in breast cancer development and targeting this pathway offers a promising strategy for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqwXuVFzf3gLVg90H21EOLACvtfcHk0lhoDMQnOFkWgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVCrtL8%253D&md5=d3108ca73b76c62ea18976f05ec13202</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1038%2Fncomms7641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7641%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%2BF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DRezaeian%26aufirst%3DA.%2BH.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%2BL.%26aulast%3DFeng%26aufirst%3DZ.%2BZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DChow%26aufirst%3DL.%2BP.%26aulast%3DZhu%26aufirst%3DX.%2BF.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DLin%26aufirst%3DH.%2BK.%26atitle%3DSkp2-macroH2A1-CDK8%2520axis%2520orchestrates%2520G2%252FM%2520transition%2520and%2520tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6641%26doi%3D10.1038%2Fncomms7641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.11.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ejmech.2018.11.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30594029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1WhsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=77-91&author=M.+Xiauthor=T.+Chenauthor=C.+Wuauthor=X.+Gaoauthor=Y.+Wuauthor=X.+Luoauthor=K.+Duauthor=L.+Yuauthor=T.+Caiauthor=R.+Shenauthor=H.+Sun&title=CDK8+as+a+therapeutic+target+for+cancers+and+recent+developments+in+discovery+of+CDK8+inhibitors&doi=10.1016%2Fj.ejmech.2018.11.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors</span></div><div class="casAuthors">Xi, Meiyang; Chen, Tingkai; Wu, Chunlei; Gao, Xiaozhong; Wu, Yonghua; Luo, Xiang; Du, Kui; Yu, Lemao; Cai, Tao; Shen, Runpu; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases 8 (CDK8) regulates transcriptional process via assocg. with the mediator complex or phosphorylating transcription factors (TF).  Overexpression of CDK8 has been obsd. in various cancers.  It mediates aberrant activation of Wnt/β-catenin signaling pathway, which is initially recognized and best studied in colorectal cancer (CRC).  CDK8 acts as an oncogene and represents a potential target for developing novel CDK8 inhibitors in cancer therapeutics.  However, other study has revealed its contrary role.  The function of CDK8 is context dependent.  Even so, a variety of potent and selective CDK8 inhibitors have been discovered after crystal structures were resolved in two states (active or inactive).  In this review, we summarize co-crystal structures, biol. mechanisms, dysregulation in cancers and recent progress in the field of CDK8 inhibitors, trying to offer an outlook of CDK8 inhibitors in cancer therapy in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg2b-dA0hErVg90H21EOLACvtfcHk0ljsV9k3Q6siLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1WhsbvM&md5=8c7eeabc1d6c4fa545d09c39004436f7</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.11.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.11.076%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DCDK8%2520as%2520a%2520therapeutic%2520target%2520for%2520cancers%2520and%2520recent%2520developments%2520in%2520discovery%2520of%2520CDK8%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D77%26epage%3D91%26doi%3D10.1016%2Fj.ejmech.2018.11.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumpler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichowicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waalboer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeniji-Popoola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TePoele, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1735</span>, <span class="refDoi"> DOI: 10.1021/jm501436m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501436m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1717-1735&author=A.+Mallingerauthor=S.+Crumplerauthor=M.+Pichowiczauthor=D.+Waalboerauthor=M.+Stubbsauthor=O.+Adeniji-Popoolaauthor=B.+Woodauthor=E.+Smithauthor=C.+Thaiauthor=A.+T.+Henleyauthor=K.+Georgiauthor=W.+Courtauthor=S.+Hobbsauthor=G.+Boxauthor=M.+J.+Ortiz-Ruizauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=R.+TePoeleauthor=B.+Leuthnerauthor=P.+Workmanauthor=W.+Aherneauthor=O.+Poeschkeauthor=T.+Daleauthor=D.+Wienkeauthor=C.+Esdarauthor=F.+Rohdichauthor=F.+Raynaudauthor=P.+A.+Clarkeauthor=S.+A.+Ecclesauthor=F.+Stieberauthor=K.+Schiemannauthor=J.+Blagg&title=Discovery+of+potent%2C+orally+bioavailable%2C+small-molecule+inhibitors+of+WNT+signaling+from+a+cell-based+pathway+screen&doi=10.1021%2Fjm501436m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen</span></div><div class="casAuthors">Mallinger, Aurelie; Crumpler, Simon; Pichowicz, Mark; Waalboer, Dennis; Stubbs, Mark; Adeniji-Popoola, Olajumoke; Wood, Bozena; Smith, Elizabeth; Thai, Ching; Henley, Alan T.; Georgi, Katrin; Court, William; Hobbs, Steve; Box, Gary; Ortiz-Ruiz, Maria-Jesus; Valenti, Melanie; De Haven Brandon, Alexis; Te Poele, Robert; Leuthner, Birgitta; Workman, Paul; Aherne, Wynne; Poeschke, Oliver; Dale, Trevor; Wienke, Dirk; Esdar, Christina; Rohdich, Felix; Raynaud, Florence; Clarke, Paul A.; Eccles, Suzanne A.; Stieber, Frank; Schiemann, Kai; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1717-1735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">WNT signaling is frequently deregulated in malignancy, particularly in colon cancer, and plays a key role in the generation and maintenance of cancer stem cells.  The authors report the discovery and optimization of a 3,4,5-trisubstituted pyridine, 1-(3,5-Dichloropyridin-4-yl)piperidine-4-carboxamide (9), using a high-throughput cell-based reporter assay of WNT pathway activity.  The authors demonstrate a twisted conformation about the pyridine-piperidine bond of (9) by small-mol. x-ray crystallog.  Medicinal chem. optimization to maintain this twisted conformation, cognisant of physicochem. properties likely to maintain good cell permeability, led to 8-[3-Chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]pyridin-4-yl]-2,8-diazaspiro[4,5]decan-1-one (74) (CCT251545), a potent small-mol. inhibitor of WNT signaling with good oral pharmacokinetics.  The authors demonstrate inhibition of WNT pathway activity in a solid human tumor xenograft model with evidence for tumor growth inhibition following oral dosing.  This work provides a successful example of hypothesis-driven medicinal chem. optimization from a singleton hit against a cell-based pathway assay without knowledge of the biochem. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGX6wdTc3jeLVg90H21EOLACvtfcHk0ljsV9k3Q6siLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGjur4%253D&md5=eab7f23a8288cb3da6665ef000558f95</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm501436m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501436m%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DCrumpler%26aufirst%3DS.%26aulast%3DPichowicz%26aufirst%3DM.%26aulast%3DWaalboer%26aufirst%3DD.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DAdeniji-Popoola%26aufirst%3DO.%26aulast%3DWood%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DGeorgi%26aufirst%3DK.%26aulast%3DCourt%26aufirst%3DW.%26aulast%3DHobbs%26aufirst%3DS.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DTePoele%26aufirst%3DR.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520orally%2520bioavailable%252C%2520small-molecule%2520inhibitors%2520of%2520WNT%2520signaling%2520from%2520a%2520cell-based%2520pathway%2520screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1717%26epage%3D1735%26doi%3D10.1021%2Fjm501436m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumpler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeniji-Popoola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, and orally bioavailable small-molecule modulators of the mediator complex-associated kinases CDK8 and CDK19</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1101</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1078-1101&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=F.+Stieberauthor=M.+Calderiniauthor=S.+Crumplerauthor=M.+Stubbsauthor=O.+Adeniji-Popoolaauthor=O.+Poeschkeauthor=M.+Buschauthor=P.+Czodrowskiauthor=D.+Musilauthor=D.+Schwarzauthor=M.+J.+Ortiz-Ruizauthor=R.+Schneiderauthor=C.+Thaiauthor=M.+Valentiauthor=A.+de+Haven%0ABrandonauthor=R.+Burkeauthor=P.+Workmanauthor=T.+Daleauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=C.+Esdarauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=F.+Rohdichauthor=J.+Blagg&title=Discovery+of+potent%2C+selective%2C+and+orally+bioavailable+small-molecule+modulators+of+the+mediator+complex-associated+kinases+CDK8+and+CDK19&doi=10.1021%2Facs.jmedchem.5b01685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Stieber, Frank; Calderini, Michel; Crumpler, Simon; Stubbs, Mark; Adeniji-Popoola, Olajumoke; Poeschke, Oliver; Busch, Michael; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Thai, Ching; Valenti, Melanie; Brandon, Alexis de Haven; Burke, Rosemary; Workman, Paul; Dale, Trevor; Wienke, Dirk; Clarke, Paul A.; Esdar, Christina; Raynaud, Florence I.; Eccles, Suzanne A.; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1078-1101</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene.  Here the authors report the discovery of I (CCT251921), a potent, selective, and orally bioavailable inhibitor of CDK8 with equipotent affinity for CDK19.  The authors describe a structure-based design approach leading to the discovery of a 3,4,5-trisubstituted-2-aminopyridine series and present the application of physicochem. property analyses to successfully reduce in vivo metabolic clearance, minimize transporter-mediated biliary elimination while maintaining acceptable aq. soly.  Compd. I affords the optimal compromise of in vitro biochem., pharmacokinetic, and physicochem. properties and is suitable for progression to animal models of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGLfsHTX285bVg90H21EOLACvtfcHk0ljjb-yH4GXkDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmsrk%253D&md5=fbe1c1a8569750a33751e87a04bf49bd</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01685%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DCalderini%26aufirst%3DM.%26aulast%3DCrumpler%26aufirst%3DS.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DAdeniji-Popoola%26aufirst%3DO.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520small-molecule%2520modulators%2520of%2520the%2520mediator%2520complex-associated%2520kinases%2520CDK8%2520and%2520CDK19%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1078%26epage%3D1101%26doi%3D10.1021%2Facs.jmedchem.5b01685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuillan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvares, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-ODeltaN89beta-catenin system</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2012.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22469981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=883-893&author=T.+Jardeauthor=R.+J.+Evansauthor=K.+L.+McQuillanauthor=L.+Parryauthor=G.+J.+Fengauthor=B.+Alvaresauthor=A.+R.+Clarkeauthor=T.+C.+Dale&title=In+vivo+and+in+vitro+models+for+the+therapeutic+targeting+of+Wnt+signaling+using+a+Tet-ODeltaN89beta-catenin+system&doi=10.1038%2Fonc.2012.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-OΔN89β-catenin system</span></div><div class="casAuthors">Jarde, T.; Evans, R. J.; McQuillan, K. L.; Parry, L.; Feng, G. J.; Alvares, B.; Clarke, A. R.; Dale, T. C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-893</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although significant progress has been made in understanding the importance of Wnt signaling in the initiation of colorectal cancer, less is known about responses that accompany the reversal of oncogenic Wnt signaling.  The aim of this study was to analyze in vivo and in vitro responses to an ideal' Wnt pathway inhibitor as a model for the therapeutic targeting of the pathway.  A tetracycline-inducible transgenic mouse model expressing truncated β-catenin (ΔN89β-catenin) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic β-catenin expression both in 3D crypt culture' and in vivo.  Oncogenic Wnt signaling was rapidly and completely reversed.  The strongest inhibition of Wnt target gene expression occurred within 24 h of doxycycline removal at which time the target genes Ascl2, Axin2 and C-myc were downregulated to levels below that in the control intestine.  In vitro, the small mol. Wnt inhibitor CCT036477 induced a response within 4 h of treatment.  By 7 days following doxycycline withdrawal, gene expression, cell proliferation and tissue morphol. were undistinguishable from control animals.  In conclusion, these results demonstrate that the reversal of Wnt signaling by inhibitors should ideally be studied within hours of treatment.  The reversible system described, involving medium throughput in vitro approaches and rapid in vivo responses, should allow the rapid advance of early stage compds. into efficacy models that are more usually considered later in the drug discovery pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLFHEYVSwmf7Vg90H21EOLACvtfcHk0ljjb-yH4GXkDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqs78%253D&md5=cc33da5c8a09b82d0ed02b4483520d2b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.103%26sid%3Dliteratum%253Aachs%26aulast%3DJarde%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%2BJ.%26aulast%3DMcQuillan%26aufirst%3DK.%2BL.%26aulast%3DParry%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DG.%2BJ.%26aulast%3DAlvares%26aufirst%3DB.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DDale%26aufirst%3DT.%2BC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520models%2520for%2520the%2520therapeutic%2520targeting%2520of%2520Wnt%2520signaling%2520using%2520a%2520Tet-ODeltaN89beta-catenin%2520system%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D883%26epage%3D893%26doi%3D10.1038%2Fonc.2012.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">2,8-Disubstituted-1,6-naphthyridines and 4,6-disubstituted-isoquinolines with potent, selective affinity for CDK8/19</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=573-578&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=J.+Sejbergauthor=M.+A.+Honeyauthor=P.+Czodrowskiauthor=M.+Stubbsauthor=O.+Poeschkeauthor=M.+Buschauthor=R.+Schneiderauthor=D.+Schwarzauthor=D.+Musilauthor=R.+Burkeauthor=K.+Urbahnsauthor=P.+Workmanauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=C.+Esdarauthor=F.+Rohdichauthor=J.+Blagg&title=2%2C8-Disubstituted-1%2C6-naphthyridines+and+4%2C6-disubstituted-isoquinolines+with+potent%2C+selective+affinity+for+CDK8%2F19&doi=10.1021%2Facsmedchemlett.6b00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Sejberg, Jimmy; Honey, Mark A.; Czodrowski, Paul; Stubbs, Mark; Poeschke, Oliver; Busch, Michael; Schneider, Richard; Schwarz, Daniel; Musil, Djordje; Burke, Rosemary; Urbahns, Klaus; Workman, Paul; Wienke, Dirk; Clarke, Paul A.; Raynaud, Florence I.; Eccles, Suzanne A.; Esdar, Christina; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">573-578</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate a designed scaffold-hop approach to the discovery of 2,8-disubstituted-1,6-naphthyridine- and 4,6-disubstituted-isoquinoline-based dual CDK8/19 ligands.  Optimized compds. in both series exhibited rapid aldehyde oxidase-mediated metab., which could be abrogated by introduction of an amino substituent at C5 of the 1,6-naphthyridine scaffold or at C1 of the isoquinoline scaffold.  Compds. 51 and 59 were progressed to in vivo pharmacokinetic studies, and 51 also demonstrated sustained inhibition of STAT1SER727 phosphorylation, a biomarker of CDK8 inhibition, in an SW620 colorectal carcinoma human tumor xenograft model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD7cu5uM2rVg90H21EOLACvtfcHk0lhG1buGVi9MxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D&md5=20854b532b81db1be40afcd811ac5731</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00022%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DHoney%26aufirst%3DM.%2BA.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3D2%252C8-Disubstituted-1%252C6-naphthyridines%2520and%25204%252C6-disubstituted-isoquinolines%2520with%2520potent%252C%2520selective%2520affinity%2520for%2520CDK8%252F19%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.6b00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9337</span>– <span class="NLM_lpage">9349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9337-9349&author=P.+Czodrowskiauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+Poschkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=M.+J.+Ortiz-Ruizauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=D.+Musilauthor=D.+Schwarzauthor=T.+Daleauthor=K.+Urbahnsauthor=J.+Blaggauthor=K.+Schiemann&title=Structure-based+optimization+of+potent%2C+selective%2C+and+orally+bioavailable+CDK8+inhibitors+discovered+by+high-throughput+screening&doi=10.1021%2Facs.jmedchem.6b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening</span></div><div class="casAuthors">Czodrowski, Paul; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Raynaud, Florence I.; Clarke, Paul A.; Musil, Djordje; Schwarz, Daniel; Dale, Trevor; Urbahns, Klaus; Blagg, Julian; Schiemann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9337-9349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin dependent kinase CDK8 regulates beta-catenin-dependent transcription following activation of WNT signaling.  Multiple lines of evidence suggest CDK8 may act as an oncogene in the development of colorectal cancer.  Here the authors describe the successful optimization of an imidazo-thiadiazole series of CDK8 inhibitors that was identified in a high-throughput screening campaign and further progressed by structure-based design.  In several optimization cycles, the authors improved the microsomal stability, potency and kinase selectivity.  The initial imidazo-thiadiazole scaffold was replaced by a 3-methyl-1H-pyrazolo[3,4-b]-pyridine which resulted in compd. MSC2530818 that displayed excellent kinase selectivity, biochem. and cellular potency, microsomal stability and is orally bioavailable.  Furthermore, the authors demonstrated modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8 activity, and tumor growth inhibition in an APC-mutant SW620 human colorectal carcinoma xenograft model after oral administration.  Compd. MSC2530818 demonstrated suitable potency and selectivity to progress into preclin. in vivo efficacy and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoP_Ycv9Xj97Vg90H21EOLACvtfcHk0lhG1buGVi9MxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF&md5=9ab270aed38647f9bafe213cf9d75171</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00597%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DPoschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DSchiemann%26aufirst%3DK.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520CDK8%2520inhibitors%2520discovered%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9337%26epage%3D9349%26doi%3D10.1021%2Facs.jmedchem.6b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmcl.2016.01.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26852363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1443-1451&author=K.+Schiemannauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+Poeschkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+Czodrowskiauthor=D.+Musilauthor=D.+Schwarzauthor=K.+Urbahnsauthor=J.+Blagg&title=Discovery+of+potent+and+selective+CDK8+inhibitors+from+an+HSP90+pharmacophore&doi=10.1016%2Fj.bmcl.2016.01.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore</span></div><div class="casAuthors">Schiemann, Kai; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Schneider, Richard; Raynaud, Florence I.; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Urbahns, Klaus; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1443-1451</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the discovery and optimization of 3-benzylindazoles as potent and selective inhibitors of CDK8, also modulating CDK19, discovered from a high-throughput screening (HTS) campaign sampling the Merck compd. collection.  The primary hits with strong HSP90 affinity were subsequently optimized to potent and selective CDK8 inhibitors which demonstrate inhibition of WNT pathway activity in cell-based assays.  X-ray crystallog. data demonstrated that 3-benzylindazoles occupy the ATP binding site of CDK8 and adopt a Type I binding mode.  Medicinal chem. optimization successfully led to improved potency, physicochem. properties and oral pharmacokinetics.  Modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8, was demonstrated in an APC-mutant SW620 human colorectal carcinoma xenograft model following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou1kKac9Bkw7Vg90H21EOLACvtfcHk0lhG1buGVi9MxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitlCitLs%253D&md5=77e9f7705c9136557195ccfb4982cb8d</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.062%26sid%3Dliteratum%253Aachs%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520CDK8%2520inhibitors%2520from%2520an%2520HSP90%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1443%26epage%3D1451%26doi%3D10.1016%2Fj.bmcl.2016.01.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shitashige, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">5024</span>– <span class="NLM_lpage">5033</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-0306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-10-0306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20530691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=5024-5033&author=M.+Shitashigeauthor=R.+Satowauthor=T.+Jigamiauthor=K.+Aokiauthor=K.+Hondaauthor=T.+Shibataauthor=M.+Onoauthor=S.+Hirohashiauthor=T.+Yamada&title=Traf2-+and+Nck-interacting+kinase+is+essential+for+Wnt+signaling+and+colorectal+cancer+growth&doi=10.1158%2F0008-5472.CAN-10-0306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth</span></div><div class="casAuthors">Shitashige, Miki; Satow, Reiko; Jigami, Takafumi; Aoki, Kazunori; Honda, Kazufumi; Shibata, Tatsuhiro; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5024-5033</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">T-cell factor-4 (TCF4) is a transcription factor essential for maintaining the undifferentiated status and self-renewal of intestinal epithelial cells.  It has therefore been considered that constitutive activation of TCF4 by aberrant Wnt signaling is a major force driving colorectal carcinogenesis.  We previously identified Traf2- and Nck-interacting kinase (TNIK) as one of the proteins that interact with TCF4 in colorectal cancer cells, but its functional significance has not been elucidated.  Here, we report that TNIK is an activating kinase for TCF4 and essential for colorectal cancer growth.  TNIK, but not its catalytically inactive mutant, phosphorylated the conserved serine 154 residue of TCF4.  Small interfering RNA targeting TNIK inhibited the proliferation of colorectal cancer cells and the growth of tumors produced by injecting colorectal cancer cells s.c. into immunodeficient mice.  The growth inhibition was abolished by restoring the catalytic domain of TNIK, thus confirming that its enzyme activity is essential for the maintenance of colorectal cancer growth.  Several ATP-competing kinase inhibitors have been applied to cancer treatment and have shown significant activity.  Our findings suggest TNIK as a feasible target for pharmacol. intervention to ablate aberrant Wnt signaling in colorectal cancer.  Cancer Res; 70(12); 5024-33.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhEBquRkxUurVg90H21EOLACvtfcHk0lhLNqO-p2lCkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKltLg%253D&md5=14fab380ba35b5d9bbe8c1a185362644</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-0306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-0306%26sid%3Dliteratum%253Aachs%26aulast%3DShitashige%26aufirst%3DM.%26aulast%3DSatow%26aufirst%3DR.%26aulast%3DJigami%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DTraf2-%2520and%2520Nck-interacting%2520kinase%2520is%2520essential%2520for%2520Wnt%2520signaling%2520and%2520colorectal%2520cancer%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D5024%26epage%3D5033%26doi%3D10.1158%2F0008-5472.CAN-10-0306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">The emergence of TNIK as a therapeutic target for colorectal cancer</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1080/14728222.2017.1297799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1080%2F14728222.2017.1297799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28281900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFKjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=353-355&author=M.+Masudaauthor=T.+Yamada&title=The+emergence+of+TNIK+as+a+therapeutic+target+for+colorectal+cancer&doi=10.1080%2F14728222.2017.1297799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of TNIK as a therapeutic target for colorectal cancer</span></div><div class="casAuthors">Masuda, Mari; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-355</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Through comprehensive mass spectrometry anal. of nuclear proteins purified from colorectal cancer cells, we identified TNIK (Traf2- and Nck-interacting kinase) as a component of the TCF4 and β-catenin transcriptional complex.  We found that TNIK phosphorylated TCF4 protein at the conserved serine 154 residue which is essential for full activation of Wnt signaling and knockdown of TNIK suppressed Wnt activity and proliferation of colorectal cancer cells.  Injection of siRNA targeting TNIK inhibits the growth of colorectal cancer xenografts, and this growth inhibition is abolished by restoring the catalytic domain of TNIK.  TNIK is required for the tumor-initiating function of colorectal cancer stem cells, and its inhibition is a promising therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbC9X352hIrVg90H21EOLACvtfcHk0lhLNqO-p2lCkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFKjsLg%253D&md5=a3acd36374e27d6cca77cc77e3868f5f</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1080%2F14728222.2017.1297799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2017.1297799%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DThe%2520emergence%2520of%2520TNIK%2520as%2520a%2520therapeutic%2520target%2520for%2520colorectal%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2017%26volume%3D21%26spage%3D353%26epage%3D355%26doi%3D10.1080%2F14728222.2017.1297799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukimoto-Niino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">TNIK inhibition abrogates colorectal cancer stemness</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12586</span>, <span class="refDoi"> DOI: 10.1038/ncomms12586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fncomms12586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27562646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12586&author=M.+Masudaauthor=Y.+Unoauthor=N.+Ohbayashiauthor=H.+Ohataauthor=A.+Mimataauthor=M.+Kukimoto-Niinoauthor=H.+Moriyamaauthor=S.+Kashimotoauthor=T.+Inoueauthor=N.+Gotoauthor=K.+Okamotoauthor=M.+Shirouzuauthor=M.+Sawaauthor=T.+Yamada&title=TNIK+inhibition+abrogates+colorectal+cancer+stemness&doi=10.1038%2Fncomms12586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">TNIK inhibition abrogates colorectal cancer stemness</span></div><div class="casAuthors">Masuda, Mari; Uno, Yuko; Ohbayashi, Naomi; Ohata, Hirokazu; Mimata, Ayako; Kukimoto-Niino, Mutsuko; Moriyama, Hideki; Kashimoto, Shigeki; Inoue, Tomoko; Goto, Naoko; Okamoto, Koji; Shirouzu, Mikako; Sawa, Masaaki; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12586</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Canonical Wnt/β-catenin signalling is essential for maintaining intestinal stem cells, and its constitutive activation has been implicated in colorectal carcinogenesis.  We and others have previously identified Traf2- and Nck-interacting kinase (TNIK) as an essential regulatory component of the T-cell factor-4 and β-catenin transcriptional complex.  Consistent with this, Tnik-deficient mice are resistant to azoxymethane-induced colon tumorigenesis, and Tnik-/-/Apcmin/+ mutant mice develop significantly fewer intestinal tumors.  Here we report the first orally available small-mol. TNIK inhibitor, NCB-0846, having anti-Wnt activity.  X-ray co-crystal structure anal. reveals that NCB-0846 binds to TNIK in an inactive conformation, and this binding mode seems to be essential for Wnt inhibition.  NCB-0846 suppresses Wnt-driven intestinal tumorigenesis in Apcmin/+ mice and the sphere- and tumor-forming activities of colorectal cancer cells.  TNIK is required for the tumor-initiating function of colorectal cancer stem cells.  Its inhibition is a promising therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpBHuWHnK3vbVg90H21EOLACvtfcHk0lhcInpBJKaxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCht7zL&md5=f93b79e2fc85bf8e26390854da52e932</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fncomms12586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12586%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DOhata%26aufirst%3DH.%26aulast%3DMimata%26aufirst%3DA.%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DMoriyama%26aufirst%3DH.%26aulast%3DKashimoto%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DSawa%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DTNIK%2520inhibition%2520abrogates%2520colorectal%2520cancer%2520stemness%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12586%26doi%3D10.1038%2Fncomms12586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokstad, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalland, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span> <span> </span><span class="NLM_article-title">Small molecule promotes beta-catenin citrullination and inhibits Wnt signaling in cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.2510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29083417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=94-101&author=Y.+Quauthor=J.+R.+Olsenauthor=X.+Yuanauthor=P.+F.+Chengauthor=M.+P.+Levesqueauthor=K.+A.+Brokstadauthor=P.+S.+Hoffmanauthor=A.+M.+Oyanauthor=W.+Zhangauthor=K.+H.+Kallandauthor=X.+Ke&title=Small+molecule+promotes+beta-catenin+citrullination+and+inhibits+Wnt+signaling+in+cancer&doi=10.1038%2Fnchembio.2510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer</span></div><div class="casAuthors">Qu, Yi; Olsen, Jan Roger; Yuan, Xing; Cheng, Phil F.; Levesque, Mitchell P.; Brokstad, Karl A.; Hoffman, Paul S.; Oyan, Anne Margrete; Zhang, Weidong; Kalland, Karl-Henning; Ke, Xisong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Wnt (wingless)/β-catenin signaling is crit. for tumor progression and is frequently activated in colorectal cancer as a result of the mutation of adenomatous polyposis coli (APC); however, therapeutic agents targeting this pathway for clin. use are lacking.  Here we report that nitazoxanide (NTZ), a clin. approved antiparasitic drug, efficiently inhibits Wnt signaling independent of APC.  Using chemoproteomic approaches, we have identified peptidyl arginine deiminase 2 (PAD2) as the functional target of NTZ in Wnt inhibition.  By targeting PAD2, NTZ increased the deamination (citrullination) and turnover of β-catenin in colon cancer cells.  Replacement of arginine residues disrupted the transcriptional activity, and NTZ induced degrdn. of β-catenin.  In Wnt-activated colon cancer cells, knockout of either PAD2 or β-catenin substantially increased resistance to NTZ treatment.  Our data highlight the potential of NTZ as a modulator of β-catenin citrullination for the treatment of cancer patients with Wnt pathway mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghMXVN66jQrVg90H21EOLACvtfcHk0lhcInpBJKaxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtrnP&md5=7aab9502787519d9f2b84ea9c58932d6</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2510%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DY.%26aulast%3DOlsen%26aufirst%3DJ.%2BR.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DP.%2BF.%26aulast%3DLevesque%26aufirst%3DM.%2BP.%26aulast%3DBrokstad%26aufirst%3DK.%2BA.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DOyan%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKalland%26aufirst%3DK.%2BH.%26aulast%3DKe%26aufirst%3DX.%26atitle%3DSmall%2520molecule%2520promotes%2520beta-catenin%2520citrullination%2520and%2520inhibits%2520Wnt%2520signaling%2520in%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D94%26epage%3D101%26doi%3D10.1038%2Fnchembio.2510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Antiepileptic drug carbamazepine binds to a novel pocket on the Wnt receptor Frizzled-8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3252</span>– <span class="NLM_lpage">3260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFyjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3252-3260&author=Y.+Zhaoauthor=J.+Renauthor=J.+Hillierauthor=W.+Luauthor=E.+Y.+Jones&title=Antiepileptic+drug+carbamazepine+binds+to+a+novel+pocket+on+the+Wnt+receptor+Frizzled-8&doi=10.1021%2Facs.jmedchem.9b02020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8</span></div><div class="casAuthors">Zhao, Yuguang; Ren, Jingshan; Hillier, James; Lu, Weixian; Jones, E. Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3252-3260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Misregulation of Wnt signaling is common in human cancer.  The development of small mol. inhibitors against the Wnt receptor, frizzled (FZD), may have potential in cancer therapy.  During small mol. screens, we obsd. binding of carbamazepine to the cysteine-rich domain (CRD) of the Wnt receptor FZD8 using surface plasmon resonance (SPR).  Cellular functional assays demonstrated that carbamazepine can suppress FZD8-mediated Wnt/β-catenin signaling.  We detd. the crystal structure of the complex at 1.7 Å resoln., which reveals that carbamazepine binds at a novel pocket on the FZD8 CRD.  The unique residue Tyr52 discriminates FZD8 from the closely related FZD5 and other FZDs for carbamazepine binding.  The first small mol.-bound FZD structure provides a basis for anti-FZD drug development.  Furthermore, the obsd. carbamazepine-mediated Wnt signaling inhibition may help to explain the phenomenon of bone loss and increased adipogenesis in some patients during long-term carbamazepine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFj5NuAyU747Vg90H21EOLACvtfcHk0lhcInpBJKaxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFyjt7g%253D&md5=073d01a57ee7fa60c96aa0fe45c08090</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02020%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHillier%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DAntiepileptic%2520drug%2520carbamazepine%2520binds%2520to%2520a%2520novel%2520pocket%2520on%2520the%2520Wnt%2520receptor%2520Frizzled-8%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3252%26epage%3D3260%26doi%3D10.1021%2Facs.jmedchem.9b02020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneidewind, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brause, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Chemical genetics reveals a Role of dCTP pyrophosphatase 1 in Wnt signaling</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">13009</span>– <span class="NLM_lpage">13013</span>, <span class="refDoi"> DOI: 10.1002/anie.201905977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fanie.201905977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlejtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=13009-13013&author=A.+Frieseauthor=S.+Kapoorauthor=T.+Schneidewindauthor=S.+R.+Vidadalaauthor=J.+Sardanaauthor=A.+Brauseauthor=T.+Forsterauthor=M.+Bischoffauthor=J.+Wagnerauthor=P.+Janningauthor=S.+Zieglerauthor=H.+Waldmann&title=Chemical+genetics+reveals+a+Role+of+dCTP+pyrophosphatase+1+in+Wnt+signaling&doi=10.1002%2Fanie.201905977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Genetics Reveals a Role of dCTP Pyrophosphatase 1 in Wnt Signaling</span></div><div class="casAuthors">Friese, Alexandra; Kapoor, Shobhna; Schneidewind, Tabea; Vidadala, Srinivasa Rao; Sardana, Juhi; Brause, Alexandra; Foerster, Tim; Bischoff, Matthias; Wagner, Jessica; Janning, Petra; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13009-13013</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cell-based screening is a powerful approach to identify novel chem. modulators and biol. components of relevant biol. processes.  The canonical Wnt pathway is essential for normal embryonic development and tissue homeostasis, and its deregulation plays a crucial role in carcinogenesis.  Therefore, the identification of new pathway members and regulators is of significant interest.  By a cell-based assay monitoring Wnt signaling the authors identified the pyrrolocoumarin Pyrcoumin as inhibitor of canonical Wnt signaling.  Target identification and validation revealed that Pyrcoumin is a competitive inhibitor of dCTP pyrophosphatase 1 (dCTPP1).  The authors demonstrate a yet unknown interaction of dCTPP1 with ubiquitin carboxyl-terminal hydrolase (USP7) that is counteracted by dCTPP1 inhibitors.  DCTPP1 plays a role in regulation of Wnt/β-catenin signaling most likely through a direct interaction with USP7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBsIF5NFs4C7Vg90H21EOLACvtfcHk0lhN2VxPJt391w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlejtL7I&md5=9121926ab95c379a964ccc6f5dc6f23c</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1002%2Fanie.201905977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201905977%26sid%3Dliteratum%253Aachs%26aulast%3DFriese%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DS.%26aulast%3DSchneidewind%26aufirst%3DT.%26aulast%3DVidadala%26aufirst%3DS.%2BR.%26aulast%3DSardana%26aufirst%3DJ.%26aulast%3DBrause%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DT.%26aulast%3DBischoff%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DJanning%26aufirst%3DP.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DChemical%2520genetics%2520reveals%2520a%2520Role%2520of%2520dCTP%2520pyrophosphatase%25201%2520in%2520Wnt%2520signaling%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D13009%26epage%3D13013%26doi%3D10.1002%2Fanie.201905977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting beta-Catenin Signaling by Natural Products for Cancer Prevention and Therapy</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffphar.2020.00984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32695004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWnsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=984&author=W.+K.+Yuauthor=Z.+Y.+Xuauthor=L.+Yuanauthor=S.+Moauthor=B.+Xuauthor=X.+D.+Chengauthor=J.+J.+Qin&title=Targeting+beta-Catenin+Signaling+by+Natural+Products+for+Cancer+Prevention+and+Therapy&doi=10.3389%2Ffphar.2020.00984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting β-catenin signaling by natural products for cancer prevention and therapy</span></div><div class="casAuthors">Yu, Wen-Kai; Xu, Zhi-Yuan; Li Yuan; Mo, Shaowei; Xu, Beihua; Cheng, Xiang-Dong; Qin, Jiang-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00984</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The mutations and deregulation of Wnt signaling pathway occur commonly in human cancer and cause the aberrant activation of β-catenin and β-catenin-dependent transcription, thus contributing to cancer development and progression.  Therefore, β-catenin has been demonstrated as a promising target for cancer prevention and therapy.  Many natural products have been characterized as inhibitors of the b-catenin signaling through down-regulating β-catenin expression, modulating its phosphorylation, promoting its ubiquitination and proteasomal degrdn., inhibiting its nuclear translocation, or other mol. mechanisms.  These natural product inhibitors have shown preventive and therapeutic efficacy in various cancer models in vitro and in vivo.  In the present review, we comprehensively discuss the natural product b-catenin inhibitors, their in vitro and in vivo anticancer activities, and underlying mol. mechanisms.  We also discuss the current β-catenin-targeting strategies and other potential strategies that may be examd. for identifying new β-catenin inhibitors as cancer preventive and therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8k16coc5jlbVg90H21EOLACvtfcHk0lhN2VxPJt391w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWnsr7P&md5=988b584fb29e5aee60b7b53ef2d8ec86</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00984%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BK.%26aulast%3DXu%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DX.%2BD.%26aulast%3DQin%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520beta-Catenin%2520Signaling%2520by%2520Natural%2520Products%2520for%2520Cancer%2520Prevention%2520and%2520Therapy%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D984%26doi%3D10.3389%2Ffphar.2020.00984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Robertis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valensin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benicchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Then, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-1176-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1535-7163.MCT-12-1176-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23619303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1180-1189&author=A.+De+Robertisauthor=S.+Valensinauthor=M.+Rossiauthor=P.+Tuniciauthor=M.+Veraniauthor=A.+De+Rosaauthor=C.+Giordanoauthor=M.+Varroneauthor=A.+Nenciniauthor=C.+Pratelliauthor=T.+Benicchiauthor=A.+Bakkerauthor=J.+Hillauthor=K.+Sangthongpitagauthor=V.+Pendharkarauthor=B.+Liuauthor=F.+M.+Ngauthor=S.+W.+Thenauthor=S.+J.+Taiauthor=S.+M.+Cheongauthor=X.+Heauthor=A.+Caricasoleauthor=M.+Salerno&title=Identification+and+characterization+of+a+small-molecule+inhibitor+of+Wnt+signaling+in+glioblastoma+cells&doi=10.1158%2F1535-7163.MCT-12-1176-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells</span></div><div class="casAuthors">De Robertis, Alessandra; Valensin, Silvia; Rossi, Marco; Tunici, Patrizia; Verani, Margherita; De Rosa, Antonella; Giordano, Cinzia; Varrone, Maurizio; Nencini, Arianna; Pratelli, Carmela; Benicchi, Tiziana; Bakker, Annette; Hill, Jeffrey; Sangthongpitag, Kanda; Pendharkar, Vishal; Liu, Boping; Ng, Fui Mee; Then, Siew Wen; Tai, Shi Jing; Cheong, Seong-Moon; He, Xi; Caricasole, Andrea; Salerno, Massimiliano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1180-1189</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common and prognostically unfavorable form of brain tumor.  The aggressive and highly invasive phenotype of these tumors makes them among the most anatomically damaging human cancers with a median survival of less than 1 yr.  Although canonical Wnt pathway activation in cancers has been historically linked to the presence of mutations involving key components of the pathway (APC, β-catenin, or Axin proteins), an increasing no. of studies suggest that elevated Wnt signaling in GBM is initiated by several alternative mechanisms that are involved in different steps of the disease.  Therefore, inhibition of Wnt signaling may represent a therapeutically relevant approach for GBM treatment.  After the selection of a GBM cell model responsive to Wnt inhibition, we set out to develop a screening approach for the identification of compds. capable of modulating canonical Wnt signaling and assocd. proliferative responses in GBM cells.  Here, we show that the small mol. SEN461 inhibits the canonical Wnt signaling pathway in GBM cells, with relevant effects at both mol. and phenotypic levels in vitro and in vivo.  These include SEN461-induced Axin stabilization, increased β-catenin phosphorylation/degrdn., and inhibition of anchorage-independent growth of human GBM cell lines and patient-derived primary tumor cells in vitro.  Moreover, in vivo administration of SEN461 antagonized Wnt signaling in Xenopus embryos and reduced tumor growth in a GBM xenograft model.  These data represent the first demonstration that small-mol.-mediated inhibition of Wnt signaling may be a potential approach for GBM therapeutics.  Mol Cancer Ther; 12(7); 1180-9. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGyMfLU6vwVrVg90H21EOLACvtfcHk0ljVaO4W62EJNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfM&md5=b09c76be297b4773d695d17a318474d4</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-1176-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-1176-T%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRobertis%26aufirst%3DA.%26aulast%3DValensin%26aufirst%3DS.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DTunici%26aufirst%3DP.%26aulast%3DVerani%26aufirst%3DM.%26aulast%3DDe%2BRosa%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DPratelli%26aufirst%3DC.%26aulast%3DBenicchi%26aufirst%3DT.%26aulast%3DBakker%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DNg%26aufirst%3DF.%2BM.%26aulast%3DThen%26aufirst%3DS.%2BW.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DCheong%26aufirst%3DS.%2BM.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DSalerno%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520Wnt%2520signaling%2520in%2520glioblastoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1180%26epage%3D1189%26doi%3D10.1158%2F1535-7163.MCT-12-1176-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shegravina, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitnikov, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faerman, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmalz, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svirshchevskaya, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of furanoallocolchicinoids</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1021/jm501678w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501678w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=692-704&author=Y.+V.+Voitovichauthor=E.+S.+Shegravinaauthor=N.+S.+Sitnikovauthor=V.+I.+Faermanauthor=V.+V.+Fokinauthor=H.+G.+Schmalzauthor=S.+Combesauthor=D.+Allegroauthor=P.+Barbierauthor=I.+P.+Beletskayaauthor=E.+V.+Svirshchevskayaauthor=A.+Y.+Fedorov&title=Synthesis+and+biological+evaluation+of+furanoallocolchicinoids&doi=10.1021%2Fjm501678w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Furanoallocolchicinoids</span></div><div class="casAuthors">Voitovich, Yuliya V.; Shegravina, Ekaterina S.; Sitnikov, Nikolay S.; Faerman, Vladimir I.; Fokin, Valery V.; Schmalz, Hans-Gunther; Combes, Sebastien; Allegro, Diane; Barbier, Pascal; Beletskaya, Irina P.; Svirshchevskaya, Elena V.; Fedorov, Alexey Yu.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of conformationally flexible furan-derived allocolchicinoids was prepd. from com. available colchicine in good to excellent yields using a three-step reaction sequence.  Cytotoxicity studies indicated the potent activity of two compds. against human epithelial and lymphoid cell lines (AsPC-1, HEK293, and Jurkat) as well as against Wnt-1 related murine epithelial cell line W1308.  The results of in vitro expts. demonstrated that the major effect of these compds. was the induction of cell cycle arrest in the G2/M phase as a direct consequence of effective tubulin binding.  In vivo testing of the most potent furanoallocolchicinoid I using C57BL/6 mice inoculated with Wnt-1 tumor cells indicated significant inhibition of the tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_x3Suuo2S0rVg90H21EOLACvtfcHk0ljVaO4W62EJNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsr3J&md5=e82912b440db9dd48ed85a2345f14889</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fjm501678w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501678w%26sid%3Dliteratum%253Aachs%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DShegravina%26aufirst%3DE.%2BS.%26aulast%3DSitnikov%26aufirst%3DN.%2BS.%26aulast%3DFaerman%26aufirst%3DV.%2BI.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSchmalz%26aufirst%3DH.%2BG.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DAllegro%26aufirst%3DD.%26aulast%3DBarbier%26aufirst%3DP.%26aulast%3DBeletskaya%26aufirst%3DI.%2BP.%26aulast%3DSvirshchevskaya%26aufirst%3DE.%2BV.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520furanoallocolchicinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D692%26epage%3D704%26doi%3D10.1021%2Fjm501678w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1832</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1821-1832&author=Y.+Zouauthor=D.+Zhaoauthor=C.+Yanauthor=Y.+Jiauthor=J.+Liuauthor=J.+Xuauthor=Y.+Laiauthor=J.+Tianauthor=Y.+Zhangauthor=Z.+Huang&title=Novel+ligustrazine-based+analogs+of+piperlongumine+potently+suppress+proliferation+and+metastasis+of+colorectal+cancer+cells+in+vitro+and+in+vivo&doi=10.1021%2Facs.jmedchem.7b01096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo</span></div><div class="casAuthors">Zou, Yu; Zhao, Di; Yan, Chang; Ji, Yanpeng; Liu, Jin; Xu, Jinyi; Lai, Yisheng; Tian, Jide; Zhang, Yihua; Huang, Zhangjian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1821-1832</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Piperlongumine 1 increases reactive oxygen species (ROS) levels and preferably induces cancer cell apoptosis by triggering different pathways.  However, the poor soly. of 1 limits its intensive investigation and clin. application.  Ligustrazine possesses a water-sol. pyrazine skeleton and can inhibit proliferation and metastasis of cancer cells.  We synthesized compd. I by replacement of the trimethoxyphenyl of 1 with ligustrazine moiety and further introduced 2-Cl, -Br, and -I to I for synthesis of 4-6, resp.  Compd. II possessed 14-fold greater aq. soly. than 1 and increased ROS levels in colorectal cancer HCT-116 cells.  Addnl., II preferably inhibited proliferation, migration, invasion, and heteroadhesion of HCT-116 cells.  Treatment with II suppressed tumor growth and lung metastasis in vivo and prolonged the survival of tumor-bearing mice.  Furthermore, II mitigated TGF-β1-induced epithelial-mesenchymal transition and Wnt/β-catenin activation by inhibiting the Akt and GSK-3β phosphorylation in HCT-116 cells.  Collectively, II displayed significant antiproliferation and antimetastasis activities, superior to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVFYsseVww97Vg90H21EOLACvtfcHk0lhphKAi5XIxSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGks7Y%253D&md5=be6500823424caca2043fa857ac72515</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01096%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DNovel%2520ligustrazine-based%2520analogs%2520of%2520piperlongumine%2520potently%2520suppress%2520proliferation%2520and%2520metastasis%2520of%2520colorectal%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1821%26epage%3D1832%26doi%3D10.1021%2Facs.jmedchem.7b01096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Pyrazole-4-carboxamide (YW2065): a therapeutic candidate for colorectal cancer via dual activities of Wnt/beta-catenin signaling inhibition and AMP-activated protein kinase (AMPK) activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11151</span>– <span class="NLM_lpage">11164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Kktb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11151-11164&author=W.+Yangauthor=Y.+Liauthor=Y.+Aiauthor=O.+N.+Obianomauthor=D.+Guoauthor=H.+Yangauthor=S.+Sakamuruauthor=M.+Xiaauthor=Y.+Shuauthor=F.+Xue&title=Pyrazole-4-carboxamide+%28YW2065%29%3A+a+therapeutic+candidate+for+colorectal+cancer+via+dual+activities+of+Wnt%2Fbeta-catenin+signaling+inhibition+and+AMP-activated+protein+kinase+%28AMPK%29+activation&doi=10.1021%2Facs.jmedchem.9b01252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation</span></div><div class="casAuthors">Yang, Wei; Li, Yingjun; Ai, Yong; Obianom, Obinna N.; Guo, Dong; Yang, Hong; Sakamuru, Srilatha; Xia, Menghang; Shu, Yan; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11151-11164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC).  Although numerous Wnt inhibitors have been developed, they commonly suffer from toxicity and unintended effects.  Moreover, concerns have been raised in targeting this pathway because of its crit. roles in maintaining stem cells and regenerating tissues and organs.  On the basis of the anthelmintic drug pyrvinium and previous lead FX1128, we have developed a compd. YW2065 (1c) which demonstrated excellent anti-CRC effects in vitro and in vivo.  YW2065 achieves its inhibitory activity for Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degrdn. of β-catenin.  Simultaneously, YW2065 also led to the activation of the tumor suppressor AMPK, providing an addnl. anticancer mechanism.  In addn., YW2065 showed favorable pharmacokinetic properties without obvious toxicity.  The anti-CRC effect of YW2065 was highlighted by its promising efficacy in a mice xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodOpjGpkTKvrVg90H21EOLACvtfcHk0lhphKAi5XIxSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Kktb3J&md5=a87008ae31b63b3fd0e38f3f9b65fe2c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01252%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSakamuru%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DPyrazole-4-carboxamide%2520%2528YW2065%2529%253A%2520a%2520therapeutic%2520candidate%2520for%2520colorectal%2520cancer%2520via%2520dual%2520activities%2520of%2520Wnt%252Fbeta-catenin%2520signaling%2520inhibition%2520and%2520AMP-activated%2520protein%2520kinase%2520%2528AMPK%2529%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11151%26epage%3D11164%26doi%3D10.1021%2Facs.jmedchem.9b01252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kypta, R.</span></span> <span> </span><span class="NLM_article-title">Secreted antagonists of the Wnt signalling pathway</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2634</span>, <span class="refDoi"> DOI: 10.1242/jcs.00623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1242%2Fjcs.00623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12775774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFamtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=2627-2634&author=Y.+Kawanoauthor=R.+Kypta&title=Secreted+antagonists+of+the+Wnt+signalling+pathway&doi=10.1242%2Fjcs.00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted antagonists of the Wnt signalling pathway</span></div><div class="casAuthors">Kawano, Yoshiaki; Kypta, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2627-2634</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular antagonists of the Wnt signalling pathway can be divided into two broad classes.  Both classes of mol. prevent ligand-receptor interactions, but by different mechanisms: members of the first class, which include the sFRP (secreted Frizzled-related protein) family, WIF (Wnt inhibitory factor)-1 and Cerberus, primarily bind to Wnt proteins; the second class comprises certain members of the Dickkopf (Dkk) family, which bind to one subunit of the Wnt receptor complex.  In addn., there are other protein interactions that contribute to Wnt antagonist function.  Moreover, certain sFRPs and Dkks do not antagonize Wnt function, which suggests that these families have as-yet-undiscovered functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHGuViJPoQVLVg90H21EOLACvtfcHk0lhphKAi5XIxSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFamtLs%253D&md5=fe0fcc326f2701f33d40473630e7ed0a</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00623%26sid%3Dliteratum%253Aachs%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DKypta%26aufirst%3DR.%26atitle%3DSecreted%2520antagonists%2520of%2520the%2520Wnt%2520signalling%2520pathway%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D2627%26epage%3D2634%26doi%3D10.1242%2Fjcs.00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0lhpu5cgl3Fcwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reineke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auslander, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beissbarth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rave-Frank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaedcke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadimi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ried, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grade, M.</span></span> <span> </span><span class="NLM_article-title">Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt/beta-catenin signaling</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1541-7786.MCR-17-0205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28811361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGisrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1481-1490&author=G.+Emonsauthor=M.+Spitznerauthor=S.+Reinekeauthor=J.+M%C3%B6llerauthor=N.+Auslanderauthor=F.+Kramerauthor=Y.+Huauthor=T.+Beissbarthauthor=H.+A.+Wolffauthor=M.+Rave-Frankauthor=E.+Hessmannauthor=J.+Gaedckeauthor=B.+M.+Ghadimiauthor=S.+A.+Johnsenauthor=T.+Riedauthor=M.+Grade&title=Chemoradiotherapy+resistance+in+colorectal+cancer+cells+is+mediated+by+Wnt%2Fbeta-catenin+signaling&doi=10.1158%2F1541-7786.MCR-17-0205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling</span></div><div class="casAuthors">Emons, Georg; Spitzner, Melanie; Reineke, Sebastian; Moller, Janneke; Auslander, Noam; Kramer, Frank; Hu, Yue; Beissbarth, Tim; Wolff, Hendrik A.; Rave-Frank, Margret; Hessmann, Elisabeth; Gaedcke, Jochen; Ghadimi, B. Michael; Johnsen, Steven A.; Ried, Thomas; Grade, Marian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1481-1490</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of Wnt/β-catenin signaling plays a central role in the development and progression of colorectal cancer.  The Wnt-transcription factor, TCF7L2, is overexpressed in primary rectal cancers that are resistant to chemoradiotherapy and TCF7L2 mediates resistance to chemoradiotherapy.  However, it is unclear whether the resistance is mediated by a TCF7L2 inherent mechanism or Wnt/β-catenin signaling in general.  Here, inhibition of β-catenin by siRNAs or a small-mol. inhibitor (XAV-939) resulted in sensitization of colorectal cancer cells to chemoradiotherapy.  To investigate the potential role of Wnt/β-catenin signaling in controlling therapeutic responsiveness, nontumorigenic RPE-1 cells were stimulated with Wnt-3a, a physiol. ligand of Frizzled receptors, which increased resistance to chemoradiotherapy.  This effect could be recapitulated by overexpression of a degrdn.-resistant mutant of β-catenin (S33Y), also boosting resistance of RPE-1 cells to chemoradiotherapy, which was, conversely, abrogated by siRNA-mediated silencing of β-catenin.  Consistent with these findings, higher expression levels of active β-catenin were obsd. as well as increased TCF/LEF reporter activity in SW1463 cells that evolved radiation resistance due to repeated radiation treatment.  Global gene expression profiling identified several altered pathways, including PPAR signaling and other metabolic pathways, assocd. with cellular response to radiation.  In summary, aberrant activation of Wnt/β-catenin signaling not only regulates the development and progression of colorectal cancer, but also mediates resistance of rectal cancers to chemoradiotherapy.  Implications: Targeting Wnt/β-catenin signaling or one of the downstream pathways represents a promising strategy to increase response to chemoradiotherapy.  Mol Cancer Res; 15(11); 1481-90. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSun2clWTLybVg90H21EOLACvtfcHk0lhpu5cgl3Fcwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGisrfI&md5=41ef220b88b6bfee9615adaa491fac2e</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0205%26sid%3Dliteratum%253Aachs%26aulast%3DEmons%26aufirst%3DG.%26aulast%3DSpitzner%26aufirst%3DM.%26aulast%3DReineke%26aufirst%3DS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DJ.%26aulast%3DAuslander%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBeissbarth%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DH.%2BA.%26aulast%3DRave-Frank%26aufirst%3DM.%26aulast%3DHessmann%26aufirst%3DE.%26aulast%3DGaedcke%26aufirst%3DJ.%26aulast%3DGhadimi%26aufirst%3DB.%2BM.%26aulast%3DJohnsen%26aufirst%3DS.%2BA.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DGrade%26aufirst%3DM.%26atitle%3DChemoradiotherapy%2520resistance%2520in%2520colorectal%2520cancer%2520cells%2520is%2520mediated%2520by%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26spage%3D1481%26epage%3D1490%26doi%3D10.1158%2F1541-7786.MCR-17-0205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arques, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicote, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbaum, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dienstmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caratu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silberschmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landolfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuciforo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, H. G.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition blocks Wnt/beta-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-14-3081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26224873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=644-656&author=O.+Arquesauthor=I.+Chicoteauthor=I.+Puigauthor=S.+P.+Tenbaumauthor=G.+Argilesauthor=R.+Dienstmannauthor=N.+Fernandezauthor=G.+Caratuauthor=J.+Matitoauthor=D.+Silberschmidtauthor=J.+Rodonauthor=S.+Landolfiauthor=A.+Pratauthor=E.+Espinauthor=R.+Charcoauthor=P.+Nuciforoauthor=A.+Vivancosauthor=W.+Shaoauthor=J.+Taberneroauthor=H.+G.+Palmer&title=Tankyrase+inhibition+blocks+Wnt%2Fbeta-catenin+pathway+and+reverts+resistance+to+PI3K+and+AKT+inhibitors+in+the+treatment+of+colorectal+cancer&doi=10.1158%2F1078-0432.CCR-14-3081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer</span></div><div class="casAuthors">Arques, Oriol; Chicote, Irene; Puig, Isabel; Tenbaum, Stephan P.; Argiles, Guillem; Dienstmann, Rodrigo; Fernandez, Natalia; Caratu, Ginevra; Matito, Judit; Silberschmidt, Daniel; Rodon, Jordi; Landolfi, Stefania; Prat, Aleix; Espin, Eloy; Charco, Ramon; Nuciforo, Paolo; Vivancos, Ana; Shao, Wenlin; Tabernero, Josep; Palmer, Hector G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">644-656</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Oncogenic mutations in the KRAS/PI3K/AKT pathway are one of the most frequent alterations in cancer.  Although PI3K or AKT inhibitors show promising results in clin. trials, drug resistance frequently emerges.  We previously revealed Wnt/β-catenin signaling hyperactivation as responsible for such resistance in colorectal cancer.  Here we investigate Wnt-mediated resistance in patients treated with PI3K or AKT inhibitors in clin. trials and evaluate the efficacy of a new Wnt/tankyrase inhibitor, NVP-TNKS656, to overcome such resistance.  Exptl. Design: Colorectal cancer patient-derived sphere cultures and mouse tumor xenografts were treated with NVP-TNKS656, in combination with PI3K or AKT inhibitors.  We analyzed progression-free survival of patients treated with different PI3K/AKT/mTOR inhibitors in correlation with Wnt/β-catenin pathway activation, oncogenic mutations, clinicopathol. traits, and gene expression patterns in 40 colorectal cancer baseline tumors.  Results: Combination with NVP-TNKS656 promoted apoptosis in PI3K or AKT inhibitor-resistant cells with high nuclear β-catenin content.  High FOXO3A activity conferred sensitivity to NVP-TNKS656 treatment.  Thirteen of 40 patients presented high nuclear β-catenin content and progressed earlier upon PI3K/AKT/mTOR inhibition.  Nuclear β-catenin levels predicted drug response, whereas clinicopathol. traits, gene expression profiles, or frequent mutations (KRAS, TP53, or PIK3CA) did not.  Conclusions: High nuclear β-catenin content independently predicts resistance to PI3K and AKT inhibitors.  Combined treatment with a Wnt/tankyrase inhibitor reduces nuclear β-catenin, reverts such resistance, and represses tumor growth.  FOXO3A content and activity predicts response to Wnt/β-catenin inhibition and together with β-catenin may be predictive biomarkers of drug response providing a rationale to stratify colorectal cancer patients to be treated with PI3K/AKT/mTOR and Wnt/β-catenin inhibitors.  Clin Cancer Res; 22(3); 644-56. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIvc6o3K2hUrVg90H21EOLACvtfcHk0lgHLkHSz25VZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFeqsrg%253D&md5=62e37267fe02681d6b023521992f0d19</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3081%26sid%3Dliteratum%253Aachs%26aulast%3DArques%26aufirst%3DO.%26aulast%3DChicote%26aufirst%3DI.%26aulast%3DPuig%26aufirst%3DI.%26aulast%3DTenbaum%26aufirst%3DS.%2BP.%26aulast%3DArgiles%26aufirst%3DG.%26aulast%3DDienstmann%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DN.%26aulast%3DCaratu%26aufirst%3DG.%26aulast%3DMatito%26aufirst%3DJ.%26aulast%3DSilberschmidt%26aufirst%3DD.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DEspin%26aufirst%3DE.%26aulast%3DCharco%26aufirst%3DR.%26aulast%3DNuciforo%26aufirst%3DP.%26aulast%3DVivancos%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DPalmer%26aufirst%3DH.%2BG.%26atitle%3DTankyrase%2520inhibition%2520blocks%2520Wnt%252Fbeta-catenin%2520pathway%2520and%2520reverts%2520resistance%2520to%2520PI3K%2520and%2520AKT%2520inhibitors%2520in%2520the%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D644%26epage%3D656%26doi%3D10.1158%2F1078-0432.CCR-14-3081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luke, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweis, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">WNT/beta-catenin pathway activation correlates with immune exclusion across human cancers</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3074</span>– <span class="NLM_lpage">3083</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-18-1942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30635339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1OlsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=3074-3083&author=J.+J.+Lukeauthor=R.+Baoauthor=R.+F.+Sweisauthor=S.+Sprangerauthor=T.+F.+Gajewski&title=WNT%2Fbeta-catenin+pathway+activation+correlates+with+immune+exclusion+across+human+cancers&doi=10.1158%2F1078-0432.CCR-18-1942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">WNT/β-catenin pathway activation correlates with immune exclusion across human cancers</span></div><div class="casAuthors">Luke, Jason J.; Bao, Riyue; Sweis, Randy F.; Spranger, Stefani; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3074-3083</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The T-cell-inflamed phenotype correlates with efficacy of immune-checkpoint blockade, whereas non-T-cell-inflamed tumors infrequently benefit.  Tumor-intrinsic WNT/β-catenin signaling mediates immune exclusion in melanoma, but assocn. with the non-T-cell-inflamed tumor microenvironment in other tumor types is not well understood.  Exptl. Design: Using The Cancer Genome Atlas (TCGA), a T-cell-inflamed gene expression signature segregated samples within tumor types.  Activation of WNT/β-catenin signaling was inferred using three approaches: somatic mutations or somatic copy no. alterations (SCNA) in β-catenin signaling elements including CTNNB1, APC, APC2, AXIN1, and AXIN2; pathway prediction from RNA-sequencing gene expression; and inverse correlation of β-catenin protein levels with the T-cell-inflamed gene expression signature.  Results: Across TCGA, 3,137/9,244 (33.9%) tumors were non-T-cell-inflamed, whereas 3,161/9,244 (34.2%) were T-cell-inflamed.  Non-T-cell-inflamed tumors demonstrated significantly lower expression of T-cell inflammation genes relative to matched normal tissue, arguing for loss of a natural immune phenotype.  Mutations of β-catenin signaling mols. in non-T-cell-inflamed tumors were enriched three-fold relative to T-cell-inflamed tumors.  Across 31 tumors, 28 (90%) demonstrated activated β-catenin signaling in the non-T-cell-inflamed subset by at least one method.  This included target mol. expression from somatic mutations and/or SCNAs of β-catenin signaling elements (19 tumors, 61%), pathway anal. (14 tumors, 45%), and increased β-catenin protein levels (20 tumors, 65%).  Conclusions: Activation of tumor-intrinsic WNT/β-catenin signaling is enriched in non-T-cell-inflamed tumors.  These data provide a strong rationale for development of pharmacol. inhibitors of this pathway with the aim of restoring immune cell infiltration and augmenting immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Rkj_ydtUBbVg90H21EOLACvtfcHk0lgHLkHSz25VZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1OlsLnN&md5=f29ada7d7d00f27f99a76ee84acc6868</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1942%26sid%3Dliteratum%253Aachs%26aulast%3DLuke%26aufirst%3DJ.%2BJ.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DSweis%26aufirst%3DR.%2BF.%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DWNT%252Fbeta-catenin%2520pathway%2520activation%2520correlates%2520with%2520immune%2520exclusion%2520across%2520human%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D3074%26epage%3D3083%26doi%3D10.1158%2F1078-0432.CCR-18-1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielske, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bommer, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldar-Finkelman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Josef, E.</span></span> <span> </span><span class="NLM_article-title">GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1593/neo.92112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1593%2Fneo.92112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20454507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvF2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=357-365&author=R.+L.+Watsonauthor=A.+C.+Spaldingauthor=S.+P.+Zielskeauthor=M.+Morganauthor=A.+C.+Kimauthor=G.+T.+Bommerauthor=H.+Eldar-Finkelmanauthor=T.+Giordanoauthor=E.+R.+Fearonauthor=G.+D.+Hammerauthor=T.+S.+Lawrenceauthor=E.+Ben-Josef&title=GSK3beta+and+beta-catenin+modulate+radiation+cytotoxicity+in+pancreatic+cancer&doi=10.1593%2Fneo.92112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3β and β-catenin modulate radiation cytotoxicity in pancreatic cancer</span></div><div class="casAuthors">Watson, Richard L.; Spalding, Aaron C.; Zielske, Steven P.; Morgan, Meredith; Kim, Alex C.; Bommer, Guido T.; Eldar-Finkelman, Hagit; Giordano, Thomas; Fearon, Eric R.; Hammer, Gary D.; Lawrence, Theodore S.; Ben-Josef, Edgar</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Knowledge of factors and mechanisms contributing to the inherent radioresistance of pancreatic cancer may improve cancer treatment.  Irradn. inhibits glycogen synthase kinase 3β (GSK3β) by phosphorylation at serine 9.  In turn, release of cytosolic membrane β-catenin with subsequent nuclear translocation promotes survival.  Both GSK3β and β-catenin have been implicated in cancer cell proliferation and resistance to death.  We investigated pancreatic cancer cell survival after radiation in vitro and in vivo, with a particular focus on the role of the function of the GSK3β/β-catenin axis.  Lithium chloride, RNAi-medicated silencing of GSK3β, or the expression of a kinase dead mutant GSK3β resulted in radioresistance of Panc1 and BxPC3 pancreatic cancer cells.  Conversely, ectopic expression of a constitutively active form of GSK3β resulted in radiosensitization of Panc1 cells.  GSK3β silencing increased radiation-induced β-catenin target gene expression asmeasured by studies of AXIN2 and LEF1 transcript levels.  Western blot anal. of total and phosphorylated levels of GSK3β and β-catenin showed that GSK3β inhibition resulted in stabilization of β-catenin.  Xenografts of both BxPC3 and Panc1 with targeted silencing of GSK3β exhibited radioresistance in vivo.  Silencing of β-catenin resulted in radiosensitization, whereas a nondegradable β-catenin construct induced radioresistance.  These data support the hypothesis that GSK3β modulates the cellular response to radiation in a β-catenin-dependent mechanism.  Further understanding of this pathway may enhance the development of clin. trials combining drugs inhibiting β-catenin activation with radiation and chemotherapy in locally advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdC_qbJgWZzbVg90H21EOLACvtfcHk0liMN8N3Eob6uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvF2kurk%253D&md5=a656ae524c51ae7157ff10e930c05ecb</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1593%2Fneo.92112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.92112%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DR.%2BL.%26aulast%3DSpalding%26aufirst%3DA.%2BC.%26aulast%3DZielske%26aufirst%3DS.%2BP.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DA.%2BC.%26aulast%3DBommer%26aufirst%3DG.%2BT.%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DBen-Josef%26aufirst%3DE.%26atitle%3DGSK3beta%2520and%2520beta-catenin%2520modulate%2520radiation%2520cytotoxicity%2520in%2520pancreatic%2520cancer%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D357%26epage%3D365%26doi%3D10.1593%2Fneo.92112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cytoplasmic GSK-3beta increases cisplatin resistance through activation of Wnt/beta-catenin signaling in A549/DDP cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23673211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlGgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2013&pages=231-239&author=Y.+Gaoauthor=Z.+Liuauthor=X.+Zhangauthor=J.+Heauthor=Y.+Panauthor=F.+Haoauthor=L.+Xieauthor=Q.+Liauthor=X.+Qiuauthor=E.+Wang&title=Inhibition+of+cytoplasmic+GSK-3beta+increases+cisplatin+resistance+through+activation+of+Wnt%2Fbeta-catenin+signaling+in+A549%2FDDP+cells&doi=10.1016%2Fj.canlet.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells</span></div><div class="casAuthors">Gao, Yuan; Liu, Zan; Zhang, Xiuwei; He, Jiani; Pan, Yongqi; Hao, Fengxia; Xie, Lingling; Li, Qingchang; Qiu, Xueshan; Wang, Enhua</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cisplatin-based chemotherapy is recommended as the first-line therapy for advanced non-small cell lung cancer (NSCLC).  However, acquired cisplatin resistance is ubiquitous in patients with NSCLC, but the mol. mechanism of such resistance remains ambiguous.  The present study sought to examine the role of the Wnt/β-catenin signaling pathway in cisplatin resistance by assessing the phosphorylation and subcellular distribution of GSK-3β in a human lung adenocarcinoma cell line, A549, and its cisplatin-resistant subline, A549/DDP.  Total GSK-3β, phosphorylated GSK-3βser9 and phosphorylated GSK-3βtyr216 in cytoplasmic and nuclear fractions of A549/DDP and A549 cells were examd. by western blot anal.  The regulation of cisplatin resistance, apoptosis, β-catenin and survivin protein expression by inhibition of cytoplasmic GSK-3β were detd. by MTT assay, flow cytometry anal., immunofluorescence technique and western blot anal.  In the present study, cytoplasmic levels of p-GSK-3βser9 were significantly increased in A549/DDP cells as compared with A549 cells (P < 0.01), and these levels were further increased by cisplatin treatment in A549/DDP cells (P < 0.01).  In contrast, cytoplasmic levels of p-GSK-3βser9 were reduced in A549 cells after treatment with cisplatin (P < 0.01).  However, cytoplasmic levels of p-GSK-3βtyr216 were significantly decreased in A549/DDP cells as compared with A549 cells (P < 0.01), and these levels were further decreased by cisplatin treatment in A549/DDP cells (P < 0.01).  Conversely, cytoplasmic levels of p-GSK-3βtyr216 were raised in A549 cells after treatment with cisplatin (P < 0.01).  Anal. of downstream effectors of the Wnt/β-catenin signaling pathway revealed upregulation of β-catenin and survivin expression in A549/DDP cells treated with cisplatin as compared to untreated cells.  In A549 cells, cisplatin treatment decreased the expression of β-catenin and survivin.  Furthermore, phosphorylation of GSK-3β at serine 9 by LiCl and transient interference of GSK-3β by siRNA increased β-catenin and survivin protein expression in A549/DDP cells.  Low exogenous and endogenous cytoplasmic GSK-3β expression enhanced the IC50 and inhibited apoptosis.  In conclusion, activation of the Wnt/β-catenin signaling pathway and upregulated survivin expression due to cytoplasmic GSK-3β inhibition might lead to cisplatin resistance in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTlRW1e5KsrVg90H21EOLACvtfcHk0liMN8N3Eob6uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlGgtrw%253D&md5=4ea4690cfd74edeb42af40825b637516</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520cytoplasmic%2520GSK-3beta%2520increases%2520cisplatin%2520resistance%2520through%2520activation%2520of%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520A549%252FDDP%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D336%26spage%3D231%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacarelli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakashev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kossenkov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showe, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span> <span> </span><span class="NLM_article-title">N<sup>6</sup>-methylation of adenosine of <i>FZD10</i> mRNA contributes to PARP inhibitor resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2812</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-18-3592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-18-3592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30967398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslCrsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=2812-2820&author=T.+Fukumotoauthor=H.+Zhuauthor=T.+Nacarelliauthor=S.+Karakashevauthor=N.+Fatkhutdinovauthor=S.+Wuauthor=P.+Liuauthor=A.+V.+Kossenkovauthor=L.+C.+Showeauthor=S.+Jeanauthor=L.+Zhangauthor=R.+Zhang&title=N6-methylation+of+adenosine+of+FZD10+mRNA+contributes+to+PARP+inhibitor+resistance&doi=10.1158%2F0008-5472.CAN-18-3592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">N6-methylation of adenosine of FZD10 mRNA contributes to PARP inhibitor resistance</span></div><div class="casAuthors">Fukumoto, Takeshi; Zhu, Hengrui; Nacarelli, Timothy; Karakashev, Sergey; Fatkhutdinov, Nail; Wu, Shuai; Liu, Pingyu; Kossenkov, Andrew V.; Showe, Louise C.; Jean, Stephanie; Zhang, Lin; Zhang, Rugang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2812-2820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite the high initial response rates to PARP inhibitors (PARPi) in BRCA-mutated epithelial ovarian cancers (EOC), PARPi resistance remains a major challenge.  Chem. modifications of RNAs have emerged as a new layer of epigenetic gene regulation.  N6-methyladenosine (m6A) is the most abundant chem. modification of mRNA, yet the role of m6A modification in PARPi resistance has not previously been explored.  Here, we show that m6A modification of FZD10 mRNA contributes to PARPi resistance by upregulating the Wnt/beta-catenin pathway in BRCA-mutated EOC cells.  Global m6A profile revealed a significant increase in m6A modification in FZD10 mRNA, which correlated with increased FZD10 mRNA stability and an upregulation of the Wnt/beta-catenin pathway.  Mechanistically, downregulation of m6A demethylases FTO and ALKBH5 was sufficient to increase FZD10 mRNA m6A modification and reduce PARPi sensitivity, which correlated with an increase in homologous recombination activity.  Moreover, combined inhibition of PARP and Wnt/beta-catenin showed synergistic suppression of PARPi-resistant cells in vitro and in vivo in a xenograft EOC mouse model.  Overall, our results show that m6A contributes to PARPi resistance in BRCA-deficient EOC cells by upregulating the Wnt/beta-catenin pathway via stabilization of FZD10.  They also suggest that inhibition of the Wnt/beta-catenin pathway represents a potential strategy to overcome PARPi resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq60ZoEmpP5RrVg90H21EOLACvtfcHk0liMN8N3Eob6uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslCrsLzE&md5=918ad8f47954926ac6b291fe53e4fa99</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-3592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-3592%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DNacarelli%26aufirst%3DT.%26aulast%3DKarakashev%26aufirst%3DS.%26aulast%3DFatkhutdinov%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DKossenkov%26aufirst%3DA.%2BV.%26aulast%3DShowe%26aufirst%3DL.%2BC.%26aulast%3DJean%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26atitle%3DN6-methylation%2520of%2520adenosine%2520of%2520FZD10%2520mRNA%2520contributes%2520to%2520PARP%2520inhibitor%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D2812%26epage%3D2820%26doi%3D10.1158%2F0008-5472.CAN-18-3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rathert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muerdter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny-Reiterer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jude, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boryn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontsch-Grunt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakoc, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span> <span> </span><span class="NLM_article-title">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>525</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/nature14898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26367798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=543-547&author=P.+Rathertauthor=M.+Rothauthor=T.+Neumannauthor=F.+Muerdterauthor=J.+S.+Roeauthor=M.+Muharauthor=S.+Deswalauthor=S.+Cerny-Reitererauthor=B.+Peterauthor=J.+Judeauthor=T.+Hoffmannauthor=L.+M.+Borynauthor=E.+Axelssonauthor=N.+Schweiferauthor=U.+Tontsch-Gruntauthor=L.+E.+Dowauthor=D.+Gianniauthor=M.+Pearsonauthor=P.+Valentauthor=A.+Starkauthor=N.+Krautauthor=C.+R.+Vakocauthor=J.+Zuber&title=Transcriptional+plasticity+promotes+primary+and+acquired+resistance+to+BET+inhibition&doi=10.1038%2Fnature14898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span></div><div class="casAuthors">Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Roe, Jae-Seok; Muhar, Matthias; Deswal, Sumit; Cerny-Reiterer, Sabine; Peter, Barbara; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Schweifer, Norbert; Tontsch-Grunt, Ulrike; Dow, Lukas E.; Gianni, Davide; Pearson, Mark; Valent, Peter; Stark, Alexander; Kraut, Norbert; Vakoc, Christopher R.; Zuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">543-547</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Following the discovery of BRD4 as a non-oncogene addiction target in acute myeloid leukemia (AML), bromodomain and extra terminal protein (BET) inhibitors are being explored as a promising therapeutic avenue in numerous cancers.  While clin. trials have reported single-agent activity in advanced hematol. malignancies, mechanisms detg. the response to BET inhibition remain poorly understood.  To identify factors involved in primary and acquired BET resistance in leukemia, here we perform a chromatin-focused RNAi screen in a sensitive MLL-AF9;NrasG12D-driven AML mouse model, and investigate dynamic transcriptional profiles in sensitive and resistant mouse and human leukemias.  Our screen shows that suppression of the PRC2 complex, contrary to effects in other contexts, promotes BET inhibitor resistance in AML.  PRC2 suppression does not directly affect the regulation of Brd4-dependent transcripts, but facilitates the remodelling of regulatory pathways that restore the transcription of key targets such as Myc.  Similarly, while BET inhibition triggers acute MYC repression in human leukemias regardless of their sensitivity, resistant leukemias are uniformly characterized by their ability to rapidly restore MYC transcription.  This process involves the activation and recruitment of WNT signaling components, which compensate for the loss of BRD4 and drive resistance in various cancer models.  Dynamic chromatin immunopptn. sequencing and self-transcribing active regulatory region sequencing of enhancer profiles reveal that BET-resistant states are characterized by remodelled regulatory landscapes, involving the activation of a focal MYC enhancer that recruits WNT machinery in response to BET inhibition.  Together, our results identify and validate WNT signaling as a driver and candidate biomarker of primary and acquired BET resistance in leukemia, and implicate the rewiring of transcriptional programs as an important mechanism promoting resistance to BET inhibitors and, potentially, other chromatin-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDgeY3nFr4GrVg90H21EOLACvtfcHk0lhXCYd6WQ_IGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO&md5=6d6cf4c4123ad6a698b88f02f95a2ebe</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature14898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14898%26sid%3Dliteratum%253Aachs%26aulast%3DRathert%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DT.%26aulast%3DMuerdter%26aufirst%3DF.%26aulast%3DRoe%26aufirst%3DJ.%2BS.%26aulast%3DMuhar%26aufirst%3DM.%26aulast%3DDeswal%26aufirst%3DS.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DB.%26aulast%3DJude%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBoryn%26aufirst%3DL.%2BM.%26aulast%3DAxelsson%26aufirst%3DE.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DZuber%26aufirst%3DJ.%26atitle%3DTranscriptional%2520plasticity%2520promotes%2520primary%2520and%2520acquired%2520resistance%2520to%2520BET%2520inhibition%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D543%26epage%3D547%26doi%3D10.1038%2Fnature14898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ftouni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giotopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Wahab, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouzarides, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntly, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinjha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papenfuss, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M. A.</span></span> <span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>525</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/β-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0lhXCYd6WQ_IGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1038/nature14404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25970248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=231-235&author=S.+Sprangerauthor=R.+Baoauthor=T.+F.+Gajewski&title=Melanoma-intrinsic+beta-catenin+signalling+prevents+anti-tumour+immunity&doi=10.1038%2Fnature14404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span></div><div class="casAuthors">Spranger, Stefani; Bao, Riyue; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma treatment is being revolutionized by the development of effective immunotherapeutic approaches.  These strategies include blockade of immune-inhibitory receptors on activated T cells; for example, using monoclonal antibodies against CTLA-4, PD-1, and PD-L1 (refs 3, 4, 5).  However, only a subset of patients responds to these treatments, and data suggest that therapeutic benefit is preferentially achieved in patients with a pre-existing T-cell response against their tumor, as evidenced by a baseline CD8+ T-cell infiltration within the tumor microenvironment.  Understanding the mol. mechanisms that underlie the presence or absence of a spontaneous anti-tumor T-cell response in subsets of cases, therefore, should enable the development of therapeutic solns. for patients lacking a T-cell infiltrate.  Here the authors identify a melanoma-cell-intrinsic oncogenic pathway that contributes to a lack of T-cell infiltration in melanoma.  Mol. anal. of human metastatic melanoma samples revealed a correlation between activation of the WNT/β-catenin signaling pathway and absence of a T-cell gene expression signature.  Using autochthonous mouse melanoma models the authors identified the mechanism by which tumor-intrinsic active β-catenin signaling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy.  Specific oncogenic signals, therefore, can mediate cancer immune evasion and resistance to immunotherapies, pointing to new candidate targets for immune potentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXZ3KSCsvVbVg90H21EOLACvtfcHk0ljYsCfJ9cyKrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL&md5=ff32a95e2614e76cf9f9167e35bf015e</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnature14404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14404%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DMelanoma-intrinsic%2520beta-catenin%2520signalling%2520prevents%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D231%26epage%3D235%26doi%3D10.1038%2Fnature14404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holtzhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orabona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, B. A.</span></span> <span> </span><span class="NLM_article-title">Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-14-0167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F2326-6066.CIR-14-0167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26041736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFartL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=1082-1095&author=A.+Holtzhausenauthor=F.+Zhaoauthor=K.+S.+Evansauthor=M.+Tsutsuiauthor=C.+Orabonaauthor=D.+S.+Tylerauthor=B.+A.+Hanks&title=Melanoma-derived+Wnt5a+promotes+local+dendritic-cell+expression+of+IDO+and+immunotolerance%3A+opportunities+for+pharmacologic+enhancement+of+immunotherapy&doi=10.1158%2F2326-6066.CIR-14-0167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy</span></div><div class="casAuthors">Holtzhausen, Alisha; Zhao, Fei; Evans, Kathy S.; Tsutsui, Masahito; Orabona, Ciriana; Tyler, Douglas S.; Hanks, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1082-1095</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The β-catenin signaling pathway has been demonstrated to promote the development of a tolerogenic dendritic cell (DC) population capable of driving regulatory T-cell (Treg) differentiation.  Further studies have implicated tolerogenic DCs in promoting carcinogenesis in preclin. models.  The mol. mechanisms underlying the establishment of immune tolerance by this DC population are poorly understood, and the methods by which developing cancers can co-opt this pathway to subvert immune surveillance are currently unknown.  This work demonstrates that melanoma-derived Wnt5a ligand upregulates the durable expression and activity of the indoleamine 2,3-dioxygenase-1 (IDO) enzyme by local DCs in a manner that depends upon the β-catenin signaling pathway.  These data indicate that Wnt5a-conditioned DCs promote the differentiation of Tregs in an IDO-dependent manner, and that this process serves to suppress melanoma immune surveillance.  We further show that the genetic silencing of the PORCN membrane-bound O-acyl transferase, which is necessary for melanoma Wnt ligand secretion, enhances antitumor T-cell immunity, and that the pharmacol. inhibition of this enzyme synergistically suppresses melanoma progression when combined with anti-CTLA-4 antibody therapy.  Finally, our data suggest that β-catenin signaling activity, based on a target gene expression profile that includes IDO in human sentinel lymph node-derived DCs, is assocd. with melanoma disease burden and diminished progression-free survival.  This work implicates the Wnt-β-catenin signaling pathway as a novel therapeutic target in the melanoma immune microenvironment and demonstrates the potential impact of manipulating DC function as a strategy for optimizing tumor immunotherapy.  Cancer Immunol Res; 3(9); 1082-95. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre5HUP7C9jNbVg90H21EOLACvtfcHk0ljYsCfJ9cyKrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFartL%252FI&md5=cf6396a672842f4f85ee65ca74e10548</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-14-0167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-14-0167%26sid%3Dliteratum%253Aachs%26aulast%3DHoltzhausen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DK.%2BS.%26aulast%3DTsutsui%26aufirst%3DM.%26aulast%3DOrabona%26aufirst%3DC.%26aulast%3DTyler%26aufirst%3DD.%2BS.%26aulast%3DHanks%26aufirst%3DB.%2BA.%26atitle%3DMelanoma-derived%2520Wnt5a%2520promotes%2520local%2520dendritic-cell%2520expression%2520of%2520IDO%2520and%2520immunotolerance%253A%2520opportunities%2520for%2520pharmacologic%2520enhancement%2520of%2520immunotherapy%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2015%26volume%3D3%26spage%3D1082%26epage%3D1095%26doi%3D10.1158%2F2326-6066.CIR-14-0167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theivanthiran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boczkowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, B. A.</span></span> <span> </span><span class="NLM_article-title">Paracrine Wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.immuni.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29343435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=147-160&author=F.+Zhaoauthor=C.+Xiaoauthor=K.+S.+Evansauthor=T.+Theivanthiranauthor=N.+DeVitoauthor=A.+Holtzhausenauthor=J.+Liuauthor=X.+Liuauthor=D.+Boczkowskiauthor=S.+Nairauthor=J.+W.+Locasaleauthor=B.+A.+Hanks&title=Paracrine+Wnt5a-beta-catenin+signaling+triggers+a+metabolic+program+that+drives+dendritic+cell+tolerization&doi=10.1016%2Fj.immuni.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization</span></div><div class="casAuthors">Zhao, Fei; Xiao, Christine; Evans, Kathy S.; Theivanthiran, Tbalamayooran; DeVito, Nicholas; Holtzhausen, Alisha; Liu, Juan; Liu, Xiaojing; Boczkowski, David; Nair, Smita; Locasale, Jason W.; Hanks, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-160.e7</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies.  Emerging evidence indicates that the tolerization of local dendritic cells (DCs) within the tumor microenvironment promotes immune evasion.  Here, we have described a mechanism by which melanomas establish a site of immune privilege via a paracrine Wnt5a-β-catenin-peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling pathway that drives fatty acid oxidn. (FAO) in DCs by upregulating the expression of the carnitine palmitoyltransferase-1A (CPT1A) fatty acid transporter.  This FAO shift increased the protoporphyrin IX prosthetic group of indoleamine 2,3-dioxgenase-1 (IDO) while suppressing interleukin(IL)-6 and IL-12 cytokine expression, culminating in enhanced IDO activity and the generation of regulatory T cells.  We demonstrated that blockade of this pathway augmented anti-melanoma immunity, enhanced the activity of anti-PD-1 antibody immunotherapy, and suppressed disease progression in a transgenic melanoma model.  This work implicates a role for tumor-mediated metabolic reprogramming of local DCs in immune evasion and immunotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRK5nTeHUckbVg90H21EOLACvtfcHk0lgIHILKr9Dk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOisrc%253D&md5=63c7ecaeb38f565b2ea7fafdea6edaf1</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DEvans%26aufirst%3DK.%2BS.%26aulast%3DTheivanthiran%26aufirst%3DT.%26aulast%3DDeVito%26aufirst%3DN.%26aulast%3DHoltzhausen%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBoczkowski%26aufirst%3DD.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26aulast%3DHanks%26aufirst%3DB.%2BA.%26atitle%3DParacrine%2520Wnt5a-beta-catenin%2520signaling%2520triggers%2520a%2520metabolic%2520program%2520that%2520drives%2520dendritic%2520cell%2520tolerization%26jtitle%3DImmunity%26date%3D2018%26volume%3D48%26spage%3D147%26epage%3D160%26doi%3D10.1016%2Fj.immuni.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamra, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodcock, S.</span></span> <span> </span><span class="NLM_article-title">Abstract 506: Wnt/β-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">506</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2019-506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1538-7445.AM2019-506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=506&author=C.+Phillipsauthor=I.+Bhamraauthor=C.+Eagleauthor=A.+E.+Cookauthor=C.+Jonesauthor=S.+Woodcock&title=Abstract+506%3A+Wnt%2F%CE%B2-Catenin+pathway+inhibitor+RXC004+enhances+the+immunity+of+pre-clinical+models+of+cancer&doi=10.1158%2F1538-7445.AM2019-506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2019-506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2019-506%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DEagle%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DWoodcock%26aufirst%3DS.%26atitle%3DAbstract%2520506%253A%2520Wnt%252F%25CE%25B2-Catenin%2520pathway%2520inhibitor%2520RXC004%2520enhances%2520the%2520immunity%2520of%2520pre-clinical%2520models%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D506%26doi%3D10.1158%2F1538-7445.AM2019-506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Proteolysis targeting chimera (PROTAC): a paradigm-shifting approach in small molecule drug discovery</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.2174/1568026618666181010101922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.2174%2F1568026618666181010101922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30306871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1354-1356&author=P.+Wangauthor=J.+Zhou&title=Proteolysis+targeting+chimera+%28PROTAC%29%3A+a+paradigm-shifting+approach+in+small+molecule+drug+discovery&doi=10.2174%2F1568026618666181010101922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis Targeting Chimera (PROTAC): A Paradigm-Shifting Approach in Small Molecule Drug Discovery</span></div><div class="casAuthors">Wang, Pingyuan; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1354-1356</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review discussing the advantages of proteolysis targeting chimera (PROTAC) technol. for drug discovery and compared to traditional small mol. drug discovery for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2zjZKjC4m_bVg90H21EOLACvtfcHk0lgIHILKr9Dk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgu7nK&md5=7b301a759d7b1c3c749a1d8ec9b5dd9c</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.2174%2F1568026618666181010101922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666181010101922%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DProteolysis%2520targeting%2520chimera%2520%2528PROTAC%2529%253A%2520a%2520paradigm-shifting%2520approach%2520in%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D1354%26epage%3D1356%26doi%3D10.2174%2F1568026618666181010101922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span> <span> </span><span class="NLM_article-title">Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">105532</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2021.105532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.phrs.2021.105532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=33677106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2021&pages=105532&author=K.+Shahauthor=S.+Panchalauthor=B.+Patel&title=Porcupine+inhibitors%3A+Novel+and+emerging+anti-cancer+therapeutics+targeting+the+Wnt+signaling+pathway&doi=10.1016%2Fj.phrs.2021.105532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway</span></div><div class="casAuthors">Shah, Karmani; Panchal, Shivangi; Patel, Bhumika</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105532</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Porcupine is a constituent of the 19 membered Wnt family with diverse biol. features such as cell differentiation, cell proliferation, cell migration, apoptosis, etc.  Porcupine is a membrane-bound o-acyltransferase family protein that modulates Wnt protein through palmitoylation to allow it to depart the secretory pathway and activate cellular responses.  Inhibition of Porcupine prevents palmitoylation of Wnt ligands which in turn blocks the transport of Wnt to the extracellular membrane, thus prevents the immoderate prodn. of β-catenin which helps to control the aberrant cell growth.  Clin., Porcupine inhibitors have shown their potential in treating majorly colorectal cancer, pancreatic cancer, hepatocellular carcinoma, head and neck cancer etc.  Till date, none of the Porcupine inhibitors have been in the market and only four mols., LGK974, ETC159, CGX1321 and RXC004 have reached the Phase I clin. trial.  Present review gives a comprehensive insight on Porcupine as a novel drug target for the treatment of cancer as well as recent update on many novel heterocyclic Porcupine inhibitors with their chem. structures and pharmacol.  Their physico chem. properties were also predicted using SwissADME server.  Major concerns during their development have also been summarised which may throw some light for the future development of novel Porcupine inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowxkMN5uivXrVg90H21EOLACvtfcHk0lgl1FYfCT0DKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmvVOhsbs%253D&md5=a3e3119f51657f5befaa2d52b56f2232</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2021.105532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2021.105532%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DK.%26aulast%3DPanchal%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DB.%26atitle%3DPorcupine%2520inhibitors%253A%2520Novel%2520and%2520emerging%2520anti-cancer%2520therapeutics%2520targeting%2520the%2520Wnt%2520signaling%2520pathway%26jtitle%3DPharmacol.%2520Res.%26date%3D2021%26volume%3D167%26spage%3D105532%26doi%3D10.1016%2Fj.phrs.2021.105532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riffell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nrd3868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrd3868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23197039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=923-936&author=J.+L.+Riffellauthor=C.+J.+Lordauthor=A.+Ashworth&title=Tankyrase-targeted+therapeutics%3A+expanding+opportunities+in+the+PARP+family&doi=10.1038%2Fnrd3868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span></div><div class="casAuthors">Riffell, Jenna L.; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-936</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The poly(ADP-ribose) polymerase (PARP) protein superfamily has wide-ranging roles in cellular processes such as DNA repair and WNT signalling.  Efforts to pharmacol. target PARP enzymes have largely focused on PARP1 and the closely related PARP2, but recent work highlighting the role of another family member, tankyrase 1 (TANK1; also known as PARP5A and ARTD5), in the control of WNT signalling has fuelled interest in the development of addnl. inhibitors to target this enzyme class.  Tankyrase function is also implicated in other processes such as the regulation of telomere length, lung fibrogenesis and myelination, suggesting that tankyrase inhibitors could have broad clin. utility.  Here, we discuss the biol. of tankyrases and the discovery of tankyrase-specific inhibitors.  We also consider the challenges that lie ahead for the clin. development of PARP family inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6R0zBQ42UELVg90H21EOLACvtfcHk0lgl1FYfCT0DKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI&md5=510c523982433e4c22f06f8d1679e6f6</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fnrd3868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3868%26sid%3Dliteratum%253Aachs%26aulast%3DRiffell%26aufirst%3DJ.%2BL.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTankyrase-targeted%2520therapeutics%253A%2520expanding%2520opportunities%2520in%2520the%2520PARP%2520family%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D923%26epage%3D936%26doi%3D10.1038%2Fnrd3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviripa, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kril, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang-Hartwich, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedaly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">An underlying mechanism of dual Wnt inhibition and AMPK activation: mitochondrial uncouplers masquerading as Wnt inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11348</span>– <span class="NLM_lpage">11358</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1KktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11348-11358&author=W.+Zhangauthor=V.+M.+Sviripaauthor=L.+M.+Krilauthor=T.+Yuauthor=Y.+Xieauthor=W.+B.+Hubbardauthor=P.+G.+Sullivanauthor=X.+Chenauthor=C.+G.+Zhanauthor=Y.+Yang-Hartwichauthor=B.+M.+Eversauthor=B.+T.+Spearauthor=R.+Gedalyauthor=D.+S.+Wattauthor=C.+Liu&title=An+underlying+mechanism+of+dual+Wnt+inhibition+and+AMPK+activation%3A+mitochondrial+uncouplers+masquerading+as+Wnt+inhibitors&doi=10.1021%2Facs.jmedchem.9b01685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors</span></div><div class="casAuthors">Zhang, Wen; Sviripa, Vitaliy M.; Kril, Liliia M.; Yu, Tianxin; Xie, Yanqi; Hubbard, W. Brad; Sullivan, Patrick G.; Chen, Xi; Zhan, Chang-Guo; Yang-Hartwich, Yang; Evers, B. Mark; Spear, Brett T.; Gedaly, Roberto; Watt, David S.; Liu, Chunming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11348-11358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of upregulated Wnt signaling in colorectal cancers led to efforts to develop inhibitors that target β-catenin in this pathway.  We now report that several "Wnt inhibitors" that allegedly target β-catenin actually function as mitochondrial proton uncouplers that independently activate AMPK and concomitantly inhibit Wnt signaling.  As expected for a process in which mitochondrial uncoupling diminishes ATP prodn., a mitochondrial proton uncoupler, FCCP, and a glucose metabolic inhibitor, 2-DG, activated AMPK and inhibited Wnt signaling.  Also consistent with these findings, a well-known "Wnt inhibitor", FH535, functioned as a proton uncoupler, and in support of this finding, the N-methylated analog, 2,5-dichloro-N-methyl-N-(2-methyl-4-nitrophenyl)benzenesulfonamide (FH535-M) was inactive as an uncoupler and Wnt inhibitor.  Apart from suggesting an opportunity to develop dual Wnt inhibitors and AMPK activators, these findings provide a cautionary tale that claims for Wnt inhibition alone require scrutiny as possible mitochondrial proton uncouplers or inhibitors of the electron transport chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSNHSheEOVOrVg90H21EOLACvtfcHk0lgl1FYfCT0DKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1KktLfK&md5=de1f473a592608bd6a556d5c4b35cd9b</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01685%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSviripa%26aufirst%3DV.%2BM.%26aulast%3DKril%26aufirst%3DL.%2BM.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHubbard%26aufirst%3DW.%2BB.%26aulast%3DSullivan%26aufirst%3DP.%2BG.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DYang-Hartwich%26aufirst%3DY.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DSpear%26aufirst%3DB.%2BT.%26aulast%3DGedaly%26aufirst%3DR.%26aulast%3DWatt%26aufirst%3DD.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DAn%2520underlying%2520mechanism%2520of%2520dual%2520Wnt%2520inhibition%2520and%2520AMPK%2520activation%253A%2520mitochondrial%2520uncouplers%2520masquerading%2520as%2520Wnt%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11348%26epage%3D11358%26doi%3D10.1021%2Facs.jmedchem.9b01685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Network pharmacology</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/nbt1007-1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnbt1007-1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17921993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1110-1111&author=A.+L.+Hopkins&title=Network+pharmacology&doi=10.1038%2Fnbt1007-1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1110-1111</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Network biol. illuminates our understanding of drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLPM5MyYqHbVg90H21EOLACvtfcHk0lhVRKgu6YEUFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagt7vO&md5=7d88f8f8d6b6e76017475bc59a314e4c</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1038%2Fnbt1007-1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1007-1110%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1110%26epage%3D1111%26doi%3D10.1038%2Fnbt1007-1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pushpakom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyers, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escott, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilliams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanseau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing: progress, challenges and recommendations</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrd.2018.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30310233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2gtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=41-58&author=S.+Pushpakomauthor=F.+Iorioauthor=P.+A.+Eyersauthor=K.+J.+Escottauthor=S.+Hopperauthor=A.+Wellsauthor=A.+Doigauthor=T.+Guilliamsauthor=J.+Latimerauthor=C.+McNameeauthor=A.+Norrisauthor=P.+Sanseauauthor=D.+Cavallaauthor=M.+Pirmohamed&title=Drug+repurposing%3A+progress%2C+challenges+and+recommendations&doi=10.1038%2Fnrd.2018.168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Drug repurposing: progress, challenges and recommendations</span></div><div class="casAuthors">Pushpakom, Sudeep; Iorio, Francesco; Eyers, Patrick A.; Escott, K. Jane; Hopper, Shirley; Wells, Andrew; Doig, Andrew; Guilliams, Tim; Latimer, Joanna; McNamee, Christine; Norris, Alan; Sanseau, Philippe; Cavalla, David; Pirmohamed, Munir</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Given the high attrition rates, substantial costs and slow pace of new drug discovery and development, repurposing of 'old' drugs to treat both common and rare diseases is increasingly becoming an attractive proposition because it involves the use of de-risked compds., with potentially lower overall development costs and shorter development timelines.  Various data-driven and exptl. approaches have been suggested for the identification of repurposable drug candidates; however, there are also major technol. and regulatory challenges that need to be addressed.  In this Review, we present approaches used for drug repurposing (also known as drug repositioning), discuss the challenges faced by the repurposing community and recommend innovative ways by which these challenges could be addressed to help realize the full potential of drug repurposing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUl_N5c2iDerVg90H21EOLACvtfcHk0lhVRKgu6YEUFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2gtr7I&md5=6bcc8f26828414de02564494fb4d3296</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.168%26sid%3Dliteratum%253Aachs%26aulast%3DPushpakom%26aufirst%3DS.%26aulast%3DIorio%26aufirst%3DF.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DEscott%26aufirst%3DK.%2BJ.%26aulast%3DHopper%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DA.%26aulast%3DDoig%26aufirst%3DA.%26aulast%3DGuilliams%26aufirst%3DT.%26aulast%3DLatimer%26aufirst%3DJ.%26aulast%3DMcNamee%26aufirst%3DC.%26aulast%3DNorris%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DCavalla%26aufirst%3DD.%26aulast%3DPirmohamed%26aufirst%3DM.%26atitle%3DDrug%2520repurposing%253A%2520progress%252C%2520challenges%2520and%2520recommendations%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D41%26epage%3D58%26doi%3D10.1038%2Fnrd.2018.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of class A GPCRs: targets, agents, and emerging concepts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=88-127&author=E.+A.+Woldauthor=J.+Chenauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Allosteric+modulation+of+class+A+GPCRs%3A+targets%2C+agents%2C+and+emerging+concepts&doi=10.1021%2Facs.jmedchem.8b00875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts</span></div><div class="casAuthors">Wold, Eric A.; Chen, Jianping; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-127</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) have been tractable drug targets for decades with over one-third of currently marketed drugs targeting GPCRs.  Of these, the class A GPCR superfamily is highly represented, and continued drug discovery for this family of receptors may provide novel therapeutics for a vast range of diseases.  GPCR allosteric modulation is an innovative targeting approach that broadens the available small mol. toolbox and is proving to be a viable drug discovery strategy, as evidenced by recent FDA approvals and clin. trials.  Numerous class A GPCR allosteric modulators have been discovered recently, and emerging trends such as the availability of GPCR crystal structures, diverse functional assays, and structure-based computational approaches are improving optimization and development.  This Perspective provides an update on allosterically targeted class A GPCRs and their disease indications and the medicinal chem. approaches toward novel allosteric modulators and highlights emerging trends and opportunities in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zBEGIhRgD7Vg90H21EOLACvtfcHk0lhVRKgu6YEUFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbK&md5=c724b7cb534a9eb52c371961bb9c9b42</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DAllosteric%2520modulation%2520of%2520class%2520A%2520GPCRs%253A%2520targets%252C%2520agents%252C%2520and%2520emerging%2520concepts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D88%26epage%3D127%26doi%3D10.1021%2Facs.jmedchem.8b00875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0031.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of WNT proteins. (A) Ribbon representation of <i>Xenopus</i> WNT8 (xWNT8), (highlighted in magenta, in complex with mouse Frizzled-8 cysteine-rich domain (mFZD8 CRD), highlighted in cyan (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0A">4F0A</a>). Post-translational modification sites (residues Ser187, Asn104, and Asn263) are labeled. (B) Crystal structure of the <i>Drosophila</i> WNTD N-terminal domain and linker (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KRR">4KRR</a>). (C) Cylinder representation of the human WNT3–mouse FZD8 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY">6AHY</a>). (D) Schematic diagram of the primary structure of hWNT3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Canonical WNT/β-catenin signaling pathway. (A) After palmitoylation by porcupine, WNT ligands are secreted and bind to receptors FZD and LRP5/6 at the membrane to initiate WNT signaling. (B) In the cytoplasm, inactivation of the destruction complex leads to the translocation of β-catenin rather than its degradation. (C) In the nucleus, β-catenin interacts with transcription factors and coactivators to evoke the transcription of downstream target genes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of representative WNT signaling inhibitors in human clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of compounds <b>5</b>–<b>7</b> as porcupine inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Discovery and development of porcupine inhibitors <b>1</b> and <b>8</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery of porcupine inhibitors <b>14</b>–<b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) PARP catalyzes PARsylation of the target proteins. (B) Domain architectures of TNKS1 and TNKS2. (C) Ribbon presentation of the TNKS2 catalytic PARP domain in complex with nicotinamide (colored in green) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U9H">3U9H</a>). Key residues participating interactions are highlighted in yellow, and hydrogen bonds are colored in red. (D) Ribbon presentation of the TNKS2 ARC domain (colored in wheat) in complex with myeloid cell leukemia-1 (MCL-1) peptide LPHLQRPPPIGQSFR (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TWT">3TWT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Chemical structure of <b>19</b> (left panel) and ribbon representations of its cocrystal structures with TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KR8">3KR8</a>) (middle panel) and PARP1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R5W">4R5W</a>) (right panel). (B) Chemical structure of compound <b>20</b> (left panel), ribbon representations of its cocomplex with TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TKF">4TKF</a>) (middle panel), and superimposition of compounds <b>19</b> and <b>20</b> in complex with TNKS2 illustrating two binding sites, the nicotinamide subsite shown in green and the adenosine subsite shown in magenta (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TNKS inhibitors derived from compound <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Chemical structures of TNKS inhibitors <b>30</b>–<b>32</b>. (B) Structures of compounds <b>33</b>–<b>35</b> (in green) and their cocomplexes with TNKS2 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQO">5ZQO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQR">5ZQR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6KRO">6KRO</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Drug discovery of TNKS inhibitors <b>36</b>–<b>41</b>. Hydrogen bonds of compounds <b>36</b> and <b>39</b> (in green) with TNKS1 residues (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4F">4K4F</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3N3R">3N3R</a>) are shown with red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Discovery of TNKS inhibitors <b>42</b>–<b>46</b> and structures of the cocomplexes of <b>43</b>, <b>44</b>, and <b>46</b> (in green) with TNKS (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD">3UDD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HYF">4HYF</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB">5NOB</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of TNKS inhibitors <b>47</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical structures and <i>in vitro</i> activities of TNKS inhibitors <b>54</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Discovery of TNKS2 ARC4 inhibitors <b>63</b>–<b>65</b> and ribbon representation of compound <b>63</b> (in green) in complex with TNKS2 ARC4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BXU">5BXU</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Chemical structures of β-catenin/TCF inhibitors <b>66</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Discovery of β-catenin/TCF inhibitors <b>69</b>–<b>74</b> and ribbon representation of peptide <b>69</b> (in magenta) from xTCF3 CBD in complex with β-catenin (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J">1G3J</a>). Critical residues are drawn as yellow sticks, and hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Development of peptides <b>75</b>–<b>78</b> that interrupt β-catenin/TCF interactions and overlay of compound <b>77</b> (in yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJS">4DJS</a>) and AXIN (in cyan, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ7">1QZ7</a>) with β-catenin (in light gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Chemical structures of β-catenin/TCF inhibitors <b>79</b>–<b>84</b> and the rationale for the design of macrocycle <b>84</b> as depicted by the ribbon representation of β-catenin/xTCF3 interactions (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J">1G3J</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Chemical structures of β-catenin/CBP PPI inhibitors <b>85</b>–<b>90</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. β-Catenin/BCL-9/TCF4 cocomplex of (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GL7">2GL7</a>) and stapled peptide <b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Chemical structures of peptides <b>92</b>–<b>95</b> that disrupt β-catenin/BCL-9 interactions. * indicates (<i>S</i>)-2-(4′-pentenyl)alanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Chemical structures of small molecules <b>96</b>–<b>99</b> that disrupt β-catenin/BCL-9 interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Chemical structures of casein kinase modulators <b>100</b>–<b>104</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Chemical structures of DVL PDZ domain inhibitors <b>105</b>–<b>108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Discovery of CDK8 inhibitors <b>109</b>–<b>113</b> and X-ray crystal structure of <b>109</b> (drawn as yellow sticks) in CDK8/cyclin C (in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BNJ">5BNJ</a>). Critical residues are drawn as magenta sticks. Hydrogen bonds are shown as red dashed lines, and the cation−π interaction is shown as a black dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Chemical structure of NCB-0846 (<b>114</b>) (in magenta) and its ribbon representation in complex with TNIK (colored in cyan) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D7A">5D7A</a>). Key residues are drawn as green sticks, and hydrogen bonds are shown as yellow dashes lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Chemical structures of WNT signaling inhibitors <b>115</b> and <b>116</b> and overlay of compound <b>116</b> (surface representation in yellow):FZD8 CRD (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TFB">6TFB</a>) and WNT3a (in green):FZD8 CRD (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY">6AHY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of compounds <b>117</b> and <b>118</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/medium/jm0c01799_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structures of WNT inhibitors <b>119</b>–<b>122</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-8/acs.jmedchem.0c01799/20210415/images/large/jm0c01799_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01799&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 208 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span> <span> </span><span class="NLM_article-title">The Wnts</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">reviews3001.1</span> <span class="refDoi"> DOI: 10.1186/gb-2001-3-1-reviews3001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1186%2Fgb-2001-3-1-reviews3001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&author=J.+R.+Miller&title=The+Wnts&doi=10.1186%2Fgb-2001-3-1-reviews3001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fgb-2001-3-1-reviews3001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2001-3-1-reviews3001%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Wnts%26jtitle%3DGenome%2520Biol.%26date%3D2001%26volume%3D3%26doi%3D10.1186%2Fgb-2001-3-1-reviews3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varmus, H. E.</span></span> <span> </span><span class="NLM_article-title">Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(82)90409-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2882%2990409-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=6297757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaL3sXht1aluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1982&pages=99-109&author=R.+Nusseauthor=H.+E.+Varmus&title=Many+tumors+induced+by+the+mouse+mammary+tumor+virus+contain+a+provirus+integrated+in+the+same+region+of+the+host+genome&doi=10.1016%2F0092-8674%2882%2990409-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome</span></div><div class="casAuthors">Nusse, Roel; Varmus, Harold E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">It was asked whether oncogenesis by the mouse mammary tumor virus (MMTV), a slowly oncogenic retrovirus, involves integration of viral DNA within a certain region of the host genome.  First, a C3H mouse mammary tumor bearing a single new MMTV provirus was identified, and a 19-kilobase (kb) DNA restriction fragment contg. a junction of viral and host sequences was cloned.  Host sequences from this clone were used to retrieve 25 kb of the uninterrupted locus (termed MMTV int1) from a library of normal mouse DNA.  Hybridization with subcloned DNA fragments of MMTV int1 detected abnormal restriction fragments in digests of DNA from 18 of 26 C3H mammary tumors.  The rearrangements all appeared to be due to the insertion of an MMTV provirus, and the integration sites were located in ≥5 clusters over a total distance of 19 kb.  A polyadenylated 2.6-kb RNA species transcribed from int1 was found in the few tumors tested but not in lactating mammary glands from C3H mice.  Of 12 tested viral oncogenes, none exhibited homol. with cloned DNA from this locus.  Apparently, tumorigenesis by MMTV is strongly favored by proviral insertion within the int1 locus, perhaps as a consequence of enhanced expression of a novel cellular oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYzg6JZuOObVg90H21EOLACvtfcHk0libfv1HqiE4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXht1aluw%253D%253D&md5=fc21bbcfc4c23ae3bd0f588664e8da42</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2882%2990409-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252882%252990409-3%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26atitle%3DMany%2520tumors%2520induced%2520by%2520the%2520mouse%2520mammary%2520tumor%2520virus%2520contain%2520a%2520provirus%2520integrated%2520in%2520the%2520same%2520region%2520of%2520the%2520host%2520genome%26jtitle%3DCell%26date%3D1982%26volume%3D31%26spage%3D99%26epage%3D109%26doi%3D10.1016%2F0092-8674%2882%2990409-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iranloye, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Disulfide bond requirements for active Wnt ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">18122</span>– <span class="NLM_lpage">18136</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.575027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M114.575027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24841207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=18122-18136&author=B.+T.+MacDonaldauthor=A.+Hienauthor=X.+Zhangauthor=O.+Iranloyeauthor=D.+M.+Virshupauthor=M.+L.+Watermanauthor=X.+He&title=Disulfide+bond+requirements+for+active+Wnt+ligands&doi=10.1074%2Fjbc.M114.575027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide Bond Requirements for Active Wnt Ligands</span></div><div class="casAuthors">MacDonald, Bryan T.; Hien, Annie; Zhang, Xinjun; Iranloye, Oladoyin; Virshup, David M.; Waterman, Marian L.; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">18122-18136</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Secreted Wnt lipoproteins are cysteine-rich and lipid-modified morphogens that bind to the Frizzled (FZD) receptor and LDL receptor-related protein 6 (LRP6).  Wnt engages FZD through protruding thumb and index finger domains, which are each assembled from paired β strands secured by disulfide bonds and grasp two sides of the FZD ectodomain.  The importance of Wnt disulfide bonds has been assumed but uncharacterized.  We systematically analyzed cysteines and assocd. disulfide bonds in the prototypic Wnt3a.  Our data show that mutation of any individual cysteine of Wnt3a results in covalent Wnt oligomers through ectopic intermol. disulfide bond formation and diminishes/abolishes Wnt signaling.  Although individual cysteine mutations in the amino part of the saposin-like domain and in the base of the index finger are better tolerated and permit residual Wnt3a secretion/activity, those in the amino terminus, the thumb, and at the tip of the index finger are incompatible with secretion and/or activity.  A few select double cysteine mutants based on the disulfide bond pattern restore Wnt secretion/activity.  Further, a double cysteine mutation at the index finger tip results in a Wnt3a with normal secretion but minimal FZD binding and dominant neg. properties.  Our results exptl. validate predictions from the Wnt crystal structure and highlight crit. but different roles of the saposin-like and cytokine-like domains, including the thumb and the index finger in Wnt folding/secretion and FZD binding.  Finally, we modified existing expression vectors for 19 epitope-tagged human WNT proteins by removal of a tag-supplied ectopic cysteine, thereby generating tagged WNT ligands active in canonical and non-canonical signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp_TrmWCaVKLVg90H21EOLACvtfcHk0libfv1HqiE4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGjsLzE&md5=8bb4036d9e6abca734caab37025d0041</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.575027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.575027%26sid%3Dliteratum%253Aachs%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DHien%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DIranloye%26aufirst%3DO.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DWaterman%26aufirst%3DM.%2BL.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DDisulfide%2520bond%2520requirements%2520for%2520active%2520Wnt%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D18122%26epage%3D18136%26doi%3D10.1074%2Fjbc.M114.575027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satomi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norioka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, S.</span></span> <span> </span><span class="NLM_article-title">Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2006.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.devcel.2006.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17141155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=791-801&author=R.+Takadaauthor=Y.+Satomiauthor=T.+Kurataauthor=N.+Uenoauthor=S.+Noriokaauthor=H.+Kondohauthor=T.+Takaoauthor=S.+Takada&title=Monounsaturated+fatty+acid+modification+of+Wnt+protein%3A+its+role+in+Wnt+secretion&doi=10.1016%2Fj.devcel.2006.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion</span></div><div class="casAuthors">Takada, Ritsuko; Satomi, Yoshinori; Kurata, Tomoko; Ueno, Naoto; Norioka, Shigemi; Kondoh, Hisato; Takao, Toshifumi; Takada, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-801</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The secretion and extracellular transport of Wnt protein are thought to be well-regulated processes.  Wnt is known to be acylated with palmitic acid at a conserved cysteine residue (Cys77 in murine Wnt-3a), and this residue appears to be required for the control of extracellular transport.  Here, we show that murine Wnt-3a is also acylated at a conserved serine residue (Ser209).  Of note, we demonstrated that this residue is modified with a monounsatd. fatty acid, palmitoleic acid.  Wnt-3a defective in acylation at Ser209 is not secreted from cells in culture or in Xenopus embryos, but it is retained in the endoplasmic reticulum (ER).  Furthermore, Porcupine, a protein with structural similarities to membrane-bound O-acyltransferases, is required for Ser209-dependent acylation, as well as for Wnt-3a transport from the ER for secretion.  These results strongly suggest that Wnt protein requires a particular lipid modification for proper intracellular transport during the secretory process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP25CDqQrcu7Vg90H21EOLACvtfcHk0libfv1HqiE4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqs7vM&md5=278d498e2c0b6ace529555e3e9b67387</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2006.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2006.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DR.%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DKurata%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DN.%26aulast%3DNorioka%26aufirst%3DS.%26aulast%3DKondoh%26aufirst%3DH.%26aulast%3DTakao%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DS.%26atitle%3DMonounsaturated%2520fatty%2520acid%2520modification%2520of%2520Wnt%2520protein%253A%2520its%2520role%2520in%2520Wnt%2520secretion%26jtitle%3DDev.%2520Cell%26date%3D2006%26volume%3D11%26spage%3D791%26epage%3D801%26doi%3D10.1016%2Fj.devcel.2006.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waghray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Wnt recognition by Frizzled</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1126/science.1222879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscience.1222879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22653731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2012&pages=59-64&author=C.+Y.+Jandaauthor=D.+Waghrayauthor=A.+M.+Levinauthor=C.+Thomasauthor=K.+C.+Garcia&title=Structural+basis+of+Wnt+recognition+by+Frizzled&doi=10.1126%2Fscience.1222879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Wnt Recognition by Frizzled</span></div><div class="casAuthors">Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">6090</span>),
    <span class="NLM_cas:pages">59-64</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Wnts are lipid-modified morphogens that play crit. roles in development, principally through engagement of Frizzled receptors.  The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites.  One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD.  In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD.  The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMgZd5hKMfLVg90H21EOLACvtfcHk0lggVOgDPshNDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKksrk%253D&md5=8a32c44b73fe281cccedc285311759ce</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222879%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DWaghray%26aufirst%3DD.%26aulast%3DLevin%26aufirst%3DA.%2BM.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructural%2520basis%2520of%2520Wnt%2520recognition%2520by%2520Frizzled%26jtitle%3DScience%26date%3D2012%26volume%3D337%26spage%3D59%26epage%3D64%26doi%3D10.1126%2Fscience.1222879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">structural Studies of Wnts and identification of an LRP6 binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1242</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.str.2013.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23791946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1235-1242&author=M.+L.+Chuauthor=V.+E.+Ahnauthor=H.+J.+Choiauthor=D.+L.+Danielsauthor=R.+Nusseauthor=W.+I.+Weis&title=structural+Studies+of+Wnts+and+identification+of+an+LRP6+binding+site&doi=10.1016%2Fj.str.2013.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Studies of Wnts and Identification of an LRP6 Binding Site</span></div><div class="casAuthors">Chu, Matthew Ling-Hon; Ahn, Victoria E.; Choi, Hee-Jung; Daniels, Danette L.; Nusse, Roel; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1235-1242</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Wnts are secreted growth factors that have crit. roles in cell fate detn. and stem cell renewal.  The Wnt/β-catenin pathway is initiated by binding of a Wnt protein to a Frizzled (Fzd) receptor and a coreceptor, LDL receptor-related protein 5 or 6 (LRP5/6).  We report the 2.1 Å resoln. crystal structure of a Drosophila WntD fragment encompassing the N-terminal domain and the linker that connects it to the C-terminal domain.  Differences in the structures of WntD and Xenopus Wnt8, including the positions of a receptor-binding β hairpin and a large solvent-filled cavity in the helical core, indicate conformational plasticity in the N-terminal domain that may be important for Wnt-Frizzled specificity.  Structure-based mutational anal. of mouse Wnt3a shows that the linker between the N- and C-terminal domains is required for LRP6 binding.  These findings provide important insights into Wnt function and evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocf8bzxBb8nLVg90H21EOLACvtfcHk0lggVOgDPshNDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymurg%253D&md5=cf27dcf85bb2711693dd0e4792b0baf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%26aulast%3DAhn%26aufirst%3DV.%2BE.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3Dstructural%2520Studies%2520of%2520Wnts%2520and%2520identification%2520of%2520an%2520LRP6%2520binding%2520site%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D1235%26epage%3D1242%26doi%3D10.1016%2Fj.str.2013.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matoba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a mammalian Wnt-frizzled complex</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/s41594-019-0216-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41594-019-0216-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31036956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosFKqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=372-379&author=H.+Hiraiauthor=K.+Matobaauthor=E.+Miharaauthor=T.+Arimoriauthor=J.+Takagi&title=Crystal+structure+of+a+mammalian+Wnt-frizzled+complex&doi=10.1038%2Fs41594-019-0216-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a mammalian Wnt-frizzled complex</span></div><div class="casAuthors">Hirai, Hidenori; Matoba, Kyoko; Mihara, Emiko; Arimori, Takao; Takagi, Junichi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">372-379</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Wnt signaling plays fundamental roles in organogenesis, tissue regeneration and cancer, but high-resoln. structural information of mammalian Wnt proteins is lacking.  We solved a 2.8-Å resoln. crystal structure of human Wnt3 in complex with mouse Frizzled 8 Cys-rich domain (CRD).  Wnt3 grabs the receptor in a manner very similar to that found in Xenopus Wnt8 complexed with the same receptor.  Unlike Xenopus Wnt8-bound CRD, however, Wnt3-bound CRD formed a sym. dimer in the crystal by exchanging the tip of the unsatd. acyl chain attached to each Wnt3, confirming the ability of Wnt and Frizzled CRD to form a 2:2 complex.  The hypervariable 'linker' region of Wnt3 formed a β-hairpin protrusion opposite from the Frizzled binding interface, consistent with its proposed role in the coreceptor recognition.  Direct binding between this segment and the Wnt coreceptor LRP6 was confirmed, enabling us to build a structural model of the Wnt-Frizzled-LRP6 ternary complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDRy21GogTH7Vg90H21EOLACvtfcHk0li2tvJ2jQTUvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosFKqtrY%253D&md5=abd63699c8b0253ae511f3f4bf794121</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41594-019-0216-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41594-019-0216-z%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DMatoba%26aufirst%3DK.%26aulast%3DMihara%26aufirst%3DE.%26aulast%3DArimori%26aufirst%3DT.%26aulast%3DTakagi%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520a%2520mammalian%2520Wnt-frizzled%2520complex%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D372%26epage%3D379%26doi%3D10.1038%2Fs41594-019-0216-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1038/346847a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F346847a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2202907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Klt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=847-850&author=K.+R.+Thomasauthor=M.+R.+Capecchi&title=Targeted+disruption+of+the+murine+int-1+proto-oncogene+resulting+in+severe+abnormalities+in+midbrain+and+cerebellar+development&doi=10.1038%2F346847a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development</span></div><div class="casAuthors">Thomas, Kirk R.; Capecchi, Mario R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6287</span>),
    <span class="NLM_cas:pages">847-50</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The function of gene int-1 in the mouse was explored by disrupting one of the two int-1 alleles in mouse embryo-derived stem cells using pos.-neg. selection.  This cell line was used to generate a chimeric mouse that transmitted the mutant allele to its progeny.  Mice heterozygous for the int-1 null mutation are normal and fertile, whereas mice homozygous for the mutation may exhibit a range of phenotypes from death before birth to survival with severe ataxia.  The latter pathol. in mice and humans is often assocd. with defects in the cerebellum.  Examn. of int-1-/int-1- mice at several stages of embryogenesis revealed severe abnormalities in the development of the mesencephalon and metencephalon indicating a prominent role for the int-1 protein is in the induction of the mesencephalon and cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1t2VtcDJgsrVg90H21EOLACvtfcHk0li2tvJ2jQTUvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Klt7g%253D&md5=f81098f10d5d25c36a40e723867bce49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F346847a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346847a0%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DK.%2BR.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520murine%2520int-1%2520proto-oncogene%2520resulting%2520in%2520severe%2520abnormalities%2520in%2520midbrain%2520and%2520cerebellar%2520development%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D847%26epage%3D850%26doi%3D10.1038%2F346847a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, A.</span></span> <span> </span><span class="NLM_article-title">The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(90)90385-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2890%2990385-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2205396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1Gms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1990&pages=1073-1085&author=A.+P.+McMahonauthor=A.+Bradley&title=The+Wnt-1+%28int-1%29+proto-oncogene+is+required+for+development+of+a+large+region+of+the+mouse+brain&doi=10.1016%2F0092-8674%2890%2990385-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain</span></div><div class="casAuthors">McMahon, Andrew P.; Bradley, Allan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1073-85</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The Wnt-1 (int-1) proto-oncogene, which encodes a putative signaling mol., is expressed exclusively in the developing central nervous system and adult testes.  To examine the role of Wnt-1, 6 independent embryonic stem cell lines were generated in which insertion of a neoR gene by homologous recombination inactivated a Wnt-1 allele.  Germline chimeras were generated from 2 lines, and progeny from matings between heterozygous parents were examd.  In all 9.5 day fetuses homozygous for mutated Wnt-1 alleles, most of the midbrain and some rostral metencephalon were absent.  The remainder of the neutral tube and all other tissues were normal.  In late-gestation homozygotes, there was virtually no midbrain and no cerebellum, while the rest of the fetus was normal.  Homozygotes are born, but die within 24 h.  Thus the normal role of Wnt-1 is in detn. or subsequent development of a specific region of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIdpxhG3usCrVg90H21EOLACvtfcHk0li2tvJ2jQTUvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1Gms7Y%253D&md5=2e375adbdb825e31bd6b821f92cb49de</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990385-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990385-R%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DBradley%26aufirst%3DA.%26atitle%3DThe%2520Wnt-1%2520%2528int-1%2529%2520proto-oncogene%2520is%2520required%2520for%2520development%2520of%2520a%2520large%2520region%2520of%2520the%2520mouse%2520brain%26jtitle%3DCell%26date%3D1990%26volume%3D62%26spage%3D1073%26epage%3D1085%26doi%3D10.1016%2F0092-8674%2890%2990385-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2Fbeta-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0lgmExS1y91xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heisenberg, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saude, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concha, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemple, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. W.</span></span> <span> </span><span class="NLM_article-title">Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/35011068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F35011068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10811221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD3c3mvFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=76-81&author=C.+P.+Heisenbergauthor=M.+Tadaauthor=G.+J.+Rauchauthor=L.+Saudeauthor=M.+L.+Conchaauthor=R.+Geislerauthor=D.+L.+Stempleauthor=J.+C.+Smithauthor=S.+W.+Wilson&title=Silberblick%2FWnt11+mediates+convergent+extension+movements+during+zebrafish+gastrulation&doi=10.1038%2F35011068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation</span></div><div class="casAuthors">Heisenberg C P; Tada M; Rauch G J; Saude L; Concha M L; Geisler R; Stemple D L; Smith J C; Wilson S W</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6782</span>),
    <span class="NLM_cas:pages">76-81</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Vertebrate gastrulation involves the specification and coordinated movement of large populations of cells that give rise to the ectodermal, mesodermal and endodermal germ layers.  Although many of the genes involved in the specification of cell identity during this process have been identified, little is known of the genes that coordinate cell movement.  Here we show that the zebrafish silberblick (slb) locus encodes Wnt11 and that Slb/Wnt11 activity is required for cells to undergo correct convergent extension movements during gastrulation.  In the absence of Slb/Wnt11 function, abnormal extension of axial tissue results in cyclopia and other midline defects in the head.  The requirement for Slb/Wnt11 is cell non-autonomous, and our results indicate that the correct extension of axial tissue is at least partly dependent on medio-lateral cell intercalation in paraxial tissue.  We also show that the slb phenotype is rescued by a truncated form of Dishevelled that does not signal through the canonical Wnt pathway, suggesting that, as in flies, Wnt signalling might mediate morphogenetic events through a divergent signal transduction cascade.  Our results provide genetic and experimental evidence that Wnt activity in lateral tissues has a crucial role in driving the convergent extension movements underlying vertebrate gastrulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaaoXCzFFPPu_Q9URG6Dx8fW6udTcc2eZk-jTkUudga7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3mvFemug%253D%253D&md5=43378fa9443ee8e719dd1d9ec2b1390a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F35011068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35011068%26sid%3Dliteratum%253Aachs%26aulast%3DHeisenberg%26aufirst%3DC.%2BP.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DRauch%26aufirst%3DG.%2BJ.%26aulast%3DSaude%26aufirst%3DL.%26aulast%3DConcha%26aufirst%3DM.%2BL.%26aulast%3DGeisler%26aufirst%3DR.%26aulast%3DStemple%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DWilson%26aufirst%3DS.%2BW.%26atitle%3DSilberblick%252FWnt11%2520mediates%2520convergent%2520extension%2520movements%2520during%2520zebrafish%2520gastrulation%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D76%26epage%3D81%26doi%3D10.1038%2F35011068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldahl, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape</span>. <i>Trends Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0168-9525(00)02028-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS0168-9525%2800%2902028-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10858654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlCnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=279-283&author=M.+Kuhlauthor=L.+C.+Sheldahlauthor=M.+Parkauthor=J.+R.+Millerauthor=R.+T.+Moon&title=The+Wnt%2FCa2%2B+pathway%3A+a+new+vertebrate+Wnt+signaling+pathway+takes+shape&doi=10.1016%2FS0168-9525%2800%2902028-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt/Ca2+ pathway, a new vertebrate Wnt signaling pathway takes shape</span></div><div class="casAuthors">Kuhl, M.; Sheldahl, L. C.; Park, M.; Miller, J. R.; Moon, R. T.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">279-283</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 27 refs.  Members of the vertebrate Wnt family have been subdivided into two functional classes according to their biol. activities.  Some Wnts signal through the canonical Wnt-1/wingless pathway by stabilizing cytoplasmic β-catenin.  By contrast other Wnts stimulate intracellular Ca2+ release and activate two kinases, CamKII and PKC, in a G-protein-dependent manner.  Moreover, putative Wnt receptors belonging to the Frizzled gene family have been identified that preferentially couple to the two prospective pathways in the absence of ectopic Wnt ligand and that might account for the signaling specificity of the Wnt pathways.  As Ca2+ release was the first described feature of the noncanonical pathway, and as Ca2+ probably plays a key role in the activation of CamKII and PKC, we have named this Wnt pathway the Wnt/Ca2+ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEmZZlWD-4bVg90H21EOLACvtfcHk0lgmExS1y91xGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlCnur8%253D&md5=7072c500b1057e6629557c94a9889d29</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2800%2902028-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252800%252902028-X%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DM.%26aulast%3DSheldahl%26aufirst%3DL.%2BC.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DThe%2520Wnt%252FCa2%252B%2520pathway%253A%2520a%2520new%2520vertebrate%2520Wnt%2520signaling%2520pathway%2520takes%2520shape%26jtitle%3DTrends%2520Genet.%26date%3D2000%26volume%3D16%26spage%3D279%26epage%3D283%26doi%3D10.1016%2FS0168-9525%2800%2902028-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">SnapShot: noncanonical Wnt signaling pathways</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1378</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2007.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18160045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD2sjms1ymuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=1378&author=M.+V.+Semenovauthor=R.+Habasauthor=B.+T.+Macdonaldauthor=X.+He&title=SnapShot%3A+noncanonical+Wnt+signaling+pathways&doi=10.1016%2Fj.cell.2007.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">SnapShot: Noncanonical Wnt Signaling Pathways</span></div><div class="casAuthors">Semenov Mikhail V; Habas Raymond; Macdonald Bryan T; He Xi</div><div class="citationInfo"><span class="NLM_cas:title">Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1378</span>
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSocIG91z82hXwOGIfWJ7-GfW6udTcc2ebEpjrYU2OAIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjms1ymuw%253D%253D&md5=f61de278fbca85e9aa8f99770763c4ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DSemenov%26aufirst%3DM.%2BV.%26aulast%3DHabas%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DB.%2BT.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DSnapShot%253A%2520noncanonical%2520Wnt%2520signaling%2520pathways%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D1378%26doi%3D10.1016%2Fj.cell.2007.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuijers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1002/embj.201385358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fembj.201385358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24413017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOhu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=146-156&author=J.+Schuijersauthor=M.+Mokryauthor=P.+Hatzisauthor=E.+Cuppenauthor=H.+Clevers&title=Wnt-induced+transcriptional+activation+is+exclusively+mediated+by+TCF%2FLEF&doi=10.1002%2Fembj.201385358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF</span></div><div class="casAuthors">Schuijers, Jurian; Mokry, Michal; Hatzis, Pantelis; Cuppen, Edwin; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-156</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Active canonical Wnt signaling results in recruitment of β-catenin to DNA by TCF/LEF family members, leading to transcriptional activation of TCF target genes.  However, addnl. transcription factors have been suggested to recruit β-catenin and tether it to DNA.  Here, we describe the genome-wide pattern of β-catenin DNA binding in murine intestinal epithelium, Wnt-responsive colorectal cancer (CRC) cells and HEK293 embryonic kidney cells.  We identify two classes of β-catenin binding sites.  The first class represents the majority of the DNA-bound β-catenin and co-localizes with TCF4, the prominent TCF/LEF family member in these cells.  The second class consists of β-catenin binding sites that colocalize with a minimal amt. of TCF4.  The latter consists of lower affinity β-catenin binding events, does not drive transcription and often does not contain a consensus TCF binding motif.  Surprisingly, a dominant-neg. form of TCF4 abrogates the β-catenin/DNA interaction of both classes of binding sites, implying that the second class comprises low affinity TCF-DNA complexes.  Our results indicate that β-catenin is tethered to chromatin overwhelmingly through the TCF/LEF transcription factors in these three systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6_rFdgL2v8rVg90H21EOLACvtfcHk0lgVKuUxNCTu6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOhu7vJ&md5=9bd0de551dc5e7b4ec08872db89e3948</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fembj.201385358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fembj.201385358%26sid%3Dliteratum%253Aachs%26aulast%3DSchuijers%26aufirst%3DJ.%26aulast%3DMokry%26aufirst%3DM.%26aulast%3DHatzis%26aufirst%3DP.%26aulast%3DCuppen%26aufirst%3DE.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt-induced%2520transcriptional%2520activation%2520is%2520exclusively%2520mediated%2520by%2520TCF%252FLEF%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D146%26epage%3D156%26doi%3D10.1002%2Fembj.201385358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling in development and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2006.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17081971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=469-480&author=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling+in+development+and+disease&doi=10.1016%2Fj.cell.2006.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling in development and disease</span></div><div class="casAuthors">Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-480</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  A remarkable interdisciplinary effort has unraveled the WNT (Wingless and INT-1) signal transduction cascade over the last 2 decades.  Wnt genes encode small secreted proteins that are found in all animal genomes.  Wnt signaling is involved in virtually every aspect of embryonic development and also controls homeostatic self-renewal in a no. of adult tissues.  Germline mutations in the Wnt pathway cause several hereditary diseases, and somatic mutations are assocd. with cancer of the intestine and a variety of other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocxHAkoIZJG7Vg90H21EOLACvtfcHk0lgVKuUxNCTu6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WhtbbN&md5=930a55e85abd29329c845dec6683fac8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%2520in%2520development%2520and%2520disease%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D469%26epage%3D480%26doi%3D10.1016%2Fj.cell.2006.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling: components, mechanisms, and diseases</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2009.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.devcel.2009.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19619488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2msb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=9-26&author=B.+T.+MacDonaldauthor=K.+Tamaiauthor=X.+He&title=Wnt%2Fbeta-catenin+signaling%3A+components%2C+mechanisms%2C+and+diseases&doi=10.1016%2Fj.devcel.2009.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling: components, mechanisms, and diseases</span></div><div class="casAuthors">MacDonald, Bryan T.; Tamai, Keiko; He, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-26</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Signaling by the Wnt family of secreted glycolipoproteins via the transcriptional coactivator β-catenin controls embryonic development and adult homeostasis.  Here we review recent progress in this so-called canonical Wnt signaling pathway.  We discuss Wnt ligands, agonists, and antagonists, and their interactions with Wnt receptors.  We also dissect crit. events that regulate β-catenin stability, from Wnt receptors to the cytoplasmic β-catenin destruction complex, and nuclear machinery that mediates β-catenin-dependent transcription.  Finally, we highlight some key aspects of Wnt/β-catenin signaling in human diseases including congenital malformations, cancer, and osteoporosis, and discuss potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNap4TpxXFWbVg90H21EOLACvtfcHk0ljHPyMMKtcULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2msb8%253D&md5=25e1a7dd5c3aca54a1cfc7993fd5bb43</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2009.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2009.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMacDonald%26aufirst%3DB.%2BT.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%253A%2520components%252C%2520mechanisms%252C%2520and%2520diseases%26jtitle%3DDev.%2520Cell%26date%3D2009%26volume%3D17%26spage%3D9%26epage%3D26%26doi%3D10.1016%2Fj.devcel.2009.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Proximal events in Wnt signal transduction</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1038/nrm2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrm2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19536106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVagtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=468-477&author=S.+Angersauthor=R.+T.+Moon&title=Proximal+events+in+Wnt+signal+transduction&doi=10.1038%2Fnrm2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proximal events in Wnt signal transduction</span></div><div class="casAuthors">Angers, Stephane; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">468-477</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The Wnt family of secreted ligands act through many receptors to stimulate distinct intracellular signaling pathways in embryonic development, in adults and in disease processes.  The binding of Wnt to the Frizzled family of receptors and to LDL receptor-related protein 5 (LRP5) or LRP6 co-receptors stimulates the intracellular Wnt-β-catenin signaling pathway, which regulates β-catenin stability and context-dependent transcription.  This signaling pathway controls many processes, such as cell fate detn., cell proliferation, and self-renewal of stem and progenitor cells.  Intriguingly, transmembrane receptor Tyr kinases Ror2 and Ryk, as well as Frizzled receptors that act independently of LRP5 or LRP6, function as receptors for Wnt and activate β-catenin-independent pathways.  This leads to changes in cell movement and polarity and to the antagonism of the β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSa8RXI0O7ibVg90H21EOLACvtfcHk0ljHPyMMKtcULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVagtLs%253D&md5=35448720b91c4b994da87f0dfd50da64</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrm2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2717%26sid%3Dliteratum%253Aachs%26aulast%3DAngers%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DProximal%2520events%2520in%2520Wnt%2520signal%2520transduction%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26spage%3D468%26epage%3D477%26doi%3D10.1038%2Fnrm2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span> <i>Wnt Target genes</i>. <a href="https://web.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes" class="extLink">https://web.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes</a> (accessed 2020-05-20).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wnt+Target+genes.+https%3A%2F%2Fweb.stanford.edu%2Fgroup%2Fnusselab%2Fcgi-bin%2Fwnt%2Ftarget_genes+%28accessed+2020-05-20%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DWnt%2520Target%2520genes" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, M.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1084-9521(02)00050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS1084-9521%2802%2900050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12137733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1Wksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=243-249&author=M.+Kuhl&title=Non-canonical+Wnt+signaling+in+Xenopus%3A+regulation+of+axis+formation+and+gastrulation&doi=10.1016%2FS1084-9521%2802%2900050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation</span></div><div class="casAuthors">Kuhl, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Wnt proteins form a family of secreted glycoproteins that are involved in different developmental processes such as differentiation, proliferation, cell migration, and cell polarity.  To exert its function, Wnt proteins activate different intracellular signaling cascades.  Whereas the canonical, Wnt/β-catenin pathway is well characterized, less is known about the function of non-canonical Wnt pathways in vertebrates.  I here summarize recent findings implicating important roles for Wnt/Ca2+ and Wnt/JNK signaling during different aspects of early X. laevis development, namely axis formation and gastrulation movements.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppTK6H_cgzrbVg90H21EOLACvtfcHk0ljHPyMMKtcULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1Wksbc%253D&md5=d502d77e666e139a1059c8d94528573a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1084-9521%2802%2900050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1084-9521%252802%252900050-2%26sid%3Dliteratum%253Aachs%26aulast%3DKuhl%26aufirst%3DM.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520in%2520Xenopus%253A%2520regulation%2520of%2520axis%2520formation%2520and%2520gastrulation%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2002%26volume%3D13%26spage%3D243%26epage%3D249%26doi%3D10.1016%2FS1084-9521%2802%2900050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortunato, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzarossa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Cejudo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, C. A.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e45853</span>, <span class="refDoi"> DOI: 10.7554/eLife.45853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.7554%2FeLife.45853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31246175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlGisLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=e45853&author=J.+R.+Carvalhoauthor=I.+C.+Fortunatoauthor=C.+G.+Fonsecaauthor=A.+Pezzarossaauthor=P.+Barbacenaauthor=M.+A.+Dominguez-Cejudoauthor=F.+F.+Vasconcelosauthor=N.+C.+Santosauthor=F.+A.+Carvalhoauthor=C.+A.+Franco&title=Non-canonical+Wnt+signaling+regulates+junctional+mechanocoupling+during+angiogenic+collective+cell+migration&doi=10.7554%2FeLife.45853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration</span></div><div class="casAuthors">Carvalho, Joana R.; Fortunato, Isabela C.; Fonseca, Catarina G.; Pezzarossa, Anna; Barbacena, Pedro; Dominguez-Cejudo, Maria A.; Vasconcelos, Francisca F.; Santos, Nuno C.; Carvalho, Filomena A.; Franco, Claudio A.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e45853/1-e45853/35</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Morphogenesis of hierarchical vascular networks depends on the integration of multiple biomech. signals by endothelial cells, the cells lining the interior of blood vessels.  Expansion of vascular networks arises through sprouting angiogenesis, a process involving extensive cell rearrangements and collective cell migration.  Yet, the mechanisms controlling angiogenic collective behavior remain poorly understood.  Here, we show this collective cell behavior is regulated by non-canonical Wnt signaling.  We identify that Wnt5a specifically activates Cdc42 at cell junctions downstream of ROR2 to reinforce coupling between adherens junctions and the actin cytoskeleton.  We show that Wnt5a signaling stabilizes vinculin binding to alpha-catenin, and abrogation of vinculin in vivo and in vitro leads to uncoordinated polarity and deficient sprouting angiogenesis in Mus musculus.  Our findings highlight how non-canonical Wnt signaling coordinates collective cell behavior during vascular morphogenesis by fine-tuning junctional mechanocoupling between endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_01o_cQcDV7Vg90H21EOLACvtfcHk0lhpZkEfvI7XzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlGisLbK&md5=f6305c8fc3ca41731ea4d3b926ca3f08</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.7554%2FeLife.45853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45853%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DJ.%2BR.%26aulast%3DFortunato%26aufirst%3DI.%2BC.%26aulast%3DFonseca%26aufirst%3DC.%2BG.%26aulast%3DPezzarossa%26aufirst%3DA.%26aulast%3DBarbacena%26aufirst%3DP.%26aulast%3DDominguez-Cejudo%26aufirst%3DM.%2BA.%26aulast%3DVasconcelos%26aufirst%3DF.%2BF.%26aulast%3DSantos%26aufirst%3DN.%2BC.%26aulast%3DCarvalho%26aufirst%3DF.%2BA.%26aulast%3DFranco%26aufirst%3DC.%2BA.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520regulates%2520junctional%2520mechanocoupling%2520during%2520angiogenic%2520collective%2520cell%2520migration%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26spage%3De45853%26doi%3D10.7554%2FeLife.45853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkosis, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garkun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A.</span></span> <span> </span><span class="NLM_article-title">Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02440-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41467-017-02440-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29296000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC1MzmvFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=36&author=M.+Chavaliauthor=M.+Klingenerauthor=A.+G.+Kokkosisauthor=Y.+Garkunauthor=S.+Felongauthor=A.+Maffeiauthor=A.+Aguirre&title=Non-canonical+Wnt+signaling+regulates+neural+stem+cell+quiescence+during+homeostasis+and+after+demyelination&doi=10.1038%2Fs41467-017-02440-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination</span></div><div class="casAuthors">Chavali Manideep; Klingener Michael; Kokkosis Alexandros G; Felong Sylwia; Aguirre Adan; Chavali Manideep; Chavali Manideep; Garkun Yury; Maffei Arianna</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adult neural stem cells (NSCs) reside in a specialized microenvironment, the subventricular zone (SVZ), which provides them with unique signaling cues to control their basic properties and prevent their exhaustion.  While the signaling mechanisms that regulate NSC lineage progression are well characterized, the molecular mechanisms that trigger the activation of quiescent NSCs during homeostasis and tissue repair are still unclear.  Here, we uncovered that the NSC quiescent state is maintained by Rho-GTPase Cdc42, a downstream target of non-canonical Wnt signaling.  Mechanistically, activation of Cdc42 induces expression of molecules involved in stem cell identity and anchorage to the niche.  Strikingly, during a demyelination injury, downregulation of non-canonical Wnt-dependent Cdc42 activity is necessary to promote activation and lineage progression of quiescent NSCs, thereby initiating the process of tissue repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFg9X85G-ufdts4TFFB11gfW6udTcc2eZ4mwbbCa0s5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzmvFKjsA%253D%253D&md5=3f6f36c454df705a8dca8c68d2e02a8c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02440-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02440-0%26sid%3Dliteratum%253Aachs%26aulast%3DChavali%26aufirst%3DM.%26aulast%3DKlingener%26aufirst%3DM.%26aulast%3DKokkosis%26aufirst%3DA.%2BG.%26aulast%3DGarkun%26aufirst%3DY.%26aulast%3DFelong%26aufirst%3DS.%26aulast%3DMaffei%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DA.%26atitle%3DNon-canonical%2520Wnt%2520signaling%2520regulates%2520neural%2520stem%2520cell%2520quiescence%2520during%2520homeostasis%2520and%2520after%2520demyelination%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D36%26doi%3D10.1038%2Fs41467-017-02440-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ctrv.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29169144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=50-60&author=N.+Krishnamurthyauthor=R.+Kurzrock&title=Targeting+the+Wnt%2Fbeta-catenin+pathway+in+cancer%3A+Update+on+effectors+and+inhibitors&doi=10.1016%2Fj.ctrv.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span></div><div class="casAuthors">Krishnamurthy, Nithya; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Wnt/beta-catenin pathway is a family of proteins that is implicated in many vital cellular functions like stem cell regeneration and organogenesis.  Several intra-cellular signal transduction pathways are induced by Wnt, notably the Wnt/beta-catenin dependent pathway or canonical pathway and the non-canonical or beta-catenin-independent pathway, the latter includes the Wnt/Ca2+ and Planar Cell Polarity pathway (PCP).  Wnt activation occurs at the intestinal crypt floor, and is crit. to optimal maintenance of stem cells.  Colorectal cancers show evidence of Wnt signaling pathway activation and this is assocd. with loss of function of the tumor regulator APC.  Wnt activation has been obsd. in breast, lung, and hematopoietic malignancies and contributes to tumor recurrence.  The Wnt pathway cross talks with the Notch and Sonic Hedgehog pathways, which has implications for therapeutic interventions in cancers.  There are significant challenges in targeting the Wnt pathway, including finding agents that are efficacious without damaging the system of normal somatic stem cell function in cellular repair and tissue homeostasis.  Here, we comprehensively review the Wnt pathway and its interactions with the Notch and Sonic Hedgehog pathways.  We present the state of the field in effectors and inhibitors of Wnt signaling, including updates on clin. trials in various cancers with inhibitors of Wnt, Notch, and Sonic Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHbcA6nGH3rVg90H21EOLACvtfcHk0lhpZkEfvI7XzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF&md5=1a46da27b4932cbd31695e004a48b3c2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DN.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520cancer%253A%2520Update%2520on%2520effectors%2520and%2520inhibitors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.ctrv.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchartre, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">The Wnt signaling pathway in cancer</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1016/j.critrevonc.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.critrevonc.2015.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26775730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28nhtVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=141-149&author=Y.+Duchartreauthor=Y.+M.+Kimauthor=M.+Kahn&title=The+Wnt+signaling+pathway+in+cancer&doi=10.1016%2Fj.critrevonc.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Wnt signaling pathway in cancer</span></div><div class="casAuthors">Duchartre Yann; Kim Yong-Mi; Kahn Michael</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Wnt signaling pathway is critically involved in both the development and homeostasis of tissues via regulation of their endogenous stem cells.  Aberrant Wnt signaling has been described as a key player in the initiation of and/or maintenance and development of many cancers, via affecting the behavior of Cancer Stem Cells (CSCs).  CSCs are considered by most to be responsible for establishment of the tumor and also for disease relapse, as they possess inherent drug-resistance properties.  The development of new therapeutic compounds targeting the Wnt signaling pathway promises new hope to eliminate CSCs and achieve cancer eradication.  However, a major challenge resides in developing a strategy efficient enough to target the dysregulated Wnt pathway in CSCs, while being safe enough to not damage the normal somatic stem cell population required for tissue homeostasis and repair.  Here we review recent therapeutic approaches to target the Wnt pathway and their clinical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFhVYHuBPqTEBuFdjgVNKSfW6udTcc2eZP3hrFvBwXyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nhtVyktA%253D%253D&md5=12c352d164ae33f2b2cfc2a2f9b0a580</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DDuchartre%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DThe%2520Wnt%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2016%26volume%3D99%26spage%3D141%26epage%3D149%26doi%3D10.1016%2Fj.critrevonc.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span> <span> </span><span class="NLM_article-title">Development of small molecules targeting the Wnt signaling pathway in cancer stem cells for the treatment of colorectal cancer</span>. <i>Clin. Colorectal Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.clcc.2015.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.clcc.2015.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25799881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmvFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=133-145&author=L.+Songauthor=Y.+Liauthor=B.+Heauthor=Y.+Gong&title=Development+of+small+molecules+targeting+the+Wnt+signaling+pathway+in+cancer+stem+cells+for+the+treatment+of+colorectal+cancer&doi=10.1016%2Fj.clcc.2015.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer</span></div><div class="casAuthors">Song Lele; Li Yuemin; He Baoming; Gong Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical colorectal cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer (CRC) was ranked third in morbidity and mortality in the United States in 2013.  Although substantial progress has been made in surgical techniques and postoperative chemotherapy in recent years, the prognosis for colon cancer is still not satisfactory, mainly because of cancer recurrence and metastasis.  The latest studies have shown that cancer stem cells (CSCs) play important roles in cancer recurrence and metastasis.  Drugs that target CSCs might therefore have great therapeutic potential in prevention of cancer recurrence and metastasis.  The wingless-int (Wnt) signaling pathway in CSCs has been suggested to play crucial roles in colorectal carcinogenesis, and has become a popular target for anti-CRC therapy.  Dysregulation of the Wnt signaling pathway, mostly by inactivating mutations of the adenomatous polyposis coli tumor suppressor or oncogenic mutations of β-catenin, has been implicated as a key factor in colorectal tumorigenesis.  Abnormal increases of β-catenin levels represents a common pathway in Wnt signaling activation and is also observed in other human malignancies.  These findings highlight the importance of developing small-molecule drugs that target the Wnt pathway.  Herein we provide an overview on the current development of small molecules that target the Wnt pathway in colorectal CSCs and discuss future research directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLC7t3nDzoRjToTC3aBaesfW6udTcc2eZP3hrFvBwXyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmvFKisA%253D%253D&md5=aaf27eaa823e8ce494d15e3345411388</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.clcc.2015.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clcc.2015.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DGong%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520small%2520molecules%2520targeting%2520the%2520Wnt%2520signaling%2520pathway%2520in%2520cancer%2520stem%2520cells%2520for%2520the%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Colorectal%2520Cancer%26date%3D2015%26volume%3D14%26spage%3D133%26epage%3D145%26doi%3D10.1016%2Fj.clcc.2015.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcaroli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderbilt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisner, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, C. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the WNT signaling pathway in cancer therapeutics</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.2015-0057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1634%2Ftheoncologist.2015-0057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26306903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1189-1198&author=D.+Taiauthor=K.+Wellsauthor=J.+Arcaroliauthor=C.+Vanderbiltauthor=D.+L.+Aisnerauthor=W.+A.+Messersmithauthor=C.+H.+Lieu&title=Targeting+the+WNT+signaling+pathway+in+cancer+therapeutics&doi=10.1634%2Ftheoncologist.2015-0057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the WNT signaling pathway in cancer therapeutics</span></div><div class="casAuthors">Tai, David; Wells, Keith; Arcaroli, John; Vaderilt, Chad; Aisner, Dara L.; Messersmith, Wells A.; Lieh, Christopher H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1189-1198</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The WNT signaling cascade is integral in numerous biol. processes including embryonic development, cell cycle regulation, inflammation, and cancer.  Hyperactivation of WNT signaling secondary to alterations to varying nodes of the pathway have been identified in multiple tumor types.  These alterations converge into increased tumorigenicity, sustained proliferation, and enhanced metastatic potential.  This review seeks to evaluate the evidence supporting the WNT pathway in cancer, the therapeutic strategies in modulating this pathway, and potential challenges in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovtyZMAmAumrVg90H21EOLACvtfcHk0lh_rYge4vKXTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1GmsL4%253D&md5=bc6a05a448bde55a59013c405063a4ab</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2015-0057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2015-0057%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DArcaroli%26aufirst%3DJ.%26aulast%3DVanderbilt%26aufirst%3DC.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DMessersmith%26aufirst%3DW.%2BA.%26aulast%3DLieu%26aufirst%3DC.%2BH.%26atitle%3DTargeting%2520the%2520WNT%2520signaling%2520pathway%2520in%2520cancer%2520therapeutics%26jtitle%3DOncologist%26date%3D2015%26volume%3D20%26spage%3D1189%26epage%3D1198%26doi%3D10.1634%2Ftheoncologist.2015-0057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bafico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span> <span> </span><span class="NLM_article-title">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ccr.2004.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15542433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=497-506&author=A.+Baficoauthor=G.+Liuauthor=L.+Goldinauthor=V.+Harrisauthor=S.+A.+Aaronson&title=An+autocrine+mechanism+for+constitutive+Wnt+pathway+activation+in+human+cancer+cells&doi=10.1016%2Fj.ccr.2004.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span></div><div class="casAuthors">Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer.  In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of β-catenin without mutations afflicting downstream components.  Extracellular Wnt antagonists FRP1 and DKK1 caused a dramatic downregulation of β-catenin levels in these tumor cells assocd. with alteration of biol. properties and increased expression of epithelial differentiation markers.  Colorectal carcinoma cells with knockout of the mutant β-catenin allele retained upregulated β-catenin levels, which also could be inhibited by these Wnt antagonists.  Together, these findings establish the involvement of autocrine Wnt signaling in human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPoqwc2vXarVg90H21EOLACvtfcHk0li2d-UeH3iXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO&md5=d120566809d1ee0f6474a22eff99630d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DBafico%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldin%26aufirst%3DL.%26aulast%3DHarris%26aufirst%3DV.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DAn%2520autocrine%2520mechanism%2520for%2520constitutive%2520Wnt%2520pathway%2520activation%2520in%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D497%26epage%3D506%26doi%3D10.1016%2Fj.ccr.2004.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span> <span> </span><span class="NLM_article-title">Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1038/nature07329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature07329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18806781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yju73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=1119-1123&author=G.+Linauthor=N.+Xuauthor=R.+Xi&title=Paracrine+Wingless+signalling+controls+self-renewal+of+Drosophila+intestinal+stem+cells&doi=10.1038%2Fnature07329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells</span></div><div class="casAuthors">Lin, Guonan; Xu, Na; Xi, Rongwen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7216</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the Drosophila midgut, multipotent intestinal stem cells (ISCs) that are scattered along the epithelial basement membrane maintain tissue homeostasis by their ability to steadily produce daughters that differentiate into either enterocytes or enteroendocrine cells, depending on the levels of Notch activity.  However, the mechanisms controlling ISC self-renewal remain elusive.  A canonical Wnt signaling pathway controls ISC self-renewal.  The ligand Wingless (Wg) is specifically expressed in the circular muscles next to ISCs, sepd. by a thin layer of basement membrane.  Reduced function of wg causes ISC quiescence and differentiation, whereas wg overexpression produces excessive ISC-like cells that express high levels of the Notch ligand, Delta.  Clonal anal. shows that the main downstream components of the Wg pathway, including Frizzled, Dishevelled and Armadillo, are autonomously required for ISC self-renewal.  Furthermore, epistatic anal. suggests that Notch acts downstream of the Wg pathway and a hierarchy of Wg/Notch signaling pathways controls the balance between self-renewal and differentiation of ISCs.  These data suggest that the underlying circular muscle constitutes the ISC niche, which produce Wg signals that act directly on ISCs to promote ISC self-renewal.  This study demonstrates markedly conserved mechanisms regulating ISCs from Drosophila to mammals.  The identification of the Drosophila ISC niche and the principal self-renewal signal will facilitate further understanding of intestinal homeostasis control and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3SDgf1C7-arVg90H21EOLACvtfcHk0li2d-UeH3iXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yju73K&md5=2a701115a03841d361cfb025e04bef19</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnature07329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07329%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DR.%26atitle%3DParacrine%2520Wingless%2520signalling%2520controls%2520self-renewal%2520of%2520Drosophila%2520intestinal%2520stem%2520cells%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature07329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">A genetic model for colorectal tumorigenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(90)90186-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2F0092-8674%2890%2990186-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=2188735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1990&pages=759-767&author=E.+R.+Fearonauthor=B.+Vogelstein&title=A+genetic+model+for+colorectal+tumorigenesis&doi=10.1016%2F0092-8674%2890%2990186-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic model for colorectal tumorigenesis</span></div><div class="casAuthors">Fearon, Eric R.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 76 refs. on various genetic aspects of colonic neoplasia, including genetic alterations of oncogenes, clonal selection, allelic losses and tumor suppressor genes, multiple allelic losses, and accumulation and multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4CC_sLtNt7Vg90H21EOLACvtfcHk0li2d-UeH3iXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D&md5=d88588a58ce05a327c3e7ff8afccd3a7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990186-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990186-I%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DA%2520genetic%2520model%2520for%2520colorectal%2520tumorigenesis%26jtitle%3DCell%26date%3D1990%26volume%3D61%26spage%3D759%26epage%3D767%26doi%3D10.1016%2F0092-8674%2890%2990186-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span> <span> </span><span class="NLM_article-title">Molecular genetics of colorectal cancer</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1146%2Fannurev-pathol-011110-130235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21090969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVWrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=479-507&author=E.+R.+Fearon&title=Molecular+genetics+of+colorectal+cancer&doi=10.1146%2Fannurev-pathol-011110-130235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular genetics of colorectal cancer</span></div><div class="casAuthors">Fearon, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-507</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past three decades, mol. genetic studies have revealed some crit. mutations underlying the pathogenesis of the sporadic and inherited forms of colorectal cancer (CRC).  A relatively limited no. of oncogenes and tumor-suppressor genes-most prominently the APC, KRAS, and p53 genes-are mutated in a sizeable fraction of CRCs, and a larger collection of genes that are mutated in subsets of CRC have begun to be defined.  Together with DNA-methylation and chromatin-structure changes, the mutations act to dysregulate conserved signaling networks that exert context-dependent effects on crit. cell phenotypes, including the regulation of cellular metab., proliferation, differentiation, and survival.  Much work remains to be done to fully understand the nature and significance of the individual and collective genetic and epigenetic defects in CRC.  Some key concepts for the field have emerged, two of which are emphasized in this review.  Specifically, the gene defects in CRC often target proteins and pathways that exert pleiotropic effects on the cancer cell phenotype, and particular genetic and epigenetic alterations are linked to biol. and clin. distinct subsets of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNapMY1VRd2bVg90H21EOLACvtfcHk0lilVa89cuDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVWrs7k%253D&md5=68a29f10d67e1dd153ca5cc6e2df8572</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130235%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26atitle%3DMolecular%2520genetics%2520of%2520colorectal%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2011%26volume%3D6%26spage%3D479%26epage%3D507%26doi%3D10.1146%2Fannurev-pathol-011110-130235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindtorff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutros, M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1461</span>– <span class="NLM_lpage">1473</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2016.304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27617575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2gsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=1461-1473&author=T.+Zhanauthor=N.+Rindtorffauthor=M.+Boutros&title=Wnt+signaling+in+cancer&doi=10.1038%2Fonc.2016.304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in cancer</span></div><div class="casAuthors">Zhan, T.; Rindtorff, N.; Boutros, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1461-1473</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Wnt signaling is one of the key cascades regulating development and stemness, and has also been tightly assocd. with cancer.  The role of Wnt signaling in carcinogenesis has most prominently been described for colorectal cancer, but aberrant Wnt signaling is obsd. in many more cancer entities.  Here, we review current insights into novel components of Wnt pathways and describe their impact on cancer development.  Furthermore, we highlight expanding functions of Wnt signaling for both solid and liq. tumors.  We also describe current findings how Wnt signaling affects maintenance of cancer stem cells, metastasis and immune control.  Finally, we provide an overview of current strategies to antagonize Wnt signaling in cancer and challenges that are assocd. with such approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5DnHKAd0M3rVg90H21EOLACvtfcHk0lilVa89cuDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2gsL3O&md5=abef967a4e295e8d997ea2f241b035bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.304%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DT.%26aulast%3DRindtorff%26aufirst%3DN.%26aulast%3DBoutros%26aufirst%3DM.%26atitle%3DWnt%2520signaling%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D1461%26epage%3D1473%26doi%3D10.1038%2Fonc.2016.304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Differential expression of human <i>Wnt</i> genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=8168088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1ynsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=2615-2621&author=E.+L.+Huguetauthor=J.+A.+McMahonauthor=A.+P.+McMahonauthor=R.+Bicknellauthor=A.+L.+Harris&title=Differential+expression+of+human+Wnt+genes+2%2C+3%2C+4%2C+and+7B+in+human+breast+cell+lines+and+normal+and+disease+states+of+human+breast+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue</span></div><div class="casAuthors">Huguet, Emmanuel L.; McMahon, Jill A.; McMahon, Andrew P.; Bicknell, Roy; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2615-21</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Wnt gene expression was investigated by RNase protection anal. in human breast cancer, nontumorous breast tissue, and a variety of human breast cell lines.  The authors report the expression of Wnt3, Wnt4, and Wnt7b in human breast cell lines and Wnt2, Wnt3, Wnt4, and Wnt7b in human breast tissues.  Wnt3 and Wnt7a were absent in the cell lines and tissues tested.  The level of expression of Wnt2 and Wnt4 was 10- to 20-fold higher in fibroadenomas than it was in normal or malignant breast tissue, and in 10% of tumors Wnt7b expression was 30-fold higher than n normal or benign breast tissues.  In contrast to the mouse, in which Wnt1 and Wnt3 are involved in tumorigenesis, the authors' results suggest that Wnt2, Wnt4, and Wnt7b may be assocd. with abnormal proliferation in human breast tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN19X-Y5nL9bVg90H21EOLACvtfcHk0lilVa89cuDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1ynsbc%253D&md5=fc2a49c10fe1bf78e17d64b394ef0924</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuguet%26aufirst%3DE.%2BL.%26aulast%3DMcMahon%26aufirst%3DJ.%2BA.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26aulast%3DBicknell%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520expression%2520of%2520human%2520Wnt%2520genes%25202%252C%25203%252C%25204%252C%2520and%25207B%2520in%2520human%2520breast%2520cell%2520lines%2520and%2520normal%2520and%2520disease%2520states%2520of%2520human%2520breast%2520tissue%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D2615%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wend, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wend, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchondo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yesayan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loddenkemper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentolila, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda-Carboni, G. A.</span></span> <span> </span><span class="NLM_article-title">WNT10B/beta-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1002/emmm.201201320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Femmm.201201320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23307470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=264-279&author=P.+Wendauthor=S.+Runkeauthor=K.+Wendauthor=B.+Anchondoauthor=M.+Yesayanauthor=M.+Jardonauthor=N.+Hardieauthor=C.+Loddenkemperauthor=I.+Ulasovauthor=M.+S.+Lesniakauthor=R.+Wolskyauthor=L.+A.+Bentolilaauthor=S.+G.+Grantauthor=D.+Elashoffauthor=S.+Lehrauthor=J.+J.+Latimerauthor=S.+Boseauthor=H.+Sattarauthor=S.+A.+Krumauthor=G.+A.+Miranda-Carboni&title=WNT10B%2Fbeta-catenin+signalling+induces+HMGA2+and+proliferation+in+metastatic+triple-negative+breast+cancer&doi=10.1002%2Femmm.201201320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer</span></div><div class="casAuthors">Wend, Peter; Runke, Stephanie; Wend, Korinna; Anchondo, Brenda; Yesayan, Maria; Jardon, Meghan; Hardie, Natalie; Loddenkemper, Christoph; Ulasov, Ilya; Lesniak, Maciej S.; Wolsky, Rebecca; Bentolila, Laurent A.; Grant, Stephen G.; Elashoff, David; Lehr, Stephan; Latimer, Jean J.; Bose, Shikha; Sattar, Husain; Krum, Susan A.; Miranda-Carboni, Gustavo A.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-279</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt/β-catenin signalling has been suggested to be active in basal-like breast cancer.  However, in highly aggressive metastatic triple-neg. breast cancers (TNBC) the role of β-catenin and the underlying mechanism(s) for the aggressiveness of TNBC remain unknown.  We illustrate that WNT10B induces transcriptionally active β-catenin in human TNBC and predicts survival-outcome of patients with both TNBC and basal-like tumors.  We provide evidence that transgenic murine Wnt10b-driven tumors are devoid of ERα, PR and HER2 expression and can model human TNBC.  Importantly, HMGA2 is specifically expressed during early stages of embryonic mammogenesis and absent when WNT10B expression is lost, suggesting a developmentally conserved mode of action.  Mechanistically, ChIP anal. uncovered that WNT10B activates canonical β-catenin signalling leading to up-regulation of HMGA2.  Treatment of mouse and human triple-neg. tumor cells with two Wnt/β-catenin pathway modulators or siRNA to HMGA2 decreases HMGA2 levels and proliferation.  We demonstrate that WNT10B has epistatic activity on HMGA2, which is necessary and sufficient for proliferation of TNBC cells.  Furthermore, HMGA2 expression predicts relapse-free-survival and metastasis in TNBC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIglwkRBu1a7Vg90H21EOLACvtfcHk0lis6LwC0kXSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyktbo%253D&md5=daab997602f31e4eff201deb3051df49</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201320%26sid%3Dliteratum%253Aachs%26aulast%3DWend%26aufirst%3DP.%26aulast%3DRunke%26aufirst%3DS.%26aulast%3DWend%26aufirst%3DK.%26aulast%3DAnchondo%26aufirst%3DB.%26aulast%3DYesayan%26aufirst%3DM.%26aulast%3DJardon%26aufirst%3DM.%26aulast%3DHardie%26aufirst%3DN.%26aulast%3DLoddenkemper%26aufirst%3DC.%26aulast%3DUlasov%26aufirst%3DI.%26aulast%3DLesniak%26aufirst%3DM.%2BS.%26aulast%3DWolsky%26aufirst%3DR.%26aulast%3DBentolila%26aufirst%3DL.%2BA.%26aulast%3DGrant%26aufirst%3DS.%2BG.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DLehr%26aufirst%3DS.%26aulast%3DLatimer%26aufirst%3DJ.%2BJ.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DSattar%26aufirst%3DH.%26aulast%3DKrum%26aufirst%3DS.%2BA.%26aulast%3DMiranda-Carboni%26aufirst%3DG.%2BA.%26atitle%3DWNT10B%252Fbeta-catenin%2520signalling%2520induces%2520HMGA2%2520and%2520proliferation%2520in%2520metastatic%2520triple-negative%2520breast%2520cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D264%26epage%3D279%26doi%3D10.1002%2Femmm.201201320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spohn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span> <span> </span><span class="NLM_article-title">Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4266</span>, <span class="refDoi"> DOI: 10.1073/pnas.060025397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.060025397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10759547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4262-4266&author=S.+Y.+Linauthor=W.+Xiaauthor=J.+C.+Wangauthor=K.+Y.+Kwongauthor=B.+Spohnauthor=Y.+Wenauthor=R.+G.+Pestellauthor=M.+C.+Hung&title=Beta-catenin%2C+a+novel+prognostic+marker+for+breast+cancer%3A+its+roles+in+cyclin+D1+expression+and+cancer+progression&doi=10.1073%2Fpnas.060025397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression</span></div><div class="casAuthors">Lin, Shiaw-Yih; Xia, Weiya; Wang, Jo C.; Kwong, Ka Yin; Spohn, Bill; Wen, Yong; Pestell, Richard G.; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4262-4266</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">β-Catenin can function as an oncogene when it is translocated to the nucleus, binds to T cell factor or lymphoid enhancer factor family members, and transactivates its target genes.  In this study, the authors demonstrate that cyclin D1 is one of the targets of β-catenin in breast cancer cells.  Transactivation of β-catenin correlated significantly with cyclin D1 expression both in eight breast cell lines in vitro and in 123 patient samples.  More importantly, the authors found that high β-catenin activity significantly correlated with poor prognosis of the patients and was a strong and independent prognostic factor in breast cancer.  The authors' studies, therefore, indicated that β-catenin can be involved in breast cancer formation and/or progression and may serve as a target for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonlL8mUVXDjbVg90H21EOLACvtfcHk0lis6LwC0kXSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSnsr4%253D&md5=62c595a192c6fb5fbeb582db0140e341</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.060025397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.060025397%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DKwong%26aufirst%3DK.%2BY.%26aulast%3DSpohn%26aufirst%3DB.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26aulast%3DHung%26aufirst%3DM.%2BC.%26atitle%3DBeta-catenin%252C%2520a%2520novel%2520prognostic%2520marker%2520for%2520breast%2520cancer%253A%2520its%2520roles%2520in%2520cyclin%2520D1%2520expression%2520and%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4262%26epage%3D4266%26doi%3D10.1073%2Fpnas.060025397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, G.</span></span> <span> </span><span class="NLM_article-title">LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">5136</span>– <span class="NLM_lpage">5141</span>, <span class="refDoi"> DOI: 10.1073/pnas.0911220107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0911220107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20194742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=5136-5141&author=C.+C.+Liuauthor=J.+Priorauthor=D.+Piwnica-Wormsauthor=G.+Bu&title=LRP6+overexpression+defines+a+class+of+breast+cancer+subtype+and+is+a+target+for+therapy&doi=10.1073%2Fpnas.0911220107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy</span></div><div class="casAuthors">Liu, Chia-Chen; Prior, Julie; Piwnica-Worms, David; Bu, Guojun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5136-5141, S5136/1-S5136/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway is activated in breast cancer, a leading cause of cancer mortality in women.  Because mutations in the key intracellular components of this pathway are rare, identifying the mol. mechanisms of aberrant Wnt activation in breast cancer is crit. for development of pathway-targeted therapy.  Here, we show that expression of the Wnt signaling coreceptor LRP6 is upregulated in a subpopulation of human breast cancers.  LRP6 silencing in breast cancer cells reduces Wnt signaling, cell proliferation, and in vivo tumor growth.  In vivo administration of an LRP6 antagonist, Mesd, markedly suppressed growth of MMTV-Wnt1 tumors without causing undesirable side effects.  These results demonstrate that Wnt activation at the cell surface contributes to breast cancer tumorigenesis.  Together, our studies highlight LRP6 as a potential therapeutic target in breast cancer, and introduce Mesd as a promising antitumor agent for treating breast cancer subtypes with Wnt activation at the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqewdoR2h7bVg90H21EOLACvtfcHk0ljxaWtsJZ8hng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFGntbo%253D&md5=e97aee8ef764393f9266ac97b2c040f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0911220107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0911220107%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DPrior%26aufirst%3DJ.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DBu%26aufirst%3DG.%26atitle%3DLRP6%2520overexpression%2520defines%2520a%2520class%2520of%2520breast%2520cancer%2520subtype%2520and%2520is%2520a%2520target%2520for%2520therapy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D5136%26epage%3D5141%26doi%3D10.1073%2Fpnas.0911220107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somlo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, Y.</span></span> <span> </span><span class="NLM_article-title">FZD7 has a critical role in cell proliferation in triple negative breast cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">4437</span>– <span class="NLM_lpage">4446</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2011.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21532620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4437-4446&author=L.+Yangauthor=X.+Wuauthor=Y.+Wangauthor=K.+Zhangauthor=J.+Wuauthor=Y.+C.+Yuanauthor=X.+Dengauthor=L.+Chenauthor=C.+C.+Kimauthor=S.+Lauauthor=G.+Somloauthor=Y.+Yen&title=FZD7+has+a+critical+role+in+cell+proliferation+in+triple+negative+breast+cancer&doi=10.1038%2Fonc.2011.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">FZD7 has a critical role in cell proliferation in triple negative breast cancer</span></div><div class="casAuthors">Yang, L.; Wu, X.; Wang, Y.; Zhang, K.; Wu, J.; Yuan, Y-C.; Deng, X.; Chen, L.; Kim, C. C. H.; Lau, S.; Somlo, G.; Yen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4437-4446</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Breast cancer is genetically and clin. heterogeneous.  Triple neg. breast cancer (TNBC) is a subtype of breast cancer that is usually assocd. with poor outcome and lack of benefit from targeted therapy.  We used microarray anal. to perform a pathway anal. of TNBC compared with non-triple neg. breast cancer (non-TNBC).  Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low d. lipoprotein receptor-related protein 6 and transcription factor 7 (TCF7) was obsd. in TNBC, and we directed our focus to the Wnt pathway receptor, FZD7.  To validate the function of FZD7, FZD7shRNA was used to knock down FZD7 expression.  Notably, reduced cell proliferation and suppressed invasiveness and colony formation were obsd. in TNBC MDA-MB-231 and BT-20 cells.  Study of the possible mechanism indicated that these effects occurred through silencing of the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of β-catenin and decreased transcriptional activity of TCF7.  In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts without FZD7 expression.  Our findings suggest that FZD7-involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC, and thus, FZD7 shows promise as a biomarker and a potential therapeutic target for TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwcoa3WO2erVg90H21EOLACvtfcHk0ljxaWtsJZ8hng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGlsLY%253D&md5=f8931e5d9d38dfd4abfd1db9cf8c8037</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DY.%2BC.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DC.%2BC.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DYen%26aufirst%3DY.%26atitle%3DFZD7%2520has%2520a%2520critical%2520role%2520in%2520cell%2520proliferation%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D4437%26epage%3D4446%26doi%3D10.1038%2Fonc.2011.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, W. L.</span></span> <span> </span><span class="NLM_article-title">Epigenetic gene silencing in the Wnt pathway in breast cancer</span>. <i>Epigenetics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.4161/epi.3.2.5899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.4161%2Fepi.3.2.5899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18398311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BD1czmvVKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=59-63&author=G.+J.+Klarmannauthor=A.+Deckerauthor=W.+L.+Farrar&title=Epigenetic+gene+silencing+in+the+Wnt+pathway+in+breast+cancer&doi=10.4161%2Fepi.3.2.5899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic gene silencing in the Wnt pathway in breast cancer</span></div><div class="casAuthors">Klarmann George J; Decker Amy; Farrar William L</div><div class="citationInfo"><span class="NLM_cas:title">Epigenetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the most common malignancies in women.  Despite advances in treatment of endocrine-dependent tumors, the complete molecular basis of transformation is still unknown.  What is clear is that a variety of genetic lesions and epigenetic modifications are present in the neoplasm.  Disregulation of several signaling pathways is known to be associated with breast cancer development, among them is the wingless and integration site growth factor (Wnt) pathway.  While genetic mutations of certain components of this pathway, such as APC, are significant contributing factors for colorectal cancers, they are typically not the predominate mechanism associated with breast cancer.  Instead, it appears that DNA hypermethylation leads to aberrant regulation of the Wnt pathway in breast cancer, and as such, this review focuses on the epigenetic regulation of Wnt pathway components in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBeaLtFoQ8kI2y4bB4mnvYfW6udTcc2eb2hAjjxOwLTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czmvVKgtA%253D%253D&md5=81310f7369d65c9b525773c02a9756bb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4161%2Fepi.3.2.5899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fepi.3.2.5899%26sid%3Dliteratum%253Aachs%26aulast%3DKlarmann%26aufirst%3DG.%2BJ.%26aulast%3DDecker%26aufirst%3DA.%26aulast%3DFarrar%26aufirst%3DW.%2BL.%26atitle%3DEpigenetic%2520gene%2520silencing%2520in%2520the%2520Wnt%2520pathway%2520in%2520breast%2520cancer%26jtitle%3DEpigenetics%26date%3D2008%26volume%3D3%26spage%3D59%26epage%3D63%26doi%3D10.4161%2Fepi.3.2.5899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonigro, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosquera, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taplin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abida, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vats, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunju, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathkopf, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balk, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaviola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sougnez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostaghel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">True, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plymate, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvinge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraldeschi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafeiriou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunariu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demichelis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanus, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagawa, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigaras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elemento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sboner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantoff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span> <span> </span><span class="NLM_article-title">Integrative clinical genomics of advanced prostate cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1215</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2015.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26000489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1Sgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1215-1228&author=D.+Robinsonauthor=E.+M.+Van+Allenauthor=Y.+M.+Wuauthor=N.+Schultzauthor=R.+J.+Lonigroauthor=J.+M.+Mosqueraauthor=B.+Montgomeryauthor=M.+E.+Taplinauthor=C.+C.+Pritchardauthor=G.+Attardauthor=H.+Beltranauthor=W.+Abidaauthor=R.+K.+Bradleyauthor=J.+Vinsonauthor=X.+Caoauthor=P.+Vatsauthor=L.+P.+Kunjuauthor=M.+Hussainauthor=F.+Y.+Fengauthor=S.+A.+Tomlinsauthor=K.+A.+Cooneyauthor=D.+C.+Smithauthor=C.+Brennanauthor=J.+Siddiquiauthor=R.+Mehraauthor=Y.+Chenauthor=D.+E.+Rathkopfauthor=M.+J.+Morrisauthor=S.+B.+Solomonauthor=J.+C.+Durackauthor=V.+E.+Reuterauthor=A.+Gopalanauthor=J.+Gaoauthor=M.+Lodaauthor=R.+T.+Lisauthor=M.+Bowdenauthor=S.+P.+Balkauthor=G.+Gaviolaauthor=C.+Sougnezauthor=M.+Guptaauthor=E.+Y.+Yuauthor=E.+A.+Mostaghelauthor=H.+H.+Chengauthor=H.+Mulcahyauthor=L.+D.+Trueauthor=S.+R.+Plymateauthor=H.+Dvingeauthor=R.+Ferraldeschiauthor=P.+Flohrauthor=S.+Mirandaauthor=Z.+Zafeiriouauthor=N.+Tunariuauthor=J.+Mateoauthor=R.+Perez-Lopezauthor=F.+Demichelisauthor=B.+D.+Robinsonauthor=M.+Schiffmanauthor=D.+M.+Nanusauthor=S.+T.+Tagawaauthor=A.+Sigarasauthor=K.+W.+Engauthor=O.+Elementoauthor=A.+Sbonerauthor=E.+I.+Heathauthor=H.+I.+Scherauthor=K.+J.+Pientaauthor=P.+Kantoffauthor=J.+S.+de+Bonoauthor=M.+A.+Rubinauthor=P.+S.+Nelsonauthor=L.+A.+Garrawayauthor=C.+L.+Sawyersauthor=A.+M.+Chinnaiyan&title=Integrative+clinical+genomics+of+advanced+prostate+cancer&doi=10.1016%2Fj.cell.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Integrative clinical genomics of advanced prostate cancer</span></div><div class="casAuthors">Robinson, Dan; Van Allen, Eliezer M.; Wu, Yi-Mi; Schultz, Nikolaus; Lonigro, Robert J.; Mosquera, Juan-Miguel; Montgomery, Bruce; Taplin, Mary-Ellen; Pritchard, Colin C.; Attard, Gerhardt; Beltran, Himisha; Abida, Wassim; Bradley, Robert K.; Vinson, Jake; Cao, Xuhong; Vats, Pankaj; Kunju, Lakshmi P.; Hussain, Maha; Feng, Felix Y.; Tomlins, Scott A.; Cooney, Kathleen A.; Smith, David C.; Brennan, Christine; Siddiqui, Javed; Mehra, Rohit; Chen, Yu; Rathkopf, Dana E.; Morris, Michael J.; Solomon, Stephen B.; Durack, Jeremy C.; Reuter, Victor E.; Gopalan, Anuradha; Gao, Jianjiong; Loda, Massimo; Lis, Rosina T.; Bowden, Michaela; Balk, Stephen P.; Gaviola, Glenn; Sougnez, Carrie; Gupta, Manaswi; Yu, Evan Y.; Mostaghel, Elahe A.; Cheng, Heather H.; Mulcahy, Hyojeong; True, Lawrence D.; Plymate, Stephen R.; Dvinge, Heidi; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; Demichelis, Francesca; Robinson, Brian D.; Schiffman, Marc; Nanus, David M.; Tagawa, Scott T.; Sigaras, Alexandros; Eng, Kenneth W.; Elemento, Olivier; Sboner, Andrea; Heath, Elisabeth I.; Scher, Howard I.; Pienta, Kenneth J.; Kantoff, Philip; de Bono, Johann S.; Rubin, Mark A.; Nelson, Peter S.; Garraway, Levi A.; Sawyers, Charles L.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1215-1228</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established a multi-institutional clin. sequencing infrastructure to conduct prospective whole-exome and transcriptome sequencing of bone or soft tissue tumor biopsies from a cohort of 150 mCRPC affected individuals.  Aberrations of AR, ETS genes, TP53, and PTEN were frequent (40%-60% of cases), with TP53 and AR alterations enriched in mCRPC compared to primary prostate cancer.  We identified new genomic alterations in PIK3CA/B, R-spondin, BRAF/RAF1, APC, β-catenin, and ZBTB16/PLZF.  Moreover, aberrations of BRCA2, BRCA1, and ATM were obsd. at substantially higher frequencies (19.3% overall) compared to those in primary prostate cancers. 89% of affected individuals harbored a clin. actionable aberration, including 62.7% with aberrations in AR, 65% in other cancer-related genes, and 8% with actionable pathogenic germline alterations.  This cohort study provides clin. actionable information that could impact treatment decisions for these affected individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewpXHDFXwNrVg90H21EOLACvtfcHk0li0MVz4pEcEcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1Sgt7w%253D&md5=11155c903c7699036c56482d39097fb6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DMosquera%26aufirst%3DJ.%2BM.%26aulast%3DMontgomery%26aufirst%3DB.%26aulast%3DTaplin%26aufirst%3DM.%2BE.%26aulast%3DPritchard%26aufirst%3DC.%2BC.%26aulast%3DAttard%26aufirst%3DG.%26aulast%3DBeltran%26aufirst%3DH.%26aulast%3DAbida%26aufirst%3DW.%26aulast%3DBradley%26aufirst%3DR.%2BK.%26aulast%3DVinson%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DVats%26aufirst%3DP.%26aulast%3DKunju%26aufirst%3DL.%2BP.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DCooney%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRathkopf%26aufirst%3DD.%2BE.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSolomon%26aufirst%3DS.%2BB.%26aulast%3DDurack%26aufirst%3DJ.%2BC.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DLis%26aufirst%3DR.%2BT.%26aulast%3DBowden%26aufirst%3DM.%26aulast%3DBalk%26aufirst%3DS.%2BP.%26aulast%3DGaviola%26aufirst%3DG.%26aulast%3DSougnez%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DE.%2BY.%26aulast%3DMostaghel%26aufirst%3DE.%2BA.%26aulast%3DCheng%26aufirst%3DH.%2BH.%26aulast%3DMulcahy%26aufirst%3DH.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26aulast%3DDvinge%26aufirst%3DH.%26aulast%3DFerraldeschi%26aufirst%3DR.%26aulast%3DFlohr%26aufirst%3DP.%26aulast%3DMiranda%26aufirst%3DS.%26aulast%3DZafeiriou%26aufirst%3DZ.%26aulast%3DTunariu%26aufirst%3DN.%26aulast%3DMateo%26aufirst%3DJ.%26aulast%3DPerez-Lopez%26aufirst%3DR.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DB.%2BD.%26aulast%3DSchiffman%26aufirst%3DM.%26aulast%3DNanus%26aufirst%3DD.%2BM.%26aulast%3DTagawa%26aufirst%3DS.%2BT.%26aulast%3DSigaras%26aufirst%3DA.%26aulast%3DEng%26aufirst%3DK.%2BW.%26aulast%3DElemento%26aufirst%3DO.%26aulast%3DSboner%26aufirst%3DA.%26aulast%3DHeath%26aufirst%3DE.%2BI.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DKantoff%26aufirst%3DP.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DP.%2BS.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DIntegrative%2520clinical%2520genomics%2520of%2520advanced%2520prostate%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1215%26epage%3D1228%26doi%3D10.1016%2Fj.cell.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quist, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonigro, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asangani, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ateeq, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prensner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palanisamy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryslik, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunju, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienta, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span> <span> </span><span class="NLM_article-title">The mutational landscape of lethal castration-resistant prostate cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1038/nature11125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature11125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22722839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWisLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=239-243&author=C.+S.+Grassoauthor=Y.+M.+Wuauthor=D.+R.+Robinsonauthor=X.+Caoauthor=S.+M.+Dhanasekaranauthor=A.+P.+Khanauthor=M.+J.+Quistauthor=X.+Jingauthor=R.+J.+Lonigroauthor=J.+C.+Brennerauthor=I.+A.+Asanganiauthor=B.+Ateeqauthor=S.+Y.+Chunauthor=J.+Siddiquiauthor=L.+Samauthor=M.+Anstettauthor=R.+Mehraauthor=J.+R.+Prensnerauthor=N.+Palanisamyauthor=G.+A.+Ryslikauthor=F.+Vandinauthor=B.+J.+Raphaelauthor=L.+P.+Kunjuauthor=D.+R.+Rhodesauthor=K.+J.+Pientaauthor=A.+M.+Chinnaiyanauthor=S.+A.+Tomlins&title=The+mutational+landscape+of+lethal+castration-resistant+prostate+cancer&doi=10.1038%2Fnature11125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The mutational landscape of lethal castration-resistant prostate cancer</span></div><div class="casAuthors">Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Anstett, Matt; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Ryslik, Gregory A.; Vandin, Fabio; Raphael, Benjamin J.; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7406</span>),
    <span class="NLM_cas:pages">239-243</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Characterization of the prostate cancer transcriptome and genome has identified chromosomal rearrangements and copy no. gains and losses, including ETS gene family fusions, PTEN loss and androgen receptor (AR) amplification, which drive prostate cancer development and progression to lethal, metastatic castration-resistant prostate cancer (CRPC).  However, less is known about the role of mutations.  Here we sequenced the exomes of 50 lethal, heavily pre-treated metastatic CRPCs obtained at rapid autopsy (including three different foci from the same patient) and 11 treatment-naive, high-grade localized prostate cancers.  We identified low overall mutation rates even in heavily treated CRPCs (2.00 per megabase) and confirmed the monoclonal origin of lethal CRPC.  Integrating exome copy no. anal. identified disruptions of CHD1 that define a subtype of ETS gene family fusion-neg. prostate cancer.  Similarly, we demonstrate that ETS2, which is deleted in approx. one-third of CRPCs (commonly through TMPRSS2:ERG fusions), is also deregulated through mutation.  Furthermore, we identified recurrent mutations in multiple chromatin- and histone-modifying genes, including MLL2 (mutated in 8.6% of prostate cancers), and demonstrate interaction of the MLL complex with the AR, which is required for AR-mediated signaling.  We also identified novel recurrent mutations in the AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers (both untreated localized prostate cancer and CRPC), and showed that mutated FOXA1 represses androgen signaling and increases tumor growth.  Proteins that phys. interact with the AR, such as the ERG gene fusion product, FOXA1, MLL2, UTX (also known as KDM6A) and ASXL1 were found to be mutated in CRPC.  In summary, we describe the mutational landscape of a heavily treated metastatic cancer, identify novel mechanisms of AR signaling deregulated in prostate cancer, and prioritize candidates for future study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzVYOnnaqVLVg90H21EOLACvtfcHk0lgBj4HRR78kiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWisLfP&md5=15b1780d9cd2189325baf4e4fec84687</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnature11125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11125%26sid%3Dliteratum%253Aachs%26aulast%3DGrasso%26aufirst%3DC.%2BS.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DKhan%26aufirst%3DA.%2BP.%26aulast%3DQuist%26aufirst%3DM.%2BJ.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DLonigro%26aufirst%3DR.%2BJ.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DAteeq%26aufirst%3DB.%26aulast%3DChun%26aufirst%3DS.%2BY.%26aulast%3DSiddiqui%26aufirst%3DJ.%26aulast%3DSam%26aufirst%3DL.%26aulast%3DAnstett%26aufirst%3DM.%26aulast%3DMehra%26aufirst%3DR.%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DPalanisamy%26aufirst%3DN.%26aulast%3DRyslik%26aufirst%3DG.%2BA.%26aulast%3DVandin%26aufirst%3DF.%26aulast%3DRaphael%26aufirst%3DB.%2BJ.%26aulast%3DKunju%26aufirst%3DL.%2BP.%26aulast%3DRhodes%26aufirst%3DD.%2BR.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26atitle%3DThe%2520mutational%2520landscape%2520of%2520lethal%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D239%26epage%3D243%26doi%3D10.1038%2Fnature11125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
La Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billuart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buendia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrane, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldjord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, C.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8847</span>– <span class="NLM_lpage">8851</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.15.8847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.95.15.8847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9671767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8847-8851&author=A.+de%0ALa+Costeauthor=B.+Romagnoloauthor=P.+Billuartauthor=C.+A.+Renardauthor=M.+A.+Buendiaauthor=O.+Soubraneauthor=M.+Fabreauthor=J.+Chellyauthor=C.+Beldjordauthor=A.+Kahnauthor=C.+Perret&title=Somatic+mutations+of+the+beta-catenin+gene+are+frequent+in+mouse+and+human+hepatocellular+carcinomas&doi=10.1073%2Fpnas.95.15.8847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas</span></div><div class="casAuthors">De La Coste, Alix; Romagnolo, Beatrice; Billuart, Pierre; Renard, Claire-Angelique; Buendia, Marie-Annick; Soubrane, Olivier; Fabre, Monique; Chelly, Jamel; Beldjord, Cherif; Kahn, Axel; Perret, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8847-8851</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the major primary malignant tumor in the human liver, but the mol. changes leading to liver cell transformation remain largely unknown.  The Wnt-β-catenin pathway is activated in colon cancers and some melanoma cell lines, but has not yet been investigated in HCC.  The authors have examd. the status of the β-catenin gene in different transgenic mouse lines of HCC obtained with the oncogenes c-myc or H-ras.  Fifty percent of the hepatic tumors in these transgenic mice had activating somatic mutations within the β-catenin gene similar to those found in colon cancers and melanomas.  These alterations in the β-catenin gene (point mutations or deletions) lead to a dysregulation of the signaling function of β-catenin and thus to carcinogenesis.  The authors then analyzed human HCCs and found similar mutations in eight of 31 (26%) human liver tumors tested and in HepG2 and HuH6 hepatoma cells.  The mutations led to the accumulation of β-catenin in the nucleus.  Thus alterations in the β-catenin gene frequently are selected for during liver tumorigenesis and suggest that dysregulation of the Wnt-β-catenin pathway is a major event in the development of HCC in humans and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vBi5Xd806LVg90H21EOLACvtfcHk0lgBj4HRR78kiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFaltrk%253D&md5=f4621e5c36e490cf39ca8a24341908b3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8847%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLa%2BCoste%26aufirst%3DA.%26aulast%3DRomagnolo%26aufirst%3DB.%26aulast%3DBilluart%26aufirst%3DP.%26aulast%3DRenard%26aufirst%3DC.%2BA.%26aulast%3DBuendia%26aufirst%3DM.%2BA.%26aulast%3DSoubrane%26aufirst%3DO.%26aulast%3DFabre%26aufirst%3DM.%26aulast%3DChelly%26aufirst%3DJ.%26aulast%3DBeldjord%26aufirst%3DC.%26aulast%3DKahn%26aufirst%3DA.%26aulast%3DPerret%26aufirst%3DC.%26atitle%3DSomatic%2520mutations%2520of%2520the%2520beta-catenin%2520gene%2520are%2520frequent%2520in%2520mouse%2520and%2520human%2520hepatocellular%2520carcinomas%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8847%26epage%3D8851%26doi%3D10.1073%2Fpnas.95.15.8847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kameyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9500465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFersL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=1021-1026&author=K.+Iwaoauthor=S.+Nakamoriauthor=M.+Kameyamaauthor=S.+Imaokaauthor=M.+Kinoshitaauthor=T.+Fukuiauthor=S.+Ishiguroauthor=Y.+Nakamuraauthor=Y.+Miyoshi&title=Activation+of+the+beta-catenin+gene+by+interstitial+deletions+involving+exon+3+in+primary+colorectal+carcinomas+without+adenomatous+polyposis+coli+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations</span></div><div class="casAuthors">Iwao, Kyoko; Nakamori, Syoji; Kameyama, Masao; Imaoka, Shingi; Kinoshita, Moritoshi; Fukui, Takafumi; Ishiguro, Shingo; Nakamura, Yusuke; Miyoshi, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1026</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Among 222 primary colorectal cancers we examd., 58 showed no detectable APC mutations by the protein truncation test.  Those 58 tumors were screened for somatic mutations in the β-catenin gene.  Although amino acid substitutions in serine or threonine residues in exon 3 had been reported, no such mutations were found; however, in 7 tumors, somatic interstitial deletions of 234-760 bp were found, each of which included all or part of exon 3.  Short nucleotide sequences at both ends of each deletion were either identical or complementary, indicating that repeated or inversely repeated sequences were involved in the somatic rearrangements.  Reverse transcription-PCR expts. using RNAs isolated from 3 of these 7 tumors detected transcripts that lacked exon 3, in addn. to the normal transcript.  In one of these cases, accumulation of aberrant β-catenin protein in cytoplasm and nuclei of cancer cells was confirmed by Western and immunohistochem. analyses.  This result suggested that, in the absence of a peptide encoded by exon 3, β-catenin is stabilized and has a dominant oncogenic effect on colorectal tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLIb1VXiKnKbVg90H21EOLACvtfcHk0liC2LkNSuxbLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFersL4%253D&md5=2ed6252edb14321accef5585479083f6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwao%26aufirst%3DK.%26aulast%3DNakamori%26aufirst%3DS.%26aulast%3DKameyama%26aufirst%3DM.%26aulast%3DImaoka%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMiyoshi%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520beta-catenin%2520gene%2520by%2520interstitial%2520deletions%2520involving%2520exon%25203%2520in%2520primary%2520colorectal%2520carcinomas%2520without%2520adenomatous%2520polyposis%2520coli%2520mutations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D1021%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zurawel, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiappa, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffel, C.</span></span> <span> </span><span class="NLM_article-title">Sporadic medulloblastomas contain oncogenic β-catenin mutations</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">896</span>– <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9500446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=896-899&author=R.+H.+Zurawelauthor=S.+A.+Chiappaauthor=C.+Allenauthor=C.+Raffel&title=Sporadic+medulloblastomas+contain+oncogenic+%CE%B2-catenin+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sporadic medulloblastomas contain oncogenic β-catenin mutations</span></div><div class="casAuthors">Zurawel, Russell H.; Chiappa, Sharon A.; Allen, Cory; Raffel, Corey</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">896-899</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The β-catenin, glycogen synthase kinase 3β (GSK-3β), and adenomatous polyposis coli (APC) gene products interact to form a network that influences the rate of cell proliferation.  Medulloblastoma occurs as part of Turcot's syndrome, and patients with Turcot's who develop medulloblastomas have been shown to harbor germ-line APC mutations.  Although APC mutations have been investigated and not identified in sporadic medulloblastomas, the status of the β-catenin and GSK-3β genes has not been evaluated in this tumor.  Here we show that 3 of 67 medulloblastomas harbor β-catenin mutations, each of which converts a GSK-3β phosphorylation site from serine to cysteine.  The β-catenin mutation seen in the tumors was not present in matched constitutional DNA in the two cases where matched DNA was available.  A loss of heterozygosity anal. of 32 medulloblastomas with paired normal DNA samples was performed with four microsatellite markers flanking the GSK-3β locus; loss of heterozygosity with at least one marker was identified in 7 tumors.  Sequencing of the remaining GSK-3β allele in these cases failed to identify any mutations.  Taken together, these data suggest that activating mutations in the β-catenin gene may be involved in the development of a subset of medulloblastomas.  The GSK-3β gene does not appear to be a target for inactivation in this tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxedg6t4SfjLVg90H21EOLACvtfcHk0liC2LkNSuxbLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFersr8%253D&md5=bf043549310f5af6cd55c6225488305e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZurawel%26aufirst%3DR.%2BH.%26aulast%3DChiappa%26aufirst%3DS.%2BA.%26aulast%3DAllen%26aufirst%3DC.%26aulast%3DRaffel%26aufirst%3DC.%26atitle%3DSporadic%2520medulloblastomas%2520contain%2520oncogenic%2520%25CE%25B2-catenin%2520mutations%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D896%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voeller, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truica, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmann, E. P.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mutations in human prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2520</span>– <span class="NLM_lpage">2523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9635571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXktVajt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2520-2523&author=H.+J.+Voellerauthor=C.+I.+Truicaauthor=E.+P.+Gelmann&title=%CE%B2-Catenin+mutations+in+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin mutations in human prostate cancer</span></div><div class="casAuthors">Voeller, H. James; Truica, Cristina I.; Gelmann, Edward P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2520-2523</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Catenin plays essential roles in both intercellular adhesion and signal transduction.  As a signaling mol., β-catenin supplies an activating domain to the T-cell factor/lymphoid enhancer-binding factor family of DNA-binding proteins and activates gene transcription.  Posttranslational stabilization of β-catenin, leading to elevated protein levels and constitutive gene activation, has been proposed as an important step in oncogenesis.  Stabilization of β-catenin can occur through mutation to highly conserved amino acids encoded in exon 3 of the β-catenin gene (CTNNB1).  To det. whether this pathway of malignant transformation is important in prostate cancer, we analyzed 104 prostate cancer tissue specimens, 4 prostate cancer cell lines, and 3 prostate tumor xenografts for activating mutations in exon 3 of CTNNB1.  Mutations were detected in 5 of the 104 prostate cancer tissue samples.  Four of the five mutations involved serine or threonine residues implicated in the degrdn. of β-catenin.  A fifth tumor had a mutation at codon 32, changing a highly conserved aspartic acid to a tyrosine.  Mutational anal. of multiple regions from several tumor samples showed that the β-catenin mutations were present focally and therefore may occur during tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vqM9ELrfR7Vg90H21EOLACvtfcHk0liC2LkNSuxbLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVajt70%253D&md5=66a78b4c65381851cde0e998e1da2be8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVoeller%26aufirst%3DH.%2BJ.%26aulast%3DTruica%26aufirst%3DC.%2BI.%26aulast%3DGelmann%26aufirst%3DE.%2BP.%26atitle%3D%25CE%25B2-Catenin%2520mutations%2520in%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2520%26epage%3D2523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9635572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXktVajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=2524-2527&author=Y.+Miyoshiauthor=K.+Iwaoauthor=Y.+Nagasawaauthor=T.+Aiharaauthor=Y.+Sasakiauthor=S.+Imaokaauthor=M.+Murataauthor=T.+Shimanoauthor=Y.+Nakamura&title=Activation+of+the+%CE%B2-catenin+gene+in+primary+hepatocellular+carcinomas+by+somatic+alterations+involving+exon+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3</span></div><div class="casAuthors">Miyoshi, Yasuo; Iwao, Kyoko; Nagasawa, Yutaka; Aihara, Tomohiko; Sasaki, Yo; Imaoka, Shingi; Murata, Masaru; Shimano, Takashi; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2524-2527</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We screened 75 primary hepatocellular carcinomas for somatic mutations in the entire coding region of the β-catenin gene.  We detected somatic mutations in 14 tumors; 12 were considered to cause amino acid substitutions and 2 were interstitial deletions of 51 or 195 nucleotides of genomic DNA, corresponding to exon 3.  Among the 12 point mutations, 6 occurred at potential serine/threonine phosphorylation residues of codons 33, 41, or 45.  The remaining six tumors contained a mutation at codon 32 (aspartic acid) or 34 (glycine), flanking to the serine residue at codon 33.  By Western blot anal., we confirmed accumulation of β-catenin in five tumors for which frozen tissues were available; the five included tumors in which amino acid alterations had occurred at codons 32, 34, or 45, and one with a 17-amino acid deletion.  Our results suggested that accumulation of β-catenin due to amino acid substitutions at potential serine/threonine phosphorylation residues or at their neighboring codons or interstitial deletions involving exon 3 could contribute to hepatocellular carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7m-OG8zR0-7Vg90H21EOLACvtfcHk0lhDHqjixrVkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVajt7o%253D&md5=90e01c724bcc55b8c9f286ad554a52b6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DIwao%26aufirst%3DK.%26aulast%3DNagasawa%26aufirst%3DY.%26aulast%3DAihara%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DImaoka%26aufirst%3DS.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DShimano%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520%25CE%25B2-catenin%2520gene%2520in%2520primary%2520hepatocellular%2520carcinomas%2520by%2520somatic%2520alterations%2520involving%2520exon%25203%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D2524%26epage%3D2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gat, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNiff, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, E.</span></span> <span> </span><span class="NLM_article-title">A common human skin tumour is caused by activating mutations in beta-catenin</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1038/7747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F7747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10192393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1MXitFKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=410-413&author=E.+F.+Chanauthor=U.+Gatauthor=J.+M.+McNiffauthor=E.+Fuchs&title=A+common+human+skin+tumour+is+caused+by+activating+mutations+in+beta-catenin&doi=10.1038%2F7747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A common human skin tumor is caused by activating mutations in β-catenin</span></div><div class="casAuthors">Chan, Edward F.; Gat, Uri; McNiff, Jennifer M.; Fuchs, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-413</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">WNT signaling orchestrates a no. of developmental programs.  In response to this stimulus, cytoplasmic β-catenin (encoded by CTNNB1) is stabilized, enabling downstream transcriptional activation by members of the LEF/TCF family.  One of the target genes for β-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon.  Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degrdn. of β-catenin, but a small percentage of colon and some other cancers harbor β-catenin-stabilizing mutations.  Recently, the authors discovered that transgenic mice expressing an activated β-catenin are predisposed to developing skin tumors resembling pilomatricomas.  Given that the skin of these adult mice also exhibits signs of de novo hair-follicle morphogenesis, human pilomatricomas might originate from hair matrix cells, and they might possess β-catenin-stabilizing mutations.  Here, the cell origin and etiol. of this common human skin tumor were explored.  Nuclear LEF-1 was found in the dividing tumor cells, providing biochem. evidence that pilomatricomas are derived from hair matrix cells.  At least 75% of these tumors possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degrdn. of the protein.  This percentage of CTNNB1 mutations is greater than in all other human tumors examd. thus far, and directly implicates β-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXAsTMyiZd6bVg90H21EOLACvtfcHk0lhDHqjixrVkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFKrsL8%253D&md5=d87581007383aa50dabb60d3047a655c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2F7747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F7747%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DE.%2BF.%26aulast%3DGat%26aufirst%3DU.%26aulast%3DMcNiff%26aufirst%3DJ.%2BM.%26aulast%3DFuchs%26aufirst%3DE.%26atitle%3DA%2520common%2520human%2520skin%2520tumour%2520is%2520caused%2520by%2520activating%2520mutations%2520in%2520beta-catenin%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D410%26epage%3D413%26doi%3D10.1038%2F7747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mutation in carcinoma of the uterine endometrium</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9721853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFajsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=3526-3528&author=T.+Fukuchiauthor=M.+Sakamotoauthor=H.+Tsudaauthor=K.+Maruyamaauthor=S.+Nozawaauthor=S.+Hirohashi&title=%CE%B2-Catenin+mutation+in+carcinoma+of+the+uterine+endometrium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin mutation in carcinoma of the uterine endometrium</span></div><div class="casAuthors">Fukuchi, Takeshi; Sakamoto, Michiie; Tsuda, Hitoshi; Maruyama, Keiji; Nozawa, Shiro; Hirohashi, Setsuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3526-3528</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Catenin forms complexes with Tcf and Lef-1 and functions as a transcriptional activator downstream of the Wnt signaling pathway.  Activation of the pathway by stabilization of β-catenin has been shown to be important in the development of colorectal carcinoma, which is mainly caused by inactivating mutations of the adenomatous polyposis coli tumor suppressor gene or by activating mutations in exon 3 of the β-catenin gene.  Here, we analyzed mutations in exon 3 of the β-catenin gene in endometrial carcinoma cases in which loss of heterozygosity at the adenomatous polyposis coli tumor suppressor gene locus has been rarely reported.  We found that 10 of 76 cases had β-catenin gene mutations.  All mutations identified were single-base missense mutations on serine/threonine residues (codons 33, 37, 41, and 45), altering the glycogen synthase kinase-3β phosphorylation consensus motif, which participates in the degrdn. of β-catenin.  To det. whether these β-catenin mutations actually led to stabilization of this protein, expression of β-catenin was analyzed immunohistochem., and 9 of 10 cases with the β-catenin mutation and 20 of 66 cases without it showed accumulation of β-catenin in the cytoplasm and/or nucleus.  In total, 38% of cases showed accumulation of β-catenin.  These data indicate that stabilization of β-catenin due to mutations in exon 3 of the β-catenin gene and other mechanisms may have an important role in development of endometrial carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0N42QpYBp7Vg90H21EOLACvtfcHk0lhDHqjixrVkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFajsbk%253D&md5=7ab581d912cbf01b0fabdd83e5c58d01</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DNozawa%26aufirst%3DS.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3D%25CE%25B2-Catenin%2520mutation%2520in%2520carcinoma%2520of%2520the%2520uterine%2520endometrium%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D3526%26epage%3D3528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chien, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonsdorf, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulikauskas, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothberg, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimm, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1073/pnas.0811902106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0811902106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19144919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1193-1198&author=A.+J.+Chienauthor=E.+C.+Mooreauthor=A.+S.+Lonsdorfauthor=R.+M.+Kulikauskasauthor=B.+G.+Rothbergauthor=A.+J.+Bergerauthor=M.+B.+Majorauthor=S.+T.+Hwangauthor=D.+L.+Rimmauthor=R.+T.+Moon&title=Activated+Wnt%2Fbeta-catenin+signaling+in+melanoma+is+associated+with+decreased+proliferation+in+patient+tumors+and+a+murine+melanoma+model&doi=10.1073%2Fpnas.0811902106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model</span></div><div class="casAuthors">Chien, Andy J.; Moore, Erin C.; Lonsdorf, Anke S.; Kulikauskas, Rima M.; Rothberg, Bonnie Gould; Berger, Aaron J.; Major, Michael B.; Hwang, Sam T.; Rimm, David L.; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1193-1198</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This study demonstrates that in malignant melanoma, elevated levels of nuclear Β-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer.  The redn. in proliferation obsd. in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-mol. activators of Β-catenin signaling.  Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice.  Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression.  These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/Β-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive.  Our results may explain the obsd. loss of nuclear Β-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/Β-catenin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoAtr4lEONxrVg90H21EOLACvtfcHk0li0UDttaw4-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyisr0%253D&md5=f2728ac61f3a81349aef7f58c501160c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0811902106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0811902106%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DA.%2BJ.%26aulast%3DMoore%26aufirst%3DE.%2BC.%26aulast%3DLonsdorf%26aufirst%3DA.%2BS.%26aulast%3DKulikauskas%26aufirst%3DR.%2BM.%26aulast%3DRothberg%26aufirst%3DB.%2BG.%26aulast%3DBerger%26aufirst%3DA.%2BJ.%26aulast%3DMajor%26aufirst%3DM.%2BB.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DActivated%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520melanoma%2520is%2520associated%2520with%2520decreased%2520proliferation%2520in%2520patient%2520tumors%2520and%2520a%2520murine%2520melanoma%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D1193%26epage%3D1198%26doi%3D10.1073%2Fpnas.0811902106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling and drug resistance in cancer</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1124/mol.119.117978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1124%2Fmol.119.117978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31787618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktVSru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2020&pages=72-89&author=Z.+Zhongauthor=D.+M.+Virshup&title=Wnt+signaling+and+drug+resistance+in+cancer&doi=10.1124%2Fmol.119.117978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling and drug resistance in cancer</span></div><div class="casAuthors">Zhong, Zheng; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-89</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Wnts are secreted proteins that bind to cell surface receptors to activate downstream signaling cascades.  Normal Wnt signaling plays key roles in embryonic development and adult tissue homeostasis.  The secretion of Wnt ligands, the turnover of Wnt receptors, and the signaling transduction are tightly regulated and fine-tuned to keep the signaling output "just right." Hyperactivated Wnt signaling due to recurrent genetic alterations drives several human cancers.  Elevated Wnt signaling also confers resistance to multiple conventional and targeted cancer therapies through diverse mechanisms including maintaining the cancer stem cell population, enhancing DNA damage repair, facilitating transcriptional plasticity, and promoting immune evasion.  Different classes of Wnt signaling inhibitors targeting key nodes of the pathway have been developed and show efficacy in treating Wnt-driven cancers and subverting Wnt-mediated therapy resistance in preclin. studies.  Several of these inhibitors have advanced to clin. trials, both singly and in combination with other existing US Food and Drug Administration-approved anti-cancer modalities.  In the near future, pharmacol. inhibition of Wnt signaling may be a real choice for patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFB7w3hUGUTbVg90H21EOLACvtfcHk0li0UDttaw4-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktVSru78%253D&md5=769a381e1d76642f8bd15c62729cc9f3</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.119.117978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.119.117978%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520signaling%2520and%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DMol.%2520Pharmacol.%26date%3D2020%26volume%3D97%26spage%3D72%26epage%3D89%26doi%3D10.1124%2Fmol.119.117978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3368</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1111/cas.13771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.13771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30137666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslCms7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=3368-3375&author=P.+Yinauthor=W.+Wangauthor=Z.+Zhangauthor=Y.+Baiauthor=J.+Gaoauthor=C.+Zhao&title=Wnt+signaling+in+human+and+mouse+breast+cancer%3A+Focusing+on+Wnt+ligands%2C+receptors+and+antagonists&doi=10.1111%2Fcas.13771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists</span></div><div class="casAuthors">Yin, Ping; Wang, Wei; Zhang, Zhongbo; Bai, Yu; Gao, Jian; Zhao, Chenghai</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3368-3375</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Wnt proteins, a group of secreted glycoproteins, mainly combine with receptors Frizzled (FZD) and/or low-d.-lipoprotein receptor-related proteins 5/6 (LRP5/6), initiating β-catenin-dependent and -independent signaling pathways.  These pathways, which can be regulated by some secreted antagonists such as secreted Frizzled-related proteins (SFRP) and dickkopf-related protein (DKK), play a crit. role in embryo development and adult homeostasis.  Overactivation of Wnt signaling has been implicated in some human diseases including cancer.  Wnt transgenic mice provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clin. breast cancer patients and studies on in vitro cultured human breast cancer cells.  This review focuses on the roles of Wnt ligands, receptors and antagonists in breast cancer development instead of mols. or signaling transactivating β-catenin independent on Wnt upstream components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcYwJ7R_KlybVg90H21EOLACvtfcHk0li0UDttaw4-qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslCms7nO&md5=5adcd73c8a91817e90561670ca98de61</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fcas.13771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13771%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DWnt%2520signaling%2520in%2520human%2520and%2520mouse%2520breast%2520cancer%253A%2520Focusing%2520on%2520Wnt%2520ligands%252C%2520receptors%2520and%2520antagonists%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D3368%26epage%3D3375%26doi%3D10.1111%2Fcas.13771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0li4InBYQhXCZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2505</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.4155%2Ffmc.15.159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26670195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2485-2505&author=S.+Zhengauthor=J.+Liuauthor=Y.+Wuauthor=T.+L.+Huangauthor=G.+Wang&title=Small-molecule+inhibitors+of+Wnt+signaling+pathway%3A+towards+novel+anticancer+therapeutics&doi=10.4155%2Ffmc.15.159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics</span></div><div class="casAuthors">Zheng, Shilong; Liu, Jiawang; Wu, Yanyuan; Huang, Tien L.; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2485-2505</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: The Wnt signaling pathway involves secreted glycoproteins that bind to the Frizzled family receptors to activate intracellular signal transduction events that regulate cell proliferation, apoptosis, cell migration and many crit. aspects of developmental biol.  Discussion: Aberrant Wnt signaling underlies a wide range of pathologies in humans including tumor initiation, tumor growth, cell senescence, cell death, differentiation and metastasis.  The inhibition of Wnt signaling offers a novel approach for anticancer therapeutics.  Conclusion: Focusing on recent developments, we reviewed the small-mol. inhibitors targeting various components of Wnt signaling pathways and the progress from the discovery of lead compds. to highly potent inhibitors with significant therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZuYMdLj6RR7Vg90H21EOLACvtfcHk0li4InBYQhXCZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeqt7fE&md5=007f442c99f3ada5037f3e6187b5eafb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.159%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520Wnt%2520signaling%2520pathway%253A%2520towards%2520novel%2520anticancer%2520therapeutics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D2485%26epage%3D2505%26doi%3D10.4155%2Ffmc.15.159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boral, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanasse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">20224</span>– <span class="NLM_lpage">20229</span>, <span class="refDoi"> DOI: 10.1073/pnas.1314239110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1314239110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24277854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=20224-20229&author=J.+Liuauthor=S.+Panauthor=M.+H.+Hsiehauthor=N.+Ngauthor=F.+Sunauthor=T.+Wangauthor=S.+Kasibhatlaauthor=A.+G.+Schullerauthor=A.+G.+Liauthor=D.+Chengauthor=J.+Liauthor=C.+Tompkinsauthor=A.+Pferdekamperauthor=A.+Steffyauthor=J.+Chengauthor=C.+Kowalauthor=V.+Phungauthor=G.+Guoauthor=Y.+Wangauthor=M.+P.+Grahamauthor=S.+Flynnauthor=J.+C.+Brennerauthor=C.+Liauthor=M.+C.+Villarroelauthor=P.+G.+Schultzauthor=X.+Wuauthor=P.+McNamaraauthor=W.+R.+Sellersauthor=L.+Petruzzelliauthor=A.+L.+Boralauthor=H.+M.+Seidelauthor=M.+E.+McLaughlinauthor=J.+Cheauthor=T.+E.+Careyauthor=G.+Vanasseauthor=J.+L.+Harris&title=Targeting+Wnt-driven+cancer+through+the+inhibition+of+Porcupine+by+LGK974&doi=10.1073%2Fpnas.1314239110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974</span></div><div class="casAuthors">Liu, Jun; Pan, Shifeng; Hsieh, Mindy H.; Ng, Nicholas; Sun, Fangxian; Wang, Tao; Kasibhatla, Shailaja; Schuller, Alwin G.; Li, Allen G.; Cheng, Dai; Li, Jie; Tompkins, Celin; Pferdekamper, Anne Marie; Steffy, Auzon; Cheng, Jane; Kowal, Colleen; Phung, Van; Guo, Guirong; Wang, Yan; Graham, Martin P.; Flynn, Shannon; Brenner, J. Chad; Li, Chun; Villarroel, M. Cristina; Schultz, Peter G.; Wu, Xu; McNamara, Peter; Sellers, William R.; Petruzzelli, Lilli; Boral, Anthony L.; Seidel, H. Martin; McLaughlin, Margaret E.; Che, Jianwei; Carey, Thomas E.; Vanasse, Gary; Harris, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">20224-20229,S20224/1-S20224/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Wnt signaling is one of the key oncogenic pathways in multiple cancers, and targeting this pathway is an attractive therapeutic approach.  However, therapeutic success was limited because of the lack of therapeutic agents for targets in the Wnt pathway and the lack of a defined patient population that would be sensitive to a Wnt inhibitor.  We developed a screen for small mols. that block Wnt secretion.  This effort led to the discovery of LGK974, a potent and specific small-mol. Porcupine (PORCN) inhibitor.  PORCN is a membrane-bound O-acyltransferase that is required for and dedicated to palmitoylation of Wnt ligands, a necessary step in the processing of Wnt ligand secretion.  We show that LGK974 potently inhibits Wnt signaling in vitro and in vivo, including redn. of the Wnt-dependent LRP6 phosphorylation and the expression of Wnt target genes, such as AXIN2.  LGK974 is potent and efficacious in multiple tumor models at well-tolerated doses in vivo, including murine and rat mechanistic breast cancer models driven by MMTV-Wnt1 and a human head and neck squamous cell carcinoma model (HN30).  We also show that head and neck cancer cell lines with loss-of-function mutations in the Notch signaling pathway have a high response rate to LGK974.  Together, these findings provide both a strategy and tools for targeting Wnt-driven cancers through the inhibition of PORCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJMitDc62tbVg90H21EOLACvtfcHk0li4InBYQhXCZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKmsL%252FL&md5=5fac5db1bd762356350f11706f1a70ae</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1314239110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1314239110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DA.%2BG.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPferdekamper%26aufirst%3DA.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKowal%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DGuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGraham%26aufirst%3DM.%2BP.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DVillarroel%26aufirst%3DM.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DPetruzzelli%26aufirst%3DL.%26aulast%3DBoral%26aufirst%3DA.%2BL.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DT.%2BE.%26aulast%3DVanasse%26aufirst%3DG.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26atitle%3DTargeting%2520Wnt-driven%2520cancer%2520through%2520the%2520inhibition%2520of%2520Porcupine%2520by%2520LGK974%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D20224%26epage%3D20229%26doi%3D10.1073%2Fpnas.1314239110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frois, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petretto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt addiction of genetically defined cancers reversed by PORCN inhibition</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2197</span>– <span class="NLM_lpage">2207</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2015.280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26257057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSntrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2197-2207&author=B.+Madanauthor=Z.+Keauthor=N.+Harmstonauthor=S.+Y.+Hoauthor=A.+O.+Froisauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=V.+Pendharkarauthor=K.+Ghoshauthor=I.+H.+Virshupauthor=V.+Manoharanauthor=E.+H.+Ongauthor=K.+Sangthongpitagauthor=J.+Hillauthor=E.+Petrettoauthor=T.+H.+Kellerauthor=M.+A.+Leeauthor=A.+Matterauthor=D.+M.+Virshup&title=Wnt+addiction+of+genetically+defined+cancers+reversed+by+PORCN+inhibition&doi=10.1038%2Fonc.2015.280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt addiction of genetically defined cancers reversed by PORCN inhibition</span></div><div class="casAuthors">Madan, B.; Ke, Z.; Harmston, N.; Ho, S. Y.; Frois, A. O.; Alam, J.; Jeyaraj, D. A.; Pendharkar, V.; Ghosh, K.; Virshup, I. H.; Manoharan, V.; Ong, E. H. Q.; Sangthongpitag, K.; Hill, J.; Petretto, E.; Keller, T. H.; Lee, M. A.; Matter, A.; Virshup, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2197-2207</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors.  Whether these mutations identify a clin. opportunity is an important question.  Inhibition of Wnt secretion by blocking an essential post-translational modification, palmitoleation, provides a useful therapeutic intervention.  We developed a novel potent, orally available PORCN inhibitor, ETC-1922159 (henceforth called ETC-159) that blocks the secretion and activity of all Wnts.  ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts.  This is the first example of effective targeted therapy for this subset of CRC.  Consistent with a central role of Wnt signaling in regulation of gene expression, inhibition of PORCN in RSPO3-translocated cancers causes a marked remodeling of the transcriptome, with loss of cell cycle, stem cell and proliferation genes, and an increase in differentiation markers.  Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLVP6tUQlqerVg90H21EOLACvtfcHk0lhr4_-vTzpiKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSntrfF&md5=a6d155fcad286c92b6cf70105a085c9f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.280%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DHarmston%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DFrois%26aufirst%3DA.%2BO.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DVirshup%26aufirst%3DI.%2BH.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DOng%26aufirst%3DE.%2BH.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DPetretto%26aufirst%3DE.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMatter%26aufirst%3DA.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520addiction%2520of%2520genetically%2520defined%2520cancers%2520reversed%2520by%2520PORCN%2520inhibition%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D2197%26epage%3D2207%26doi%3D10.1038%2Fonc.2015.280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1111/cas.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24975284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=1087-1092&author=H.+J.+Lenzauthor=M.+Kahn&title=Safely+targeting+cancer+stem+cells+via+selective+catenin+coactivator+antagonism&doi=10.1111%2Fcas.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Safely targeting cancer stem cells via selective catenin coactivator antagonism</span></div><div class="casAuthors">Lenz, Heinz-Josef; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1087-1092</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Throughout our life, long-lived somatic stem cells (SSC) regenerate adult tissues both during homeostatic processes and repair after injury.  The role of aberrant regulation of SSC has also recently gained prominence in the field of cancer research.  Following malignant transformation, so termed cancer stem cells (CSC), endowed with the same properties as SSC (i.e. the ability to both self-renew and generate differentiated progenitors), play a major part in tumor initiation, therapy resistance and ultimately relapse.  The same signaling pathways involved in regulating SSC maintenance are involved in the regulation of CSC.  CSC exist in a wide array of tumor types, including leukemias, and brain, breast, prostate and colon tumors.  Consequently, one of the key goals in cancer research over the past decade has been to develop therapeutic strategies to safely eliminate the CSC population without damaging the endogenous SSC population.  A major hurdle to this goal lies in the identification of the key mechanisms that distinguish CSC from the normal endogenous tissue stem cells.  This review will discuss the discovery of the specific CBP/catenin antagonist ICG-001 and the ongoing clin. development of the second generation CBP/catenin antagonist PRI-724.  Importantly, specific CBP/catenin antagonists appear to have the ability to safely eliminate CSC by taking advantage of an intrinsic differential preference in the way SSC and CSC divide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb-k-p-7uTHrVg90H21EOLACvtfcHk0lhr4_-vTzpiKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFymu7rN&md5=dc580aeb47d1aeb8d95b1c02f428fca8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fcas.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12471%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DSafely%2520targeting%2520cancer%2520stem%2520cells%2520via%2520selective%2520catenin%2520coactivator%2520antagonism%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D1087%26epage%3D1092%26doi%3D10.1111%2Fcas.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlindon, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibofsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clauw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFrancesco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simsek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambiah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochberg, M. C.</span></span> <span> </span><span class="NLM_article-title">Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment of knee osteoarthritis: a phase II randomized trial</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1694</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.1002/art.41315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fart.41315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32432388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOitb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2020&pages=1694-1706&author=Y.+Yaziciauthor=T.+E.+McAlindonauthor=A.+Gibofskyauthor=N.+E.+Laneauthor=D.+Clauwauthor=M.+Jonesauthor=J.+Bergfeldauthor=C.+J.+Swearingenauthor=A.+DiFrancescoauthor=I.+Simsekauthor=J.+Tambiahauthor=M.+C.+Hochberg&title=Lorecivivint%2C+a+novel+intraarticular+CDC-like+kinase+2+and+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+inhibitor+and+Wnt+pathway+modulator+for+the+treatment+of+knee+osteoarthritis%3A+a+phase+II+randomized+trial&doi=10.1002%2Fart.41315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial</span></div><div class="casAuthors">Yazici, Yusuf; McAlindon, Timothy E.; Gibofsky, Allan; Lane, Nancy E.; Clauw, Daniel; Jones, Morgan; Bergfeld, John; Swearingen, Christopher J.; DiFrancesco, Anita; Simsek, Ismail; Tambiah, Jeyanesh; Hochberg, Marc C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1694-1706</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To assess the safety and efficacy of a novel Wnt pathway modulator, lorecivivint (SM04690), for treating pain and inhibiting structural progression in moderately to severely symptomatic knee osteoarthritis (OA).  Methods : Subjects in this 52-wk, phase IIa, multicenter, randomized, double-blind, placebo-controlled, dose-ranging trial received a single 2-mL intraarticular injection of lorecivivint (dose of 0.03 mg, 0.07 mg, or 0.23 mg) or placebo.  Efficacy was assessed based on change from baseline on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score subscales for pain and function (scale 0-100 for each) and change from baseline in the radiog. medial joint space width (JSW).  Baseline-adjusted anal. of covariance with multiple imputation was performed sep. to evaluate efficacy.  This proof-of-concept study evaluated the intent-to-treat population as well as a prespecified group of subjects with unilateral symptoms of knee OA (designated UNI) and an addnl. post hoc subgroup of subjects with unilateral symptoms but without widespread pain (designated UNI WP-).  Results : In this trial, 455 subjects were randomized to a treatment group.  The primary end point, significant improvement in the WOMAC pain score compared with placebo at week 13, was not met by any lorecivivint dose group (mean ± SD change from baseline, -23.3 ± 2.2 in the 0.03 mg group, -23.5 ± 2.1 in the 0.07 mg group, -21.3 ± 2.2 in the 0.23 mg group, and -22.1 ± 2.1 in the placebo group; each P > 0.05 vs. placebo).  All groups (including placebo) demonstrated clin. meaningful (≥20-point) improvements from baseline in the WOMAC pain score.  The durability of response was evaluated through week 52.  In the prespecified UNI group and post hoc UNI WP- group at week 52, treatment with 0.07 mg lorecivivint significantly improved the WOMAC pain score (between-group difference vs. placebo, -8.73, 95% confidence interval [95% CI] -17.44, -0.03 [P = 0.049] and -11.21, 95% CI -20.99, -1.43 [P = 0.025], resp.) and WOMAC function score (between-group difference vs. placebo, -10.26, 95% CI -19.82, -0.69 [P = 0.036] and -13.38, 95% CI -24.33, -2.43 [P = 0.017], resp.).  Relative to baseline, the mean change in the medial JSW at week 52 was -0.04 mm in the 0.03 mg cohort, -0.09 mm in the 0.07 mg cohort, -0.16 mm in the 0.23 mg cohort, and -0.14 mm in the placebo cohort; no treatment group achieved a significant change in medial JSW compared with placebo at week 52.  In both unilateral symptom subgroups, the 0.07 mg lorecivivint dose significantly increased medial JSW compared with placebo at week 52 (medial JSW 0.39 mm, 95% CI 0.06, 0.72 in the UNI group [P = 0.021] and 0.42 mm, 95% CI 0.04, 0.80 in the UNI WP- group [P = 0.032]).  Changes obsd. in the 0.03 mg and 0.23 mg dose groups were not significantly different from those in the placebo group for any of these measures.  Lorecivivint appeared safe and well tolerated.  Conclusion : This phase IIa, proof-of-concept trial in patients with symptomatic knee OA did not meet its primary end point.  Nevertheless, the study identified a target population in whom to evaluate the potential efficacy of lorecivivint for the treatment of knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5ujK29FWXrVg90H21EOLACvtfcHk0lif1thvRXXovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOitb%252FO&md5=c86a3f9bac8837387ad725fda5513f7b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fart.41315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.41315%26sid%3Dliteratum%253Aachs%26aulast%3DYazici%26aufirst%3DY.%26aulast%3DMcAlindon%26aufirst%3DT.%2BE.%26aulast%3DGibofsky%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DN.%2BE.%26aulast%3DClauw%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBergfeld%26aufirst%3DJ.%26aulast%3DSwearingen%26aufirst%3DC.%2BJ.%26aulast%3DDiFrancesco%26aufirst%3DA.%26aulast%3DSimsek%26aufirst%3DI.%26aulast%3DTambiah%26aufirst%3DJ.%26aulast%3DHochberg%26aufirst%3DM.%2BC.%26atitle%3DLorecivivint%252C%2520a%2520novel%2520intraarticular%2520CDC-like%2520kinase%25202%2520and%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520inhibitor%2520and%2520Wnt%2520pathway%2520modulator%2520for%2520the%2520treatment%2520of%2520knee%2520osteoarthritis%253A%2520a%2520phase%2520II%2520randomized%2520trial%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2020%26volume%3D72%26spage%3D1694%26epage%3D1706%26doi%3D10.1002%2Fart.41315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Modulating Wnt signaling at the root: Porcupine and Wnt acylation</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.pharmthera.2019.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30790642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslOlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2019&pages=34-45&author=V.+I.+Torresauthor=J.+A.+Godoyauthor=N.+C.+Inestrosa&title=Modulating+Wnt+signaling+at+the+root%3A+Porcupine+and+Wnt+acylation&doi=10.1016%2Fj.pharmthera.2019.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Wnt signaling at the root: Porcupine and Wnt acylation</span></div><div class="casAuthors">Torres, Viviana I.; Godoy, Juan A.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-45</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Communication between cells occurs through secreted mols., among which Wnt ligands play a crit. role in balancing cell proliferation, differentiation and cellular homeostasis.  The action of Wnt signaling can be modulated at several levels, including posttranslational modification of the Wnt ligands, whose acylation is crit. for biol. activity.  At least three enzymes are necessary for Wnt acylation/deacylation: stearoyl CoA desaturase (SCD), porcupine (PORCN) and Notum.  At the endoplasmic reticulum (ER), SCD provides the monounsatd. fatty acid to PORCN, which adds it to the Wnt ligand; at the extracellular matrix, the fatty acid is removed by Notum.  Obviously, the interplay between these enzymes will define Wnt signaling ligand secretion and activity.  Excessive activation of Wnt signaling has been obsd. in a variety of solid tumors, which has led the pharmaceutical industry to develop specific inhibitors for this pathway that mainly target PORCN, some of which are in early clin. trials.  In the central nervous system (CNS), Wnt signaling activation has been shown to have a neuroprotective effect, and conversely, its inhibition induces neurodegeneration, which implies that the inhibition of PORCN in cancer therapies should be used with caution, and the cognitive performance of the patient should be monitored during treatment.  This review collects information about the PORCN enzyme in relation to its role in the Wnt pathway through the acylation of Wnt ligands, its inhibition by drugs in the treatment of some cancers, and its putative modulation in the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRYOk4Y_x7urVg90H21EOLACvtfcHk0lif1thvRXXovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslOlsbo%253D&md5=681889dc0efbd794c6409473ae05ce2c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DV.%2BI.%26aulast%3DGodoy%26aufirst%3DJ.%2BA.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DModulating%2520Wnt%2520signaling%2520at%2520the%2520root%253A%2520Porcupine%2520and%2520Wnt%2520acylation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D198%26spage%3D34%26epage%3D45%26doi%3D10.1016%2Fj.pharmthera.2019.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Precise regulation of porcupine activity is required for physiological Wnt signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">34167</span>– <span class="NLM_lpage">34178</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.381970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M112.381970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22888000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=34167-34178&author=K.+D.+Proffittauthor=D.+M.+Virshup&title=Precise+regulation+of+porcupine+activity+is+required+for+physiological+Wnt+signaling&doi=10.1074%2Fjbc.M112.381970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling</span></div><div class="casAuthors">Proffitt, Kyle D.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34167-34178</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Gradients of diverse Wnt proteins regulate development, renewal, and differentiation.  Porcupine (PORCN) is a membrane-bound O-acyltransferase that is required for post-translational modification of all Wnts to enable their transport, secretion, and activity.  Mutations in PORCN are assocd. with focal dermal hypoplasia (FDH), whereas gene deletion causes embryonic lethality in mice.  To study the protein in more detail, zinc finger nucleases were used to edit the PORCN genomic locus, establishing two HT1080 fibrosarcoma clones null for PORCN activity that facilitate the study of PORCN structure and function.  We establish that PORCN is a key non-redundant node for the regulation of global Wnt signaling because PORCN null cells are completely incapable of autocrine Wnt signaling.  The strength of Wnt signaling is exquisitely sensitive to PORCN expression, with a dynamic range of at least 3 orders of magnitude, suggesting that PORCN activity is a key modulator of all Wnt ligand activity.  Consistent with this, we find that multiple FDH-assocd. mutants have only subtle alterations in enzyme activity yet are assocd. with a severe FDH phenotype.  These studies support an essential regulatory role of PORCN in shaping Wnt signaling gradients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk2OwLjD27rVg90H21EOLACvtfcHk0lgTSlBtNqkcSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLnN&md5=91c827f5f6076c8e9ef25b0660c78290</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.381970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.381970%26sid%3Dliteratum%253Aachs%26aulast%3DProffitt%26aufirst%3DK.%2BD.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPrecise%2520regulation%2520of%2520porcupine%2520activity%2520is%2520required%2520for%2520physiological%2520Wnt%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D34167%26epage%3D34178%26doi%3D10.1074%2Fjbc.M112.381970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannoush, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">507</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-12-2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23188502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlalug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=502-507&author=K.+D.+Proffittauthor=B.+Madanauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+Dingauthor=M.+A.+Leeauthor=R.+N.+Hannoushauthor=D.+M.+Virshup&title=Pharmacological+inhibition+of+the+Wnt+acyltransferase+PORCN+prevents+growth+of+WNT-driven+mammary+cancer&doi=10.1158%2F0008-5472.CAN-12-2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer</span></div><div class="casAuthors">Proffitt, Kyle David; Madan, Babita; Ke, Zhiyuan; Pendharkar, Vishal; Ding, Lijun; Lee, May Ann; Hannoush, Rami N.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study offers preclin. proof of concept for a safe and effective strategy to target the many types of tumors driven by a deregulated Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU7Y0ZVAxwrbVg90H21EOLACvtfcHk0lgTSlBtNqkcSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlalug%253D%253D&md5=156f5bbfc77a717b297eb8b1f21933f1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-2258%26sid%3Dliteratum%253Aachs%26aulast%3DProffitt%26aufirst%3DK.%2BD.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DHannoush%26aufirst%3DR.%2BN.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPharmacological%2520inhibition%2520of%2520the%2520Wnt%2520acyltransferase%2520PORCN%2520prevents%2520growth%2520of%2520WNT-driven%2520mammary%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D502%26epage%3D507%26doi%3D10.1158%2F0008-5472.CAN-12-2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, K.</span></span> <span> </span><span class="NLM_article-title">WNT secretion and signalling in human disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.molmed.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22796206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKns7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=483-493&author=P.+Herrauthor=G.+Hausmannauthor=K.+Basler&title=WNT+secretion+and+signalling+in+human+disease&doi=10.1016%2Fj.molmed.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">WNT secretion and signalling in human disease</span></div><div class="casAuthors">Herr, Patrick; Hausmann, George; Basler, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">483-493</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Wnt signalling, a key pathway involved in various aspects of embryonic development, also underlies many human diseases, in particular, cancer.  Research focused on signal transduction within signal-receiving cells led to the discovery of many Wnt pathway components, but study of the secretion of Wnt ligands themselves was neglected until recently.  Attention was drawn to this highly regulated process by the assocn. of aberrant Wnt levels with an increasing no. of diseases.  Studying the biogenesis and processing of active Wnt ligands will open new avenues for generating therapeutics to specifically target aberrant Wnt signalling.  Here we review the proteins required for Wnt secretion and signalling at the plasma membrane, ending with a discussion on potential therapeutic approaches to treat Wnt-induced diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq_X3hsEStgLVg90H21EOLACvtfcHk0lgTSlBtNqkcSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKns7zE&md5=fcff68d21b33b931aa854a581d27e230</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DHerr%26aufirst%3DP.%26aulast%3DHausmann%26aufirst%3DG.%26aulast%3DBasler%26aufirst%3DK.%26atitle%3DWNT%2520secretion%2520and%2520signalling%2520in%2520human%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D483%26epage%3D493%26doi%3D10.1016%2Fj.molmed.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. M.</span></span> <span> </span><span class="NLM_article-title">Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3483</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1211006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fsj.onc.1211006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18193088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVagu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3483-3488&author=Z.+Chenauthor=J.+Liauthor=Q.+S.+Liauthor=J.+Q.+Fanauthor=X.+M.+Dongauthor=J.+P.+Xuauthor=X.+M.+Wangauthor=G.+W.+Yangauthor=P.+Yanauthor=G.+Z.+Wenauthor=Y.+T.+Zhangauthor=R.+G.+Niuauthor=P.+H.+Nanauthor=J.+Heauthor=H.+M.+Zhou&title=Suppression+of+PPN%2FMG61+attenuates+Wnt%2Fbeta-catenin+signaling+pathway+and+induces+apoptosis+in+human+lung+cancer&doi=10.1038%2Fsj.onc.1211006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of PPN/MG61 attenuates Wnt/β-catenin signaling pathway and induces apoptosis in human lung cancer</span></div><div class="casAuthors">Chen, Z.; Li, J.; Li, Q. S.; Fan, J. Q.; Dong, X. M.; Xu, J. P.; Wang, X. M.; Yang, G. W.; Yan, P.; Wen, G. Z.; Zhang, Y. T.; Niu, R. G.; Nan, P. H.; He, J.; Zhou, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3483-3488</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wingless and int homolog (Wnt) family proteins have been shown to have important roles in the decision of cell fate and behavior at multiple stages during the development and tumorigenesis.  One of the Drosophila segment polarity genes, porcupine (porc) gene, encodes an evolutionarily conserved endoplasmic reticulum membrane protein involving in the post-translational processing of the Wnt family proteins.  Here, we report that human homolog of Drosophila porc gene, PPN/MG61, was abundantly expressed in human cancer cell lines, but not in normal cells.  We also found that PPN/MG61 was overexpressed in primary lung cancer tissue samples, compared to their matched normal tissue samples.  Furthermore, when we used small interfering RNA to knock down PPN/MG61 mRNA in lung cancer cells expressing the gene, we obsd. apoptosis induction, along with decreased activity of Wnt pathway in those lung cancer cells.  These data suggest that PPN/MG61 may be a novel marker for human lung cancer and that post-translational modification of the Wnt signal mols. by PPN/MG61 may be important for the function of Wnt pathway in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppLv49RKwC7rVg90H21EOLACvtfcHk0lixPPFh3YRpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVagu7s%253D&md5=3604f3d97eaba53827320f560d65593e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211006%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%2BS.%26aulast%3DFan%26aufirst%3DJ.%2BQ.%26aulast%3DDong%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYang%26aufirst%3DG.%2BW.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DWen%26aufirst%3DG.%2BZ.%26aulast%3DZhang%26aufirst%3DY.%2BT.%26aulast%3DNiu%26aufirst%3DR.%2BG.%26aulast%3DNan%26aufirst%3DP.%2BH.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%2BM.%26atitle%3DSuppression%2520of%2520PPN%252FMG61%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520pathway%2520and%2520induces%2520apoptosis%2520in%2520human%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3483%26epage%3D3488%26doi%3D10.1038%2Fsj.onc.1211006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span> <span> </span><span class="NLM_article-title">Wnt signaling in development, disease and translational medicine</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.2174/138945008784911796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.2174%2F138945008784911796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18673238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=513-531&author=G.+S.+Coombsauthor=T.+M.+Coveyauthor=D.+M.+Virshup&title=Wnt+signaling+in+development%2C+disease+and+translational+medicine&doi=10.2174%2F138945008784911796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in development, disease and translational medicine</span></div><div class="casAuthors">Coombs, Gary S.; Covey, Tracy M.; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-531</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Wnt signaling regulates a multitude of crit. processes in development and tissue homeostasis.  The wingless (wg) gene product was first identified in Drosophila in 1973.  Subsequently, the proto-oncogene INT-1 was identified in mice in 1984 when its activation by mouse mammary tumor virus' proviral insertion was found to induce tumor formation.  The discovery in 1987 that wg and INT-1 are orthologs contributed to an appreciation of the intimate connection between oncogenic and developmental processes.  Diverse diseases including cancer, diabetes, osteoporosis and psychiatric disorders may be amenable to treatment via modulation of Wnt-mediated signaling pathways.  There are a no. of attractive targets that are the object of ongoing drug development studies aiming to capitalize on these opportunities.  In this review, we present a historical overview of key events in this field that have elucidated the known signaling cascades assocd. with Wnt ligands and shaped our understanding of the roles of these cascades in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpVdAnUrHZprVg90H21EOLACvtfcHk0lixPPFh3YRpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOqtLo%253D&md5=34ce96a870ae6894be8e1462bd2c591f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F138945008784911796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945008784911796%26sid%3Dliteratum%253Aachs%26aulast%3DCoombs%26aufirst%3DG.%2BS.%26aulast%3DCovey%26aufirst%3DT.%2BM.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DWnt%2520signaling%2520in%2520development%252C%2520disease%2520and%2520translational%2520medicine%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2008%26volume%3D9%26spage%3D513%26epage%3D531%26doi%3D10.2174%2F138945008784911796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.+W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0lixPPFh3YRpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mongera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argenton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karner, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23246</span>– <span class="NLM_lpage">23254</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.372029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M112.372029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22593577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23246-23254&author=M.+E.+Dodgeauthor=J.+Moonauthor=R.+Tuladharauthor=J.+Luauthor=L.+S.+Jacobauthor=L.+S.+Zhangauthor=H.+Shiauthor=X.+Wangauthor=E.+Moroauthor=A.+Mongeraauthor=F.+Argentonauthor=C.+M.+Karnerauthor=T.+J.+Carrollauthor=C.+Chenauthor=J.+F.+Amatrudaauthor=L.+Lum&title=Diverse+chemical+scaffolds+support+direct+inhibition+of+the+membrane-bound+O-acyltransferase+porcupine&doi=10.1074%2Fjbc.M112.372029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Chemical Scaffolds Support Direct Inhibition of the Membrane-bound O-Acyltransferase Porcupine</span></div><div class="casAuthors">Dodge, Michael E.; Moon, Jesung; Tuladhar, Rubina; Lu, Jianming; Jacob, Leni S.; Zhang, Li-shu; Shi, Heping; Wang, Xiaolei; Moro, Enrico; Mongera, Alessandro; Argenton, Francesco; Karner, Courtney M.; Carroll, Thomas J.; Chen, Chuo; Amatruda, James F.; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23246-23254</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Secreted Wnt proteins constitute one of the largest families of intercellular signaling mols. in vertebrates with essential roles in embryonic development and adult tissue homeostasis.  The functional redundancy of Wnt genes and the many forms of cellular responses they elicit, including some utilizing the transcriptional co-activator β-catenin, has limited the ability of classical genetic strategies to uncover their roles in vivo.  The authors had previously identified a chem. compd. class termed Inhibitor of Wnt Prodn. (or IWP) that targets Porcupine (Porcn), an acyltransferase catalyzing the addn. of fatty acid adducts onto Wnt proteins.  Diverse chem. structures are able to inhibit Porcn by targeting its putative active site.  When deployed in concert with small mols. that modulate the activity of Tankyrase enzymes and glycogen synthase kinase 3 β (GSK3β), addnl. transducers of Wnt/β-catenin signaling, the IWP compds. reveal an essential role for Wnt protein fatty acylation in eliciting β-catenin-dependent and -independent forms of Wnt signaling during zebrafish development.  This collection of small mols. facilitates rapid dissection of Wnt gene function in vivo by limiting the influence of redundant Wnt gene functions on phenotypic outcomes and enables temporal manipulation of Wnt-mediated signaling in vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Vku7lZhTOrVg90H21EOLACvtfcHk0lj832eV8sLgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmtb0%253D&md5=88ddad96c49cb032ec0347a6d3029ba1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.372029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.372029%26sid%3Dliteratum%253Aachs%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DTuladhar%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DL.%2BS.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMoro%26aufirst%3DE.%26aulast%3DMongera%26aufirst%3DA.%26aulast%3DArgenton%26aufirst%3DF.%26aulast%3DKarner%26aufirst%3DC.%2BM.%26aulast%3DCarroll%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DDiverse%2520chemical%2520scaffolds%2520support%2520direct%2520inhibition%2520of%2520the%2520membrane-bound%2520O-acyltransferase%2520porcupine%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23246%26epage%3D23254%26doi%3D10.1074%2Fjbc.M112.372029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuladhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">The development of highly potent inhibitors for porcupine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2700</span>– <span class="NLM_lpage">2704</span>, <span class="refDoi"> DOI: 10.1021/jm400159c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2700-2704&author=X.+Wangauthor=J.+Moonauthor=M.+E.+Dodgeauthor=X.+Panauthor=L.+Zhangauthor=J.+M.+Hansonauthor=R.+Tuladharauthor=Z.+Maauthor=H.+Shiauthor=N.+S.+Williamsauthor=J.+F.+Amatrudaauthor=T.+J.+Carrollauthor=L.+Lumauthor=C.+Chen&title=The+development+of+highly+potent+inhibitors+for+porcupine&doi=10.1021%2Fjm400159c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of Highly Potent Inhibitors for Porcupine</span></div><div class="casAuthors">Wang, Xiaolei; Moon, Jesung; Dodge, Michael E.; Pan, Xinchao; Zhang, Lishu; Hanson, Jordan M.; Tuladhar, Rubina; Ma, Zhiqiang; Shi, Heping; Williams, Noelle S.; Amatruda, James F.; Carroll, Thomas J.; Lum, Lawrence; Chen, Chuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2700-2704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Porcupine is a member of the membrane-bound O-acyltransferase family of proteins.  It catalyzes the palmitoylation of Wnt proteins, a process required for their secretion and activity.  We recently disclosed a class of small mols. (IWPs) as the first reported Porcn inhibitors.  We now describe the structure-activity relationship studies and the identification of subnanomolar inhibitors.  We also report herein the effects of IWPs on Wnt-dependent developmental processes, including zebrafish posterior axis formation and kidney tubule formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KrCYiGjajLVg90H21EOLACvtfcHk0lj832eV8sLgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGns7w%253D&md5=61a2891ab476e52b62ffad123711067a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm400159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400159c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DJ.%2BM.%26aulast%3DTuladhar%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DCarroll%26aufirst%3DT.%2BJ.%26aulast%3DLum%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DThe%2520development%2520of%2520highly%2520potent%2520inhibitors%2520for%2520porcupine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2700%26epage%3D2704%26doi%3D10.1021%2Fjm400159c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompkins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyridinyl acetamide derivatives as potent, selective, and orally bioavailable porcupine inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=676-680&author=D.+Chengauthor=J.+Liuauthor=D.+Hanauthor=G.+Zhangauthor=W.+Gaoauthor=M.+H.+Hsiehauthor=N.+Ngauthor=S.+Kasibhatlaauthor=C.+Tompkinsauthor=J.+Liauthor=A.+Steffyauthor=F.+Sunauthor=C.+Liauthor=H.+M.+Seidelauthor=J.+L.+Harrisauthor=S.+Pan&title=Discovery+of+pyridinyl+acetamide+derivatives+as+potent%2C+selective%2C+and+orally+bioavailable+porcupine+inhibitors&doi=10.1021%2Facsmedchemlett.6b00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors</span></div><div class="casAuthors">Cheng, Dai; Liu, Jun; Han, Dong; Zhang, Guobao; Gao, Wenqi; Hsieh, Mindy H.; Ng, Nicholas; Kasibhatla, Shailaja; Tompkins, Celin; Li, Jie; Steffy, Auzon; Sun, Fangxian; Li, Chun; Seidel, H. Martin; Harris, Jennifer L.; Pan, Shifeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">676-680</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blockade of aberrant Wnt signaling is an attractive therapeutic approach in multiple cancers.  We developed and performed a cellular high-throughput screen for inhibitors of Wnt secretion and pathway activation.  A lead structure (GNF-1331) was identified from the screen.  Further studies identified the mol. target of GNF-1331 as Porcupine, a membrane bound O-acyl transferase.  Structure-activity relationship studies led to the discovery of a novel series of potent and selective Porcupine inhibitors.  Compd. 19, GNF-6231, demonstrated excellent pathway inhibition and induced robust antitumor efficacy in a mouse MMTV-WNT1 xenograft tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGZaZIx4MI7Vg90H21EOLACvtfcHk0lhIB0loIqKnxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFWitb8%253D&md5=b4634dbc71bdfade7e5a71de96b37e2b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00038%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DHsieh%26aufirst%3DM.%2BH.%26aulast%3DNg%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BL.%26aulast%3DPan%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520pyridinyl%2520acetamide%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520porcupine%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D676%26epage%3D680%26doi%3D10.1021%2Facsmedchemlett.6b00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6855</span>– <span class="NLM_lpage">6868</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26455655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6855-6868&author=Y.+Dongauthor=K.+Liauthor=Z.+Xuauthor=H.+Maauthor=J.+Zhengauthor=Z.+Huauthor=S.+Heauthor=Y.+Wuauthor=Z.+Sunauthor=L.+Luoauthor=J.+Liauthor=H.+Zhangauthor=X.+Zhang&title=Exploration+of+the+linkage+elements+of+porcupine+antagonists+led+to+potent+Wnt+signaling+pathway+inhibitors&doi=10.1016%2Fj.bmc.2015.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors</span></div><div class="casAuthors">Dong, Yan; Li, Kehuang; Xu, Zhixiang; Ma, Haikuo; Zheng, Jiyue; Hu, Zhilin; He, Sudan; Wu, Yiyuan; Sun, Zhijian; Luo, Lusong; Li, Jiajun; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6855-6868</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is a pivotal developmental pathway.  It operates through control of cellular functions such as proliferation, differentiation, migration and polarity.  Aberrant Wnt signaling has been implicated in the formation and metastasis of tumors.  Porcupine is a component of the Wnt signaling pathway.  It is a member of the membrane-bound O-acyltransferase family of proteins.  Porcupine catalyzes the palmitoylation of Wnt proteins, a process which is essential to their secretion and activity.  Here we report a novel series of compds. obtained by a scaffold hybridization strategy from two known porcupine inhibitor classes.  The leading compd. 62 demonstrated subnanomolar (IC50 0.11 nM) inhibition of Wnt signaling in a paracrine cellular reporter gene assay.  Compd. 62 also potently inhibited Wnt secretion into culture medium, an indication of direct inhibition of the porcupine protein.  Furthermore, compd. 62 showed excellent chem., plasma and liver microsomal stabilities.  Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5CxdsEaQJzLVg90H21EOLACvtfcHk0lhIB0loIqKnxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLnE&md5=be49dceee0597ec439af4ef1b720a789</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DExploration%2520of%2520the%2520linkage%2520elements%2520of%2520porcupine%2520antagonists%2520led%2520to%2520potent%2520Wnt%2520signaling%2520pathway%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6855%26epage%3D6868%26doi%3D10.1016%2Fj.bmc.2015.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ejmech.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26647303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFantbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=154-165&author=Z.+Xuauthor=J.+Liauthor=Y.+Wuauthor=Z.+Sunauthor=L.+Luoauthor=Z.+Huauthor=S.+Heauthor=J.+Zhengauthor=H.+Zhangauthor=X.+Zhang&title=Design%2C+synthesis%2C+and+evaluation+of+potent+Wnt+signaling+inhibitors+featuring+a+fused+3-ring+system&doi=10.1016%2Fj.ejmech.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system</span></div><div class="casAuthors">Xu, Zhixiang; Li, Jiajun; Wu, Yiyuan; Sun, Zhijian; Luo, Lusong; Hu, Zhilin; He, Sudan; Zheng, Jiyue; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">154-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is a crit. developmental pathway which operates through control of cellular functions such as proliferation and differentiation.  Aberrant Wnt signaling has been linked to the formation and metastasis of tumors.  Porcupine, a member of the membrane-bound O-acyltransferase family of proteins, is an important component of the Wnt pathway.  Porcupine catalyzes the palmitoylation of Wnt proteins, a process needed for their secretion and activity.  Here we report a novel series of compds. obtained by a scaffold hybridization strategy from a known porcupine inhibitor class.  The leading compd. 59 demonstrated subnanomolar inhibition of Wnt signaling in a paracrine cellular assay.  Compd. 59 also showed excellent chem., plasma and liver microsomal stabilities.  Furthermore, compd. 59 exhibited good pharmacokinetic profiles with 30% oral bioavailability in rat.  Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj_OMopMr2d7Vg90H21EOLACvtfcHk0lhpXLLgy-q5lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFantbnP&md5=b7741015a9cec46673a375ead5be57a2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520Wnt%2520signaling%2520inhibitors%2520featuring%2520a%2520fused%25203-ring%2520system%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D154%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Laoi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the “reversed” amide scaffold</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5861</span>– <span class="NLM_lpage">5872</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2016.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27692509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOrtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5861-5872&author=Z.+Xuauthor=X.+Xuauthor=R.+O%E2%80%99Laoiauthor=H.+Maauthor=J.+Zhengauthor=S.+Chenauthor=L.+Luoauthor=Z.+Huauthor=S.+Heauthor=J.+Liauthor=H.+Zhangauthor=X.+Zhang&title=Design%2C+synthesis%2C+and+evaluation+of+novel+porcupine+inhibitors+featuring+a+fused+3-ring+system+based+on+the+%E2%80%9Creversed%E2%80%9D+amide+scaffold&doi=10.1016%2Fj.bmc.2016.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold</span></div><div class="casAuthors">Xu, Zhixiang; Xu, Xiangxiang; O'Laoi, Ruadhan; Ma, Haikuo; Zheng, Jiyue; Chen, Shuaishuai; Luo, Lusong; Hu, Zhilin; He, Sudan; Li, Jiajun; Zhang, Hongjian; Zhang, Xiaohu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5861-5872</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is an essential signal transduction pathway which leads to the regulation of cellular processes such as proliferation, differentiation and migration.  Aberrant Wnt signaling is known to have an assocn. with multiple cancers.  Porcupine is an enzyme that catalyzes the addn. of palmitoleate to a serine residue in Wnt proteins, a process which is required for the secretion of Wnt proteins.  Here the authors report the synthesis and structure-activity-relationship of the novel porcupine inhibitors based on a 'reversed' amide scaffold.  The leading compd. I was as potent as the clin. compd. LGK974 in a cell based STF reporter gene assay.  Compd. I potently inhibited the secretion of Wnt3A, therefore was confirmed to be a porcupine inhibitor.  Furthermore, compd. I showed excellent chem. and plasma stabilities.  However, the clearance of compd. I in liver microsomal tests was moderate to high, and the soly. of compd. I was suboptimal.  Collective efforts toward further optimization of this novel tricyclic template to develop better porcupine inhibitors will be subsequently undertaken and reported in due course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjAFRMGIf9TLVg90H21EOLACvtfcHk0lhpXLLgy-q5lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOrtrrO&md5=f58d5e064fb64cba7f9ec153806ed6ed</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Laoi%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520porcupine%2520inhibitors%2520featuring%2520a%2520fused%25203-ring%2520system%2520based%2520on%2520the%2520%25E2%2580%259Creversed%25E2%2580%259D%2520amide%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5861%26epage%3D5872%26doi%3D10.1016%2Fj.bmc.2016.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraiswamy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of a porcupine inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5889</span>– <span class="NLM_lpage">5899</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKitb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5889-5899&author=A.+J.+Duraiswamyauthor=M.+A.+Leeauthor=B.+Madanauthor=S.+H.+Angauthor=E.+S.+Tanauthor=W.+W.+Cheongauthor=Z.+Keauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=Y.+S.+Chewauthor=V.+Manoharanauthor=K.+Sangthongpitagauthor=J.+Alamauthor=A.+Poulsenauthor=S.+Y.+Hoauthor=D.+M.+Virshupauthor=T.+H.+Keller&title=Discovery+and+optimization+of+a+porcupine+inhibitor&doi=10.1021%2Facs.jmedchem.5b00507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of a Porcupine Inhibitor</span></div><div class="casAuthors">Duraiswamy, Athisayamani Jeyaraj; Lee, May Ann; Madan, Babita; Ang, Shi Hua; Tan, Eldwin Sum Wai; Cheong, Wei Wen Vivien; Ke, Zhiyuan; Pendharkar, Vishal; Ding, Li Jun; Chew, Yun Shan; Manoharan, Vithya; Sangthongpitag, Kanda; Alam, Jenefer; Poulsen, Anders; Ho, Soo Yei; Virshup, David M.; Keller, Thomas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5889-5899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Wnt proteins regulate various cellular functions and serve distinct roles in normal development throughout life.  Wnt signaling is dysregulated in various diseases including cancers.  Porcupine (PORCN) is a membrane-bound O-acyltransferase that palmitoleates the Wnts and hence is essential for their secretion and function.  The inhibition of PORCN could serve as a therapeutic approach for the treatment of a no. of Wnt-dependent cancers.  Herein, the authors describe the identification of a Wnt secretion inhibitor from cellular high throughput screening.  Classical SAR based cellular optimization provided us with a PORCN inhibitor I with nanomolar activity and excellent bioavailability that demonstrated efficacy in a Wnt-driven murine tumor model.  Finally, the authors also discovered that enantiomeric PORCN inhibitors show very different activity in the reporter assay, suggesting that such compds. may be useful for mode of action studies on the PORCN O-acyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93eq8v4hPU7Vg90H21EOLACvtfcHk0lhpXLLgy-q5lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKitb7P&md5=11decbf7f776098c61a4cec7796ac07f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDuraiswamy%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%26aulast%3DCheong%26aufirst%3DW.%2BW.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520porcupine%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5889%26epage%3D5899%26doi%3D10.1021%2Facs.jmedchem.5b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span> <span> </span><span class="NLM_article-title">Scaffold hopping and optimization of maleimide based porcupine inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6678-6692&author=S.+Y.+Hoauthor=J.+Alamauthor=D.+A.+Jeyarajauthor=W.+Wangauthor=G.+R.+Linauthor=S.+H.+Angauthor=E.+S.+W.+Tanauthor=M.+A.+Leeauthor=Z.+Keauthor=B.+Madanauthor=D.+M.+Virshupauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=C.+B.+Lowauthor=V.+Pendharkarauthor=K.+Sangthongpitagauthor=J.+Hillauthor=T.+H.+Kellerauthor=A.+Poulsen&title=Scaffold+hopping+and+optimization+of+maleimide+based+porcupine+inhibitors&doi=10.1021%2Facs.jmedchem.7b00662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors</span></div><div class="casAuthors">Ho, Soo Yei; Alam, Jenefer; Jeyaraj, Duraiswamy Athisayamani; Wang, Weiling; Lin, Grace Ruiting; Ang, Shi Hua; Tan, Eldwin Sum Wai; Lee, May Ann; Ke, Zhiyuan; Madan, Babita; Virshup, David M.; Ding, Li Jun; Manoharan, Vithya; Chew, Yun Shan; Low, Choon Bing; Pendharkar, Vishal; Sangthongpitag, Kanda; Hill, Jeffrey; Keller, Thomas H.; Poulsen, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6678-6692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Porcupine is an O-acyltransferase that regulates Wnt secretion.  Inhibiting porcupine may block the Wnt pathway which is often dysregulated in various cancers.  Consequently porcupine inhibitors are thought to be promising oncol. therapeutics.  A high throughput screen against porcupine revealed several potent hits that were confirmed to be Wnt pathway inhibitors in secondary assays.  We developed a pharmacophore model and used the putative bioactive conformation of a xanthine inhibitor for scaffold hopping.  The resulting maleimide scaffold was optimized to subnanomolar potency while retaining good phys. druglike properties.  A preclin. development candidate was selected for which extensive in vitro and in vivo profiling is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ENAXwy5NLbVg90H21EOLACvtfcHk0lgRs8h9_8eRDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr%252FP&md5=e3d6e7267c9270905b5166a3688f00c5</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00662%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAng%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DE.%2BS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DZ.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DLow%26aufirst%3DC.%2BB.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DPoulsen%26aufirst%3DA.%26atitle%3DScaffold%2520hopping%2520and%2520optimization%2520of%2520maleimide%2520based%2520porcupine%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6678%26epage%3D6692%26doi%3D10.1021%2Facs.jmedchem.7b00662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hottiger, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassa, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch-Nolte, F.</span></span> <span> </span><span class="NLM_article-title">Toward a unified nomenclature for mammalian ADP-ribosyltransferases</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.tibs.2009.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20106667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVegs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=208-219&author=M.+O.+Hottigerauthor=P.+O.+Hassaauthor=B.+Luscherauthor=H.+Schulerauthor=F.+Koch-Nolte&title=Toward+a+unified+nomenclature+for+mammalian+ADP-ribosyltransferases&doi=10.1016%2Fj.tibs.2009.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a unified nomenclature for mammalian ADP-ribosyltransferases</span></div><div class="casAuthors">Hottiger, Michael O.; Hassa, Paul O.; Luescher, Bernhard; Schueler, Herwig; Koch-Nolte, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">208-219</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  ADP-ribosylation is a post-translational modification of proteins catalyzed by ADP-ribosyltransferases.  It comprises the transfer of the ADP-ribose moiety from NAD+ to specific amino acid residues on substrate proteins or to ADP-ribose itself.  Currently, 22 human genes encoding proteins that possess an ADP-ribosyltransferase catalytic domain are known.  Recent structural and enzymol. evidence of poly(ADP-ribose)polymerase (PARP) family members demonstrate that earlier proposed names and classifications of these proteins are no longer accurate.  Here we summarize these new findings and propose a new consensus nomenclature for all ADP-ribosyltransferases (ARTs) based on the catalyzed reaction and on structural features.  A unified nomenclature would facilitate communication between researchers both inside and outside the ADP-ribosylation field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg6kR-35XzU7Vg90H21EOLACvtfcHk0lgRs8h9_8eRDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVegs70%253D&md5=0e63a298da9140bea11180b58bec7357</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHottiger%26aufirst%3DM.%2BO.%26aulast%3DHassa%26aufirst%3DP.%2BO.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DKoch-Nolte%26aufirst%3DF.%26atitle%3DToward%2520a%2520unified%2520nomenclature%2520for%2520mammalian%2520ADP-ribosyltransferases%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2010%26volume%3D35%26spage%3D208%26epage%3D219%26doi%3D10.1016%2Fj.tibs.2009.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendzel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, G. G.</span></span> <span> </span><span class="NLM_article-title">PARP inhibition: PARP1 and beyond</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1038/nrc2812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrc2812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20200537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=293-301&author=M.+Rouleauauthor=A.+Patelauthor=M.+J.+Hendzelauthor=S.+H.+Kaufmannauthor=G.+G.+Poirier&title=PARP+inhibition%3A+PARP1+and+beyond&doi=10.1038%2Fnrc2812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">PARP inhibition: PARP1 and beyond</span></div><div class="casAuthors">Rouleau, Michele; Patel, Anand; Hendzel, Michael J.; Kaufmann, Scott H.; Poirier, Guy G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-301</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent findings have thrust poly(ADP-ribose) polymerases (PARPs) into the limelight as potential chemotherapeutic targets.  To provide a framework for understanding these recent observations, the authors have reviewed what is known about the structures and functions of the family of PARP enzymes, and then outlined a series of questions that should be addressed to guide the rational development of PARP inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOiY_n1IClmbVg90H21EOLACvtfcHk0lgLOVHpqmsF8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yms7w%253D&md5=fa3e3964e84229317dadbd505f11ad86</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrc2812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2812%26sid%3Dliteratum%253Aachs%26aulast%3DRouleau%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DHendzel%26aufirst%3DM.%2BJ.%26aulast%3DKaufmann%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DG.%2BG.%26atitle%3DPARP%2520inhibition%253A%2520PARP1%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D293%26epage%3D301%26doi%3D10.1038%2Fnrc2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castroviejo-Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaknin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span> <span> </span><span class="NLM_article-title">A decade of clinical development of PARP inhibitors in perspective</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdz192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1093%2Fannonc%2Fmdz192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31218365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3M3os1Kjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=1437-1447&author=J.+Mateoauthor=C.+J.+Lordauthor=V.+Serraauthor=A.+Tuttauthor=J.+Balmanaauthor=M.+Castroviejo-Bermejoauthor=C.+Cruzauthor=A.+Oakninauthor=S.+B.+Kayeauthor=J.+S.+de+Bono&title=A+decade+of+clinical+development+of+PARP+inhibitors+in+perspective&doi=10.1093%2Fannonc%2Fmdz192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A decade of clinical development of PARP inhibitors in perspective</span></div><div class="casAuthors">Mateo J; Balmana J; Cruz C; Oaknin A; Lord C J; Serra V; Castroviejo-Bermejo M; Tutt A; Kaye S B; de Bono J S</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1437-1447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells.  DNA damage repair defects are common in different cancer types; these alterations can also induce tumour-specific vulnerabilities that can be exploited therapeutically.  In 2009, a first-in-man clinical trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib clinically validated the synthetic lethal interaction between inhibition of PARP1, a key sensor of DNA damage, and BRCA1/BRCA2 deficiency.  In this review, we summarize a decade of PARP inhibitor clinical development, a work that has resulted in the registration of several PARP inhibitors in breast (olaparib and talazoparib) and ovarian cancer (olaparib, niraparib and rucaparib, either alone or following platinum chemotherapy as maintenance therapy).  Over the past 10 years, our knowledge on the mechanism of action of PARP inhibitor as well as how tumours become resistant has been extended, and we summarise this work here.  We also discuss opportunities for expanding the precision medicine approach with PARP inhibitors, identifying a wider population who could benefit from this drug class.  This includes developing and validating better predictive biomarkers for patient stratification, mainly based on homologous recombination defects beyond BRCA1/BRCA2 mutations, identifying DNA repair deficient tumours in other cancer types such as prostate or pancreatic cancer, or by designing combination therapies with PARP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA9h2s1R9Zwcjl5L8hwNX0fW6udTcc2ebDSoh6mg_8Lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3os1Kjtg%253D%253D&md5=f7755588b156a5fe67ba16dfbccdf889</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdz192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdz192%26sid%3Dliteratum%253Aachs%26aulast%3DMateo%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DTutt%26aufirst%3DA.%26aulast%3DBalmana%26aufirst%3DJ.%26aulast%3DCastroviejo-Bermejo%26aufirst%3DM.%26aulast%3DCruz%26aufirst%3DC.%26aulast%3DOaknin%26aufirst%3DA.%26aulast%3DKaye%26aufirst%3DS.%2BB.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26atitle%3DA%2520decade%2520of%2520clinical%2520development%2520of%2520PARP%2520inhibitors%2520in%2520perspective%26jtitle%3DAnn.%2520Oncol.%26date%3D2019%26volume%3D30%26spage%3D1437%26epage%3D1447%26doi%3D10.1093%2Fannonc%2Fmdz192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giriat, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lange, T.</span></span> <span> </span><span class="NLM_article-title">Tankyrase, a poly(ADP-ribose) polymerase at human telomeres</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1126/science.282.5393.1484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscience.282.5393.1484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9822378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXns1yms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1484-1487&author=S.+Smithauthor=I.+Giriatauthor=A.+Schmittauthor=T.+de+Lange&title=Tankyrase%2C+a+poly%28ADP-ribose%29+polymerase+at+human+telomeres&doi=10.1126%2Fscience.282.5393.1484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase, a poly(ADP-ribose) polymerase at human telomeres</span></div><div class="casAuthors">Smith, Susan; Giriat, Izabela; Schmitt, Anja; De Langet, Titia</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5393</span>),
    <span class="NLM_cas:pages">1484-1488</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Tankyrase, a protein with homol. to ankyrins and to the catalytic domain of poly(ADP-ribose) polymerase (PARP), was identified and localized to human telomeres.  Tankyrase binds to the telomeric protein TRF1 (telomeric repeat binding factor-1), a neg. regulator of telomere length maintenance.  Like ankyrins, tankyrase contains 24 ankyrin repeats in a domain responsible for its interaction with TRF1.  Recombinant tankyrase was found to have PARP activity in vitro, with both TRF1 and tankyrase functioning as acceptors for ADP-ribosylation.  ADP-ribosylation of TRF1 diminished its ability to bind to telomeric DNA in vitro, suggesting that telomere function in human cells is regulated by poly(ADP-ribosyl)ation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxdALI6ymFrVg90H21EOLACvtfcHk0lgLOVHpqmsF8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1yms78%253D&md5=8c991efb258d26af8fcc8c0126f76eee</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5393.1484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5393.1484%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DGiriat%26aufirst%3DI.%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3Dde%2BLange%26aufirst%3DT.%26atitle%3DTankyrase%252C%2520a%2520poly%2528ADP-ribose%2529%2520polymerase%2520at%2520human%2520telomeres%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1484%26epage%3D1487%26doi%3D10.1126%2Fscience.282.5393.1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruo, T.</span></span> <span> </span><span class="NLM_article-title">Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ccr.2004.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15652747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVaitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=25-37&author=H.+Seimiyaauthor=Y.+Muramatsuauthor=T.+Ohishiauthor=T.+Tsuruo&title=Tankyrase+1+as+a+target+for+telomere-directed+molecular+cancer+therapeutics&doi=10.1016%2Fj.ccr.2004.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics</span></div><div class="casAuthors">Seimiya, Hiroyuki; Muramatsu, Yukiko; Ohishi, Tomokazu; Tsuruo, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-37</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Telomere elongation by telomerase is repressed in cis by the telomeric protein TRF1.  Tankyrase 1 poly(ADP-ribosyl)ates TRF1 and releases it from telomeres, allowing access of telomerase to telomeres.  Here we demonstrate that tankyrase 1 inhibition in human cancer cells enhances telomere shortening by a telomerase inhibitor and hastens cell death.  Conversely, either tankyrase 1 upregulation or telomere shortening, each of which decreased TRF1 loading on a chromosome end, attenuated the impact of telomerase inhibition.  These results are consistent with the idea that telomeres having fewer TRF1s increase the efficiency of their elongation by telomerase.  This study implies that both enzyme activity and accessibility to telomeres can be targets for telomerase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl5BeU2RExnrVg90H21EOLACvtfcHk0lhM__JxNFWxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVaitrg%253D&md5=b1f4ea3ea97d3415371b0354451485e3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DTankyrase%25201%2520as%2520a%2520target%2520for%2520telomere-directed%2520molecular%2520cancer%2520therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D25%26epage%3D37%26doi%3D10.1016%2Fj.ccr.2004.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0lhM__JxNFWxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Structural basis of selective inhibition of human tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1367</span>, <span class="refDoi"> DOI: 10.1021/jm201510p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201510p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1360-1367&author=M.+Narwalauthor=H.+Venkannagariauthor=L.+Lehtio&title=Structural+basis+of+selective+inhibition+of+human+tankyrases&doi=10.1021%2Fjm201510p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Selective Inhibition of Human Tankyrases</span></div><div class="casAuthors">Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1360-1367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases are poly(ADP-ribose) polymerases that have many cellular functions.  They play pharmaceutically important roles, at least in telomere homeostasis and Wnt signaling, by covalently ADP-ribosylating target proteins and consequently regulating their functions.  These features make tankyrases potential targets for treatment of cancer.  We report here crystal structures of human tankyrase 2 catalytic fragment in complex with a byproduct, nicotinamide, and with selective inhibitors of tankyrases (IWR-1) and PARPs 1 and 2 (olaparib).  Binding of these inhibitors to tankyrase 2 induces specific conformational changes.  The crystal structures explain the selectivity of the inhibitors, reveal the flexibility of a substrate binding loop, and explain existing structure-activity relationship data.  The first crystal structure of a PARP enzyme in complex with a potent inhibitor, IWR-1, that does not bind to the widely utilized nicotinamide-binding site makes the structure valuable for development of PARP inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84kvenfSo3rVg90H21EOLACvtfcHk0lgiUIA8oEb_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ajsg%253D%253D&md5=7865a047f39d4b65fee0008a800f25ce</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm201510p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201510p%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DStructural%2520basis%2520of%2520selective%2520inhibition%2520of%2520human%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1360%26epage%3D1367%26doi%3D10.1021%2Fjm201510p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guettler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petsalaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gish, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottapel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1354</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.10.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.cell.2011.10.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22153077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1340-1354&author=S.+Guettlerauthor=J.+LaRoseauthor=E.+Petsalakiauthor=G.+Gishauthor=A.+Scotterauthor=T.+Pawsonauthor=R.+Rottapelauthor=F.+Sicheri&title=Structural+basis+and+sequence+rules+for+substrate+recognition+by+Tankyrase+explain+the+basis+for+cherubism+disease&doi=10.1016%2Fj.cell.2011.10.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease</span></div><div class="casAuthors">Guettler, Sebastian; LaRose, Jose; Petsalaki, Evangelia; Gish, Gerald; Scotter, Andy; Pawson, Tony; Rottapel, Robert; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1340-1354</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The poly(ADP-ribose)polymerases Tankyrase 1/2 (TNKS/TNKS2) catalyze the covalent linkage of ADP-ribose polymer chains onto target proteins, regulating their ubiquitylation, stability, and function.  Dysregulation of substrate recognition by Tankyrases underlies the human disease cherubism.  Tankyrases recruit specific motifs (often called RxxPDG "hexapeptides") in their substrates via an N-terminal region of ankyrin repeats.  These ankyrin repeats form five domains termed ankyrin repeat clusters (ARCs), each predicted to bind substrate.  Here we report crystal structures of a representative ARC of TNKS2 bound to targeting peptides from six substrates.  Using a soln.-based peptide library screen, we derive a rule-based consensus for Tankyrase substrates common to four functionally conserved ARCs.  This 8-residue consensus allows us to rationalize all known Tankyrase substrates and explains the basis for cherubism-causing mutations in the Tankyrase substrate 3BP2.  Structural and sequence information allows us to also predict and validate other Tankyrase targets, including Disc1, Striatin, Fat4, RAD54, BCR, and MERIT40.  Structural studies combined with a peptide library screen reveal the rules of substrate recognition by the poly(ADP-ribose)polymerase Tankyrase, explaining how mutations that cause cherubism disrupt the interaction between Tankyrase and one of its substrates, 3BP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXBvt-q3D-MLVg90H21EOLACvtfcHk0lgiUIA8oEb_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgtr3N&md5=cd3925d7dbbdf0e9893906e37befde9f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.046%26sid%3Dliteratum%253Aachs%26aulast%3DGuettler%26aufirst%3DS.%26aulast%3DLaRose%26aufirst%3DJ.%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520and%2520sequence%2520rules%2520for%2520substrate%2520recognition%2520by%2520Tankyrase%2520explain%2520the%2520basis%2520for%2520cherubism%2520disease%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1340%26epage%3D1354%26doi%3D10.1016%2Fj.cell.2011.10.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorsell, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresaugues, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and Tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2hu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1262-1271&author=A.+G.+Thorsellauthor=T.+Ekbladauthor=T.+Karlbergauthor=M.+Lowauthor=A.+F.+Pintoauthor=L.+Tresauguesauthor=M.+Mocheauthor=M.+S.+Cohenauthor=H.+Schuler&title=Structural+basis+for+potency+and+promiscuity+in+poly%28ADP-ribose%29+polymerase+%28PARP%29+and+Tankyrase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors</span></div><div class="casAuthors">Thorsell, Ann-Gerd; Ekblad, Torun; Karlberg, Tobias; Loew, Mirjam; Pinto, Ana Filipa; Tresaugues, Lionel; Moche, Martin; Cohen, Michael S.; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1262-1271</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors could help unveil the mechanisms by which inhibition of poly(ADP-ribose) polymerases (PARPs) elicits clin. benefits in cancer therapy.  The authors profiled ten clin. PARP inhibitors and commonly used research tools for their inhibition of multiple PARP enzymes.  The authors also detd. crystal structures of these compds. bound to PARP1 or PARP2.  Veliparib and Niraparib are selective inhibitors of PARP1 and PARP2; Olaparib, Rucaparib and Talazoparib are more potent inhibitors of PARP1, but are less selective.  PJ34 and UPF1069 are broad PARP inhibitors; PJ34 inserts a flexible moiety into hydrophobic subpockets in various ADP-ribosyltransferases.  XAV939 is a promiscuous tankyrase inhibitor, and a potent inhibitor of PARP1 in vitro and in cells, whereas IWR1 and AZ6102 are tankyrase selective.  The authors' biochem. and structural anal. of PARP inhibitor potencies establishes a mol. basis for either selectivity or promiscuity and provides a benchmark for exptl. design in assessment of PARP inhibitor effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQSmV0dV9abrVg90H21EOLACvtfcHk0lgiUIA8oEb_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2hu77E&md5=fce2c08efcf47cbc24929b62df782a39</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00990%26sid%3Dliteratum%253Aachs%26aulast%3DThorsell%26aufirst%3DA.%2BG.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DLow%26aufirst%3DM.%26aulast%3DPinto%26aufirst%3DA.%2BF.%26aulast%3DTresaugues%26aufirst%3DL.%26aulast%3DMoche%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520potency%2520and%2520promiscuity%2520in%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520and%2520Tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1262%26epage%3D1271%26doi%3D10.1021%2Facs.jmedchem.6b00990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5352</span>– <span class="NLM_lpage">5355</span>, <span class="refDoi"> DOI: 10.1021/jm100249w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100249w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5352-5355&author=T.+Karlbergauthor=N.+Markovaauthor=I.+Johanssonauthor=M.+Hammarstromauthor=P.+Schutzauthor=J.+Weigeltauthor=H.+Schuler&title=Structural+basis+for+the+interaction+between+tankyrase-2+and+a+potent+Wnt-signaling+inhibitor&doi=10.1021%2Fjm100249w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor</span></div><div class="casAuthors">Karlberg, Tobias; Markova, Natalia; Johansson, Ida; Hammarstrom, Martin; Schutz, Patrick; Weigelt, Johan; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5352-5355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report two crystal structures of the PARP domain of human tankyrase-2 (TNKS2).  Tankyrases are involved in fundamental cellular processes such as telomere homeostasis and Wnt signaling.  The complex of TNKS2 with the potent inhibitor XAV939 provides insights into the mol. basis of the strong interaction and suggests routes for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8HUahD927bVg90H21EOLACvtfcHk0lg_fUQpqftQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D&md5=3b037afbe6f4dc86a492855fa800fb44</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm100249w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100249w%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DHammarstrom%26aufirst%3DM.%26aulast%3DSchutz%26aufirst%3DP.%26aulast%3DWeigelt%26aufirst%3DJ.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520tankyrase-2%2520and%2520a%2520potent%2520Wnt-signaling%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5352%26epage%3D5355%26doi%3D10.1021%2Fjm100249w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Neves, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Oliveira, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes-Ribeiro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. M. F.</span></span> <span> </span><span class="NLM_article-title">IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>414</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29126913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2018&pages=1-15&author=S.+R.+Martins-Nevesauthor=D.+I.+Paiva-Oliveiraauthor=C.+Fontes-Ribeiroauthor=J.+Boveeauthor=A.+M.+Cleton-Jansenauthor=C.+M.+F.+Gomes&title=IWR-1%2C+a+tankyrase+inhibitor%2C+attenuates+Wnt%2Fbeta-catenin+signaling+in+cancer+stem-like+cells+and+inhibits+in+vivo+the+growth+of+a+subcutaneous+human+osteosarcoma+xenograft&doi=10.1016%2Fj.canlet.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span></div><div class="casAuthors">Martins-Neves, Sara R.; Paiva-Oliveira, Daniela I.; Fontes-Ribeiro, Carlos; Bovee, Judith V. M. G.; Cleton-Jansen, Anne-Marie; Gomes, Celia M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Wnt/β-catenin or canonical Wnt signaling pathway regulates the self-renewal of cancer stem-like cells (CSCs) and is involved in tumor progression and chemotherapy resistance.  Previously, we reported that this pathway is activated in a subset of osteosarcoma CSCs and that doxorubicin induced stemness properties in differentiated cells through Wnt/β-catenin activation.  Here, we investigated whether pharmacol. Wnt/β-catenin inhibition, using a tankyrase inhibitor (IWR-1), might constitute a strategy to target CSCs and improve chemotherapy efficacy in osteosarcoma.  IWR-1 was specifically cytotoxic for osteosarcoma CSCs.  IWR-1 impaired spheres' self-renewal capacity by compromising landmark steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets.  IWR-1 also hampered the activity and expression of key stemness-related markers.  In vitro, IWR-1 induced apoptosis of osteosarcoma spheres and combined with doxorubicin elicited synergistic cytotoxicity, reversing spheres' resistance to this drug.  In vivo, IWR-1 co-administration with doxorubicin substantially decreased tumor progression, assocd. with specific down-regulation of TCF/LEF transcriptional activity, nuclear β-catenin and expression of the putative CSC marker Sox2.  We suggest that targeting the Wnt/β-catenin pathway can eliminate CSCs populations in osteosarcoma.  Combining conventional chemotherapy with Wnt/β-catenin inhibition may ameliorate therapeutic outcomes, by eradicating the aggressive osteosarcoma CSCs and reducing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocG-gCNsSkwbVg90H21EOLACvtfcHk0lg_fUQpqftQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK&md5=c3aa5ed1a5fa31daa1d180ed72394202</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Neves%26aufirst%3DS.%2BR.%26aulast%3DPaiva-Oliveira%26aufirst%3DD.%2BI.%26aulast%3DFontes-Ribeiro%26aufirst%3DC.%26aulast%3DBovee%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.%2BM.%26aulast%3DGomes%26aufirst%3DC.%2BM.%2BF.%26atitle%3DIWR-1%252C%2520a%2520tankyrase%2520inhibitor%252C%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520cancer%2520stem-like%2520cells%2520and%2520inhibits%2520in%2520vivo%2520the%2520growth%2520of%2520a%2520subcutaneous%2520human%2520osteosarcoma%2520xenograft%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D414%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.canlet.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1341</span>– <span class="NLM_lpage">1345</span>, <span class="refDoi"> DOI: 10.1021/jm301607v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301607v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1341-1345&author=H.+Bregmanauthor=H.+Gunaydinauthor=Y.+Guauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauroauthor=X.+Huang&title=Discovery+of+a+class+of+novel+tankyrase+inhibitors+that+bind+to+both+the+nicotinamide+pocket+and+the+induced+pocket&doi=10.1021%2Fjm301607v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Class of Novel Tankyrase Inhibitors that Bind to Both the Nicotinamide Pocket and the Induced Pocket</span></div><div class="casAuthors">Bregman, Howard; Gunaydin, Hakan; Gu, Yan; Schneider, Steve; Wilson, Cindy; DiMauro, Erin F.; Huang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1341-1345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent and selective inhibitors of tankyrases have recently been characterized to bind to an induced pocket.  Here we report the identification of a novel potent and selective tankyrase inhibitor that binds to both the nicotinamide pocket and the induced pocket.  The crystal structure of human TNKS1 in complex with this "dual-binder" provides a mol. basis for their strong and specific interactions and suggests clues for the further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHc_P8ufAdAbVg90H21EOLACvtfcHk0lgOU9mIeb-YlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeitQ%253D%253D&md5=09681629c9a117caa6faeb64474091a5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm301607v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301607v%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520a%2520class%2520of%2520novel%2520tankyrase%2520inhibitors%2520that%2520bind%2520to%2520both%2520the%2520nicotinamide%2520pocket%2520and%2520the%2520induced%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1341%26epage%3D1345%26doi%3D10.1021%2Fjm301607v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emkey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10003</span>– <span class="NLM_lpage">10015</span>, <span class="refDoi"> DOI: 10.1021/jm401317z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401317z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10003-10015&author=Z.+Huaauthor=H.+Bregmanauthor=J.+L.+Buchananauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=X.+Huangauthor=Y.+Guauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=R.+Emkeyauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=L.+Acquavivaauthor=J.+Doveyauthor=A.+Mishraauthor=J.+Newcombauthor=D.+Saffranauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=M.+Stantonauthor=C.+Wilsonauthor=E.+F.+Dimauro&title=Development+of+novel+dual+binders+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm401317z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Hua, Zihao; Bregman, Howard; Buchanan, John L.; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Huang, Xin; Gu, Yan; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Emkey, Renee; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Acquaviva, Lisa; Dovey, Jennifer; Mishra, Ankita; Newcomb, John; Saffran, Douglas; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Stanton, Mary; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10003-10015</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS1 and TNKS2) are proteins in the poly ADP-ribose polymerase (PARP) family.  They have been shown to directly bind to axin proteins, which neg. regulate the Wnt pathway by promoting β-catenin degrdn.  Inhibition of tankyrases may offer a novel approach to the treatment of APC-mutant colorectal cancer.  Hit compd. N-(2-methoxyphenyl)-4-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamido)benzamide was identified as an inhibitor of tankyrases through a combination of substructure searching of the Amgen compd. collection based on a minimal binding pharmacophore hypothesis and high-throughput screening.  Herein the authors report the structure- and property-based optimization of N-(2-methoxyphenyl)-4-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamido)benzamide leading to the identification of more potent and selective tankyrase inhibitors with improved pharmacokinetic properties in rodents, which are well suited as tool compds. for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-WJLflGn1C7Vg90H21EOLACvtfcHk0lgOU9mIeb-YlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbN&md5=4620a3232873c1767b8289df2fac0c49</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm401317z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401317z%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DAcquaviva%26aufirst%3DL.%26aulast%3DDovey%26aufirst%3DJ.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSaffran%26aufirst%3DD.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DStanton%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26atitle%3DDevelopment%2520of%2520novel%2520dual%2520binders%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10003%26epage%3D10015%26doi%3D10.1021%2Fjm401317z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1021/jm400807n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400807n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6495-6511&author=M.+D.+Shultzauthor=A.+K.+Cheungauthor=C.+A.+Kirbyauthor=B.+Firestoneauthor=J.+Fanauthor=C.+H.+Chenauthor=Z.+Chenauthor=D.+N.+Chinauthor=L.+Dipietroauthor=A.+Fazalauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Gouldauthor=B.+Laguauthor=H.+Leiauthor=F.+Lenoirauthor=D.+Majumdarauthor=E.+Ochalaauthor=M.+G.+Palermoauthor=L.+Phamauthor=M.+Puauthor=T.+Smithauthor=T.+Stamsauthor=R.+C.+Tomlinsonauthor=B.+B.+Toureauthor=M.+Visserauthor=R.+M.+Wangauthor=N.+J.+Watersauthor=W.+Shao&title=Identification+of+NVP-TNKS656%3A+the+use+of+structure-efficiency+relationships+to+generate+a+highly+potent%2C+selective%2C+and+orally+active+tankyrase+inhibitor&doi=10.1021%2Fjm400807n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></div><div class="casAuthors">Shultz, Michael D.; Cheung, Atwood K.; Kirby, Christina A.; Firestone, Brant; Fan, Jianmei; Chen, Christine Hiu-Tung; Chen, Zhouliang; Chin, Donovan N.; DiPietro, Lucian; Fazal, Aleem; Feng, Yun; Fortin, Pascal D.; Gould, Ty; Lagu, Bharat; Lei, Huangshu; Lenoir, Francois; Majumdar, Dyuti; Ochala, Etienne; Palermo, M. G.; Pham, Ly; Pu, Minying; Smith, Troy; Stams, Travis; Tomlinson, Ronald C.; Toure, B. Barry; Visser, Michael; Wang, Run Ming; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6495-6511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway.  As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair.  By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7.  This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders.  NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model.  With an enthalpy-driven thermodn. signature of binding, highly favorable physicochem. properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDGWOimaJ0I7Vg90H21EOLACvtfcHk0ljm1xJrE4npEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2msbfE&md5=db3f1a471ca757e0219a5175c5017e9b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DCheung%26aufirst%3DA.%2BK.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DDipietro%26aufirst%3DL.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DOchala%26aufirst%3DE.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DPham%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTomlinson%26aufirst%3DR.%2BC.%26aulast%3DToure%26aufirst%3DB.%2BB.%26aulast%3DVisser%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%2BM.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520NVP-TNKS656%253A%2520the%2520use%2520of%2520structure-efficiency%2520relationships%2520to%2520generate%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520tankyrase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6495%26epage%3D6511%26doi%3D10.1021%2Fjm400807n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 2-arylquinazolin-4-ones as potent and selective inhibitors of Tankyrases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1021/ml400260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1173-1177&author=A.+Nathubhaiauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=M.+D.+Threadgill&title=Design+and+discovery+of+2-arylquinazolin-4-ones+as+potent+and+selective+inhibitors+of+Tankyrases&doi=10.1021%2Fml400260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of 2 Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases</span></div><div class="casAuthors">Nathubhai, Amit; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKSs) are poly-(ADP-ribose)-polymerases (PARPs) that are overexpressed in several clin. cancers.  They regulate elongation of telomeres, regulate the Wnt system, and are essential for the function of the mitotic spindle.  A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs.  TNKS-2.  Me was preferred at the 8-position and modest bulk at the 4-position of the 2-Ph group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided.  Mol. modeling facilitated initial design of the compds. and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes.  These compds. have potential for further development into anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfmX1o7LIsrVg90H21EOLACvtfcHk0lgcSTH_naJhzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aht7nM&md5=23eb9a910b7952c76392bb1ae3b1185b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fml400260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400260b%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520discovery%2520of%25202-arylquinazolin-4-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Tankyrases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1173%26epage%3D1177%26doi%3D10.1021%2Fml400260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paine, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunderland, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5891</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26189030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5891-5908&author=H.+A.+Paineauthor=A.+Nathubhaiauthor=E.+C.+Woonauthor=P.+T.+Sunderlandauthor=P.+J.+Woodauthor=M.+F.+Mahonauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=M.+Narwalauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Exploration+of+the+nicotinamide-binding+site+of+the+tankyrases%2C+identifying+3-arylisoquinolin-1-ones+as+potent+and+selective+inhibitors+in+vitro&doi=10.1016%2Fj.bmc.2015.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span></div><div class="casAuthors">Paine, Helen A.; Nathubhai, Amit; Woon, Esther C. Y.; Sunderland, Peter T.; Wood, Pauline J.; Mahon, Mary F.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Narwal, Mohit; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5891-5908</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases-1 and -2 (TNKS-1 and TNKS-2) have three cellular roles which make them important targets in cancer.  Using NAD+ as a substrate, they poly(ADP-ribosyl)ate TRF1 (regulating lengths of telomeres), NuMA (facilitating mitosis) and axin (in wnt/β-catenin signaling).  Using mol. modeling and the structure of the weak inhibitor 5-aminoiso quinolin-1-one, 3-aryl-5-substituted-isoquinolin-1-ones were designed as inhibitors to explore the structure-activity relationships (SARs) for binding and to define the shape of a hydrophobic cavity in the active site.  5-Amino-3-arylisoquinolinones were synthesized by Suzuki-Miyaura coupling of arylboronic acids to 3-bromo-1-methoxy-5-nitro-isoquinoline, redn. and O-demethylation.  3-Aryl-5-methylisoquinolin-1-ones, 3-aryl-5-fluoroisoquinolin-1-ones and 3-aryl-5-methoxyisoquinolin-1-ones were accessed by deprotonation of 3-substituted-N,N,2-trimethylbenzamides and quench with an appropriate benzonitrile.  SAR around the isoquinolinone core showed that aryl was required at the 3-position, optimally with a para-substituent.  Small meta-substituents were tolerated but groups in the ortho-positions reduced or abolished activity.  This was not due to lack of coplanarity of the rings, as shown by the potency of 4,5-dimethyl-3-phenylisoquinolin-1-one.  Me and methoxy were optimal at the 5-position.  SAR was rationalized by modeling and by crystal structures of examples with TNKS-2.  The 3-aryl unit was located in a large hydrophobic cavity and the para-substituents projected into a tunnel leading to the exterior.  Potency against TNKS-1 paralleled potency against TNKS-2.  Most inhibitors were highly selective for TNKSs over PARP-1 and PARP-2.  A range of highly potent and selective inhibitors is now available for cellular studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorPYvLKQ94bVg90H21EOLACvtfcHk0lgcSTH_naJhzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK&md5=a0c5d0ca6be15f5a565e66ba201d0c57</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DH.%2BA.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSunderland%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DExploration%2520of%2520the%2520nicotinamide-binding%2520site%2520of%2520the%2520tankyrases%252C%2520identifying%25203-arylisoquinolin-1-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520in%2520vitro%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5891%26epage%3D5908%26doi%3D10.1016%2Fj.bmc.2015.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumpan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3013</span>– <span class="NLM_lpage">3032</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2015.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26026769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlGrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3013-3032&author=K.+Kumpanauthor=A.+Nathubhaiauthor=C.+Zhangauthor=P.+J.+Woodauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Structure-based+design%2C+synthesis+and+evaluation+in+vitro+of+arylnaphthyridinones%2C+arylpyridopyrimidinones+and+their+tetrahydro+derivatives+as+inhibitors+of+the+tankyrases&doi=10.1016%2Fj.bmc.2015.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases</span></div><div class="casAuthors">Kumpan, Katerina; Nathubhai, Amit; Zhang, Chenlu; Wood, Pauline J.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3013-3032</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The tankyrase enzymes [i.e., poly(ADP-ribose) polymerase enzymes] are members of the PARP superfamily.  They poly(ADP-ribosyl)ate their target proteins using NAD+ as a source of electrophilic ADP-ribosyl units.  The three principal protein substrates of the tankyrase enzymes (TRF1, NuMA and axins) are involved in replication of cancer cells.  Thus, inhibitors of the tankyrase enzymes may have anticancer activity (antitumor activity).  Using a structure-based drug design and by analogy with known 3-aryl-1-isoquinolinone and 2-aryl-4-quinazolinone inhibitors, series of (aryl)naphthyridinone derivs., (aryl)pyridopyrimidinone derivs. and their tetrahydro-derivs. were synthesized and evaluated in vitro.  7-Aryl-1,6-naphthyridin-5-one derivs., 3-aryl-2,6-naphthyridin-1-one derivs. and 3-aryl-2,7-naphthyridin-1-ones were prepd. by an acid-catalyzed cyclization of the corresponding [(aryl)ethynyl]pyridinecarbonitrile derivs. or reaction of (bromo)pyridinecarboxylic acids with β-diketones, followed by treatment with NH3.  The 7-aryl-1,6-naphthyridin-5-ones were methylated at 1-N and reduced to 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones.  A copper-catalyzed reaction of benzamidines with (bromo)pyridinecarboxylic acids furnished 2-(aryl)pyrido[2,3-d]pyrimidin-4-ones.  A condensation of benzamidines with Me 1-benzyl-4-oxopiperidine-3-carboxylate and deprotection gave 2-aryl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-ones, aza analogs of the known inhibitor XAV939.  Introduction of a ring-nitrogen in the arylnaphthyridinones and the arylpyridopyrimidinones caused >1000-fold loss in activity, compared with their carbocyclic isoquinolinone and quinazolinone analogs (structure-activity relationship).  However, the 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones showed excellent inhibition of the tankyrase enzymes, with some examples having IC50 = 2 nM.  One compd. (7-(4-bromophenyl)-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-one) showed 70-fold selectivity for inhibition of tankyrase-2 vs. tankyrase-1.  The mode of binding was explored through crystal structures of inhibitors in complex with tankyrase-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9836Di5rfRLVg90H21EOLACvtfcHk0lgcSTH_naJhzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlGrsbk%253D&md5=367e1965fd9d3f1d458b1d38bc5a1ca7</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DKumpan%26aufirst%3DK.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520evaluation%2520in%2520vitro%2520of%2520arylnaphthyridinones%252C%2520arylpyridopyrimidinones%2520and%2520their%2520tetrahydro%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520tankyrases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3013%26epage%3D3032%26doi%3D10.1016%2Fj.bmc.2015.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumanov, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Highly potent and isoform selective dual site binding Tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=814-820&author=A.+Nathubhaiauthor=T.+Haikarainenauthor=J.+Koivunenauthor=S.+Murthyauthor=F.+Koumanovauthor=M.+D.+Lloydauthor=G.+D.+Holmanauthor=T.+Pihlajaniemiauthor=D.+Toshauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Highly+potent+and+isoform+selective+dual+site+binding+Tankyrase%2FWnt+signaling+inhibitors+that+increase+cellular+glucose+uptake+and+have+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.6b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity</span></div><div class="casAuthors">Nathubhai, Amit; Haikarainen, Teemu; Koivunen, Jarkko; Murthy, Sudarshan; Koumanov, Francoise; Lloyd, Matthew D.; Holman, Geoffrey D.; Pihlajaniemi, Taina; Tosh, David; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the "std." inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 μM vs. PARP1 for 14.  In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeH2cfPlBFBLVg90H21EOLACvtfcHk0lgcR7sxDVn6bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O&md5=2eb1a9ae15a5b9402b730e67f1ba3d79</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01574%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DKoumanov%26aufirst%3DF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DHolman%26aufirst%3DG.%2BD.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DHighly%2520potent%2520and%2520isoform%2520selective%2520dual%2520site%2520binding%2520Tankyrase%252FWnt%2520signaling%2520inhibitors%2520that%2520increase%2520cellular%2520glucose%2520uptake%2520and%2520have%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D814%26epage%3D820%26doi%3D10.1021%2Facs.jmedchem.6b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective Tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.+P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+Tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lgcR7sxDVn6bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520Tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johannes, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boriack-Sjodin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dishington, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingipalli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmirski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1021/ml5003663</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=254-259&author=J.+W.+Johannesauthor=L.+Almeidaauthor=B.+Barlaamauthor=P.+A.+Boriack-Sjodinauthor=R.+Casellaauthor=R.+A.+Croftauthor=A.+P.+Dishingtonauthor=L.+Gingipalliauthor=C.+Guauthor=J.+L.+Hawkinsauthor=J.+L.+Holmesauthor=T.+Howardauthor=J.+Huangauthor=S.+Ioannidisauthor=S.+Kazmirskiauthor=M.+L.+Lambauthor=T.+M.+McGuireauthor=J.+E.+Mooreauthor=D.+Oggauthor=A.+Patelauthor=K.+G.+Pikeauthor=T.+Pontzauthor=G.+R.+Robbauthor=N.+Suauthor=H.+Wangauthor=X.+Wuauthor=H.+J.+Zhangauthor=Y.+Zhangauthor=X.+Zhengauthor=T.+Wang&title=Pyrimidinone+nicotinamide+mimetics+as+selective+tankyrase+and+wnt+pathway+inhibitors+suitable+for+in+vivo+pharmacology&doi=10.1021%2Fml5003663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology</span></div><div class="casAuthors">Johannes, Jeffrey W.; Almeida, Lynsie; Barlaam, Bernard; Boriack-Sjodin, P. Ann; Casella, Robert; Croft, Rosemary A.; Dishington, Allan P.; Gingipalli, Lakshmaiah; Gu, Chungang; Hawkins, Janet L.; Holmes, Jane L.; Howard, Tina; Huang, Jian; Ioannidis, Stephanos; Kazmirski, Steven; Lamb, Michelle L.; McGuire, Thomas M.; Moore, Jane E.; Ogg, Derek; Patel, Anil; Pike, Kurt G.; Pontz, Timothy; Robb, Graeme R.; Su, Nancy; Wang, Haiyun; Wu, Xiaoyun; Zhang, Hai-Jun; Zhang, Yue; Zheng, Xiaolan; Wang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254-259</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The canonical Wnt pathway plays an important role in embryonic development, adult tissue homeostasis, and cancer.  Germline mutations of several Wnt pathway components, such as Axin, APC, and ss-catenin, can lead to oncogenesis.  Inhibition of the poly(ADP-ribose) polymerase (PARP) catalytic domain of the tankyrases (TNKS1 and TNKS2) is known to inhibit the Wnt pathway via increased stabilization of Axin.  In order to explore the consequences of tankyrase and Wnt pathway inhibition in preclin. models of cancer and its impact on normal tissue, the authors sought a small mol. inhibitor of TNKS1/2 with suitable physicochem. properties and pharmacokinetics for hypothesis testing in vivo.  Starting from a 2-Ph quinazolinone hit I, the authors discovered the pyrrolopyrimidinone compd. II (AZ6102), which is a potent TNKS1/2 inhibitor that has 100-fold selectivity against other PARP family enzymes and shows 5 nM Wnt pathway inhibition in DLD-1 cells.  Moreover, compd. II can be formulated well in a clin. relevant i.v. soln. at 20 mg/mL, has demonstrated good pharmacokinetics in preclin. species, and shows low Caco2 efflux to avoid possible tumor resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-61oay9RJRrVg90H21EOLACvtfcHk0lg_Dnsxw_xb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVyhuw%253D%253D&md5=c9502fbd9bb7823646af8ae60b6a9980</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fml5003663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003663%26sid%3Dliteratum%253Aachs%26aulast%3DJohannes%26aufirst%3DJ.%2BW.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DCasella%26aufirst%3DR.%26aulast%3DCroft%26aufirst%3DR.%2BA.%26aulast%3DDishington%26aufirst%3DA.%2BP.%26aulast%3DGingipalli%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DPyrimidinone%2520nicotinamide%2520mimetics%2520as%2520selective%2520tankyrase%2520and%2520wnt%2520pathway%2520inhibitors%2520suitable%2520for%2520in%2520vivo%2520pharmacology%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D254%26epage%3D259%26doi%3D10.1021%2Fml5003663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfrich, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas-Selves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuller, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskurth, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaberezhnyy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGregori, J.</span></span> <span> </span><span class="NLM_article-title">AZ1366: an inhibitor of Tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1531</span>– <span class="NLM_lpage">1541</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-16-1179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-16-1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27663586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1531-1541&author=H.+A.+Scarboroughauthor=B.+A.+Helfrichauthor=M.+Casas-Selvesauthor=A.+G.+Schullerauthor=S.+E.+Grosskurthauthor=J.+Kimauthor=A.+C.+Tanauthor=D.+C.+Chanauthor=Z.+Zhangauthor=V.+Zaberezhnyyauthor=P.+A.+Bunnauthor=J.+DeGregori&title=AZ1366%3A+an+inhibitor+of+Tankyrase+and+the+canonical+Wnt+pathway+that+limits+the+persistence+of+non-small+cell+lung+cancer+cells+following+EGFR+inhibition&doi=10.1158%2F1078-0432.CCR-16-1179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition</span></div><div class="casAuthors">Scarborough, Hannah A.; Helfrich, Barbara A.; Casas-Selves, Matias; Schuller, Alwin G.; Grosskurth, Shaun E.; Kim, Jihye; Tan, Aik-Choon; Chan, Daniel C.; Zhang, Zhiyong; Zaberezhnyy, Vadym; Bunn, Paul A.; DeGregori, James</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1531-1541</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The emergence of EGFR inhibitors such as gefitinib, erlotinib, and osimertinib has provided novel treatment opportunities in EGFR-driven non-small cell lung cancer (NSCLC).  However, most patients with EGFR-driven cancers treated with these inhibitors eventually relapse.  Recent efforts have identified the canonical Wnt pathway as a mechanism of protection from EGFR inhibition and that inhibiting tankyrase, a key player in this pathway, is a potential therapeutic strategy for the treatment of EGFR-driven tumors.  We performed a preclin. evaluation of tankyrase inhibitor AZ1366 in combination with multiple EGFR-inhibitors across NSCLC lines, characterizing its antitumor activity, impingement on canonical Wnt signaling, and effects on gene expression.  We performed pharmacokinetic and pharmacodynamic profiling of AZ1366 in mice and evaluated its therapeutic activity in an orthotopic NSCLC model.  Results: In combination with EGFR inhibitors, AZ1366 synergistically suppressed proliferation of multiple NSCLC lines and amplified global transcriptional changes brought about by EGFR inhibition.  Its ability to work synergistically with EGFR inhibition coincided with its ability to modulate the canonical Wnt pathway.  Pharmacokinetic and pharmacodynamic profiling of AZ1366-treated orthotopic tumors demonstrated clin. relevant serum drug levels and intratumoral target inhibition.  Finally, coadministration of an EGFR inhibitor and AZ1366 provided better tumor control and improved survival for Wnt-responsive lung cancers in an orthotopic mouse model.  Tankyrase inhibition is a potent route of tumor control in EGFR-dependent NSCLC with confirmed dependence on canonical Wnt signaling.  These data strongly support further evaluation of tankyrase inhibition as a cotreatment strategy with EGFR inhibition in an identifiable subset of EGFR-driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MFhKGoLoCrVg90H21EOLACvtfcHk0lg_Dnsxw_xb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOlur4%253D&md5=71faff9bb76dac0a912fabba448428c7</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-16-1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-16-1179%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DH.%2BA.%26aulast%3DHelfrich%26aufirst%3DB.%2BA.%26aulast%3DCasas-Selves%26aufirst%3DM.%26aulast%3DSchuller%26aufirst%3DA.%2BG.%26aulast%3DGrosskurth%26aufirst%3DS.%2BE.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZaberezhnyy%26aufirst%3DV.%26aulast%3DBunn%26aufirst%3DP.%2BA.%26aulast%3DDeGregori%26aufirst%3DJ.%26atitle%3DAZ1366%253A%2520an%2520inhibitor%2520of%2520Tankyrase%2520and%2520the%2520canonical%2520Wnt%2520pathway%2520that%2520limits%2520the%2520persistence%2520of%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520following%2520EGFR%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D1531%26epage%3D1541%26doi%3D10.1158%2F1078-0432.CCR-16-1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel spiroindoline derivatives as selective Tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3407</span>– <span class="NLM_lpage">3427</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3407-3427&author=F.+Shiraiauthor=T.+Tsumuraauthor=Y.+Yashirodaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=T.+Chikadaauthor=Y.+Kodaauthor=K.+Washizukaauthor=N.+Yoshimotoauthor=M.+Abeauthor=T.+Onukiauthor=Y.+Mazakiauthor=C.+Hiramaauthor=T.+Fukamiauthor=H.+Watanabeauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=M.+Okueauthor=Y.+Kanoauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=A.+Mizutaniauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Discovery+of+novel+spiroindoline+derivatives+as+selective+Tankyrase+inhibitors&doi=10.1021%2Facs.jmedchem.8b01888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors</span></div><div class="casAuthors">Shirai, Fumiyuki; Tsumura, Takeshi; Yashiroda, Yoko; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Chikada, Tsubasa; Koda, Yasuko; Washizuka, Kenichi; Yoshimoto, Nobuko; Abe, Masako; Onuki, Tetsuo; Mazaki, Yui; Hirama, Chizuko; Fukami, Takehiro; Watanabe, Hirofumi; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Okue, Masayuki; Kano, Yuko; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Muramatsu, Yukiko; Yoshida, Haruka; Mizutani, Anna; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3407-3427</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The canonical WNT pathway plays an important role in cancer pathogenesis.  Inhibition of poly(ADP-ribose) polymerase catalytic activity of the tankyrases (TNKS/TNKS2) has been reported to reduce the Wnt/β-catenin signal by preventing poly ADP-ribosylation dependent degrdn. of AXIN, a neg. regulator of Wnt/β-catenin signaling.  With the goal of investigating the effects of tankyrase and Wnt pathway inhibition on tumor growth, we set out to find small mol. inhibitors of TNKS/TNKS2 with suitable drug-like properties.  Starting from 1a(I), a high-throughput screening hit, the spiroindoline deriv. 40c(II) (RK-287107) was discovered as a potent TNKS/TNKS2 inhibitor with >7,000-fold selectivity against the PARP1 enzyme, which inhibits WNT-responsive TCF reporter activity and proliferation of human colorectal cancer cell line COLO-320DM.  II also demonstrated dose-dependent tumor growth inhibition in a mouse xenograft model.  These observations suggest that II is a promising lead compd. for the development of novel tankyrase inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb10HXpjf717Vg90H21EOLACvtfcHk0lhy1HVmnn9m2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFertbg%253D&md5=7877414ff5e5cfc908b1248017867639</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01888%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DYoshimoto%26aufirst%3DN.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DOnuki%26aufirst%3DT.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DHirama%26aufirst%3DC.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520novel%2520spiroindoline%2520derivatives%2520as%2520selective%2520Tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3407%26epage%3D3427%26doi%3D10.1021%2Facs.jmedchem.8b01888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0lhy1HVmnn9m2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washizuka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, H.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of an orally efficacious spiroindolinone-based Tankyrase inhibitor for the treatment of colon cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4204</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4183-4204&author=F.+Shiraiauthor=A.+Mizutaniauthor=Y.+Yashirodaauthor=T.+Tsumuraauthor=Y.+Kanoauthor=Y.+Muramatsuauthor=T.+Chikadaauthor=H.+Yukiauthor=H.+Niwaauthor=S.+Satoauthor=K.+Washizukaauthor=Y.+Kodaauthor=Y.+Mazakiauthor=M.+K.+Jangauthor=H.+Yoshidaauthor=A.+Nagamoriauthor=M.+Okueauthor=T.+Watanabeauthor=K.+Kitamuraauthor=E.+Shitaraauthor=T.+Honmaauthor=T.+Umeharaauthor=M.+Shirouzuauthor=T.+Fukamiauthor=H.+Seimiyaauthor=M.+Yoshidaauthor=H.+Koyama&title=Design+and+discovery+of+an+orally+efficacious+spiroindolinone-based+Tankyrase+inhibitor+for+the+treatment+of+colon+cancer&doi=10.1021%2Facs.jmedchem.0c00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer</span></div><div class="casAuthors">Shirai, Fumiyuki; Mizutani, Anna; Yashiroda, Yoko; Tsumura, Takeshi; Kano, Yuko; Muramatsu, Yukiko; Chikada, Tsubasa; Yuki, Hitomi; Niwa, Hideaki; Sato, Shin; Washizuka, Kenichi; Koda, Yasuko; Mazaki, Yui; Jang, Myung-Kyu; Yoshida, Haruka; Nagamori, Akiko; Okue, Masayuki; Watanabe, Takashi; Kitamura, Kouichi; Shitara, Eiki; Honma, Teruki; Umehara, Takashi; Shirouzu, Mikako; Fukami, Takehiro; Seimiya, Hiroyuki; Yoshida, Minoru; Koyama, Hiroo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4183-4204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases (TNKS/TNKS2) belong to the poly(ADP-ribose) polymerase family.  Inhibition of their enzymic activities attenuates the Wnt/β-catenin signaling, which plays an important role in cancer pathogenesis.  We previously reported the discovery of RK-287107, a spiroindoline-based, highly selective, potent tankyrase inhibitor.  Herein we describe the optimization process of RK-287107 leading to RK-582, which exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.  In addn. to the dose-dependent elevation and attenuation of the levels of biomarkers AXIN2 and β-catenin, resp., results of the TCF reporter and cell proliferation studies on COLO-320DM are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnxMuxDScpWLVg90H21EOLACvtfcHk0lgSkCBmsyY4Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltl2mt7g%253D&md5=8c55fd054daf7ccc91975379c2d8085b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00045%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DWashizuka%26aufirst%3DK.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DMazaki%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DNagamori%26aufirst%3DA.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DK.%26aulast%3DShitara%26aufirst%3DE.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKoyama%26aufirst%3DH.%26atitle%3DDesign%2520and%2520discovery%2520of%2520an%2520orally%2520efficacious%2520spiroindolinone-based%2520Tankyrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520colon%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4183%26epage%3D4204%26doi%3D10.1021%2Facs.jmedchem.0c00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lgSkCBmsyY4Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquaviva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1218</span>– <span class="NLM_lpage">1223</span>, <span class="refDoi"> DOI: 10.1021/ml4003315</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003315" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1218-1223&author=H.+Huangauthor=A.+Guzman-Perezauthor=L.+Acquavivaauthor=V.+Berryauthor=H.+Bregmanauthor=J.+Doveyauthor=H.+Gunaydinauthor=X.+Huangauthor=L.+Huangauthor=D.+Saffranauthor=R.+Serafinoauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Structure-based+design+of+2-aminopyridine+oxazolidinones+as+potent+and+selective+tankyrase+inhibitors&doi=10.1021%2Fml4003315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors</span></div><div class="casAuthors">Huang, Hongbing; Guzman-Perez, Angel; Acquaviva, Lisa; Berry, Virginia; Bregman, Howard; Dovey, Jennifer; Gunaydin, Hakan; Huang, Xin; Huang, Liyue; Saffran, Doug; Serafino, Randy; Schneider, Steve; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1218-1223</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant activation of the Wnt pathway has been implicated in the development and formation of many cancers.  TNKS inhibition has been shown to antagonize Wnt signaling via Axin stabilization in APC mutant colon cancer cell lines.  We employed structure-based design to identify a series of 2-aminopyridine oxazolidinones as potent and selective TNKS inhibitors.  These compds. exhibited good enzyme and cell potency as well as selectivity over other PARP isoforms.  Co-crystal structures of these 2-aminopyridine oxazolidinones complexed to TNKS reveal an induced-pocket binding mode that does not involve interactions with the nicotinamide binding pocket.  Oral dosing of lead compds. 3 and 4 resulted in significant effects on several Wnt-pathway biomarkers in a three day DLD-1 mouse tumor PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQcoLA6UEfbVg90H21EOLACvtfcHk0li97kdzEVRuwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktrvP&md5=9aa2a27d3694d8ed6dded65ccf85d186</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml4003315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003315%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DAcquaviva%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDovey%26aufirst%3DJ.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSaffran%26aufirst%3DD.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DStructure-based%2520design%2520of%25202-aminopyridine%2520oxazolidinones%2520as%2520potent%2520and%2520selective%2520tankyrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1218%26epage%3D1223%26doi%3D10.1021%2Fml4003315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundenes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedlich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembinski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-10-1282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21199802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=197-205&author=J.+Waalerauthor=O.+Machonauthor=J.+P.+von+Kriesauthor=S.+R.+Wilsonauthor=E.+Lundenesauthor=D.+Wedlichauthor=D.+Gradlauthor=J.+E.+Paulsenauthor=O.+Machonovaauthor=J.+L.+Dembinskiauthor=H.+Dinhauthor=S.+Krauss&title=Novel+synthetic+antagonists+of+canonical+Wnt+signaling+inhibit+colorectal+cancer+cell+growth&doi=10.1158%2F0008-5472.CAN-10-1282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; von Kries, Jens Peter; Wilson, Steven Ray; Lundenes, Elsa; Wedlich, Doris; Gradl, Dietmar; Paulsen, Jan Erik; Machonova, Olga; Dembinski, Jennifer L.; Dinh, Huyen; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is deregulated in several types of human cancer where it plays a central role in tumor cell growth and progression.  Here we report the identification of 2 new small mols. that specifically inhibit canonical Wnt pathway at the level of the destruction complex.  Specificity was verified in various cellular reporter systems, a Xenopus double-axis formation assay and a gene expression profile anal.  In human colorectal cancer (CRC) cells, the new compds. JW67 and JW74 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.  Notably, AXIN2 protein levels were strongly increased after compd. exposure.  Long-term treatment with JW74 inhibited the growth of tumor cells in both a mouse xenograft model of CRC and in ApcMin mice (multiple intestinal neoplasia, Min).  Our findings rationalize further preclin. and clin. evaluation of these new compds. as novel modalities for cancer treatment.  Cancer Res; 71(1); 197-205.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zbK2VV5PbVg90H21EOLACvtfcHk0li97kdzEVRuwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFOh&md5=e641536f7aea88b75d5cacc8b10458ab</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1282%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DLundenes%26aufirst%3DE.%26aulast%3DWedlich%26aufirst%3DD.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DDembinski%26aufirst%3DJ.%2BL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DNovel%2520synthetic%2520antagonists%2520of%2520canonical%2520Wnt%2520signaling%2520inhibit%2520colorectal%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D197%26epage%3D205%26doi%3D10.1158%2F0008-5472.CAN-10-1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">[1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1021/jm2011222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1127-1136&author=M.+D.+Shultzauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=D.+N.+Chinauthor=J.+Blankauthor=O.+Charlatauthor=H.+Chengauthor=A.+Cheungauthor=F.+Congauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Hoodauthor=V.+Tyagiauthor=M.+Xuauthor=B.+Zhangauthor=W.+Shao&title=%5B1%2C2%2C4%5Dtriazol-3-ylsulfanylmethyl%29-3-phenyl-%5B1%2C2%2C4%5Doxadiazoles%3A+antagonists+of+the+Wnt+pathway+that+inhibit+tankyrases+1+and+2+via+novel+adenosine+pocket+binding&doi=10.1021%2Fjm2011222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">[1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt Pathway That Inhibit Tankyrases 1 and 2 via Novel Adenosine Pocket Binding</span></div><div class="casAuthors">Shultz, Michael D.; Kirby, Christina A.; Stams, Travis; Chin, Donovan N.; Blank, Jutta; Charlat, Olga; Cheng, Hong; Cheung, Atwood; Cong, Feng; Feng, Yun; Fortin, Pascal D.; Hood, Tami; Tyagi, Viraj; Xu, Ming; Zhang, Bailin; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1127-1136</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt signaling pathway is crit. to the regulation of key cellular processes.  When deregulated, it has been shown to play a crucial role in the growth and progression of multiple human cancers.  The identification of small mol. modulators of Wnt signaling has proven challenging, largely due to the relative paucity of druggable nodes in this pathway.  Several recent publications have identified small mol. inhibitors of the Wnt pathway, and tankyrase (TNKS) inhibition has been demonstrated to antagonize Wnt signaling via axin stabilization.  Herein, we report the early hit assessment of a series of compds. previously reported to antagonize Wnt signaling.  We report the biophys., computational characterization, structure-activity relationship, and physicochem. properties of a novel series of ([1,2,4]-triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazole inhibitors of TNKS1 and 2.  Furthermore, a cocrystal structure of compd. 24 complexed to TNKS1 demonstrates an alternate binding mode for PARP family member proteins that does not involve interactions with the nicotinamide binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt6LM9w0WsSLVg90H21EOLACvtfcHk0lhcEerYbTmggg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVyisg%253D%253D&md5=bfa82a3296a7c620cd5a71eec07f4f75</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm2011222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011222%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShao%26aufirst%3DW.%26atitle%3D%255B1%252C2%252C4%255Dtriazol-3-ylsulfanylmethyl%2529-3-phenyl-%255B1%252C2%252C4%255Doxadiazoles%253A%2520antagonists%2520of%2520the%2520Wnt%2520pathway%2520that%2520inhibit%2520tankyrases%25201%2520and%25202%2520via%2520novel%2520adenosine%2520pocket%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1127%26epage%3D1136%26doi%3D10.1021%2Fjm2011222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lhsncXdm9DZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lhsncXdm9DZVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anumala, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazare, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of Tankyrase inhibitors by a hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10025</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10013-10025&author=U.+R.+Anumalaauthor=J.+Waalerauthor=Y.+Nkizinkikoauthor=A.+Ignatevauthor=K.+Lazarowauthor=P.+Lindemannauthor=P.+A.+Olsenauthor=S.+Murthyauthor=E.+Obajiauthor=A.+G.+Majougaauthor=S.+Leonovauthor=J.+P.+von+Kriesauthor=L.+Lehtioauthor=S.+Kraussauthor=M.+Nazare&title=Discovery+of+a+novel+series+of+Tankyrase+inhibitors+by+a+hybridization+approach&doi=10.1021%2Facs.jmedchem.7b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach</span></div><div class="casAuthors">Anumala, Upendra Rao; Waaler, Jo; Nkizinkiko, Yves; Ignatev, Alexander; Lazarow, Katina; Lindemann, Peter; Olsen, Petter Angell; Murthy, Sudarshan; Obaji, Ezeogo; Majouga, Alexander G.; Leonov, Sergey; von Kries, Jens Peter; Lehtioe, Lari; Krauss, Stefan; Nazare, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10013-10025</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-guided hybridization approach using two privileged substructures gave instant access to a new series of tankyrase inhibitors.  The identified inhibitor 16 (1-(trans-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)cyclobutyl)-2,3-dihydro-2-oxo-1H-benzimidazole-5-carbonitrile) displays high target affinity on tankyrase 1 and 2 with biochem. and cellular IC50 values of 29 nM, 6.3 nM and 19 nM, resp., and high selectivity toward other poly (ADP-ribose) polymerase enzymes.  The identified inhibitor shows a favorable in vitro ADME profile as well as good oral bioavailability in mice, rats, and dogs.  Crit. for the approach was the utilization of an appropriate linker between 1,2,4-triazole and benzimidazolone moieties, whereby a cyclobutyl linker displayed superior affinity compared to a cyclohexane and Ph linker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOvTL0NvY8bVg90H21EOLACvtfcHk0lhJ6gDPv89qGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ&md5=d6bf8c8d971a158cdddc7d1c84b5144c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00883%26sid%3Dliteratum%253Aachs%26aulast%3DAnumala%26aufirst%3DU.%2BR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DLazarow%26aufirst%3DK.%26aulast%3DLindemann%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DLeonov%26aufirst%3DS.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DNazare%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520Tankyrase%2520inhibitors%2520by%2520a%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10013%26epage%3D10025%26doi%3D10.1021%2Facs.jmedchem.7b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biechele, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span> <span> </span><span class="NLM_article-title">WIKI4, a novel inhibitor of tankyrase and Wnt/ss-catenin signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e50457</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0050457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1371%2Fjournal.pone.0050457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23227175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVygsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e50457&author=R.+G.+Jamesauthor=K.+C.+Davidsonauthor=K.+A.+Boschauthor=T.+L.+Biecheleauthor=N.+C.+Robinauthor=R.+J.+Taylorauthor=M.+B.+Majorauthor=N.+D.+Campauthor=K.+Fowlerauthor=T.+J.+Martinsauthor=R.+T.+Moon&title=WIKI4%2C+a+novel+inhibitor+of+tankyrase+and+Wnt%2Fss-catenin+signaling&doi=10.1371%2Fjournal.pone.0050457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">WIKI4, a novel inhibitor of Tankyrase and Wnt/β-catenin signaling</span></div><div class="casAuthors">James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Major, Michael B.; Camp, Nathan D.; Fowler, Kerry; Martins, Timothy J.; Moon, Randall T.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e50457</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway controls important cellular events during development and often contributes to disease when dysregulated.  Using high throughput screening we have identified a new small mol. inhibitor of Wnt/β-catenin signaling, WIKI4.  WIKI4 inhibits expression of β-catenin target genes and cellular responses to Wnt/β-catenin signaling in cancer cell lines as well as in human embryonic stem cells.  Furthermore, we demonstrate that WIKI4 mediates its effects on Wnt/β-catenin signaling by inhibiting the enzymic activity of TNKS2, a regulator of AXIN ubiquitylation and degrdn.  While TNKS has previously been shown to be the target of small mol. inhibitors of Wnt/β-catenin signaling, WIKI4 is structurally distinct from previously identified TNKS inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-vg3VMIiDnLVg90H21EOLACvtfcHk0lhJ6gDPv89qGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVygsr%252FO&md5=d8bdd1d89e91cadbd83b739b96ca88b2</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050457%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DR.%2BG.%26aulast%3DDavidson%26aufirst%3DK.%2BC.%26aulast%3DBosch%26aufirst%3DK.%2BA.%26aulast%3DBiechele%26aufirst%3DT.%2BL.%26aulast%3DRobin%26aufirst%3DN.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DMajor%26aufirst%3DM.%2BB.%26aulast%3DCamp%26aufirst%3DN.%2BD.%26aulast%3DFowler%26aufirst%3DK.%26aulast%3DMartins%26aufirst%3DT.%2BJ.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26atitle%3DWIKI4%252C%2520a%2520novel%2520inhibitor%2520of%2520tankyrase%2520and%2520Wnt%252Fss-catenin%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De50457%26doi%3D10.1371%2Fjournal.pone.0050457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liscio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asciutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellocchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llacuna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarulo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellicciari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaioni, E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2807</span>– <span class="NLM_lpage">2812</span>, <span class="refDoi"> DOI: 10.1021/jm401356t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401356t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2807-2812&author=P.+Liscioauthor=A.+Carottiauthor=S.+Asciuttiauthor=T.+Karlbergauthor=D.+Bellocchiauthor=L.+Llacunaauthor=A.+Macchiaruloauthor=S.+A.+Aaronsonauthor=H.+Schulerauthor=R.+Pellicciariauthor=E.+Camaioni&title=Design%2C+synthesis%2C+crystallographic+studies%2C+and+preliminary+biological+appraisal+of+new+substituted+triazolo%5B4%2C3-b%5Dpyridazin-8-amine+derivatives+as+tankyrase+inhibitors&doi=10.1021%2Fjm401356t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors</span></div><div class="casAuthors">Liscio, Paride; Carotti, Andrea; Asciutti, Stefania; Karlberg, Tobias; Bellocchi, Daniele; Llacuna, Laura; Macchiarulo, Antonio; Aaronson, Stuart A.; Schuler, Herwig; Pellicciari, Roberto; Camaioni, Emidio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2807-2812</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Searching for selective tankyrases (TNKSs) inhibitors, a new small series of 6,8-disubstituted triazolo[4,3-b]pyridazines has been synthesized and characterized biol.  Structure-based optimization of the starting hit compd. N-(4-chlorophenyl)-6-methyl[1,2,4]triazolo[4,3-b]pyridazin-8-amine (NNL) prompted the authors to the discovery of 4-(2-(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-ylamino)ethyl)phenol (I), a low nanomolar selective TNKSs inhibitor working as NAD isostere as ascertained by crystallog. anal.  Preliminary biol. data candidate this new class of derivs. as a powerful pharmacol. tools in the unraveling of TNKS implications in physiopathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTmQIcE86MErVg90H21EOLACvtfcHk0ljp1zXzmm6WnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKhtrs%253D&md5=bd398c0a7ae372ba54863263ff6a6593</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm401356t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401356t%26sid%3Dliteratum%253Aachs%26aulast%3DLiscio%26aufirst%3DP.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAsciutti%26aufirst%3DS.%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DBellocchi%26aufirst%3DD.%26aulast%3DLlacuna%26aufirst%3DL.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DSchuler%26aufirst%3DH.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DCamaioni%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%252C%2520crystallographic%2520studies%252C%2520and%2520preliminary%2520biological%2520appraisal%2520of%2520new%2520substituted%2520triazolo%255B4%252C3-b%255Dpyridazin-8-amine%2520derivatives%2520as%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2807%26epage%3D2812%26doi%3D10.1021%2Fjm401356t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duempelfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeckel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muelbaier, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly selective Tankyrase inhibitor displaying growth inhibition effects against a diverse range of tumor derived cell lines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5455</span>– <span class="NLM_lpage">5471</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5455-5471&author=D.+W.+Thomsonauthor=A.+J.+Wagnerauthor=M.+Bantscheffauthor=R.+E.+Bensonauthor=L.+Dittusauthor=B.+Duempelfeldauthor=G.+Drewesauthor=J.+Krauseauthor=J.+T.+Mooreauthor=K.+Muellerauthor=D.+Poeckelauthor=C.+Rauauthor=E.+Salzerauthor=L.+Shewchukauthor=C.+Hopfauthor=J.+G.+Emeryauthor=M.+Muelbaier&title=Discovery+of+a+highly+selective+Tankyrase+inhibitor+displaying+growth+inhibition+effects+against+a+diverse+range+of+tumor+derived+cell+lines&doi=10.1021%2Facs.jmedchem.7b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines</span></div><div class="casAuthors">Thomson, Douglas W.; Wagner, Anne J.; Bantscheff, Marcus; Benson, R. Edward; Dittus, Lars; Duempelfeld, Birgit; Drewes, Gerard; Krause, Jana; Moore, John T.; Mueller, Katrin; Poeckel, Daniel; Rau, Christina; Salzer, Elsa; Shewchuk, Lisa; Hopf, Carsten; Emery, John G.; Muelbaier, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5455-5471</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The availability of high quality probes for specific protein targets is fundamental to the investigation of their function and their validation as therapeutic targets.  The authors report the utilization of a dedicated chemoproteomic assay platform combining affinity enrichment technol. with high-resoln. protein mass spectrometry to the discovery of a novel nicotinamide isoster, the tetrazoloquinoxaline I, a highly potent and selective tankyrase inhibitor.  The authors also describe the use of I to investigate the biol. of tankyrase, revealing the compd. induced growth inhibition of a no. of tumor derived cell lines, demonstrating the potential of tankyrase inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwOPXRn1c-LVg90H21EOLACvtfcHk0ljp1zXzmm6WnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSksrc%253D&md5=d39fa9046ab072dbc592482769e0833c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00137%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBenson%26aufirst%3DR.%2BE.%26aulast%3DDittus%26aufirst%3DL.%26aulast%3DDuempelfeld%26aufirst%3DB.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKrause%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DMueller%26aufirst%3DK.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSalzer%26aufirst%3DE.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DMuelbaier%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520selective%2520Tankyrase%2520inhibitor%2520displaying%2520growth%2520inhibition%2520effects%2520against%2520a%2520diverse%2520range%2520of%2520tumor%2520derived%2520cell%2520lines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5455%26epage%3D5471%26doi%3D10.1021%2Facs.jmedchem.7b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span> <span> </span><span class="NLM_article-title">Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7049</span>– <span class="NLM_lpage">7059</span>, <span class="refDoi"> DOI: 10.1021/jm400826j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400826j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7049-7059&author=M.+D.+Shultzauthor=D.+Majumdarauthor=D.+N.+Chinauthor=P.+D.+Fortinauthor=Y.+Fengauthor=T.+Gouldauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=N.+J.+Watersauthor=W.+Shao&title=Structure-efficiency+relationship+of+%5B1%2C2%2C4%5Dtriazol-3-ylamines+as+novel+nicotinamide+isosteres+that+inhibit+tankyrases&doi=10.1021%2Fjm400826j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases</span></div><div class="casAuthors">Shultz, Michael D.; Majumdar, Dyuti; Chin, Donovan N.; Fortin, Pascal D.; Feng, Yun; Gould, Ty; Kirby, Christina A.; Stams, Travis; Waters, Nigel J.; Shao, Wenlin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7049-7059</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 are members of the poly(ADP-ribose) polymerase (PARP) family of enzymes that modulate Wnt pathway signaling.  While amide- and lactam-based nicotinamide mimetics that inhibit tankyrase activity, such as XAV939, are well-known, the discovery and evaluation of a novel nicotinamide isostere that demonstrates selectivity over other PARP family members is reprted.  The utilization of lipophilic efficiency-based structure-efficiency relationships (SER) to rapidly drive the evaluation of this series is demonstrated.  These efforts led to a series of selective, cell-active compds. with soly., physicochem., and in vitro properties suitable for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrevWmitTKelbVg90H21EOLACvtfcHk0libw40SW_E_fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7%252FL&md5=b9174e9070c813b598cf15b261de9471</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm400826j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400826j%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DShao%26aufirst%3DW.%26atitle%3DStructure-efficiency%2520relationship%2520of%2520%255B1%252C2%252C4%255Dtriazol-3-ylamines%2520as%2520novel%2520nicotinamide%2520isosteres%2520that%2520inhibit%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7049%26epage%3D7059%26doi%3D10.1021%2Fjm400826j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lhEi5jXNMpkpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada-Iwasaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span> <span> </span><span class="NLM_article-title">The discovery and characterization of K-756, a novel Wnt/beta-catenin pathway inhibitor targeting Tankyrase</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1534</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1535-7163.MCT-15-0938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27196752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1525-1534&author=R.+Okada-Iwasakiauthor=Y.+Takahashiauthor=Y.+Watanabeauthor=H.+Ishidaauthor=J.+Saitoauthor=R.+Nakaiauthor=A.+Asai&title=The+discovery+and+characterization+of+K-756%2C+a+novel+Wnt%2Fbeta-catenin+pathway+inhibitor+targeting+Tankyrase&doi=10.1158%2F1535-7163.MCT-15-0938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase</span></div><div class="casAuthors">Okada-Iwasaki, Ryoko; Takahashi, Yuichi; Watanabe, Yasuo; Ishida, Hiroshi; Saito, Jun-ichi; Nakai, Ryuichiro; Asai, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1525-1534</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Wnt/β-catenin pathway is a well-known oncogenic pathway.  Its suppression has long been considered as an important challenge in treating cancer patients.  Among colon cancer patients in particular, most patients carry an adenomatous polyposis coli (APC) mutation that leads to an aberration of Wnt/β-catenin pathway.  To discover the small mol. inhibitors of the Wnt/β-catenin pathway, we conducted high-throughput screening in APC-mutant colon cancer DLD-1 cells using a transcriptional reporter assay, which identified a selective Wnt/β-catenin pathway inhibitor, K-756.  K-756 stabilizes Axin and reduces active β-catenin, and inhibits the genes downstream of endogenous Wnt/β-catenin.  We subsequently identified that K-756 is a tankyrase (TNKS) inhibitor.  TNKS, which belongs to the PARP family, poly-ADP ribosylates Axin and promotes Axin degrdn. via the proteasome pathway.  K-756 binds to the induced pocket of TNKS and inhibits its enzyme activity.  Moreover, PARP family enzyme assays showed that K-756 is a selective TNKS inhibitor.  K-756 inhibited the cell growth of APC-mutant colorectal cancer COLO 320DM and SW403 cells by inhibiting the Wnt/β-catenin pathway.  An in vivo study showed that the oral administration of K-756 inhibited the Wnt/β-catenin pathway in colon cancer xenografts in mice.  To further explore the therapeutic potential of K-756, we also evaluated the effects of K-756 in non-small cell lung cancer cells.  Although a single treatment of K-756 did not induce antiproliferative activity, when K-756 was combined with an EGFR inhibitor (gefitinib), it showed a strong synergistic effect.  Therefore, K-756, a novel selective TNKS inhibitor, could be a leading compd. in the development of anticancer agents.  Mol Cancer Ther; 15(7); 1525-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpSTLQpJ57hbVg90H21EOLACvtfcHk0lhEi5jXNMpkpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrtbfM&md5=7fcb0eee155b92e654d83645661769aa</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0938%26sid%3Dliteratum%253Aachs%26aulast%3DOkada-Iwasaki%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DJ.%26aulast%3DNakai%26aufirst%3DR.%26aulast%3DAsai%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520and%2520characterization%2520of%2520K-756%252C%2520a%2520novel%2520Wnt%252Fbeta-catenin%2520pathway%2520inhibitor%2520targeting%2520Tankyrase%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1525%26epage%3D1534%26doi%3D10.1158%2F1535-7163.MCT-15-0938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatsugai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bbrc.2010.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20214890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1KisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2010&pages=569-573&author=Y.+Yashirodaauthor=R.+Okamotoauthor=K.+Hatsugaiauthor=Y.+Takemotoauthor=N.+Goshimaauthor=T.+Saitoauthor=M.+Hamamotoauthor=Y.+Sugimotoauthor=H.+Osadaauthor=H.+Seimiyaauthor=M.+Yoshida&title=A+novel+yeast+cell-based+screen+identifies+flavone+as+a+tankyrase+inhibitor&doi=10.1016%2Fj.bbrc.2010.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor</span></div><div class="casAuthors">Yashiroda, Yoko; Okamoto, Reika; Hatsugai, Kaori; Takemoto, Yasushi; Goshima, Naoki; Saito, Tamio; Hamamoto, Makiko; Sugimoto, Yoshikazu; Osada, Hiroyuki; Seimiya, Hiroyuki; Yoshida, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-573</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The telomere-assocd. protein tankyrase 1 is a poly(ADP-ribose) polymerase and is considered to be a promising target for cancer therapy, esp. for BRCA-assocd. cancers.  However, an efficient assay system for inhibitor screening has not been established, mainly due to the difficulty of efficient prepn. of the enzyme and its substrate.  Here, we report a cell-based assay system for detecting inhibitory activity against tankyrase 1.  We found that overexpression of the human tankyrase 1 gene causes a growth defect in the fission yeast Schizosaccharomyces pombe.  Chems. that restore the growth defect phenotype can be identified as potential tankyrase 1 inhibitors.  We performed a high-throughput screen using this system, and identified flavone as a compd. that restores the growth of yeast cells overexpressing tankyrase 1.  Indeed, flavone inhibited poly(ADP-ribosyl)ation of proteins caused by overexpression of tankyrase 1 in yeast cells.  This system allows rapid identification of inhibitory activity against tankyrase 1 and is amenable to high-throughput screening using robotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10crBBVUDnbVg90H21EOLACvtfcHk0lj_mKQx4QhC9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1KisrY%253D&md5=9e3dbf16bb77e5d90d7dc453abde7a47</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DR.%26aulast%3DHatsugai%26aufirst%3DK.%26aulast%3DTakemoto%26aufirst%3DY.%26aulast%3DGoshima%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DHamamoto%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DSeimiya%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DA%2520novel%2520yeast%2520cell-based%2520screen%2520identifies%2520flavone%2520as%2520a%2520tankyrase%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D394%26spage%3D569%26epage%3D573%26doi%3D10.1016%2Fj.bbrc.2010.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Homogeneous screening assay for human tankyrase</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1177/1087057112436558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1177%2F1087057112436558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22357873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=593-604&author=M.+Narwalauthor=A.+Fallareroauthor=P.+Vuorelaauthor=L.+Lehtio&title=Homogeneous+screening+assay+for+human+tankyrase&doi=10.1177%2F1087057112436558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous screening assay for human tankyrase</span></div><div class="casAuthors">Narwal, Mohit; Fallarero, Adyary; Vuorela, Pia; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-604</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Tankyrase, a member of human PARP protein super-family, catalyzes a covalent post-translational modification of substrate proteins.  This modification, poly(ADP-ribos)ylation, leads to changes in protein interactions and modifies downstream signaling events.  Tankyrase 1 is a potential drug target due to its functions in telomere homeostasis and in Wnt signaling.  We describe here optimization and application of an activity-based homogenous assay for tankyrase inhibitors in a high-throughput screening format.  The method measures the consumption of substrate by the chem. conversion of the remaining NAD+ into a stable fluorescent condensation product.  Conditions were optimized to measure the enzymic auto-modification of a recombinant catalytic fragment of tankyrase 1.  The fluorescence assay is inexpensive, operationally easy and performs well according to the statistical anal. (Z'= 0.7).  A validatory screen with a natural product library confirmed suitability of the assay for finding new tankyrase inhibitors.  Flavone was the most potent (IC50=325 nM) hit from the natural compds.  A flavone deriv., apigenin, and iso-Pr gallate showed potency on the micromolar range, but displayed over 30-fold selectivity for tankyrase over the studied isoenzymes PARP1 and PARP2.  The assay is robust and will be useful for screening new tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAQgc8t_53rVg90H21EOLACvtfcHk0lh-PWsxbWzOTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D&md5=e5736a4723ceff0fe1fc072ab9bac977</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1177%2F1087057112436558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112436558%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DHomogeneous%2520screening%2520assay%2520for%2520human%2520tankyrase%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D593%26epage%3D604%26doi%3D10.1177%2F1087057112436558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Screening and structural analysis of flavones inhibiting tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/jm3018783</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3018783" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls12ktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3507-3517&author=M.+Narwalauthor=T.+Haikarainenauthor=A.+Fallareroauthor=P.+M.+Vuorelaauthor=L.+Lehtio&title=Screening+and+structural+analysis+of+flavones+inhibiting+tankyrases&doi=10.1021%2Fjm3018783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and Structural Analysis of Flavones Inhibiting Tankyrases</span></div><div class="casAuthors">Narwal, Mohit; Haikarainen, Teemu; Fallarero, Adyary; Vuorela, Pia M.; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3507-3517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flavonoids are known for their beneficial effects on human health, and therefore the therapeutic potential of these compds. have been extensively studied.  Flavone has been previously identified as a tankyrase inhibitor, and to further elucidate whether tankyrases would be inhibited by other flavonoids, the authors performed a systematic screening of tankyrase 2 inhibitory activity using 500 natural and naturally derived flavonoids covering nine different flavonoid classes.  All identified tankyrase inhibitors were flavones.  The authors report crystal structures of all the hit compds. in complex with the catalytic domain of human tankyrase 2.  Flavone derivs. in all 10 crystal structures bind to the nicotinamide binding site of tankyrase 2.  Potencies of the active flavones toward tankyrases vary between 50 nM and 1.1 μM, and flavones show up to 200-fold selectivity for tankyrases over ARTD1.  The mol. details of the interactions revealed by cocrystal structures efficiently describe the properties of potent flavone derivs. inhibiting tankyrases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok3ooeOpXbt7Vg90H21EOLACvtfcHk0ljP6gnmpJOkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls12ktLc%253D&md5=e27db99eeecde2bd3a4ff9fb03e10024</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm3018783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3018783%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%2BM.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DScreening%2520and%2520structural%2520analysis%2520of%2520flavones%2520inhibiting%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3507%26epage%3D3517%26doi%3D10.1021%2Fjm3018783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legala, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensuu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7880</span>– <span class="NLM_lpage">7889</span>, <span class="refDoi"> DOI: 10.1021/jm401463y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401463y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFals7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7880-7889&author=M.+Narwalauthor=J.+Koivunenauthor=T.+Haikarainenauthor=E.+Obajiauthor=O.+E.+Legalaauthor=H.+Venkannagariauthor=P.+Joensuuauthor=T.+Pihlajaniemiauthor=L.+Lehtio&title=Discovery+of+tankyrase+inhibiting+flavones+with+increased+potency+and+isoenzyme+selectivity&doi=10.1021%2Fjm401463y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tankyrase Inhibiting Flavones with Increased Potency and Isoenzyme Selectivity</span></div><div class="casAuthors">Narwal, Mohit; Koivunen, Jarkko; Haikarainen, Teemu; Obaji, Ezeogo; Legala, Ongey E.; Venkannagari, Harikanth; Joensuu, Paivi; Pihlajaniemi, Taina; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7880-7889</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer.  Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivs.  Com. available flavones with single substitutions were used for structure-activity relation studies, and cocrystal structures of the 18 hit compds. were analyzed to explain their potency and selectivity.  The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling.  To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases.  The most effective compd.(I; MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.  This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPfQ4Kazcx4LVg90H21EOLACvtfcHk0ljP6gnmpJOkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFals7%252FM&md5=4f4e2021caf3334462fe597e9e24095b</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm401463y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401463y%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DLegala%26aufirst%3DO.%2BE.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DJoensuu%26aufirst%3DP.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520tankyrase%2520inhibiting%2520flavones%2520with%2520increased%2520potency%2520and%2520isoenzyme%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7880%26epage%3D7889%26doi%3D10.1021%2Fjm401463y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Then, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panicker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Fragment-based ligand design of novel potent inhibitors of tankyrases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4497</span>– <span class="NLM_lpage">4508</span>, <span class="refDoi"> DOI: 10.1021/jm400211f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400211f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFartr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4497-4508&author=E.+A.+Larssonauthor=A.+Janssonauthor=F.+M.+Ngauthor=S.+W.+Thenauthor=R.+Panickerauthor=B.+Liuauthor=K.+Sangthongpitagauthor=V.+Pendharkarauthor=S.+J.+Taiauthor=J.+Hillauthor=C.+Danauthor=S.+Y.+Hoauthor=W.+W.+Cheongauthor=A.+Poulsenauthor=S.+Blanchardauthor=G.+R.+Linauthor=J.+Alamauthor=T.+H.+Kellerauthor=P.+Nordlund&title=Fragment-based+ligand+design+of+novel+potent+inhibitors+of+tankyrases&doi=10.1021%2Fjm400211f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based ligand design of novel potent inhibitors of tankyrases</span></div><div class="casAuthors">Larsson, E. Andreas; Jansson, Anna; Ng, Fui Mee; Then, Siew Wen; Panicker, Resmi; Liu, Boping; Sangthongpitag, Kanda; Pendharkar, Vishal; Tai, Shi Jing; Hill, Jeffrey; Dan, Chen; Ho, Soo Yei; Cheong, Wei Wen; Poulsen, Anders; Blanchard, Stephanie; Lin, Grace Ruiting; Alam, Jenefer; Keller, Thomas H.; Nordlund, Par</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4497-4508</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases constitute potential drug targets for cancer and myelin-degrading diseases.  We have applied a structure- and biophysics-driven fragment-based ligand design strategy to discover a novel family of potent inhibitors for human tankyrases.  Biophys. screening based on a thermal shift assay identified highly efficient fragments binding in the nicotinamide-binding site, a local hot spot for fragment binding.  Evolution of the fragment hit 4-methyl-1,2-dihydroquinolin-2-one (2) along its 7-vector yields dramatic affinity improvements in the first cycle of expansion.  A crystal structure of 7-(2-fluorophenyl)-4-methylquinolin-2(1H)-one (11) reveals that the nonplanar compd. extends with its fluorine atom into a pocket, which coincides with a region of the active site where structural differences are seen between tankyrases and other poly(ADP-ribose) polymerase (PARP) family members.  A further cycle of optimization yielded compds. with affinities and IC50 values in the low nanomolar range and with good soly., PARP selectivity, and ligand efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxampX4n-xLVg90H21EOLACvtfcHk0lhcT4jnwy1KoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFartr4%253D&md5=4cd39f8715bfc51807129bb04da1e6f0</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm400211f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400211f%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DF.%2BM.%26aulast%3DThen%26aufirst%3DS.%2BW.%26aulast%3DPanicker%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DS.%2BY.%26aulast%3DCheong%26aufirst%3DW.%2BW.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DG.%2BR.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DFragment-based%2520ligand%2520design%2520of%2520novel%2520potent%2520inhibitors%2520of%2520tankyrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4497%26epage%3D4508%26doi%3D10.1021%2Fjm400211f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Vicente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design of novel pyranopyridones as cell active and orally bioavailable Tankyrase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1024</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00251</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00251" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1019-1024&author=J.+de+Vicenteauthor=P.+Tivitmahaisoonauthor=P.+Berryauthor=D.+R.+Bolinauthor=D.+Carvajalauthor=W.+Heauthor=K.+S.+Huangauthor=C.+Jansonauthor=L.+Liangauthor=C.+Lukacsauthor=A.+Petersenauthor=H.+Qianauthor=L.+Yiauthor=Y.+Zhuangauthor=J.+C.+Hermann&title=Fragment-based+drug+design+of+novel+pyranopyridones+as+cell+active+and+orally+bioavailable+Tankyrase+inhibitors&doi=10.1021%2Facsmedchemlett.5b00251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">de Vicente, Javier; Tivitmahaisoon, Parcharee; Berry, Pamela; Bolin, David R.; Carvajal, Daisy; He, Wei; Huang, Kuo-Sen; Janson, Cheryl; Liang, Lena; Lukacs, Christine; Petersen, Ann; Qian, Hong; Yi, Lin; Zhuang, Yong; Hermann, Johannes C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1019-1024</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase activity has been linked to the regulation of intracellular axin levels, which have been shown to be crucial for the Wnt pathway.  Deregulated Wnt signaling is important for the genesis of many diseases including cancer.  The authors describe herein the discovery and development of a new series of tankyrase inhibitors.  These pyranopyridones are highly active in various cell-based assays.  A fragment/structure based optimization strategy led to a compd. with good pharmacokinetic properties that is suitable for in vivo studies and further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr89-Awr3wTrrVg90H21EOLACvtfcHk0lhcT4jnwy1KoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqsL3L&md5=6b1d805d04727286bc324e6f1f99e691</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00251%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DBolin%26aufirst%3DD.%2BR.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DK.%2BS.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DL.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26atitle%3DFragment-based%2520drug%2520design%2520of%2520novel%2520pyranopyridones%2520as%2520cell%2520active%2520and%2520orally%2520bioavailable%2520Tankyrase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1019%26epage%3D1024%26doi%3D10.1021%2Facsmedchemlett.5b00251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Roche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyvonen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span> <span> </span><span class="NLM_article-title">Macrocyclized extended peptides: inhibiting the substrate-recognition domain of Tankyrase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2256</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b10234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b10234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=2245-2256&author=W.+Xuauthor=Y.+H.+Lauauthor=G.+Fischerauthor=Y.+S.+Tanauthor=A.+Chattopadhyayauthor=M.+de+la+Rocheauthor=M.+Hyvonenauthor=C.+Vermaauthor=D.+R.+Springauthor=L.+S.+Itzhaki&title=Macrocyclized+extended+peptides%3A+inhibiting+the+substrate-recognition+domain+of+Tankyrase&doi=10.1021%2Fjacs.6b10234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase</span></div><div class="casAuthors">Xu, Wenshu; Lau, Yu Heng; Fischer, Gerhard; Tan, Yaw Sing; Chattopadhyay, Anasuya; de la Roche, Marc; Hyvonen, Marko; Verma, Chandra; Spring, David R.; Itzhaki, Laura S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2245-2256</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a double-click macrocyclization approach for the design of constrained peptide inhibitors having non-helical or extended conformations.  Our targets are the tankyrase proteins (TNKS), poly(ADP-ribose) polymerases (PARP) that regulate Wnt signaling by targeting Axin for degrdn.  TNKS are deregulated in many different cancer types, and inhibition of TNKS therefore represents an attractive therapeutic strategy.  However, clin. development of TNKS-specific PARP catalytic inhibitors is challenging due to off-target effects and cellular toxicity.  We instead targeted the substrate-recognition domain of TNKS, as it is unique among PARP family members.  We employed a two-component strategy, allowing peptide and linker to be sep. engineered and then assembled in a combinatorial fashion via click chem.  Using the consensus substrate-peptide sequence as a starting point, we optimized the length and rigidity of the linker and its position along the peptide.  Optimization was further guided by high-resoln. crystal structures of two of the macrocyclized peptides in complex with TNKS.  This approach led to macrocyclized peptides with submicromolar affinities for TNKS and high proteolytic stability that are able to disrupt the interaction between TNKS and Axin substrate and to inhibit Wnt signaling in a dose-dependent manner.  The peptides therefore represent a promising starting point for a new class of substrate-competitive inhibitors of TNKS with potential for suppressing Wnt signaling in cancer.  Moreover, by demonstrating the application of the double-click macrocyclization approach to non-helical, extended, or irregularly structured peptides, we greatly extend its potential and scope, esp. given the frequency with which such motifs mediate protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF7lE97s7FALVg90H21EOLACvtfcHk0lg2v8_WEJ20rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKjtbs%253D&md5=7997fc39b425f6862bd208ba35b37c7f</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b10234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b10234%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DY.%2BS.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3Dde%2Bla%2BRoche%26aufirst%3DM.%26aulast%3DHyvonen%26aufirst%3DM.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26atitle%3DMacrocyclized%2520extended%2520peptides%253A%2520inhibiting%2520the%2520substrate-recognition%2520domain%2520of%2520Tankyrase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D2245%26epage%3D2256%26doi%3D10.1021%2Fjacs.6b10234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2018.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30472184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2019&pages=80-90&author=H.+Chengauthor=X.+Liauthor=C.+Wangauthor=Y.+Chenauthor=S.+Liauthor=J.+Tanauthor=B.+Tanauthor=Y.+He&title=Inhibition+of+tankyrase+by+a+novel+small+molecule+significantly+attenuates+prostate+cancer+cell+proliferation&doi=10.1016%2Fj.canlet.2018.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation</span></div><div class="casAuthors">Cheng, Honglin; Li, Xin; Wang, Chuanlin; Chen, Yujie; Li, Sijiang; Tan, Jincai; Tan, Bing; He, Yunfeng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80-90</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a crucial mediator of Wnt signal transduction and has been recognized as a novel mol. target for Wnt-pathway dependent cancer.  TNKS is stabilized by the ubiquitin-specific protease 25 (USP25).  The effect of disruption of the interaction between TNKS and USP25 by small mols. on prostate cancer proliferation is unknown.  This study conducted a hierarchical virtual screening with more than 200,000 compds. on the characterized structures of the USP25/TNKS-ARC5 protein complex.  In silico anal. and in vitro validation revealed that a small mol., called C44, binds to the protein-protein interaction (PPI) interface of TNKS and USP25.  This show that C44 disrupts the interaction between TNKS and USP25 leading to a higher half-life of AXIN and the breakdown of <beta>-catenin protein.  It also show that the selective inhibition of the TNKS-USP25 interaction by C44 significantly reduces proliferation of prostate cancer cells in vitro and in vivo.  Our study reveals a new PPI inhibitor that lowers the stability of TNKS protein and inhibits Wnt pathway signaling.  C44 is a promising new drug for the treatment of Wnt-pathway dependent prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEO5Jl9KTRLVg90H21EOLACvtfcHk0lg2v8_WEJ20rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyktr3L&md5=bf474dd36db235d575c9807dc6336c1f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520tankyrase%2520by%2520a%2520novel%2520small%2520molecule%2520significantly%2520attenuates%2520prostate%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D443%26spage%3D80%26epage%3D90%26doi%3D10.1016%2Fj.canlet.2018.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waltzer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienz, M.</span></span> <span> </span><span class="NLM_article-title">Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1038/26785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F26785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=9774110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1cXms1aks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=1998&pages=521-525&author=L.+Waltzerauthor=M.+Bienz&title=Drosophila+CBP+represses+the+transcription+factor+TCF+to+antagonize+Wingless+signalling&doi=10.1038%2F26785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Drosophila CBP represses the transcription factor TCF to antagonize Wingless signaling</span></div><div class="casAuthors">Waltzer, Lucas; Bienz, Mariann</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">6701</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">T-cell factor (TCF), a high-mobility-group domain protein, is the transcription factor activated by Wnt/Wingless signalling.  When signalling occurs, TCF binds to its coactivator, beta-catenin/Armadillo, and stimulates the transcription of the target genes of Wnt/Wingless by binding to TCF-responsive enhancers.  Inappropriate activation of TCF in the colon epithelium and other cells leads to cancer.  It is therefore desirable for unstimulated cells to have a neg. control mechanism to keep TCF inactive.  Here we report that Drosophila CREB-binding protein (dCBP) binds to dTCF.  DCBP mutants show mild Wingless overactivation phenotypes in various tissues.  Consistent with this, dCBP loss-of-function suppresses the effects of armadillo mutation.  Moreover, our data show that dCBP acetylates a conserved lysine in the Armadillo-binding domain of dTCF, and that this acetylation lowers the affinity of Armadillo binding to dTCF.  Although CBP is a coactivator of other transcription factors, our data show that CBP represses TCF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70BOPMN0p-bVg90H21EOLACvtfcHk0lg2v8_WEJ20rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1aks7s%253D&md5=4532698946afd3e4ac10b994432b7548</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2F26785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F26785%26sid%3Dliteratum%253Aachs%26aulast%3DWaltzer%26aufirst%3DL.%26aulast%3DBienz%26aufirst%3DM.%26atitle%3DDrosophila%2520CBP%2520represses%2520the%2520transcription%2520factor%2520TCF%2520to%2520antagonize%2520Wingless%2520signalling%26jtitle%3DNature%26date%3D1998%26volume%3D395%26spage%3D521%26epage%3D525%26doi%3D10.1038%2F26785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, M. V.</span></span> <span> </span><span class="NLM_article-title">Drug discovery approaches to target Wnt signaling in cancer stem cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.18632%2Foncotarget.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21317452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ovFaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=563-577&author=J.+C.+Curtinauthor=M.+V.+Lorenzi&title=Drug+discovery+approaches+to+target+Wnt+signaling+in+cancer+stem+cells&doi=10.18632%2Foncotarget.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery approaches to target Wnt signaling in cancer stem cells</span></div><div class="casAuthors">Curtin Joshua C; Lorenzi Matthew V</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">563-577</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer stem cells (CSCs) represent a unique subset of cells within a tumor that possess self-renewal capacity and pluripotency, and can drive tumor initiation and maintenance.  First identified in hematological malignancies, CSCs are now thought to play an important role in a wide variety of solid tumors such as NSCLC, breast and colorectal cancer.  The role of CSCs in driving tumor formation illustrates the dysregulation of differentiation in tumorigenesis.  The Wnt, Notch and Hedgehog (HH) pathways are developmental pathways that are commonly activated in many types of cancer.  While substantial progress has been made in developing therapeutics targeting Notch and HH, the Wnt pathway has remained an elusive therapeutic target.  This review will focus on the clinical relevance of the Wnt pathway in CSCs and tumor cell biology, as well as points of therapeutic intervention and recent advances in targeting Wnt/β-catenin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFBfpnQKj7OdTiMd2aNQVUfW6udTcc2ebWnVZCKRhsW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ovFaluw%253D%253D&md5=4aa4638b4a1ef0976793623acb8c5fa6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.191%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DJ.%2BC.%26aulast%3DLorenzi%26aufirst%3DM.%2BV.%26atitle%3DDrug%2520discovery%2520approaches%2520to%2520target%2520Wnt%2520signaling%2520in%2520cancer%2520stem%2520cells%26jtitle%3DOncotarget%26date%3D2010%26volume%3D1%26spage%3D563%26epage%3D577%26doi%3D10.18632%2Foncotarget.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span> <span> </span><span class="NLM_article-title">Is beta-catenin a druggable target for cancer therapy?</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2018.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.tibs.2018.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30056837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Sjs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=623-634&author=C.+Cuiauthor=X.+Zhouauthor=W.+Zhangauthor=Y.+Quauthor=X.+Ke&title=Is+beta-catenin+a+druggable+target+for+cancer+therapy%3F&doi=10.1016%2Fj.tibs.2018.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Is β-Catenin a Druggable Target for Cancer Therapy?</span></div><div class="casAuthors">Cui, Can; Zhou, Xianglian; Zhang, Weidong; Qu, Yi; Ke, Xisong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">623-634</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mutations of canonical Wnt signaling pathway genes frequently occur in cancer and lead to abnormal accumulation of the key effector β-catenin.  Over the past decades, a no. of Wnt inhibitors have been identified through high-throughput screenings, however, very few of them target β-catenin directly, raising questions regarding its druggability.  Here, we review Wnt inhibitors with a focus on small mols. that directly bind β-catenin, discuss the druggability of β-catenin, and why it has rarely been targeted, esp. in the cellular context.  We also propose strategies to develop small mol. binding and depleting cellular β-catenin, which are generally applicable to other difficult-to-drug or yet-to-be-drugged targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrL5XRxhPzrVg90H21EOLACvtfcHk0lg57aj_gOd7Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Sjs7vI&md5=55c9d706caee90039aae17a2c8bdb3e0</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2018.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2018.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DX.%26atitle%3DIs%2520beta-catenin%2520a%2520druggable%2520target%2520for%2520cancer%2520therapy%253F%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2018%26volume%3D43%26spage%3D623%26epage%3D634%26doi%3D10.1016%2Fj.tibs.2018.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemaru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a full-length beta-catenin</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1016/j.str.2007.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.str.2007.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18334222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVKjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=478-487&author=Y.+Xingauthor=K.+Takemaruauthor=J.+Liuauthor=J.+D.+Berndtauthor=J.+J.+Zhengauthor=R.+T.+Moonauthor=W.+Xu&title=Crystal+structure+of+a+full-length+beta-catenin&doi=10.1016%2Fj.str.2007.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Full-Length β-Catenin</span></div><div class="casAuthors">Xing, Yi; Takemaru, Ken-Ichi; Liu, Jing; Berndt, Jason D.; Zheng, Jie J.; Moon, Randall T.; Xu, Wenqing</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">478-487</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">β-Catenin plays essential roles in cell adhesion and Wnt signaling, while deregulation of β-catenin is assocd. with multiple diseases including cancers.  Here, we report the crystal structures of full-length zebrafish β-catenin and a human β-catenin fragment that contains both the armadillo repeat and the C-terminal domains.  Our structures reveal that the N-terminal region of the C-terminal domain, a key component of the C-terminal transactivation domain, forms a long α helix that packs on the C-terminal end of the armadillo repeat domain, and thus forms part of the β-catenin superhelical core.  The existence of this helix redefines our view of interactions of β-catenin with some of its crit. partners, including ICAT and Chibby, which may form extensive interactions with this C-terminal domain α helix.  Our crystallog. and NMR studies also suggest that the unstructured N-terminal and C-terminal tails interact with the ordered armadillo repeat domain in a dynamic and variable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrW7RJCw0FLVg90H21EOLACvtfcHk0lg57aj_gOd7Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVKjs7k%253D&md5=4fb8e4ebe99b4fe121817b2a8ae7b231</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DTakemaru%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBerndt%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520full-length%2520beta-catenin%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D478%26epage%3D487%26doi%3D10.1016%2Fj.str.2007.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0lh_kX_58HnMyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trosset, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundstrom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/prot.20955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fprot.20955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16568448" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=60-67&author=J.+Y.+Trossetauthor=C.+Dalvitauthor=S.+Knappauthor=M.+Fasoliniauthor=M.+Veronesiauthor=S.+Manteganiauthor=L.+M.+Gianelliniauthor=C.+Catanaauthor=M.+Sundstromauthor=P.+F.+Stoutenauthor=J.+K.+Moll&title=Inhibition+of+protein-protein+interactions%3A+the+discovery+of+druglike+beta-catenin+inhibitors+by+combining+virtual+and+biophysical+screening&doi=10.1002%2Fprot.20955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fprot.20955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20955%26sid%3Dliteratum%253Aachs%26aulast%3DTrosset%26aufirst%3DJ.%2BY.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DGianellini%26aufirst%3DL.%2BM.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DStouten%26aufirst%3DP.%2BF.%26aulast%3DMoll%26aufirst%3DJ.%2BK.%26atitle%3DInhibition%2520of%2520protein-protein%2520interactions%253A%2520the%2520discovery%2520of%2520druglike%2520beta-catenin%2520inhibitors%2520by%2520combining%2520virtual%2520and%2520biophysical%2520screening%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2006%26volume%3D64%26spage%3D60%26epage%3D67%26doi%3D10.1002%2Fprot.20955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors for beta-catenin/T-cell factor protein-protein interactions by bioisostere replacement</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/cb300564v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300564v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslKq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=524-529&author=B.+Yuauthor=Z.+Huangauthor=M.+Zhangauthor=D.+R.+Dillardauthor=H.+Ji&title=Rational+design+of+small-molecule+inhibitors+for+beta-catenin%2FT-cell+factor+protein-protein+interactions+by+bioisostere+replacement&doi=10.1021%2Fcb300564v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein-Protein Interactions by Bioisostere Replacement</span></div><div class="casAuthors">Yu, Binxun; Huang, Zheng; Zhang, Min; Dillard, Darren R.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">524-529</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new hot spot-based design strategy using bioisostere replacement is reported to rationally design nonpeptidic small-mol. inhibitors for protein-protein interactions.  This method is applied to design new potent inhibitors for β-catenin/T-cell factor (Tcf) interactions.  Three hot spot regions of Tcf for binding to β-catenin were quant. evaluated; the key binding elements around K435 and K508 of β-catenin were derived; a bioisostere library was used to generate new fragments that can match the proposed crit. binding elements.  The most potent inhibitor, with a mol. wt. of 230, has a Kd of 0.531 μM for binding to β-catenin and a Ki of 3.14 μM to completely disrupt β-catenin/Tcf interactions.  The binding mode of the designed inhibitors was validated by the site-directed mutagenesis and structure-activity relationship (SAR) studies.  This study provides a new approach to design new small-mol. inhibitors that bind to β-catenin and effectively disrupt β-catenin/Tcf interactions specific for canonical Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9WgJGihEBbVg90H21EOLACvtfcHk0lghhOtpD6Qp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslKq&md5=631c9dd6d7f87f92758b73af74e5dbdb</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fcb300564v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300564v%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDillard%26aufirst%3DD.%2BR.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520for%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%2520by%2520bioisostere%2520replacement%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D524%26epage%3D529%26doi%3D10.1021%2Fcb300564v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsakhyan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt beta-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1021/cb400795x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400795x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=193-201&author=Z.+Huangauthor=M.+Zhangauthor=S.+D.+Burtonauthor=L.+N.+Katsakhyanauthor=H.+Ji&title=Targeting+the+Tcf4+G13ANDE17+binding+site+to+selectively+disrupt+beta-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fcb400795x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein-Protein Interactions</span></div><div class="casAuthors">Huang, Zheng; Zhang, Min; Burton, Shawn D.; Katsakhyan, Levon N.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective disruption of protein-protein interactions by small mols. is important for probing the structure and dynamic aspects of cellular network.  It can also provide new therapeutic targets. β-Catenin of the canonical Wnt signaling pathway uses the same pos. charged groove to bind with T-cell factor (Tcf), cadherin, and adenomatous polysis coli (APC).  The extravagant formation of β-catenin/Tcf interactions drives the initiation and progression of many cancers and fibroses, while β-catenin/cadherin and β-catenin/APC interactions are essential for cell-cell adhesion and β-catenin degrdn.  In this study, a selective binding site that can differentiate β-catenin/Tcf, β-catenin/cadherin, and β-catenin/APC interactions was identified by alanine scanning and biochem. assays.  A new peptidomimetic strategy that incorporates SiteMap and multiple-copy simultaneous search was used to design selective small-mol. inhibitors for β-catenin/Tcf interactions.  A potent inhibitor was discovered to bind with β-catenin and completely disrupt β-catenin/Tcf interactions.  It also exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC interactions in both biochem. and cell-based assays.  This study provides a proof of concept for designing selective inhibitors for β-catenin/Tcf interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNcaw5jsvhZbVg90H21EOLACvtfcHk0lghhOtpD6Qp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN&md5=9f59f92f44e5b6cd486d351bd0bf77c6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fcb400795x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400795x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DS.%2BD.%26aulast%3DKatsakhyan%26aufirst%3DL.%2BN.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520Tcf4%2520G13ANDE17%2520binding%2520site%2520to%2520selectively%2520disrupt%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D193%26epage%3D201%26doi%3D10.1021%2Fcb400795x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Optimization of peptidomimetics as selective inhibitors for the beta-catenin/T-cell factor protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3617</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00147</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00147" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFentb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3617-3635&author=Z.+Wangauthor=M.+Zhangauthor=J.+Wangauthor=H.+Ji&title=Optimization+of+peptidomimetics+as+selective+inhibitors+for+the+beta-catenin%2FT-cell+factor+protein-protein+interaction&doi=10.1021%2Facs.jmedchem.9b00147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction</span></div><div class="casAuthors">Wang, Zhen; Zhang, Min; Wang, Jin; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3617-3635</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-catenin/T-cell factor (Tcf) protein-protein interaction (PPI) plays a crit. role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses.  Based on compd. 1, which was designed to target the Tcf4 G13ANDE17 binding site of β-catenin, extensive structure-activity relationship studies have been conducted.  As a result, compds. 53 and 57 were found to disrupt the β-catenin/Tcf PPI with the Ki values of 0.64 and 0.44 μM, resp., and exhibit good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/adenomatous polyposis coli (APC) PPIs.  The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assays revealed that 56, the Et ester of 53, was more potent than 53 in inhibiting viability of most of the Wnt/β-catenin hyperactive cancer cells.  Further cell-based studies indicated that 56 disrupted the β-catenin/Tcf PPI without affecting the β-catenin/E-cadherin and β-catenin/APC PPIs, suppressed transactivation of Wnt/β-catenin signaling in dose-dependent manners, and inhibited migration and invasiveness of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQ02RIKeK5LVg90H21EOLACvtfcHk0lhMOaXDGfu4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFentb8%253D&md5=8b4a19745fe5ae7561093523b07681a6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00147%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DOptimization%2520of%2520peptidomimetics%2520as%2520selective%2520inhibitors%2520for%2520the%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3617%26epage%3D3635%26doi%3D10.1021%2Facs.jmedchem.9b00147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of oncogenic Wnt signaling through direct targeting of beta-catenin</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17942</span>– <span class="NLM_lpage">17947</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208396109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1208396109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23071338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17942-17947&author=T.+N.+Grossmannauthor=J.+T.+Yehauthor=B.+R.+Bowmanauthor=Q.+Chuauthor=R.+E.+Moelleringauthor=G.+L.+Verdine&title=Inhibition+of+oncogenic+Wnt+signaling+through+direct+targeting+of+beta-catenin&doi=10.1073%2Fpnas.1208396109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span></div><div class="casAuthors">Grossmann, Tom N.; Yeh, Johannes T.-H.; Bowman, Brian R.; Chu, Qian; Moellering, Raymond E.; Verdine, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17942-17947, S17942/1-S17942/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of signaling by the Wnt pathway is strongly implicated in the onset and progression of numerous types of cancer.  Owing to the persistent dependence of these tumors on Wnt signaling for growth and survival, inhibition of this pathway is considered an attractive mechanism-based therapeutic approach.  Oncogenic activation of Wnt signaling can ensue from a variety of distinct aberrations in the signaling pathway, but most share the common feature of causing increased cellular levels of β-catenin by interfering with its constitutive degrdn.  β-Catenin serves as a central hub in Wnt signaling by engaging in crucial protein-protein interactions with both neg. and pos. effectors of the pathway.  Direct interference with these protein-protein interactions is a biol. compelling approach toward suppression of β-catenin hyperactivity, but such interactions have proven intransigent with respect to small-mol. targeting.  Hence β-catenin remains an elusive target for translational cancer therapy.  Here the authors report the discovery of a hydrocarbon-stapled peptide that directly targets β-catenin and interferes with its ability to serve as a transcriptional coactivator for T-cell factor (TCF) proteins, the downstream transcriptional regulators of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD9Q6Y8-IAI7Vg90H21EOLACvtfcHk0lhMOaXDGfu4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI&md5=3f2fc0f4f616ef057317639fe7c465c6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208396109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208396109%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DYeh%26aufirst%3DJ.%2BT.%26aulast%3DBowman%26aufirst%3DB.%2BR.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DInhibition%2520of%2520oncogenic%2520Wnt%2520signaling%2520through%2520direct%2520targeting%2520of%2520beta-catenin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17942%26epage%3D17947%26doi%3D10.1073%2Fpnas.1208396109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bange, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schade, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Cell permeable stapled peptide inhibitor of Wnt signaling that targets beta-catenin protein-protein interactions</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.chembiol.2017.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28757184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=958-968&author=L.+Dietrichauthor=B.+Rathmerauthor=K.+Ewanauthor=T.+Bangeauthor=S.+Heinrichsauthor=T.+C.+Daleauthor=D.+Schadeauthor=T.+N.+Grossmann&title=Cell+permeable+stapled+peptide+inhibitor+of+Wnt+signaling+that+targets+beta-catenin+protein-protein+interactions&doi=10.1016%2Fj.chembiol.2017.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeable stapled peptide inhibitor of wnt signaling that targets β-catenin protein-protein interactions</span></div><div class="casAuthors">Dietrich, Laura; Rathmer, Bernd; Ewan, Kenneth; Bange, Tanja; Heinrichs, Stefan; Dale, Trevor C.; Schade, Dennis; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">958-968.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a crit. role in cell proliferation and differentiation, thus it is often assocd. with diseases such as cancers.  Unfortunately, although attractive, developing anti-cancer strategy targeting Wnt signaling has been challenging given that the most attractive targets are involved in protein-protein interactions (PPIs).  Here, we develop a stapled peptide inhibitor that targets the interaction between β-catenin and T cell factor/lymphoid enhancer-binding factor transcription factors, which are crucially involved in Wnt signaling.  Our integrative approach combines peptide stapling to optimize proteolytic stability, with lessons learned from cell-penetrating peptide (CPP) design to maximize cellular uptake resulting in NLS-StAx-h, a selective, cell permeable, stapled peptide inhibitor of oncogenic Wnt signaling that efficiently inhibits β-catenin-transcription factor interactions.  We expect that this type of integrative strategy that endows stapled peptides with CPP features will be generally useful for developing inhibitors of intracellular PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4mcl8B_B0B7Vg90H21EOLACvtfcHk0lhMOaXDGfu4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK&md5=cbf0b96aab1e21c298b9a6d22b7f05d1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%26aulast%3DRathmer%26aufirst%3DB.%26aulast%3DEwan%26aufirst%3DK.%26aulast%3DBange%26aufirst%3DT.%26aulast%3DHeinrichs%26aufirst%3DS.%26aulast%3DDale%26aufirst%3DT.%2BC.%26aulast%3DSchade%26aufirst%3DD.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DCell%2520permeable%2520stapled%2520peptide%2520inhibitor%2520of%2520Wnt%2520signaling%2520that%2520targets%2520beta-catenin%2520protein-protein%2520interactions%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D958%26epage%3D968%26doi%3D10.1016%2Fj.chembiol.2017.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective small-molecule inhibitors for the beta-catenin/T-cell factor protein-protein interaction through the optimization of the acyl hydrazone moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4678</span>– <span class="NLM_lpage">4692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4678-4692&author=J.+L.+Catrowauthor=Y.+Zhangauthor=M.+Zhangauthor=H.+Ji&title=Discovery+of+selective+small-molecule+inhibitors+for+the+beta-catenin%2FT-cell+factor+protein-protein+interaction+through+the+optimization+of+the+acyl+hydrazone+moiety&doi=10.1021%2Facs.jmedchem.5b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety</span></div><div class="casAuthors">Catrow, J. Leon; Zhang, Yongqiang; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4678-4692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl hydrazone is an important functional group for the discovery of bioactive small mols.  This functional group is also recognized as a pan assay interference structure.  In this study, a new small-mol. inhibitor for the β-catenin/Tcf protein-protein interaction (PPI), ZINC02092166, was identified through AlphaScreen and FP assays.  This compd. contains an acyl hydrazone group and exhibits higher inhibitory activities in cell-based assays than biochem. assays.  Inhibitor optimization resulted in chem. stable derivs. that disrupt the β-catenin/Tcf PPI.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This series of inhibitors with a new scaffold exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC PPIs.  One deriv. of this series suppresses canonical Wnt signaling, downregulates the expression of Wnt target genes, and inhibits the growth of cancer cells.  This compd. represents a solid starting point for the development of potent and selective β-catenin/Tcf inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusdU2c6KIQLVg90H21EOLACvtfcHk0ljAkVGgq0NotA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D&md5=11aa0209009144341d692c4cf6966790</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00223%26sid%3Dliteratum%253Aachs%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520the%2520beta-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%2520through%2520the%2520optimization%2520of%2520the%2520acyl%2520hydrazone%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4678%26epage%3D4692%26doi%3D10.1021%2Facs.jmedchem.5b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf-Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the beta-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-15-1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26645562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=891-901&author=L.+Fangauthor=Q.+Zhuauthor=M.+Neuenschwanderauthor=E.+Speckerauthor=A.+Wulf-Goldenbergauthor=W.+I.+Weisauthor=J.+P.+von+Kriesauthor=W.+Birchmeier&title=A+small-molecule+antagonist+of+the+beta-catenin%2FTCF4+interaction+blocks+the+self-renewal+of+cancer+stem+cells+and+suppresses+tumorigenesis&doi=10.1158%2F0008-5472.CAN-15-1519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis</span></div><div class="casAuthors">Fang, Liang; Zhu, Qionghua; Neuenschwander, Martin; Specker, Edgar; Wulf-Goldenberg, Annika; Weis, William I.; von Kries, Jens P.; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">891-901</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is a highly conserved pathway essential for embryogenesis and tissue homeostasis.  However, deregulation of this pathway can initiate and promote human malignancies, esp. of the colon and head and neck.  Therefore, Wnt/β-catenin signaling represents an attractive target for cancer therapy.  We performed high-throughput screening using AlphaScreen and ELISA techniques to identify small mols. that disrupt the crit. interaction between β-catenin and the transcription factor TCF4 required for signal transduction.  We found that compd. LF3, a 4-thioureido-benzenesulfonamide deriv., robustly inhibited this interaction.  Biochem. assays revealed clues that the core structure of LF3 was essential for inhibition.  LF3 inhibited Wnt/β-catenin signals in cells with exogenous reporters and in colon cancer cells with endogenously high Wnt activity.  LF3 also suppressed features of cancer cells related to Wnt signaling, including high cell motility, cell-cycle progression, and the overexpression of Wnt target genes.  However, LF3 did not cause cell death or interfere with cadherin-mediated cell-cell adhesion.  Remarkably, the self-renewal capacity of cancer stem cells was blocked by LF3 in concn.-dependent manners, as examd. by sphere formation of colon and head and neck cancer stem cells under nonadherent conditions.  Finally, LF3 reduced tumor growth and induced differentiation in a mouse xenograft model of colon cancer.  Collectively, our results strongly suggest that LF3 is a specific inhibitor of canonical Wnt signaling with anticancer activity that warrants further development for preclin. and clin. studies as a novel cancer therapy.  Cancer Res; 76(4); 891-901. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3MyJLga-90rVg90H21EOLACvtfcHk0ljAkVGgq0NotA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGlsrk%253D&md5=bbf6184c7c61b3eda96d22f458f277e5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1519%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520beta-catenin%252FTCF4%2520interaction%2520blocks%2520the%2520self-renewal%2520of%2520cancer%2520stem%2520cells%2520and%2520suppresses%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D891%26epage%3D901%26doi%3D10.1158%2F0008-5472.CAN-15-1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craven, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garabedian, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S. K.</span></span> <span> </span><span class="NLM_article-title">Design of peptoid-peptide macrocycles to inhibit the β-catenin TCF interaction in prostate cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4396</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fs41467-018-06845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30352998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4396&author=J.+A.+Schneiderauthor=T.+W.+Cravenauthor=A.+C.+Kasperauthor=C.+Yunauthor=M.+Haugbroauthor=E.+M.+Briggsauthor=V.+Svetlovauthor=E.+Nudlerauthor=H.+Knautauthor=R.+Bonneauauthor=M.+J.+Garabedianauthor=K.+Kirshenbaumauthor=S.+K.+Logan&title=Design+of+peptoid-peptide+macrocycles+to+inhibit+the+%CE%B2-catenin+TCF+interaction+in+prostate+cancer&doi=10.1038%2Fs41467-018-06845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer</span></div><div class="casAuthors">Schneider Jeffrey A; Briggs Erica M; Garabedian Michael J; Logan Susan K; Craven Timothy W; Kasper Amanda C; Haugbro Michael; Kirshenbaum Kent; Craven Timothy W; Bonneau Richard; Yun Chi; Knaut Holger; Briggs Erica M; Svetlov Vladimir; Nudler Evgeny; Logan Susan K; Svetlov Vladimir; Nudler Evgeny; Garabedian Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New chemical inhibitors of protein-protein interactions are needed to propel advances in molecular pharmacology.  Peptoids are peptidomimetic oligomers with the capability to inhibit protein-protein interactions by mimicking protein secondary structure motifs.  Here we report the in silico design of a macrocycle primarily composed of peptoid subunits that targets the β-catenin:TCF interaction.  The β-catenin:TCF interaction plays a critical role in the Wnt signaling pathway which is over-activated in multiple cancers, including prostate cancer.  Using the Rosetta suite of protein design algorithms, we evaluate how different macrocycle structures can bind a pocket on β-catenin that associates with TCF.  The in silico designed macrocycles are screened in vitro using luciferase reporters to identify promising compounds.  The most active macrocycle inhibits both Wnt and AR-signaling in prostate cancer cell lines, and markedly diminishes their proliferation.  In vivo potential is demonstrated through a zebrafish model, in which Wnt signaling is potently inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUDToTC3aBaesfW6udTcc2eZqBgYP6BV8S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D&md5=1c04088452bbaf704ced21bf03541253</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06845-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DCraven%26aufirst%3DT.%2BW.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DYun%26aufirst%3DC.%26aulast%3DHaugbro%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DE.%2BM.%26aulast%3DSvetlov%26aufirst%3DV.%26aulast%3DNudler%26aufirst%3DE.%26aulast%3DKnaut%26aufirst%3DH.%26aulast%3DBonneau%26aufirst%3DR.%26aulast%3DGarabedian%26aufirst%3DM.%2BJ.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DS.%2BK.%26atitle%3DDesign%2520of%2520peptoid-peptide%2520macrocycles%2520to%2520inhibit%2520the%2520%25CE%25B2-catenin%2520TCF%2520interaction%2520in%2520prostate%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4396%26doi%3D10.1038%2Fs41467-018-06845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+beta-catenin%2FCREB-binding+protein+transcription+%5Bcorrected%5D&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0ljPEmd0J9d-wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520beta-catenin%252FCREB-binding%2520protein%2520transcription%2520%255Bcorrected%255D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oboki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojika, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saibara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)/beta-catenin reduces liver fibrosis in mice</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2015.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ebiom.2015.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26870800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28jgt1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=1751-1758&author=Y.+Osawaauthor=K.+Obokiauthor=J.+Imamuraauthor=E.+Kojikaauthor=Y.+Hayashiauthor=T.+Hishimaauthor=T.+Saibaraauthor=F.+Shibasakiauthor=M.+Koharaauthor=K.+Kimura&title=Inhibition+of+cyclic+adenosine+monophosphate+%28cAMP%29-response+element-binding+protein+%28CREB%29-binding+protein+%28CBP%29%2Fbeta-catenin+reduces+liver+fibrosis+in+mice&doi=10.1016%2Fj.ebiom.2015.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice</span></div><div class="casAuthors">Osawa Yosuke; Imamura Jun; Kojika Ekumi; Kimura Kiminori; Oboki Keisuke; Shibasaki Futoshi; Hayashi Yukiko; Hishima Tsunekazu; Saibara Toshiji; Kohara Michinori</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1751-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Wnt/β-catenin is involved in every aspect of embryonic development and in the pathogenesis of many human diseases, and is also implicated in organ fibrosis.  However, the role of β-catenin-mediated signaling on liver fibrosis remains unclear.  To explore this issue, the effects of PRI-724, a selective inhibitor of the cAMP-response element-binding protein-binding protein (CBP)/β-catenin interaction, on liver fibrosis were examined using carbon tetrachloride (CCl4)- or bile duct ligation (BDL)-induced mouse liver fibrosis models.  Following repetitive CCl4 administrations, the nuclear translocation of β-catenin was observed only in the non-parenchymal cells in the liver.  PRI-724 treatment reduced the fibrosis induced by CCl4 or BDL.  C-82, an active form of PRI-724, inhibited the activation of isolated primary mouse quiescent hepatic stellate cells (HSCs) and promoted cell death in culture-activated HSCs.  During the fibrosis resolution period, an increase in F4/80(+) CD11b(+) and Ly6C(low) CD11b(+) macrophages was induced by CCl4 and was sustained for two weeks thereafter, even after having stopped CCl4 treatment.  PRI-724 accelerated the resolution of CCl4-induced liver fibrosis, and this was accompanied by increased matrix metalloproteinase (MMP)-9, MMP-2, and MMP-8 expression in intrahepatic leukocytes.  In conclusion, targeting the CBP/β-catenin interaction may become a new therapeutic strategy in treating liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyynf43J2DM7mQt-ICR3qNfW6udTcc2eZqBgYP6BV8S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jgt1Ortw%253D%253D&md5=cfad915dfce8069236820b2f01c2737e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2015.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2015.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DOboki%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DJ.%26aulast%3DKojika%26aufirst%3DE.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DHishima%26aufirst%3DT.%26aulast%3DSaibara%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DF.%26aulast%3DKohara%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520cyclic%2520adenosine%2520monophosphate%2520%2528cAMP%2529-response%2520element-binding%2520protein%2520%2528CREB%2529-binding%2520protein%2520%2528CBP%2529%252Fbeta-catenin%2520reduces%2520liver%2520fibrosis%2520in%2520mice%26jtitle%3DEBioMedicine%26date%3D2015%26volume%3D2%26spage%3D1751%26epage%3D1758%26doi%3D10.1016%2Fj.ebiom.2015.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikoma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okusaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizokami, M.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and preliminary efficacy of the anti-fibrotic small molecule PRI-724, a CBP/beta-catenin inhibitor, in patients with hepatitis C virus-related cirrhosis: a single-center, open-label, dose escalation phase 1 trial</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2017.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ebiom.2017.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28844410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhvF2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=79-87&author=K.+Kimuraauthor=A.+Ikomaauthor=M.+Shibakawaauthor=S.+Shimodaauthor=K.+Haradaauthor=M.+Saioauthor=J.+Imamuraauthor=Y.+Osawaauthor=M.+Kimuraauthor=K.+Nishikawaauthor=T.+Okusakaauthor=S.+Moritaauthor=K.+Inoueauthor=T.+Kantoauthor=K.+Todakaauthor=Y.+Nakanishiauthor=M.+Koharaauthor=M.+Mizokami&title=Safety%2C+tolerability%2C+and+preliminary+efficacy+of+the+anti-fibrotic+small+molecule+PRI-724%2C+a+CBP%2Fbeta-catenin+inhibitor%2C+in+patients+with+hepatitis+C+virus-related+cirrhosis%3A+a+single-center%2C+open-label%2C+dose+escalation+phase+1+trial&doi=10.1016%2Fj.ebiom.2017.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial</span></div><div class="casAuthors">Kimura Kiminori; Ikoma Akemi; Shibakawa Maki; Imamura Jun; Osawa Yosuke; Kimura Masamichi; Nishikawa Koji; Shimoda Shinji; Harada Kenichi; Saio Masanao; Okusaka Takuji; Morita Satoshi; Inoue Kazuaki; Kanto Tatsuya; Mizokami Masashi; Todaka Koji; Nakanishi Yoichi; Kohara Michinori</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is currently no anti-fibrotic drug therapy available to treat hepatitis C virus (HCV) cirrhosis.  The aim of this study was to assess the safety, tolerability, and anti-fibrotic effect of PRI-724, a small-molecule modulator of Wnt signaling, in patients with HCV cirrhosis.  METHODS:  In this single-center, open-label, phase 1 trial, we sequentially enrolled patients with HCV cirrhosis who were classified as Child-Pugh (CP) class A or B.  PRI-724 was administered as a continuous intravenous infusion of 10, 40, or 160mg/m(2)/day for six cycles of 1week on and 1week off.  The primary endpoints were frequency and severity of adverse events.  The secondary endpoint was efficacy of PRI-724 in treating cirrhosis based on CP score and liver biopsy.  This study is registered with ClinicalTrials.gov (no.  NCT02195440).  FINDINGS:  Between Sept 3, 2014 and May 2, 2016, 14 patients were enrolled: CP class A:B, 6:8; median age, 62 (range: 43 to 74) years; male:female, 10:4.  Twelve of the 14 patients completed six cycles of treatment; one was withdrawn from the study due to possible study drug-related liver injury (grade 3) in the 160mg/m(2)/day dose cohort and one withdrew for personal reasons.  Serious adverse events occurred in three patients [21% (3/14)], one of which was possibly related to PRI-724.  The most common adverse events were nausea [29% (4/14)] and fatigue [21% (3/14)].  After PRI-724 administration, the CP scores worsened by 1 point in two patients in the 10mg/m(2)/day cohort, improved in three patients at 1, 1, and 2 points in the 40mg/m(2)/day cohort, and improved in one patient by 3 points in the 160mg/m(2)/day cohort.  The histology activity index scores of the liver tissue improved in two patients and exacerbated in two patients in the 10mg/m(2)/day cohort, and improved in one patient in the 40mg/m(2)/day cohort.  INTERPRETATION:  This study showed that administration of 10 or 40mg/m(2)/day intravenous PRI-724 over 12weeks was well-tolerated by patients with HCV cirrhosis; however, liver injury as a possible related serious adverse event was observed in the 160mg/m(2)/day cohort.  FUNDING SOURCE:  AMED.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE5aQERxw85wWRJ3OJdH_qfW6udTcc2eY33wSJZruqk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhvF2jtw%253D%253D&md5=be646fe1fe15edef6386c48ad666e0e7</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2017.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2017.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DIkoma%26aufirst%3DA.%26aulast%3DShibakawa%26aufirst%3DM.%26aulast%3DShimoda%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DSaio%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DJ.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKanto%26aufirst%3DT.%26aulast%3DTodaka%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DKohara%26aufirst%3DM.%26aulast%3DMizokami%26aufirst%3DM.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520preliminary%2520efficacy%2520of%2520the%2520anti-fibrotic%2520small%2520molecule%2520PRI-724%252C%2520a%2520CBP%252Fbeta-catenin%2520inhibitor%252C%2520in%2520patients%2520with%2520hepatitis%2520C%2520virus-related%2520cirrhosis%253A%2520a%2520single-center%252C%2520open-label%252C%2520dose%2520escalation%2520phase%25201%2520trial%26jtitle%3DEBioMedicine%26date%3D2017%26volume%3D23%26spage%3D79%26epage%3D87%26doi%3D10.1016%2Fj.ebiom.2017.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. S.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1702</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-14-2041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25660951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=1691-1702&author=G.+B.+Jangauthor=I.+S.+Hongauthor=R.+J.+Kimauthor=S.+Y.+Leeauthor=S.+J.+Parkauthor=E.+S.+Leeauthor=J.+H.+Parkauthor=C.+H.+Yunauthor=J.+U.+Chungauthor=K.+J.+Leeauthor=H.+Y.+Leeauthor=J.+S.+Nam&title=Wnt%2Fbeta-catenin+small-molecule+inhibitor+CWP232228+preferentially+inhibits+the+growth+of+breast+cancer+stem-like+cells&doi=10.1158%2F0008-5472.CAN-14-2041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells</span></div><div class="casAuthors">Jang, Gyu-Beom; Hong, In-Sun; Kim, Ran-Ju; Lee, Su-Youn; Park, Se-Jin; Lee, Eun-Sook; Park, Jung Hyuck; Yun, Chi-Ho; Chung, Jae-Uk; Lee, Kyoung-June; Lee, Hwa-Yong; Nam, Jeong-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1691-1702</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">These findings highlight a candidate therapeutic agent that may target stem-like cells as well as bulk tumor cells and lead to more effective treatment of breast cancer.  Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but not all BCSC that can mediate relapses.  In the present study, we showed that the level of Wnt/β-catenin signaling in BCSC is relatively higher than in bulk tumor cells, contributing to a relatively higher level of therapeutic resistance.  We designed a highly potent small-mol. inhibitor, CWP232228, which antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus.  Notably, although CWP232228 inhibited the growth of both BCSC and bulk tumor cells by inhibiting β-catenin-mediated transcription, BCSC exhibited greater growth inhibition than bulk tumor cells.  We also documented evidence of greater insulin-like growth factor-I (IGF-I) expression by BCSC than by bulk tumor cells and that CWP232228 attenuated IGF-I-mediated BCSC functions.  These results suggested that the inhibitory effect of CWP232228 on BCSC growth might be achieved through the disruption of IGF-I activity.  Taken together, our findings indicate that CWP232228 offers a candidate therapeutic agent for breast cancer that preferentially targets BCSC as well as bulk tumor cells.  Cancer Res; 75(8); 1691-702. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqQfzkL0A6K7Vg90H21EOLACvtfcHk0lj3zdYHBTnezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsb8%253D&md5=7534a35b1407b55131327cc17368f2c2</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2041%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DG.%2BB.%26aulast%3DHong%26aufirst%3DI.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DChung%26aufirst%3DJ.%2BU.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DNam%26aufirst%3DJ.%2BS.%26atitle%3DWnt%252Fbeta-catenin%2520small-molecule%2520inhibitor%2520CWP232228%2520preferentially%2520inhibits%2520the%2520growth%2520of%2520breast%2520cancer%2520stem-like%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D1691%26epage%3D1702%26doi%3D10.1158%2F0008-5472.CAN-14-2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, I. S.</span></span> <span> </span><span class="NLM_article-title">CWP232228 targets liver cancer stem cells through Wnt/beta-catenin signaling: a novel therapeutic approach for liver cancer treatment</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">20395</span>– <span class="NLM_lpage">20409</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.18632%2Foncotarget.7954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26967248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC28jptFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=20395-20409&author=J.+Y.+Kimauthor=H.+Y.+Leeauthor=K.+K.+Parkauthor=Y.+K.+Choiauthor=J.+S.+Namauthor=I.+S.+Hong&title=CWP232228+targets+liver+cancer+stem+cells+through+Wnt%2Fbeta-catenin+signaling%3A+a+novel+therapeutic+approach+for+liver+cancer+treatment&doi=10.18632%2Foncotarget.7954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment</span></div><div class="casAuthors">Kim Ji-Young; Kim Ji-Young; Choi Yang-Kyu; Lee Hwa-Yong; Park Kwan-Kyu; Nam Jeong-Seok; Hong In-Sun; Hong In-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">20395-409</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not all liver CSCs contribute to tumor initiation, metastasis, and relapse.  In the present study, we showed that liver CSCs with elevated Wnt/β-catenin signaling possess much greater self-renewal and clonogenic potential.  We further documented that the increased clonogenic potential of liver CSCs is highly associated with changes in Wnt/β-catenin signaling and that Wnt/β-catenin signaling activity is positively correlated with CD133 expression and aldehyde dehydrogenase (ALDH) enzymatic activity.  Notably, the small molecule inhibitor CWP232228, which antagonizes the binding of β-catenin to TCF in the nucleus, inhibits Wnt/β-catenin signaling and depletes CD133+/ALDH+ liver CSCs, thus ultimately diminishing the self-renewal capacity of CSCs and decreasing tumorigenicity in vitro and in vivo.  Taken together, our findings suggest that CWP232228 acts as a candidate therapeutic agent for liver cancer by preferentially targeting liver CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYNq4keDr1UQWRJ3OJdH_qfW6udTcc2ebdTlE9HVBitrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jptFOktQ%253D%253D&md5=7dcb30f34a96d6e08a013d2c9bbb0dea</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7954%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DK.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BK.%26aulast%3DNam%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DI.%2BS.%26atitle%3DCWP232228%2520targets%2520liver%2520cancer%2520stem%2520cells%2520through%2520Wnt%252Fbeta-catenin%2520signaling%253A%2520a%2520novel%2520therapeutic%2520approach%2520for%2520liver%2520cancer%2520treatment%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D20395%26epage%3D20409%26doi%3D10.18632%2Foncotarget.7954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risueno, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanasijevic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslostovar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salci, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapovalova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golubeva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xenocostas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trus, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, M.</span></span> <span> </span><span class="NLM_article-title">Sam68 allows selective targeting of human cancer stem cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.chembiol.2017.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28648376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=833-844&author=Y.+D.+Benoitauthor=R.+R.+Mitchellauthor=R.+M.+Risuenoauthor=L.+Orlandoauthor=B.+Tanasijevicauthor=A.+L.+Boydauthor=L.+Aslostovarauthor=K.+R.+Salciauthor=Z.+Shapovalovaauthor=J.+Russellauthor=M.+Eguchiauthor=D.+Golubevaauthor=M.+Grahamauthor=A.+Xenocostasauthor=M.+R.+Trusauthor=R.+Foleyauthor=B.+Leberauthor=T.+J.+Collinsauthor=M.+Bhatia&title=Sam68+allows+selective+targeting+of+human+cancer+stem+cells&doi=10.1016%2Fj.chembiol.2017.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Sam68 Allows Selective Targeting of Human Cancer Stem Cells</span></div><div class="casAuthors">Benoit, Yannick D.; Mitchell, Ryan R.; Risueno, Ruth M.; Orlando, Luca; Tanasijevic, Borko; Boyd, Allison L.; Aslostovar, Lili; Salci, Kyle R.; Shapovalova, Zoya; Russell, Jennifer; Eguchi, Masakatsu; Golubeva, Diana; Graham, Monica; Xenocostas, Anargyros; Trus, Michael R.; Foley, Ronan; Leber, Brian; Collins, Tony J.; Bhatia, Mickie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">833-844.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Targeting of human cancer stem cells (CSCs) requires the identification of vulnerabilities unique to CSCs vs. healthy resident stem cells (SCs).  Unfortunately, dysregulated pathways that support transformed CSCs, such as Wnt/β-catenin signaling, are also crit. regulators of healthy SCs.  Using the ICG-001 and CWP family of small mols., we reveal Sam68 as a previously unappreciated modulator of Wnt/β-catenin signaling within CSCs.  Disruption of CBP-β-catenin interaction via ICG-001/CWP induces the formation of a Sam68-CBP complex in CSCs that alters Wnt signaling toward apoptosis and differentiation induction.  Our study identifies Sam68 as a regulator of human CSC vulnerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzo6C9FRMuj7Vg90H21EOLACvtfcHk0lgENLMfd5EfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrvJ&md5=fe6d9637ccb3adecaf29358aa25671cc</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DBenoit%26aufirst%3DY.%2BD.%26aulast%3DMitchell%26aufirst%3DR.%2BR.%26aulast%3DRisueno%26aufirst%3DR.%2BM.%26aulast%3DOrlando%26aufirst%3DL.%26aulast%3DTanasijevic%26aufirst%3DB.%26aulast%3DBoyd%26aufirst%3DA.%2BL.%26aulast%3DAslostovar%26aufirst%3DL.%26aulast%3DSalci%26aufirst%3DK.%2BR.%26aulast%3DShapovalova%26aufirst%3DZ.%26aulast%3DRussell%26aufirst%3DJ.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DGolubeva%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DM.%26aulast%3DXenocostas%26aufirst%3DA.%26aulast%3DTrus%26aufirst%3DM.%2BR.%26aulast%3DFoley%26aufirst%3DR.%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DCollins%26aufirst%3DT.%2BJ.%26aulast%3DBhatia%26aufirst%3DM.%26atitle%3DSam68%2520allows%2520selective%2520targeting%2520of%2520human%2520cancer%2520stem%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D833%26epage%3D844%26doi%3D10.1016%2Fj.chembiol.2017.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Briaud, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenzin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of small molecule inhibitor of Wnt signaling in acute myelogenous leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">4001</span>– <span class="NLM_lpage">4001</span>, <span class="refDoi"> DOI: 10.1182/blood.V112.11.4001.4001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1182%2Fblood.V112.11.4001.4001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=4001-4001&author=I.+Briaudauthor=F.+Tenzinauthor=J.+K.+Chunauthor=S.-W.+Ohauthor=J.+U.+Chungauthor=K.+Y.+Jungauthor=M.+W.+Jeongauthor=J.+Y.+Chaauthor=Y.+Pyonauthor=D.+Leeauthor=J.+E.+Jungauthor=K.+H.+Emami&title=Therapeutic+potential+of+small+molecule+inhibitor+of+Wnt+signaling+in+acute+myelogenous+leukemia&doi=10.1182%2Fblood.V112.11.4001.4001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1182%2Fblood.V112.11.4001.4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V112.11.4001.4001%26sid%3Dliteratum%253Aachs%26aulast%3DBriaud%26aufirst%3DI.%26aulast%3DTenzin%26aufirst%3DF.%26aulast%3DChun%26aufirst%3DJ.%2BK.%26aulast%3DOh%26aufirst%3DS.-W.%26aulast%3DChung%26aufirst%3DJ.%2BU.%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DJeong%26aufirst%3DM.%2BW.%26aulast%3DCha%26aufirst%3DJ.%2BY.%26aulast%3DPyon%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DJ.%2BE.%26aulast%3DEmami%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520potential%2520of%2520small%2520molecule%2520inhibitor%2520of%2520Wnt%2520signaling%2520in%2520acute%2520myelogenous%2520leukemia%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D4001%26epage%3D4001%26doi%3D10.1182%2Fblood.V112.11.4001.4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H.</span></span> <span> </span><span class="NLM_article-title">The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">342</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1342-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1186%2Fs13046-019-1342-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31387608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BB3MvlsVymsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=342&author=S.+Pakauthor=S.+Parkauthor=Y.+Kimauthor=J.+H.+Parkauthor=C.+H.+Parkauthor=K.+J.+Leeauthor=C.+S.+Kimauthor=H.+Ahn&title=The+small+molecule+WNT%2Fbeta-catenin+inhibitor+CWP232291+blocks+the+growth+of+castration-resistant+prostate+cancer+by+activating+the+endoplasmic+reticulum+stress+pathway&doi=10.1186%2Fs13046-019-1342-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway</span></div><div class="casAuthors">Pak Sahyun; Park Sejun; Kim Yunlim; Kim Choung-Soo; Ahn Hanjong; Kim Yunlim; Park Jung-Hyuck; Park Chan-Hee; Lee Kyoung-June</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients.  Therefore, alternative therapeutic targets are urgently needed.  Since growing evidence demonstrates that WNT/β-catenin signaling plays an important role in CRPC, the antitumor activity and mechanism of action of CWP232291, a small molecule β-catenin inhibitor, were investigated in prostate cancer.  METHODS:  We assessed the antitumor activity of CWP232291 in prostate cancer cell lines and primary cells derived from CRPC patients.  The effect of CWP232291 on apoptotic cell death, endoplasmic reticulum (ER) stress, cell viability, and WNT/β-catenin signaling was evaluated by flow cytometry, western blotting, luciferase reporter assay, and fluorescence microscopy.  Antitumor efficacy was assessed in two CRPC xenograft mouse models.  RESULTS:  CWP232291 induced ER stress, resulting in upregulation of the proapoptotic protein CHOP and activation of caspase-3-dependent apoptosis.  In addition, CWP232291 suppressed the expression of β-catenin by affecting WNT-dependent transcriptional activity, and downregulated AR and its splice variants in prostate cancer cells.  Antitumor activity was observed in prostate cancer cells in vitro and ex vivo, and antitumor efficacy was observed in vivo.  CONCLUSIONS:  Beyond providing preclinical evidence of therapeutic efficacy for the novel small molecule β-catenin inhibitor CWP232291 in CRPC, our results show that inducing ER stress and targeting WNT/β-catenin signaling may be a novel strategy against CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3B7oaVKQRJDUE-swuRqsHfW6udTcc2eZJvFYNVvm3irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvlsVymsA%253D%253D&md5=57de59965a5462c30196dde15deeb568</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1342-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1342-5%26sid%3Dliteratum%253Aachs%26aulast%3DPak%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DAhn%26aufirst%3DH.%26atitle%3DThe%2520small%2520molecule%2520WNT%252Fbeta-catenin%2520inhibitor%2520CWP232291%2520blocks%2520the%2520growth%2520of%2520castration-resistant%2520prostate%2520cancer%2520by%2520activating%2520the%2520endoplasmic%2520reticulum%2520stress%2520pathway%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D342%26doi%3D10.1186%2Fs13046-019-1342-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faderl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardanani, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J. E.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome</span>. <i>Blood Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2043</span>, <span class="refDoi"> DOI: 10.1182/bloodadvances.2019000757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1182%2Fbloodadvances.2019000757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32396615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis12ksLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2020&pages=2032-2043&author=J.+H.+Leeauthor=S.+Faderlauthor=J.+M.+Pagelauthor=C.+W.+Jungauthor=S.+S.+Yoonauthor=A.+D.+Pardananiauthor=P.+S.+Beckerauthor=H.+Leeauthor=J.+Choiauthor=K.+Leeauthor=M.+Kimauthor=J.+E.+Cortes&title=Phase+1+study+of+CWP232291+in+patients+with+relapsed+or+refractory+acute+myeloid+leukemia+and+myelodysplastic+syndrome&doi=10.1182%2Fbloodadvances.2019000757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome</span></div><div class="casAuthors">Lee, Je-Hwan; Faderl, Stefan; Pagel, John M.; Jung, Chul Won; Yoon, Sung-Soo; Pardanani, Animesh D.; Becker, Pamela S.; Lee, Howard; Choi, Jeongeun; Lee, Kyoungjune; Kim, Minkyoung; Cortes, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Advances</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2032-2043</span>CODEN:
                <span class="NLM_cas:coden">BALDBA</span>;
        ISSN:<span class="NLM_cas:issn">2473-9537</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">CWP232291 (CWP291) is a small-mol. inhibitor of Wnt signaling that causes degrdn. of β-catenin via apoptosis induction through endoplasmic reticulum stress activation.  This first-in-human, open-label, dose-escalation study to evaluate the safety, max. tolerated dose (MTD), and preliminary efficacy of CWP291 enrolled 69 patients with hematol. malignancies (acute myeloid leukemia [AML], n = 64; myelodysplastic syndrome, n = 5) in 15 dose-escalation cohorts of 4 to 334 mg/m2 using a modified 313 design and 1 doseexpansion cohort.  CWP291 was administered IV daily for 7 days every 21 days.  The most common treatment-emergent adverse events (TEAEs) were nausea (n = 44, 64%), vomiting (n = 32, 46%), diarrhea (n = 25, 36%), and infusion-related reactions (n = 20, 29%).  Grade ≥3 TEAEs in .3 patients (5%) were pneumonia (n = 8, 12%); hypophosphatemia (n = 6, 8%); leukocytosis, nausea, cellulitis, sepsis, and hypokalemia (n = 5 each, 7% each); and hypertension (n = 4, 6%).  Dose-limiting toxicities included nausea (n = 3) and abdominal pain, anaphylactic reaction, myalgia, and rash (n =1, each); theMTD was defined at 257 mg/m2.  CWP232204, the active metabolite of CWP291, showed pharmacokinetic linearity on both days 1 and 7, and a terminal half-life of ~ 12 h.  Among 54 response-evaluable AML patients, there was one complete response at a dose of 153 mg/m2 and one partial response at 198 mg/m2; bone marrow blast percentage reduced from a median of 58.3% to 3.5% and 15.0% to 4.2%, resp.  Future studies will explore CWP291, with a mechanism of action aimed at eradication of earlier progenitors via Wnt pathway blockade, as combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMEiCukmHSA7Vg90H21EOLACvtfcHk0ljsAbSfrlNaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis12ksLnL&md5=d4c7c55918b5547ec94f75dc2ca3c863</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1182%2Fbloodadvances.2019000757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fbloodadvances.2019000757%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFaderl%26aufirst%3DS.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DJung%26aufirst%3DC.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BS.%26aulast%3DPardanani%26aufirst%3DA.%2BD.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26atitle%3DPhase%25201%2520study%2520of%2520CWP232291%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520acute%2520myeloid%2520leukemia%2520and%2520myelodysplastic%2520syndrome%26jtitle%3DBlood%2520Adv.%26date%3D2020%26volume%3D4%26spage%3D2032%26epage%3D2043%26doi%3D10.1182%2Fbloodadvances.2019000757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leimgruber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustata
Wilson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monga, S. P.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">2111</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ajpath.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24819961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVarsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2014&pages=2111-2122&author=E.+R.+Delgadoauthor=J.+Yangauthor=J.+Soauthor=M.+Fantiauthor=S.+Leimgruberauthor=M.+Kahnauthor=T.+Ishitaniauthor=D.+Shinauthor=G.+Mustata%0AWilsonauthor=S.+P.+Monga&title=Identification+and+characterization+of+a+novel+small-molecule+inhibitor+of+%CE%B2-catenin+signaling&doi=10.1016%2Fj.ajpath.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling</span></div><div class="casAuthors">Delgado, Evan R.; Yang, Jing; So, Juhoon; Leimgruber, Stephanie; Kahn, Michael; Ishitani, Tohru; Shin, Donghun; Mustata Wilson, Gabriela; Monga, Satdarshan P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2111-2122</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC), the third most common cause of cancer-related deaths worldwide, lacks effective medical therapy.  Large subsets of HCC demonstrate Wnt/β-catenin activation, making this an attractive therapeutic target.  We report strategy and characterization of a novel small-mol. inhibitor, ICG-001, known to affect Wnt signaling by disrupting β-catenin-CREB binding protein interactions.  We queried the ZINC online database for structural similarity to ICG-001 and identified PMED-1 as the lead compd., with ≥70% similarity to ICG-001.  PMED-1 significantly reduced β-catenin activity in hepatoblastoma and several HCC cells, as detd. by TOPflash reporter assay, with an IC50 ranging from 4.87 to 32 μmol/L.  Although no toxicity was obsd. in primary human hepatocytes, PMED-1 inhibited Wnt target expression in HCC cells, including those with CTNNB1 mutations, and impaired cell proliferation and viability.  PMED-1 treatment decreased β-catenin-CREB binding protein interactions without affecting total β-catenin levels or activity of other common kinases.  PMED-1 treatment of Tg(OTM:d2EGFP) zebrafish expressing GFP under the β-catenin/Tcf reporter led to a notable decrease in β-catenin activity.  The PMED effect on β-catenin signaling lasted from 12 to 24 h in vitro and 6 to 15 h in vivo.  Thus, using a rapid and cost-effective computational methodol., we have identified a novel and specific small-mol. inhibitor of Wnt signaling that may have implications for HCC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEeNmAsFM0YbVg90H21EOLACvtfcHk0liRZQz8NDXYvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVarsrrF&md5=c4a237249fe31982d0ec73ed3c40dc1c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DE.%2BR.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSo%26aufirst%3DJ.%26aulast%3DFanti%26aufirst%3DM.%26aulast%3DLeimgruber%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DIshitani%26aufirst%3DT.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DMustata%2BWilson%26aufirst%3DG.%26aulast%3DMonga%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520%25CE%25B2-catenin%2520signaling%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2014%26volume%3D184%26spage%3D2111%26epage%3D2122%26doi%3D10.1016%2Fj.ajpath.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frist, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. C.</span></span> <span> </span><span class="NLM_article-title">Selective small molecule targeting beta-catenin function discovered by in vivo chemical genetic screen</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.celrep.2013.07.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24012757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWisLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=898-904&author=J.+Haoauthor=A.+Aoauthor=L.+Zhouauthor=C.+K.+Murphyauthor=A.+Y.+Fristauthor=J.+J.+Keelauthor=C.+A.+Thorneauthor=K.+Kimauthor=E.+Leeauthor=C.+C.+Hong&title=Selective+small+molecule+targeting+beta-catenin+function+discovered+by+in+vivo+chemical+genetic+screen&doi=10.1016%2Fj.celrep.2013.07.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Targeting β-Catenin Function Discovered by In Vivo Chemical Genetic Screen</span></div><div class="casAuthors">Hao, Jijun; Ao, Ada; Zhou, Li; Murphy, Clare K.; Frist, Audrey Y.; Keel, Jessica J.; Thorne, Curtis A.; Kim, Kwangho; Lee, Ethan; Hong, Charles C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">898-904</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The canonical Wnt signaling pathway, mediated by the transcription factor β-catenin, plays crit. roles in embryonic development and represents an important therapeutic target.  In a zebrafish-based in vivo screen for small mols. that specifically perturb embryonic dorsoventral patterning, we discovered a compd. named windorphen that selectively blocks the Wnt signal required for ventral development.  Windorphen exhibits remarkable specificity toward β-catenin-1 function, indicating that the two β-catenin isoforms found in zebrafish are not functionally redundant.  We show that windorphen is a selective inhibitor of p300 histone acetyltransferase, a coactivator that assocs. with β-catenin.  Finally, windorphen robustly and selectively kills cancer cells that harbor Wnt-activating mutations, supporting the therapeutic potential of this Wnt inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou1t5KgGNwA7Vg90H21EOLACvtfcHk0liRZQz8NDXYvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWisLzE&md5=08159627e7c7bc18e4cd6d56744c46c9</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DAo%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DC.%2BK.%26aulast%3DFrist%26aufirst%3DA.%2BY.%26aulast%3DKeel%26aufirst%3DJ.%2BJ.%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520small%2520molecule%2520targeting%2520beta-catenin%2520function%2520discovered%2520by%2520in%2520vivo%2520chemical%2520genetic%2520screen%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D4%26spage%3D898%26epage%3D904%26doi%3D10.1016%2Fj.celrep.2013.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramps, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nellen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froesch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zullig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, K.</span></span> <span> </span><span class="NLM_article-title">Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(02)00679-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS0092-8674%2802%2900679-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=11955446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=47-60&author=T.+Krampsauthor=O.+Peterauthor=E.+Brunnerauthor=D.+Nellenauthor=B.+Froeschauthor=S.+Chatterjeeauthor=M.+Muroneauthor=S.+Zulligauthor=K.+Basler&title=Wnt%2Fwingless+signaling+requires+BCL9%2Flegless-mediated+recruitment+of+pygopus+to+the+nuclear+beta-catenin-TCF+complex&doi=10.1016%2FS0092-8674%2802%2900679-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/Wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex</span></div><div class="casAuthors">Kramps, Thomas; Peter, Oliver; Brunner, Erich; Nellen, Denise; Froesch, Barbara; Chatterjee, Sandipan; Murone, Maximilien; Zullig, Stephanie; Basler, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Wnt/Wingless signaling controls many fundamental processes during animal development.  Wnt transduction is mediated by the assocn. of β-catenin with nuclear TCF DNA binding factors.  Here we report the identification of 2 segment polarity genes in Drosophila, legless (lgs), and pygopus (pygo), and we show that their products are required for Wnt signal transduction at the level of nuclear β-catenin.  Lgs encodes the homolog of human BCL9, and we provide genetic and mol. evidence that these proteins exert their function by phys. linking Pygo to β-catenin.  Our results suggest that the recruitment of Pygo permits β-catenin to transcriptionally activate Wnt target genes and raise the possibility that a deregulation of these events may play a causal role in the development of B cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfE9xkxx8BY7Vg90H21EOLACvtfcHk0lgdyTxy8Kdcwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVOntL4%253D&md5=180d88e509dbf21aadf6761e6542b0e2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900679-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900679-7%26sid%3Dliteratum%253Aachs%26aulast%3DKramps%26aufirst%3DT.%26aulast%3DPeter%26aufirst%3DO.%26aulast%3DBrunner%26aufirst%3DE.%26aulast%3DNellen%26aufirst%3DD.%26aulast%3DFroesch%26aufirst%3DB.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DMurone%26aufirst%3DM.%26aulast%3DZullig%26aufirst%3DS.%26aulast%3DBasler%26aufirst%3DK.%26atitle%3DWnt%252Fwingless%2520signaling%2520requires%2520BCL9%252Flegless-mediated%2520recruitment%2520of%2520pygopus%2520to%2520the%2520nuclear%2520beta-catenin-TCF%2520complex%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D47%26epage%3D60%26doi%3D10.1016%2FS0092-8674%2802%2900679-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of triazole-stapled BCL9 alpha-helical peptides to target the beta-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1146</span>, <span class="refDoi"> DOI: 10.1021/jm201125d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201125d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1137-1146&author=S.+A.+Kawamotoauthor=A.+Coleskaauthor=X.+Ranauthor=H.+Yiauthor=C.+Y.+Yangauthor=S.+Wang&title=Design+of+triazole-stapled+BCL9+alpha-helical+peptides+to+target+the+beta-catenin%2FB-cell+CLL%2Flymphoma+9+%28BCL9%29+protein-protein+interaction&doi=10.1021%2Fjm201125d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein-Protein Interaction</span></div><div class="casAuthors">Kawamoto, Steven A.; Coleska, Adriana; Ran, Xu; Yi, Han; Yang, Chao-Yie; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1137-1146</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interaction between β-catenin and B-cell CLL/lymphoma 9 (BCL9), crit. for the transcriptional activity of β-catenin, is mediated by a helical segment from BCL9 and a large binding groove in β-catenin.  Design of potent, metabolically stable BCL9 peptides represents an attractive approach to inhibit the activity of β-catenin.  In this study, we report the use of the Huisgen 1,3-dipolar cycloaddn. reaction to generate triazole-stapled BCL9 α-helical peptides.  The high efficiency and mild conditions of this 'click' reaction combined with the ease of synthesis of the necessary unnatural amino acids allows for facile synthesis of triazole-stapled peptides.  We have performed extensive optimization of this approach and identified the optimal combinations of azido and alkynyl linkers necessary for stapling BCL9 helixes.  The unsym. nature of the triazole staple also allowed the synthesis of double-stapled BCL9 peptides, which show a marked increase in helical character and an improvement in binding affinity and metabolic stability relative to wild-type and linear BCL9 peptides.  This study lays the foundation for further optimization of these triazole-stapled BCL9 peptides as potent, metabolically stable, and cell-permeable inhibitors to target the β-catenin and BCL9 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf88hHn2HxybVg90H21EOLACvtfcHk0lgdyTxy8Kdcwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfL&md5=d0ab7aaf4074398402ae5f8b004a481b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm201125d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201125d%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DS.%2BA.%26aulast%3DColeska%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520triazole-stapled%2520BCL9%2520alpha-helical%2520peptides%2520to%2520target%2520the%2520beta-catenin%252FB-cell%2520CLL%252Flymphoma%25209%2520%2528BCL9%2529%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1137%26epage%3D1146%26doi%3D10.1021%2Fjm201125d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulciniti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">148ra117</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscitranslmed.3003808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22914623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=148ra117&author=K.+Takadaauthor=D.+Zhuauthor=G.+H.+Birdauthor=K.+Sukhdeoauthor=J.+J.+Zhaoauthor=M.+Maniauthor=M.+Lemieuxauthor=D.+E.+Carrascoauthor=J.+Ryanauthor=D.+Horstauthor=M.+Fulcinitiauthor=N.+C.+Munshiauthor=W.+Xuauthor=A.+L.+Kungauthor=R.+A.+Shivdasaniauthor=L.+D.+Walenskyauthor=D.+R.+Carrasco&title=Targeted+disruption+of+the+BCL9%2F%CE%B2-catenin+complex+inhibits+oncogenic+Wnt+signaling&doi=10.1126%2Fscitranslmed.3003808"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003808%26sid%3Dliteratum%253Aachs%26aulast%3DTakada%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DLemieux%26aufirst%3DM.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DHorst%26aufirst%3DD.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252F%25CE%25B2-catenin%2520complex%2520inhibits%2520oncogenic%2520Wnt%2520signaling%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D148ra117%26doi%3D10.1126%2Fscitranslmed.3003808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of beta-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">eaau5240</span>, <span class="refDoi"> DOI: 10.1126/sciadv.aau5240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fsciadv.aau5240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31086813" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=eaau5240&author=M.+Fengauthor=J.+Q.+Jinauthor=L.+Xiaauthor=T.+Xiaoauthor=S.+Meiauthor=X.+Wangauthor=X.+Huangauthor=J.+Chenauthor=M.+Liuauthor=C.+Chenauthor=S.+Rafiauthor=A.+X.+Zhuauthor=Y.+X.+Fengauthor=D.+Zhu&title=Pharmacological+inhibition+of+beta-catenin%2FBCL9+interaction+overcomes+resistance+to+immune+checkpoint+blockades+by+modulating+Treg+cells&doi=10.1126%2Fsciadv.aau5240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aau5240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aau5240%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%2BQ.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DRafi%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DFeng%26aufirst%3DY.%2BX.%26aulast%3DZhu%26aufirst%3DD.%26atitle%3DPharmacological%2520inhibition%2520of%2520beta-catenin%252FBCL9%2520interaction%2520overcomes%2520resistance%2520to%2520immune%2520checkpoint%2520blockades%2520by%2520modulating%2520Treg%2520cells%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26spage%3Deaau5240%26doi%3D10.1126%2Fsciadv.aau5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the BCL9/beta-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide</span>. <i>Nanotechnology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">115102</span>, <span class="refDoi"> DOI: 10.1088/1361-6528/ab5a03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1088%2F1361-6528%2Fab5a03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31751960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWnurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=115102&author=G.+Yangauthor=J.+Zhangauthor=W.+Youauthor=X.+Zhaoauthor=P.+Houauthor=W.+Heauthor=J.+Yanauthor=H.+Guo&title=Targeted+disruption+of+the+BCL9%2Fbeta-catenin+interaction+by+endosomal-escapable+nanoparticles+functionalized+with+an+E-cadherin-derived+peptide&doi=10.1088%2F1361-6528%2Fab5a03"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the BCL9/β-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide</span></div><div class="casAuthors">Yang, Guang; Zhang, Jun; You, Weiming; Zhao, Xinhan; Hou, Peng; He, Wangxiao; Yan, Jin; Guo, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Nanotechnology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">115102</span>CODEN:
                <span class="NLM_cas:coden">NNOTER</span>;
        ISSN:<span class="NLM_cas:issn">1361-6528</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">Abnormal activation of the Wnt/β-catenin signaling pathway, which underlies multiple malignancies, promotes tumor progression; drugs that can block this pathway are therefore highly attractive candidates for anticancer therapy.  Using a therapeutic peptide derived from E-cadherin region V (cECRV), we sought to develop a potent and selective antagonist of β-catenin that can disrupt the carcinogenic interaction between β-catenin and BCL9.  More importantly, to overcome the pharmacol. obstacles of peptide-derived therapeutics (poor nuclease stability and low membrane permeability), a gold nanoparticle (AuNP)-based nanocarrier was designed to deliver cECRV into the cytoplasm to modulate the intracellular interaction of β-catenin and BCL9.  The resultant nanoparticle, pAuNP-cECRV, showed no cytotoxicity towards normal peripheral blood mononuclear cells and induced cycle arrest and subsequent apoptosis of Wnt-hyperactive cancer cells by antagonizing β-catenin to inhibit the Wnt pathway.  Our results indicate that pAuNP-cECRV is very promising for application as an efficient and safe peptide delivery vector for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2l26o_E5ZcLVg90H21EOLACvtfcHk0lipn7u7DTAJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWnurvP&md5=fc5c979a3be3ac0a9405a927f9c9a1f8</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1088%2F1361-6528%2Fab5a03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1361-6528%252Fab5a03%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHou%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520BCL9%252Fbeta-catenin%2520interaction%2520by%2520endosomal-escapable%2520nanoparticles%2520functionalized%2520with%2520an%2520E-cadherin-derived%2520peptide%26jtitle%3DNanotechnology%26date%3D2020%26volume%3D31%26spage%3D115102%26doi%3D10.1088%2F1361-6528%2Fab5a03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulkadir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of β-catenin/B cell lymphoma 9 protein–protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">10757</span>– <span class="NLM_lpage">10762</span>, <span class="refDoi"> DOI: 10.1073/pnas.1819663116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1073%2Fpnas.1819663116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=31088961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVChsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=10757-10762&author=P.+Sangauthor=M.+Zhangauthor=Y.+Shiauthor=C.+Liauthor=S.+Abdulkadirauthor=Q.+Liauthor=H.+Jiauthor=J.+Cai&title=Inhibition+of+%CE%B2-catenin%2FB+cell+lymphoma+9+protein%E2%80%93protein+interaction+using+%CE%B1-helix-mimicking+sulfono-%CE%B3-AApeptide+inhibitors&doi=10.1073%2Fpnas.1819663116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors</span></div><div class="casAuthors">Sang, Peng; Zhang, Min; Shi, Yan; Li, Chunpu; Abdulkadir, Sami; Li, Qi; Ji, Haitao; Cai, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10757-10762</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The rational design of α-helix-mimicking peptidomimetics provides a streamlined approach to discover potent inhibitors for protein-protein interactions (PPIs).  However, designing cell-penetrating long peptidomimetic scaffolds equipped with various functional groups necessary for interacting with large protein-binding interfaces remains challenging.  This is particularly true for targeting β-catenin/BCL9 PPIs.  Here the authors designed a series of unprecedented helical sulfono-γ-AApeptides that mimic the binding mode of the α-helical HD2 domain of B Cell Lymphoma 9 (BCL9).  The studies show that sulfono-γ-AApeptides can structurally and functionally mimic the α-helical domain of BCL9 and selectively disrupt β-catenin/BCL9 PPIs with even higher potency.  More intriguingly, these sulfono-γ-AApeptides can enter cancer cells, bind with β-catenin and disrupt β-catenin/BCL9 PPIs, and exhibit excellent cellular activity, which is much more potent than the BCL9 peptide.  Furthermore, the enzymic stability studies demonstrate the remarkable stability of the helical sulfono-γ-AApeptides, with no degrdn. in the presence of pronase for 24 h, augmenting their biol. potential.  This work represents not only an example of helical sulfono-γ-AApeptides that mimic α-helix and disrupt protein-protein interactions, but also an excellent example of potent, selective, and cell-permeable unnatural foldameric peptidomimetics that disrupt the β-catenin/BCL9 PPI.  The design of helical sulfono-γ-AApeptides may lead to a new strategy to modulate a myriad of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_pKlgpb-_U7Vg90H21EOLACvtfcHk0lgtzOEudjVT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVChsr%252FE&md5=145172aa8475bfe4a20b97d6b88d12dd</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1819663116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1819663116%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DAbdulkadir%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520%25CE%25B2-catenin%252FB%2520cell%2520lymphoma%25209%2520protein%25E2%2580%2593protein%2520interaction%2520using%2520%25CE%25B1-helix-mimicking%2520sulfono-%25CE%25B3-AApeptide%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D10757%26epage%3D10762%26doi%3D10.1073%2Fpnas.1819663116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoggard, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of selective small-molecule inhibitors for beta-catenin/B-cell lymphoma 9 protein-protein interactions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">12249</span>– <span class="NLM_lpage">12260</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b04988</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b04988" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=12249-12260&author=L.+R.+Hoggardauthor=Y.+Zhangauthor=M.+Zhangauthor=V.+Panicauthor=J.+A.+Wisniewskiauthor=H.+Ji&title=Rational+design+of+selective+small-molecule+inhibitors+for+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interactions&doi=10.1021%2Fjacs.5b04988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Selective Small-Molecule Inhibitors for β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interactions</span></div><div class="casAuthors">Hoggard, Logan R.; Zhang, Yongqiang; Zhang, Min; Panic, Vanja; Wisniewski, John A.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12249-12260</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibition of α-helix-mediated protein-protein interactions (PPIs) with small org. mols. provides great potential for the discovery of chem. probes and therapeutic agents.  Protein Data Bank data mining using the HippDB database indicated that (1) the side chains of hydrophobic projecting hot spots at positions i, i + 3, and i + 7 of an α-helix had few orientations when interacting with the second protein and (2) the hot spot pockets of PPI complexes had different sizes, shapes, and chem. groups when interacting with the same hydrophobic projecting hot spots of α-helix.  On the basis of these observations, a small org. mol., 4'-fluoro-N-phenyl-[1,1'-biphenyl]-3-carboxamide, was designed as a generic scaffold that itself directly mimics the binding mode of the side chains of hydrophobic projecting hot spots at positions i, i + 3, and i + 7 of an α-helix.  Convenient decoration of this generic scaffold led to the selective disruption of α-helix-mediated PPIs.  A series of small-mol. inhibitors, e.g. I, selective for β-catenin/B-cell lymphoma 9 (BCL9) over β-catenin/cadherin PPIs was designed and synthesized.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This new class of inhibitors can selectively disrupt β-catenin/BCL9 over β-catenin/cadherin PPIs, suppress the transactivation of canonical Wnt signaling, downregulate the expression of Wnt target genes, and inhibit the growth of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-evFFAIdibVg90H21EOLACvtfcHk0lgtzOEudjVT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7jI&md5=37b926ed7c76fbd010394cae8bb54d43</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b04988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b04988%26sid%3Dliteratum%253Aachs%26aulast%3DHoggard%26aufirst%3DL.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DPanic%26aufirst%3DV.%26aulast%3DWisniewski%26aufirst%3DJ.%2BA.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D12249%26epage%3D12260%26doi%3D10.1021%2Fjacs.5b04988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of 1,4-dibenzoylpiperazines as beta-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00284</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00284" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=508-513&author=J.+A.+Wisniewskiauthor=J.+Yinauthor=K.+B.+Teuscherauthor=M.+Zhangauthor=H.+Ji&title=Structure-based+design+of+1%2C4-dibenzoylpiperazines+as+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interaction+inhibitors&doi=10.1021%2Facsmedchemlett.5b00284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors</span></div><div class="casAuthors">Wisniewski, John A.; Yin, Jinya; Teuscher, Kevin B.; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small-mol. inhibitor with a 1,4-dibenzoylpiperazine scaffold was designed to match the crit. binding elements in the β-catenin/B-cell lymphoma 9 (BCL9) protein-protein interaction interface.  Inhibitor optimization led to a potent inhibitor that can disrupt the β-catenin/BCL9 interaction and exhibit 98-fold selectivity over the β-catenin/cadherin interaction.  The binding mode of new inhibitors was characterized by structure-activity relationships and site-directed mutagenesis studies.  Cell-based studies demonstrated that this series of inhibitors can selectively suppress canonical Wnt signaling and inhibit growth of Wnt/β-catenin-dependent cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsn0fnki55DrVg90H21EOLACvtfcHk0lgtzOEudjVT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrsrc%253D&md5=9e4e1a892bdd6221b9775235fb84231b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00284%26sid%3Dliteratum%253Aachs%26aulast%3DWisniewski%26aufirst%3DJ.%2BA.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DTeuscher%26aufirst%3DK.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%25201%252C4-dibenzoylpiperazines%2520as%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D508%26epage%3D513%26doi%3D10.1021%2Facsmedchemlett.5b00284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of small-molecule inhibitors for the beta-catenin/B-cell lymphoma 9 protein-protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3007</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls12kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2989-3007&author=M.+Zhangauthor=Z.+Wangauthor=Y.+Zhangauthor=W.+Guoauthor=H.+Ji&title=Structure-based+optimization+of+small-molecule+inhibitors+for+the+beta-catenin%2FB-cell+lymphoma+9+protein-protein+interaction&doi=10.1021%2Facs.jmedchem.8b00068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction</span></div><div class="casAuthors">Zhang, Min; Wang, Zhen; Zhang, Yongqiang; Guo, Wenxing; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3007</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based optimization was conducted to improve the potency, selectivity, and cell-based activities of β-catenin/B-cell lymphoma 9 (BCL9) inhibitors based on the 4'-fluoro-N-phenyl-[1,1'-biphenyl]-3-carboxamide scaffold, which was designed to mimic the side chains of the hydrophobic α-helical hot spots at positions i, i + 3, and i + 7.  Compd. I was found to disrupt the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.47 μM and >1900-fold selectivity for β-catenin/BCL9 over β-catenin/E-cadherin PPIs.  The proposed binding mode of new inhibitors was consistent with the results of site-directed mutagenesis and structure-activity relationship studies.  Cell-based studies indicated that I disrupted the β-catenin/BCL9 interaction without affecting the β-catenin/E-cadherin interaction, selectively suppressed transactivation of Wnt/β-catenin signaling, downregulated expression of Wnt target genes, and inhibited viability of Wnt/β-catenin-dependent cancer cells in dose-dependent manners.  A comparison of the biochem. and cell-based assay results offered the directions for future inhibitor optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjKijQp_D7qLVg90H21EOLACvtfcHk0lhVzkgsBFoXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls12kurg%253D&md5=11d6f311eb3ef90c8749c8440335bf71</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00068%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DStructure-based%2520optimization%2520of%2520small-molecule%2520inhibitors%2520for%2520the%2520beta-catenin%252FB-cell%2520lymphoma%25209%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2989%26epage%3D3007%26doi%3D10.1021%2Facs.jmedchem.8b00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burzio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allende, J. E.</span></span> <span> </span><span class="NLM_article-title">Biochemical and cellular characteristics of the four splice variants of protein kinase CK1alpha from zebrafish (Danio rerio)</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1002/jcb.10263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fjcb.10263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12210746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVOhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2002&pages=805-814&author=V.+Burzioauthor=M.+Antonelliauthor=C.+C.+Allendeauthor=J.+E.+Allende&title=Biochemical+and+cellular+characteristics+of+the+four+splice+variants+of+protein+kinase+CK1alpha+from+zebrafish+%28Danio+rerio%29&doi=10.1002%2Fjcb.10263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and cellular characteristics of the four splice variants of protein kinase CK1α from zebrafish (Danio rerio)</span></div><div class="casAuthors">Burzio, Veronica; Antonelli, Marcelo; Allende, Catherine C.; Allende, Jorge E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">805-814</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Protein kinase CK1 (previously known as casein kinase 1) conforms to a subgroup of the great protein kinase family found in eukaryotic organisms.  The CK1 subgroup of vertebrates contains seven members known as α, β, γ1, γ2, γ3, δ, and ε.  The CK1α gene can generate four variants (CK1α, CK1αS, CK1αL, and CK1αLS) through alternate splicing, characterized by the presence or absence of two addnl. coding sequences.  Exon "L" encodes a 28-amino acid stretch that is inserted after lysine 152, in the center of the catalytic domain.  The "S" insert encodes 12 amino acid residues and is located close to the C-terminus of the protein.  This work reports some biochem. and cellular properties of the four CK1α variants found to be expressed in zebrafish (Danio rerio).  The results obtained indicate that the presence of the "L" insert affects several biochem. properties of CK1α: (a) it increases the apparent Km for ATP twofold, from ∼30 to ∼60 μM; (b) it decreases the sensitivity to the CK1-7 inhibitor, raising the IC50 values from 113 to ∼230 μM; (c) it greatly decreases the heat stability of the enzyme at 40°.  In addn., the insertion of the "L" fragment exerts very important effects on some cellular properties of the enzyme.  CK1αL concs. in the cell nucleus, excluding nucleoli, while the CK1α variant is predominantly cytoplasmic, although some presence is obsd. in the nucleus.  This finding supports the thesis that the basic-rich region found in the "L" insert acts as a nuclear localization signal.  The "L" insert-contg. variant was also found to be more rapidly degraded (half-life of 100 min) than the CK1α variant (half-life of 400 min) in transfected Cos-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZODmQyffCtLVg90H21EOLACvtfcHk0lhVzkgsBFoXYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVOhurc%253D&md5=5d0d712d8e53e8c4b7702799e363d685</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fjcb.10263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.10263%26sid%3Dliteratum%253Aachs%26aulast%3DBurzio%26aufirst%3DV.%26aulast%3DAntonelli%26aufirst%3DM.%26aulast%3DAllende%26aufirst%3DC.%2BC.%26aulast%3DAllende%26aufirst%3DJ.%2BE.%26atitle%3DBiochemical%2520and%2520cellular%2520characteristics%2520of%2520the%2520four%2520splice%2520variants%2520of%2520protein%2520kinase%2520CK1alpha%2520from%2520zebrafish%2520%2528Danio%2520rerio%2529%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2002%26volume%3D86%26spage%3D805%26epage%3D814%26doi%3D10.1002%2Fjcb.10263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knippschild, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Reyes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peifer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halekotte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakulev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischof, J.</span></span> <span> </span><span class="NLM_article-title">The CK1 family: contribution to cellular stress response and its role in carcinogenesis</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fonc.2014.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffonc.2014.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=24904820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=96&author=U.+Knippschildauthor=M.+Kr%C3%BCgerauthor=J.+Richterauthor=P.+Xuauthor=B.+Garc%C3%ADa-Reyesauthor=C.+Peiferauthor=J.+Halekotteauthor=V.+Bakulevauthor=J.+Bischof&title=The+CK1+family%3A+contribution+to+cellular+stress+response+and+its+role+in+carcinogenesis&doi=10.3389%2Ffonc.2014.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis</span></div><div class="casAuthors">Knippschild Uwe; Kruger Marc; Richter Julia; Xu Pengfei; Garcia-Reyes Balbina; Bischof Joachim; Peifer Christian; Halekotte Jakob; Bakulev Vasiliy</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Members of the highly conserved and ubiquitously expressed pleiotropic CK1 family play major regulatory roles in many cellular processes including DNA-processing and repair, proliferation, cytoskeleton dynamics, vesicular trafficking, apoptosis, and cell differentiation.  As a consequence of cellular stress conditions, interaction of CK1 with the mitotic spindle is manifold increased pointing to regulatory functions at the mitotic checkpoint.  Furthermore, CK1 is able to alter the activity of key proteins in signal transduction and signal integration molecules.  In line with this notion, CK1 is tightly connected to the regulation and degradation of β-catenin, p53, and MDM2.  Considering the importance of CK1 for accurate cell division and regulation of tumor suppressor functions, it is not surprising that mutations and alterations in the expression and/or activity of CK1 isoforms are often detected in various tumor entities including cancer of the kidney, choriocarcinomas, breast carcinomas, oral cancer, adenocarcinomas of the pancreas, and ovarian cancer.  Therefore, scientific effort has enormously increased (i) to understand the regulation of CK1 and its involvement in tumorigenesis- and tumor progression-related signal transduction pathways and (ii) to develop CK1-specific inhibitors for the use in personalized therapy concepts.  In this review, we summarize the current knowledge regarding CK1 regulation, function, and interaction with cellular proteins playing central roles in cellular stress-responses and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTjHiOSmRmv6BottYdIAWfW6udTcc2eas4KaenYLC6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFOmtw%253D%253D&md5=bb32cb676ab1dd0ba2ae290a282e4042</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00096%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DKr%25C3%25BCger%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Reyes%26aufirst%3DB.%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DHalekotte%26aufirst%3DJ.%26aulast%3DBakulev%26aufirst%3DV.%26aulast%3DBischof%26aufirst%3DJ.%26atitle%3DThe%2520CK1%2520family%253A%2520contribution%2520to%2520cellular%2520stress%2520response%2520and%2520its%2520role%2520in%2520carcinogenesis%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26spage%3D96%26doi%3D10.3389%2Ffonc.2014.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. A.</span></span> <span> </span><span class="NLM_article-title">CKI, there’s more than one: casein kinase I family members in Wnt and Hedgehog signaling</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1101/gad.1394306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1101%2Fgad.1394306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16481469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=399-410&author=M.+A.+Price&title=CKI%2C+there%E2%80%99s+more+than+one%3A+casein+kinase+I+family+members+in+Wnt+and+Hedgehog+signaling&doi=10.1101%2Fgad.1394306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling</span></div><div class="casAuthors">Price, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">399-410</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Multiple members of the casein kinase I family of serine/threonine protein kinases are involved in pos. and neg. roles in Wnt and Hedgehog signaling.  Here authors review these roles, including recent results on casein kinase I (CKI) phosphorylation and activation of LRP6, and CKI phosphorylation of Ci and mediation of Ci-Slimb/β-TrCP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL3VS0330bDLVg90H21EOLACvtfcHk0ljti85qAJTG5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqurg%253D&md5=31844a6a74863b7de9329c47e1ed40c4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1101%2Fgad.1394306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1394306%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3DCKI%252C%2520there%25E2%2580%2599s%2520more%2520than%2520one%253A%2520casein%2520kinase%2520I%2520family%2520members%2520in%2520Wnt%2520and%2520Hedgehog%2520signaling%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D399%26epage%3D410%26doi%3D10.1101%2Fgad.1394306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, N T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorhoeve, P M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virshup, D M</span></span> <span> </span><span class="NLM_article-title">IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1delta/varepsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2569</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2010.627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=21258417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2558-2569&author=J+K+Cheongauthor=N+T+Hungauthor=H+Wangauthor=P+Tanauthor=P+M+Voorhoeveauthor=S+H+Leeauthor=D+M+Virshup&title=IC261+induces+cell+cycle+arrest+and+apoptosis+of+human+cancer+cells+via+CK1delta%2Fvarepsilon+and+Wnt%2Fbeta-catenin+independent+inhibition+of+mitotic+spindle+formation&doi=10.1038%2Fonc.2010.627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/.vepsiln. and Wnt/β-catenin independent inhibition of mitotic spindle formation</span></div><div class="casAuthors">Cheong, J.-K.; Hung, N.-T.; Wang, H.; Tan, P.; Voorhoeve, P. M.; Lee, S.-H.; Virshup, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2558-2569</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Casein kinase 1 delta and epsilon (CK1δ/.vepsiln.) are key regulators of diverse cellular growth and survival processes including Wnt signaling, DNA repair, and circadian rhythms.  Recent studies suggest that they have an important role in oncogenesis.  RNA interference screens identified CK1.vepsiln. as a pro-survival factor in cancer cells in vitro and the CK1δ/.vepsiln.-specific inhibitor IC261 is remarkably effective at selective, synthetic lethal killing of cancer cells.  The recent development of the nanomolar CK1δ/.vepsiln.-selective inhibitor, PF670462 (PF670) and the CK1.vepsiln.-selective inhibitor PF4800567 (PF480) offers an opportunity to further test the role of CK1δ/.vepsiln. in cancer.  Unexpectedly, and unlike IC261, PF670, and PF480 were unable to induce cancer cell death.  PF670 is a potent inhibitor of CK1δ/.vepsiln. in cells; nanomolar concns. are sufficient to inhibit CK1δ/.vepsiln. activity as measured by repression of intramol. autophosphorylation, phosphorylation of disheveled2 proteins and Wnt/β-catenin signaling.  Likewise, small interfering RNA knockdown of CK1δ and CK1.vepsiln. reduced Wnt/β-catenin signaling without affecting cell viability, further suggesting that CK1δ/.vepsiln. inhibition may not be relevant to the IC261-induced cell death.  Thus, while PF670 is a potent inhibitor of Wnt signaling, it only modestly inhibits cell proliferation.  In contrast, while sub-micromolar concns. of IC261 neither inhibited CK1δ/.vepsiln. kinase activity nor blocked Wnt/β-catenin signaling in cancer cells, it caused a rapid induction of prometaphase arrest and subsequent apoptosis in multiple cancer cell lines.  In a stepwise transformation model, IC261-induced killing required both overactive Ras and inactive p53.  IC261 binds to tubulin with an affinity similar to colchicine and is a potent inhibitor of microtubule polymn.  This activity accounts for many of the diverse biol. effects of IC261 and, most importantly, for its selective cancer cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2-oBoBuERhLVg90H21EOLACvtfcHk0lhwU71u7GA1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1aiug%253D%253D&md5=c4e1582494dfbfd3fce5084dd5864d41</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.627%26sid%3Dliteratum%253Aachs%26aulast%3DCheong%26aufirst%3DJ%2BK%26aulast%3DHung%26aufirst%3DN%2BT%26aulast%3DWang%26aufirst%3DH%26aulast%3DTan%26aufirst%3DP%26aulast%3DVoorhoeve%26aufirst%3DP%2BM%26aulast%3DLee%26aufirst%3DS%2BH%26aulast%3DVirshup%26aufirst%3DD%2BM%26atitle%3DIC261%2520induces%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520of%2520human%2520cancer%2520cells%2520via%2520CK1delta%252Fvarepsilon%2520and%2520Wnt%252Fbeta-catenin%2520independent%2520inhibition%2520of%2520mitotic%2520spindle%2520formation%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2558%26epage%3D2569%26doi%3D10.1038%2Fonc.2010.627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. M.</span></span> <span> </span><span class="NLM_article-title">Casein kinase I transduces Wnt signals</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1038/43830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F43830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10517632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFalsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=345-350&author=J.+M.+Petersauthor=R.+M.+McKayauthor=J.+P.+McKayauthor=J.+M.+Graff&title=Casein+kinase+I+transduces+Wnt+signals&doi=10.1038%2F43830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase I transduces Wnt signals</span></div><div class="casAuthors">Peters, John M.; McKay, Renee M.; McKay, James P.; Graff, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6751</span>),
    <span class="NLM_cas:pages">345-350</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">We describe a serine kinase, casein kinase I (CKI), which was isolated by expression cloning in Xenopus embryos.  CKI reproduces several properties of Wnt signals, including generation of complete dorsal axes, stabilization of β-catenin, and induction of genes that are direct targets of Wnt signals.  Dominant-neg. forms of CKI and a pharmacol. blocker of CKI inhibited Wnt signals in Xenopus.  Inhibiting CKI in Caenorhabditis elegans generated worms with a mom phenotype, indicative of a loss of Wnt signals.  In addn., CKI bound to and increased the phosphorylation of dishevelled, a known component of the Wnt pathway.  These data indicate that CKI may be a conserved component of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6A1qcH4qY6rVg90H21EOLACvtfcHk0lhwU71u7GA1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFalsbg%253D&md5=94c19810e000cc6432bf74f8ab019c96</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2F43830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43830%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26aulast%3DMcKay%26aufirst%3DR.%2BM.%26aulast%3DMcKay%26aufirst%3DJ.%2BP.%26aulast%3DGraff%26aufirst%3DJ.%2BM.%26atitle%3DCasein%2520kinase%2520I%2520transduces%2520Wnt%2520signals%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D345%26epage%3D350%26doi%3D10.1038%2F43830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+Wnt+signaling+through+activation+of+casein+kinase+1alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0lhwU71u7GA1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520Wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neitzel, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkbride, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doundoulakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreu, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Differential abundance of CK1alpha provides selectivity for pharmacological CK1alpha activators to target WNT-dependent tumors</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">eaak9916</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aak9916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscisignal.aak9916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28655862" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=eaak9916&author=B.+Liauthor=D.+Ortonauthor=L.+R.+Neitzelauthor=L.+Astudilloauthor=C.+Shenauthor=J.+Longauthor=X.+Chenauthor=K.+C.+Kirkbrideauthor=T.+Doundoulakisauthor=M.+L.+Guerraauthor=J.+Zaiasauthor=D.+L.+Feiauthor=J.+Rodriguez-Blancoauthor=C.+Thorneauthor=Z.+Wangauthor=K.+Jinauthor=D.+M.+Nguyenauthor=L.+R.+Sandsauthor=F.+Marchettiauthor=M.+T.+Abreuauthor=M.+H.+Cobbauthor=A.+J.+Capobiancoauthor=E.+Leeauthor=D.+J.+Robbins&title=Differential+abundance+of+CK1alpha+provides+selectivity+for+pharmacological+CK1alpha+activators+to+target+WNT-dependent+tumors&doi=10.1126%2Fscisignal.aak9916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aak9916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aak9916%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DNeitzel%26aufirst%3DL.%2BR.%26aulast%3DAstudillo%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKirkbride%26aufirst%3DK.%2BC.%26aulast%3DDoundoulakis%26aufirst%3DT.%26aulast%3DGuerra%26aufirst%3DM.%2BL.%26aulast%3DZaias%26aufirst%3DJ.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DThorne%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DSands%26aufirst%3DL.%2BR.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DAbreu%26aufirst%3DM.%2BT.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DDifferential%2520abundance%2520of%2520CK1alpha%2520provides%2520selectivity%2520for%2520pharmacological%2520CK1alpha%2520activators%2520to%2520target%2520WNT-dependent%2520tumors%26jtitle%3DSci.%2520Signaling%26date%3D2017%26volume%3D10%26spage%3Deaak9916%26doi%3D10.1126%2Fscisignal.aak9916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaim, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleveland, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Development of highly selective casein kinase 1delta/1epsilon (CK1delta/epsilon) inhibitors with potent antiproliferative properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4374</span>– <span class="NLM_lpage">4380</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmcl.2013.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23787102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4374-4380&author=M.+Bibianauthor=R.+J.+Rahaimauthor=J.+Y.+Choiauthor=Y.+Noguchiauthor=S.+Schurerauthor=W.+Chenauthor=S.+Nakanishiauthor=K.+Lichtauthor=L.+H.+Rosenbergauthor=L.+Liauthor=Y.+Fengauthor=M.+D.+Cameronauthor=D.+R.+Duckettauthor=J.+L.+Clevelandauthor=W.+R.+Roush&title=Development+of+highly+selective+casein+kinase+1delta%2F1epsilon+%28CK1delta%2Fepsilon%29+inhibitors+with+potent+antiproliferative+properties&doi=10.1016%2Fj.bmcl.2013.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties</span></div><div class="casAuthors">Bibian, Mathieu; Rahaim, Ronald J.; Choi, Jun Yong; Noguchi, Yoshihiko; Schurer, Stephan; Chen, Weimin; Nakanishi, Shima; Licht, Konstantin; Rosenberg, Laura H.; Li, Lin; Feng, Yangbo; Cameron, Michael D.; Duckett, Derek R.; Cleveland, John L.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4374-4380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of a series of potent and highly selective casein kinase 1δ/ε (CK1δ/ε) inhibitors is described.  Starting from a purine scaffold inhibitor (SR-653234) identified by high throughput screening, the authors developed a series of potent and highly kinase selective inhibitors, including SR-2890 and SR-3029, which have IC50 ≤ 50 nM vs. CK1δ.  The two lead compds. have ≤100 nM EC50 values in MTT assays against the human A375 melanoma cell line and have phys., in vitro and in vivo PK properties suitable for use in proof of principle animal xenograft studies against human cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4EwGWzCSXbVg90H21EOLACvtfcHk0ljUtwrKwRG2QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGitLo%253D&md5=b9e2f0685bede426f981301cbe87dd7b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DRahaim%26aufirst%3DR.%2BJ.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DSchurer%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DLicht%26aufirst%3DK.%26aulast%3DRosenberg%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DDevelopment%2520of%2520highly%2520selective%2520casein%2520kinase%25201delta%252F1epsilon%2520%2528CK1delta%252Fepsilon%2529%2520inhibitors%2520with%2520potent%2520antiproliferative%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4374%26epage%3D4380%26doi%3D10.1016%2Fj.bmcl.2013.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafitte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quereda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallahi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleveland, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, D. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of casein kinase 1delta in breast cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">318ra202</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aac8773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1126%2Fscitranslmed.aac8773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26676609" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=318ra202&author=L.+H.+Rosenbergauthor=M.+Lafitteauthor=V.+Queredaauthor=W.+Grantauthor=W.+Chenauthor=M.+Bibianauthor=Y.+Noguchiauthor=M.+Fallahiauthor=C.+Yangauthor=J.+C.+Changauthor=W.+R.+Roushauthor=J.+L.+Clevelandauthor=D.+R.+Duckett&title=Therapeutic+targeting+of+casein+kinase+1delta+in+breast+cancer&doi=10.1126%2Fscitranslmed.aac8773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aac8773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aac8773%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DL.%2BH.%26aulast%3DLafitte%26aufirst%3DM.%26aulast%3DQuereda%26aufirst%3DV.%26aulast%3DGrant%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBibian%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DFallahi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DCleveland%26aufirst%3DJ.%2BL.%26aulast%3DDuckett%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520targeting%2520of%2520casein%2520kinase%25201delta%2520in%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D318ra202%26doi%3D10.1126%2Fscitranslmed.aac8773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span> <span> </span><span class="NLM_article-title">Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">18394</span>– <span class="NLM_lpage">18400</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601112200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M601112200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=16672224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVagsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=18394-18400&author=Y.+Gaoauthor=H.+Y.+Wang&title=Casein+kinase+2+Is+activated+and+essential+for+Wnt%2Fbeta-catenin+signaling&doi=10.1074%2Fjbc.M601112200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Casein Kinase 2 Is Activated and Essential for Wnt/β-Catenin Signaling</span></div><div class="casAuthors">Gao, Yuan; Wang, Hsien-yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">18394-18400</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is essential to early development.  Activation of Frizzled-1 by Wnts induces nuclear accumulation of β-catenin and activation of Lef/Tcf-dependent gene expression.  Casein kinase 2 has been shown to affect Wnt/β-catenin signaling.  How casein kinase 2 exerts an influence in Wnt signaling is not clear; casein kinase 2 has been reported to be constitutively active (i.e. not regulated).  Herein we show to the contrary that casein kinase 2 activity is rapidly and transiently increased in response to Wnt3a stimulation and is essential for Wnt/β-catenin signaling.  Chem. inhibition of casein kinase 2 or suppression of its expression blocks Frizzled-1 activation of Lef/Tcf-sensitive gene expression.  Treatment with pertussis toxin or knock down of Gαq or Gαo blocks Wnt stimulation of casein kinase 2 activation, as does suppression of the phosphoprotein Dishevelled, demonstrating that casein kinase 2 is downstream of heterotrimeric G proteins and Dishevelled.  Expression of a constitutively active mutant of either Gαq or Gαo stimulates casein kinase 2 activation and Lef/Tcf-sensitive gene expression.  Thus, casein kinase 2 is shown to be regulated by Wnt3a and essential to stimulation of the Frizzled-1/β-catenin/Lef-Tcf pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVEwpTgwH-7Vg90H21EOLACvtfcHk0liWwtGDZ3N97w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVagsbc%253D&md5=31abb9123eaebaca5510424d40cb77b2</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601112200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601112200%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%2BY.%26atitle%3DCasein%2520kinase%25202%2520Is%2520activated%2520and%2520essential%2520for%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D18394%26epage%3D18400%26doi%3D10.1074%2Fjbc.M601112200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racicot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, E.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibitors of CK2 kinase identified through structure-guided hybridization</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1021/ml200257n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200257n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=278-283&author=J.+E.+Dowlingauthor=C.+Chuaquiauthor=T.+W.+Pontzauthor=P.+D.+Lyneauthor=N.+A.+Larsenauthor=M.+H.+Blockauthor=H.+Chenauthor=N.+Suauthor=A.+Wuauthor=D.+Russellauthor=H.+Pollardauthor=J.+W.+Leeauthor=B.+Pengauthor=K.+Thakurauthor=Q.+Yeauthor=T.+Zhangauthor=P.+Brassilauthor=V.+Racicotauthor=L.+Baoauthor=C.+R.+Denzauthor=E.+Cooke&title=Potent+and+selective+inhibitors+of+CK2+kinase+identified+through+structure-guided+hybridization&doi=10.1021%2Fml200257n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization</span></div><div class="casAuthors">Dowling, James E.; Chuaqui, Claudio; Pontz, Timothy W.; Lyne, Paul D.; Larsen, Nicholas A.; Block, Michael H.; Chen, Huawei; Su, Nancy; Wu, Allan; Russell, Daniel; Pollard, Hannah; Lee, John W.; Peng, Bo; Thakur, Kumar; Ye, Qing; Zhang, Tao; Brassil, Patrick; Racicot, Vicki; Bao, Larry; Denz, Christopher R.; Cooke, Emma</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we describe a series of 3-cyano-5-aryl-7-aminopyrazolo[1,5-a]pyrimidine hits identified by kinase-focused subset screening as starting points for the structure-based design of conformationally constrained 6-acetamido-indole inhibitors of CK2.  The synthesis, SAR, and effects of this novel series on Akt signaling and cell proliferation in vitro are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KiKEaopMGLVg90H21EOLACvtfcHk0liza6fy4Xu9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFems7k%253D&md5=4220eac03a382c3e6849da723fd5fc6d</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fml200257n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200257n%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DPontz%26aufirst%3DT.%2BW.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DThakur%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DRacicot%26aufirst%3DV.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DCooke%26aufirst%3DE.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520CK2%2520kinase%2520identified%2520through%2520structure-guided%2520hybridization%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D278%26epage%3D283%26doi%3D10.1021%2Fml200257n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimzhanov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyne, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span> <span> </span><span class="NLM_article-title">Potent and selective CK2 kinase inhibitors with effects on Wnt pathway signaling in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=300-305&author=J.+E.+Dowlingauthor=M.+Alimzhanovauthor=L.+Baoauthor=C.+Chuaquiauthor=C.+R.+Denzauthor=E.+Jenkinsauthor=N.+A.+Larsenauthor=P.+D.+Lyneauthor=T.+Pontzauthor=Q.+Yeauthor=G.+A.+Holdgateauthor=L.+Snowauthor=N.+O%E2%80%99Connellauthor=A.+D.+Ferguson&title=Potent+and+selective+CK2+kinase+inhibitors+with+effects+on+Wnt+pathway+signaling+in+vivo&doi=10.1021%2Facsmedchemlett.5b00452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo</span></div><div class="casAuthors">Dowling, James E.; Alimzhanov, Marat; Bao, Larry; Chuaqui, Claudio; Denz, Christopher R.; Jenkins, Emma; Larsen, Nicholas A.; Lyne, Paul D.; Pontz, Timothy; Ye, Qing; Holdgate, Geoff A.; Snow, Lindsay; O'Connell, Nichole; Ferguson, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt pathway is an evolutionarily conserved and tightly regulated signaling network with important roles in embryonic development and adult tissue regeneration.  Impaired Wnt pathway regulation, arising from mutations in Wnt signaling components, such as Axin, APC, and β-catenin, results in uncontrolled cell growth and triggers oncogenesis.  To explore the reported link between CK2 kinase activity and Wnt pathway signaling, the authors sought to identify a potent, selective inhibitor of CK2 suitable for proof of concept studies in vivo.  Starting from a pyrazolo[1,5-a]pyrimidine lead, the authors identified N-(2-((2-aminoethyl)(methyl)amino)-5-(3-cyano-7-(cyclopropylamino) pyrazolo[1,5-a]pyrimidin-5-ylamino)phenyl)acetamide (compd. 7h), a potent CK2 inhibitor with picomolar affinity that is highly selectivity against other kinase family enzymes and inhibits Wnt pathway signaling (IC50 = 50 nM) in DLD-1 cells.  In addn., (compd. 7h) has physicochem. properties that are suitable for formulation as an i.v. soln., has demonstrated good pharmacokinetics in preclin. species, and exhibits a high level of activity as a monotherapy in HCT-116 and SW-620 xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO9Sjmp1vsrLVg90H21EOLACvtfcHk0liza6fy4Xu9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVamtLk%253D&md5=515b631b98c356f27733856cfdca78b7</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00452%26sid%3Dliteratum%253Aachs%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DDenz%26aufirst%3DC.%2BR.%26aulast%3DJenkins%26aufirst%3DE.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DPontz%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DSnow%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26atitle%3DPotent%2520and%2520selective%2520CK2%2520kinase%2520inhibitors%2520with%2520effects%2520on%2520Wnt%2520pathway%2520signaling%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D300%26epage%3D305%26doi%3D10.1021%2Facsmedchemlett.5b00452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/82047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2F82047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=11101902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVahsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=1178-1184&author=H.+C.+Wongauthor=J.+Maoauthor=J.+T.+Nguyenauthor=S.+Srinivasauthor=W.+Zhangauthor=B.+Liuauthor=L.+Liauthor=D.+Wuauthor=J.+Zheng&title=Structural+basis+of+the+recognition+of+the+dishevelled+DEP+domain+in+the+Wnt+signaling+pathway&doi=10.1038%2F82047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of the recognition of the Dishevelled DEP domain in the Wnt signaling pathway</span></div><div class="casAuthors">Wong, Hing C.; Mao, Junhao; Nguyen, Jason T.; Srinivas, Shamala; Zhang, Weixing; Liu, Bo; Li, Lin; Wu, Dianqing; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1178-1184</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The DEP domain of Dishevelled (Dvl) proteins transduces signals to effector proteins downstream of Dvl in the Wnt pathway.  Here we report that DEP-contg. mutants inhibit Wnt-induced, but not Dvl-induced, activation of the transcription factor Lef-1.  This inhibitory effect is weakened by a K434M mutation.  NMR spectroscopy revealed that the DEP domain of mouse Dvl1 comprises a 3-helix bundle, a β-hairpin arm, and 2 short β-strands at the C-terminal region.  Lys 434 is located at the tip of the β-hairpin arm.  Based on our findings, we conclude that DEP interacts with regulators upstream of Dvl via a strong elec. dipole on the mol.'s surface created by Lys 434, Asp 445, and Asp 448; the elec. dipole and the putative membrane binding site are at 2 different locations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX7wgDtrv3QLVg90H21EOLACvtfcHk0lh5022ti-0GPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVahsbY%253D&md5=b8519f7eb67edac732dbcd02dc61c2d0</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2F82047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F82047%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BC.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DJ.%2BT.%26aulast%3DSrinivas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520the%2520recognition%2520of%2520the%2520dishevelled%2520DEP%2520domain%2520in%2520the%2520Wnt%2520signaling%2520pathway%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D1178%26epage%3D1184%26doi%3D10.1038%2F82047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlodzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00427-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2FS1097-2765%2803%2900427-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=14636582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1251-1260&author=H.+C.+Wongauthor=A.+Bourdelasauthor=A.+Kraussauthor=H.+J.+Leeauthor=Y.+Shaoauthor=D.+Wuauthor=M.+Mlodzikauthor=D.+L.+Shiauthor=J.+Zheng&title=Direct+binding+of+the+PDZ+domain+of+Dishevelled+to+a+conserved+internal+sequence+in+the+C-terminal+region+of+Frizzled&doi=10.1016%2FS1097-2765%2803%2900427-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled</span></div><div class="casAuthors">Wong, Hing-C.; Bourdelas, Audrey; Krauss, Anke; Lee, Ho-jin; Shao, Youming; Wu, Dianqing; Mlodzik, Marek; Shi, De-li; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cytoplasmic protein Dishevelled (Dvl) and the assocd. membrane-bound receptor Frizzled (Fz) are essential in canonical and noncanonical Wnt signaling pathways.  However, the mol. mechanisms underlying this signaling are not well understood.  By using NMR spectroscopy, we detd. that an internal sequence of Fz binds to the conventional peptide binding site in the PDZ domain of Dvl; this type of site typically binds to C-terminal binding motifs.  The C-terminal region of the Dvl inhibitor Dapper (Dpr) and Frodo bound to the same site.  In Xenopus, Dvl binding peptides of Fz and Dpr/Frodo inhibited canonical Wnt signaling and blocked Wnt-induced secondary axis formation in a dose-dependent manner, but did not block noncanonical Wnt signaling mediated by the DEP domain.  Together, our results identify a missing mol. connection within the Wnt pathway.  Differences in the binding affinity of the Dvl PDZ domain and its binding partners may be important in regulating signal transduction by Dvl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOkZJXRHLR2rVg90H21EOLACvtfcHk0lh5022ti-0GPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGhtbc%253D&md5=fcae6a79c94783ee442a260755f0dff1</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900427-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900427-1%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BC.%26aulast%3DBourdelas%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMlodzik%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DDirect%2520binding%2520of%2520the%2520PDZ%2520domain%2520of%2520Dishevelled%2520to%2520a%2520conserved%2520internal%2520sequence%2520in%2520the%2520C-terminal%2520region%2520of%2520Frizzled%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2FS1097-2765%2803%2900427-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a specific inhibitor of the dishevelled PDZ domain</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">15495</span>– <span class="NLM_lpage">15503</span>, <span class="refDoi"> DOI: 10.1021/bi0512602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0512602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFynur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=15495-15503&author=J.+Shanauthor=D.+L.+Shiauthor=J.+Wangauthor=J.+Zheng&title=Identification+of+a+specific+inhibitor+of+the+dishevelled+PDZ+domain&doi=10.1021%2Fbi0512602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Specific Inhibitor of the Dishevelled PDZ Domain</span></div><div class="casAuthors">Shan, Jufang; Shi, De-Li; Wang, Junmei; Zheng, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15495-15503</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Wnt signaling pathways are involved in embryo development as well as in tumorigenesis.  Dishevelled (Dvl) transduces Wnt signals from the receptor Frizzled (Fz) to downstream components in canonical and noncanonical Wnt signaling pathways.  The Dvl PDZ domain is thought to play an essential role in both pathways, and we recently demonstrated that the Dvl PDZ domain binds directly to Fz receptors.  In this study, using structure-based virtual ligand screening, we identified an org. mol. (NSC668036) from the National Cancer Institute small-mol. library that can bind to the Dvl PDZ domain.  We then used mol. dynamics simulation to analyze the binding between the PDZ domain and NSC668036 in detail.  In addn., we showed that, in Xenopus, as expected, NSC668036 inhibited the signaling induced by Wnt3A.  This compd. provides a basis for rational design of high-affinity inhibitors of the PDZ domain, which can block Wnt signaling by interrupting the Fz-Dvl interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5nd8jL6L9KLVg90H21EOLACvtfcHk0lh5022ti-0GPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFynur%252FK&md5=e65f625e85f18f9386fbb181f19e37f9</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fbi0512602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0512602%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520dishevelled%2520PDZ%2520domain%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D15495%26epage%3D15503%26doi%3D10.1021%2Fbi0512602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Identification of tripeptides recognized by the PDZ domain of Dishevelled</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1708</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.12.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmc.2008.12.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19157887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1701-1708&author=H.+J.+Leeauthor=N.+X.+Wangauthor=Y.+Shaoauthor=J.+J.+Zheng&title=Identification+of+tripeptides+recognized+by+the+PDZ+domain+of+Dishevelled&doi=10.1016%2Fj.bmc.2008.12.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of tripeptides recognized by the PDZ domain of Dishevelled</span></div><div class="casAuthors">Lee, Ho-Jin; Wang, Nick X.; Shao, Youming; Zheng, Jie J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1701-1708</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of inhibitors of Dishevelled (Dvl) PDZ protein-protein interactions attracts attention due to a possible application in drug discovery and development.  Using NMR spectroscopy, we found that a tripeptide VVV binds to the PDZ domain of Dvl, which is a key component involved in Wnt signaling.  Using a computational approach calcg. the binding free energy of the complexes of the Dvl PDZ domain and each of the tripeptides VXV (X: any amino acid residue except Pro), we found that a tripeptide VWV had the highest binding affinity.  Consistent with the computational result, exptl. results showed that the binding of the tripeptide VWV to the Dvl PDZ domain was stronger than that of the tripeptide VVV.  The binding affinity of the tripeptide VWV was comparable to that of the org. mol. NSC668036, which was the first identified Dvl PDZ inhibitor.  The three-dimensional structure of the complex Dvl1 PDZ/VWV was detd. to investigate the role of the energetically favorable W(-1) residue in binding.  These interactions were also explored by using mol. dynamic simulation and the mol. mechanics Poisson-Boltzmann surface area method.  Taken together, these two tripeptides may be used as modulators of Wnt signaling or as a scaffold to optimize an antagonist for targeting Dvl1 PDZ protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWTheAYjhZ77Vg90H21EOLACvtfcHk0lhNERnvccFjXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVyit78%253D&md5=5c97873f33a2066f5fa16bb2215400c7</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.12.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.12.060%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DN.%2BX.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520tripeptides%2520recognized%2520by%2520the%2520PDZ%2520domain%2520of%2520Dishevelled%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1701%26epage%3D1708%26doi%3D10.1016%2Fj.bmc.2008.12.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpatov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">16256</span>– <span class="NLM_lpage">16263</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.009647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1074%2Fjbc.M109.009647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=19383605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16256-16263&author=D.+Grandyauthor=J.+Shanauthor=X.+Zhangauthor=S.+Raoauthor=S.+Akunuruauthor=H.+Liauthor=Y.+Zhangauthor=I.+Alpatovauthor=X.+A.+Zhangauthor=R.+A.+Langauthor=D.+L.+Shiauthor=J.+J.+Zheng&title=Discovery+and+characterization+of+a+small+molecule+inhibitor+of+the+PDZ+domain+of+dishevelled&doi=10.1074%2Fjbc.M109.009647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled</span></div><div class="casAuthors">Grandy, David; Shan, Jufang; Zhang, Xinxin; Rao, Sujata; Akunuru, Shailaja; Li, Hongyan; Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.; Lang, Richard A.; Shi, De-Li; Zheng, Jie J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16256-16263</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Dishevelled (Dvl) is an essential protein in the Wnt signaling pathways; it uses its PDZ domain to transduce the Wnt signals from the membrane receptor Frizzled to downstream components.  Here, we report identifying a drug-like small mol. compd. through structure-based ligand screening and NMR spectroscopy and show the compd. to interact at low micromolar affinity with the PDZ domain of Dvl.  In a Xenopus testing system, the compd. could permeate the cell membrane and block the Wnt signaling pathways.  In addn., the compd. inhibited Wnt signaling and reduced the levels of apoptosis in the hyaloid vessels of eye.  Moreover, this compd. also suppressed the growth of prostate cancer PC-3 cells.  These biol. effects suggest that by blocking the PDZ domain of Dvl, the compd. identified in our studies effectively inhibits the Wnt signaling and thus provides a useful tool for studies dissecting the Wnt signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTIN1BUc6M1LVg90H21EOLACvtfcHk0lhNERnvccFjXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtrk%253D&md5=73ad7afb362cbcbf226f0f0b7cefdead</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.009647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.009647%26sid%3Dliteratum%253Aachs%26aulast%3DGrandy%26aufirst%3DD.%26aulast%3DShan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DAkunuru%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAlpatov%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DX.%2BA.%26aulast%3DLang%26aufirst%3DR.%2BA.%26aulast%3DShi%26aufirst%3DD.%2BL.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520the%2520PDZ%2520domain%2520of%2520dishevelled%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16256%26epage%3D16263%26doi%3D10.1074%2Fjbc.M109.009647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroaki, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent Disheveled/Dvl Inhibitors using virtual screening optimized with NMR-based docking performance index</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">983</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffphar.2018.00983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30233369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=983&author=K.+Horiauthor=K.+Ajiokaauthor=N.+Godaauthor=A.+Shindoauthor=M.+Takagishiauthor=T.+Tennoauthor=H.+Hiroaki&title=Discovery+of+potent+Disheveled%2FDvl+Inhibitors+using+virtual+screening+optimized+with+NMR-based+docking+performance+index&doi=10.3389%2Ffphar.2018.00983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent disheveled/Dvl inhibitors using virtual screening optimized with NMR-based docking performance index</span></div><div class="casAuthors">Hori, Kiminori; Ajioka, Kasumi; Goda, Natsuko; Shindo, Asako; Takagishi, Maki; Tenno, Takeshi; Hiroaki, Hidekazu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">983/1-983/14</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Most solid tumors have their own cancer stem cells (CSCs), which are resistant to std. chemo-therapies.  Recent reports have described that Wnt pathway plays a key role in self-renewal and tumorigenesis of CSCs.  Regarding the Wnt/β-catenin pathway, Dvl (mammalian Disheveled) is an attractive target of drug discovery.  After analyzing the PDZ domain of human Dvl1 (Dvl1-PDZ) using NMR, we subjected it to preliminary NMR titrn. studies with 17 potential PDZ-binding mols. including CalBioChem-322338, a com. available Dvl PDZ domain inhibitor.  Next, we performed virtual screening (VS) using the program GOLD with nine parameter sets.  Results were evaluated using the NMR-derived docking performance index (NMRDPI).  One parameter set of GOLD docking showing the best NMR-DPI was selected and used for the second VS against 5,135 compds.  The second docking trial identified more than 1,700 compds. that exhibited higher scores than CalBioChem- 322338.  Subsequent NMR titrn. expts. with five new candidate mols. (NPL-4001, 4004, 4011, 4012, and 4013), Dvl1-PDZ revealed larger chem. shift changes than those of CalBioChem-322338.  Finally, these compds. showed partial proliferation inhibition activity against BT-20, a triple neg. breast cancer (TNBC) cell.  These compds. are promising Wnt pathway inhibitors that are potentially useful for anti-TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Rjep1UlkkLVg90H21EOLACvtfcHk0liXK8aSgG3okg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSltL0%253D&md5=078093aed383e3e5a03a3fa4425e8df5</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00983%26sid%3Dliteratum%253Aachs%26aulast%3DHori%26aufirst%3DK.%26aulast%3DAjioka%26aufirst%3DK.%26aulast%3DGoda%26aufirst%3DN.%26aulast%3DShindo%26aufirst%3DA.%26aulast%3DTakagishi%26aufirst%3DM.%26aulast%3DTenno%26aufirst%3DT.%26aulast%3DHiroaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520Disheveled%252FDvl%2520Inhibitors%2520using%2520virtual%2520screening%2520optimized%2520with%2520NMR-based%2520docking%2520performance%2520index%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D983%26doi%3D10.3389%2Ffphar.2018.00983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, N. J.</span></span> <span> </span><span class="NLM_article-title">E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">552</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1038/nature07310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature07310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=18794899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKhtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=552-556&author=E.+J.+Morrisauthor=J.+Y.+Jiauthor=F.+Yangauthor=L.+Di+Stefanoauthor=A.+Herrauthor=N.+S.+Moonauthor=E.+J.+Kwonauthor=K.+M.+Haigisauthor=A.+M.+Naarauthor=N.+J.+Dyson&title=E2F1+represses+beta-catenin+transcription+and+is+antagonized+by+both+pRB+and+CDK8&doi=10.1038%2Fnature07310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8</span></div><div class="casAuthors">Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Kwon, Eun-Jeong; Haigis, Kevin M.; Naeaer, Anders M.; Dyson, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7212</span>),
    <span class="NLM_cas:pages">552-556</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumor suppressor protein (pRB).  Here we show that E2F1 is a potent and specific inhibitor of β-catenin/T-cell factor (TCF)-dependent transcription, and that this function contributes to E2F1-induced apoptosis.  E2F1 deregulation suppresses β-catenin activity in an adenomatous polyposis coli (APC)/glycogen synthase kinase-3 (GSK3)-independent manner, reducing the expression of key β-catenin targets including c-MYC.  This interaction explains why colorectal tumors, which depend on β-catenin transcription for their abnormal proliferation, keep RB1 intact.  Remarkably, E2F1 activity is also repressed by cyclin-dependent kinase-8 (CDK8), a colorectal oncoprotein.  Elevated levels of CDK8 protect β-catenin/TCF-dependent transcription from inhibition by E2F1.  Thus, by retaining RB1 and amplifying CDK8, colorectal tumor cells select conditions that collectively suppress E2F1 and enhance the activity of β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DfW83G97UbVg90H21EOLACvtfcHk0liXK8aSgG3okg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKhtLbE&md5=b770664f18e774a33f2c7aedbbeb24c6</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnature07310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07310%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DE.%2BJ.%26aulast%3DJi%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DDi%2BStefano%26aufirst%3DL.%26aulast%3DHerr%26aufirst%3DA.%26aulast%3DMoon%26aufirst%3DN.%2BS.%26aulast%3DKwon%26aufirst%3DE.%2BJ.%26aulast%3DHaigis%26aufirst%3DK.%2BM.%26aulast%3DNaar%26aufirst%3DA.%2BM.%26aulast%3DDyson%26aufirst%3DN.%2BJ.%26atitle%3DE2F1%2520represses%2520beta-catenin%2520transcription%2520and%2520is%2520antagonized%2520by%2520both%2520pRB%2520and%2520CDK8%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D552%26epage%3D556%26doi%3D10.1038%2Fnature07310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szostek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, J. M.</span></span> <span> </span><span class="NLM_article-title">CDK8 is a stimulus-specific positive coregulator of p53 target genes</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.molcel.2007.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17612495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1elsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=121-133&author=A.+J.+Donnerauthor=S.+Szostekauthor=J.+M.+Hooverauthor=J.+M.+Espinosa&title=CDK8+is+a+stimulus-specific+positive+coregulator+of+p53+target+genes&doi=10.1016%2Fj.molcel.2007.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">CDK8 is a stimulus-specific positive coregulator of p53 target genes</span></div><div class="casAuthors">Donner, Aaron Joseph; Szostek, Stephanie; Hoover, Jennifer Michelle; Espinosa, Joaquin Maximiliano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-133</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The p53 transcriptional network orchestrates alternative stress responses such as cell-cycle arrest and apoptosis.  Here we investigate the mechanism of differential expression of p21, a key mediator of p53-dependent cell-cycle arrest.  We demonstrate that the transcriptional activity of the p21 promoter varies greatly in response to distinct p53-activating stimuli.  Chromatin immunopptn. anal. of the p21 locus indicates that histone acetyltransferases, general transcription factors, and Mediator subunits are assembled into alternative transcriptional complexes of different activity.  Interestingly, core Mediator subunits MED1 and MED17 are recruited to the p21 locus regardless of the p53-activating stimuli utilized.  In contrast, three subunits of the CDK module of Mediator (CDK8, MED12, and cyclin C) are exclusively recruited during conditions of strong p21 transcriptional activation.  Furthermore, increased binding of CDK8 to p53 target genes correlates pos. with transcriptional strength.  RNAi expts. demonstrate that CDK8 functions as a coactivator within the p53 transcriptional program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXx_jyLXAX7Vg90H21EOLACvtfcHk0lhcCjWfRJjFJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1elsL4%253D&md5=27ddf924be6fcd3dca6fda0f7d52de45</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DDonner%26aufirst%3DA.%2BJ.%26aulast%3DSzostek%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DJ.%2BM.%26aulast%3DEspinosa%26aufirst%3DJ.%2BM.%26atitle%3DCDK8%2520is%2520a%2520stimulus-specific%2520positive%2520coregulator%2520of%2520p53%2520target%2520genes%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D121%26epage%3D133%26doi%3D10.1016%2Fj.molcel.2007.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaeian, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. K.</span></span> <span> </span><span class="NLM_article-title">Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6641</span>, <span class="refDoi"> DOI: 10.1038/ncomms7641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fncomms7641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25818643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVCrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6641&author=D.+Xuauthor=C.+F.+Liauthor=X.+Zhangauthor=Z.+Gongauthor=C.+H.+Chanauthor=S.+W.+Leeauthor=G.+Jinauthor=A.+H.+Rezaeianauthor=F.+Hanauthor=J.+Wangauthor=W.+L.+Yangauthor=Z.+Z.+Fengauthor=W.+Chenauthor=C.+Y.+Wuauthor=Y.+J.+Wangauthor=L.+P.+Chowauthor=X.+F.+Zhuauthor=Y.+X.+Zengauthor=H.+K.+Lin&title=Skp2-macroH2A1-CDK8+axis+orchestrates+G2%2FM+transition+and+tumorigenesis&doi=10.1038%2Fncomms7641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis</span></div><div class="casAuthors">Xu, Dazhi; Li, Chien-Feng; Zhang, Xian; Gong, Zhaohui; Chan, Chia-Hsin; Lee, Szu-Wei; Jin, Guoxiang; Rezaeian, Abdol-Hossein; Han, Fei; Wang, Jing; Yang, Wei-Lei; Feng, Zi-Zhen; Chen, Wei; Wu, Ching-Yuan; Wang, Ying-Jan; Chow, Lu-Ping; Zhu, Xiao-Feng; Zeng, Yi-Xin; Lin, Hui-Kuan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6641</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Understanding the mechanism by which cell growth, migration, polyploidy, and tumorigenesis are regulated may provide important therapeutic strategies for cancer therapy.  Here we identify the Skp2-macroH2A1 (mH2A1)-cyclin-dependent kinase 8 (CDK8) axis as a crit. pathway for these processes, and deregulation of this pathway is assocd. with human breast cancer progression and patient survival outcome.  We showed that mH2A1 is a new substrate of Skp2 SCF complex whose degrdn. by Skp2 promotes CDK8 gene and protein expression.  Strikingly, breast tumor suppression on Skp2 deficiency can be rescued by mH2A1 knockdown or CDK8 restoration using mouse tumor models.  We further show that CDK8 regulates p27 protein expression by facilitating Skp2-mediated p27 ubiquitination and degrdn.  Our study establishes a crit. role of Skp2-mH2A1-CDK8 axis in breast cancer development and targeting this pathway offers a promising strategy for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqwXuVFzf3gLVg90H21EOLACvtfcHk0lhcCjWfRJjFJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVCrtL8%253D&md5=d3108ca73b76c62ea18976f05ec13202</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1038%2Fncomms7641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7641%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%2BF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DRezaeian%26aufirst%3DA.%2BH.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%2BL.%26aulast%3DFeng%26aufirst%3DZ.%2BZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DChow%26aufirst%3DL.%2BP.%26aulast%3DZhu%26aufirst%3DX.%2BF.%26aulast%3DZeng%26aufirst%3DY.%2BX.%26aulast%3DLin%26aufirst%3DH.%2BK.%26atitle%3DSkp2-macroH2A1-CDK8%2520axis%2520orchestrates%2520G2%252FM%2520transition%2520and%2520tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6641%26doi%3D10.1038%2Fncomms7641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.11.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.ejmech.2018.11.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30594029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1WhsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=77-91&author=M.+Xiauthor=T.+Chenauthor=C.+Wuauthor=X.+Gaoauthor=Y.+Wuauthor=X.+Luoauthor=K.+Duauthor=L.+Yuauthor=T.+Caiauthor=R.+Shenauthor=H.+Sun&title=CDK8+as+a+therapeutic+target+for+cancers+and+recent+developments+in+discovery+of+CDK8+inhibitors&doi=10.1016%2Fj.ejmech.2018.11.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors</span></div><div class="casAuthors">Xi, Meiyang; Chen, Tingkai; Wu, Chunlei; Gao, Xiaozhong; Wu, Yonghua; Luo, Xiang; Du, Kui; Yu, Lemao; Cai, Tao; Shen, Runpu; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases 8 (CDK8) regulates transcriptional process via assocg. with the mediator complex or phosphorylating transcription factors (TF).  Overexpression of CDK8 has been obsd. in various cancers.  It mediates aberrant activation of Wnt/β-catenin signaling pathway, which is initially recognized and best studied in colorectal cancer (CRC).  CDK8 acts as an oncogene and represents a potential target for developing novel CDK8 inhibitors in cancer therapeutics.  However, other study has revealed its contrary role.  The function of CDK8 is context dependent.  Even so, a variety of potent and selective CDK8 inhibitors have been discovered after crystal structures were resolved in two states (active or inactive).  In this review, we summarize co-crystal structures, biol. mechanisms, dysregulation in cancers and recent progress in the field of CDK8 inhibitors, trying to offer an outlook of CDK8 inhibitors in cancer therapy in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg2b-dA0hErVg90H21EOLACvtfcHk0lhJpEpHq9mtZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1WhsbvM&md5=8c7eeabc1d6c4fa545d09c39004436f7</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.11.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.11.076%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DCDK8%2520as%2520a%2520therapeutic%2520target%2520for%2520cancers%2520and%2520recent%2520developments%2520in%2520discovery%2520of%2520CDK8%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D77%26epage%3D91%26doi%3D10.1016%2Fj.ejmech.2018.11.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumpler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichowicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waalboer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeniji-Popoola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TePoele, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1717</span>– <span class="NLM_lpage">1735</span>, <span class="refDoi"> DOI: 10.1021/jm501436m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501436m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1717-1735&author=A.+Mallingerauthor=S.+Crumplerauthor=M.+Pichowiczauthor=D.+Waalboerauthor=M.+Stubbsauthor=O.+Adeniji-Popoolaauthor=B.+Woodauthor=E.+Smithauthor=C.+Thaiauthor=A.+T.+Henleyauthor=K.+Georgiauthor=W.+Courtauthor=S.+Hobbsauthor=G.+Boxauthor=M.+J.+Ortiz-Ruizauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=R.+TePoeleauthor=B.+Leuthnerauthor=P.+Workmanauthor=W.+Aherneauthor=O.+Poeschkeauthor=T.+Daleauthor=D.+Wienkeauthor=C.+Esdarauthor=F.+Rohdichauthor=F.+Raynaudauthor=P.+A.+Clarkeauthor=S.+A.+Ecclesauthor=F.+Stieberauthor=K.+Schiemannauthor=J.+Blagg&title=Discovery+of+potent%2C+orally+bioavailable%2C+small-molecule+inhibitors+of+WNT+signaling+from+a+cell-based+pathway+screen&doi=10.1021%2Fjm501436m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen</span></div><div class="casAuthors">Mallinger, Aurelie; Crumpler, Simon; Pichowicz, Mark; Waalboer, Dennis; Stubbs, Mark; Adeniji-Popoola, Olajumoke; Wood, Bozena; Smith, Elizabeth; Thai, Ching; Henley, Alan T.; Georgi, Katrin; Court, William; Hobbs, Steve; Box, Gary; Ortiz-Ruiz, Maria-Jesus; Valenti, Melanie; De Haven Brandon, Alexis; Te Poele, Robert; Leuthner, Birgitta; Workman, Paul; Aherne, Wynne; Poeschke, Oliver; Dale, Trevor; Wienke, Dirk; Esdar, Christina; Rohdich, Felix; Raynaud, Florence; Clarke, Paul A.; Eccles, Suzanne A.; Stieber, Frank; Schiemann, Kai; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1717-1735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">WNT signaling is frequently deregulated in malignancy, particularly in colon cancer, and plays a key role in the generation and maintenance of cancer stem cells.  The authors report the discovery and optimization of a 3,4,5-trisubstituted pyridine, 1-(3,5-Dichloropyridin-4-yl)piperidine-4-carboxamide (9), using a high-throughput cell-based reporter assay of WNT pathway activity.  The authors demonstrate a twisted conformation about the pyridine-piperidine bond of (9) by small-mol. x-ray crystallog.  Medicinal chem. optimization to maintain this twisted conformation, cognisant of physicochem. properties likely to maintain good cell permeability, led to 8-[3-Chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]pyridin-4-yl]-2,8-diazaspiro[4,5]decan-1-one (74) (CCT251545), a potent small-mol. inhibitor of WNT signaling with good oral pharmacokinetics.  The authors demonstrate inhibition of WNT pathway activity in a solid human tumor xenograft model with evidence for tumor growth inhibition following oral dosing.  This work provides a successful example of hypothesis-driven medicinal chem. optimization from a singleton hit against a cell-based pathway assay without knowledge of the biochem. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGX6wdTc3jeLVg90H21EOLACvtfcHk0lhJpEpHq9mtZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGjur4%253D&md5=eab7f23a8288cb3da6665ef000558f95</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm501436m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501436m%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DCrumpler%26aufirst%3DS.%26aulast%3DPichowicz%26aufirst%3DM.%26aulast%3DWaalboer%26aufirst%3DD.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DAdeniji-Popoola%26aufirst%3DO.%26aulast%3DWood%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DGeorgi%26aufirst%3DK.%26aulast%3DCourt%26aufirst%3DW.%26aulast%3DHobbs%26aufirst%3DS.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DTePoele%26aufirst%3DR.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520orally%2520bioavailable%252C%2520small-molecule%2520inhibitors%2520of%2520WNT%2520signaling%2520from%2520a%2520cell-based%2520pathway%2520screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1717%26epage%3D1735%26doi%3D10.1021%2Fjm501436m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumpler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeniji-Popoola, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, and orally bioavailable small-molecule modulators of the mediator complex-associated kinases CDK8 and CDK19</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1101</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1078-1101&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=F.+Stieberauthor=M.+Calderiniauthor=S.+Crumplerauthor=M.+Stubbsauthor=O.+Adeniji-Popoolaauthor=O.+Poeschkeauthor=M.+Buschauthor=P.+Czodrowskiauthor=D.+Musilauthor=D.+Schwarzauthor=M.+J.+Ortiz-Ruizauthor=R.+Schneiderauthor=C.+Thaiauthor=M.+Valentiauthor=A.+de+Haven%0ABrandonauthor=R.+Burkeauthor=P.+Workmanauthor=T.+Daleauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=C.+Esdarauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=F.+Rohdichauthor=J.+Blagg&title=Discovery+of+potent%2C+selective%2C+and+orally+bioavailable+small-molecule+modulators+of+the+mediator+complex-associated+kinases+CDK8+and+CDK19&doi=10.1021%2Facs.jmedchem.5b01685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Stieber, Frank; Calderini, Michel; Crumpler, Simon; Stubbs, Mark; Adeniji-Popoola, Olajumoke; Poeschke, Oliver; Busch, Michael; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Thai, Ching; Valenti, Melanie; Brandon, Alexis de Haven; Burke, Rosemary; Workman, Paul; Dale, Trevor; Wienke, Dirk; Clarke, Paul A.; Esdar, Christina; Raynaud, Florence I.; Eccles, Suzanne A.; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1078-1101</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene.  Here the authors report the discovery of I (CCT251921), a potent, selective, and orally bioavailable inhibitor of CDK8 with equipotent affinity for CDK19.  The authors describe a structure-based design approach leading to the discovery of a 3,4,5-trisubstituted-2-aminopyridine series and present the application of physicochem. property analyses to successfully reduce in vivo metabolic clearance, minimize transporter-mediated biliary elimination while maintaining acceptable aq. soly.  Compd. I affords the optimal compromise of in vitro biochem., pharmacokinetic, and physicochem. properties and is suitable for progression to animal models of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGLfsHTX285bVg90H21EOLACvtfcHk0lj6Pfz7nb57vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmsrk%253D&md5=fbe1c1a8569750a33751e87a04bf49bd</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01685%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DStieber%26aufirst%3DF.%26aulast%3DCalderini%26aufirst%3DM.%26aulast%3DCrumpler%26aufirst%3DS.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DAdeniji-Popoola%26aufirst%3DO.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DThai%26aufirst%3DC.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520small-molecule%2520modulators%2520of%2520the%2520mediator%2520complex-associated%2520kinases%2520CDK8%2520and%2520CDK19%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1078%26epage%3D1101%26doi%3D10.1021%2Facs.jmedchem.5b01685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuillan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvares, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-ODeltaN89beta-catenin system</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fonc.2012.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=22469981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=883-893&author=T.+Jardeauthor=R.+J.+Evansauthor=K.+L.+McQuillanauthor=L.+Parryauthor=G.+J.+Fengauthor=B.+Alvaresauthor=A.+R.+Clarkeauthor=T.+C.+Dale&title=In+vivo+and+in+vitro+models+for+the+therapeutic+targeting+of+Wnt+signaling+using+a+Tet-ODeltaN89beta-catenin+system&doi=10.1038%2Fonc.2012.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-OΔN89β-catenin system</span></div><div class="casAuthors">Jarde, T.; Evans, R. J.; McQuillan, K. L.; Parry, L.; Feng, G. J.; Alvares, B.; Clarke, A. R.; Dale, T. C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-893</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although significant progress has been made in understanding the importance of Wnt signaling in the initiation of colorectal cancer, less is known about responses that accompany the reversal of oncogenic Wnt signaling.  The aim of this study was to analyze in vivo and in vitro responses to an ideal' Wnt pathway inhibitor as a model for the therapeutic targeting of the pathway.  A tetracycline-inducible transgenic mouse model expressing truncated β-catenin (ΔN89β-catenin) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic β-catenin expression both in 3D crypt culture' and in vivo.  Oncogenic Wnt signaling was rapidly and completely reversed.  The strongest inhibition of Wnt target gene expression occurred within 24 h of doxycycline removal at which time the target genes Ascl2, Axin2 and C-myc were downregulated to levels below that in the control intestine.  In vitro, the small mol. Wnt inhibitor CCT036477 induced a response within 4 h of treatment.  By 7 days following doxycycline withdrawal, gene expression, cell proliferation and tissue morphol. were undistinguishable from control animals.  In conclusion, these results demonstrate that the reversal of Wnt signaling by inhibitors should ideally be studied within hours of treatment.  The reversible system described, involving medium throughput in vitro approaches and rapid in vivo responses, should allow the rapid advance of early stage compds. into efficacy models that are more usually considered later in the drug discovery pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLFHEYVSwmf7Vg90H21EOLACvtfcHk0lj6Pfz7nb57vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqs78%253D&md5=cc33da5c8a09b82d0ed02b4483520d2b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.103%26sid%3Dliteratum%253Aachs%26aulast%3DJarde%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%2BJ.%26aulast%3DMcQuillan%26aufirst%3DK.%2BL.%26aulast%3DParry%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DG.%2BJ.%26aulast%3DAlvares%26aufirst%3DB.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DDale%26aufirst%3DT.%2BC.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520models%2520for%2520the%2520therapeutic%2520targeting%2520of%2520Wnt%2520signaling%2520using%2520a%2520Tet-ODeltaN89beta-catenin%2520system%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D883%26epage%3D893%26doi%3D10.1038%2Fonc.2012.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sejberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">2,8-Disubstituted-1,6-naphthyridines and 4,6-disubstituted-isoquinolines with potent, selective affinity for CDK8/19</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=573-578&author=A.+Mallingerauthor=K.+Schiemannauthor=C.+Rinkauthor=J.+Sejbergauthor=M.+A.+Honeyauthor=P.+Czodrowskiauthor=M.+Stubbsauthor=O.+Poeschkeauthor=M.+Buschauthor=R.+Schneiderauthor=D.+Schwarzauthor=D.+Musilauthor=R.+Burkeauthor=K.+Urbahnsauthor=P.+Workmanauthor=D.+Wienkeauthor=P.+A.+Clarkeauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=C.+Esdarauthor=F.+Rohdichauthor=J.+Blagg&title=2%2C8-Disubstituted-1%2C6-naphthyridines+and+4%2C6-disubstituted-isoquinolines+with+potent%2C+selective+affinity+for+CDK8%2F19&doi=10.1021%2Facsmedchemlett.6b00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19</span></div><div class="casAuthors">Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Sejberg, Jimmy; Honey, Mark A.; Czodrowski, Paul; Stubbs, Mark; Poeschke, Oliver; Busch, Michael; Schneider, Richard; Schwarz, Daniel; Musil, Djordje; Burke, Rosemary; Urbahns, Klaus; Workman, Paul; Wienke, Dirk; Clarke, Paul A.; Raynaud, Florence I.; Eccles, Suzanne A.; Esdar, Christina; Rohdich, Felix; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">573-578</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate a designed scaffold-hop approach to the discovery of 2,8-disubstituted-1,6-naphthyridine- and 4,6-disubstituted-isoquinoline-based dual CDK8/19 ligands.  Optimized compds. in both series exhibited rapid aldehyde oxidase-mediated metab., which could be abrogated by introduction of an amino substituent at C5 of the 1,6-naphthyridine scaffold or at C1 of the isoquinoline scaffold.  Compds. 51 and 59 were progressed to in vivo pharmacokinetic studies, and 51 also demonstrated sustained inhibition of STAT1SER727 phosphorylation, a biomarker of CDK8 inhibition, in an SW620 colorectal carcinoma human tumor xenograft model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHD7cu5uM2rVg90H21EOLACvtfcHk0ljeY-RYeJeP0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrs70%253D&md5=20854b532b81db1be40afcd811ac5731</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00022%26sid%3Dliteratum%253Aachs%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DRink%26aufirst%3DC.%26aulast%3DSejberg%26aufirst%3DJ.%26aulast%3DHoney%26aufirst%3DM.%2BA.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DM.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3D2%252C8-Disubstituted-1%252C6-naphthyridines%2520and%25204%252C6-disubstituted-isoquinolines%2520with%2520potent%252C%2520selective%2520affinity%2520for%2520CDK8%252F19%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.6b00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Ruiz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9337</span>– <span class="NLM_lpage">9349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9337-9349&author=P.+Czodrowskiauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+Poschkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=M.+J.+Ortiz-Ruizauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=D.+Musilauthor=D.+Schwarzauthor=T.+Daleauthor=K.+Urbahnsauthor=J.+Blaggauthor=K.+Schiemann&title=Structure-based+optimization+of+potent%2C+selective%2C+and+orally+bioavailable+CDK8+inhibitors+discovered+by+high-throughput+screening&doi=10.1021%2Facs.jmedchem.6b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening</span></div><div class="casAuthors">Czodrowski, Paul; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Ortiz-Ruiz, Maria-Jesus; Schneider, Richard; Raynaud, Florence I.; Clarke, Paul A.; Musil, Djordje; Schwarz, Daniel; Dale, Trevor; Urbahns, Klaus; Blagg, Julian; Schiemann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9337-9349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Mediator complex-assocd. cyclin dependent kinase CDK8 regulates beta-catenin-dependent transcription following activation of WNT signaling.  Multiple lines of evidence suggest CDK8 may act as an oncogene in the development of colorectal cancer.  Here the authors describe the successful optimization of an imidazo-thiadiazole series of CDK8 inhibitors that was identified in a high-throughput screening campaign and further progressed by structure-based design.  In several optimization cycles, the authors improved the microsomal stability, potency and kinase selectivity.  The initial imidazo-thiadiazole scaffold was replaced by a 3-methyl-1H-pyrazolo[3,4-b]-pyridine which resulted in compd. MSC2530818 that displayed excellent kinase selectivity, biochem. and cellular potency, microsomal stability and is orally bioavailable.  Furthermore, the authors demonstrated modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8 activity, and tumor growth inhibition in an APC-mutant SW620 human colorectal carcinoma xenograft model after oral administration.  Compd. MSC2530818 demonstrated suitable potency and selectivity to progress into preclin. in vivo efficacy and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoP_Ycv9Xj97Vg90H21EOLACvtfcHk0ljeY-RYeJeP0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtbvF&md5=9ab270aed38647f9bafe213cf9d75171</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00597%26sid%3Dliteratum%253Aachs%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DPoschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DOrtiz-Ruiz%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DDale%26aufirst%3DT.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DSchiemann%26aufirst%3DK.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520CDK8%2520inhibitors%2520discovered%2520by%2520high-throughput%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9337%26epage%3D9349%26doi%3D10.1021%2Facs.jmedchem.6b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wienke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czodrowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.bmcl.2016.01.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26852363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1443-1451&author=K.+Schiemannauthor=A.+Mallingerauthor=D.+Wienkeauthor=C.+Esdarauthor=O.+Poeschkeauthor=M.+Buschauthor=F.+Rohdichauthor=S.+A.+Ecclesauthor=R.+Schneiderauthor=F.+I.+Raynaudauthor=P.+Czodrowskiauthor=D.+Musilauthor=D.+Schwarzauthor=K.+Urbahnsauthor=J.+Blagg&title=Discovery+of+potent+and+selective+CDK8+inhibitors+from+an+HSP90+pharmacophore&doi=10.1016%2Fj.bmcl.2016.01.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore</span></div><div class="casAuthors">Schiemann, Kai; Mallinger, Aurelie; Wienke, Dirk; Esdar, Christina; Poeschke, Oliver; Busch, Michael; Rohdich, Felix; Eccles, Suzanne A.; Schneider, Richard; Raynaud, Florence I.; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Urbahns, Klaus; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1443-1451</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the discovery and optimization of 3-benzylindazoles as potent and selective inhibitors of CDK8, also modulating CDK19, discovered from a high-throughput screening (HTS) campaign sampling the Merck compd. collection.  The primary hits with strong HSP90 affinity were subsequently optimized to potent and selective CDK8 inhibitors which demonstrate inhibition of WNT pathway activity in cell-based assays.  X-ray crystallog. data demonstrated that 3-benzylindazoles occupy the ATP binding site of CDK8 and adopt a Type I binding mode.  Medicinal chem. optimization successfully led to improved potency, physicochem. properties and oral pharmacokinetics.  Modulation of phospho-STAT1, a pharmacodynamic biomarker of CDK8, was demonstrated in an APC-mutant SW620 human colorectal carcinoma xenograft model following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou1kKac9Bkw7Vg90H21EOLACvtfcHk0liBOzyn9UqVRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitlCitLs%253D&md5=77e9f7705c9136557195ccfb4982cb8d</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.062%26sid%3Dliteratum%253Aachs%26aulast%3DSchiemann%26aufirst%3DK.%26aulast%3DMallinger%26aufirst%3DA.%26aulast%3DWienke%26aufirst%3DD.%26aulast%3DEsdar%26aufirst%3DC.%26aulast%3DPoeschke%26aufirst%3DO.%26aulast%3DBusch%26aufirst%3DM.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DCzodrowski%26aufirst%3DP.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DD.%26aulast%3DUrbahns%26aufirst%3DK.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520CDK8%2520inhibitors%2520from%2520an%2520HSP90%2520pharmacophore%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1443%26epage%3D1451%26doi%3D10.1016%2Fj.bmcl.2016.01.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shitashige, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jigami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirohashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">5024</span>– <span class="NLM_lpage">5033</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-0306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-10-0306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20530691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=5024-5033&author=M.+Shitashigeauthor=R.+Satowauthor=T.+Jigamiauthor=K.+Aokiauthor=K.+Hondaauthor=T.+Shibataauthor=M.+Onoauthor=S.+Hirohashiauthor=T.+Yamada&title=Traf2-+and+Nck-interacting+kinase+is+essential+for+Wnt+signaling+and+colorectal+cancer+growth&doi=10.1158%2F0008-5472.CAN-10-0306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth</span></div><div class="casAuthors">Shitashige, Miki; Satow, Reiko; Jigami, Takafumi; Aoki, Kazunori; Honda, Kazufumi; Shibata, Tatsuhiro; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5024-5033</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">T-cell factor-4 (TCF4) is a transcription factor essential for maintaining the undifferentiated status and self-renewal of intestinal epithelial cells.  It has therefore been considered that constitutive activation of TCF4 by aberrant Wnt signaling is a major force driving colorectal carcinogenesis.  We previously identified Traf2- and Nck-interacting kinase (TNIK) as one of the proteins that interact with TCF4 in colorectal cancer cells, but its functional significance has not been elucidated.  Here, we report that TNIK is an activating kinase for TCF4 and essential for colorectal cancer growth.  TNIK, but not its catalytically inactive mutant, phosphorylated the conserved serine 154 residue of TCF4.  Small interfering RNA targeting TNIK inhibited the proliferation of colorectal cancer cells and the growth of tumors produced by injecting colorectal cancer cells s.c. into immunodeficient mice.  The growth inhibition was abolished by restoring the catalytic domain of TNIK, thus confirming that its enzyme activity is essential for the maintenance of colorectal cancer growth.  Several ATP-competing kinase inhibitors have been applied to cancer treatment and have shown significant activity.  Our findings suggest TNIK as a feasible target for pharmacol. intervention to ablate aberrant Wnt signaling in colorectal cancer.  Cancer Res; 70(12); 5024-33.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhEBquRkxUurVg90H21EOLACvtfcHk0liBOzyn9UqVRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKltLg%253D&md5=14fab380ba35b5d9bbe8c1a185362644</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-0306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-0306%26sid%3Dliteratum%253Aachs%26aulast%3DShitashige%26aufirst%3DM.%26aulast%3DSatow%26aufirst%3DR.%26aulast%3DJigami%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DHonda%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHirohashi%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DTraf2-%2520and%2520Nck-interacting%2520kinase%2520is%2520essential%2520for%2520Wnt%2520signaling%2520and%2520colorectal%2520cancer%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D5024%26epage%3D5033%26doi%3D10.1158%2F0008-5472.CAN-10-0306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">The emergence of TNIK as a therapeutic target for colorectal cancer</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1080/14728222.2017.1297799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1080%2F14728222.2017.1297799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28281900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFKjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=353-355&author=M.+Masudaauthor=T.+Yamada&title=The+emergence+of+TNIK+as+a+therapeutic+target+for+colorectal+cancer&doi=10.1080%2F14728222.2017.1297799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of TNIK as a therapeutic target for colorectal cancer</span></div><div class="casAuthors">Masuda, Mari; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-355</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Through comprehensive mass spectrometry anal. of nuclear proteins purified from colorectal cancer cells, we identified TNIK (Traf2- and Nck-interacting kinase) as a component of the TCF4 and β-catenin transcriptional complex.  We found that TNIK phosphorylated TCF4 protein at the conserved serine 154 residue which is essential for full activation of Wnt signaling and knockdown of TNIK suppressed Wnt activity and proliferation of colorectal cancer cells.  Injection of siRNA targeting TNIK inhibits the growth of colorectal cancer xenografts, and this growth inhibition is abolished by restoring the catalytic domain of TNIK.  TNIK is required for the tumor-initiating function of colorectal cancer stem cells, and its inhibition is a promising therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbC9X352hIrVg90H21EOLACvtfcHk0liywR4ONrBRKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFKjsLg%253D&md5=a3acd36374e27d6cca77cc77e3868f5f</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1080%2F14728222.2017.1297799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2017.1297799%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DThe%2520emergence%2520of%2520TNIK%2520as%2520a%2520therapeutic%2520target%2520for%2520colorectal%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2017%26volume%3D21%26spage%3D353%26epage%3D355%26doi%3D10.1080%2F14728222.2017.1297799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukimoto-Niino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">TNIK inhibition abrogates colorectal cancer stemness</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12586</span>, <span class="refDoi"> DOI: 10.1038/ncomms12586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fncomms12586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=27562646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12586&author=M.+Masudaauthor=Y.+Unoauthor=N.+Ohbayashiauthor=H.+Ohataauthor=A.+Mimataauthor=M.+Kukimoto-Niinoauthor=H.+Moriyamaauthor=S.+Kashimotoauthor=T.+Inoueauthor=N.+Gotoauthor=K.+Okamotoauthor=M.+Shirouzuauthor=M.+Sawaauthor=T.+Yamada&title=TNIK+inhibition+abrogates+colorectal+cancer+stemness&doi=10.1038%2Fncomms12586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">TNIK inhibition abrogates colorectal cancer stemness</span></div><div class="casAuthors">Masuda, Mari; Uno, Yuko; Ohbayashi, Naomi; Ohata, Hirokazu; Mimata, Ayako; Kukimoto-Niino, Mutsuko; Moriyama, Hideki; Kashimoto, Shigeki; Inoue, Tomoko; Goto, Naoko; Okamoto, Koji; Shirouzu, Mikako; Sawa, Masaaki; Yamada, Tesshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12586</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Canonical Wnt/β-catenin signalling is essential for maintaining intestinal stem cells, and its constitutive activation has been implicated in colorectal carcinogenesis.  We and others have previously identified Traf2- and Nck-interacting kinase (TNIK) as an essential regulatory component of the T-cell factor-4 and β-catenin transcriptional complex.  Consistent with this, Tnik-deficient mice are resistant to azoxymethane-induced colon tumorigenesis, and Tnik-/-/Apcmin/+ mutant mice develop significantly fewer intestinal tumors.  Here we report the first orally available small-mol. TNIK inhibitor, NCB-0846, having anti-Wnt activity.  X-ray co-crystal structure anal. reveals that NCB-0846 binds to TNIK in an inactive conformation, and this binding mode seems to be essential for Wnt inhibition.  NCB-0846 suppresses Wnt-driven intestinal tumorigenesis in Apcmin/+ mice and the sphere- and tumor-forming activities of colorectal cancer cells.  TNIK is required for the tumor-initiating function of colorectal cancer stem cells.  Its inhibition is a promising therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpBHuWHnK3vbVg90H21EOLACvtfcHk0liywR4ONrBRKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCht7zL&md5=f93b79e2fc85bf8e26390854da52e932</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fncomms12586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12586%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DOhata%26aufirst%3DH.%26aulast%3DMimata%26aufirst%3DA.%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DMoriyama%26aufirst%3DH.%26aulast%3DKashimoto%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DN.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DSawa%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DTNIK%2520inhibition%2520abrogates%2520colorectal%2520cancer%2520stemness%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12586%26doi%3D10.1038%2Fncomms12586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokstad, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalland, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, X.</span></span> <span> </span><span class="NLM_article-title">Small molecule promotes beta-catenin citrullination and inhibits Wnt signaling in cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnchembio.2510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29083417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=94-101&author=Y.+Quauthor=J.+R.+Olsenauthor=X.+Yuanauthor=P.+F.+Chengauthor=M.+P.+Levesqueauthor=K.+A.+Brokstadauthor=P.+S.+Hoffmanauthor=A.+M.+Oyanauthor=W.+Zhangauthor=K.+H.+Kallandauthor=X.+Ke&title=Small+molecule+promotes+beta-catenin+citrullination+and+inhibits+Wnt+signaling+in+cancer&doi=10.1038%2Fnchembio.2510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer</span></div><div class="casAuthors">Qu, Yi; Olsen, Jan Roger; Yuan, Xing; Cheng, Phil F.; Levesque, Mitchell P.; Brokstad, Karl A.; Hoffman, Paul S.; Oyan, Anne Margrete; Zhang, Weidong; Kalland, Karl-Henning; Ke, Xisong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Wnt (wingless)/β-catenin signaling is crit. for tumor progression and is frequently activated in colorectal cancer as a result of the mutation of adenomatous polyposis coli (APC); however, therapeutic agents targeting this pathway for clin. use are lacking.  Here we report that nitazoxanide (NTZ), a clin. approved antiparasitic drug, efficiently inhibits Wnt signaling independent of APC.  Using chemoproteomic approaches, we have identified peptidyl arginine deiminase 2 (PAD2) as the functional target of NTZ in Wnt inhibition.  By targeting PAD2, NTZ increased the deamination (citrullination) and turnover of β-catenin in colon cancer cells.  Replacement of arginine residues disrupted the transcriptional activity, and NTZ induced degrdn. of β-catenin.  In Wnt-activated colon cancer cells, knockout of either PAD2 or β-catenin substantially increased resistance to NTZ treatment.  Our data highlight the potential of NTZ as a modulator of β-catenin citrullination for the treatment of cancer patients with Wnt pathway mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpghMXVN66jQrVg90H21EOLACvtfcHk0liywR4ONrBRKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtrnP&md5=7aab9502787519d9f2b84ea9c58932d6</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2510%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DY.%26aulast%3DOlsen%26aufirst%3DJ.%2BR.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DP.%2BF.%26aulast%3DLevesque%26aufirst%3DM.%2BP.%26aulast%3DBrokstad%26aufirst%3DK.%2BA.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DOyan%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKalland%26aufirst%3DK.%2BH.%26aulast%3DKe%26aufirst%3DX.%26atitle%3DSmall%2520molecule%2520promotes%2520beta-catenin%2520citrullination%2520and%2520inhibits%2520Wnt%2520signaling%2520in%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D94%26epage%3D101%26doi%3D10.1038%2Fnchembio.2510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Antiepileptic drug carbamazepine binds to a novel pocket on the Wnt receptor Frizzled-8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3252</span>– <span class="NLM_lpage">3260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFyjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3252-3260&author=Y.+Zhaoauthor=J.+Renauthor=J.+Hillierauthor=W.+Luauthor=E.+Y.+Jones&title=Antiepileptic+drug+carbamazepine+binds+to+a+novel+pocket+on+the+Wnt+receptor+Frizzled-8&doi=10.1021%2Facs.jmedchem.9b02020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8</span></div><div class="casAuthors">Zhao, Yuguang; Ren, Jingshan; Hillier, James; Lu, Weixian; Jones, E. Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3252-3260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Misregulation of Wnt signaling is common in human cancer.  The development of small mol. inhibitors against the Wnt receptor, frizzled (FZD), may have potential in cancer therapy.  During small mol. screens, we obsd. binding of carbamazepine to the cysteine-rich domain (CRD) of the Wnt receptor FZD8 using surface plasmon resonance (SPR).  Cellular functional assays demonstrated that carbamazepine can suppress FZD8-mediated Wnt/β-catenin signaling.  We detd. the crystal structure of the complex at 1.7 Å resoln., which reveals that carbamazepine binds at a novel pocket on the FZD8 CRD.  The unique residue Tyr52 discriminates FZD8 from the closely related FZD5 and other FZDs for carbamazepine binding.  The first small mol.-bound FZD structure provides a basis for anti-FZD drug development.  Furthermore, the obsd. carbamazepine-mediated Wnt signaling inhibition may help to explain the phenomenon of bone loss and increased adipogenesis in some patients during long-term carbamazepine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFj5NuAyU747Vg90H21EOLACvtfcHk0ljmrUHFfE0frw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFyjt7g%253D&md5=073d01a57ee7fa60c96aa0fe45c08090</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02020%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHillier%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DAntiepileptic%2520drug%2520carbamazepine%2520binds%2520to%2520a%2520novel%2520pocket%2520on%2520the%2520Wnt%2520receptor%2520Frizzled-8%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3252%26epage%3D3260%26doi%3D10.1021%2Facs.jmedchem.9b02020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneidewind, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidadala, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brause, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Chemical genetics reveals a Role of dCTP pyrophosphatase 1 in Wnt signaling</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">13009</span>– <span class="NLM_lpage">13013</span>, <span class="refDoi"> DOI: 10.1002/anie.201905977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1002%2Fanie.201905977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlejtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=13009-13013&author=A.+Frieseauthor=S.+Kapoorauthor=T.+Schneidewindauthor=S.+R.+Vidadalaauthor=J.+Sardanaauthor=A.+Brauseauthor=T.+Forsterauthor=M.+Bischoffauthor=J.+Wagnerauthor=P.+Janningauthor=S.+Zieglerauthor=H.+Waldmann&title=Chemical+genetics+reveals+a+Role+of+dCTP+pyrophosphatase+1+in+Wnt+signaling&doi=10.1002%2Fanie.201905977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Genetics Reveals a Role of dCTP Pyrophosphatase 1 in Wnt Signaling</span></div><div class="casAuthors">Friese, Alexandra; Kapoor, Shobhna; Schneidewind, Tabea; Vidadala, Srinivasa Rao; Sardana, Juhi; Brause, Alexandra; Foerster, Tim; Bischoff, Matthias; Wagner, Jessica; Janning, Petra; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13009-13013</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cell-based screening is a powerful approach to identify novel chem. modulators and biol. components of relevant biol. processes.  The canonical Wnt pathway is essential for normal embryonic development and tissue homeostasis, and its deregulation plays a crucial role in carcinogenesis.  Therefore, the identification of new pathway members and regulators is of significant interest.  By a cell-based assay monitoring Wnt signaling the authors identified the pyrrolocoumarin Pyrcoumin as inhibitor of canonical Wnt signaling.  Target identification and validation revealed that Pyrcoumin is a competitive inhibitor of dCTP pyrophosphatase 1 (dCTPP1).  The authors demonstrate a yet unknown interaction of dCTPP1 with ubiquitin carboxyl-terminal hydrolase (USP7) that is counteracted by dCTPP1 inhibitors.  DCTPP1 plays a role in regulation of Wnt/β-catenin signaling most likely through a direct interaction with USP7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBsIF5NFs4C7Vg90H21EOLACvtfcHk0ljmrUHFfE0frw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlejtL7I&md5=9121926ab95c379a964ccc6f5dc6f23c</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1002%2Fanie.201905977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201905977%26sid%3Dliteratum%253Aachs%26aulast%3DFriese%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DS.%26aulast%3DSchneidewind%26aufirst%3DT.%26aulast%3DVidadala%26aufirst%3DS.%2BR.%26aulast%3DSardana%26aufirst%3DJ.%26aulast%3DBrause%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DT.%26aulast%3DBischoff%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DJanning%26aufirst%3DP.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DChemical%2520genetics%2520reveals%2520a%2520Role%2520of%2520dCTP%2520pyrophosphatase%25201%2520in%2520Wnt%2520signaling%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D13009%26epage%3D13013%26doi%3D10.1002%2Fanie.201905977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting beta-Catenin Signaling by Natural Products for Cancer Prevention and Therapy</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.3389%2Ffphar.2020.00984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=32695004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWnsr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=984&author=W.+K.+Yuauthor=Z.+Y.+Xuauthor=L.+Yuanauthor=S.+Moauthor=B.+Xuauthor=X.+D.+Chengauthor=J.+J.+Qin&title=Targeting+beta-Catenin+Signaling+by+Natural+Products+for+Cancer+Prevention+and+Therapy&doi=10.3389%2Ffphar.2020.00984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting β-catenin signaling by natural products for cancer prevention and therapy</span></div><div class="casAuthors">Yu, Wen-Kai; Xu, Zhi-Yuan; Li Yuan; Mo, Shaowei; Xu, Beihua; Cheng, Xiang-Dong; Qin, Jiang-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00984</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  The mutations and deregulation of Wnt signaling pathway occur commonly in human cancer and cause the aberrant activation of β-catenin and β-catenin-dependent transcription, thus contributing to cancer development and progression.  Therefore, β-catenin has been demonstrated as a promising target for cancer prevention and therapy.  Many natural products have been characterized as inhibitors of the b-catenin signaling through down-regulating β-catenin expression, modulating its phosphorylation, promoting its ubiquitination and proteasomal degrdn., inhibiting its nuclear translocation, or other mol. mechanisms.  These natural product inhibitors have shown preventive and therapeutic efficacy in various cancer models in vitro and in vivo.  In the present review, we comprehensively discuss the natural product b-catenin inhibitors, their in vitro and in vivo anticancer activities, and underlying mol. mechanisms.  We also discuss the current β-catenin-targeting strategies and other potential strategies that may be examd. for identifying new β-catenin inhibitors as cancer preventive and therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8k16coc5jlbVg90H21EOLACvtfcHk0lj7b-XuCrxGBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWnsr7P&md5=988b584fb29e5aee60b7b53ef2d8ec86</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00984%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BK.%26aulast%3DXu%26aufirst%3DZ.%2BY.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DMo%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DX.%2BD.%26aulast%3DQin%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520beta-Catenin%2520Signaling%2520by%2520Natural%2520Products%2520for%2520Cancer%2520Prevention%2520and%2520Therapy%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D984%26doi%3D10.3389%2Ffphar.2020.00984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Robertis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valensin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benicchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Then, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-1176-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1535-7163.MCT-12-1176-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23619303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1180-1189&author=A.+De+Robertisauthor=S.+Valensinauthor=M.+Rossiauthor=P.+Tuniciauthor=M.+Veraniauthor=A.+De+Rosaauthor=C.+Giordanoauthor=M.+Varroneauthor=A.+Nenciniauthor=C.+Pratelliauthor=T.+Benicchiauthor=A.+Bakkerauthor=J.+Hillauthor=K.+Sangthongpitagauthor=V.+Pendharkarauthor=B.+Liuauthor=F.+M.+Ngauthor=S.+W.+Thenauthor=S.+J.+Taiauthor=S.+M.+Cheongauthor=X.+Heauthor=A.+Caricasoleauthor=M.+Salerno&title=Identification+and+characterization+of+a+small-molecule+inhibitor+of+Wnt+signaling+in+glioblastoma+cells&doi=10.1158%2F1535-7163.MCT-12-1176-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells</span></div><div class="casAuthors">De Robertis, Alessandra; Valensin, Silvia; Rossi, Marco; Tunici, Patrizia; Verani, Margherita; De Rosa, Antonella; Giordano, Cinzia; Varrone, Maurizio; Nencini, Arianna; Pratelli, Carmela; Benicchi, Tiziana; Bakker, Annette; Hill, Jeffrey; Sangthongpitag, Kanda; Pendharkar, Vishal; Liu, Boping; Ng, Fui Mee; Then, Siew Wen; Tai, Shi Jing; Cheong, Seong-Moon; He, Xi; Caricasole, Andrea; Salerno, Massimiliano</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1180-1189</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common and prognostically unfavorable form of brain tumor.  The aggressive and highly invasive phenotype of these tumors makes them among the most anatomically damaging human cancers with a median survival of less than 1 yr.  Although canonical Wnt pathway activation in cancers has been historically linked to the presence of mutations involving key components of the pathway (APC, β-catenin, or Axin proteins), an increasing no. of studies suggest that elevated Wnt signaling in GBM is initiated by several alternative mechanisms that are involved in different steps of the disease.  Therefore, inhibition of Wnt signaling may represent a therapeutically relevant approach for GBM treatment.  After the selection of a GBM cell model responsive to Wnt inhibition, we set out to develop a screening approach for the identification of compds. capable of modulating canonical Wnt signaling and assocd. proliferative responses in GBM cells.  Here, we show that the small mol. SEN461 inhibits the canonical Wnt signaling pathway in GBM cells, with relevant effects at both mol. and phenotypic levels in vitro and in vivo.  These include SEN461-induced Axin stabilization, increased β-catenin phosphorylation/degrdn., and inhibition of anchorage-independent growth of human GBM cell lines and patient-derived primary tumor cells in vitro.  Moreover, in vivo administration of SEN461 antagonized Wnt signaling in Xenopus embryos and reduced tumor growth in a GBM xenograft model.  These data represent the first demonstration that small-mol.-mediated inhibition of Wnt signaling may be a potential approach for GBM therapeutics.  Mol Cancer Ther; 12(7); 1180-9. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGyMfLU6vwVrVg90H21EOLACvtfcHk0lj7b-XuCrxGBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfM&md5=b09c76be297b4773d695d17a318474d4</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-1176-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-1176-T%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRobertis%26aufirst%3DA.%26aulast%3DValensin%26aufirst%3DS.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DTunici%26aufirst%3DP.%26aulast%3DVerani%26aufirst%3DM.%26aulast%3DDe%2BRosa%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DPratelli%26aufirst%3DC.%26aulast%3DBenicchi%26aufirst%3DT.%26aulast%3DBakker%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DNg%26aufirst%3DF.%2BM.%26aulast%3DThen%26aufirst%3DS.%2BW.%26aulast%3DTai%26aufirst%3DS.%2BJ.%26aulast%3DCheong%26aufirst%3DS.%2BM.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DSalerno%26aufirst%3DM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520Wnt%2520signaling%2520in%2520glioblastoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1180%26epage%3D1189%26doi%3D10.1158%2F1535-7163.MCT-12-1176-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voitovich, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shegravina, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitnikov, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faerman, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmalz, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svirshchevskaya, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, A. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of furanoallocolchicinoids</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1021/jm501678w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501678w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=692-704&author=Y.+V.+Voitovichauthor=E.+S.+Shegravinaauthor=N.+S.+Sitnikovauthor=V.+I.+Faermanauthor=V.+V.+Fokinauthor=H.+G.+Schmalzauthor=S.+Combesauthor=D.+Allegroauthor=P.+Barbierauthor=I.+P.+Beletskayaauthor=E.+V.+Svirshchevskayaauthor=A.+Y.+Fedorov&title=Synthesis+and+biological+evaluation+of+furanoallocolchicinoids&doi=10.1021%2Fjm501678w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Furanoallocolchicinoids</span></div><div class="casAuthors">Voitovich, Yuliya V.; Shegravina, Ekaterina S.; Sitnikov, Nikolay S.; Faerman, Vladimir I.; Fokin, Valery V.; Schmalz, Hans-Gunther; Combes, Sebastien; Allegro, Diane; Barbier, Pascal; Beletskaya, Irina P.; Svirshchevskaya, Elena V.; Fedorov, Alexey Yu.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of conformationally flexible furan-derived allocolchicinoids was prepd. from com. available colchicine in good to excellent yields using a three-step reaction sequence.  Cytotoxicity studies indicated the potent activity of two compds. against human epithelial and lymphoid cell lines (AsPC-1, HEK293, and Jurkat) as well as against Wnt-1 related murine epithelial cell line W1308.  The results of in vitro expts. demonstrated that the major effect of these compds. was the induction of cell cycle arrest in the G2/M phase as a direct consequence of effective tubulin binding.  In vivo testing of the most potent furanoallocolchicinoid I using C57BL/6 mice inoculated with Wnt-1 tumor cells indicated significant inhibition of the tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_x3Suuo2S0rVg90H21EOLACvtfcHk0lh7_3jtifmxWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsr3J&md5=e82912b440db9dd48ed85a2345f14889</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fjm501678w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501678w%26sid%3Dliteratum%253Aachs%26aulast%3DVoitovich%26aufirst%3DY.%2BV.%26aulast%3DShegravina%26aufirst%3DE.%2BS.%26aulast%3DSitnikov%26aufirst%3DN.%2BS.%26aulast%3DFaerman%26aufirst%3DV.%2BI.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSchmalz%26aufirst%3DH.%2BG.%26aulast%3DCombes%26aufirst%3DS.%26aulast%3DAllegro%26aufirst%3DD.%26aulast%3DBarbier%26aufirst%3DP.%26aulast%3DBeletskaya%26aufirst%3DI.%2BP.%26aulast%3DSvirshchevskaya%26aufirst%3DE.%2BV.%26aulast%3DFedorov%26aufirst%3DA.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520furanoallocolchicinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D692%26epage%3D704%26doi%3D10.1021%2Fjm501678w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1832</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1821-1832&author=Y.+Zouauthor=D.+Zhaoauthor=C.+Yanauthor=Y.+Jiauthor=J.+Liuauthor=J.+Xuauthor=Y.+Laiauthor=J.+Tianauthor=Y.+Zhangauthor=Z.+Huang&title=Novel+ligustrazine-based+analogs+of+piperlongumine+potently+suppress+proliferation+and+metastasis+of+colorectal+cancer+cells+in+vitro+and+in+vivo&doi=10.1021%2Facs.jmedchem.7b01096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo</span></div><div class="casAuthors">Zou, Yu; Zhao, Di; Yan, Chang; Ji, Yanpeng; Liu, Jin; Xu, Jinyi; Lai, Yisheng; Tian, Jide; Zhang, Yihua; Huang, Zhangjian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1821-1832</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Piperlongumine 1 increases reactive oxygen species (ROS) levels and preferably induces cancer cell apoptosis by triggering different pathways.  However, the poor soly. of 1 limits its intensive investigation and clin. application.  Ligustrazine possesses a water-sol. pyrazine skeleton and can inhibit proliferation and metastasis of cancer cells.  We synthesized compd. I by replacement of the trimethoxyphenyl of 1 with ligustrazine moiety and further introduced 2-Cl, -Br, and -I to I for synthesis of 4-6, resp.  Compd. II possessed 14-fold greater aq. soly. than 1 and increased ROS levels in colorectal cancer HCT-116 cells.  Addnl., II preferably inhibited proliferation, migration, invasion, and heteroadhesion of HCT-116 cells.  Treatment with II suppressed tumor growth and lung metastasis in vivo and prolonged the survival of tumor-bearing mice.  Furthermore, II mitigated TGF-β1-induced epithelial-mesenchymal transition and Wnt/β-catenin activation by inhibiting the Akt and GSK-3β phosphorylation in HCT-116 cells.  Collectively, II displayed significant antiproliferation and antimetastasis activities, superior to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVFYsseVww97Vg90H21EOLACvtfcHk0lh7_3jtifmxWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGks7Y%253D&md5=be6500823424caca2043fa857ac72515</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01096%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DNovel%2520ligustrazine-based%2520analogs%2520of%2520piperlongumine%2520potently%2520suppress%2520proliferation%2520and%2520metastasis%2520of%2520colorectal%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1821%26epage%3D1832%26doi%3D10.1021%2Facs.jmedchem.7b01096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Pyrazole-4-carboxamide (YW2065): a therapeutic candidate for colorectal cancer via dual activities of Wnt/beta-catenin signaling inhibition and AMP-activated protein kinase (AMPK) activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11151</span>– <span class="NLM_lpage">11164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Kktb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11151-11164&author=W.+Yangauthor=Y.+Liauthor=Y.+Aiauthor=O.+N.+Obianomauthor=D.+Guoauthor=H.+Yangauthor=S.+Sakamuruauthor=M.+Xiaauthor=Y.+Shuauthor=F.+Xue&title=Pyrazole-4-carboxamide+%28YW2065%29%3A+a+therapeutic+candidate+for+colorectal+cancer+via+dual+activities+of+Wnt%2Fbeta-catenin+signaling+inhibition+and+AMP-activated+protein+kinase+%28AMPK%29+activation&doi=10.1021%2Facs.jmedchem.9b01252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation</span></div><div class="casAuthors">Yang, Wei; Li, Yingjun; Ai, Yong; Obianom, Obinna N.; Guo, Dong; Yang, Hong; Sakamuru, Srilatha; Xia, Menghang; Shu, Yan; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11151-11164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dysregulation of the Wnt/β-catenin signaling pathway has been widely recognized as a pathogenic mechanism for colorectal cancer (CRC).  Although numerous Wnt inhibitors have been developed, they commonly suffer from toxicity and unintended effects.  Moreover, concerns have been raised in targeting this pathway because of its crit. roles in maintaining stem cells and regenerating tissues and organs.  On the basis of the anthelmintic drug pyrvinium and previous lead FX1128, we have developed a compd. YW2065 (1c) which demonstrated excellent anti-CRC effects in vitro and in vivo.  YW2065 achieves its inhibitory activity for Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degrdn. of β-catenin.  Simultaneously, YW2065 also led to the activation of the tumor suppressor AMPK, providing an addnl. anticancer mechanism.  In addn., YW2065 showed favorable pharmacokinetic properties without obvious toxicity.  The anti-CRC effect of YW2065 was highlighted by its promising efficacy in a mice xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodOpjGpkTKvrVg90H21EOLACvtfcHk0lgwR3wFg4mjdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Kktb3J&md5=a87008ae31b63b3fd0e38f3f9b65fe2c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01252%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSakamuru%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DPyrazole-4-carboxamide%2520%2528YW2065%2529%253A%2520a%2520therapeutic%2520candidate%2520for%2520colorectal%2520cancer%2520via%2520dual%2520activities%2520of%2520Wnt%252Fbeta-catenin%2520signaling%2520inhibition%2520and%2520AMP-activated%2520protein%2520kinase%2520%2528AMPK%2529%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11151%26epage%3D11164%26doi%3D10.1021%2Facs.jmedchem.9b01252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kypta, R.</span></span> <span> </span><span class="NLM_article-title">Secreted antagonists of the Wnt signalling pathway</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2634</span>, <span class="refDoi"> DOI: 10.1242/jcs.00623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1242%2Fjcs.00623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=12775774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFamtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=2627-2634&author=Y.+Kawanoauthor=R.+Kypta&title=Secreted+antagonists+of+the+Wnt+signalling+pathway&doi=10.1242%2Fjcs.00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted antagonists of the Wnt signalling pathway</span></div><div class="casAuthors">Kawano, Yoshiaki; Kypta, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2627-2634</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The extracellular antagonists of the Wnt signalling pathway can be divided into two broad classes.  Both classes of mol. prevent ligand-receptor interactions, but by different mechanisms: members of the first class, which include the sFRP (secreted Frizzled-related protein) family, WIF (Wnt inhibitory factor)-1 and Cerberus, primarily bind to Wnt proteins; the second class comprises certain members of the Dickkopf (Dkk) family, which bind to one subunit of the Wnt receptor complex.  In addn., there are other protein interactions that contribute to Wnt antagonist function.  Moreover, certain sFRPs and Dkks do not antagonize Wnt function, which suggests that these families have as-yet-undiscovered functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHGuViJPoQVLVg90H21EOLACvtfcHk0lgwR3wFg4mjdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFamtLs%253D&md5=fe0fcc326f2701f33d40473630e7ed0a</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00623%26sid%3Dliteratum%253Aachs%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DKypta%26aufirst%3DR.%26atitle%3DSecreted%2520antagonists%2520of%2520the%2520Wnt%2520signalling%2520pathway%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D2627%26epage%3D2634%26doi%3D10.1242%2Fjcs.00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0lh72hCRGAOZgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reineke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auslander, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beissbarth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rave-Frank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaedcke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadimi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ried, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grade, M.</span></span> <span> </span><span class="NLM_article-title">Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt/beta-catenin signaling</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1541-7786.MCR-17-0205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=28811361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGisrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=1481-1490&author=G.+Emonsauthor=M.+Spitznerauthor=S.+Reinekeauthor=J.+M%C3%B6llerauthor=N.+Auslanderauthor=F.+Kramerauthor=Y.+Huauthor=T.+Beissbarthauthor=H.+A.+Wolffauthor=M.+Rave-Frankauthor=E.+Hessmannauthor=J.+Gaedckeauthor=B.+M.+Ghadimiauthor=S.+A.+Johnsenauthor=T.+Riedauthor=M.+Grade&title=Chemoradiotherapy+resistance+in+colorectal+cancer+cells+is+mediated+by+Wnt%2Fbeta-catenin+signaling&doi=10.1158%2F1541-7786.MCR-17-0205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling</span></div><div class="casAuthors">Emons, Georg; Spitzner, Melanie; Reineke, Sebastian; Moller, Janneke; Auslander, Noam; Kramer, Frank; Hu, Yue; Beissbarth, Tim; Wolff, Hendrik A.; Rave-Frank, Margret; Hessmann, Elisabeth; Gaedcke, Jochen; Ghadimi, B. Michael; Johnsen, Steven A.; Ried, Thomas; Grade, Marian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1481-1490</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of Wnt/β-catenin signaling plays a central role in the development and progression of colorectal cancer.  The Wnt-transcription factor, TCF7L2, is overexpressed in primary rectal cancers that are resistant to chemoradiotherapy and TCF7L2 mediates resistance to chemoradiotherapy.  However, it is unclear whether the resistance is mediated by a TCF7L2 inherent mechanism or Wnt/β-catenin signaling in general.  Here, inhibition of β-catenin by siRNAs or a small-mol. inhibitor (XAV-939) resulted in sensitization of colorectal cancer cells to chemoradiotherapy.  To investigate the potential role of Wnt/β-catenin signaling in controlling therapeutic responsiveness, nontumorigenic RPE-1 cells were stimulated with Wnt-3a, a physiol. ligand of Frizzled receptors, which increased resistance to chemoradiotherapy.  This effect could be recapitulated by overexpression of a degrdn.-resistant mutant of β-catenin (S33Y), also boosting resistance of RPE-1 cells to chemoradiotherapy, which was, conversely, abrogated by siRNA-mediated silencing of β-catenin.  Consistent with these findings, higher expression levels of active β-catenin were obsd. as well as increased TCF/LEF reporter activity in SW1463 cells that evolved radiation resistance due to repeated radiation treatment.  Global gene expression profiling identified several altered pathways, including PPAR signaling and other metabolic pathways, assocd. with cellular response to radiation.  In summary, aberrant activation of Wnt/β-catenin signaling not only regulates the development and progression of colorectal cancer, but also mediates resistance of rectal cancers to chemoradiotherapy.  Implications: Targeting Wnt/β-catenin signaling or one of the downstream pathways represents a promising strategy to increase response to chemoradiotherapy.  Mol Cancer Res; 15(11); 1481-90. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSun2clWTLybVg90H21EOLACvtfcHk0lh72hCRGAOZgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGisrfI&md5=41ef220b88b6bfee9615adaa491fac2e</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0205%26sid%3Dliteratum%253Aachs%26aulast%3DEmons%26aufirst%3DG.%26aulast%3DSpitzner%26aufirst%3DM.%26aulast%3DReineke%26aufirst%3DS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DJ.%26aulast%3DAuslander%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBeissbarth%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DH.%2BA.%26aulast%3DRave-Frank%26aufirst%3DM.%26aulast%3DHessmann%26aufirst%3DE.%26aulast%3DGaedcke%26aufirst%3DJ.%26aulast%3DGhadimi%26aufirst%3DB.%2BM.%26aulast%3DJohnsen%26aufirst%3DS.%2BA.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DGrade%26aufirst%3DM.%26atitle%3DChemoradiotherapy%2520resistance%2520in%2520colorectal%2520cancer%2520cells%2520is%2520mediated%2520by%2520Wnt%252Fbeta-catenin%2520signaling%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2017%26volume%3D15%26spage%3D1481%26epage%3D1490%26doi%3D10.1158%2F1541-7786.MCR-17-0205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arques, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicote, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puig, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenbaum, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argiles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dienstmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caratu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silberschmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landolfi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuciforo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, H. G.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition blocks Wnt/beta-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-3081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-14-3081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26224873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFeqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=644-656&author=O.+Arquesauthor=I.+Chicoteauthor=I.+Puigauthor=S.+P.+Tenbaumauthor=G.+Argilesauthor=R.+Dienstmannauthor=N.+Fernandezauthor=G.+Caratuauthor=J.+Matitoauthor=D.+Silberschmidtauthor=J.+Rodonauthor=S.+Landolfiauthor=A.+Pratauthor=E.+Espinauthor=R.+Charcoauthor=P.+Nuciforoauthor=A.+Vivancosauthor=W.+Shaoauthor=J.+Taberneroauthor=H.+G.+Palmer&title=Tankyrase+inhibition+blocks+Wnt%2Fbeta-catenin+pathway+and+reverts+resistance+to+PI3K+and+AKT+inhibitors+in+the+treatment+of+colorectal+cancer&doi=10.1158%2F1078-0432.CCR-14-3081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer</span></div><div class="casAuthors">Arques, Oriol; Chicote, Irene; Puig, Isabel; Tenbaum, Stephan P.; Argiles, Guillem; Dienstmann, Rodrigo; Fernandez, Natalia; Caratu, Ginevra; Matito, Judit; Silberschmidt, Daniel; Rodon, Jordi; Landolfi, Stefania; Prat, Aleix; Espin, Eloy; Charco, Ramon; Nuciforo, Paolo; Vivancos, Ana; Shao, Wenlin; Tabernero, Josep; Palmer, Hector G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">644-656</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Oncogenic mutations in the KRAS/PI3K/AKT pathway are one of the most frequent alterations in cancer.  Although PI3K or AKT inhibitors show promising results in clin. trials, drug resistance frequently emerges.  We previously revealed Wnt/β-catenin signaling hyperactivation as responsible for such resistance in colorectal cancer.  Here we investigate Wnt-mediated resistance in patients treated with PI3K or AKT inhibitors in clin. trials and evaluate the efficacy of a new Wnt/tankyrase inhibitor, NVP-TNKS656, to overcome such resistance.  Exptl. Design: Colorectal cancer patient-derived sphere cultures and mouse tumor xenografts were treated with NVP-TNKS656, in combination with PI3K or AKT inhibitors.  We analyzed progression-free survival of patients treated with different PI3K/AKT/mTOR inhibitors in correlation with Wnt/β-catenin pathway activation, oncogenic mutations, clinicopathol. traits, and gene expression patterns in 40 colorectal cancer baseline tumors.  Results: Combination with NVP-TNKS656 promoted apoptosis in PI3K or AKT inhibitor-resistant cells with high nuclear β-catenin content.  High FOXO3A activity conferred sensitivity to NVP-TNKS656 treatment.  Thirteen of 40 patients presented high nuclear β-catenin content and progressed earlier upon PI3K/AKT/mTOR inhibition.  Nuclear β-catenin levels predicted drug response, whereas clinicopathol. traits, gene expression profiles, or frequent mutations (KRAS, TP53, or PIK3CA) did not.  Conclusions: High nuclear β-catenin content independently predicts resistance to PI3K and AKT inhibitors.  Combined treatment with a Wnt/tankyrase inhibitor reduces nuclear β-catenin, reverts such resistance, and represses tumor growth.  FOXO3A content and activity predicts response to Wnt/β-catenin inhibition and together with β-catenin may be predictive biomarkers of drug response providing a rationale to stratify colorectal cancer patients to be treated with PI3K/AKT/mTOR and Wnt/β-catenin inhibitors.  Clin Cancer Res; 22(3); 644-56. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIvc6o3K2hUrVg90H21EOLACvtfcHk0liEeL3GTZCE6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFeqsrg%253D&md5=62e37267fe02681d6b023521992f0d19</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-3081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-3081%26sid%3Dliteratum%253Aachs%26aulast%3DArques%26aufirst%3DO.%26aulast%3DChicote%26aufirst%3DI.%26aulast%3DPuig%26aufirst%3DI.%26aulast%3DTenbaum%26aufirst%3DS.%2BP.%26aulast%3DArgiles%26aufirst%3DG.%26aulast%3DDienstmann%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DN.%26aulast%3DCaratu%26aufirst%3DG.%26aulast%3DMatito%26aufirst%3DJ.%26aulast%3DSilberschmidt%26aufirst%3DD.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DEspin%26aufirst%3DE.%26aulast%3DCharco%26aufirst%3DR.%26aulast%3DNuciforo%26aufirst%3DP.%26aulast%3DVivancos%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DPalmer%26aufirst%3DH.%2BG.%26atitle%3DTankyrase%2520inhibition%2520blocks%2520Wnt%252Fbeta-catenin%2520pathway%2520and%2520reverts%2520resistance%2520to%2520PI3K%2520and%2520AKT%2520inhibitors%2520in%2520the%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D22%26spage%3D644%26epage%3D656%26doi%3D10.1158%2F1078-0432.CCR-14-3081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luke, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweis, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">WNT/beta-catenin pathway activation correlates with immune exclusion across human cancers</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3074</span>– <span class="NLM_lpage">3083</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1078-0432.CCR-18-1942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30635339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1OlsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=3074-3083&author=J.+J.+Lukeauthor=R.+Baoauthor=R.+F.+Sweisauthor=S.+Sprangerauthor=T.+F.+Gajewski&title=WNT%2Fbeta-catenin+pathway+activation+correlates+with+immune+exclusion+across+human+cancers&doi=10.1158%2F1078-0432.CCR-18-1942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">WNT/β-catenin pathway activation correlates with immune exclusion across human cancers</span></div><div class="casAuthors">Luke, Jason J.; Bao, Riyue; Sweis, Randy F.; Spranger, Stefani; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3074-3083</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The T-cell-inflamed phenotype correlates with efficacy of immune-checkpoint blockade, whereas non-T-cell-inflamed tumors infrequently benefit.  Tumor-intrinsic WNT/β-catenin signaling mediates immune exclusion in melanoma, but assocn. with the non-T-cell-inflamed tumor microenvironment in other tumor types is not well understood.  Exptl. Design: Using The Cancer Genome Atlas (TCGA), a T-cell-inflamed gene expression signature segregated samples within tumor types.  Activation of WNT/β-catenin signaling was inferred using three approaches: somatic mutations or somatic copy no. alterations (SCNA) in β-catenin signaling elements including CTNNB1, APC, APC2, AXIN1, and AXIN2; pathway prediction from RNA-sequencing gene expression; and inverse correlation of β-catenin protein levels with the T-cell-inflamed gene expression signature.  Results: Across TCGA, 3,137/9,244 (33.9%) tumors were non-T-cell-inflamed, whereas 3,161/9,244 (34.2%) were T-cell-inflamed.  Non-T-cell-inflamed tumors demonstrated significantly lower expression of T-cell inflammation genes relative to matched normal tissue, arguing for loss of a natural immune phenotype.  Mutations of β-catenin signaling mols. in non-T-cell-inflamed tumors were enriched three-fold relative to T-cell-inflamed tumors.  Across 31 tumors, 28 (90%) demonstrated activated β-catenin signaling in the non-T-cell-inflamed subset by at least one method.  This included target mol. expression from somatic mutations and/or SCNAs of β-catenin signaling elements (19 tumors, 61%), pathway anal. (14 tumors, 45%), and increased β-catenin protein levels (20 tumors, 65%).  Conclusions: Activation of tumor-intrinsic WNT/β-catenin signaling is enriched in non-T-cell-inflamed tumors.  These data provide a strong rationale for development of pharmacol. inhibitors of this pathway with the aim of restoring immune cell infiltration and augmenting immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Rkj_ydtUBbVg90H21EOLACvtfcHk0ljL-AIuNmUNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1OlsLnN&md5=f29ada7d7d00f27f99a76ee84acc6868</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1942%26sid%3Dliteratum%253Aachs%26aulast%3DLuke%26aufirst%3DJ.%2BJ.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DSweis%26aufirst%3DR.%2BF.%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DWNT%252Fbeta-catenin%2520pathway%2520activation%2520correlates%2520with%2520immune%2520exclusion%2520across%2520human%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D3074%26epage%3D3083%26doi%3D10.1158%2F1078-0432.CCR-18-1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spalding, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielske, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bommer, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldar-Finkelman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Josef, E.</span></span> <span> </span><span class="NLM_article-title">GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1593/neo.92112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1593%2Fneo.92112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=20454507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvF2kurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=357-365&author=R.+L.+Watsonauthor=A.+C.+Spaldingauthor=S.+P.+Zielskeauthor=M.+Morganauthor=A.+C.+Kimauthor=G.+T.+Bommerauthor=H.+Eldar-Finkelmanauthor=T.+Giordanoauthor=E.+R.+Fearonauthor=G.+D.+Hammerauthor=T.+S.+Lawrenceauthor=E.+Ben-Josef&title=GSK3beta+and+beta-catenin+modulate+radiation+cytotoxicity+in+pancreatic+cancer&doi=10.1593%2Fneo.92112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3β and β-catenin modulate radiation cytotoxicity in pancreatic cancer</span></div><div class="casAuthors">Watson, Richard L.; Spalding, Aaron C.; Zielske, Steven P.; Morgan, Meredith; Kim, Alex C.; Bommer, Guido T.; Eldar-Finkelman, Hagit; Giordano, Thomas; Fearon, Eric R.; Hammer, Gary D.; Lawrence, Theodore S.; Ben-Josef, Edgar</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Knowledge of factors and mechanisms contributing to the inherent radioresistance of pancreatic cancer may improve cancer treatment.  Irradn. inhibits glycogen synthase kinase 3β (GSK3β) by phosphorylation at serine 9.  In turn, release of cytosolic membrane β-catenin with subsequent nuclear translocation promotes survival.  Both GSK3β and β-catenin have been implicated in cancer cell proliferation and resistance to death.  We investigated pancreatic cancer cell survival after radiation in vitro and in vivo, with a particular focus on the role of the function of the GSK3β/β-catenin axis.  Lithium chloride, RNAi-medicated silencing of GSK3β, or the expression of a kinase dead mutant GSK3β resulted in radioresistance of Panc1 and BxPC3 pancreatic cancer cells.  Conversely, ectopic expression of a constitutively active form of GSK3β resulted in radiosensitization of Panc1 cells.  GSK3β silencing increased radiation-induced β-catenin target gene expression asmeasured by studies of AXIN2 and LEF1 transcript levels.  Western blot anal. of total and phosphorylated levels of GSK3β and β-catenin showed that GSK3β inhibition resulted in stabilization of β-catenin.  Xenografts of both BxPC3 and Panc1 with targeted silencing of GSK3β exhibited radioresistance in vivo.  Silencing of β-catenin resulted in radiosensitization, whereas a nondegradable β-catenin construct induced radioresistance.  These data support the hypothesis that GSK3β modulates the cellular response to radiation in a β-catenin-dependent mechanism.  Further understanding of this pathway may enhance the development of clin. trials combining drugs inhibiting β-catenin activation with radiation and chemotherapy in locally advanced pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdC_qbJgWZzbVg90H21EOLACvtfcHk0ljL-AIuNmUNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvF2kurk%253D&md5=a656ae524c51ae7157ff10e930c05ecb</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1593%2Fneo.92112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.92112%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DR.%2BL.%26aulast%3DSpalding%26aufirst%3DA.%2BC.%26aulast%3DZielske%26aufirst%3DS.%2BP.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DA.%2BC.%26aulast%3DBommer%26aufirst%3DG.%2BT.%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DLawrence%26aufirst%3DT.%2BS.%26aulast%3DBen-Josef%26aufirst%3DE.%26atitle%3DGSK3beta%2520and%2520beta-catenin%2520modulate%2520radiation%2520cytotoxicity%2520in%2520pancreatic%2520cancer%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D357%26epage%3D365%26doi%3D10.1593%2Fneo.92112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cytoplasmic GSK-3beta increases cisplatin resistance through activation of Wnt/beta-catenin signaling in A549/DDP cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.canlet.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23673211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlGgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2013&pages=231-239&author=Y.+Gaoauthor=Z.+Liuauthor=X.+Zhangauthor=J.+Heauthor=Y.+Panauthor=F.+Haoauthor=L.+Xieauthor=Q.+Liauthor=X.+Qiuauthor=E.+Wang&title=Inhibition+of+cytoplasmic+GSK-3beta+increases+cisplatin+resistance+through+activation+of+Wnt%2Fbeta-catenin+signaling+in+A549%2FDDP+cells&doi=10.1016%2Fj.canlet.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells</span></div><div class="casAuthors">Gao, Yuan; Liu, Zan; Zhang, Xiuwei; He, Jiani; Pan, Yongqi; Hao, Fengxia; Xie, Lingling; Li, Qingchang; Qiu, Xueshan; Wang, Enhua</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">231-239</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cisplatin-based chemotherapy is recommended as the first-line therapy for advanced non-small cell lung cancer (NSCLC).  However, acquired cisplatin resistance is ubiquitous in patients with NSCLC, but the mol. mechanism of such resistance remains ambiguous.  The present study sought to examine the role of the Wnt/β-catenin signaling pathway in cisplatin resistance by assessing the phosphorylation and subcellular distribution of GSK-3β in a human lung adenocarcinoma cell line, A549, and its cisplatin-resistant subline, A549/DDP.  Total GSK-3β, phosphorylated GSK-3βser9 and phosphorylated GSK-3βtyr216 in cytoplasmic and nuclear fractions of A549/DDP and A549 cells were examd. by western blot anal.  The regulation of cisplatin resistance, apoptosis, β-catenin and survivin protein expression by inhibition of cytoplasmic GSK-3β were detd. by MTT assay, flow cytometry anal., immunofluorescence technique and western blot anal.  In the present study, cytoplasmic levels of p-GSK-3βser9 were significantly increased in A549/DDP cells as compared with A549 cells (P < 0.01), and these levels were further increased by cisplatin treatment in A549/DDP cells (P < 0.01).  In contrast, cytoplasmic levels of p-GSK-3βser9 were reduced in A549 cells after treatment with cisplatin (P < 0.01).  However, cytoplasmic levels of p-GSK-3βtyr216 were significantly decreased in A549/DDP cells as compared with A549 cells (P < 0.01), and these levels were further decreased by cisplatin treatment in A549/DDP cells (P < 0.01).  Conversely, cytoplasmic levels of p-GSK-3βtyr216 were raised in A549 cells after treatment with cisplatin (P < 0.01).  Anal. of downstream effectors of the Wnt/β-catenin signaling pathway revealed upregulation of β-catenin and survivin expression in A549/DDP cells treated with cisplatin as compared to untreated cells.  In A549 cells, cisplatin treatment decreased the expression of β-catenin and survivin.  Furthermore, phosphorylation of GSK-3β at serine 9 by LiCl and transient interference of GSK-3β by siRNA increased β-catenin and survivin protein expression in A549/DDP cells.  Low exogenous and endogenous cytoplasmic GSK-3β expression enhanced the IC50 and inhibited apoptosis.  In conclusion, activation of the Wnt/β-catenin signaling pathway and upregulated survivin expression due to cytoplasmic GSK-3β inhibition might lead to cisplatin resistance in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTlRW1e5KsrVg90H21EOLACvtfcHk0ljL-AIuNmUNMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlGgtrw%253D&md5=4ea4690cfd74edeb42af40825b637516</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520cytoplasmic%2520GSK-3beta%2520increases%2520cisplatin%2520resistance%2520through%2520activation%2520of%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520A549%252FDDP%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D336%26spage%3D231%26epage%3D239%26doi%3D10.1016%2Fj.canlet.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacarelli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakashev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkhutdinov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kossenkov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showe, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span> <span> </span><span class="NLM_article-title">N<sup>6</sup>-methylation of adenosine of <i>FZD10</i> mRNA contributes to PARP inhibitor resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">2812</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-18-3592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F0008-5472.CAN-18-3592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30967398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslCrsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=2812-2820&author=T.+Fukumotoauthor=H.+Zhuauthor=T.+Nacarelliauthor=S.+Karakashevauthor=N.+Fatkhutdinovauthor=S.+Wuauthor=P.+Liuauthor=A.+V.+Kossenkovauthor=L.+C.+Showeauthor=S.+Jeanauthor=L.+Zhangauthor=R.+Zhang&title=N6-methylation+of+adenosine+of+FZD10+mRNA+contributes+to+PARP+inhibitor+resistance&doi=10.1158%2F0008-5472.CAN-18-3592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">N6-methylation of adenosine of FZD10 mRNA contributes to PARP inhibitor resistance</span></div><div class="casAuthors">Fukumoto, Takeshi; Zhu, Hengrui; Nacarelli, Timothy; Karakashev, Sergey; Fatkhutdinov, Nail; Wu, Shuai; Liu, Pingyu; Kossenkov, Andrew V.; Showe, Louise C.; Jean, Stephanie; Zhang, Lin; Zhang, Rugang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2812-2820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite the high initial response rates to PARP inhibitors (PARPi) in BRCA-mutated epithelial ovarian cancers (EOC), PARPi resistance remains a major challenge.  Chem. modifications of RNAs have emerged as a new layer of epigenetic gene regulation.  N6-methyladenosine (m6A) is the most abundant chem. modification of mRNA, yet the role of m6A modification in PARPi resistance has not previously been explored.  Here, we show that m6A modification of FZD10 mRNA contributes to PARPi resistance by upregulating the Wnt/beta-catenin pathway in BRCA-mutated EOC cells.  Global m6A profile revealed a significant increase in m6A modification in FZD10 mRNA, which correlated with increased FZD10 mRNA stability and an upregulation of the Wnt/beta-catenin pathway.  Mechanistically, downregulation of m6A demethylases FTO and ALKBH5 was sufficient to increase FZD10 mRNA m6A modification and reduce PARPi sensitivity, which correlated with an increase in homologous recombination activity.  Moreover, combined inhibition of PARP and Wnt/beta-catenin showed synergistic suppression of PARPi-resistant cells in vitro and in vivo in a xenograft EOC mouse model.  Overall, our results show that m6A contributes to PARPi resistance in BRCA-deficient EOC cells by upregulating the Wnt/beta-catenin pathway via stabilization of FZD10.  They also suggest that inhibition of the Wnt/beta-catenin pathway represents a potential strategy to overcome PARPi resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq60ZoEmpP5RrVg90H21EOLACvtfcHk0lgXJ2OFeP6vpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslCrsLzE&md5=918ad8f47954926ac6b291fe53e4fa99</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-3592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-3592%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DNacarelli%26aufirst%3DT.%26aulast%3DKarakashev%26aufirst%3DS.%26aulast%3DFatkhutdinov%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DKossenkov%26aufirst%3DA.%2BV.%26aulast%3DShowe%26aufirst%3DL.%2BC.%26aulast%3DJean%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26atitle%3DN6-methylation%2520of%2520adenosine%2520of%2520FZD10%2520mRNA%2520contributes%2520to%2520PARP%2520inhibitor%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D2812%26epage%3D2820%26doi%3D10.1158%2F0008-5472.CAN-18-3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rathert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muerdter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deswal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerny-Reiterer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jude, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boryn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontsch-Grunt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakoc, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuber, J.</span></span> <span> </span><span class="NLM_article-title">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>525</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/nature14898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26367798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=543-547&author=P.+Rathertauthor=M.+Rothauthor=T.+Neumannauthor=F.+Muerdterauthor=J.+S.+Roeauthor=M.+Muharauthor=S.+Deswalauthor=S.+Cerny-Reitererauthor=B.+Peterauthor=J.+Judeauthor=T.+Hoffmannauthor=L.+M.+Borynauthor=E.+Axelssonauthor=N.+Schweiferauthor=U.+Tontsch-Gruntauthor=L.+E.+Dowauthor=D.+Gianniauthor=M.+Pearsonauthor=P.+Valentauthor=A.+Starkauthor=N.+Krautauthor=C.+R.+Vakocauthor=J.+Zuber&title=Transcriptional+plasticity+promotes+primary+and+acquired+resistance+to+BET+inhibition&doi=10.1038%2Fnature14898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional plasticity promotes primary and acquired resistance to BET inhibition</span></div><div class="casAuthors">Rathert, Philipp; Roth, Mareike; Neumann, Tobias; Muerdter, Felix; Roe, Jae-Seok; Muhar, Matthias; Deswal, Sumit; Cerny-Reiterer, Sabine; Peter, Barbara; Jude, Julian; Hoffmann, Thomas; Boryn, Lukasz M.; Axelsson, Elin; Schweifer, Norbert; Tontsch-Grunt, Ulrike; Dow, Lukas E.; Gianni, Davide; Pearson, Mark; Valent, Peter; Stark, Alexander; Kraut, Norbert; Vakoc, Christopher R.; Zuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">543-547</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Following the discovery of BRD4 as a non-oncogene addiction target in acute myeloid leukemia (AML), bromodomain and extra terminal protein (BET) inhibitors are being explored as a promising therapeutic avenue in numerous cancers.  While clin. trials have reported single-agent activity in advanced hematol. malignancies, mechanisms detg. the response to BET inhibition remain poorly understood.  To identify factors involved in primary and acquired BET resistance in leukemia, here we perform a chromatin-focused RNAi screen in a sensitive MLL-AF9;NrasG12D-driven AML mouse model, and investigate dynamic transcriptional profiles in sensitive and resistant mouse and human leukemias.  Our screen shows that suppression of the PRC2 complex, contrary to effects in other contexts, promotes BET inhibitor resistance in AML.  PRC2 suppression does not directly affect the regulation of Brd4-dependent transcripts, but facilitates the remodelling of regulatory pathways that restore the transcription of key targets such as Myc.  Similarly, while BET inhibition triggers acute MYC repression in human leukemias regardless of their sensitivity, resistant leukemias are uniformly characterized by their ability to rapidly restore MYC transcription.  This process involves the activation and recruitment of WNT signaling components, which compensate for the loss of BRD4 and drive resistance in various cancer models.  Dynamic chromatin immunopptn. sequencing and self-transcribing active regulatory region sequencing of enhancer profiles reveal that BET-resistant states are characterized by remodelled regulatory landscapes, involving the activation of a focal MYC enhancer that recruits WNT machinery in response to BET inhibition.  Together, our results identify and validate WNT signaling as a driver and candidate biomarker of primary and acquired BET resistance in leukemia, and implicate the rewiring of transcriptional programs as an important mechanism promoting resistance to BET inhibitors and, potentially, other chromatin-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDgeY3nFr4GrVg90H21EOLACvtfcHk0lj6Y0F6NpZESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fO&md5=6d6cf4c4123ad6a698b88f02f95a2ebe</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature14898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14898%26sid%3Dliteratum%253Aachs%26aulast%3DRathert%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DNeumann%26aufirst%3DT.%26aulast%3DMuerdter%26aufirst%3DF.%26aulast%3DRoe%26aufirst%3DJ.%2BS.%26aulast%3DMuhar%26aufirst%3DM.%26aulast%3DDeswal%26aufirst%3DS.%26aulast%3DCerny-Reiterer%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DB.%26aulast%3DJude%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBoryn%26aufirst%3DL.%2BM.%26aulast%3DAxelsson%26aufirst%3DE.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DGianni%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DZuber%26aufirst%3DJ.%26atitle%3DTranscriptional%2520plasticity%2520promotes%2520primary%2520and%2520acquired%2520resistance%2520to%2520BET%2520inhibition%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D543%26epage%3D547%26doi%3D10.1038%2Fnature14898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ftouni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giotopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Wahab, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouzarides, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntly, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinjha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papenfuss, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M. A.</span></span> <span> </span><span class="NLM_article-title">BET inhibitor resistance emerges from leukaemia stem cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>525</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1038/nature14888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26367796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=525&publication_year=2015&pages=538-542&author=C.+Y.+Fongauthor=O.+Gilanauthor=E.+Y.+Lamauthor=A.+F.+Rubinauthor=S.+Ftouniauthor=D.+Tylerauthor=K.+Stanleyauthor=D.+Sinhaauthor=P.+Yehauthor=J.+Morisonauthor=G.+Giotopoulosauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+C.+Leeauthor=C.+Carpenterauthor=R.+Gregoryauthor=R.+G.+Ramsayauthor=S.+W.+Laneauthor=O.+Abdel-Wahabauthor=T.+Kouzaridesauthor=R.+W.+Johnstoneauthor=S.+J.+Dawsonauthor=B.+J.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+T.+Papenfussauthor=M.+A.+Dawson&title=BET+inhibitor+resistance+emerges+from+leukaemia+stem+cells&doi=10.1038%2Fnature14888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibitor resistance emerges from leukaemia stem cells</span></div><div class="casAuthors">Fong, Chun Yew; Gilan, Omer; Lam, Enid Y. N.; Rubin, Alan F.; Ftouni, Sarah; Tyler, Dean; Stanley, Kym; Sinha, Devbarna; Yeh, Paul; Morison, Jessica; Giotopoulos, George; Lugo, Dave; Jeffrey, Philip; Lee, Stanley Chun-Wei; Carpenter, Christopher; Gregory, Richard; Ramsay, Robert G.; Lane, Steven W.; Abdel-Wahab, Omar; Kouzarides, Tony; Johnstone, Ricky W.; Dawson, Sarah-Jane; Huntly, Brian J. P.; Prinjha, Rab K.; Papenfuss, Anthony T.; Dawson, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">525</span>
        (<span class="NLM_cas:issue">7570</span>),
    <span class="NLM_cas:pages">538-542</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal protein (BET) inhibitors are first-in-class targeted therapies that deliver a new therapeutic opportunity by directly targeting bromodomain proteins that bind acetylated chromatin marks.  Early clin. trials have shown promise, esp. in acute myeloid leukemia, and therefore the evaluation of resistance mechanisms is crucial to optimize the clin. efficacy of these drugs.  Here we use primary mouse hematopoietic stem and progenitor cells immortalized with the fusion protein MLL-AF9 to generate several single-cell clones that demonstrate resistance, in vitro and in vivo, to the prototypical BET inhibitor, I-BET.  Resistance to I-BET confers cross-resistance to chem. distinct BET inhibitors such as JQ1, as well as resistance to genetic knockdown of BET proteins.  Resistance is not mediated through increased drug efflux or metab., but is shown to emerge from leukemia stem cells both ex vivo and in vivo.  Chromatin-bound BRD4 is globally reduced in resistant cells, whereas the expression of key target genes such as Myc remains unaltered, highlighting the existence of alternative mechanisms to regulate transcription.  We demonstrate that resistance to BET inhibitors, in human and mouse leukemia cells, is in part a consequence of increased Wnt/β-catenin signaling, and neg. regulation of this pathway results in restoration of sensitivity to I-BET in vitro and in vivo.  Together, these findings provide new insights into the biol. of acute myeloid leukemia, highlight potential therapeutic limitations of BET inhibitors, and identify strategies that may enhance the clin. utility of these unique targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Lg1n64SCWrVg90H21EOLACvtfcHk0lj6Y0F6NpZESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeiu7fL&md5=47d1769e077b1c6c92ff52a051368404</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1038%2Fnature14888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14888%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DC.%2BY.%26aulast%3DGilan%26aufirst%3DO.%26aulast%3DLam%26aufirst%3DE.%2BY.%26aulast%3DRubin%26aufirst%3DA.%2BF.%26aulast%3DFtouni%26aufirst%3DS.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DStanley%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DYeh%26aufirst%3DP.%26aulast%3DMorison%26aufirst%3DJ.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DCarpenter%26aufirst%3DC.%26aulast%3DGregory%26aufirst%3DR.%26aulast%3DRamsay%26aufirst%3DR.%2BG.%26aulast%3DLane%26aufirst%3DS.%2BW.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DDawson%26aufirst%3DS.%2BJ.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DPapenfuss%26aufirst%3DA.%2BT.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26atitle%3DBET%2520inhibitor%2520resistance%2520emerges%2520from%2520leukaemia%2520stem%2520cells%26jtitle%3DNature%26date%3D2015%26volume%3D525%26spage%3D538%26epage%3D542%26doi%3D10.1038%2Fnature14888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1038/nature14404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnature14404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=25970248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=231-235&author=S.+Sprangerauthor=R.+Baoauthor=T.+F.+Gajewski&title=Melanoma-intrinsic+beta-catenin+signalling+prevents+anti-tumour+immunity&doi=10.1038%2Fnature14404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span></div><div class="casAuthors">Spranger, Stefani; Bao, Riyue; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma treatment is being revolutionized by the development of effective immunotherapeutic approaches.  These strategies include blockade of immune-inhibitory receptors on activated T cells; for example, using monoclonal antibodies against CTLA-4, PD-1, and PD-L1 (refs 3, 4, 5).  However, only a subset of patients responds to these treatments, and data suggest that therapeutic benefit is preferentially achieved in patients with a pre-existing T-cell response against their tumor, as evidenced by a baseline CD8+ T-cell infiltration within the tumor microenvironment.  Understanding the mol. mechanisms that underlie the presence or absence of a spontaneous anti-tumor T-cell response in subsets of cases, therefore, should enable the development of therapeutic solns. for patients lacking a T-cell infiltrate.  Here the authors identify a melanoma-cell-intrinsic oncogenic pathway that contributes to a lack of T-cell infiltration in melanoma.  Mol. anal. of human metastatic melanoma samples revealed a correlation between activation of the WNT/β-catenin signaling pathway and absence of a T-cell gene expression signature.  Using autochthonous mouse melanoma models the authors identified the mechanism by which tumor-intrinsic active β-catenin signaling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy.  Specific oncogenic signals, therefore, can mediate cancer immune evasion and resistance to immunotherapies, pointing to new candidate targets for immune potentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXZ3KSCsvVbVg90H21EOLACvtfcHk0liWhF-L5uy9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL&md5=ff32a95e2614e76cf9f9167e35bf015e</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnature14404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14404%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DMelanoma-intrinsic%2520beta-catenin%2520signalling%2520prevents%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D231%26epage%3D235%26doi%3D10.1038%2Fnature14404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holtzhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orabona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, B. A.</span></span> <span> </span><span class="NLM_article-title">Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-14-0167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F2326-6066.CIR-14-0167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=26041736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFartL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=1082-1095&author=A.+Holtzhausenauthor=F.+Zhaoauthor=K.+S.+Evansauthor=M.+Tsutsuiauthor=C.+Orabonaauthor=D.+S.+Tylerauthor=B.+A.+Hanks&title=Melanoma-derived+Wnt5a+promotes+local+dendritic-cell+expression+of+IDO+and+immunotolerance%3A+opportunities+for+pharmacologic+enhancement+of+immunotherapy&doi=10.1158%2F2326-6066.CIR-14-0167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy</span></div><div class="casAuthors">Holtzhausen, Alisha; Zhao, Fei; Evans, Kathy S.; Tsutsui, Masahito; Orabona, Ciriana; Tyler, Douglas S.; Hanks, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1082-1095</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The β-catenin signaling pathway has been demonstrated to promote the development of a tolerogenic dendritic cell (DC) population capable of driving regulatory T-cell (Treg) differentiation.  Further studies have implicated tolerogenic DCs in promoting carcinogenesis in preclin. models.  The mol. mechanisms underlying the establishment of immune tolerance by this DC population are poorly understood, and the methods by which developing cancers can co-opt this pathway to subvert immune surveillance are currently unknown.  This work demonstrates that melanoma-derived Wnt5a ligand upregulates the durable expression and activity of the indoleamine 2,3-dioxygenase-1 (IDO) enzyme by local DCs in a manner that depends upon the β-catenin signaling pathway.  These data indicate that Wnt5a-conditioned DCs promote the differentiation of Tregs in an IDO-dependent manner, and that this process serves to suppress melanoma immune surveillance.  We further show that the genetic silencing of the PORCN membrane-bound O-acyl transferase, which is necessary for melanoma Wnt ligand secretion, enhances antitumor T-cell immunity, and that the pharmacol. inhibition of this enzyme synergistically suppresses melanoma progression when combined with anti-CTLA-4 antibody therapy.  Finally, our data suggest that β-catenin signaling activity, based on a target gene expression profile that includes IDO in human sentinel lymph node-derived DCs, is assocd. with melanoma disease burden and diminished progression-free survival.  This work implicates the Wnt-β-catenin signaling pathway as a novel therapeutic target in the melanoma immune microenvironment and demonstrates the potential impact of manipulating DC function as a strategy for optimizing tumor immunotherapy.  Cancer Immunol Res; 3(9); 1082-95. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre5HUP7C9jNbVg90H21EOLACvtfcHk0liWhF-L5uy9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFartL%252FI&md5=cf6396a672842f4f85ee65ca74e10548</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-14-0167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-14-0167%26sid%3Dliteratum%253Aachs%26aulast%3DHoltzhausen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DK.%2BS.%26aulast%3DTsutsui%26aufirst%3DM.%26aulast%3DOrabona%26aufirst%3DC.%26aulast%3DTyler%26aufirst%3DD.%2BS.%26aulast%3DHanks%26aufirst%3DB.%2BA.%26atitle%3DMelanoma-derived%2520Wnt5a%2520promotes%2520local%2520dendritic-cell%2520expression%2520of%2520IDO%2520and%2520immunotolerance%253A%2520opportunities%2520for%2520pharmacologic%2520enhancement%2520of%2520immunotherapy%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2015%26volume%3D3%26spage%3D1082%26epage%3D1095%26doi%3D10.1158%2F2326-6066.CIR-14-0167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theivanthiran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzhausen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boczkowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locasale, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, B. A.</span></span> <span> </span><span class="NLM_article-title">Paracrine Wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.immuni.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=29343435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=147-160&author=F.+Zhaoauthor=C.+Xiaoauthor=K.+S.+Evansauthor=T.+Theivanthiranauthor=N.+DeVitoauthor=A.+Holtzhausenauthor=J.+Liuauthor=X.+Liuauthor=D.+Boczkowskiauthor=S.+Nairauthor=J.+W.+Locasaleauthor=B.+A.+Hanks&title=Paracrine+Wnt5a-beta-catenin+signaling+triggers+a+metabolic+program+that+drives+dendritic+cell+tolerization&doi=10.1016%2Fj.immuni.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization</span></div><div class="casAuthors">Zhao, Fei; Xiao, Christine; Evans, Kathy S.; Theivanthiran, Tbalamayooran; DeVito, Nicholas; Holtzhausen, Alisha; Liu, Juan; Liu, Xiaojing; Boczkowski, David; Nair, Smita; Locasale, Jason W.; Hanks, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-160.e7</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies.  Emerging evidence indicates that the tolerization of local dendritic cells (DCs) within the tumor microenvironment promotes immune evasion.  Here, we have described a mechanism by which melanomas establish a site of immune privilege via a paracrine Wnt5a-β-catenin-peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling pathway that drives fatty acid oxidn. (FAO) in DCs by upregulating the expression of the carnitine palmitoyltransferase-1A (CPT1A) fatty acid transporter.  This FAO shift increased the protoporphyrin IX prosthetic group of indoleamine 2,3-dioxgenase-1 (IDO) while suppressing interleukin(IL)-6 and IL-12 cytokine expression, culminating in enhanced IDO activity and the generation of regulatory T cells.  We demonstrated that blockade of this pathway augmented anti-melanoma immunity, enhanced the activity of anti-PD-1 antibody immunotherapy, and suppressed disease progression in a transgenic melanoma model.  This work implicates a role for tumor-mediated metabolic reprogramming of local DCs in immune evasion and immunotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRK5nTeHUckbVg90H21EOLACvtfcHk0liWhF-L5uy9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOisrc%253D&md5=63c7ecaeb38f565b2ea7fafdea6edaf1</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DEvans%26aufirst%3DK.%2BS.%26aulast%3DTheivanthiran%26aufirst%3DT.%26aulast%3DDeVito%26aufirst%3DN.%26aulast%3DHoltzhausen%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBoczkowski%26aufirst%3DD.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DLocasale%26aufirst%3DJ.%2BW.%26aulast%3DHanks%26aufirst%3DB.%2BA.%26atitle%3DParacrine%2520Wnt5a-beta-catenin%2520signaling%2520triggers%2520a%2520metabolic%2520program%2520that%2520drives%2520dendritic%2520cell%2520tolerization%26jtitle%3DImmunity%26date%3D2018%26volume%3D48%26spage%3D147%26epage%3D160%26doi%3D10.1016%2Fj.immuni.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhamra, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eagle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodcock, S.</span></span> <span> </span><span class="NLM_article-title">Abstract 506: Wnt/β-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">506</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2019-506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1158%2F1538-7445.AM2019-506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=506&author=C.+Phillipsauthor=I.+Bhamraauthor=C.+Eagleauthor=A.+E.+Cookauthor=C.+Jonesauthor=S.+Woodcock&title=Abstract+506%3A+Wnt%2F%CE%B2-Catenin+pathway+inhibitor+RXC004+enhances+the+immunity+of+pre-clinical+models+of+cancer&doi=10.1158%2F1538-7445.AM2019-506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2019-506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2019-506%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DEagle%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DWoodcock%26aufirst%3DS.%26atitle%3DAbstract%2520506%253A%2520Wnt%252F%25CE%25B2-Catenin%2520pathway%2520inhibitor%2520RXC004%2520enhances%2520the%2520immunity%2520of%2520pre-clinical%2520models%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26spage%3D506%26doi%3D10.1158%2F1538-7445.AM2019-506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Proteolysis targeting chimera (PROTAC): a paradigm-shifting approach in small molecule drug discovery</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1354</span>– <span class="NLM_lpage">1356</span>, <span class="refDoi"> DOI: 10.2174/1568026618666181010101922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.2174%2F1568026618666181010101922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30306871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1354-1356&author=P.+Wangauthor=J.+Zhou&title=Proteolysis+targeting+chimera+%28PROTAC%29%3A+a+paradigm-shifting+approach+in+small+molecule+drug+discovery&doi=10.2174%2F1568026618666181010101922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis Targeting Chimera (PROTAC): A Paradigm-Shifting Approach in Small Molecule Drug Discovery</span></div><div class="casAuthors">Wang, Pingyuan; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1354-1356</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review discussing the advantages of proteolysis targeting chimera (PROTAC) technol. for drug discovery and compared to traditional small mol. drug discovery for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2zjZKjC4m_bVg90H21EOLACvtfcHk0ljAPdZvx0xK_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgu7nK&md5=7b301a759d7b1c3c749a1d8ec9b5dd9c</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.2174%2F1568026618666181010101922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666181010101922%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DProteolysis%2520targeting%2520chimera%2520%2528PROTAC%2529%253A%2520a%2520paradigm-shifting%2520approach%2520in%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D1354%26epage%3D1356%26doi%3D10.2174%2F1568026618666181010101922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span> <span> </span><span class="NLM_article-title">Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">105532</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2021.105532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1016%2Fj.phrs.2021.105532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=33677106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2021&pages=105532&author=K.+Shahauthor=S.+Panchalauthor=B.+Patel&title=Porcupine+inhibitors%3A+Novel+and+emerging+anti-cancer+therapeutics+targeting+the+Wnt+signaling+pathway&doi=10.1016%2Fj.phrs.2021.105532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway</span></div><div class="casAuthors">Shah, Karmani; Panchal, Shivangi; Patel, Bhumika</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105532</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Porcupine is a constituent of the 19 membered Wnt family with diverse biol. features such as cell differentiation, cell proliferation, cell migration, apoptosis, etc.  Porcupine is a membrane-bound o-acyltransferase family protein that modulates Wnt protein through palmitoylation to allow it to depart the secretory pathway and activate cellular responses.  Inhibition of Porcupine prevents palmitoylation of Wnt ligands which in turn blocks the transport of Wnt to the extracellular membrane, thus prevents the immoderate prodn. of β-catenin which helps to control the aberrant cell growth.  Clin., Porcupine inhibitors have shown their potential in treating majorly colorectal cancer, pancreatic cancer, hepatocellular carcinoma, head and neck cancer etc.  Till date, none of the Porcupine inhibitors have been in the market and only four mols., LGK974, ETC159, CGX1321 and RXC004 have reached the Phase I clin. trial.  Present review gives a comprehensive insight on Porcupine as a novel drug target for the treatment of cancer as well as recent update on many novel heterocyclic Porcupine inhibitors with their chem. structures and pharmacol.  Their physico chem. properties were also predicted using SwissADME server.  Major concerns during their development have also been summarised which may throw some light for the future development of novel Porcupine inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowxkMN5uivXrVg90H21EOLACvtfcHk0ljAPdZvx0xK_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmvVOhsbs%253D&md5=a3e3119f51657f5befaa2d52b56f2232</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2021.105532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2021.105532%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DK.%26aulast%3DPanchal%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DB.%26atitle%3DPorcupine%2520inhibitors%253A%2520Novel%2520and%2520emerging%2520anti-cancer%2520therapeutics%2520targeting%2520the%2520Wnt%2520signaling%2520pathway%26jtitle%3DPharmacol.%2520Res.%26date%3D2021%26volume%3D167%26spage%3D105532%26doi%3D10.1016%2Fj.phrs.2021.105532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riffell, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1038/nrd3868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrd3868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=23197039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=923-936&author=J.+L.+Riffellauthor=C.+J.+Lordauthor=A.+Ashworth&title=Tankyrase-targeted+therapeutics%3A+expanding+opportunities+in+the+PARP+family&doi=10.1038%2Fnrd3868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase-targeted therapeutics: expanding opportunities in the PARP family</span></div><div class="casAuthors">Riffell, Jenna L.; Lord, Christopher J.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-936</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The poly(ADP-ribose) polymerase (PARP) protein superfamily has wide-ranging roles in cellular processes such as DNA repair and WNT signalling.  Efforts to pharmacol. target PARP enzymes have largely focused on PARP1 and the closely related PARP2, but recent work highlighting the role of another family member, tankyrase 1 (TANK1; also known as PARP5A and ARTD5), in the control of WNT signalling has fuelled interest in the development of addnl. inhibitors to target this enzyme class.  Tankyrase function is also implicated in other processes such as the regulation of telomere length, lung fibrogenesis and myelination, suggesting that tankyrase inhibitors could have broad clin. utility.  Here, we discuss the biol. of tankyrases and the discovery of tankyrase-specific inhibitors.  We also consider the challenges that lie ahead for the clin. development of PARP family inhibitors in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6R0zBQ42UELVg90H21EOLACvtfcHk0lh-t1OgNRLizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCntbvI&md5=510c523982433e4c22f06f8d1679e6f6</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1038%2Fnrd3868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3868%26sid%3Dliteratum%253Aachs%26aulast%3DRiffell%26aufirst%3DJ.%2BL.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DTankyrase-targeted%2520therapeutics%253A%2520expanding%2520opportunities%2520in%2520the%2520PARP%2520family%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D923%26epage%3D936%26doi%3D10.1038%2Fnrd3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviripa, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kril, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang-Hartwich, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedaly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">An underlying mechanism of dual Wnt inhibition and AMPK activation: mitochondrial uncouplers masquerading as Wnt inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11348</span>– <span class="NLM_lpage">11358</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1KktLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11348-11358&author=W.+Zhangauthor=V.+M.+Sviripaauthor=L.+M.+Krilauthor=T.+Yuauthor=Y.+Xieauthor=W.+B.+Hubbardauthor=P.+G.+Sullivanauthor=X.+Chenauthor=C.+G.+Zhanauthor=Y.+Yang-Hartwichauthor=B.+M.+Eversauthor=B.+T.+Spearauthor=R.+Gedalyauthor=D.+S.+Wattauthor=C.+Liu&title=An+underlying+mechanism+of+dual+Wnt+inhibition+and+AMPK+activation%3A+mitochondrial+uncouplers+masquerading+as+Wnt+inhibitors&doi=10.1021%2Facs.jmedchem.9b01685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors</span></div><div class="casAuthors">Zhang, Wen; Sviripa, Vitaliy M.; Kril, Liliia M.; Yu, Tianxin; Xie, Yanqi; Hubbard, W. Brad; Sullivan, Patrick G.; Chen, Xi; Zhan, Chang-Guo; Yang-Hartwich, Yang; Evers, B. Mark; Spear, Brett T.; Gedaly, Roberto; Watt, David S.; Liu, Chunming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11348-11358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of upregulated Wnt signaling in colorectal cancers led to efforts to develop inhibitors that target β-catenin in this pathway.  We now report that several "Wnt inhibitors" that allegedly target β-catenin actually function as mitochondrial proton uncouplers that independently activate AMPK and concomitantly inhibit Wnt signaling.  As expected for a process in which mitochondrial uncoupling diminishes ATP prodn., a mitochondrial proton uncoupler, FCCP, and a glucose metabolic inhibitor, 2-DG, activated AMPK and inhibited Wnt signaling.  Also consistent with these findings, a well-known "Wnt inhibitor", FH535, functioned as a proton uncoupler, and in support of this finding, the N-methylated analog, 2,5-dichloro-N-methyl-N-(2-methyl-4-nitrophenyl)benzenesulfonamide (FH535-M) was inactive as an uncoupler and Wnt inhibitor.  Apart from suggesting an opportunity to develop dual Wnt inhibitors and AMPK activators, these findings provide a cautionary tale that claims for Wnt inhibition alone require scrutiny as possible mitochondrial proton uncouplers or inhibitors of the electron transport chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSNHSheEOVOrVg90H21EOLACvtfcHk0lh-t1OgNRLizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1KktLfK&md5=de1f473a592608bd6a556d5c4b35cd9b</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01685%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSviripa%26aufirst%3DV.%2BM.%26aulast%3DKril%26aufirst%3DL.%2BM.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHubbard%26aufirst%3DW.%2BB.%26aulast%3DSullivan%26aufirst%3DP.%2BG.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DYang-Hartwich%26aufirst%3DY.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26aulast%3DSpear%26aufirst%3DB.%2BT.%26aulast%3DGedaly%26aufirst%3DR.%26aulast%3DWatt%26aufirst%3DD.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DAn%2520underlying%2520mechanism%2520of%2520dual%2520Wnt%2520inhibition%2520and%2520AMPK%2520activation%253A%2520mitochondrial%2520uncouplers%2520masquerading%2520as%2520Wnt%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11348%26epage%3D11358%26doi%3D10.1021%2Facs.jmedchem.9b01685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Network pharmacology</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1110</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/nbt1007-1110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnbt1007-1110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=17921993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1110-1111&author=A.+L.+Hopkins&title=Network+pharmacology&doi=10.1038%2Fnbt1007-1110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1110-1111</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Network biol. illuminates our understanding of drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLPM5MyYqHbVg90H21EOLACvtfcHk0lh-t1OgNRLizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagt7vO&md5=7d88f8f8d6b6e76017475bc59a314e4c</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1038%2Fnbt1007-1110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1007-1110%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1110%26epage%3D1111%26doi%3D10.1038%2Fnbt1007-1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pushpakom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyers, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escott, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilliams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanseau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing: progress, challenges and recommendations</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=10.1038%2Fnrd.2018.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=30310233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2gtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=41-58&author=S.+Pushpakomauthor=F.+Iorioauthor=P.+A.+Eyersauthor=K.+J.+Escottauthor=S.+Hopperauthor=A.+Wellsauthor=A.+Doigauthor=T.+Guilliamsauthor=J.+Latimerauthor=C.+McNameeauthor=A.+Norrisauthor=P.+Sanseauauthor=D.+Cavallaauthor=M.+Pirmohamed&title=Drug+repurposing%3A+progress%2C+challenges+and+recommendations&doi=10.1038%2Fnrd.2018.168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Drug repurposing: progress, challenges and recommendations</span></div><div class="casAuthors">Pushpakom, Sudeep; Iorio, Francesco; Eyers, Patrick A.; Escott, K. Jane; Hopper, Shirley; Wells, Andrew; Doig, Andrew; Guilliams, Tim; Latimer, Joanna; McNamee, Christine; Norris, Alan; Sanseau, Philippe; Cavalla, David; Pirmohamed, Munir</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Given the high attrition rates, substantial costs and slow pace of new drug discovery and development, repurposing of 'old' drugs to treat both common and rare diseases is increasingly becoming an attractive proposition because it involves the use of de-risked compds., with potentially lower overall development costs and shorter development timelines.  Various data-driven and exptl. approaches have been suggested for the identification of repurposable drug candidates; however, there are also major technol. and regulatory challenges that need to be addressed.  In this Review, we present approaches used for drug repurposing (also known as drug repositioning), discuss the challenges faced by the repurposing community and recommend innovative ways by which these challenges could be addressed to help realize the full potential of drug repurposing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUl_N5c2iDerVg90H21EOLACvtfcHk0ljKKQf6fCKHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2gtr7I&md5=6bcc8f26828414de02564494fb4d3296</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.168%26sid%3Dliteratum%253Aachs%26aulast%3DPushpakom%26aufirst%3DS.%26aulast%3DIorio%26aufirst%3DF.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DEscott%26aufirst%3DK.%2BJ.%26aulast%3DHopper%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DA.%26aulast%3DDoig%26aufirst%3DA.%26aulast%3DGuilliams%26aufirst%3DT.%26aulast%3DLatimer%26aufirst%3DJ.%26aulast%3DMcNamee%26aufirst%3DC.%26aulast%3DNorris%26aufirst%3DA.%26aulast%3DSanseau%26aufirst%3DP.%26aulast%3DCavalla%26aufirst%3DD.%26aulast%3DPirmohamed%26aufirst%3DM.%26atitle%3DDrug%2520repurposing%253A%2520progress%252C%2520challenges%2520and%2520recommendations%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D41%26epage%3D58%26doi%3D10.1038%2Fnrd.2018.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wold, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of class A GPCRs: targets, agents, and emerging concepts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=88-127&author=E.+A.+Woldauthor=J.+Chenauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Allosteric+modulation+of+class+A+GPCRs%3A+targets%2C+agents%2C+and+emerging+concepts&doi=10.1021%2Facs.jmedchem.8b00875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts</span></div><div class="casAuthors">Wold, Eric A.; Chen, Jianping; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-127</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) have been tractable drug targets for decades with over one-third of currently marketed drugs targeting GPCRs.  Of these, the class A GPCR superfamily is highly represented, and continued drug discovery for this family of receptors may provide novel therapeutics for a vast range of diseases.  GPCR allosteric modulation is an innovative targeting approach that broadens the available small mol. toolbox and is proving to be a viable drug discovery strategy, as evidenced by recent FDA approvals and clin. trials.  Numerous class A GPCR allosteric modulators have been discovered recently, and emerging trends such as the availability of GPCR crystal structures, diverse functional assays, and structure-based computational approaches are improving optimization and development.  This Perspective provides an update on allosterically targeted class A GPCRs and their disease indications and the medicinal chem. approaches toward novel allosteric modulators and highlights emerging trends and opportunities in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zBEGIhRgD7Vg90H21EOLACvtfcHk0ljKKQf6fCKHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2lsLbK&md5=c724b7cb534a9eb52c371961bb9c9b42</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DAllosteric%2520modulation%2520of%2520class%2520A%2520GPCRs%253A%2520targets%252C%2520agents%252C%2520and%2520emerging%2520concepts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D88%26epage%3D127%26doi%3D10.1021%2Facs.jmedchem.8b00875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0A','PDB','4F0A'); return false;">PDB: 4F0A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KRR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KRR','PDB','4KRR'); return false;">PDB: 4KRR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AHY','PDB','6AHY'); return false;">PDB: 6AHY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U9H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U9H','PDB','3U9H'); return false;">PDB: 3U9H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TWT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TWT','PDB','3TWT'); return false;">PDB: 3TWT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KR8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KR8','PDB','3KR8'); return false;">PDB: 3KR8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R5W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R5W','PDB','4R5W'); return false;">PDB: 4R5W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TKF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TKF','PDB','4TKF'); return false;">PDB: 4TKF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQO','PDB','5ZQO'); return false;">PDB: 5ZQO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZQR','PDB','5ZQR'); return false;">PDB: 5ZQR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6KRO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6KRO','PDB','6KRO'); return false;">PDB: 6KRO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4F','PDB','4K4F'); return false;">PDB: 4K4F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3N3R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3N3R','PDB','3N3R'); return false;">PDB: 3N3R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD','PDB','3UDD'); return false;">PDB: 3UDD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HYF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HYF','PDB','4HYF'); return false;">PDB: 4HYF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB','PDB','5NOB'); return false;">PDB: 5NOB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BXU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BXU','PDB','5BXU'); return false;">PDB: 5BXU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1G3J','PDB','1G3J'); return false;">PDB: 1G3J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DJS','PDB','4DJS'); return false;">PDB: 4DJS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ7','PDB','1QZ7'); return false;">PDB: 1QZ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GL7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GL7','PDB','2GL7'); return false;">PDB: 2GL7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BNJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BNJ','PDB','5BNJ'); return false;">PDB: 5BNJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D7A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5D7A','PDB','5D7A'); return false;">PDB: 5D7A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TFB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TFB','PDB','6TFB'); return false;">PDB: 6TFB</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01799&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01799" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01799" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797f805e12d1ab","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
